<SEC-DOCUMENT>0001628280-22-020893.txt : 20220804
<SEC-HEADER>0001628280-22-020893.hdr.sgml : 20220804
<ACCEPTANCE-DATETIME>20220804093322
ACCESSION NUMBER:		0001628280-22-020893
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220804
DATE AS OF CHANGE:		20220804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CROSS COUNTRY HEALTHCARE INC
		CENTRAL INDEX KEY:			0001141103
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HELP SUPPLY SERVICES [7363]
		IRS NUMBER:				134066229
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-33169
		FILM NUMBER:		221135130

	BUSINESS ADDRESS:	
		STREET 1:		6551 PARK OF COMMERCE BOULEVARD, N.W.
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487
		BUSINESS PHONE:		8003472264

	MAIL ADDRESS:	
		STREET 1:		6551 PARK OF COMMERCE BOULEVARD, N.W.
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROSS COUNTRY INC
		DATE OF NAME CHANGE:	20010521
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ccrn-20220630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:5ab65a54-411a-4f77-8134-d4db92a3ff6c,g:6015d444-ff7a-4976-923c-b8be5a21a758,d:cbcc3b9b4b5d4dffac1c85669cdfe7d3--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ccrn="http://www.crosscountryhealthcare.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ccrn-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180L2ZyYWc6Nzg2YjA1YzFiYWRhNGU1YzlhZjUxZjA5MGEzMzgxZDkvdGFibGU6Yzk4N2RjZGU5NDY1NDg3OTlkNGQ2NjVjMjBjYjhiNzIvdGFibGVyYW5nZTpjOTg3ZGNkZTk0NjU0ODc5OWQ0ZDY2NWMyMGNiOGI3Ml8zLTEtMS0xLTM5MzMx_703e5471-e7a2-4857-b5a8-2b8d18a56c02">0001141103</ix:nonNumeric><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180L2ZyYWc6Nzg2YjA1YzFiYWRhNGU1YzlhZjUxZjA5MGEzMzgxZDkvdGFibGU6Yzk4N2RjZGU5NDY1NDg3OTlkNGQ2NjVjMjBjYjhiNzIvdGFibGVyYW5nZTpjOTg3ZGNkZTk0NjU0ODc5OWQ0ZDY2NWMyMGNiOGI3Ml80LTEtMS0xLTM5MzMx_4f09dfd4-9b93-4bc3-9417-e318e1407e14">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180L2ZyYWc6Nzg2YjA1YzFiYWRhNGU1YzlhZjUxZjA5MGEzMzgxZDkvdGFibGU6Yzk4N2RjZGU5NDY1NDg3OTlkNGQ2NjVjMjBjYjhiNzIvdGFibGVyYW5nZTpjOTg3ZGNkZTk0NjU0ODc5OWQ0ZDY2NWMyMGNiOGI3Ml81LTEtMS0xLTM5MzMx_1d202324-b3b6-4c2b-8bda-dad8ec2ccc72">2022</ix:nonNumeric><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180L2ZyYWc6Nzg2YjA1YzFiYWRhNGU1YzlhZjUxZjA5MGEzMzgxZDkvdGFibGU6Yzk4N2RjZGU5NDY1NDg3OTlkNGQ2NjVjMjBjYjhiNzIvdGFibGVyYW5nZTpjOTg3ZGNkZTk0NjU0ODc5OWQ0ZDY2NWMyMGNiOGI3Ml82LTEtMS0xLTM5MzMx_bee120b2-2d3c-432b-8b08-ab9f66148c99">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180L2ZyYWc6Nzg2YjA1YzFiYWRhNGU1YzlhZjUxZjA5MGEzMzgxZDkvdGFibGU6Yzk4N2RjZGU5NDY1NDg3OTlkNGQ2NjVjMjBjYjhiNzIvdGFibGVyYW5nZTpjOTg3ZGNkZTk0NjU0ODc5OWQ0ZDY2NWMyMGNiOGI3Ml83LTEtMS0xLTM5MzMx_3fa4770d-8ead-4468-b091-78ecb87746a7">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0wLTEtMS0zOTMzMQ_33870ac4-7a5d-4666-b864-06e3c6e8fa8f">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0wLTEtMS0zOTMzMQ_4df3da1c-5136-4a23-a756-78c13d836a34">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0wLTEtMS0zOTMzMQ_62909d48-4125-45af-9432-4ba33e5741cc">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0wLTEtMS0zOTMzMQ_eccdff06-1bc8-40b8-9d1b-0325ebbdf6bd">http://fasb.org/us-gaap/2022#ServiceMember</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ccrn-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i226685b20fe64fcdbefcd85507b14d38_I20220721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i531629651f344ec6a65beff4a5deca32_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i449c5e6731f340f7b56a94edc4b9d609_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14bf0f7b08e64965a1a24ab1083597f2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46f7ed285cae40089dae6c224378c0dc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i537dd183eaec41c087e74135b134f4bf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9d2332650c84b7e8d003bddf5a15b05_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31dcc4001be54470acb6bfeafeab8e86_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8356e77d185d42a595240bb06077cf3b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i206b5bfd38994bada2f7ed528b90c58c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5890a7c02b9f453b81942f2d23ca6ee1_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2818c901fa294008b0ac70a7926b7750_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5c162997fa542aaaa564c877f405887_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7ad72ba2a404b11bce5d4ba287b2050_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i500e0f29c7f04d4abc254b61775901d9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e41c385e2a54c60ac848e6147a19f67_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f6433f078ee4dd6a65f2bc4bf4d7164_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i604483a0fb4648eead96a92019de1c64_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7728dd1404d4128a2d0f589c4c7d344_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i760e91ed75f744d1bfb84b6d6b15c919_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59307db96ef44b038e0df4fa3bf234ea_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90078daa01da46fa9dc40d6cdc958040_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2224a68f821e43b997df6840a0be749e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i987aabb9817140daad5b016172020182_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90bd49deece64987b9a9f7ed50a970cd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fa7d8c493de45b58bafdfed07b02f38_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0235582b9294676b1724db099df1dbf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifccfe432a49541508ac24bf9eba96187_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ebafd2e0fb647129b868a2a74277f49_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf69140622c542a2a5dbade330bed92f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73fb24814a2c4f2dbce0205fa38c054e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2ddb987bb1248dfb24dea790e19f923_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1299054e8f31469fb1fada07913bbe8c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57bb4502177a4191a1ce7b5ac9398fca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaacba8aeb0b5485c8876a3714cb90244_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7c2dc5236e64eada06aea8f7ef16bc5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d8a1a73be9c419f95a1bb64e4383005_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e54d79ab9284085bcf0c45bcd9c139a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic34a4d1e4be64eceb08f27f939e04b69_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia32b475baddb40bb9ed523ad5ff77137_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2cc9574c5784fdba767ee2f4418cd46_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f3bea820d5244fd87508196dd2090f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44e8f4bbd7df49c8b09fc53f08598fee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf4dd3e30f8e4cfc9b12d4d8ae0ab312_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eeb9206ba354b3889aeee34d83cfee0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8163ebc66fb43e29c1f37f64b2ca55b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i681334a1907145ebba1a62d2883f0d2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25f9ce0742594c3b883c445ec9f65431_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i265e0b6608b74677b7e23b6bf871bc6a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cf3b0130dbb44d58977a9439465a5c4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i135d7bd16c8c4b9c9ec3f80f3ad82fd8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i901eb837ca884f56bf62787429027b0d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65d90e4671ee4c59a461a36fb4feb935_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b1af1a6ef9b4991a2becb162f578c28_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3442c709c0ae4842936f9b013f384d0b_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f2b21ab37dd434787d065fd619cd08e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56adbc127d1b4228a9fb7d5d917ebda6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc7b147a6f3c4703ad97384ca78b4e51_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id41486ab11b34eedb4414956313b30ba_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24f024b630474e2eba6a4f4bcaa226b9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86e3eb14987b43ce8e00a87a48966e2a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77211dc7914343a3b578681823086312_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic88b4cd36ee341d99b6656eabb36c7e7_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2b2bf1c40f44f96806300198d700199_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37eea076df3941df808a4bb9a9957bf9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec98b500e7134221858e7e81d469419a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd0f16019530428fa69ea61f71c26e30_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibec9a7eb25a8452ab4f07a8f19d5a7ca_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie19fee64a40e4a429338db3ef66cb9e8_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81d0bf790acc4fbf9d552dc8c5ccd7f8_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0637eaa261ae423fbb4cfefcf4952957_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd91226911de469ebcf68a20f0c11784_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48182d1c2a094a3da085fb747d293f3e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i796e252f03f54d9bab2ef196b1644ea2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i491217535f4143388e3f0a3eb3413c6e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i551d5f3fb9c24cf798e78e30f611b1d0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9e70abbbf7c43c7911d3bd4476e4fff_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85c04ae276924053a85cf7f653efd272_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2898ec216b2457c81230fdf865b2026_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ccb0817428f4985b0301b681c4ab64a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee0a4262a80f406a86e3cfc6a645adae_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ef77dfdd3394746b59eef004634995d_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1db1376854a41a8923d1dd5d7564232_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35ea3df9e838469981abd5e5723b5fc5_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61ed7a3d39b74440a4a96aaf98594c7c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie38297005b1e41d9b478ecea2d5d91e8_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6779ceb8952242a1b84e123a93be0258_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0d06303bf64411ebac22da90bae8bc6_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iababccf169c64eb497cc9f14a300ad39_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19e1810adf8a4e9c8ff08ecbfcd00221_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa24deb39bf0450eba559976b6616ac0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d0f582d5c5c480b9e485784c87df1a9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4a09364018146ecb6ada9bb466c7e10_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idda00ec1c753498c8a69045746a652ca_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2eb18fd6b6844a0907cdf3d269c615b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d6e818748004cac8bd53aeb8e5fcb4a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6936f0dd73f149a284028ca151da158a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81ed68aa78894c6b82beb72c410707bf_D20211216-20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-16</xbrli:startDate><xbrli:endDate>2021-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id353cd1c4a224e5ca74c740f0046d0e9_I20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60247132b56844b7b090215e36d1bcd5_I20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c13f3c9c6d5496795d1db28f45e48bf_D20211216-20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-16</xbrli:startDate><xbrli:endDate>2021-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3ea81fad99645bf83db89997adc7652_I20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfc8232348364f31b8fab71bfb70b6e5_D20211216-20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-16</xbrli:startDate><xbrli:endDate>2021-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic62e27dff65649e6b35f5937f91d27d5_I20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if26f3065692a439ea180f58828581dab_D20211216-20211216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-16</xbrli:startDate><xbrli:endDate>2021-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idff5fc97df814ca3a4732c20943377d7_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1d9b43633a64c3b89445a5e452d6ea7_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1671691aefa34321882545ccf2019faf_I20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a281909e341489e93181970ce395c4b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1c9b2c7cc8a4a979b20f24f8720ad94_I20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib19a69210f684fa48653b01303c034bf_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a171810dfba45719542dcd325b21e11_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12dc2febc4c84d4288a4906fe94e7c1b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10b1ca7fabaa4095b85f6b18a5b65654_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib72123a2c3914fce9452ab74a8a3a3ba_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i539c9e6b43fb478fae6799603240e6dc_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i207e780bad744a04ae7391b8036f801f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d386cdc5efb4d9582172fa5148def89_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32f84c71196b460ab5a3ae5a4826c77e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic36e0417ede14c6988b1777707b1f8f9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifca6652933cd479d898cbf242f81426d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieabbbda1a0c74a69bcac845525179f61_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f1314ae8d2a4bef96916b457d74c9c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8f0cc98b9f24950a7b4b12b08aefbd3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc74fefee46742279f8b45d775c187b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50b7d147bfc6416cabda9cebd8aef26b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04576ab71ad14259b8dde82aaf1a434d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic64dfa83d28e423e96e7ed34d4fd500c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76c278957a754512b8adac480fa3184b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1105535cc021464682c0f1266a44a41f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8742261c00d64b76a788ed6c05a3ad95_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3e8f0444e0d4d5eb1c366333ffac9d3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie958469fcde64897ae4e65a0e3c3dca4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4278c04c7f5f4845bcc68a5828e1da06_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09567f48a192498ab1e23194314c8143_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i59183c7b0a0d42569a396d37e5f31cf2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8adc557041bd46c1aad7c9618f831b96_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a27e7c144ff4f158da5313fe7ca7cf6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e98009a6e864c61960639454ed150b9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifefa74c81dd046a4a182bdbcbbcd35d9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i192f55a490bc4b13a11411bf8375331d_D20220623-20220623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-23</xbrli:startDate><xbrli:endDate>2022-06-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50264a0fdd1a433d9a8447d69f0035fd_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68be6e52da804315993d34ceb671e045_I20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13740719146d46bfa5f350cbdd53411e_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ided7cff52c6e4850b72dad17899abe6e_D20210930-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-30</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab471474c53b443eb54c1499c93e0f21_I20211118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementIncrementalTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54b8d8616dab4fadae7e75406657ca20_I20211118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c3977ce54064bf697411bb87b1c135b_D20211231-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i292cd5b0d4684b41981daf8445d9f078_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15fbcb21001e48dbbc8416ff64ed2806_D20191025-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-25</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2408cf0e0744cf0a51dbfcd008b71e2_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83732e8193cb492394faa19420b680d4_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ccrn:LineOfCreditSublimitAxis">ccrn:SwingLoansSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c0d2cadfb0a4cfb9357b9111fdacb7a_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ccrn:LineOfCreditSublimitAxis">ccrn:StandbyLettersOfCreditSublimitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82b501029b6b4759a00e12cfe8165a29_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if24ce204b488479499da054c091fc827_I20210308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i522e12765bc4480e83302783fd04656b_I20211118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f0de89c6ea44abd90a514fbdcf1d0c8_I20220321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia26394bf64ed4410939d860acc9b1d9d_D20220321-20220321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-21</xbrli:startDate><xbrli:endDate>2022-03-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i217e4a8af4e34fdba46527b4d110ea93_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1e947347db04c70921aea757a478098_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79663bc76cf8454ea92834abe34d819f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i744622b84e6e4593840fc16870ce088e_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib11f714337624b81b95fbf29632b3e86_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec21b6d449de4e3c8935b693d4938157_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife18debf13894b69a0178110599379d5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2384a0e875f4fe2ab84ead51c98f914_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia801d6ec97434f77b5185c504d4dd03d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8757da1f937e4835a03d88e39ffd3134_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if30c1a9abfaa4b8591cc814cac5da11b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia28c4adf56ef473b81222066e0f6bab4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2b289aa8b0f4bb297cf5af62491dd19_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib938672d8ae84dcaaf92e08eb3bd8e91_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34f90c0620cd48ca9ad8a72c38f6bd27_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd2145204d454b038df9969fda6aba63_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc259a1981dd4d899a03b46cd1bd6311_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i400cb6bbb3d8415c9ce00409549a9981_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d0a8e32b5d9415ea6ddc671aea7986c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id739059325464c648e732b5b9492ad1b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1337e8b15554efd83e0ffd2872603fa_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide48511e0c344631b47d7e4c4b0171bd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6df7ed8d4d9942dfa095df93b4a7ae83_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie33c5b897ac646ec9c437ba3d4e036bd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fbdf4e4242e42b081d7c65a199e7f48_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d26b10494d9470ca481d6bcf4a4096c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4875239875ba43d69f254dacac91eda3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifca25155201b4bddafc6f616f359148c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf0b19c2fa5d44578370990b5584d68a_I20080228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2008-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie26d32fbbb214db89f00ca5ce7718efc_I20200519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3a6eab5e44b46c9aa104ee3b7965107_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4eba8a27a3045758fc0c06e41d5704b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i956eb0b29bb74ffdb6756b06306769ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieff115cae5e34e28b5383a9a88245810_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ab71c9c84ee4815b1628aa855d13c01_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i343cbe120aa04706a172fc551f526ec0_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="installment"><xbrli:measure>ccrn:installment</xbrli:measure></xbrli:unit><xbrli:context id="i488f7313d7ea4152874fdd22f4842f51_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45d3569daa544f6ba38c9b4d1d64b515_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie37e701f5bf845919892f1792910aac5_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id12cc7870c3344898d8faa6c6deb3e69_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ccrn:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a976517796d4a5a90410a85dfa2fcd2_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ccrn:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i272ddda01d4c4d8ab777088cc19278c1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aac8a7b75f44c50bf673b0750cb5e38_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d1a96b65b9a4f4cb322a36a20b6c8a2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88fe5a3577e44e7f93025fcc20ad13e0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91fdc80f57044a50afa1d6033fa5183f_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e0108cb028149ccb9de91110e533b39_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2612021a1b9a4426b3de852fbbf51315_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48c021a3ed524ae4a24a7c9d9e8eca04_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001141103</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzk0_5c8b01ef-894f-431b-8e21-0d2a3b3803ce">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzg4_751deaf2-d2e7-475a-811c-0eda1a601c89">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;Quarterly Report Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl83Mjc1_b0516099-0455-45bf-b7eb-0bb9220dca7b">June 30, 2022</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Or</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzg5_fe4f7291-e5fc-475b-8fab-13faa22486fc">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;Transition Report Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the Transition Period From</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> _________ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> _________</span></div><div style="text-align:center"><img src="ccrn-20220630_g1.jpg" alt="ccrn-20220630_g1.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:249px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzc3_9039c7f4-f726-46b7-815f-4e13b57650e5">CROSS COUNTRY HEALTHCARE, INC</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.064%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGFibGU6ZDU3NjdlMzM2Nzk2NGFkMDljZDJmYTc5OGE2ZWIwZDcvdGFibGVyYW5nZTpkNTc2N2UzMzY3OTY0YWQwOWNkMmZhNzk4YTZlYjBkN18wLTAtMS0xLTM5MzMx_bd5bdafc-494d-44ec-bd8a-f0e75116f51b">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGFibGU6ZDU3NjdlMzM2Nzk2NGFkMDljZDJmYTc5OGE2ZWIwZDcvdGFibGVyYW5nZTpkNTc2N2UzMzY3OTY0YWQwOWNkMmZhNzk4YTZlYjBkN18wLTEtMS0xLTM5MzMx_8033af61-2019-49f2-9f51-a04bf0f89b0f">0-33169</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGFibGU6ZDU3NjdlMzM2Nzk2NGFkMDljZDJmYTc5OGE2ZWIwZDcvdGFibGVyYW5nZTpkNTc2N2UzMzY3OTY0YWQwOWNkMmZhNzk4YTZlYjBkN18wLTItMS0xLTM5MzMx_7a342b46-37de-4faa-a959-e013f5c10b12">13-4066229</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>Incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Commission<br/>file number</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzc4_af9e8899-cbcd-4ab8-9d51-920913f128e9">6551 Park of Commerce Boulevard, N.W.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzkx_965f6029-7a35-4acb-bb50-bfc06721849e">Boca Raton</ix:nonNumeric>, <ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzcw_4c7ad0f0-0c6e-4f3e-86df-44a4b916a212">Florida</ix:nonNumeric> <ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzc5_a5e31428-fede-4890-871e-6f52f8f9ab2c">33487</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Address of principal executive offices)(Zip Code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzcx_6a1d49a8-da64-4771-89c9-7f71087541d6">561</ix:nonNumeric>) <ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzcy_c1a2c3f6-d5d9-4a8a-9fd9-67c8ec8d24e0">998-2232</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:33.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGFibGU6NmE4MTQ5OWVjZjRlNDhlMWI0MWI0ZDE3N2I0NGU5OWUvdGFibGVyYW5nZTo2YTgxNDk5ZWNmNGU0OGUxYjQxYjRkMTc3YjQ0ZTk5ZV8xLTAtMS0xLTM5MzMx_4fcca47d-5fbd-4e69-aa9d-048cac5e0717">Common stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGFibGU6NmE4MTQ5OWVjZjRlNDhlMWI0MWI0ZDE3N2I0NGU5OWUvdGFibGVyYW5nZTo2YTgxNDk5ZWNmNGU0OGUxYjQxYjRkMTc3YjQ0ZTk5ZV8xLTEtMS0xLTM5MzMx_d96042ce-68db-4e34-aaa6-d08ce6661674">CCRN</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGFibGU6NmE4MTQ5OWVjZjRlNDhlMWI0MWI0ZDE3N2I0NGU5OWUvdGFibGVyYW5nZTo2YTgxNDk5ZWNmNGU0OGUxYjQxYjRkMTc3YjQ0ZTk5ZV8xLTItMS0xLTM5MzMx_74b426da-71c3-432b-9b0f-79429e070b3f">The Nasdaq Stock Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzgw_9ce1c77d-f1c4-40cf-9e25-4cc4e8ac9a1d">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit and post such files).&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzcz_393240d4-dfda-4e97-a6da-3b01b1ff6a05">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;No</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of &#8220;accelerated filer and large accelerated filer&#8221; in Rule&#160;12b-2 of the Exchange Act:</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Large&#160;accelerated filer&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzc0_387458d4-4fd3-4599-9e39-bf24377f11ee">Accelerated filer</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-accelerated&#160;filer&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744; </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Smaller reporting company&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzc1_448a9021-ba07-4a30-889b-61f5adc02ad4">&#9744;</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzc2_388da574-3379-4285-980b-77dabff4c926">&#9744;</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzg2_c8959893-1677-4f37-b5e5-ddd2c1ff0b5f">&#9746;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The registrant had outstandin</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">g <ix:nonFraction unitRef="shares" contextRef="i226685b20fe64fcdbefcd85507b14d38_I20220721" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl8zODQ4MjkwNzA2NjE3_89f7c9d2-b734-4cc3-8c7d-cdba99c446c2">38,231,338</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> shares of common stock, par value $0.0001 per share, as of July&#160;21, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to historical information, this Quarterly Report on Form&#160;10-Q contains statements relating to our future results (including certain projections and business trends) that are &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), and the Private Securities Litigation Reform Act of 1995, and are subject to the &#8220;safe harbor&#8221; created by those sections. Forward-looking statements consist of statements that are predictive in nature, depend upon or refer to future events. Words such as &#8220;expects&#8221;, &#8220;anticipates&#8221;, &#8220;intends&#8221;, &#8220;plans&#8221;, &#8220;believes&#8221;, &#8220;estimates&#8221;, &#8220;suggests&#8221;, &#8220;appears&#8221;, &#8220;seeks&#8221;, &#8220;will&#8221;, &#8220;could&#8221;, and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. These factors include, but are not limited to, the following: </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the potential impacts of the coronavirus pandemic (COVID) or (COVID-19) on our business, financial condition, and results of operations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our ability to attract and retain qualified nurses, physicians and other healthcare personnel, costs and availability of short-term housing for our travel healthcare professionals, demand for the healthcare services we provide, both nationally and in the regions in which we operate, the functioning of our information systems, the effect of cyber security risks and cyber incidents on our business, the effect of existing or future government regulation and federal and state legislative and enforcement initiatives on our business, our clients&#8217; ability to pay us for our services, our ability to successfully implement our acquisition and development strategies, including our ability to successfully integrate acquired businesses and realize synergies from such acquisitions, the effect of liabilities and other claims asserted against us, the effect of competition in the markets we serve, our ability to successfully defend the Company, its subsidiaries, and its officers and directors on the merits of any lawsuit or determine its potential liability, if any, and other factors set forth in Item 1A. &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December 31, 2021 (2021 Form 10-K), as filed and updated in our Quarterly Reports on Form&#160;10-Q and other filings with the Securities and Exchange Commission (SEC).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management&#8217;s opinions only as of the date of this filing. There can be no assurance that (i)&#160;we have correctly measured or identified all of the factors affecting our business or the extent of these factors&#8217; likely impact, (ii)&#160;the available information with respect to these factors on which such analysis is based is complete or accurate, (iii)&#160;such analysis is correct or (iv)&#160;our strategy, which is based in part on this analysis, will be successful. Except as may be required by law, the Company undertakes no obligation to update or revise forward-looking statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All references to &#8220;the Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, or &#8220;Cross Country&#8221; in this Quarterly Report on Form&#160;10-Q mean Cross Country Healthcare, Inc., and its consolidated subsidiaries.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June&#160;30, 2022</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PAGE</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_13">PART I. &#8211; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_13">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_16">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_16">Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_16">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_19">Condensed Consolidated Balance Sheets (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_19">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_22">Condensed Consolidated Statements of Operations (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_22">2</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_25">Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_25">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_31">Condensed Consolidated Statements of Cash Flows (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_31">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_34">Notes to Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_34">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_88">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_88">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_88">24</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_130">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_130">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_130">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_133">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_133">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_133">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_136">PART II. &#8211; OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_136">37</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_139">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_139">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_139">37</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_142">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_142">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_142">37</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Item 6.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_145">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_145">38</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_148">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#icbcc3b9b4b5d4dffac1c85669cdfe7d3_148">39</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I.&#160;FINANCIAL INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, amounts in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:73.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.827%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.343%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNC0xLTEtMS0zOTMzMQ_a40c6eb2-8708-4909-bcbb-a704de8b79cb">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNC0zLTEtMS0zOTMzMQ_5511d36b-fbb1-41d9-a2ea-46157fbaf97f">1,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNS0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOjc2ODQwM2Y2N2I3NTQ2MjA4OTdkZGFkYTU3Y2MwNTA0XzQ3_6837d920-c636-483b-a947-229162750031">11,896</ix:nonFraction> in 2022 and $<ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNS0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOjc2ODQwM2Y2N2I3NTQ2MjA4OTdkZGFkYTU3Y2MwNTA0XzYz_c1a73bb7-5df7-4ca3-9efc-56b7dbd607b0">6,881</ix:nonFraction> in 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNS0xLTEtMS0zOTMzMQ_0bfe95d3-1982-4e6c-b149-a10b62fb1a13">701,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNS0zLTEtMS0zOTMzMQ_4149bd2b-6382-4cd2-9647-5004b1a737fd">493,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNi0xLTEtMS0zOTMzMQ_afa6afb1-a286-4a6f-8832-cb3ac56be72c">6,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNi0zLTEtMS0zOTMzMQ_d0c68e3b-27a4-4f55-9be5-1ecba3aa4e20">7,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance recovery receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:InsuranceSettlementsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNy0xLTEtMS0zOTMzMQ_c3df4604-1c8b-4d47-81c7-ee83834c915c">5,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:InsuranceSettlementsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNy0zLTEtMS0zOTMzMQ_b6961811-85f1-4912-9040-d4813eb12dee">5,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfOC0xLTEtMS0zOTMzMQ_c1f36198-2ef4-40a2-860f-f317144da6ab">3,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfOC0zLTEtMS0zOTMzMQ_2a578b55-9842-4c3f-8672-ee578b22ea2e">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfOS0xLTEtMS0zOTMzMQ_6675070a-6bba-4e7f-badc-8424cccee4f6">718,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfOS0zLTEtMS0zOTMzMQ_ba8eae15-7b44-46ab-aad7-07d884e575db">508,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net of accumulated depreciation of $<ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTAtMC0xLTEtMzkzMzEvdGV4dHJlZ2lvbjo1MDg1NTM3MTAzNTI0OWFhYjMwMjZkMDI4MzBlYzM0Zl82NA_f770a47c-81c5-44f6-b4e6-ecc392015cac">19,240</ix:nonFraction> in 2022 and $<ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTAtMC0xLTEtMzkzMzEvdGV4dHJlZ2lvbjo1MDg1NTM3MTAzNTI0OWFhYjMwMjZkMDI4MzBlYzM0Zl84MA_57db5e31-8340-4e3b-8306-59d1bfc9b749">17,729</ix:nonFraction>  in 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTAtMS0xLTEtMzkzMzE_cb1160df-f8c4-47c7-bf48-582ef660acdc">18,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTAtMy0xLTEtMzkzMzE_2681bbcd-7228-49cb-8248-7173ed6e6a63">15,833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTEtMS0xLTEtMzkzMzE_1dcd425a-e792-4c5d-a21a-2dd71a73244c">5,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTEtMy0xLTEtMzkzMzE_57f9e90d-4bb3-4d8c-a08e-790bb94191e9">7,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTItMS0xLTEtMzkzMzE_b6a6d569-3e35-412b-a759-56500943bd33">113,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTItMy0xLTEtMzkzMzE_9edbc6eb-5e27-4930-b818-acdde085968e">119,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names, indefinite-lived</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:IndefiniteLivedTradeNames" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTMtMS0xLTEtMzkzMzE_df3b863d-b03a-4f27-a2de-1bce0952da1f">5,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedTradeNames" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTMtMy0xLTEtMzkzMzE_4a51a2f6-aff8-4839-8b34-2adc508718b0">5,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTQtMS0xLTEtMzkzMzE_6cafae18-65ef-48de-8a60-4ee991de64f0">42,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTQtMy0xLTEtMzkzMzE_9483b609-937d-4e74-81e6-e08e4308c571">42,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTUtMS0xLTEtMzkzMzE_5f62993d-625a-4753-8beb-f21153b715dd">8,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTUtMy0xLTEtMzkzMzE_a06d41b6-ab2c-41dd-848e-0acff3b0d0c7">11,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTYtMS0xLTEtMzkzMzE_f4852748-bad6-4f49-932d-9fd3e46b7006">27,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTYtMy0xLTEtMzkzMzE_ebdf6a6b-110b-46c6-9827-c9274c6b14fa">21,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTctMS0xLTEtMzkzMzE_16ffa9eb-08a7-45a9-aaa9-f0d92d16bece">938,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTctMy0xLTEtMzkzMzE_7fd7571b-c81d-430b-b600-6efc9a69e646">732,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and Stockholders' Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjEtMS0xLTEtMzkzMzE_4f3a3c96-21a8-4488-b995-6fb7f0e158a5">189,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjEtMy0xLTEtMzkzMzE_1b664a42-d485-4269-985b-03cedb9fb748">109,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjItMS0xLTEtMzkzMzE_dc0597d6-8758-4c49-828d-f291e04e4e25">65,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjItMy0xLTEtMzkzMzE_d660f337-2cf3-43ee-86cf-fd7a661bbd26">65,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjMtMS0xLTEtMzkzMzE_30dd5343-b6c6-4511-8b1d-52df3e841b57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjMtMy0xLTEtMzkzMzE_06aed4a8-6d04-473e-9113-85d54b554c77">4,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjQtMS0xLTEtMzkzMzE_4bd34f6d-cdd7-4626-bdaf-697cc50621ef">4,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjQtMy0xLTEtMzkzMzE_82eea03f-b543-4034-acd0-7f0a89e67753">4,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjUtMS0xLTEtMzkzMzE_5be9121e-462c-408b-bc20-62087752c453">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjUtMy0xLTEtMzkzMzE_71f3c463-d6f2-4827-be77-7d5555f103f2">7,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of earnout liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjYtMS0xLTEtMzkzMzE_61be3043-5bc1-4182-bed1-b8f4e1c4a6b9">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjYtMy0xLTEtMzkzMzE_7ca8ad05-61c7-4e95-9432-3f1e90fb7ab9">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjctMS0xLTEtMzkzMzE_e6aa699b-966e-4b12-981a-13f2b288161e">1,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjctMy0xLTEtMzkzMzE_79b68b59-0973-4a56-8865-6aafce1e4837">1,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjgtMS0xLTEtMzkzMzE_e6ea1b5d-4dfb-40da-93d2-d5fae1363ea0">268,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjgtMy0xLTEtMzkzMzE_73ecf31d-0a39-4635-a6dd-1a41a595ebbe">199,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OtherLongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjktMS0xLTEtMzkzMzE_9f4508b3-21d6-44db-bfda-2d4beada2a70">205,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:OtherLongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjktMy0xLTEtMzkzMzE_27ff041f-fba4-4bda-b07e-7919b2250bd7">176,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzAtMS0xLTEtMzkzMzE_da456a4c-ccf9-44bc-9eb8-448e5496e19d">7,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzAtMy0xLTEtMzkzMzE_c5e3a65a-2463-4fc6-b25d-faec24dc4ef1">10,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzEtMS0xLTEtMzkzMzE_40a1e0f7-facc-4444-9819-c022feeca91f">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzEtMy0xLTEtMzkzMzE_aaa603d8-a066-4841-8e51-fdbd329699e9">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term accrued claims</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzItMS0xLTEtMzkzMzE_1c498cc4-c5c9-44cf-aaa8-c38126a7ec19">26,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzItMy0xLTEtMzkzMzE_fbecb373-9d65-48f9-a320-c57d79d0946d">25,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current earnout liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzMtMS0xLTEtMzkzMzE_8dd593d9-e8dc-4757-a4a5-09a98301898a">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzMtMy0xLTEtMzkzMzE_a9369df8-2a53-4720-a458-8ead1d5ebc5c">9,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzQtMS0xLTEtMzkzMzE_e3e786dc-8d4c-4da5-ad0e-0af738fba2a5">12,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzQtMy0xLTEtMzkzMzE_673870f1-e063-4776-8d2a-66d329fdd01f">13,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzUtMS0xLTEtMzkzMzE_9cf2e555-b7da-4fa3-991e-05022e4d6c0c">528,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzUtMy0xLTEtMzkzMzE_ea916977-80bb-45bf-99a5-5341cb9b2ecc">435,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzctMS0xLTEtMzkzMzE_dced551a-bc77-4ed3-835a-53f1b9ee9058"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzctMy0xLTEtMzkzMzE_a1ee82cb-3d8b-42ae-9a7a-daed8b27442c"></ix:nonFraction></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDAtMS0xLTEtMzkzMzE_c3cdde0f-9f2f-4649-bf0e-638430e48181">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDAtMy0xLTEtMzkzMzE_a755849f-b20c-4c0b-81a9-5e3c27d94227">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDEtMS0xLTEtMzkzMzE_338b784e-bf0e-4f4d-bdc7-422bb9de3331">320,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDEtMy0xLTEtMzkzMzE_93ac8de8-7c8f-47e4-97ce-6ad9672a3c84">321,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDItMS0xLTEtMzkzMzE_122a5404-b1b2-4f06-a703-859398cdce5f">1,335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDItMy0xLTEtMzkzMzE_14d69348-dcd3-4f56-832e-12faef0813f4">1,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings (accumulated deficit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDMtMS0xLTEtMzkzMzE_6ffd61ee-a88a-41c9-a5f0-33cd6da5771d">92,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDMtMy0xLTEtMzkzMzE_cd2b3f7c-fbf2-4a99-8eff-b19ae7d2219a">22,735</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDYtMS0xLTEtMzkzMzE_1d0e6c67-a8c6-4999-9ea5-4adbb38e5ef3">410,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDYtMy0xLTEtMzkzMzE_2580ccb4-702c-4a70-bad9-76c9cf48d756">297,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDctMS0xLTEtMzkzMzE_a3a96981-0997-4a10-8c50-2c619467fca0">938,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDctMy0xLTEtMzkzMzE_5485fe7d-7e67-4c2c-8cad-299640b589e5">732,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                     </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, amounts in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0wLTEtMS0zOTMzMQ_33870ac4-7a5d-4666-b864-06e3c6e8fa8f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0wLTEtMS0zOTMzMQ_4df3da1c-5136-4a23-a756-78c13d836a34"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0wLTEtMS0zOTMzMQ_62909d48-4125-45af-9432-4ba33e5741cc"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0wLTEtMS0zOTMzMQ_eccdff06-1bc8-40b8-9d1b-0325ebbdf6bd">Revenue from services</span></span></span></span> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0xLTEtMS0zOTMzMQ_fd38ba6d-6bed-42bd-aafc-19080a325e3f">753,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0zLTEtMS0zOTMzMQ_b5951de5-be1d-4ea8-a428-5158e7f576a0">331,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC01LTEtMS0zOTMzMQ_5a9f7bb0-28ed-42e3-a141-0a4a1efe75fa">1,542,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC03LTEtMS0zOTMzMQ_a9bb6891-88d9-464b-b3d0-e63c0ea09a7a">661,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:DirectOperatingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNi0xLTEtMS0zOTMzMQ_ee13de4f-7363-40e1-a9b7-b4e8a74829c5">583,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:DirectOperatingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNi0zLTEtMS0zOTMzMQ_2f41e015-1f92-4e98-9ebc-5f5f2ce844ab">259,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:DirectOperatingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNi01LTEtMS0zOTMzMQ_1a956aae-97de-4599-a6f2-90fad881f1f7">1,197,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:DirectOperatingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNi03LTEtMS0zOTMzMQ_7cdf18c0-23a6-4a97-9698-8e3d6361da7c">517,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNy0xLTEtMS0zOTMzMQ_3edb0a26-a78d-434d-ab43-b6c39d53cca1">86,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNy0zLTEtMS0zOTMzMQ_ea053cef-ee72-41ad-a4e9-367f9a390643">50,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNy01LTEtMS0zOTMzMQ_0e67ada4-b0aa-415b-9d5a-4098c7a55869">162,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNy03LTEtMS0zOTMzMQ_94d08d35-a797-4d18-83b3-b106917cda33">96,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOC0xLTEtMS0zOTMzMQ_8b9a27c0-d491-46ce-84de-425c841d2c24">3,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOC0zLTEtMS0zOTMzMQ_92115f99-8381-41a8-8ec5-1fdf830f761e">466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOC01LTEtMS0zOTMzMQ_5580326d-7d41-4402-bcb6-3dd84ee0a92a">5,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOC03LTEtMS0zOTMzMQ_bef60045-5e26-49bc-98ae-e5d582905482">970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOS0xLTEtMS0zOTMzMQ_6eb0212c-77d8-47b7-ac9a-1cf34c248531">3,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOS0zLTEtMS0zOTMzMQ_aceffee7-5cf7-4355-a014-87bfec052994">2,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOS01LTEtMS0zOTMzMQ_0491c614-721b-4d9e-b831-188bfda239bb">6,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOS03LTEtMS0zOTMzMQ_6c22ba90-738f-4b03-9c83-13dffa02e58d">4,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTAtMS0xLTEtMzkzMzE_d37a4aa8-abaa-4371-95dc-8f29e075273c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTAtMy0xLTEtMzkzMzE_214e6f44-b86c-4c04-ba40-c139bbd44cab">924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTAtNS0xLTEtMzkzMzE_477dbcae-e03a-41e4-a52b-ce805622256f">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTAtNy0xLTEtMzkzMzE_55545450-d0c7-4aa6-a401-514f35c323ce">924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring (benefits) costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTEtMS0xLTEtMzkzMzE_9175ce51-b181-4810-8655-d92741d874e4">1,114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTEtMy0xLTEtMzkzMzE_0170e515-02fd-495e-b48a-ce4bd49d4fa8">835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTEtNS0xLTEtMzkzMzE_7e4cd63c-d341-46c6-bd5d-32a44d3a920a">634</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTEtNy0xLTEtMzkzMzE_ade835df-4246-4263-b585-23280792c58e">2,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTItMS0xLTEtMzkzMzE_a3a356bb-c330-433c-8548-3f323baa33d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTItMy0xLTEtMzkzMzE_d966caa6-50a8-4a9d-9e3d-cad5a8c0645f">1,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTItNS0xLTEtMzkzMzE_63fa2c28-dac0-4871-b93d-cc52868ead2c">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTItNy0xLTEtMzkzMzE_6bee77a2-5262-46e6-8c7c-c01911a8ba47">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTMtMS0xLTEtMzkzMzE_db4f24e4-af8e-44e9-9932-467e46ef2f27">674,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTMtMy0xLTEtMzkzMzE_b98857c0-568d-4878-8d1d-3a1ca7277fc1">315,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTMtNS0xLTEtMzkzMzE_9cc5a356-93cc-40c5-a0d3-7f02d7d01a8e">1,372,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTMtNy0xLTEtMzkzMzE_0d6842ea-8728-4d3d-9df6-dad531cf459e">624,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTQtMS0xLTEtMzkzMzE_c2e8fe15-194b-47aa-ba11-9f330359fca7">78,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTQtMy0xLTEtMzkzMzE_899b89e4-a58a-48f2-a7e8-5e9ef2376d3d">15,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTQtNS0xLTEtMzkzMzE_6f952527-c64d-4e3b-85b9-afc687d367fa">169,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTQtNy0xLTEtMzkzMzE_e3c43b4c-c5f3-4e76-934d-804e03e14073">36,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses (income):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTYtMS0xLTEtMzkzMzE_dc57b222-2361-45b1-967c-9134b5fcd4b1">3,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTYtMy0xLTEtMzkzMzE_99c43d9e-f302-4ed2-9e78-9e2fd80e7533">1,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTYtNS0xLTEtMzkzMzE_93574f72-19de-4432-b0fc-d367b7996147">7,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTYtNy0xLTEtMzkzMzE_ec2f5b90-9892-4c82-98c9-5ccd43e768f8">1,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctMS0xLTEtNDMzNDI_229d7f64-3d8f-4a6e-b748-2537bde47228">1,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctMy0xLTEtNDMzNDU_2e31fcec-4016-4847-bff2-095a5c3e46d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctNS0xLTEtNDMzMzY_1095e31b-0929-4190-8532-f6e5f875069e">1,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctNy0xLTEtNDMzMzk_0b6c3318-a77b-4b64-8da4-a902b334d1dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctMS0xLTEtMzkzMzE_f5a03e2c-3f3b-48d6-b85b-a175ab0748ab">1,084</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctMy0xLTEtMzkzMzE_296c9495-5a4a-48d9-a472-e80d6a523ee1">204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctNS0xLTEtMzkzMzE_41e911f6-d6d9-4722-8bc2-c83ba88dd3c7">1,092</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctNy0xLTEtMzkzMzE_0031121b-9d75-4604-836f-76d959d78c98">241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTgtMS0xLTEtMzkzMzE_fd7d7009-f2b3-411e-8f3f-21d02f79d761">74,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTgtMy0xLTEtMzkzMzE_1fc6cc7b-0878-4475-998c-b1b4b4dc6b8c">14,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTgtNS0xLTEtMzkzMzE_62f2ff20-22be-4d52-aa31-972851952f57">161,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTgtNy0xLTEtMzkzMzE_acdcdd9f-d77d-4a36-b75d-2a2abac90e3d">35,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTktMS0xLTEtMzkzMzE_512d3242-8b86-4cb0-a67a-91b669c2d788">21,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTktMy0xLTEtMzkzMzE_ef760ebe-ed4b-4c4b-b0d3-7f540f211345">3,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTktNS0xLTEtMzkzMzE_d8dfa5ac-7658-44b9-b4eb-230d0ac65fb5">46,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTktNy0xLTEtMzkzMzE_5809e4d6-27b8-4c35-9d1a-ded5179dd44e">4,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjItMS0xLTEtMzkzMzE_58460700-ee09-488e-985a-2d56438b6226">52,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjItMy0xLTEtMzkzMzE_825ebb46-d1ad-47fe-b1f9-ad58a8cbd9ec">11,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjItNS0xLTEtMzkzMzE_4d6a79bc-6ab7-4305-ad94-9f60679ae574">114,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjItNy0xLTEtMzkzMzE_6cef8223-8ab3-4e08-a484-db8cbbf0edf6">30,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized foreign currency translation loss, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjUtMS0xLTEtMzkzMzE_ee72a1e2-a96d-49f4-8641-eff0f2e9a8c1">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjUtMy0xLTEtMzkzMzE_ab9315e7-be7b-4ddf-8556-d96abba4f925">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjUtNS0xLTEtNDA4MDQ_05885003-b2ec-453c-b1a3-0b88e46b01b9">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjUtNy0xLTEtNDA4MDQ_f5c4fedd-dc84-465b-b8ee-4b9889a5367c">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjYtMS0xLTEtMzkzMzE_735bff1e-5f71-4f70-b034-5e40fbf7b222">52,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjYtMy0xLTEtMzkzMzE_0b352df7-d9f6-4c27-9c8f-774b2de2201d">11,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjYtNS0xLTEtNDEzODk_297e8181-71b3-4253-9fbb-ef2d451229b4">114,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjYtNy0xLTEtNDEzODk_ec216047-690a-4b9b-bea1-33636208c162">30,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjgtMS0xLTEtMzkzMzE_0aa4ac6f-fb28-454d-8919-ba255078212a">1.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjgtMy0xLTEtMzkzMzE_eedd0d69-fc6a-4023-b61b-29b8d39a0621">0.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjgtNS0xLTEtMzkzMzE_bececd0b-7f50-464c-a4d6-d631878dc19f">3.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjgtNy0xLTEtMzkzMzE_6bcdda43-f2ab-410b-b9b8-f61d17b68ede">0.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzAtMS0xLTEtMzkzMzE_0d12d27e-0786-44fb-9758-1f7458cc2700">1.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzAtMy0xLTEtMzkzMzE_548c31c6-afeb-4c59-83dd-13509d21da6e">0.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzAtNS0xLTEtMzkzMzE_754e918d-cb90-45ed-8402-c1feef3393b0">3.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzAtNy0xLTEtMzkzMzE_26fb2db1-5067-45d4-a914-e692cf9bd21f">0.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzMtMS0xLTEtMzkzMzE_59f33e88-f3fb-4cf5-a594-524c85c06411">37,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzMtMy0xLTEtMzkzMzE_5c942686-39da-4195-975a-0cf92c7dc2ee">36,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzMtNS0xLTEtMzkzMzE_08b457f2-3aa2-45f5-9117-5513f4554893">37,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzMtNy0xLTEtMzkzMzE_f8b65cf2-f6de-4326-8bfc-84b779239d65">36,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzQtMS0xLTEtMzkzMzE_2a541b50-6307-48a0-8532-cc6f8f25b0ba">37,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzQtMy0xLTEtMzkzMzE_9c83ce26-6aa5-460e-955d-71332ae36f61">37,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzQtNS0xLTEtMzkzMzE_48b35b07-917f-431a-8317-fdc3033608ae">37,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzQtNy0xLTEtMzkzMzE_3ce7838f-1eb3-47b6-91f3-be5055430fe6">37,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended June 30, 2022 and 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, amounts in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.919%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-In Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Accumulated Other <br/>Comprehensive Loss, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Noncontrolling Interest in Subsidiary</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Dollars</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i531629651f344ec6a65beff4a5deca32_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi0xLTEtMS0zOTMzMQ_fab4ddbb-f186-4101-838c-84550ca98bf3">37,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i531629651f344ec6a65beff4a5deca32_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi0zLTEtMS0zOTMzMQ_69ed3f6d-6fe8-4d37-b873-cbf3e96a2549">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i449c5e6731f340f7b56a94edc4b9d609_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi01LTEtMS0zOTMzMQ_8f1e2515-e1c5-4b77-8a58-9ece1e493962">318,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14bf0f7b08e64965a1a24ab1083597f2_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi03LTEtMS0zOTMzMQ_38024879-2a9d-43e6-a921-5a208d0fe036">1,304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f7ed285cae40089dae6c224378c0dc_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi05LTEtMS0zOTMzMQ_58598565-6346-489d-b333-b8e8de7ff5a7">39,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i537dd183eaec41c087e74135b134f4bf_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi0xMS0xLTEtMzkzMzE_dcadc6c9-8312-4d61-830f-f2f69eda82e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9d2332650c84b7e8d003bddf5a15b05_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi0xMy0xLTEtMzkzMzE_a9c087b7-5ebe-4b61-adb7-df52e72fc5d0">356,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31dcc4001be54470acb6bfeafeab8e86_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMy0xLTEtMS0zOTMzMQ_2e0adc61-0ec5-429e-97ad-ffb7a0017d15">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8356e77d185d42a595240bb06077cf3b_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMy01LTEtMS0zOTMzMQ_3b44f5cb-6cde-456b-87f4-4d94d2171cb9">239</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMy0xMy0xLTEtMzkzMzE_71780a54-a126-4307-aa2c-ed625a9ab080">239</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8356e77d185d42a595240bb06077cf3b_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfNC01LTEtMS0zOTMzMQ_ce793045-493f-4615-8d71-129bcba4b00b">2,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfNC0xMy0xLTEtMzkzMzE_305aec30-8ba3-4f1e-aec6-d7cf2e78e667">2,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i206b5bfd38994bada2f7ed528b90c58c_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfNS03LTEtMS0zOTMzMQ_e82464b4-71c7-481b-aff8-eb84905b89f6">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfNS0xMy0xLTEtMzkzMzE_fedb0df8-a4b6-44e7-ba1e-0402ddc535f7">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5890a7c02b9f453b81942f2d23ca6ee1_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOC05LTEtMS0zOTMzMQ_c2a28c88-d7a8-4ad4-a792-2983d3523c76">52,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOC0xMy0xLTEtMzkzMzE_64c10ddd-e49f-4ac7-8731-06c42ba4746a">52,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2818c901fa294008b0ac70a7926b7750_I20220630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS0xLTEtMS0zOTMzMQ_49a328a8-5ad8-4278-87c1-4e51f75ace89">37,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2818c901fa294008b0ac70a7926b7750_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS0zLTEtMS0zOTMzMQ_7b4a7567-2d3a-4e85-931e-8ae3425666d9">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c162997fa542aaaa564c877f405887_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS01LTEtMS0zOTMzMQ_2b10ecf2-0fff-459c-b3c1-3d794a6a7215">320,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7ad72ba2a404b11bce5d4ba287b2050_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS03LTEtMS0zOTMzMQ_78886692-e0d1-4094-8989-a658652ed737">1,335</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i500e0f29c7f04d4abc254b61775901d9_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS05LTEtMS0zOTMzMQ_2a84489f-ae6b-493d-83e1-c2dad4e95878">92,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e41c385e2a54c60ac848e6147a19f67_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS0xMS0xLTEtMzkzMzE_539d5d12-52bf-437c-a2d1-cf7b0d6e6982">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS0xMy0xLTEtMzkzMzE_eeaa33d4-2043-4ac6-9053-8c273e9c46f9">410,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-In Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Accumulated Other <br/>Comprehensive Loss, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Accumulated Deficit) Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Noncontrolling Interest in Subsidiary</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Dollars</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at March&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8f6433f078ee4dd6a65f2bc4bf4d7164_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtMS0xLTEtMzkzMzE_1d80024f-b911-45cc-8640-91a4b8ec64b1">36,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f6433f078ee4dd6a65f2bc4bf4d7164_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtMy0xLTEtMzkzMzE_58de9f59-782a-46f3-be45-031fcd13d5c6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604483a0fb4648eead96a92019de1c64_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtNS0xLTEtMzkzMzE_90a245fe-45b8-4d7f-bd34-b26bf7ff6f03">309,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7728dd1404d4128a2d0f589c4c7d344_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtNy0xLTEtMzkzMzE_fbf035ad-ee8b-44bc-8aee-5a132bf29a29">1,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i760e91ed75f744d1bfb84b6d6b15c919_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtOS0xLTEtMzkzMzE_7c30867e-b6ca-48d1-a8c1-3e1ace0c9200">135,289</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59307db96ef44b038e0df4fa3bf234ea_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtMTEtMS0xLTM5MzMx_54348d94-ae99-4bdc-86f4-887acbfe6221">534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90078daa01da46fa9dc40d6cdc958040_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtMTMtMS0xLTM5MzMx_49903a2d-dc12-45b0-9ccb-85ee9d6b6259">173,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2224a68f821e43b997df6840a0be749e_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTQtMS0xLTEtMzkzMzE_d34cc94f-f1aa-498f-ad97-716e7875748b">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i987aabb9817140daad5b016172020182_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTQtNS0xLTEtMzkzMzE_c9d7600e-1cdf-44dc-a4b2-284755adf318">204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTQtMTMtMS0xLTM5MzMx_690024e5-0c55-41bf-9f5e-1b4d267032ab">204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987aabb9817140daad5b016172020182_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTUtNS0xLTEtMzkzMzE_d0a01cb7-190d-470c-bdb2-751a7a7100fb">2,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTUtMTMtMS0xLTM5MzMx_300f5c2c-e2f1-49ca-9c3d-3671160c0f7a">2,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90bd49deece64987b9a9f7ed50a970cd_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTYtNy0xLTEtMzkzMzE_f1ae9e99-2cf0-47bb-b05a-116b2bd219b2">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTYtMTMtMS0xLTM5MzMx_c4c67e6c-ed3d-4ae0-bb27-8d0760424a51">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Acquisition of WSG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2224a68f821e43b997df6840a0be749e_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTctMS0xLTEtMzkzMzE_5d260e3e-8f9c-4145-82a4-20a62ff81fda">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987aabb9817140daad5b016172020182_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTctNS0xLTEtMzkzMzE_611f258c-d960-45aa-bffe-6db7b4f7250a">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTctMTMtMS0xLTM5MzMx_feb56c1e-0043-4256-a3d8-9684b52fdd5f">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa7d8c493de45b58bafdfed07b02f38_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTgtOS0xLTEtMzkzMzE_77497417-4ebc-470e-bcf5-ec00cda06efe">11,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTgtMTMtMS0xLTM5MzMx_ae87e237-8484-4727-8fa1-9ff9dd8c0789">11,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0235582b9294676b1724db099df1dbf_I20210630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktMS0xLTEtMzkzMzE_914c9603-69bd-4018-9a52-5fea6655712c">36,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0235582b9294676b1724db099df1dbf_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktMy0xLTEtMzkzMzE_5ad106dc-174e-4893-b761-d00b3b6cee82">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccfe432a49541508ac24bf9eba96187_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktNS0xLTEtMzkzMzE_c13d6ac1-6be3-43fe-a306-e2d678316bfb">316,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ebafd2e0fb647129b868a2a74277f49_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktNy0xLTEtMzkzMzE_2ddbcbcf-4ea3-44aa-85fa-087e966bc501">1,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf69140622c542a2a5dbade330bed92f_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktOS0xLTEtMzkzMzE_0cc73def-986e-4d43-b0cb-83ea86cf62ab">123,741</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73fb24814a2c4f2dbce0205fa38c054e_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktMTEtMS0xLTM5MzMx_dec2c686-9d0a-4feb-8c3a-aacc72b9714a">534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ddb987bb1248dfb24dea790e19f923_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktMTMtMS0xLTM5MzMx_aabbec9c-22bf-4937-aafb-e5361d9b3db6">192,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2022 and 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, amounts in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:24.597%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.919%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-In Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Accumulated Other <br/>Comprehensive Loss, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Accumulated Deficit) Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Noncontrolling Interest in Subsidiary</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Dollars</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1299054e8f31469fb1fada07913bbe8c_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi0xLTEtMS0zOTMzMQ_4623551c-130a-4bc4-b62c-029471001084">37,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1299054e8f31469fb1fada07913bbe8c_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi0zLTEtMS0zOTMzMQ_fe0a761d-42db-47c8-979e-f38588120201">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57bb4502177a4191a1ce7b5ac9398fca_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi01LTEtMS0zOTMzMQ_9a8891a6-58d0-46dd-84a0-48133068773a">321,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaacba8aeb0b5485c8876a3714cb90244_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi03LTEtMS0zOTMzMQ_d505ea0b-3cfc-48d8-9123-3e8b271ed775">1,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7c2dc5236e64eada06aea8f7ef16bc5_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi05LTEtMS0zOTMzMQ_9ca5ddec-9c0d-430b-b69c-e4df83579284">22,735</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8a1a73be9c419f95a1bb64e4383005_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi0xMS0xLTEtMzkzMzE_5f53755f-75d5-440b-aa52-5bd1b42dcd9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi0xMy0xLTEtMzkzMzE_c8cc4584-1391-46f1-a2db-7312f7d23d66">297,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e54d79ab9284085bcf0c45bcd9c139a_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMy0xLTEtMS0zOTMzMQ_038192c5-48b6-4343-bb3e-061bb0867e4b">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic34a4d1e4be64eceb08f27f939e04b69_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMy01LTEtMS0zOTMzMQ_631a813c-3245-4d42-828c-917dd11cd91c">5,267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMy0xMy0xLTEtMzkzMzE_22723723-dd8b-49e5-b4f7-7dbcce5b09bf">5,267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic34a4d1e4be64eceb08f27f939e04b69_D20220101-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfNC01LTEtMS0zOTMzMQ_697def5e-60e8-4534-8180-5e64fafeedce">3,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfNC0xMy0xLTEtMzkzMzE_aa074ddd-e31a-47a4-8677-f090345f1f75">3,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia32b475baddb40bb9ed523ad5ff77137_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfNS03LTEtMS0zOTMzMQ_01c515f5-4afc-4150-b6c8-7d81d949daac">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfNS0xMy0xLTEtMzkzMzE_15f66352-1593-411b-bc23-7ec75ef03ab4">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2cc9574c5784fdba767ee2f4418cd46_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfOS05LTEtMS0zOTMzMQ_2ff1785b-f314-4ecd-aa70-e70bf3e0e547">114,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfOS0xMy0xLTEtMzkzMzE_5f36e1e5-ea86-4002-9a1c-99aee7da525a">114,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at June&#160;30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2818c901fa294008b0ac70a7926b7750_I20220630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtMS0xLTEtMzkzMzE_8725ab1e-5811-435a-b6cc-36ba34066f1f">37,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2818c901fa294008b0ac70a7926b7750_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtMy0xLTEtMzkzMzE_b7cb128c-384f-4098-ac48-2fbe31109986">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c162997fa542aaaa564c877f405887_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtNS0xLTEtMzkzMzE_7ea0f159-2f77-4659-8625-3bea53ec1ecf">320,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7ad72ba2a404b11bce5d4ba287b2050_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtNy0xLTEtMzkzMzE_5f80eead-56e7-4fe2-9f7d-0251456a5d3c">1,335</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i500e0f29c7f04d4abc254b61775901d9_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtOS0xLTEtMzkzMzE_de2939ce-d462-4083-a3a5-8d8c7be75647">92,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e41c385e2a54c60ac848e6147a19f67_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtMTEtMS0xLTM5MzMx_6a5afd99-976b-4280-a5c1-fccdeef0817f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtMTMtMS0xLTM5MzMx_1fd5a0da-ac1a-42ce-8329-4128a506abbf">410,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-In Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Accumulated Other <br/>Comprehensive Loss, net</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">(Accumulated Deficit) Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Noncontrolling Interest in Subsidiary</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Dollars</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at December&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f3bea820d5244fd87508196dd2090f4_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtMS0xLTEtMzkzMzE_5ccfa0b9-bea7-4f1a-836f-7d9bb374b415">36,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3bea820d5244fd87508196dd2090f4_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtMy0xLTEtMzkzMzE_1a870f17-0bd9-49e4-bad4-a51e77ec8c5e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44e8f4bbd7df49c8b09fc53f08598fee_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtNS0xLTEtMzkzMzE_25d7b0dc-5f29-4bd8-ac7a-9e477cf3c8c1">310,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf4dd3e30f8e4cfc9b12d4d8ae0ab312_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtNy0xLTEtMzkzMzE_472add39-b3e0-40e3-8bba-422bd4e39b14">1,280</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeb9206ba354b3889aeee34d83cfee0_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtOS0xLTEtMzkzMzE_28b7f4f2-a0bc-445c-b25f-fa57669b56a5">154,737</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8163ebc66fb43e29c1f37f64b2ca55b_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtMTEtMS0xLTM5MzMx_8bf51c99-0d7c-464d-ae1c-e0727a50f18d">534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681334a1907145ebba1a62d2883f0d2e_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtMTMtMS0xLTM5MzMx_12396954-3ebf-4107-964a-53766dc2f283">154,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i25f9ce0742594c3b883c445ec9f65431_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTUtMS0xLTEtMzkzMzE_0e3d4067-b4b7-49b7-bfb5-a9dcdf888275">477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i265e0b6608b74677b7e23b6bf871bc6a_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTUtNS0xLTEtMzkzMzE_c377aed8-2f43-4e1a-ba3d-363a51b5394b">2,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTUtMTMtMS0xLTM5MzMx_4ddb31de-3a21-47dc-8859-9c0f02e36a84">2,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i265e0b6608b74677b7e23b6bf871bc6a_D20210101-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTYtNS0xLTEtMzkzMzE_3f893f8f-609c-4423-b337-e395dc3d1a6c">3,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTYtMTMtMS0xLTM5MzMx_94366e59-d485-4618-b06d-698922ea64b8">3,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7cf3b0130dbb44d58977a9439465a5c4_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTctNy0xLTEtMzkzMzE_ddf81694-f8c9-4e37-a838-b59a080a6c14">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTctMTMtMS0xLTM5MzMx_5a647f9d-5931-4885-8de0-ff55f862ab4a">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Acquisition of WSG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i25f9ce0742594c3b883c445ec9f65431_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTgtMS0xLTEtMzkzMzE_bdd3bc58-0f69-43a7-ad40-fcd2044da2ed">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i265e0b6608b74677b7e23b6bf871bc6a_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTgtNS0xLTEtMzkzMzE_9776b218-c128-491f-925b-0f8de9a628fb">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTgtMTMtMS0xLTM5MzMx_d5e75efd-2dac-4d09-9b08-a26043dbfc39">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i135d7bd16c8c4b9c9ec3f80f3ad82fd8_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTktOS0xLTEtMzkzMzE_9f6f7058-3a04-4621-9332-754257e709f4">30,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTktMTMtMS0xLTM5MzMx_56456a02-515d-4358-9c62-ed373c087b8d">30,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Balances at June&#160;30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0235582b9294676b1724db099df1dbf_I20210630" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtMS0xLTEtMzkzMzE_4ddd2da7-7aa9-4a27-bdf6-344a3d6c84e3">36,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0235582b9294676b1724db099df1dbf_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtMy0xLTEtMzkzMzE_7a2501e3-fee7-43d5-bc39-5b9e881de092">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifccfe432a49541508ac24bf9eba96187_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtNS0xLTEtMzkzMzE_6cae219b-9f56-4d34-a3ca-390612a5903b">316,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ebafd2e0fb647129b868a2a74277f49_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtNy0xLTEtMzkzMzE_7ef5558b-fa9a-4cf2-9a0a-df28e65ce2fc">1,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf69140622c542a2a5dbade330bed92f_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtOS0xLTEtMzkzMzE_b0bb1157-c842-4837-b69e-d7871e2cc761">123,741</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73fb24814a2c4f2dbce0205fa38c054e_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtMTEtMS0xLTM5MzMx_3337b497-a7c7-4890-9ba6-9fce97418374">534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ddb987bb1248dfb24dea790e19f923_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtMTMtMS0xLTM5MzMx_3502f672-f34a-4624-88d7-470c372adb4a">192,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited, amounts in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNC0xLTEtMS0zOTMzMQ_20f35d8a-faed-40e7-be2b-6255969cf674">114,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNC0zLTEtMS0zOTMzMQ_e27d42a5-56cc-4660-a9db-544c64179076">30,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNi0xLTEtMS0zOTMzMQ_7d364953-c5d7-470b-b9ea-440cfdd32c51">6,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNi0zLTEtMS0zOTMzMQ_b89598d4-ff83-40e3-b8ca-bf8a574e98b3">4,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNy0xLTEtMS0zOTMzMQ_e9d4e874-b6bb-490a-9bf0-a8c0a9101a80">7,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNy0zLTEtMS0zOTMzMQ_5414b408-3c0c-40f1-aea4-e1f36a80692c">1,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfOC0xLTEtMS0zOTMzMQ_69aafc47-ccf7-4f98-a7f3-f6c38f444cc8">3,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfOC0zLTEtMS0zOTMzMQ_0dc51452-042b-4440-8e87-84b680ec1b35">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="ccrn:OperatingLeaseExpenseNonCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfOS0xLTEtMS0zOTMzMQ_e6e64c28-e34e-4f1d-aaae-aba7b2351c8d">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="ccrn:OperatingLeaseExpenseNonCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfOS0zLTEtMS0zOTMzMQ_685746c3-af50-421c-a123-5ec5be042548">1,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTAtMS0xLTEtMzkzMzE_654776a6-4aa9-4557-87f8-9060c39f1979">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTAtMy0xLTEtMzkzMzE_63f2c9da-6e2a-4a33-9cba-db08e1c1e127">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTEtMS0xLTEtNDQ0MDQ_2cf13d58-57d4-41eb-ae6f-1ecd94db1df6">1,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTEtMy0xLTEtNDQ0MDQ_beb607d8-d66e-4324-9845-9ec926b5da72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTEtMS0xLTEtMzkzMzE_a2c1f1b7-9143-4a73-93a0-bee2773769af">3,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTEtMy0xLTEtMzkzMzE_ed1414f6-6a1d-4915-ac84-a69b252b0a2f">3,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash (benefits) costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTItMS0xLTEtMzkzMzE_5039fef9-98b8-4c19-8a4f-e1cbbf37293d">301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTItMy0xLTEtMzkzMzE_b4bd5660-5f56-4a8c-83e6-d8fd6e81c365">772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTQtMS0xLTEtMzkzMzE_5a3190b5-df52-4691-9904-9595d41d63d9">215,230</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTQtMy0xLTEtMzkzMzE_c9049ca4-9efe-465d-baf6-d4ebadf5d79c">76,274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTUtMS0xLTEtMzkzMzE_4e3bd0f0-e786-4e7e-8910-a8a808e3b2f6">424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTUtMy0xLTEtMzkzMzE_924b5398-8b86-4009-a40f-2f029b8504c7">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTYtMS0xLTEtMzkzMzE_30dba9a7-4e6a-4dfb-af39-3244b41f6bc0">9,021</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTYtMy0xLTEtMzkzMzE_e1d475ad-2f64-42eb-b995-a611fd44ca9c">479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTctMS0xLTEtMzkzMzE_ae890074-b34a-412d-a255-8d91e3cc587f">78,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTctMy0xLTEtMzkzMzE_80541cd5-afba-4f57-8afd-038ad4ae7cea">22,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="ccrn:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTgtMS0xLTEtMzkzMzE_f808afde-935f-4bf9-9aa0-b216593b0522">2,674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" sign="-" name="ccrn:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTgtMy0xLTEtMzkzMzE_0496a7e6-929a-43f0-8df9-e6a03444f514">3,365</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTktMS0xLTEtMzkzMzE_3454808a-0aa3-44f9-b5ce-6dea6d92dd1a">1,824</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTktMy0xLTEtMzkzMzE_c19b6a5f-c371-4d14-981f-46ac850b41f3">122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjAtMS0xLTEtMzkzMzE_88b69c3a-6d2d-4f66-a24a-fb62de9a3462">10,897</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjAtMy0xLTEtMzkzMzE_f78e84e5-40df-4c4a-af44-5e50da9c85a3">9,422</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjMtMS0xLTEtMzkzMzE_86181db0-b919-4eb2-b568-8e53e6f770fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjMtMy0xLTEtMzkzMzE_35abe9de-c134-4651-b6a4-f990ad257ce1">24,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjQtMS0xLTEtMzkzMzE_d319ac4e-176a-4cf3-86a7-2944601ab3a3">3,848</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjQtMy0xLTEtMzkzMzE_a63bd334-a817-45a9-92e1-24ea0b89ef44">3,002</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjUtMS0xLTEtMzkzMzE_a47dc582-9b7e-4025-95d6-466b559dc1d1">3,848</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjUtMy0xLTEtMzkzMzE_6d399c6f-6f94-4227-8c42-b43299cd1715">27,472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjgtMS0xLTEtMzkzMzE_83383b1e-7312-441b-b250-8e8372032a05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjgtMy0xLTEtMzkzMzE_c5db7f44-90c6-495e-b169-1ae2b6ee52f9">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjktMS0xLTEtMzkzMzE_b01c2dfc-1bed-49e1-8054-2bee9900ca25">50,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:RepaymentsOfSecuredDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjktMy0xLTEtMzkzMzE_f1b4f9c9-efc2-46e9-8685-c8e8f2037836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzAtMS0xLTEtMzkzMzE_eee3e5d5-0af1-4ab6-bef2-454a3adfa5d2">3,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzAtMy0xLTEtMzkzMzE_a08f88bf-3b42-4bbd-bac4-f5f37db90b2d">4,465</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings under Senior Secured Asset-Based revolving credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzEtMS0xLTEtMzkzMzE_8f0eff44-380b-4cd5-81c7-090c544b0ef1">900,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzEtMy0xLTEtMzkzMzE_995a96a5-d802-4bc4-a97b-319b33d557a0">273,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments on Senior Secured Asset-Based revolving credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzItMS0xLTEtMzkzMzE_d2ae7084-1d1c-42ce-9f97-3d4bbf975717">824,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzItMy0xLTEtMzkzMzE_bba7dc80-f76e-49f5-94b2-391c8ce19d20">311,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for shares withheld for taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzMtMS0xLTEtMzkzMzE_f5c0efe9-93b7-4a6e-bb2a-367a76f93008">5,267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzMtMy0xLTEtMzkzMzE_6892fa38-60ac-4bc3-acb3-787ec844d70c">2,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzQtMS0xLTEtMzkzMzE_dab24e46-27fd-4eaf-a839-452739daef7d">2,426</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzQtMy0xLTEtMzkzMzE_0b64ac09-56c4-44e4-8c30-2732eb35ae90">2,426</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzYtMS0xLTEtMzkzMzE_c7e63469-7302-490b-8116-b1dc7991abc2">523</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzYtMy0xLTEtMzkzMzE_db338f20-40d3-4b31-9bcf-705ca2f62e33">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzctMS0xLTEtMzkzMzE_33aea0fb-9ab3-434e-994a-62e8b96ed5e3">13,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzctMy0xLTEtMzkzMzE_29ebfebe-2a75-476b-af6b-b1598eb001c6">53,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzktMS0xLTEtMzkzMzE_ef2b004d-6ad2-44ee-90e7-65d5532fab1e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzktMy0xLTEtMzkzMzE_edd74cf7-9e7d-4cf1-80fb-2e4550588a4c">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNDAtMS0xLTEtMzkzMzE_6c09a055-ceae-4c6c-9140-c8ed6145bb28">757</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNDAtMy0xLTEtMzkzMzE_38a20734-c951-48b5-bd8c-bb629892c9f8">16,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNDEtMS0xLTEtMzkzMzE_19605f74-df6d-40a1-8750-5ad732eb5745">1,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681334a1907145ebba1a62d2883f0d2e_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNDEtMy0xLTEtMzkzMzE_9629476d-0be5-402d-bc45-5be0af5f91ed">1,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNDItMS0xLTEtMzkzMzE_12c74b4a-352a-4422-835c-88b75932b50f">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ddb987bb1248dfb24dea790e19f923_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNDItMy0xLTEtMzkzMzE_8020b11b-6af5-4e3f-866a-326cd24f0051">18,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                                                      </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed consolidated financial statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CROSS COUNTRY HEALTHCARE, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)</span></div><div style="text-align:justify"><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_37"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zNy9mcmFnOmU1MTVjMjg4NDk4YzQ0NGY4ZWU0MDYxOWU4ODY5YjJhL3RleHRyZWdpb246ZTUxNWMyODg0OThjNDQ0ZjhlZTQwNjE5ZTg4NjliMmFfMTY5OA_1fcb363d-2c12-421e-9f2e-597256aba169" continuedAt="i816fd684818c41bc85075eb8b4954dd0" escape="true">ORGANIZATION AND BASIS OF PRESENTATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i816fd684818c41bc85075eb8b4954dd0"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zNy9mcmFnOmU1MTVjMjg4NDk4YzQ0NGY4ZWU0MDYxOWU4ODY5YjJhL3RleHRyZWdpb246ZTUxNWMyODg0OThjNDQ0ZjhlZTQwNjE5ZTg4NjliMmFfMTcwMA_3c200846-89b2-45c5-ae1d-0afe37d8f87d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). In the opinion of management, all adjustments necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. All such adjustments consisted of all normal recurring items, including the elimination of all intercompany transactions and balances.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zNy9mcmFnOmU1MTVjMjg4NDk4YzQ0NGY4ZWU0MDYxOWU4ODY5YjJhL3RleHRyZWdpb246ZTUxNWMyODg0OThjNDQ0ZjhlZTQwNjE5ZTg4NjliMmFfMTcwOQ_82ad0bc5-8c0b-42ec-9fa8-d9a52aafded6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (U.S. GAAP) for interim financial information and with the instructions to Form&#160;10-Q and Article 10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021 included in the 2021 Form 10-K. The December&#160;31, 2021 condensed consolidated balance sheet included herein was derived from the December&#160;31, 2021 audited consolidated balance sheet included in the 2021 Form&#160;10-K.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation. See the condensed consolidated statements of cash flows.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNjc2NA_90bfce6a-1c47-4981-bacb-8153f62322b1" continuedAt="i3e073abbe9034c9898c7f6076fdc0b60" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3e073abbe9034c9898c7f6076fdc0b60" continuedAt="ifec8e58f407f42e48cba2def468a3783"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNjc1Mg_afc69d92-fbf1-418a-9b70-039b183d7a58" continuedAt="i121fe6ced4be456cb89f7e95cd6e828f" escape="true">Use of Estimates</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="i121fe6ced4be456cb89f7e95cd6e828f" continuedAt="if0acaadaa97d4df4a19a349948b86969"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Management has assessed various accounting estimates and other matters, including those that require consideration of forecasted financial information, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in context of the unknown future impacts of the global pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> using information that is reasonably available to the Company at the time. Significant estimates and assumptions are used for, but not limited to: (i) the valuation of accounts receivable; (ii) goodwill, trade names, and other intangible assets; (iii) other long-lived assets; (iv) revenue recognition; (v) accruals for health, workers&#8217; compensation, and professional liability claims; (vi) valuation of deferred tax assets; (vii) legal contingencies; and (viii) income taxes. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. As additional information becomes available to the Company, its future assessment of these estimates</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including management's expectations at the time regarding the duration, scope, and severity of the pandemic, as well as other factors,</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if0acaadaa97d4df4a19a349948b86969"> could materially and adversely impact the Company's consolidated financial statements in future reporting periods. Actual results could differ from those estimates.</ix:continuation>  </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prioritizes the mental health and well-being of its employees, especially in response to the COVID pandemic. While operating primarily through a remote workforce, the Company's offices remain open with stringent safety guidelines and procedures in place. Business travel, including visits to healthcare clients, continues to be somewhat limited at the request of the Company's clients who are continuing to cope with the pandemic twenty-four hours a day/seven days a week.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022, average bill rates were down in the mid-single digits as expected, but volumes were stronger as the Company continued to experience high demand across a wide range of specialties spanning the healthcare continuum. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in people and technology, along with other improvements the Company has made during the pandemic, have allowed it to quickly respond to high demand levels that it is continuing to see across a wide range of specialties, including operating room, emergency room, pediatrics, labor and delivery, and medical and surgical services, not all of which are directly related to COVID needs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the pandemic, the Company worked collaboratively with clients on adjusting bill rates in order to adapt to the rapidly changing market conditions. One of the Company's core values is to act ethically and responsibly, and it has been especially important during this pandemic to be transparent and build trust with its clients to re-enforce long-lasting relationships as both demand and bill rates increased to unprecedented levels.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNjc2Ng_a73428c4-16a8-4b17-9d13-4de673cc1d63" continuedAt="i35215315e4dc4a449d445dcdedf7faff" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The timing of revenue recognition, billings, and collections results in billed and unbilled accounts receivable from customers, which are classified as accounts receivable on the condensed consolidated balance sheets and are presented net of allowances for doubtful accounts and sales allowances. Estimated revenue for the Company employees', subcontracted employees', and independent contractors&#8217; time worked but not yet billed at June 30, 2022 and December 31, 2021 totaled $<ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-5" name="us-gaap:UnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfMzU2OQ_9f27ad59-e1b2-4058-975b-26961a8e9473">217.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-5" name="us-gaap:UnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfMzU3Ng_53e801aa-d9e8-4ae3-99a8-6d8b4e312806">140.0</ix:nonFraction>&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts is established for losses expected to be incurred on accounts receivable balances. Accounts receivable are written off against the allowance for doubtful accounts when the Company determines amounts are no longer collectible. Judgment is required in the estimation of the allowance and the Company evaluates the collectability of its accounts receivable and contract assets based on a combination of factors. The Company bases its allowance for doubtful account estimates on its historical write-off experience, current conditions, an analysis of the aging of outstanding receivable and customer payment patterns, and specific reserves for customers in adverse condition adjusted for current expectations for the customers or industry. Based on the information currently available, the Company also considered current expectations of future economic condition</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, including the impact of COVID, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">when estimating its allowance for doubtful accounts.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifec8e58f407f42e48cba2def468a3783"><div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNjc1Mw_ad248e62-da17-4d86-9914-606eca70418f" escape="true"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The opening balance of the allowance for doubtful accounts is reconciled to the closing balance for expected credit losses as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNC0xLTEtMS0zOTMzMQ_8baabf2f-7035-4be0-a7ea-60a1f78feba8">6,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681334a1907145ebba1a62d2883f0d2e_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNC0zLTEtMS0zOTMzMQ_98ac80d9-7a18-4838-bfb2-af797f01188b">3,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i901eb837ca884f56bf62787429027b0d_D20220101-20220331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNS0xLTEtMS0zOTMzMQ_771f39ad-76bb-4570-ac4f-6191031b1478">2,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65d90e4671ee4c59a461a36fb4feb935_D20210101-20210331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNS0zLTEtMS0zOTMzMQ_af34c3f2-5800-4fac-ac0e-8b5fe4bb1941">504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i901eb837ca884f56bf62787429027b0d_D20220101-20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNi0xLTEtMS0zOTMzMQ_aad574eb-5071-4892-aaeb-0b49e243fb2d">365</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65d90e4671ee4c59a461a36fb4feb935_D20210101-20210331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNi0zLTEtMS0zOTMzMQ_da417dc7-a049-4fc6-9821-1f9e781b66f7">699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9d2332650c84b7e8d003bddf5a15b05_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNy0xLTEtMS0zOTMzMQ_12fbc0ba-8c31-4307-8242-75c3af3154d2">8,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90078daa01da46fa9dc40d6cdc958040_I20210331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNy0zLTEtMS0zOTMzMQ_7c8d1122-30ec-48dc-a751-4ff5ece52028">3,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfOC0xLTEtMS0zOTMzMQ_33dce108-7c05-4177-bf79-c34b8c9ad056">3,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfOC0zLTEtMS0zOTMzMQ_eb95bddb-0056-48bf-9ee0-7c0213c941b7">466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfOS0xLTEtMS0zOTMzMQ_5c5ddee8-8ee0-48bc-a3de-12e2a3ba1f9d">426</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfOS0zLTEtMS0zOTMzMQ_b3a53504-6fca-4265-9da7-39ddfdb64fc2">358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfMTAtMS0xLTEtMzkzMzE_86acff3e-afd9-4a5e-a8b3-c2934c4b58af">10,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ddb987bb1248dfb24dea790e19f923_I20210630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfMTAtMy0xLTEtMzkzMzE_1aebc9c4-558b-4ebd-905a-100f08587600">3,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i35215315e4dc4a449d445dcdedf7faff" continuedAt="i9d6a9a86f9f245e6bbb12687c1b5f236">In addition to the allowance for doubtful accounts, the Company maintains a sales allowance for billing-related adjustments which may arise in the ordinary course of business and adjustments to the reserve are recorded as contra-revenue. The balance of this allowance as of June 30, 2022 and December 31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-5" name="ccrn:SalesAllowanceBillingRelatedAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNTE3Ng_65fd63b9-367f-4332-9a38-89bbe6f21219">1.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-5" name="ccrn:SalesAllowanceBillingRelatedAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNTE4Mw_e7172148-a9b2-4523-8a93-a710e403d9ff">0.8</ix:nonFraction>&#160;million, respectively.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9d6a9a86f9f245e6bbb12687c1b5f236">The Company&#8217;s contract terms typically require payment between <ix:nonNumeric contextRef="i6b1af1a6ef9b4991a2becb162f578c28_D20220101-20220630" name="ccrn:ThresholdPeriodPastDueForPaymentOfServicesProvided" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNTI2NQ_e9e0133c-352d-4c89-a53d-8250a1611275">30</ix:nonNumeric> to <ix:nonNumeric contextRef="i3442c709c0ae4842936f9b013f384d0b_D20220101-20220630" name="ccrn:ThresholdPeriodPastDueForPaymentOfServicesProvided" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNTI3MQ_a2da6dca-18e0-4482-a822-1e615bf09f43">60</ix:nonNumeric> days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's customers are U.S. based healthcare systems with a significant percentage in acute-care facilities.</ix:continuation> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single customer accounted for more than 10% of the Company&#8217;s revenue for the three and six months ended June 30, 2022 and 2021, or the accounts receivable balance as of June 30, 2022 and December 31, 2021.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNjc1NA_69167179-18d9-43bf-b4e7-01606bc34640" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring (Benefits) Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring (benefits) costs on the condensed consolidated statements of operations primarily include employee termination costs and lease-related exit costs.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNjc0OA_b9aa442d-80de-44cb-b2f6-8c88f17b1b7f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation of the employee termination costs and lease-related exit costs (benefits) beginning and ending liability balance is presented below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:50.437%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.593%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.742%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Termination</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease-Related</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2b21ab37dd434787d065fd619cd08e_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfMy0xLTEtMS0zOTMzMQ_877fe257-4b4b-4157-abee-9dd038155072">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56adbc127d1b4228a9fb7d5d917ebda6_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfMy0zLTEtMS0zOTMzMQ_23e8b5c3-036a-4fad-9601-3b78e76a1e42">2,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7b147a6f3c4703ad97384ca78b4e51_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNC0xLTEtMS0zOTMzMQ_a59c4659-8638-4c29-928c-2f74a3c79aba">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id41486ab11b34eedb4414956313b30ba_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNC0zLTEtMS0zOTMzMQ_42111aec-c04c-428e-b388-d743cf6bad31">389</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc7b147a6f3c4703ad97384ca78b4e51_D20220101-20220331" decimals="-3" name="ccrn:PaymentsForRestructuringAndAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNS0xLTEtMS0zOTMzMQ_0ec0dc29-81fa-4e1c-b742-9ad89340bce2">160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id41486ab11b34eedb4414956313b30ba_D20220101-20220331" decimals="-3" name="ccrn:PaymentsForRestructuringAndAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNS0zLTEtMS0zOTMzMQ_9b19c65f-2517-4ceb-9e93-7f0726ca1041">192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f024b630474e2eba6a4f4bcaa226b9_I20220331" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNi0xLTEtMS0zOTMzMQ_93fa0e08-1183-4289-bd5c-44b83cf747f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86e3eb14987b43ce8e00a87a48966e2a_I20220331" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNi0zLTEtMS0zOTMzMQ_cd58c2e4-1186-4ac9-bd7d-267ccb98f865">2,620</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77211dc7914343a3b578681823086312_D20220401-20220630" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNy0xLTEtMS0zOTMzMQ_981d5886-19a5-4e7e-b194-fdf94fdcd722">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic88b4cd36ee341d99b6656eabb36c7e7_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNy0zLTEtMS0zOTMzMQ_3b47f037-9d9e-4115-b227-2f8fe7b518b4">1,379</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77211dc7914343a3b578681823086312_D20220401-20220630" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfOC0xLTEtMS0zOTMzMQ_35f6857b-bf45-4d1d-8f31-2c10d0d14f3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic88b4cd36ee341d99b6656eabb36c7e7_D20220401-20220630" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfOC0zLTEtMS0zOTMzMQ_bdc3fe6e-35c7-4c84-be22-5fa0bbd710a0">202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2b2bf1c40f44f96806300198d700199_I20220630" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfOS0xLTEtMS0zOTMzMQ_472fea5a-20a6-48cf-ad46-037ed07d9954">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37eea076df3941df808a4bb9a9957bf9_I20220630" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfOS0zLTEtMS0zOTMzMQ_37d43bb2-936a-40fa-bb98-339fa0a69cf8">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Restructuring (benefits) costs in the condensed consolidated statements of operations for the six months ended June 30, 2022 include a benefit of $<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-5" name="us-gaap:BusinessExitCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNDM5ODA0NjUyMDMzNA_f1eefc3a-fb84-44c7-b466-9de38da0aeb4">1.4</ix:nonFraction>&#160;million associated with the early termination of one of the Company's corporate offices which was previously restructured. Other costs were immaterial for the six months ended June 30, 2022.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RleHRyZWdpb246NGMwYjFhYzg2ZGU0NDY2YTkxZmE2OWYxMTE1NjBjYzlfMzk1_12625a81-5736-4eb6-b9f6-1c4bdb28b7e5" continuedAt="i5a9f13f01ddf4ca481e8e879191178e6" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5a9f13f01ddf4ca481e8e879191178e6" continuedAt="i5fda08a883334d33abed7dcdadedcc28"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RleHRyZWdpb246NGMwYjFhYzg2ZGU0NDY2YTkxZmE2OWYxMTE1NjBjYzlfMzkx_93131373-f520-49cf-abad-a555bd282f55" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues from customer contracts are generated from temporary staffing services and other services. Revenue is disaggregated by segment in the following table. Sales and usage-based taxes are excluded from revenue.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.961%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec98b500e7134221858e7e81d469419a_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMy0xLTEtMS0zOTMzMQ_ca8f0477-7d7f-4080-b29e-a01427c7e2d1">712,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd0f16019530428fa69ea61f71c26e30_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMy0zLTEtMS0zOTMzMQ_492e72aa-5305-4371-82b8-54e7c39c3a86">21,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibec9a7eb25a8452ab4f07a8f19d5a7ca_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMy03LTEtMS0zOTMzMQ_d41d04e0-9210-492f-87e3-7d90c514639e">733,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie19fee64a40e4a429338db3ef66cb9e8_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfNC0xLTEtMS0zOTMzMQ_f80e13b0-e863-4d00-adc6-0a5b98b3a9ae">19,353</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81d0bf790acc4fbf9d552dc8c5ccd7f8_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfNC0zLTEtMS0zOTMzMQ_b01ffaea-7c64-4b47-99f6-7de952bd2cf6">911</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0637eaa261ae423fbb4cfefcf4952957_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfNC03LTEtMS0zOTMzMQ_f62eff6e-97be-477c-811a-a729ce7c0c07">20,264</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd91226911de469ebcf68a20f0c11784_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfNS0xLTEtMS0zOTMzMQ_7f69567a-ee07-4634-a122-2e826134e6d0">731,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48182d1c2a094a3da085fb747d293f3e_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfNS0zLTEtMS0zOTMzMQ_d0494636-7982-407a-80c5-e7d6aeaabfc1">22,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfNS03LTEtMS0zOTMzMQ_920b3af0-cea7-46bc-9bf3-6655cbbd6f79">753,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i796e252f03f54d9bab2ef196b1644ea2_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTAtMS0xLTEtMzkzMzE_8a3f0f39-17f6-4c9e-b5a0-2f8c0616eeb3">308,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491217535f4143388e3f0a3eb3413c6e_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTAtMy0xLTEtMzkzMzE_3cf56379-1d67-4b3c-a1a1-95ae4b61e92d">15,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551d5f3fb9c24cf798e78e30f611b1d0_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTAtNy0xLTEtMzkzMzE_e128ed26-2c18-4235-8edf-90231b69b331">323,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9e70abbbf7c43c7911d3bd4476e4fff_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTEtMS0xLTEtMzkzMzE_d0dc8a74-8533-46db-a6e9-2cdc1f8aeac2">7,669</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85c04ae276924053a85cf7f653efd272_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTEtMy0xLTEtMzkzMzE_b9e59e25-4fc1-4ace-9be1-151fffff0a12">567</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2898ec216b2457c81230fdf865b2026_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTEtNy0xLTEtMzkzMzE_f413a34a-a93d-4839-967f-f00ce5fe5530">8,236</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ccb0817428f4985b0301b681c4ab64a_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTItMS0xLTEtMzkzMzE_8203bbf6-4d1f-4ce0-af41-c5f49e1382a1">316,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee0a4262a80f406a86e3cfc6a645adae_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTItMy0xLTEtMzkzMzE_229c7c0e-2edb-4141-95b6-ffe3831c98a5">15,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTItNy0xLTEtMzkzMzE_b981a28b-3d89-4d4b-baab-35f4ebb25a8e">331,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">  Six Months ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef77dfdd3394746b59eef004634995d_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTctMS0xLTEtMzkzMzE_29ff0131-d623-4e11-bcf6-df0b2e691dde">1,461,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1db1376854a41a8923d1dd5d7564232_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTctMy0xLTEtMzkzMzE_4f0b3047-05c7-4d0b-b959-65fe30f1ed8e">43,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ea3df9e838469981abd5e5723b5fc5_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTctNy0xLTEtMzkzMzE_ca499ebd-12bb-46f9-be43-d938dd393e83">1,504,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61ed7a3d39b74440a4a96aaf98594c7c_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTgtMS0xLTEtMzkzMzE_74dd22d3-6f4e-41f6-8e4f-b5445a1fdf58">35,486</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38297005b1e41d9b478ecea2d5d91e8_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTgtMy0xLTEtMzkzMzE_4c95e1c4-9f9e-4ca7-89b3-6e772424c15b">1,959</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6779ceb8952242a1b84e123a93be0258_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTgtNy0xLTEtMzkzMzE_5ccf6e9d-bfbe-4d22-97b1-6cd6dd956069">37,445</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0d06303bf64411ebac22da90bae8bc6_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTktMS0xLTEtMzkzMzE_4001b803-643c-46d8-bd9e-ac0b58b08155">1,497,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iababccf169c64eb497cc9f14a300ad39_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTktMy0xLTEtMzkzMzE_673213ce-4798-4017-ab6f-800348541f76">45,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTktNy0xLTEtMzkzMzE_caa78af1-4249-4cc3-a4d4-3ebf3c89c5dc">1,542,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> Six Months ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e1810adf8a4e9c8ff08ecbfcd00221_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjQtMS0xLTEtMzkzMzE_72350e23-442a-4cad-a9a3-a907ef603910">614,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa24deb39bf0450eba559976b6616ac0_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjQtMy0xLTEtMzkzMzE_592b6d93-2250-48c3-aae1-8c0f05680c14">30,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d0f582d5c5c480b9e485784c87df1a9_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjQtNy0xLTEtMzkzMzE_6c455729-1228-466a-88eb-106238bb490c">644,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4a09364018146ecb6ada9bb466c7e10_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjUtMS0xLTEtMzkzMzE_10dc2fc3-11d3-40a7-9c02-25128c8cc56c">14,702</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda00ec1c753498c8a69045746a652ca_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjUtMy0xLTEtMzkzMzE_62256862-ebdf-457f-8ed2-8ee1f6fa1e09">1,394</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2eb18fd6b6844a0907cdf3d269c615b_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjUtNy0xLTEtMzkzMzE_a09fd552-3db4-46f9-85a5-abc6dc67ed2a">16,096</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d6e818748004cac8bd53aeb8e5fcb4a_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjYtMS0xLTEtMzkzMzE_0636f75f-3ac1-4db2-b822-c0afac43ef60">629,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6936f0dd73f149a284028ca151da158a_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjYtMy0xLTEtMzkzMzE_f915736c-f886-47ef-892e-bad61452726f">31,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjYtNy0xLTEtMzkzMzE_67a3f408-5ea1-4b5c-83d9-e64ca8f62bfe">661,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     </span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5fda08a883334d33abed7dcdadedcc28">See Note 12 - Segment Data.</ix:continuation>                                                                                                </span></div><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzU3NQ_ffb0035a-be7d-4043-b518-abb199d82ce2" continuedAt="id07ba1e57ce84cb388b70ced000eec1f" escape="true">ACQUISITIONS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id07ba1e57ce84cb388b70ced000eec1f" continuedAt="i6e892601e5ed4ef5ad03dada9414ca7f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selected</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2021, the Company purchased and acquired substantially all of the assets and assumed certain liabilities of Selected, Inc. (Selected) for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i81ed68aa78894c6b82beb72c410707bf_D20211216-20211216" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjA2_74bc3605-a069-437a-80c4-92ab51988639">3.5</ix:nonFraction>&#160;million in cash, subject to adjustment, and $<ix:nonFraction unitRef="usd" contextRef="i81ed68aa78894c6b82beb72c410707bf_D20211216-20211216" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjQ1_36326811-958d-4d7f-b303-b75a077551a4">1.5</ix:nonFraction>&#160;million in shares (or <ix:nonFraction unitRef="shares" contextRef="i81ed68aa78894c6b82beb72c410707bf_D20211216-20211216" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjYy_87f9d041-fc1a-409e-b5f6-6edaa88022aa">59,429</ix:nonFraction> shares) of the Company's common stock. The transaction was treated as a purchase of assets for income tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sellers were eligible to receive up to an additional $<ix:nonFraction unitRef="usd" contextRef="id353cd1c4a224e5ca74c740f0046d0e9_I20211216" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfNTEz_7dbd1f0f-53ff-4a89-ab04-14f27b55a9d7">1.5</ix:nonFraction>&#160;million in earnout cash consideration, based on Selected's revenues for each of the twelve-month periods ending on the first and second anniversaries of the first day after the closing date. In the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6e892601e5ed4ef5ad03dada9414ca7f" continuedAt="ie4766b4e91e544338d0d316f0648acbf"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">second quarter of 2022, the Company determined that the contingent consideration earnout related to the Selected acquisition would not be achieved for 2022 and 2023 and, as a result, the entire liability was reversed. See Note 10 - Fair Value Measurements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assigned the following values to other identifiable intangible assets: (i) an <ix:nonFraction unitRef="usd" contextRef="i60247132b56844b7b090215e36d1bcd5_I20211216" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzg0ODI5MDcwMjE4Mw_ba2e571a-79f3-4808-9a98-7ecb8f84bdf8">immaterial</ix:nonFraction> amount to trade names with a weighted average estimated useful life of <ix:nonNumeric contextRef="i9c13f3c9c6d5496795d1db28f45e48bf_D20211216-20211216" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfNDM5ODA0NjUxNjcyOQ_d9991f96-c9cd-4ea7-b159-12de6500d929">2</ix:nonNumeric> years; (ii) $<ix:nonFraction unitRef="usd" contextRef="ib3ea81fad99645bf83db89997adc7652_I20211216" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzg0ODI5MDcwMjA0MA_28012367-933e-4ddc-a378-852d0fcf6bd0">1.7</ix:nonFraction>&#160;million to software with a weighted average estimated useful life of <ix:nonNumeric contextRef="ibfc8232348364f31b8fab71bfb70b6e5_D20211216-20211216" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfNDM5ODA0NjUxNjczMA_c790f6f5-4ca7-4688-a57a-4c6479c69b51">5</ix:nonNumeric> years; and (iii) $<ix:nonFraction unitRef="usd" contextRef="ic62e27dff65649e6b35f5937f91d27d5_I20211216" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzg0ODI5MDcwMjA1Nw_b60b8874-4ae6-4638-9ba2-40dac30f3244">2.9</ix:nonFraction>&#160;million to a database, consisting of education professionals, with a weighted average estimated useful life of <ix:nonNumeric contextRef="if26f3065692a439ea180f58828581dab_D20211216-20211216" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfNDM5ODA0NjUxNjczMQ_753f82e3-5179-4d73-aa62-591bd0eca6c4">5</ix:nonNumeric> years, for a total of $<ix:nonFraction unitRef="usd" contextRef="id353cd1c4a224e5ca74c740f0046d0e9_I20211216" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzg0ODI5MDcwMjE5Mg_f4f6e994-1cfe-4a3a-8f17-65cb15caa322">4.6</ix:nonFraction>&#160;million in definite life intangible assets with a weighted average estimated useful life of <ix:nonNumeric contextRef="i81ed68aa78894c6b82beb72c410707bf_D20211216-20211216" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfNDM5ODA0NjUxNjczMg_efaaff99-873d-4e74-9f12-340897aaf10d">5</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining excess purchase price over the fair value of net assets acquired of $<ix:nonFraction unitRef="usd" contextRef="id353cd1c4a224e5ca74c740f0046d0e9_I20211216" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzg0ODI5MDcwMjgxMQ_c006fcd8-4e4c-4778-a86a-2267e17bd887">0.4</ix:nonFraction>&#160;million was recorded as goodwill on the Company's condensed consolidated balance sheets. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was not significant and has been accounted for using the acquisition method of accounting. Associated immaterial acquisition-related costs incurred have been included in acquisition and integration-related costs on the Company's condensed consolidated statements of operations for the six months ended June 30, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross Country Workforce Solutions Group (CCWSG)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 8, 2021, the Company purchased and acquired substantially all of the assets and assumed certain liabilities of Workforce Solutions Group, Inc. (WSG) for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="idff5fc97df814ca3a4732c20943377d7_D20210608-20210608" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMTY0MQ_b6d48a06-c000-41b6-980f-6fd757fd1daf">25.0</ix:nonFraction>&#160;million in cash and $<ix:nonFraction unitRef="usd" contextRef="idff5fc97df814ca3a4732c20943377d7_D20210608-20210608" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMTY1Ng_71073730-6fd7-4434-87e7-21bbde2c427a">5.0</ix:nonFraction>&#160;million in shares (or <ix:nonFraction unitRef="shares" contextRef="idff5fc97df814ca3a4732c20943377d7_D20210608-20210608" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMTY3Mw_06333609-ed6e-418a-8037-274c356df940">307,730</ix:nonFraction> shares) of the Company's common stock. The parties agreed to a final net working capital reduction of $<ix:nonFraction unitRef="usd" contextRef="id1d9b43633a64c3b89445a5e452d6ea7_D20211001-20211231" decimals="-5" name="ccrn:BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMTc3OA_c181d15b-576e-4513-b981-e9d5f4aa2d92">1.1</ix:nonFraction>&#160;million which was received in the fourth quarter of 2021. The transaction was treated as a purchase of assets for income tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sellers are also eligible to receive an earnout based on the business' performance through <ix:nonNumeric contextRef="idff5fc97df814ca3a4732c20943377d7_D20210608-20210608" name="ccrn:BusinessCombinationContingentConsiderationTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjAwMw_ee91b710-387e-4fe3-aa75-f767a96dae0f">three years</ix:nonNumeric> after the acquisition date that could provide up to an additional $<ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjA3Mg_b7ef1591-e8cd-467f-8190-e2c75e1c9750">15.0</ix:nonFraction>&#160;million in cash. The current portion of the liability of $<ix:nonFraction unitRef="usd" contextRef="i2a281909e341489e93181970ce395c4b_I20220630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjEyNA_0a9ab7d3-40f5-49f9-a27b-23c1a2c5daab">7.5</ix:nonFraction>&#160;million is included in current portion of earnout liability and the non-current portion of $<ix:nonFraction unitRef="usd" contextRef="i2a281909e341489e93181970ce395c4b_I20220630" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjIxMA_c7dd6a19-a489-45d7-aa26-4b55ac9604aa">7.5</ix:nonFraction>&#160;million is included in non-current earnout liability on the condensed consolidated balance sheets. See Note 10 - Fair Value Measurements.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzU3NA_a1d5c8c5-cb4e-447e-901f-e8bce82fccb1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the assets acquired and liabilities assumed on June 8, 2021:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMS0xLTEtMS0zOTMzMQ_43b2dcbc-e4c5-49ef-9522-0055e3f551ca">957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMi0xLTEtMS0zOTMzMQ_5daf47a8-a5a5-417c-8d49-c70fe7d97427">11,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMy0xLTEtMS0zOTMzMQ_94500847-82ee-497d-bb32-ae5a2caf9d24">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfNC0xLTEtMS0zOTMzMQ_d2bc6959-0383-47ca-862f-f7f17f968671">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfNS0xLTEtMS0zOTMzMQ_11f150e8-184d-4b73-a5dc-f4edd10bf0ea">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfNi0xLTEtMS0zOTMzMQ_27d6d608-d359-461d-b905-2a21b78a43a1">22,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfNy0xLTEtMS0zOTMzMQ_143d34f1-f9a8-441b-bd9b-ac91a6ccfbfa">14,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfOC0xLTEtMS0zOTMzMQ_fd0b068e-e773-4c1b-b3ba-7dae36087e03">50,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfOS0xLTEtMS0zOTMzMQ_bfed23a5-0b4a-4865-8e38-8a85803451b9">3,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMTAtMS0xLTEtMzkzMzE_5594816e-8f2e-41e8-9a07-9cbb3b974f5b">1,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="ccrn:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMTEtMS0xLTEtMzkzMzE_b2e58728-29db-4ec1-8614-665d0506a8e0">316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="ccrn:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMTItMS0xLTEtMzkzMzE_75c44932-8b10-4b2c-8329-23b63287f18c">762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMTMtMS0xLTEtMzkzMzE_9ec43a55-5d99-4d3b-93ff-47d22022307e">15,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMTQtMS0xLTEtMzkzMzE_8cee4573-8dfd-4132-a2a6-f5aba413b1db">21,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMTUtMS0xLTEtMzkzMzE_2d5a0ffd-3748-4eec-9407-63a1e5bb3430">29,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assigned a value to other identifiable intangible assets of $<ix:nonFraction unitRef="usd" contextRef="ia1c9b2c7cc8a4a979b20f24f8720ad94_I20210608" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjUzMA_60c86c49-a6c4-49dd-8e51-af1f8fc8d6ef">14.2</ix:nonFraction>&#160;million in customer relationships with a weighted average estimated useful life of <ix:nonNumeric contextRef="ib19a69210f684fa48653b01303c034bf_D20210608-20210608" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjYwOA_ee106b58-cdce-43c3-9afb-977d881ab635">11.5</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining excess purchase price over the fair value of net assets acquired of $<ix:nonFraction unitRef="usd" contextRef="i1671691aefa34321882545ccf2019faf_I20210608" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjY5NQ_6344d554-7d34-4a29-be3c-7242bf0a3085">22.1</ix:nonFraction>&#160;million was recorded as goodwill on the Company's condensed consolidated balance sheets. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie4766b4e91e544338d0d316f0648acbf">The acquisition was not significant and has been accounted for using the acquisition method of accounting. The pro-forma impact on the Company's consolidated revenue from services and net income, including the pro forma effect of events that are directly attributable to the acquisition, was not significant.</ix:continuation> </span></div><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_49"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180OS9mcmFnOjZkNjYwZTY0OGUxOTRjZjE4OTQxNzc1NjMxODdhYzFhL3RleHRyZWdpb246NmQ2NjBlNjQ4ZTE5NGNmMTg5NDE3NzU2MzE4N2FjMWFfODM3_87563906-04a4-4705-af53-39b09a3a078a" continuedAt="i52c863dc2385425eb2a0b34f86cdf550" escape="true">COMPREHENSIVE INCOME</ix:nonNumeric></span></div><ix:continuation id="i52c863dc2385425eb2a0b34f86cdf550"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total comprehensive income includes net income or loss and foreign currency translation adjustments, net of any related deferred taxes, and is included within the accompanying condensed consolidated statements of operations. Certain of the Company&#8217;s foreign subsidiaries use their respective local currency as their functional currency. Assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying condensed consolidated balance sheets and was an unrealized loss of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-5" sign="-" name="ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180OS9mcmFnOjZkNjYwZTY0OGUxOTRjZjE4OTQxNzc1NjMxODdhYzFhL3RleHRyZWdpb246NmQ2NjBlNjQ4ZTE5NGNmMTg5NDE3NzU2MzE4N2FjMWFfNzk3_3de3e541-7558-4454-90e4-e5b772e2837d">1.4</ix:nonFraction>&#160;million at June 30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-5" sign="-" name="ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180OS9mcmFnOjZkNjYwZTY0OGUxOTRjZjE4OTQxNzc1NjMxODdhYzFhL3RleHRyZWdpb246NmQ2NjBlNjQ4ZTE5NGNmMTg5NDE3NzU2MzE4N2FjMWFfODIy_a2d9ca17-85b3-4091-b460-5e62431ff1c9">1.3</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> at December&#160;31, 2021.</span></div></ix:continuation><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_52"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RleHRyZWdpb246ZjVkY2VlNDM1NmVlNDBhYThjMWM4NjdmODI2OWQwOGRfNjE2_6d3c9cb5-3496-47f4-9fe2-5cda8399f137" continuedAt="i091f713e9a3a4579b723f16a483eac84" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><ix:continuation id="i091f713e9a3a4579b723f16a483eac84"><div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RleHRyZWdpb246ZjVkY2VlNDM1NmVlNDBhYThjMWM4NjdmODI2OWQwOGRfNjE3_f7d992ce-6dbf-417e-ba6c-61dd4e3013ed" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.115%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(amounts in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common stockholders - Basic and Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS0xLTEtMS0zOTMzMQ_59c0b380-6f2d-4cdc-bf5c-6e7fced5a390"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS0xLTEtMS0zOTMzMQ_cd3582dd-adc3-4bf9-8b8d-2568cd690a13">52,894</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS0zLTEtMS0zOTMzMQ_05fe1b13-5ea1-47c1-b2ea-b23489458277"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS0zLTEtMS0zOTMzMQ_9939e6eb-e91d-452f-a761-55dfd7f7fda3">11,548</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS01LTEtMS0zOTMzMQ_24915f90-af4a-4194-a2f9-aba2b8f5809f"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS01LTEtMS0zOTMzMQ_4d62d431-33ba-42e8-bb8b-a86151701d08">114,877</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS03LTEtMS0zOTMzMQ_31925176-a353-49f4-81b1-10b30fd03bd3"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS03LTEtMS0zOTMzMQ_547d5f65-1c7f-46a6-8b9e-d22ebacf1cfc">30,996</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares - Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfOC0xLTEtMS0zOTMzMQ_d9e811bb-aeaf-4754-b28a-40db03f3285a">37,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfOC0zLTEtMS0zOTMzMQ_c35307a8-450d-4362-8a6e-5a5125bc94e0">36,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfOC01LTEtMS0zOTMzMQ_083a7aaf-270f-4bb8-a15a-d668abc49f39">37,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfOC03LTEtMS0zOTMzMQ_fa5d8ae2-cb25-403b-a656-487c3824a33e">36,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of diluted shares:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTAtMS0xLTEtMzkzMzE_8cf5955a-f632-4508-bcdf-823c6a5a1d2a">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTAtMy0xLTEtMzkzMzE_b7239229-ae10-4965-9da6-ac6c6933529f">578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTAtNS0xLTEtMzkzMzE_fca7a5bf-bc17-4304-9774-cc983c4e8f7d">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTAtNy0xLTEtMzkzMzE_6aa34075-9c8a-448b-b0a3-46dea3dc1835">716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares - Diluted</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTEtMS0xLTEtMzkzMzE_da9f25c8-6932-4029-be34-5681bb56090b">37,757</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTEtMy0xLTEtMzkzMzE_051ff3de-88ef-457d-abc8-bb3bdc531fd0">37,203</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTEtNS0xLTEtMzkzMzE_36b0f0fd-c64d-4fff-b958-dd679b37f5fb">37,866</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTEtNy0xLTEtMzkzMzE_bc74d315-b85e-4b77-a303-bf48586b6bc9">37,120</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTMtMS0xLTEtMzkzMzE_cdbc517c-cf90-4d5c-944a-3e95f0b71b59">1.41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTMtMy0xLTEtMzkzMzE_1eee09c7-d6e7-42c3-8213-1399c30d5a69">0.32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTMtNS0xLTEtMzkzMzE_7708ab08-4488-47e2-b56a-730ab021b924">3.08</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTMtNy0xLTEtMzkzMzE_ccb4a89b-a91d-45a6-a11c-a09f9323578e">0.85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Diluted</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTUtMS0xLTEtMzkzMzE_b1d02290-1f71-4a23-b9c2-5dc3b071b7a9">1.40</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTUtMy0xLTEtMzkzMzE_46a59f82-28e9-4767-a0a4-89e27199116e">0.31</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTUtNS0xLTEtMzkzMzE_bd2bad28-5bac-419f-9309-9dd07821369f">3.03</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTUtNy0xLTEtMzkzMzE_ccfda9ea-1c22-4ef7-87c0-f3d6e18e3644">0.84</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RleHRyZWdpb246ZjVkY2VlNDM1NmVlNDBhYThjMWM4NjdmODI2OWQwOGRfNDM5ODA0NjUxMjExMA_f195302b-e2fa-47a0-a0c9-6bfa8c9b77f4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the share-based awards that could potentially dilute net income per share attributable to common stockholders in the future that were not included in the computation of diluted net income per share attributable to common stockholders because to do so would have been anti-dilutive for the periods presented.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a171810dfba45719542dcd325b21e11_D20220401-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOjc4NDM2MjMwYjljYTQ5MGViMDdlZTU1ZTQ3MjI0ODk5L3RhYmxlcmFuZ2U6Nzg0MzYyMzBiOWNhNDkwZWIwN2VlNTVlNDcyMjQ4OTlfNC0xLTEtMS00NDUyMQ_7fa9d64f-3cb5-4a8c-b952-ac34b0abba2d">220</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i12dc2febc4c84d4288a4906fe94e7c1b_D20210401-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOjc4NDM2MjMwYjljYTQ5MGViMDdlZTU1ZTQ3MjI0ODk5L3RhYmxlcmFuZ2U6Nzg0MzYyMzBiOWNhNDkwZWIwN2VlNTVlNDcyMjQ4OTlfNC0zLTEtMS00NDUyMQ_b24b0542-5485-4c40-8926-38b1505f5400">21</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10b1ca7fabaa4095b85f6b18a5b65654_D20220101-20220630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOjc4NDM2MjMwYjljYTQ5MGViMDdlZTU1ZTQ3MjI0ODk5L3RhYmxlcmFuZ2U6Nzg0MzYyMzBiOWNhNDkwZWIwN2VlNTVlNDcyMjQ4OTlfNC01LTEtMS00NDUyMQ_a2728943-5db4-467b-955a-0923e46ca728">110</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib72123a2c3914fce9452ab74a8a3a3ba_D20210101-20210630" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOjc4NDM2MjMwYjljYTQ5MGViMDdlZTU1ZTQ3MjI0ODk5L3RhYmxlcmFuZ2U6Nzg0MzYyMzBiOWNhNDkwZWIwN2VlNTVlNDcyMjQ4OTlfNC03LTEtMS00NDUyMQ_2bd75778-d6f3-4bbb-ae35-cbb20a4d4d0f">13</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RleHRyZWdpb246NmI2ZTY3ZDVhYzYwNDk0Zjg3YTVjNjcwNzY3NDBlNmFfMjk1Ng_139ca939-297e-4125-8945-0b0d106c4553" continuedAt="i86236a55503e4622b252b0bcb6c20716" escape="true">GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i86236a55503e4622b252b0bcb6c20716" continuedAt="if97c98d4185847ee8ac96b12e845977e"><div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RleHRyZWdpb246NmI2ZTY3ZDVhYzYwNDk0Zjg3YTVjNjcwNzY3NDBlNmFfMjk0NA_21857151-13f1-4f38-8ab4-d4d88c1be473" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had the following acquired intangible assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets subject to amortization:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Databases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i539c9e6b43fb478fae6799603240e6dc_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNC0xLTEtMS0zOTMzMQ_6e7acab8-a10a-406c-8178-b4fa6c998aab">33,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i539c9e6b43fb478fae6799603240e6dc_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNC0zLTEtMS0zOTMzMQ_9d9288a2-4890-4852-b7ee-21824aecf8bc">20,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i539c9e6b43fb478fae6799603240e6dc_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNC01LTEtMS0zOTMzMQ_0a566279-8b6b-4f39-8b2e-b36c681fe834">13,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207e780bad744a04ae7391b8036f801f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNC03LTEtMS0zOTMzMQ_9e856a10-9113-4df7-8c5a-38871b2f0f61">30,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207e780bad744a04ae7391b8036f801f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNC05LTEtMS0zOTMzMQ_c9440e45-cbf0-4278-b833-18c5dd2b9cf0">18,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207e780bad744a04ae7391b8036f801f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNC0xMS0xLTEtMzkzMzE_bd56502a-10eb-439d-b3c9-ca8ce9ba05ed">12,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d386cdc5efb4d9582172fa5148def89_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNS0xLTEtMS0zOTMzMQ_f1432fa3-0f3e-47ef-a615-f39c7db6643b">47,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d386cdc5efb4d9582172fa5148def89_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNS0zLTEtMS0zOTMzMQ_9dcbe208-d674-4c14-80c4-28dffcc0eeb2">19,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d386cdc5efb4d9582172fa5148def89_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNS01LTEtMS0zOTMzMQ_d2e95900-e4aa-4d10-9ad1-d7171bab069f">28,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32f84c71196b460ab5a3ae5a4826c77e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNS03LTEtMS0zOTMzMQ_d354048e-364c-466a-9277-37a50cc8eeaf">47,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32f84c71196b460ab5a3ae5a4826c77e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNS05LTEtMS0zOTMzMQ_b9433eb3-519c-44ce-b4f7-f9c2eed3bada">17,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32f84c71196b460ab5a3ae5a4826c77e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNS0xMS0xLTEtMzkzMzE_cc465e27-3ff7-4504-a81b-82e9dfe7dcf0">30,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36e0417ede14c6988b1777707b1f8f9_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNi0xLTEtMS0zOTMzMQ_bf8b0ddf-bd62-47d6-82a3-0d4361f546c4">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36e0417ede14c6988b1777707b1f8f9_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNi0zLTEtMS0zOTMzMQ_c4bdc802-cc76-437e-970f-2aa6ddb6c931">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic36e0417ede14c6988b1777707b1f8f9_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNi01LTEtMS0zOTMzMQ_b3ae5aa6-9a76-4359-be6b-0676817b4798">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca6652933cd479d898cbf242f81426d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNi03LTEtMS0zOTMzMQ_9051ce31-f6c8-4e84-8ef9-e887291ffa0c">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca6652933cd479d898cbf242f81426d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNi05LTEtMS0zOTMzMQ_45c70697-c998-40c3-b271-d2eff31ede0f">272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca6652933cd479d898cbf242f81426d_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNi0xMS0xLTEtMzkzMzE_7526591a-bba7-45a1-92a4-3318120eb2a1">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieabbbda1a0c74a69bcac845525179f61_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy0xLTEtMS00Mjk1Mg_d7abc423-0e4c-400d-ad11-bb22294ddb2d">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieabbbda1a0c74a69bcac845525179f61_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy0zLTEtMS00Mjk1Mg_c71393ea-9ade-4b9d-93eb-38f71fb7d897">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieabbbda1a0c74a69bcac845525179f61_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy01LTEtMS00Mjk1Mg_3bd306b7-13af-4b45-bdfd-ca90dd8b2992">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f1314ae8d2a4bef96916b457d74c9c8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy03LTEtMS00Mjk1Mg_b20e54d8-38da-45c5-8429-833179553e7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f1314ae8d2a4bef96916b457d74c9c8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy05LTEtMS00Mjk1Mg_654716ce-5f1f-4527-888c-4eef5fe0b13e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f1314ae8d2a4bef96916b457d74c9c8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy0xMS0xLTEtNDI5NTI_a7eaf6e0-a39e-46a0-a943-3c3ce78eda72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f0cc98b9f24950a7b4b12b08aefbd3_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfOC0xLTEtMS00Mjk2Ng_c9053fb0-bafb-4b9e-ac2b-3d9b701e729d">1,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f0cc98b9f24950a7b4b12b08aefbd3_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfOC0zLTEtMS00Mjk2Ng_b0b15dec-2974-4cb7-8337-0df3865a57f2">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f0cc98b9f24950a7b4b12b08aefbd3_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfOC01LTEtMS00Mjk2Ng_ffb2a060-4cb1-4dee-9bab-ce1a6fd818f6">1,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc74fefee46742279f8b45d775c187b8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfOC03LTEtMS00Mjk2Ng_f1a704f3-4c1f-442e-b65d-bbd2640ed1ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc74fefee46742279f8b45d775c187b8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfOC05LTEtMS00Mjk2Ng_b416f5b9-d550-4918-9aa7-a8d7b29e023e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc74fefee46742279f8b45d775c187b8_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfOC0xMS0xLTEtNDI5NjY_1a078db8-eed7-42b9-b371-da4ee9b27707">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy0xLTEtMS0zOTMzMQ_7bcfbfa1-36f2-492f-b4e6-bb9d7e60104b">83,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy0zLTEtMS0zOTMzMQ_9d8aa4ee-8075-416d-b50f-1f6124c79add">40,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy01LTEtMS0zOTMzMQ_4b8f63e3-4758-4b67-bdfe-8db3e2bc4e95">42,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy03LTEtMS0zOTMzMQ_894e6377-479e-4fa2-9ca1-5d2e01a1e0fd">78,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy05LTEtMS0zOTMzMQ_c838b346-1c98-4ec3-8625-e1b127198ad3">36,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy0xMS0xLTEtMzkzMzE_86f43fd7-4944-4106-9510-8eec96ec7a12">42,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets not subject to amortization:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names, indefinite-lived</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:IndefiniteLivedTradeNames" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfMTAtNS0xLTEtMzkzMzE_263d4385-35ad-4b35-815b-3f874e0ddb97">5,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedTradeNames" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfMTAtMTEtMS0xLTM5MzMx_caa79cb7-a8b6-45f3-a544-7b374277ebbd">5,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RleHRyZWdpb246NmI2ZTY3ZDVhYzYwNDk0Zjg3YTVjNjcwNzY3NDBlNmFfMjk0NQ_7561e2d3-3a71-4030-ad4c-6e5f70c92044" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, estimated annual amortization expense is as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:80.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfMi0xLTEtMS0zOTMzMQ_7d89d1b4-79eb-4b8b-9fa5-b18c11c5b22d">4,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfMy0xLTEtMS0zOTMzMQ_e0ad6de5-bd61-4425-95fb-5909a745ae3f">8,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfNC0xLTEtMS0zOTMzMQ_3d07b2e7-6b12-4cf9-b83f-49a59c5bb94b">7,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfNS0xLTEtMS0zOTMzMQ_7e6d1755-1312-418b-9927-ee0dd402f785">6,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfNi0xLTEtMS0zOTMzMQ_30983343-0749-4559-bf8a-aafd0f635a7f">5,632</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="ccrn:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfNy0xLTEtMS0zOTMzMQ_6d94d06d-3e5a-4df8-8159-42b684f80ee4">10,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfOC0xLTEtMS0zOTMzMQ_4e058302-451b-45f6-a5e9-be1b5de4dab6">42,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if97c98d4185847ee8ac96b12e845977e"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RleHRyZWdpb246NmI2ZTY3ZDVhYzYwNDk0Zjg3YTVjNjcwNzY3NDBlNmFfNDM5ODA0NjUxNjQ0Ng_2d4edb41-e7ea-4107-9382-098385f741e5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The changes in the carrying amount of goodwill by reportable segment are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate goodwill acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b7d147bfc6416cabda9cebd8aef26b_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMy0xLTEtMS00MTk3NA_a805381f-ac99-45c6-a089-e1ae63f21158">396,446</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04576ab71ad14259b8dde82aaf1a434d_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMy0zLTEtMS00MTk3NA_2f962e66-6de9-4044-a67e-ca2a8143644c">43,405</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMy01LTEtMS00MTk3NA_f2a13139-66d4-452c-ae9c-55c82fcd5b6d">439,851</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic64dfa83d28e423e96e7ed34d4fd500c_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNC0xLTEtMS00MTk3NA_472fa93c-8be7-426d-baba-363fed81e047">9,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76c278957a754512b8adac480fa3184b_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNC0zLTEtMS00MTk3NA_17fecac1-1b82-4224-8ff5-fa86ae16ae51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1105535cc021464682c0f1266a44a41f_I20211231" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNC01LTEtMS00MTk3NA_6bf7d2d9-483c-4575-a47d-13d45789f4e9">9,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50b7d147bfc6416cabda9cebd8aef26b_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNS0xLTEtMS00MTk3NA_4b46616d-2423-493d-9dca-3035633562cd">269,874</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04576ab71ad14259b8dde82aaf1a434d_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNS0zLTEtMS00MTk3NA_74ef288b-52e2-4071-b491-b96ea0211e6c">40,598</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNS01LTEtMS00MTk3NA_d5d5964f-15bf-48c3-ab3d-9be3f78204a7">310,472</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net of impairment loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b7d147bfc6416cabda9cebd8aef26b_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNi0xLTEtMS00MTk3NA_765d3746-f999-444b-8993-9cb9fb492e0f">116,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04576ab71ad14259b8dde82aaf1a434d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNi0zLTEtMS00MTk3NA_4a792d37-4c45-4600-8757-18b55309a505">2,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNi01LTEtMS00MTk3NA_d723c0bf-d125-4e3f-8580-9f42edc72240">119,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes to aggregate goodwill in 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquisition adjustment - Selected </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0d06303bf64411ebac22da90bae8bc6_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfOS0xLTEtMS00MTk3NA_01c91f0c-cd91-4a21-a178-7096353c88e0">6,130</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iababccf169c64eb497cc9f14a300ad39_D20220101-20220630" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfOS0zLTEtMS00MTk3NA_51ec9839-0928-43e2-9f42-23043e9fafd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfOS01LTEtMS00MTk3NA_b4a2be9c-7b2d-4e4f-8f76-5bde6cce4ea8">6,130</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8742261c00d64b76a788ed6c05a3ad95_I20220630" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTItMS0xLTEtNDE5NzQ_7db57869-e21f-4b7b-b828-fbbdf736f8df">390,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e8f0444e0d4d5eb1c366333ffac9d3_I20220630" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTItMy0xLTEtNDE5NzQ_98163feb-3960-4893-bea3-19c7e4dc1bc4">43,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTItNS0xLTEtNDE5NzQ_5039fbed-240c-4e7c-9783-52299ccad46b">433,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of business</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie958469fcde64897ae4e65a0e3c3dca4_I20220630" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTMtMS0xLTEtNDE5NzQ_8108f028-f65d-47c8-bf99-5148e0ad4c97">9,889</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4278c04c7f5f4845bcc68a5828e1da06_I20220630" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTMtMy0xLTEtNDE5NzQ_8f45c6e4-2c1e-4c6c-b69d-23bfbc8531f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09567f48a192498ab1e23194314c8143_I20220630" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTMtNS0xLTEtNDE5NzQ_893a805a-4dda-472b-bba9-ee66a5d9c42f">9,889</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8742261c00d64b76a788ed6c05a3ad95_I20220630" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTQtMS0xLTEtNDE5NzQ_7c356888-9719-43e0-958e-ed49c969904f">269,874</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3e8f0444e0d4d5eb1c366333ffac9d3_I20220630" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTQtMy0xLTEtNDE5NzQ_3c78dc17-b36e-4171-ab14-c275520dacf7">40,598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTQtNS0xLTEtNDE5NzQ_bab08349-3dfc-4807-9e7d-48661d29d03d">310,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net of impairment loss</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8742261c00d64b76a788ed6c05a3ad95_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTUtMS0xLTEtNDE5NzQ_7311a0f7-cf4b-4e51-ba05-e39a82b40699">110,553</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3e8f0444e0d4d5eb1c366333ffac9d3_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTUtMy0xLTEtNDE5NzQ_968ee99c-da45-42c8-878c-d335e6d84269">2,807</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTUtNS0xLTEtNDE5NzQ_fd11dc8c-6cd1-4255-8dd2-f08c817f4a20">113,360</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Represents an adjustment to the fair value of the identifiable net assets acquired, with a corresponding offset to goodwill, made during the measurement period related to the acquisition of Selected. See Note 4 - Acquisitions.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Goodwill, Trade Names, and Other Intangible Assets Impairment </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests reporting units&#8217; goodwill and intangible assets with indefinite lives for impairment annually during the fourth quarter and more frequently if impairment indicators exist. The Company performs quarterly qualitative assessments of significant events and circumstances such as reporting units&#8217; historical and current results, assumptions regarding future performance, strategic initiatives and overall economic factors,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> including COVID,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and macro-economic developments, to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of reporting units or intangible assets is less than their carrying value. If indicators of impairments are identified a quantitative impairment test is performed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022 and 2021, the Company performed a qualitative assessment of each of its reporting units and determined it was not more likely than not that the fair value of its reporting units dropped below their carrying value. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lthough management believes that the Company's current estimates and assumptions utilized in its qualitative testing are reasonable and supportable, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including its assumptions on the impact and timing related to COVID,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> there can be no assurance that the estimates and assumptions management used for purposes of its qualitative assessment as of June 30, 2022 will prove to be accurate predictions of future performance.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For its long-lived assets and definite-lived intangible assets, the Company reviews for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. As of June 30, 2022, the Company performed a qualitative assessment of its trade names and other intangible assets and determined it was not more likely than not that their carrying value may not be recoverable. During the six months ended June 30, 2021, the Company wrote off a discontinued software development project, resulting in an immaterial impairment charge.</span></div></ix:continuation><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_58"></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfOTQwMg_455bb6ea-f8dd-45cd-8815-fb0736d59308" continuedAt="i321c3741fc2c4fa8a8a4a446f8f642c6" escape="true">DEBT</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i321c3741fc2c4fa8a8a4a446f8f642c6" continuedAt="i6179f7bbaed1499e811cc62851d7a853"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfOTQxMg_5bbec4ad-b2db-4b86-ad9e-066d1ffb00bc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's long-term debt consists of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, interest of <ix:nonFraction unitRef="number" contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfMy0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOjRiNTY5NmRjYjU3NDQ1MWRiY2QxOWE2MjM1ZjM3ZWI3XzI3_f5772e24-1362-475d-9bf5-3561f05ae0fa">7.39</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i59183c7b0a0d42569a396d37e5f31cf2_I20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfMy0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOjRiNTY5NmRjYjU3NDQ1MWRiY2QxOWE2MjM1ZjM3ZWI3XzI3NDg3NzkwNjk1OTE_49ee3c8b-45cb-4eae-b03e-e53947ad150b">6.50</ix:nonFraction>% at June 30, 2022 and December 31, 2021, respectively</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfMy0xLTEtMS0zOTMzMQ_b071502d-9a82-41b3-be2d-d88a8158796a">123,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfMy0zLTEtMS0zOTMzMQ_f0279f85-afae-4a01-9d51-911cfa686dbc">3,499</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59183c7b0a0d42569a396d37e5f31cf2_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfMy01LTEtMS0zOTMzMQ_645e02fe-3ea9-46fc-9dea-ed365185a264">174,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59183c7b0a0d42569a396d37e5f31cf2_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfMy03LTEtMS0zOTMzMQ_d551f5e4-c3e2-451b-9a41-37dccf3b391a">5,396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Asset-Based Loan, interest of <ix:nonFraction unitRef="number" contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNC0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOmYxYWMwYmIzZTVlZjQ3MjdhM2I1NjNhMTYxODBhMWVlXzQ5_aa847823-d029-4b4d-83a1-8d5babdaa7f1">3.12</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i5a27e7c144ff4f158da5313fe7ca7cf6_I20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNC0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOmYxYWMwYmIzZTVlZjQ3MjdhM2I1NjNhMTYxODBhMWVlXzU2_d244a28e-fe69-48c6-a45a-bb2eae1351e3">1.60</ix:nonFraction>% at June 30, 2022 and December 31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNC0xLTEtMS0zOTMzMQ_871a9e6a-3a6f-45fd-a61e-7081f38ebfd9">85,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNC0zLTEtMS0zOTMzMQ_f7830119-693d-4aca-a06f-4ed1d293f775">3,848</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a27e7c144ff4f158da5313fe7ca7cf6_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNC01LTEtMS0zOTMzMQ_76ac289e-3f76-46cd-ab8b-47e36e04850c">9,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a27e7c144ff4f158da5313fe7ca7cf6_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNC03LTEtMS0zOTMzMQ_2e805510-f797-4345-a425-4a6c29fcacd3">991</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Payable, interest of <ix:nonFraction unitRef="number" contextRef="i4e98009a6e864c61960639454ed150b9_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNS0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOjkzMjE4M2Q0YzdiYjRkYWE4MWZjZGIwN2IyYjVlNGNkXzMw_58717450-ee71-4498-9b87-10780ef7d0f9">2.00</ix:nonFraction>% per annum at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifefa74c81dd046a4a182bdbcbbcd35d9_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNS0xLTEtMS0zOTMzMQ_cced58e0-50e9-4e0b-9efd-0af413929549">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifefa74c81dd046a4a182bdbcbbcd35d9_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNS0zLTEtMS0zOTMzMQ_821fd933-71ff-4e49-b5a2-cf764dc7764b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e98009a6e864c61960639454ed150b9_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNS01LTEtMS0zOTMzMQ_31824963-2dea-4ef9-a1e2-5a92c7092ccf">2,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e98009a6e864c61960639454ed150b9_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNS03LTEtMS0zOTMzMQ_e372788a-7692-438d-9da0-c7b70c03c193">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNi0xLTEtMS0zOTMzMQ_24eb8f13-7612-47cb-8673-b4ed8a269db9">208,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNi0zLTEtMS0zOTMzMQ_458b46c0-ad8e-49bd-962b-065ba4deddc8">7,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNi01LTEtMS0zOTMzMQ_92782557-5c98-4200-8273-ce37b92de9e8">185,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNi03LTEtMS0zOTMzMQ_894f6641-7647-48de-ac41-4468acc40742">6,387</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion - Note Payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifefa74c81dd046a4a182bdbcbbcd35d9_I20220630" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNy0xLTEtMS0zOTMzMQ_2fc50930-991d-4ad5-8188-48c89c21085e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e98009a6e864c61960639454ed150b9_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNy01LTEtMS0zOTMzMQ_5ea64850-77b6-4834-ba96-af2d09261291">2,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion - Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfOC0xLTEtMS0zOTMzMQ_be70a53c-8ca2-4445-9bba-890cab42c2b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59183c7b0a0d42569a396d37e5f31cf2_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfOC01LTEtMS0zOTMzMQ_1966c554-7657-4c14-88b8-dc12678e7bf0">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfOS0xLTEtMS0zOTMzMQ_44780552-7f61-4b76-ada0-8d44d51f4b2d">208,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfOS0zLTEtMS0zOTMzMQ_4764ef23-334d-44e5-82c0-9722e80b6b79">7,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfOS01LTEtMS0zOTMzMQ_945cae5a-1dc2-4dcb-aadb-c07b3740185b">181,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfOS03LTEtMS0zOTMzMQ_ebb39c26-7a9a-4832-845a-10c8c80143ce">6,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the current portion of the term loan and the note payable are included in current portion of debt on the condensed consolidated balance sheets. The final installment of the note payable, related to contingent consideration assumed as part of a prior period acquisition, was paid in the first quarter of 2022. The Company has elected to present the debt issuance costs associated with its revolving line-of-credit as an asset, which is included in other non-current assets on the condensed consolidated balance sheets. As a result, the long-term debt in the above table will not agree to long-term debt, net of current portion on the condensed consolidated balance sheets herein.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Late in the second quarter of 2022, the Company made an optional prepayment of $<ix:nonFraction unitRef="usd" contextRef="i192f55a490bc4b13a11411bf8375331d_D20220623-20220623" decimals="-5" name="ccrn:PaymentForDebtPrepayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzg0ODI5MDcwOTI1Ng_b1eca3d1-1d8c-4359-b4b6-77a572dc76cc">50.0</ix:nonFraction>&#160;million on its term loan. The Company was entitled to determine the application of the prepayment, which was applied to all future amortization payments, with the balance applied to the remaining balloon payment in 2027. <ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfOTQwNw_4e08b0a9-c971-4ae7-ad90-4246b264e77a" continuedAt="i0af4bd154ae649b88f46594e11acc66b" escape="true">As of June 30, 2022, the aggregate schedule for maturities of debt are as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="i0af4bd154ae649b88f46594e11acc66b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Secured Asset-Based Loan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Through Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfMy0xLTEtMS0zOTMzMQ_514580a1-f1b3-4450-801f-963486aec1db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfMy0zLTEtMS0zOTMzMQ_7c6bb9cd-3623-417f-b340-a5bea48941fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNC0xLTEtMS0zOTMzMQ_f4d8b4b8-3566-4776-a77c-652122f16862">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNC0zLTEtMS0zOTMzMQ_3c966f60-8dec-4962-b62e-fd53402945ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNS0xLTEtMS0zOTMzMQ_977a36be-d8f1-4d8e-8fc9-744318bd247a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNS0zLTEtMS0zOTMzMQ_0f6645a2-b8dd-4aff-bac0-9ef6df02bfd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNi0xLTEtMS0zOTMzMQ_51a0b6da-c019-4a41-a4e6-658ec2c4817e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNi0zLTEtMS0zOTMzMQ_bbdab2d1-349d-432b-8cba-aa5eb5ab0b30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNy0xLTEtMS0zOTMzMQ_681fc178-c5dd-4094-a9fe-8285d7cf72da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNy0zLTEtMS0zOTMzMQ_8cc485d7-3bc5-4643-8f88-8a9f174cc0e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630" decimals="-3" name="ccrn:LongTermDebtMaturityAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfOC0xLTEtMS0zOTMzMQ_41c8d11d-98dc-4367-9c55-0abeaa9729d7">123,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630" decimals="-3" name="ccrn:LongTermDebtMaturityAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfOC0zLTEtMS0zOTMzMQ_29e8f691-2b07-4abc-b3a5-ac2b251fb68a">85,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfOS0xLTEtMS0zOTMzMQ_e22631bb-4da0-48dc-8d0b-7cebdc77c567">123,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfOS0zLTEtMS0zOTMzMQ_5bd96dda-9f16-4994-9895-5fe762da1003">85,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Term Loan Credit Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 8, 2021, the Company entered into a Term Loan Credit Agreement (Term Loan Agreement) with</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> certain lenders identified therein (collectively, the Lenders) and Wilmington Trust</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, National Association as administrative agent and collateral agent, pursuant to which the Lenders extended to the Company a <ix:nonNumeric contextRef="i50264a0fdd1a433d9a8447d69f0035fd_D20210608-20210608" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfOTQwOQ_1a4f2934-54ba-4b1f-be77-00a734612762">six-year</ix:nonNumeric> second lien subordinated term loan in the amount of $<ix:nonFraction unitRef="usd" contextRef="i68be6e52da804315993d34ceb671e045_I20210608" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMTI1NQ_3c48b456-0c60-4cd0-acdc-5a0b8b315837">100.0</ix:nonFraction>&#160;million (term loan). The term loan has an interest rate of one-month London Inter-Bank Offered Rate (LIBOR) plus <ix:nonFraction unitRef="number" contextRef="i13740719146d46bfa5f350cbdd53411e_D20210608-20210608" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMTM2Mw_d68b00bc-0f03-445e-aa5f-fa48ca583ae5">5.75</ix:nonFraction>% per annum, subject to a <ix:nonFraction unitRef="number" contextRef="i13740719146d46bfa5f350cbdd53411e_D20210608-20210608" decimals="INF" name="ccrn:DebtInstrumentVariableInterestRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMTM5MA_ba6ff6ab-e48c-485d-85d8-ae6026920868">0.75</ix:nonFraction>% LIBOR floor. The term loan was used to pay the cash consideration, as well as any costs, fees, and expenses in connection with the WSG acquisition (see Note 4 - Acquisitions), with the remainder used to pay down a  of the asset based credit facility. Fees paid in connection with the Term Loan Agreement have been included as debt issuance costs and as a reduction to the carrying amount of the term loan and are expected to be amortized to interest expense over the term of the Term Loan Agreement.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6179f7bbaed1499e811cc62851d7a853" continuedAt="i34c31c85264a4456b22ea26a711d3f40"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The borrowings under the Term Loan Agreement generally bear interest at a variable rate based on either LIBOR or Base Rate (as defined in the Term Loan Agreement) and are subject to mandatory prepayments of principal payable in quarterly installments, commencing on September 30, 2021, with each installment being in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="ided7cff52c6e4850b72dad17899abe6e_D20210930-20210930" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMjI1Mw_530e98f5-8190-4e63-9f4a-ede233cd13d0">0.3</ix:nonFraction> million (subject to adjustment as a result of prepayments) provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. The Term Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum net leverage ratio. The Company was in compliance with this covenant as of June 30, 2022. Obligations under the Term Loan Agreement are secured by substantially all the assets of the borrowers and guarantors under the Term Loan Agreement, subject to customary exceptions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2021, the Company amended its Term Loan Agreement (Term Loan First Amendment), which provided the Company an incremental term loan in an aggregate amount equal to $<ix:nonFraction unitRef="usd" contextRef="iab471474c53b443eb54c1499c93e0f21_I20211118" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzA1NA_b6165a74-1d06-4b85-9b9d-b4cd1f26a012">75.0</ix:nonFraction>&#160;million. Additionally, the Term Loan First Amendment increased the aggregate amount of all increases (as defined in the Term Loan Agreement) to be no greater than $<ix:nonFraction unitRef="usd" contextRef="i54b8d8616dab4fadae7e75406657ca20_I20211118" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzIxMg_887ba4e6-c693-4c13-83fb-2acf4c32cebb">115.0</ix:nonFraction>&#160;million. The borrowings will be used primarily to fund organic growth. Commencing on December 31, 2021, installments of the mandatory prepayments will be in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i5c3977ce54064bf697411bb87b1c135b_D20211231-20211231" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzM5OA_2cd51686-5bf8-4f16-96d7-522f36675162">0.4</ix:nonFraction>&#160;million. All other terms, conditions, covenants, and pricing of the Term Loan Agreement remain the same. In conjunction with the Term Loan First Amendment, the Company entered into the Term Loan First Amendment to the Intercreditor Agreement, effective as of November 18, 2021, which sets forth the lien priority, relative rights, and other creditors&#8217; rights issues in respect of the collateral lenders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aside from its scheduled payments, on June 23, 2022, the Company made an optional prepayment of $<ix:nonFraction unitRef="usd" contextRef="i192f55a490bc4b13a11411bf8375331d_D20220623-20220623" decimals="-5" name="ccrn:PaymentForDebtPrepayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzg0ODI5MDcwNzMzOQ_8eb1fb1b-21b5-448e-8c98-7e3cd64b16d2">50.0</ix:nonFraction>&#160;million to reduce interest costs, and paid a prepayment premium of $<ix:nonFraction unitRef="usd" contextRef="i192f55a490bc4b13a11411bf8375331d_D20220623-20220623" decimals="-5" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzg0ODI5MDcwNzMyMg_87e0fcff-48c1-4c55-8fc3-8a763ccc10e8">0.5</ix:nonFraction>&#160;million pursuant to the Term Loan Agreement. As a result of the early prepayment, debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i292cd5b0d4684b41981daf8445d9f078_D20220401-20220630" decimals="-5" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzg0ODI5MDcwNzkwNA_38a9e602-154e-45fc-8705-310432bcfcbd">1.4</ix:nonFraction>&#160;million were written off in the three months ended June 30, 2022. The prepayment premium and the write-off of debt issuance costs are included as loss on early extinguishment of debt in the condensed consolidated statements of operations. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term loan is secured by a second-priority security interest in the collateral as defined in the ABL Credit Agreement (Loan Agreement) (as described below), and Wells Fargo Bank, National Association as agent, as amended by the First Amendment, Second Amendment, Third Amendment, Fourth Amendment, and Fifth Amendment to the Loan Agreement (as described below). The lien priority, relative rights, and other creditors&#8217; rights issues in respect of the collateral lenders are set forth in the Intercreditor Agreement, by and among Wells Fargo Bank, National Association, as first lien agent, and Wilmington Trust, National Association, as second lien agent, as amended, restated, amended and restated, supplemented or otherwise modified from time to time in accordance with the terms thereof dated June 8, 2021 (Intercreditor Agreement).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Loan Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective October 25, 2019, the Company terminated its commitments under its prior senior credit facility entered into in August 2017 and entered into a Loan Agreement, by and among the Company and certain of its domestic subsidiaries, as borrowers or guarantors, Wells Fargo, PNC Bank N.A., as well as other Lenders (as defined) from time to time parties thereto. The Loan Agreement provides for a <ix:nonNumeric contextRef="i15fbcb21001e48dbbc8416ff64ed2806_D20191025-20191025" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfOTQxNA_a759d129-d762-4faa-805b-a7c57c806768">five-year</ix:nonNumeric> revolving senior secured asset-based credit facility (ABL) in the aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="if2408cf0e0744cf0a51dbfcd008b71e2_I20191025" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTE2Ng_857c5aba-9db2-4944-b4f7-947f54ca75f7">120.0</ix:nonFraction>&#160;million (as described below), including a sublimit for swing loans up to $<ix:nonFraction unitRef="usd" contextRef="i83732e8193cb492394faa19420b680d4_I20191025" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTIzNA_f6f68f98-191c-428d-95ea-b511e35a443d">15.0</ix:nonFraction>&#160;million and a $<ix:nonFraction unitRef="usd" contextRef="i3c0d2cadfb0a4cfb9357b9111fdacb7a_I20191025" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTI0Mw_d5ee4971-bce1-434b-ad85-bd1b1206a98d">35.0</ix:nonFraction>&#160;million sublimit for standby letters of credit.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, the Company amended its Loan Agreement (First Amendment), which increased the current aggregate committed size of the ABL from $<ix:nonFraction unitRef="usd" contextRef="if2408cf0e0744cf0a51dbfcd008b71e2_I20191025" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTQzMQ_1489aaca-c5b3-43b2-be7a-acf5ccc4cb57">120.0</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="i82b501029b6b4759a00e12cfe8165a29_I20200630" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTQzNw_1a3f47d6-21d4-4a51-8427-c86d58583cca">130.0</ix:nonFraction>&#160;million. All other terms, conditions, covenants, and pricing of the Loan Agreement remained the same. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2021, the Company amended its Loan Agreement (Second Amendment), which increased the current aggregate committed size of the ABL from $<ix:nonFraction unitRef="usd" contextRef="i82b501029b6b4759a00e12cfe8165a29_I20200630" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTY4MQ_ecdf2270-86ba-470a-80ac-eba4152f7b24">130.0</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="if24ce204b488479499da054c091fc827_I20210308" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTY4Nw_e2066efd-f03d-467b-afbf-9bc9a4e6c291">150.0</ix:nonFraction>&#160;million, increased certain borrowing base sub-limits, and decreased both the cash dominion event and financial reporting triggers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 8, 2021, the Company amended its Loan Agreement (Third Amendment), which permits the incurrence of indebtedness and grant of security as set forth in the Loan Agreement and in accordance with the Intercreditor Agreement, and provides mechanics relating to a transition away from LIBOR as a benchmark interest rate to a replacement alternative benchmark rate or mechanism for loans made in U.S. dollars.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2021, the Company amended its Loan Agreement (Fourth Amendment), whereby the permitted indebtedness (as defined in the Loan Agreement), was increased to $<ix:nonFraction unitRef="usd" contextRef="i522e12765bc4480e83302783fd04656b_I20211118" decimals="INF" name="ccrn:LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNjM5Mw_d156afc4-89b4-41c4-b734-bf7012a227a0">175.0</ix:nonFraction> million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 21, 2022, the Company amended its Loan Agreement (Fifth Amendment), which increased the current aggregate committed size of the ABL from $<ix:nonFraction unitRef="usd" contextRef="if24ce204b488479499da054c091fc827_I20210308" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNjU0Mw_7f22f4c6-bd43-4ba4-94d5-767401b420b0">150.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i7f0de89c6ea44abd90a514fbdcf1d0c8_I20220321" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNjU0OQ_d306d6d1-c84c-4e53-88ba-6b4aac293b7a">300.0</ix:nonFraction> million, extended the credit facility for an additional <ix:nonNumeric contextRef="ia26394bf64ed4410939d860acc9b1d9d_D20220321-20220321" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfOTQwNA_79a44350-4adf-4b86-8b46-86a527e730bb">five years</ix:nonNumeric>, and increased certain borrowing base sub-limits. In addition, the agreement provides the option for all or a portion of the borrowings to bear interest at a rate based on the Secured Overnight Financing Rate (SOFR) or Base Rate, at the election of the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i34c31c85264a4456b22ea26a711d3f40"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">borrowers, plus an applicable margin. The applicable margin will increase <ix:nonFraction unitRef="number" contextRef="ia26394bf64ed4410939d860acc9b1d9d_D20220321-20220321" decimals="INF" name="ccrn:LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNjkzOA_8e26440a-2bff-4edb-ab5d-c760fa1f7fb9">10</ix:nonFraction> basis points due to the credit spread associated with the transition to SOFR.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amendments were treated as modifications of debt and, as a result, the associated fees and costs were included in debt issuance costs and will be amortized ratably over the remaining term of the Loan Agreement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Availability of the ABL commitments is subject to a borrowing base of up to <ix:nonFraction unitRef="number" contextRef="if2408cf0e0744cf0a51dbfcd008b71e2_I20191025" decimals="INF" name="ccrn:LineOfCreditBorrowingBasePercentageOfAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNzMxMg_331e93c0-feda-459f-99fa-5714310adc25">85</ix:nonFraction>% of secured eligible accounts receivable, subject to adjustment at certain quality levels, minus customary reserves and subject to customary adjustments. Revolving loans and letters of credit issued under the Loan Agreement reduce availability under the ABL on a dollar-for-dollar basis. Availability under the ABL will be used for general corporate purposes. At June 30, 2022, borrowing base availability under the ABL was $<ix:nonFraction unitRef="usd" contextRef="i217e4a8af4e34fdba46527b4d110ea93_I20220630" decimals="INF" name="ccrn:LineOfCreditFacilityBorrowingBaseAvailability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNzczOQ_dc330a9e-b78d-489c-bfa8-97ca2e8fc2e5">300.0</ix:nonFraction>&#160;million and the Company had $<ix:nonFraction unitRef="usd" contextRef="i217e4a8af4e34fdba46527b4d110ea93_I20220630" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNzc2Mg_a4e6f0b2-b8b2-4cce-8ded-863aa099b8d1">85.0</ix:nonFraction>&#160;million of borrowings drawn, as well as $<ix:nonFraction unitRef="usd" contextRef="i217e4a8af4e34fdba46527b4d110ea93_I20220630" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNzc5Nw_27e34538-d19a-4b7c-9ad2-6d14a19228b4">17.5</ix:nonFraction>&#160;million of letters of credit outstanding related to workers' compensation and professional liability policies, leaving $<ix:nonFraction unitRef="usd" contextRef="i217e4a8af4e34fdba46527b4d110ea93_I20220630" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNzkxMQ_9e505152-b056-469e-b283-b838e29db875">197.5</ix:nonFraction>&#160;million of excess availability.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the interest rate spreads and fees under the Loan Agreement were based on SOFR plus <ix:nonFraction unitRef="number" contextRef="id1e947347db04c70921aea757a478098_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfODA0NA_045cbd0b-1e23-4345-9a7e-d7fac9e8dfb6">1.60</ix:nonFraction>% for the revolving portion of the borrowing base. The Base Rate (as defined by the Loan Agreement) margin would have been <ix:nonFraction unitRef="number" contextRef="i79663bc76cf8454ea92834abe34d819f_D20220101-20220630" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfODE2OA_f0eb2036-c73e-4a2b-8b5c-eab177e49f4d">0.50</ix:nonFraction>%  for the revolving portion</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The SOFR and Base Rate margins are subject to monthly pricing adjustments, pursuant to a pricing matrix based on the Company&#8217;s excess availability under the revolving credit facility. In addition, the facility is subject to an unused line fee, letter of credit fees, and an administrative fee. The unused line fee is <ix:nonFraction unitRef="number" contextRef="i744622b84e6e4593840fc16870ce088e_D20220101-20220630" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfODUxNg_586e3f68-ef26-4706-964a-0b33e24eeded">0.375</ix:nonFraction>% of the average daily unused portion of the revolving credit facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum fixed charge coverage ratio. The Company was in compliance with this covenant as of June 30, 2022. Obligations under the ABL are secured by substantially all the assets of the borrowers and guarantors, subject to customary exceptions.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_61"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfMzMwNg_076e258a-e92b-45b2-90fa-67c574d0bfd7" continuedAt="i55da7dcf916441d3ba9f341cda52634c" escape="true">LEASES</ix:nonNumeric></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><ix:continuation id="i55da7dcf916441d3ba9f341cda52634c" continuedAt="i7778ca20d27b48cb9507af1cb7b0738b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's lease population of its right-of-use asset and lease liabilities is substantially related to the rental of office space. The Company enters into lease agreements as a lessee that may include options to extend or terminate early. Some of these real estate leases require variable payments of property taxes, insurance, and common area maintenance, in addition to base rent. Certain of the leases have provisions for free rent months during the lease term and/or escalating rent payments and, particularly for the Company&#8217;s longer-term leases for its corporate offices, it has received incentives to enter into the leases, such as receiving up to a specified dollar amount to construct tenant improvements. These leases do not include residual value guarantees, covenants, or other restrictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the second quarter of 2020, in connection with the continuing developments from COVID, the Company expedited restructuring plans and either reduced or fully vacated leased office space. The Company is in the process of seeking to sublet some of the space where possible. The Company did <ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="INF" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfNDM5ODA0NjUxNTA5MQ_1530fd1b-3766-4d3f-a653-793890901975"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="INF" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfNDM5ODA0NjUxNTA5MQ_77135d52-c685-443f-b198-d02715196cdc">no</ix:nonFraction></ix:nonFraction>t record any lease-related impairment charges for the three months ended June 30, 2022. The decision and change in the use of space resulted in a right-of-use asset impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i901eb837ca884f56bf62787429027b0d_D20220101-20220331" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfMzg0ODI5MDcwMTUzMg_367749dd-d73c-44a1-b4bf-e55ee72ceacc">1.5</ix:nonFraction>&#160;million for the three months ended March 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfMzg0ODI5MDcwMDYxOA_971d63be-a997-45bd-8c40-fafb48cde072">1.7</ix:nonFraction>&#160;million for the three months ended June 30, 2021. This loss was determined by comparing the fair value of the impacted right-of-use assets to the carrying value of the assets as of the impairment measurement date. The fair value of the right-of-use assets was based on the estimated sublease income for the space taking into consideration the time period it will take to obtain a subtenant, the applicable discount rate, and the sublease rate. For the three months ended March 31, 2022 and June 30, 2021, the Company wrote off an immaterial amount of leasehold improvements and other property and equipment related to these locations. The measurement of the right-of-use asset impairments, using the assumptions described, is a Level 3 fair value measurement. See Note 10 - Fair Value Measurements for a description of Level 3 inputs.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="ccrn:AssetsAndLiabilitiesLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfMzMwOQ_641724c0-a7cc-4e80-91b2-ec7b390b169e" continuedAt="ia6f97a89c2664c8ba9fcc54934000a21" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the lease-related assets and liabilities included on the condensed consolidated balance sheets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification on Condensed Consolidated Balance Sheets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmFkYTdjZWJjNTIyMTQ1NDM4Y2JkY2Y5YmM3ODc4MGUyL3RhYmxlcmFuZ2U6YWRhN2NlYmM1MjIxNDU0MzhjYmRjZjliYzc4NzgwZTJfMi0xLTEtMS0zOTMzMQ_1dcd425a-e792-4c5d-a21a-2dd71a73244c">5,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmFkYTdjZWJjNTIyMTQ1NDM4Y2JkY2Y5YmM3ODc4MGUyL3RhYmxlcmFuZ2U6YWRhN2NlYmM1MjIxNDU0MzhjYmRjZjliYzc4NzgwZTJfMi0zLTEtMS0zOTMzMQ_2251b7e2-5c36-4861-a8f6-66ad42bd5ac9">7,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - current</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmFkYTdjZWJjNTIyMTQ1NDM4Y2JkY2Y5YmM3ODc4MGUyL3RhYmxlcmFuZ2U6YWRhN2NlYmM1MjIxNDU0MzhjYmRjZjliYzc4NzgwZTJfMy0xLTEtMS0zOTMzMQ_4bd34f6d-cdd7-4626-bdaf-697cc50621ef">4,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmFkYTdjZWJjNTIyMTQ1NDM4Y2JkY2Y5YmM3ODc4MGUyL3RhYmxlcmFuZ2U6YWRhN2NlYmM1MjIxNDU0MzhjYmRjZjliYzc4NzgwZTJfMy0zLTEtMS0zOTMzMQ_57eed3e6-28e0-4cde-badd-a00e3c632c35">4,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmFkYTdjZWJjNTIyMTQ1NDM4Y2JkY2Y5YmM3ODc4MGUyL3RhYmxlcmFuZ2U6YWRhN2NlYmM1MjIxNDU0MzhjYmRjZjliYzc4NzgwZTJfNC0xLTEtMS0zOTMzMQ_da456a4c-ccf9-44bc-9eb8-448e5496e19d">7,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmFkYTdjZWJjNTIyMTQ1NDM4Y2JkY2Y5YmM3ODc4MGUyL3RhYmxlcmFuZ2U6YWRhN2NlYmM1MjIxNDU0MzhjYmRjZjliYzc4NzgwZTJfNC0zLTEtMS0zOTMzMQ_cd081710-d736-459d-b834-e51e2c7f8bd0">10,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7778ca20d27b48cb9507af1cb7b0738b" continuedAt="i5fa2c4c7a1484ea69445545213297337"><div style="text-align:center"><ix:continuation id="ia6f97a89c2664c8ba9fcc54934000a21"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.853%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjRlZjIyYzJkMzU0MjRjYzk4ODg0NGM2MTI1YTVmMmE3L3RhYmxlcmFuZ2U6NGVmMjJjMmQzNTQyNGNjOTg4ODQ0YzYxMjVhNWYyYTdfMS0xLTEtMS0zOTMzMQ_55219b9d-8cb3-42a2-9a33-a09dbbe256eb">2.6</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjRlZjIyYzJkMzU0MjRjYzk4ODg0NGM2MTI1YTVmMmE3L3RhYmxlcmFuZ2U6NGVmMjJjMmQzNTQyNGNjOTg4ODQ0YzYxMjVhNWYyYTdfMS0zLTEtMS0zOTMzMQ_efcbd14f-0caa-483a-94c8-3545e6770899">3.4</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjRlZjIyYzJkMzU0MjRjYzk4ODg0NGM2MTI1YTVmMmE3L3RhYmxlcmFuZ2U6NGVmMjJjMmQzNTQyNGNjOTg4ODQ0YzYxMjVhNWYyYTdfMi0xLTEtMS0zOTMzMQ_170eb928-bae9-42fe-9407-86c99018399d">6.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjRlZjIyYzJkMzU0MjRjYzk4ODg0NGM2MTI1YTVmMmE3L3RhYmxlcmFuZ2U6NGVmMjJjMmQzNTQyNGNjOTg4ODQ0YzYxMjVhNWYyYTdfMi0zLTEtMS0zOTMzMQ_268385d6-4f6a-4320-902a-2b90feda2584">6.39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfMzMxMQ_f9c4b61c-5f4c-49f2-bad6-b1661f115498" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles the undiscounted cash flows for each of, and total of, the remaining years to the operating lease liabilities (which do not include short-term leases) recorded on the condensed consolidated balance sheets as of June 30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:75.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.989%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfMi0xLTEtMS0zOTMzMQ_6ca37513-a71f-46c3-91b8-9ce5c865ee79">2,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfMy0xLTEtMS0zOTMzMQ_bfa13862-5b25-4a08-9dc7-f98f8753d143">5,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfNC0xLTEtMS0zOTMzMQ_10b38e5b-8fd7-42a8-bca1-0d90101111f4">3,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfNS0xLTEtMS0zOTMzMQ_168b71e3-ee09-45c1-97b6-98fc854d7dd2">1,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfNy0xLTEtMS0zOTMzMQ_be48b6ee-7f8e-463e-b674-57c3709d1c1d">12,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amount of lease payments representing interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfOC0xLTEtMS0zOTMzMQ_463ee713-de2a-4be0-8b97-0b79fc44641e">1,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfOS0xLTEtMS0zOTMzMQ_49c9c38d-b9ad-4bd9-8745-a43bd83619aa">11,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: operating lease liabilities - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfMTAtMS0xLTEtMzkzMzE_c7f12a93-d41a-4d9f-9362-f083b88de79d">4,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfMTEtMS0xLTEtMzkzMzE_b7ccf843-6807-402d-88dd-10a3f1db4054">7,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Information</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfMzMwNA_84b84236-dc08-4b38-98d8-dcac051cab88" continuedAt="id3745f36cb2a4d959ded768622f1498e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information regarding supplemental cash flows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjJmZDhmYTBlYmQxZDRkNjViNGVkZWE5N2YxN2FjNGE3L3RhYmxlcmFuZ2U6MmZkOGZhMGViZDFkNGQ2NWI0ZWRlYTk3ZjE3YWM0YTdfNS0xLTEtMS0zOTMzMQ_1b42e4d0-ca92-45ea-85bc-4c5dc4f19855">3,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjJmZDhmYTBlYmQxZDRkNjViNGVkZWE5N2YxN2FjNGE3L3RhYmxlcmFuZ2U6MmZkOGZhMGViZDFkNGQ2NWI0ZWRlYTk3ZjE3YWM0YTdfNS0zLTEtMS0zOTMzMQ_8dc9bd35-9086-47c8-8e9d-e33052d0fdde">3,189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets acquired under operating lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjJmZDhmYTBlYmQxZDRkNjViNGVkZWE5N2YxN2FjNGE3L3RhYmxlcmFuZ2U6MmZkOGZhMGViZDFkNGQ2NWI0ZWRlYTk3ZjE3YWM0YTdfNi0xLTEtMS0zOTMzMQ_226a0b59-d6dd-43e5-9f80-18dbd1a768a0">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjJmZDhmYTBlYmQxZDRkNjViNGVkZWE5N2YxN2FjNGE3L3RhYmxlcmFuZ2U6MmZkOGZhMGViZDFkNGQ2NWI0ZWRlYTk3ZjE3YWM0YTdfNi0zLTEtMS0zOTMzMQ_0da02c70-ade8-49d3-b701-7ad46b55d218">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5fa2c4c7a1484ea69445545213297337"><div><ix:continuation id="id3745f36cb2a4d959ded768622f1498e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Included in Condensed Consolidated Statements of Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfNS0xLTEtMS0zOTMzMQ_b20f6a59-4cb8-4f95-83e1-eccb0062c678">645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfNS0zLTEtMS0zOTMzMQ_93d04f5e-d670-4c3d-bd60-76fb35116831">938</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:ShortTermLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfNi0xLTEtMS0zOTMzMQ_0a11bf2c-3c30-4eef-82ed-e8b6ee6fb828">1,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfNi0zLTEtMS0zOTMzMQ_820451fd-14cd-4a5b-ac4c-84531e482188">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable and other lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfNy0xLTEtMS0zOTMzMQ_34231674-6cb4-40e5-bc24-ef303ea4894a">1,110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfNy0zLTEtMS0zOTMzMQ_9a8789c4-6ab3-48e2-9f42-79e7f363ac76">751</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Included in Condensed Consolidated Statements of Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfMTQtMS0xLTEtMzkzMzE_050f6852-98cd-487f-a2a1-aee92dd2f9c5">1,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfMTQtMy0xLTEtMzkzMzE_6f5807e5-50ec-4892-8dcd-f899699aada1">1,852</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:ShortTermLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfMTUtMS0xLTEtMzkzMzE_31a729ea-7186-43fc-86bb-a6dd6162d7e3">2,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:ShortTermLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfMTUtMy0xLTEtMzkzMzE_7a0cf056-6f59-4e10-b41b-b3aee51b1529">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable and other lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfMTYtMS0xLTEtMzkzMzE_090e097e-4b1f-4b6e-8348-29d65d54050e">353</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfMTYtMy0xLTEtMzkzMzE_11e235d7-e8c1-4eb8-8893-d557fe90d32e">1,220</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense, short-term lease expense, and variable and other lease costs are included in selling, general and administrative expenses, direct operating expenses, and restructuring (benefits) costs in the condensed consolidated statements of operations, depending on the nature of the leased asset. Operating lease expense is reported net of sublease income, which is not material. Variable and other lease costs for the three and six months ended June 30, 2022 include a benefit associated with the early termination of one of the Company's corporate offices which was previously restructured.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the Company does not have any material operating leases which have not yet commenced. The Company has an immaterial</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount of finance lease contracts related to other equipment rentals which are not included in the above disclosures.</span></div></ix:continuation><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_64"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RleHRyZWdpb246Y2E4MWRhM2JlZDJjNGU0M2EzZDRiYTJjN2M3NTFiNTRfNTA0MQ_65c8b806-b37a-4784-8712-32c97aa9de07" continuedAt="i4e46244de94e416996552c35988836fc" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="i4e46244de94e416996552c35988836fc" continuedAt="i4d52c8583ea142d49d2e665d808ba9a9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy was established which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Quoted prices in active markets for identical assets or liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items Measured at Fair Value on a Recurring Basis:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial assets/liabilities required to be measured on a recurring basis were its: (i) deferred compensation asset included in other non-current assets; and (ii) deferred compensation liability included in other long-term liabilities on its condensed consolidated balance sheets.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4d52c8583ea142d49d2e665d808ba9a9" continuedAt="i0e03f49206784d54a4b6d91ec0dadf03"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company utilizes Level 1 inputs to value its deferred compensation assets and liabilities. The Company&#8217;s deferred compensation assets and liabilities are measured using publicly available indices, as per the plan documents.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RleHRyZWdpb246Y2E4MWRhM2JlZDJjNGU0M2EzZDRiYTJjN2M3NTFiNTRfNTA1Mw_97f28c4a-4bc5-4f17-8566-c039269b84d1" continuedAt="ic795843b88be4ecda7a45903e0435f8d" escape="true">The estimated fair value of the Company&#8217;s financial assets and liabilities measured on a recurring basis is as follows:&#160;</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><ix:continuation id="ic795843b88be4ecda7a45903e0435f8d"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:58.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation asset</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib11f714337624b81b95fbf29632b3e86_I20220630" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmY3N2JkOWVhNmM4NjQ1NjM4ZGQ4MDY0ODFiYWYyOTVkL3RhYmxlcmFuZ2U6Zjc3YmQ5ZWE2Yzg2NDU2MzhkZDgwNjQ4MWJhZjI5NWRfNC0xLTEtMS0zOTMzMQ_48936987-70c1-42f9-b06c-935c92938bb3">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec21b6d449de4e3c8935b693d4938157_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmY3N2JkOWVhNmM4NjQ1NjM4ZGQ4MDY0ODFiYWYyOTVkL3RhYmxlcmFuZ2U6Zjc3YmQ5ZWE2Yzg2NDU2MzhkZDgwNjQ4MWJhZjI5NWRfNC0zLTEtMS0zOTMzMQ_fc38d009-084b-44e0-bcbf-c7f88041491b">1,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="9" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife18debf13894b69a0178110599379d5_I20220630" decimals="-3" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmY3N2JkOWVhNmM4NjQ1NjM4ZGQ4MDY0ODFiYWYyOTVkL3RhYmxlcmFuZ2U6Zjc3YmQ5ZWE2Yzg2NDU2MzhkZDgwNjQ4MWJhZjI5NWRfNy0xLTEtMS0zOTMzMQ_dd7defd2-018e-48b3-8d92-d6fbacbc891c">2,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2384a0e875f4fe2ab84ead51c98f914_I20211231" decimals="-3" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmY3N2JkOWVhNmM4NjQ1NjM4ZGQ4MDY0ODFiYWYyOTVkL3RhYmxlcmFuZ2U6Zjc3YmQ5ZWE2Yzg2NDU2MzhkZDgwNjQ4MWJhZjI5NWRfNy0zLTEtMS0zOTMzMQ_f4971b73-6396-4728-b104-33176fa0cb62">2,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items Measured at Fair Value on a Non-Recurring Basis:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's non-financial assets, such as goodwill, trade names, other intangible assets, right-of-use assets, and property and equipment, are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The six months ended June 30, 2022 and 2021 included impairment charges to right-of-use assets along with related property and equipment in connection with leases that were vacated. Accordingly, as of June 30, 2022 and 2021, these assets were recorded at fair value using Level 3 inputs. See Note 9 - Leases for more information about these fair value measurements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Fair Value Disclosures:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financial instruments not measured or recorded at fair value in the condensed consolidated balance sheets consist of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses. The estimated fair value of accounts receivable and accounts payable and&#160;accrued expenses approximate their carrying amount due to the short-term nature of these instruments. Other financial instruments not measured or recorded at fair value include: (i) note payable, (ii) ABL, (iii) term loan, and (iv) and (v) earnout liabilities, as discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i) The Company paid the third and final installment on its note payable in the first quarter of 2022. Due to its relatively short-term nature, the carrying value of the note payable approximated its fair value. (ii) The carrying amount of the Company's ABL approximates fair value because the interest rates are variable and reflective of market rates. (iii) The estimated fair value of the Company's term loan was calculated applying an interest rate lattice model using Level 2 inputs from available market information. (iv) Potential earnout payments related to the WSG acquisition are contingent upon meeting certain performance requirements based on 2021 through 2023 performance. The Company performed an analysis using multiple forecasted scenarios to determine the fair value of the earnout liability. The earnout liability's carrying amount approximates fair value and is included in current portion of earnout liability and non-current earnout liability on the condensed consolidated balance sheets. (v) Potential earnout payments related to the Selected acquisition were contingent upon meeting certain performance requirements based on 2022 and 2023 revenues. The earnout liability's carrying amount approximates fair value and was included in current portion of earnout liability and non-current earnout liability on the condensed consolidated balance sheets. In the second quarter of 2022, the Company determined that the contingent consideration earnout related to the Selected acquisition would not be achieved for 2022 and 2023 and, as a result, the entire liability was reversed. See Note 4 - Acquisitions.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0e03f49206784d54a4b6d91ec0dadf03"><div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RleHRyZWdpb246Y2E4MWRhM2JlZDJjNGU0M2EzZDRiYTJjN2M3NTFiNTRfNTAzMw_84797f3a-4d65-4f28-8447-0f8b7ebda503" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and estimated fair value of the Company&#8217;s significant financial instruments that were not measured at fair value are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.108%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia801d6ec97434f77b5185c504d4dd03d_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNS0xLTEtMS0zOTMzMQ_9fec7eb1-28a3-4880-a75c-9860254ecfc3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8757da1f937e4835a03d88e39ffd3134_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNS0zLTEtMS0zOTMzMQ_f0e377b4-741c-4a0c-906d-64b53423dea7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if30c1a9abfaa4b8591cc814cac5da11b_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNS01LTEtMS0zOTMzMQ_0647c9d9-b807-472a-be7c-ec39662d5e0d">2,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia28c4adf56ef473b81222066e0f6bab4_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNS03LTEtMS0zOTMzMQ_c8a699f8-a038-4d0e-906b-1fc1a20f4ba1">2,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Asset-Based Loan</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2b289aa8b0f4bb297cf5af62491dd19_I20220630" decimals="-3" name="us-gaap:LinesOfCreditFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNi0xLTEtMS0zOTMzMQ_8b6e388e-3048-404f-b567-69101e161bee">85,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib938672d8ae84dcaaf92e08eb3bd8e91_I20220630" decimals="-3" name="us-gaap:LinesOfCreditFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNi0zLTEtMS0zOTMzMQ_7e3bdcc3-48c5-4112-8615-4e301cbe7b24">85,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34f90c0620cd48ca9ad8a72c38f6bd27_I20211231" decimals="-3" name="us-gaap:LinesOfCreditFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNi01LTEtMS0zOTMzMQ_2aa0c470-9ee0-485a-8ca1-98c2539c7854">9,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd2145204d454b038df9969fda6aba63_I20211231" decimals="-3" name="us-gaap:LinesOfCreditFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNi03LTEtMS0zOTMzMQ_78e597ed-f27c-4c61-b597-bbc49b55191f">9,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, net</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc259a1981dd4d899a03b46cd1bd6311_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNy0xLTEtMS0zOTMzMQ_b6e396af-dd2b-474a-96ed-c8d7cc9968d9">123,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i400cb6bbb3d8415c9ce00409549a9981_I20220630" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNy0zLTEtMS0zOTMzMQ_7d78a9ec-c105-4061-83b7-ef1180465972">118,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0a8e32b5d9415ea6ddc671aea7986c_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNy01LTEtMS0zOTMzMQ_47161363-e3f4-462a-9561-5cc8c7551fdd">174,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id739059325464c648e732b5b9492ad1b_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNy03LTEtMS0zOTMzMQ_f823c681-2872-440a-bafc-ffc73eb8e781">174,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout Liability (WSG)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1337e8b15554efd83e0ffd2872603fa_I20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOC0xLTEtMS0zOTMzMQ_b41fd570-3076-41fa-8523-cac840198328">15,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide48511e0c344631b47d7e4c4b0171bd_I20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOC0zLTEtMS0zOTMzMQ_afb523fa-1bf3-4a76-b624-9f4c98a3e62d">15,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6df7ed8d4d9942dfa095df93b4a7ae83_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOC01LTEtMS0zOTMzMQ_63e24e2c-b043-485f-a969-62095a6a1a26">15,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie33c5b897ac646ec9c437ba3d4e036bd_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOC03LTEtMS0zOTMzMQ_76e549eb-db4b-411c-9cbe-ce3b0dad62f4">15,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout Liability (Selected)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fbdf4e4242e42b081d7c65a199e7f48_I20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOS0xLTEtMS0zOTMzMQ_4a189785-00f6-49b4-a89d-d2a14859779d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d26b10494d9470ca481d6bcf4a4096c_I20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOS0zLTEtMS0zOTMzMQ_d8beea54-2ccd-49d4-a75c-894e477a81d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4875239875ba43d69f254dacac91eda3_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOS01LTEtMS0zOTMzMQ_9d9bbae0-9846-4056-95bd-12e14722e6ab">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifca25155201b4bddafc6f616f359148c_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOS03LTEtMS0zOTMzMQ_f7ba91f3-fb65-44be-90a1-f7ec138587ab">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk:</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See discussion of credit losses and allowance for doubtful accounts in Note 2 - Summary of Significant Accounting Policies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, based on the large number of customers in differing geographic areas, primarily throughout the United States and its territories, the Company believes the concentration of credit risk is limited.</span></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzIxMg_beed8cbd-627c-4bb0-98b9-bd29e0fa5fe2" continuedAt="id8a2f929db9a486695f951c55858d921" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="id8a2f929db9a486695f951c55858d921" continuedAt="i7c9e919a539b4fd4bc93c308b64a0717"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February 28, 2008, our Board of Directors authorized our most recent stock repurchase program whereby we may purchase up to <ix:nonFraction unitRef="shares" contextRef="iaf0b19c2fa5d44578370990b5584d68a_I20080228" decimals="INF" name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzg0ODI5MDcwMTIzMA_7e93ef3a-5cb1-4ebd-9022-89e6e81dfc73">1.5</ix:nonFraction>&#160;million of our common shares, subject to the terms of our current credit agreements. The shares may be repurchased from time-to-time in the open market and the repurchase program may be discontinued at any time at our discretion. During the six months ended June 30, 2022 and 2021, the Company did <ix:nonFraction unitRef="shares" contextRef="i25f9ce0742594c3b883c445ec9f65431_D20210101-20210630" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMTI5_1b8df652-a6a9-416e-996e-48e2e9bc5c3f"><ix:nonFraction unitRef="shares" contextRef="i8e54d79ab9284085bcf0c45bcd9c139a_D20220101-20220630" decimals="INF" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMTI5_8e59cc47-c793-4cd0-9081-ec2817f07942">no</ix:nonFraction></ix:nonFraction>t repurchase any shares of its common stock. As of June&#160;30, 2022, the Company has <ix:nonFraction unitRef="shares" contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630" decimals="INF" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMjAx_0f5dec32-fbef-49c7-9d4e-b1b5ecbf767c">510,004</ix:nonFraction> shares of common stock under the current share repurchase program available to repurchase, subject to certain conditions in the Company's Loan Agreement and Term Loan Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Payments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2020, the Company's stockholders approved the Cross Country Healthcare, Inc. 2020 Omnibus Incentive Plan (2020 Plan), which replaced the 2017 Omnibus Incentive Plan (2017 Plan), and applies to awards granted after May 19, 2020. The remaining shares available for grant under the 2017 Plan were cancelled and no further awards will be granted under that plan. The 2020 Plan generally mirrors the terms of the 2017 Plan and includes the following provisions: (i) an aggregate share reserve of <ix:nonFraction unitRef="shares" contextRef="ie26d32fbbb214db89f00ca5ce7718efc_I20200519" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfOTA3_096484a4-a332-492c-b84a-749df20c5647">3,000,000</ix:nonFraction> shares; (2) annual dollar and share limits of awards granted to employees and consultants, as well as non-employee directors, based on type of award; (3) awards granted generally will be subject to a minimum <ix:nonNumeric contextRef="if3a6eab5e44b46c9aa104ee3b7965107_D20220101-20220630" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzIyMg_9e5b5dea-fcb8-49a3-869c-2564d4953d64">one-year</ix:nonNumeric> vesting schedule; and (4) awards may be granted under the 2020 Plan until March 24, 2030.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7c9e919a539b4fd4bc93c308b64a0717"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzIyNA_cbd3fb70-7777-43a4-98e7-02f643f4d01b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan and the 2020 Plan (Plans) for the six months ended June&#160;30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:42.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Target <br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards, January&#160;1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4eba8a27a3045758fc0c06e41d5704b_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMi0xLTEtMS0zOTMzMQ_38bb0c99-8d8d-44be-9833-fd500dba779c">1,039,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4eba8a27a3045758fc0c06e41d5704b_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMi0zLTEtMS0zOTMzMQ_89a9fe30-593c-4d95-8303-f8ead4fb6574">9.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i956eb0b29bb74ffdb6756b06306769ab_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMi01LTEtMS0zOTMzMQ_9dfe94f3-fd5b-420f-b850-1a7bab71e629">522,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i956eb0b29bb74ffdb6756b06306769ab_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMi03LTEtMS0zOTMzMQ_6730fd4f-48f7-49bb-a616-8dcbcc5e2ff1">8.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMy0xLTEtMS0zOTMzMQ_fadfe065-5621-4a7b-97a9-d7f31d8afcfb">283,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMy0zLTEtMS0zOTMzMQ_ff6190fa-b373-47ec-8eea-cc450aff505c">20.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMy01LTEtMS0zOTMzMQ_e100d32f-7cd6-487f-8156-451c354c3e5d">171,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMy03LTEtMS0zOTMzMQ_99c525d7-4343-4411-8df0-7cd17d7332c9">18.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNC0xLTEtMS0zOTMzMQ_294e2b58-d126-4bb4-918c-01a86e05ea96">575,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNC0zLTEtMS0zOTMzMQ_412cea03-887c-4317-916a-98369b06bb35">9.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNC01LTEtMS0zOTMzMQ_281cc66d-2934-41a2-8c5a-fc886b921650">170,278</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNC03LTEtMS0zOTMzMQ_0f7844a7-dc47-4532-8aee-cf4ee269d1ba">7.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNS0xLTEtMS0zOTMzMQ_5f7f118a-dd2f-43ab-9171-e6e11f8797b5">35,117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNS0zLTEtMS0zOTMzMQ_05b75417-7be1-47da-b3f0-c39840ac9a55">14.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNS01LTEtMS0zOTMzMQ_1f523795-bf25-4ddf-b6c3-ddbfa27f97ca">13,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNS03LTEtMS0zOTMzMQ_125297c1-5821-4632-8a1b-f96a7d1dece5">12.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards, June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieff115cae5e34e28b5383a9a88245810_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNi0xLTEtMS0zOTMzMQ_02f302a0-f080-4f2d-94d4-99c477df0129">712,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ieff115cae5e34e28b5383a9a88245810_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNi0zLTEtMS0zOTMzMQ_ea07ce54-8a67-42a2-b002-9e81778abbd8">14.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ab71c9c84ee4815b1628aa855d13c01_I20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNi01LTEtMS0zOTMzMQ_c6f3de40-546e-48d6-9fb9-85ff1ab56279">509,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0ab71c9c84ee4815b1628aa855d13c01_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNi03LTEtMS0zOTMzMQ_9d140b73-d570-4358-8c9b-003acc8e15e6">12.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards granted under the Company&#8217;s Plans entitle the holder to receive, at the end of a vesting period, a specified number of shares of the Company&#8217;s common stock. Share-based compensation expense is measured by the market value of the Company&#8217;s stock on the date of grant. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards granted to non-employee directors under the 2017 Plan, prior to the adoption of the 2020 Plan, vest in <ix:nonFraction unitRef="installment" contextRef="i343cbe120aa04706a172fc551f526ec0_D20220101-20220630" decimals="INF" name="ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMTc5Ng_a6a97506-55d4-4555-99cd-f2487c142fd1">three</ix:nonFraction> equal installments on the first, second, and third anniversaries of the grant date, while restricted shares granted under the 2020 Plan on and subsequent to June 2020 will vest on the first anniversary of such grant date, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or earlier subject to retirement eligibility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, effective in the three months ended June 30, 2020, the Company implemented modified guidelines that provide for accelerated vesting of restricted stock grants on the last date of service when a retirement-eligible director retires.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Plans, the number of target shares that are issued for performance-based stock awards are determined based on the level of attainment of the targets. During the first quarter of 2022, the Company's Compensation Committee of the Board of Directors approved a <ix:nonFraction unitRef="number" contextRef="i901eb837ca884f56bf62787429027b0d_D20220101-20220331" decimals="INF" name="ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMjU4Ng_87589200-851e-4179-b207-8c926898a07b">120</ix:nonFraction>% level of attainment for the 2019 performance-based share awards, resulting in the issuance of <ix:nonFraction unitRef="shares" contextRef="i488f7313d7ea4152874fdd22f4842f51_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMjY4Mw_faece6cb-8150-437f-adfd-437467d460d6">170,278</ix:nonFraction> performance shares that vested on March 31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three and six months ended June 30, 2022, $<ix:nonFraction unitRef="usd" contextRef="i45d3569daa544f6ba38c9b4d1d64b515_D20220401-20220630" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMjc4MA_651435d0-f02c-4fbc-a41a-94b5b0c50c2e">2.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie37e701f5bf845919892f1792910aac5_D20220101-20220630" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzg0ODI5MDcwMDUwNQ_c062fe17-d315-4431-8ca8-a75fe569ff3d">3.7</ix:nonFraction>&#160;million, respectively, was included in selling, general and administrative expenses related to share-based payments, and a net of <ix:nonFraction unitRef="shares" contextRef="id12cc7870c3344898d8faa6c6deb3e69_D20220401-20220630" decimals="INF" name="ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMjg5MA_50f4717c-4c5f-4b6d-853f-b134aaa0b116">80,200</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i9a976517796d4a5a90410a85dfa2fcd2_D20220101-20220630" decimals="INF" name="ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzg0ODI5MDcwMDUzMQ_51054180-e67b-4a93-9c39-bda9950bca44">499,700</ix:nonFraction> shares, respectively, of common stock were issued upon the vesting of restricted and performance stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June 30, 2021, $<ix:nonFraction unitRef="usd" contextRef="i272ddda01d4c4d8ab777088cc19278c1_D20210401-20210630" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzAyNg_06eaf671-2371-4286-b882-54e4202a083d">2.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7aac8a7b75f44c50bf673b0750cb5e38_D20210101-20210630" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzg0ODI5MDcwMDU5OA_ea6b180c-1229-4a83-8ba0-379c8329bb51">3.5</ix:nonFraction>&#160;million, respectively, was included in selling, general and administrative expenses related to share-based payments, and a net of <ix:nonFraction unitRef="shares" contextRef="i4d1a96b65b9a4f4cb322a36a20b6c8a2_D20210401-20210630" decimals="INF" name="ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzEzNg_0b1ef5eb-8348-4262-b10c-73682852f45e">159,025</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i88fe5a3577e44e7f93025fcc20ad13e0_D20210101-20210630" decimals="INF" name="ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzg0ODI5MDcwMDY1MQ_df7f7e15-d23e-46df-8748-13a7b6b1829f">476,630</ix:nonFraction> shares, respectively, of common stock were issued upon the vesting of restricted stock.</span></div></ix:continuation><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_70"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RleHRyZWdpb246ODc5YmVmOGFkOWFmNDZjMTliMDg0MzBiMWEwMmMxYWVfMjU3MQ_2edc98ec-376f-4bfa-82c5-5a439d42b046" continuedAt="ic1463df71b004d7a8e57ae1f4ae40f55" escape="true">SEGMENT DATA</ix:nonNumeric></span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><ix:continuation id="ic1463df71b004d7a8e57ae1f4ae40f55" continuedAt="ie4d801a8b4134c1badbc72e6feec9926"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s segments offer services to its customers as described below:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nurse and Allied Staffing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added total talent solutions including: temporary and permanent placement of travel and local nurse and allied professionals, managed services programs (MSP) services, education healthcare services, in-home care services, and outsourcing services. In addition, Nurse and Allied Staffing provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. Its clients include: public and private acute-care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public schools and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and many other healthcare providers throughout the United States.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Physician Staffing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Physician Staffing provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates performance of each segment primarily based on revenue and contribution income. The Company defines contribution income as income (loss) from operations before depreciation and amortization, acquisition and integration-</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie4d801a8b4134c1badbc72e6feec9926"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related costs, restructuring (benefits) costs, legal settlement charges, impairment charges, and corporate overhead. The Company does not evaluate, manage, or measure performance of segments using asset information; accordingly, total asset information by segment is not prepared or disclosed. The information in the following table is derived from the segments&#8217; internal financial information as used for corporate management purposes. Certain corporate expenses are not allocated to and/or among the operating segments.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RleHRyZWdpb246ODc5YmVmOGFkOWFmNDZjMTliMDg0MzBiMWEwMmMxYWVfMjU1NQ_8c9257da-e65d-459e-9316-e8140d2ea3f2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information on operating segments and a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reconciliation to income from operations for the periods indicated are as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.057%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd91226911de469ebcf68a20f0c11784_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNS0xLTEtMS0zOTMzMQ_fe590dbe-706f-4395-ad41-122b3b264e48">731,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ccb0817428f4985b0301b681c4ab64a_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNS0zLTEtMS0zOTMzMQ_6858fb90-6f4a-4e36-8fe4-d1f1df93702a">316,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0d06303bf64411ebac22da90bae8bc6_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNS01LTEtMS0zOTMzMQ_c5f56d3c-c67d-45a0-911f-5dd1c96005ec">1,497,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d6e818748004cac8bd53aeb8e5fcb4a_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNS03LTEtMS0zOTMzMQ_add32d9a-c0f7-467e-b3de-f488d38d1d96">629,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48182d1c2a094a3da085fb747d293f3e_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNi0xLTEtMS0zOTMzMQ_f6d4bc65-0da0-4d12-9745-6694ce103af0">22,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee0a4262a80f406a86e3cfc6a645adae_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNi0zLTEtMS0zOTMzMQ_c2ab07e5-9d9a-444b-aefa-23ede15d4bd8">15,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iababccf169c64eb497cc9f14a300ad39_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNi01LTEtMS0zOTMzMQ_27aa0a1a-9187-4260-9111-5f9b5d67da29">45,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6936f0dd73f149a284028ca151da158a_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNi03LTEtMS0zOTMzMQ_1bdc2cd4-c4e0-4eaa-b0ae-65d285a0f5bf">31,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNy0xLTEtMS0zOTMzMQ_828a551b-c536-46e8-94d1-49f444c6431c">753,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNy0zLTEtMS0zOTMzMQ_65666470-b996-425a-a24f-22a61b322b4f">331,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNy01LTEtMS0zOTMzMQ_26982b36-524b-4d0a-87b0-c63463c1b694">1,542,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNy03LTEtMS0zOTMzMQ_c1b9e9cc-a181-40af-8759-96cc60ee81e7">661,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd91226911de469ebcf68a20f0c11784_D20220401-20220630" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTAtMS0xLTEtMzkzMzE_66bb7622-7eb2-491b-a135-bd4308edcffd">97,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ccb0817428f4985b0301b681c4ab64a_D20210401-20210630" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTAtMy0xLTEtMzkzMzE_6dca640e-7159-4d82-8a9f-b093b377d720">35,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0d06303bf64411ebac22da90bae8bc6_D20220101-20220630" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTAtNS0xLTEtMzkzMzE_7a6b73ce-d455-432e-a9cd-6d430767574c">207,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d6e818748004cac8bd53aeb8e5fcb4a_D20210101-20210630" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTAtNy0xLTEtMzkzMzE_56cbd52a-37e7-4017-8ed1-15547b6288e6">72,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48182d1c2a094a3da085fb747d293f3e_D20220401-20220630" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTEtMS0xLTEtMzkzMzE_888925c5-0e1f-4979-b315-aa0c600b508f">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee0a4262a80f406a86e3cfc6a645adae_D20210401-20210630" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTEtMy0xLTEtMzkzMzE_b04b1ec9-72b9-466d-91b1-ce87c16748f3">562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iababccf169c64eb497cc9f14a300ad39_D20220101-20220630" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTEtNS0xLTEtMzkzMzE_1118d5cf-b007-4617-97cf-13909beef4f5">2,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6936f0dd73f149a284028ca151da158a_D20210101-20210630" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTEtNy0xLTEtMzkzMzE_b3d3201a-b015-4671-b472-f2d4b811d058">1,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTItMS0xLTEtMzkzMzE_dbd27b3e-c5ca-412e-91d5-9777098c7c85">98,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTItMy0xLTEtMzkzMzE_7eedd93b-be31-4063-8a8d-bdb2b7413ef0">35,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTItNS0xLTEtMzkzMzE_f99ba65d-f82f-4b53-90f6-eb99a74397f7">210,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTItNy0xLTEtMzkzMzE_ca5f71a0-a504-413b-9ab9-d90f16478a7d">74,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate overhead </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="ccrn:SegmentReportingUnallocatedCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTQtMS0xLTEtMzkzMzE_b186e9a8-f6bf-4532-8384-040be5f20f89">17,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="ccrn:SegmentReportingUnallocatedCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTQtMy0xLTEtMzkzMzE_26aa3fbe-19b1-4e19-b347-1ceb5e9f7620">14,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="ccrn:SegmentReportingUnallocatedCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTQtNS0xLTEtMzkzMzE_a8e85ef9-c1f8-4f10-aa26-ba8f197cb2e3">33,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="ccrn:SegmentReportingUnallocatedCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTQtNy0xLTEtMzkzMzE_54267610-5018-4724-841d-765080e8e0ed">28,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTUtMS0xLTEtMzkzMzE_45673dbf-d77d-425d-9782-219836608bde">3,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTUtMy0xLTEtMzkzMzE_6142724a-b2c4-4856-936a-eff87276adf5">2,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTUtNS0xLTEtMzkzMzE_ff00d451-d062-401f-82b7-24b887ccb242">6,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTUtNy0xLTEtMzkzMzE_cbba06d3-716c-47b9-86d9-799b873455ac">4,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTYtMS0xLTEtMzkzMzE_295f9c63-6e33-43e7-9b31-f46a1216b00e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTYtMy0xLTEtMzkzMzE_8c011606-29bb-4c24-a821-6be9e93a6d12">924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTYtNS0xLTEtMzkzMzE_07293cdb-2e0f-4595-92a8-6e36632c36cf">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="ccrn:AcquisitionAndIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTYtNy0xLTEtMzkzMzE_a5052f7a-1a8e-410b-a08f-d50554b9d5c8">924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring (benefits) costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTctMS0xLTEtMzkzMzE_20bd9529-dcd6-4aa5-8c78-fe338100b933">1,114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTctMy0xLTEtMzkzMzE_b52c9cbe-3158-4e6a-af3d-4b2c67e1a896">835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTctNS0xLTEtMzkzMzE_b579e03b-a461-44db-ad91-b5f35acb317d">634</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTctNy0xLTEtMzkzMzE_a53099ca-b4c6-480b-be45-2948add94905">2,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTgtMS0xLTEtMzkzMzE_95293a25-a2e5-453c-962e-744e88cc2779">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTgtMy0xLTEtMzkzMzE_4f5fb767-09f8-4509-bae3-13132ca619be">1,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTgtNS0xLTEtMzkzMzE_d0d7d022-ff65-4938-b591-669085a1b978">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTgtNy0xLTEtMzkzMzE_ba1499a1-8610-45a0-bbac-9bdfeca03a02">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTktMS0xLTEtMzkzMzE_11202872-ae00-40f9-b57c-dc8a24c28286">78,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTktMy0xLTEtMzkzMzE_6acaddb8-f84e-44db-a9b0-e7ccdd616239">15,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTktNS0xLTEtMzkzMzE_ae3d9e5e-1b57-4e61-8929-fb6814139dbb">169,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTktNy0xLTEtMzkzMzE_cd9f2f4c-4fd3-4277-8724-426d9fff4235">36,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Corporate overhead includes unallocated executive leadership and other centralized corporate functional support costs such as finance, IT, legal, human resources, and marketing, as well as public company expenses and corporate-wide projects (initiatives).</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183My9mcmFnOjBhNzVkNjNmYzczYzQ2MzM5MmEzZjE4MDk4MzJlOGVlL3RleHRyZWdpb246MGE3NWQ2M2ZjNzNjNDYzMzkyYTNmMTgwOTgzMmU4ZWVfMjg1Mw_8372adbb-313a-4856-83db-4b0eba0730b7" continuedAt="i6ac77be6760445e080f9c8d2c5da7b11" escape="true">CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i6ac77be6760445e080f9c8d2c5da7b11" continuedAt="ifa280f43c791468c8a3df68f6c4608dd"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in various litigation, claims, investigations, and other proceedings that arise in the ordinary course of its business. These matters primarily relate to employee-related matters that include individual and collective claims, professional liability, tax, and payroll practices. The Company establishes reserves when available information indicates that a loss is probable and an amount or range of loss can be reasonably estimated. These assessments are performed at least quarterly and are based on the information available to management at the time and involve significant management judgment to determine the probability and estimated amount of potential losses, if any. Based on the available information considered in its reviews, the Company adjusts its loss contingency accruals and its disclosures as may be required. Actual outcomes or losses may differ materially from those estimated by the Company's current assessments, including available insurance recoveries, which would impact the Company's profitability. Adverse developments in existing litigation claims or legal proceedings involving the Company or new claims could require management to establish or increase litigation reserves or enter into unfavorable settlements or satisfy judgments for monetary damages for amounts in excess of current reserves, which could adversely affect the Company's financial results. The Company believes the outcome of any outstanding loss contingencies as of June 30, 2022 will not have a material adverse effect on its business, financial condition, results of operations, or cash flows.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="ifa280f43c791468c8a3df68f6c4608dd" continuedAt="if15180f19af443fbbb2d4c4659c85c8e">Sales and Other State Non-Income Tax Liabilities </ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if15180f19af443fbbb2d4c4659c85c8e">The Company's sales and other state non-income tax filings are subject to routine audits by authorities in the jurisdictions where it conducts business in the United States which may result in assessments of additional taxes. The Company accrues sales and other non-income tax liabilities based on the Company's best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company's business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions. The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised. The expense is included in selling, general and administrative expenses in the Company's condensed consolidated statements of operations and the liability is reflected in sales tax payable within other current liabilities in its condensed consolidated balance sheets.</ix:continuation> </span></div><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_76"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMTk2Nw_3be8e1e6-a60d-48f5-8d4a-8710697d61a4" continuedAt="i6866a4bb87ab45c7985a907e6145c440" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i6866a4bb87ab45c7985a907e6145c440"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended June 30, 2022, the Company calculated its effective tax rate estimating its annual effective tax rate, as opposed to the three and six months ended June 30, 2021 whereby the Company calculated its effective tax rate based on year-to-date results. The Company&#8217;s effective tax rate for the three and six months ended June 30, 2022 was <ix:nonFraction unitRef="number" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMzgx_de986d47-ae5a-4c9b-aed9-c7e8f74e0b91">28.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMzg4_a58e7956-ae53-4106-a7ab-1d5d7e63a44c">28.8</ix:nonFraction>%, respectively, including the impact of discrete items, and <ix:nonFraction unitRef="number" contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630" decimals="3" name="ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMzg0ODI5MDY5OTM5Nw_cf0cfe32-842a-4f14-b497-d1268b06dbf3">28.9</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" decimals="3" name="ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMzg0ODI5MDY5OTQwNA_ccd3d24f-fddb-4555-acd1-ed142da7a6c1">29.5</ix:nonFraction>%, respectively, excluding discrete items. The Company's effective tax rate for the three and six months ended June 30, 2021 was <ix:nonFraction unitRef="number" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfNTYw_2004538a-dee6-4a82-930d-84667672c487">22.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfNTY3_6172304f-0a85-471b-9d09-6947ae37dfd6">12.1</ix:nonFraction>%, respectively, including the impact of discrete items, and <ix:nonFraction unitRef="number" contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630" decimals="3" name="ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMzg0ODI5MDY5OTU2Mg_18b04fa0-d451-4f6a-929b-5a8a8d7a88ef">9.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630" decimals="3" name="ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMzg0ODI5MDY5OTU2OA_899c6305-2ba8-4cfd-80d2-9ba442bf6114">6.6</ix:nonFraction>%, respectively, excluding discrete items. The effective tax rate for the three and six months ended June 30, 2022 was primarily impacted by federal and state taxes. As a result of the Company's valuation allowance on substantially all of its domestic deferred tax assets, the effective tax rate for the three and six months ended June 30, 2021 was primarily impacted by international taxes, state taxes, and additional valuation allowance required as a result of the WSG acquisition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company concluded that it was more likely than not that a benefit from a substantial portion of its United States federal and state deferred tax assets would be realized and released the majority of its valuation allowance. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022 and December 31, 2021, the Company had an immaterial amount of valuation allowance on its deferred tax assets related to state net operating losses not expected to be realized before expiration.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax years 2012 through 2021 remain open to examination by certain taxing jurisdictions to which the Company is subject to tax.</span></div></ix:continuation><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183OS9mcmFnOjUzMDY1MTIyMzU3YzQ0MjNiNDk2NzQxNTM2MjJkMzkzL3RleHRyZWdpb246NTMwNjUxMjIzNTdjNDQyM2I0OTY3NDE1MzYyMmQzOTNfMjM0NA_07fd9979-c37d-49cc-8cd1-3c989c619d72" continuedAt="i51f2158bbdfb406caaffe78967102a78" escape="true">RELATED PARTY TRANSACTIONS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i51f2158bbdfb406caaffe78967102a78"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has entered into an arrangement for digital marketing services provided by a firm that is related to Mr. Clark, the Company's non-executive Chairman of the Board since April 1, 2022, and the Company's Co-Founder &amp; Chief Executive Officer through March 31, 2022. Mr. Clark is a minority shareholder in the firm's parent company and is a member of the parent company's Board of Directors. Management believes the terms of the arrangement are equivalent to those prevailing in an arm's-length transaction and have been approved by the Company through its related party process. The digital marketing firm manages a limited number of digital publishers covering various Company brands for a monthly management fee. During the three and six months ended June 30, 2022 and 2021, the Company incurred an immaterial amount in expenses. The Company had an immaterial payable balance at June 30, 2022 and December 31, 2021.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides services to entities which are affiliated with certain members of the Company&#8217;s Board of Directors. Management believes the services were conducted on terms equivalent to those prevailing in an arm's-length transaction. Revenue related to these transactions was $<ix:nonFraction unitRef="usd" contextRef="i91fdc80f57044a50afa1d6033fa5183f_D20220401-20220630" decimals="-5" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183OS9mcmFnOjUzMDY1MTIyMzU3YzQ0MjNiNDk2NzQxNTM2MjJkMzkzL3RleHRyZWdpb246NTMwNjUxMjIzNTdjNDQyM2I0OTY3NDE1MzYyMmQzOTNfMzg0ODI5MDcwMDQ1NA_11d5fa22-08c8-427e-9f1e-659f1ffca445">0.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1e0108cb028149ccb9de91110e533b39_D20220101-20220630" decimals="-5" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183OS9mcmFnOjUzMDY1MTIyMzU3YzQ0MjNiNDk2NzQxNTM2MjJkMzkzL3RleHRyZWdpb246NTMwNjUxMjIzNTdjNDQyM2I0OTY3NDE1MzYyMmQzOTNfMzg0ODI5MDcwMDY2Nw_999248de-daaf-491f-894c-9024a44e550e">0.9</ix:nonFraction> million, respectively, for the three and six months ended June 30, 2022. Revenue was <ix:nonFraction unitRef="usd" contextRef="i2612021a1b9a4426b3de852fbbf51315_D20210101-20210630" decimals="-5" name="us-gaap:RevenueFromRelatedParties" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183OS9mcmFnOjUzMDY1MTIyMzU3YzQ0MjNiNDk2NzQxNTM2MjJkMzkzL3RleHRyZWdpb246NTMwNjUxMjIzNTdjNDQyM2I0OTY3NDE1MzYyMmQzOTNfMzg0ODI5MDcwMDc4Mw_166ac6aa-a390-442b-878d-886670f33946"><ix:nonFraction unitRef="usd" contextRef="i48c021a3ed524ae4a24a7c9d9e8eca04_D20210401-20210630" decimals="-5" name="us-gaap:RevenueFromRelatedParties" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183OS9mcmFnOjUzMDY1MTIyMzU3YzQ0MjNiNDk2NzQxNTM2MjJkMzkzL3RleHRyZWdpb246NTMwNjUxMjIzNTdjNDQyM2I0OTY3NDE1MzYyMmQzOTNfMzg0ODI5MDcwMDc4Mw_2064b892-e776-4ae1-9ba6-9ca8b72c2ac5">immaterial</ix:nonFraction></ix:nonFraction> for the three and six months ended June 30, 2021. Accounts receivable due from these entities was an immaterial amount at June 30, 2022 and December 31, 2021.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the WSG acquisition on June 8, 2021, the Company continues to rent WSG's headquarters. The Chief Executive Officer and Founder of WSG, and currently a business unit president with the Company, is an agent of the lessor. The lease term is from January 1, 2020 through December 31, 2024. The Company paid an immaterial amount in rent expense for these premises for the three and six months ended June 30, 2022 and the month ended June 30, 2021. The Company had an immaterial payable balance at June 30, 2022 and no payable balance at December 31, 2021.</span></div></ix:continuation><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_85"></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM184NS9mcmFnOjcxNWUzMTM1MjY1ZjRjYmM4NGQ3ODBiNTlmZjcxMDQ2L3RleHRyZWdpb246NzE1ZTMxMzUyNjVmNGNiYzg0ZDc4MGI1OWZmNzEwNDZfMTE5OQ_f15cd08a-c14f-4b0f-9455-d7d2f8347b43" continuedAt="i69a2445111d14142a69c79db5ec9be14" escape="true">RECENT ACCOUNTING PRONOUNCEMENTS</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="i69a2445111d14142a69c79db5ec9be14"><ix:nonNumeric contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM184NS9mcmFnOjcxNWUzMTM1MjY1ZjRjYmM4NGQ3ODBiNTlmZjcxMDQ2L3RleHRyZWdpb246NzE1ZTMxMzUyNjVmNGNiYzg0ZDc4MGI1OWZmNzEwNDZfMTE5Mg_aed9cc70-fdc7-4c22-ac84-59af034bb7fd" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities such as deferred revenue acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Generally, this amendment will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically such amounts were recognized by the acquirer at fair value in acquisition accounting. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The Company is currently in the process of evaluating this standard and expects to adopt this standard in its first quarter of 2023.</span></ix:nonNumeric></ix:continuation></div><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_88"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the following Management&#8217;s Discussion and Analysis (MD&amp;A) is to help facilitate the understanding of significant factors influencing the quarterly operating results, financial condition, and cash flows of the Company. Additionally, MD&amp;A also conveys our current expectations of the potential impact of known trends, events, or uncertainties that may impact future results. MD&amp;A is provided as a supplement to, and should be read in conjunction with, our 2021 Form 10-K (including Part I, Item 1A, "Risk Factors"), our financial statements and the accompanying notes to our financial statements, as well as the Risk Factors contained herein.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We provide total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers across the continuum of care, by recruiting and placing highly qualified healthcare professionals in virtually every specialty and area of expertise. In addition to clinical roles such as school nurses, speech language, and behavioral therapists, we place non-clinical professionals such as teachers, substitute teachers, and other education specialties at educational facilities across the nation. Our diverse customer base includes both public and private acute care and non-acute care hospitals, outpatient clinics, ambulatory care facilities, single- and multi-specialty physician practices, rehabilitation facilities, Program of All-Inclusive Care for the Elderly (PACE) programs, urgent care centers, local and national healthcare systems, managed care providers, public and charter schools, correctional facilities, government facilities, pharmacies, and many other healthcare providers. Through our national staffing teams, we offer our workforce solutions and place clinicians on travel and per diem assignments, local short-term contracts, and permanent positions. In addition, we continually evaluate opportunities to acquire companies that would complement or enhance our business, like Selected and WSG.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our workforce solutions include managed service programs (MSPs), recruitment process outsourcing (RPO), project management, and other outsourcing and consultative services as described in Item 1. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Business</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in our 2021 Form 10-K. By utilizing the solutions we offer, customers are able to better plan their personnel needs, optimize their talent acquisition and management processes, strategically flex and balance their workforce, have access to quality healthcare personnel, and provide continuity of care for improved patient outcomes. We have a history of investing in diversity, equality, and inclusion as a key component of the organization&#8217;s overall corporate social responsibility program, closely aligned with our core values to create a better future for our people, communities, and our stockholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating results of our business segments are regularly reviewed by the chief operating decision maker.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nurse and Allied Staffing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Nurse and Allied Staffing represented approximately 97% of our total revenue in the second quarter of 2022. The Nurse and Allied Staffing segment provides workforce solutions and traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, as well as per diem and contract nurses and allied personnel. We also provide clinical and non-clinical professionals on short-term and long-term assignments to clients such as local and national healthcare plans, managed care providers, public and charter schools, correctional facilities, skilled nursing facilities, and other non-acute settings. In addition, Nurse and Allied Staffing provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. We provide flexible workforce solutions to our healthcare customers through diversified offerings designed to meet their unique needs, including: MSP, RPO, and consulting services.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Physician Staffing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Physician Staffing represented approximately 3% of our total revenue in the second quarter of 2022. Physician Staffing provides physicians in many specialties, as well as certified registered nurse anesthetists, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Summary of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the quarter ended June 30, 2022, revenue from services increased 127% year-over-year to $753.6 million, due to continued growth in both our Nurse and Allied Staffing and our Physician Staffing segments. V</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">olumes were stronger as we continued to experience high demand across a wide range of specialties spanning the healthcare continuum, with the highest number of professionals on assignment across our businesses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In the second quarter of 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">r</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">evenue decreased 4% sequentially, primarily as a result of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">average bill rates declining in the mid-single digits as expected, partly offset by an increase in billable hours</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Net income attributable to common stockholders in the second quarter of 2022 was $52.9 million, as compared to $11.5 million in the prior year.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the remainder of 2022, average travel bill rates are anticipated to experience a mid-teen decline sequentially, as previously discussed. Looking beyond the third quarter, we anticipate volumes to remain strong, driving further market share gains despite potential headwinds from changing bill rates or demand from certain specialties. We remain committed to investing in our people and technology, doubling our IT project budget for 2022, versus 2021. In the second quarter of 2022, we launched Intellify, our proprietary Vendor Management System (VMS), which will be deployed to new and existing MSP clients.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June 30, 2022, cash flow provided by operating activities was $18.1 million, with net borrowings of $33.5 million on our senior-secured asset-based credit facility (ABL), and an increase in working capital stemming from an increase in accounts receivable partly offset by the timing of disbursements. As of June 30, 2022, we had $0.3 million of cash and cash equivalents, with a principal balance of $123.9 million outstanding on our term loan. Borrowing base availability under the ABL was $300.0 million, with $85.0 million of borrowings drawn under our ABL, and $17.5 million of undrawn letters of credit outstanding, leaving $197.5 million of excess availability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022, given positive cash from operations, we made a $50.0&#160;million optional prepayment on our term loan to reduce interest costs. We paid a prepayment premium of $0.5&#160;million pursuant to the Term Loan Agreement and, as a result of the early prepayment, wrote off debt issuance costs of $1.4&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See Results of Operations, Segment Results, and Liquidity and Capital Resources sections that follow for further information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Operating Metrics</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our financial condition by tracking operating metrics and financial results specific to each of our segments. Key operating metrics include hours worked, days filled, number of contract personnel on a full-time equivalent (FTE) basis, revenue per FTE, and revenue per day filled. Other operating metrics include number of open orders, candidate applications, contract bookings, length of assignment, bill and pay rates, and renewal and fill rates, number of active searches, and number of placements. These operating metrics are representative of trends that assist management in evaluating business performance. Due to the timing of our business process and other factors, certain of these operating metrics may not necessarily correlate to the reported U.S. GAAP results for the periods presented. Some of the segment financial results analyzed include revenue, operating expenses, and contribution income. In addition, we monitor cash flow, as well as operating and leverage ratios, to help us assess our liquidity needs.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business Segment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business Measurement</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse and Allied Staffing </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FTEs represent the average number of Nurse and Allied Staffing contract personnel on a full-time equivalent basis.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average revenue per FTE per day is calculated by dividing the Nurse and Allied Staffing revenue, excluding permanent placement, per FTE by the number of days worked in the respective periods.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician Staffing</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Days filled is calculated by dividing the total hours invoiced during the period, including an estimate for the impact of accrued revenue,  by eight hours.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue per day filled is calculated by dividing revenue as reported by days filled for the period presented.</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Results of Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes, for the periods indicated, selected condensed consolidated statements of operations data expressed as a&#160;percentage of revenue. Our historical results of operations are not necessarily indicative of future operating results.&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring (benefits) costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common stockholders</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Comparison of Results for the Three Months Ended June 30, 2022 compared to the Three Months Ended June 30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct operating expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,237&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323,919&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,726&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(924)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring (benefits) costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,949)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,921)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,901&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,084)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(880)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,909&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,243&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,258&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,361&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,897&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common stockholders</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue from services</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue from services increased 127.1% to $753.6 million for the three months ended June&#160;30, 2022, as compared to $331.8 million for the three months ended June&#160;30, 2021, due to strong performance in both our Nurse and Allied Staffing and Physician Staffing segments, primarily driven by an increase in the number of professionals on assignment, as well as higher bill rates in Nurse and Allied. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">See further discussion in Segment Results. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Direct operating expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct operating expenses are comprised primarily of field employee compensation and independent contractor expenses, housing expenses, travel expenses, and related insurance expenses. Direct operating expenses increased $323.9 million, or 125.0%, to $583.2 million for the three months ended June&#160;30, 2022, as compared to $259.2 million for the three months ended June&#160;30, 2021, as a result of revenue increases. As a percentage of total revenue, direct operating expenses decreased to 77.4% compared to 78.1% in the prior year period.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased 70.8% to $86.0 million for the three months ended June&#160;30, 2022, as compared to $50.3 million for the three months ended June&#160;30, 2021, primarily </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to increases in compensation and benefit expense, as well as marketing and consulting expense and computer subscription fees. As a&#160;percentage of total revenue, selling, general and administrative expenses decreased to 11.4% for the three months ended June&#160;30, 2022, as compared to 15.2% for the three months ended June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and amortization expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense&#160;for the three months ended June&#160;30, 2022 was $3.5 million, as compared to $2.2 million for the three months ended June&#160;30, 2021. The increase is primarily due to the additional amortization of other intangible assets from the Workforce Solutions Group (WSG) and Selected acquisitions. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets to our condensed consolidated financial statements. As a percentage of revenue, depreciation and amortization expense was 0.5% for the three months ended June&#160;30, 2022 and 0.7% for the three months ended June&#160;30, 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition and integration-related costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition and integration-related costs for the three months ended June&#160;30, 2021 include costs for legal and advisory fees for the WSG acquisition that closed on June 8, 2021. There were no such costs for the three months ended June&#160;30, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring (benefits) costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was a restructuring benefit of $1.1 million for the three months ended June&#160;30, 2022, associated with the early termination of one of the Company's corporate offices which was previously restructured, partially offset by employee termination costs. Restructuring costs for the three months ended June&#160;30, 2021 were primarily comprised of employee termination costs and ongoing lease costs related to the Company's strategic reduction of its real estate footprint and totaled $0.8 million. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash impairment charges totaled $1.9 million for the three months ended June 30, 2021, related to real estate restructuring activities. There were no such charges for the three months ended June 30, 2022. See Note 9 - Leases to our condensed consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $3.9 million for the three months ended June&#160;30, 2022, as compared to $1.2 million for the three months ended June&#160;30, 2021, due to higher average borrowings and a higher effective interest rate. The effective interest rate on our borrowings was 6.8% and 4.1% for the three months ended June&#160;30, 2022 and 2021, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss on early extinguishment of debt</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on early extinguishment of debt for the three months ended June 30, 2022 consists of a prepayment premium and the write-off of debt issuance costs related to the optional prepayment on our term loan made in the second quarter of 2022. There were no such expenses for the three months ended June 30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other income, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June 30, 2022, other income, net includes a $1.1 million gain on lease termination as a result of the early termination of one of our corporate offices.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense totaled $21.3 million for the three months ended June&#160;30, 2022, compared to $3.4 million for the three months ended June&#160;30, 2021. The increase in income tax expense was primarily driven by federal and state taxes as in the prior year there was a valuation allowance on substantially all of our domestic deferred tax assets. See Note 14 - Income Taxes to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:115%">Comparison of Results for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Six Months Ended June 30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:115%"> compared to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Six Months Ended June 30, 2021</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (Decrease)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct operating expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,197,094&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517,013&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680,081&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,561&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(884)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring (benefits) costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(634)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,707)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,895&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,092)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(851)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,273&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common shareholders</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,996&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,881&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Revenue from services</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from services increased 133.3% to $1.5 billion for the six months ended June&#160;30, 2022, as compared to $661.1 million for the six months ended June&#160;30, 2021, due to strong performance in both our Nurse and Allied Staffing and Physician Staffing  segments, primarily driven by an increase in the number of professionals on assignment, as well as higher bill rates in Nurse and Allied. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See further discussion in Segment Results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Direct operating expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct operating expenses increased $680.1 million, or 131.5%, to $1.2 billion for the six months ended June&#160;30, 2022, as compared to $517.0 million for the six months ended June&#160;30, 2021 as a result of revenue increases. As a percentage of total revenue, direct operating expenses decreased to 77.6% compared to 78.2% in the prior year period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased 68.4% to $162.8 million for the six months ended June&#160;30, 2022, as compared to $96.7 million for the six months ended June&#160;30, 2021, primarily </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to increases in compensation and benefits, as well as marketing and consulting expense and computer subscription fees, partially offset by decreases in legal expenses. As a&#160;percentage of total revenue, selling, general and administrative expenses decreased to 10.5% for the six months ended June&#160;30, 2022 as compared to 14.6% for the six months ended June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Depreciation and amortization expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense&#160;for the six months ended June&#160;30, 2022 was $6.2 million as compared to $4.5 million for the six months ended June&#160;30, 2021. The increase is primarily due to the additional amortization of other intangible assets from the WSG and Selected acquisitions. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets to our condensed consolidated financial statements. As a percentage of revenue, depreciation and amortization expense was 0.4% for the six months ended June&#160;30, 2022 and 0.7% for the six months ended June&#160;30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition and integration-related costs</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition and integration-related costs for the six months ended June 30, 2022 include an immaterial amount of legal, professional, and advisory fees for the Selected acquisition that closed late in the fourth quarter of 2021. Acquisition and integration-related costs for the six months ended June 30, 2021 include costs for legal and advisory fees for the WSG acquisition that closed on June 8, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring (benefits) costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was a restructuring benefit of $0.6 million for the six months ended June&#160;30, 2022, associated with the early termination of one of the Company's corporate offices which was previously restructured, partially offset by ongoing lease costs and employee termination costs. Restructuring costs for the six months ended June 30, 2021 were primarily comprised of employee termination costs and ongoing lease costs related to the Company's strategic reduction of its real estate footprint and totaled $2.1 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash impairment charges totaled $1.7 million for the six months ended June 30, 2022 and related to real estate activities. Non-cash impairment charges totaled $2.1 million for the six months ended June 30, 2021 and related to real estate restructuring activities and the write-off of a discontinued software development project. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets and Note 9 - Leases to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $7.4 million for the six months ended June&#160;30, 2022 as compared to $1.9 million for the six months ended June&#160;30, 2021, due to higher average borrowings and a higher effective interest rate. The effective interest rate on our borrowings was 6.6% for the six months ended June&#160;30, 2022 compared to 3.1% for the six months ended June&#160;30, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss on early extinguishment of debt</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on early extinguishment of debt for the six months ended June 30, 2022 consists of a prepayment premium and the write-off of debt issuance costs related to the optional prepayment on our term loan made in the second quarter of 2022. There were no such expenses for the six months ended June 30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other income, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2022, other income, net includes a $1.1 million gain on lease termination as a result of the early termination of one of our corporate offices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense was $46.4 million for the six months ended June 30, 2022 as compared to $4.3 million for the six months ended June 30, 2021. The increase in income tax expense was primarily driven by federal and state taxes as in the prior year there was a valuation allowance on substantially all of our domestic deferred tax assets. See Note 14 - Income Taxes to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="margin-top:3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Segment Results</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information on operating segments and a reconciliation to income from operations for the periods indicated are as follows:  </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.499%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,561&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,827&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,293&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,068&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate overhead</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring (benefits) costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(634)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,837&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,901&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,469&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,895&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 - Segment Data to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statistical data for our business segments for the periods indicated are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:44.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.686%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Nurse and Allied Staffing statistical data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FTEs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,916&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average Nurse and Allied Staffing revenue per FTE per day </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Physician Staffing statistical data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Days filled </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,416&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,775&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,641&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue per day filled </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Nurse and Allied Staffing statistical data: (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FTEs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,096&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,378&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average Nurse and Allied Staffing revenue per FTE per day </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Physician Staffing statistical data: (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Days filled </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,484&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,244&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,240&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue per day filled </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See definition of Business Measurements under the Operating Metrics section of our MD&amp;A.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Segment Comparison - Three Months Ended June 30, 2022 compared to the Three Months Ended June 30, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Nurse and Allied Staffing</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenue increased $415.2 million, or 131.3%, to $731.4 million for the three months ended June&#160;30, 2022, compared to $316.2 million for the three months ended June&#160;30, 2021, through strong performance driven by volume increases and higher bill rates</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution income increased $62.3 million, or 176.5%, to $97.6 million for the three months ended June&#160;30, 2022, compared to $35.3 million for the three months ended June&#160;30, 2021, driven by increased revenue and lower costs. As a&#160;percentage of segment revenue, contribution income margin was 13.3% for the three months ended June&#160;30, 2022, compared to 11.2% for the three months ended June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The average number of FTEs on contract during the three months ended June&#160;30, 2022 increased 78.1% from the three months ended June&#160;30, 2021, primarily due to headcount growth in travel nurse and allied, as well as additional headcount resulting from the WSG acquisition. The average revenue per FTE per day increased 30.2%, due to the increase in the average bill rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician Staffing</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue increased $6.5 million, or 41.4%, to $22.1 million for the three months ended June&#160;30, 2022, compared to $15.6 million for the three months ended June&#160;30, 2021, primarily due to an increase in volume in both primary care physicians and certified registered nurse anesthetists.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution income was $1.2 million for the three months ended June&#160;30, 2022, compared to $0.6 million for the three months ended June&#160;30, 2021. As a&#160;percentage of segment revenue, contribution income was 5.5% for the three months ended June&#160;30, 2022, compared to 3.6% for the three months ended June&#160;30, 2021, driven by higher revenue and lower costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total days filled for the three months ended June&#160;30, 2022 were 12,416, as compared with 9,775 in the prior year. Revenue per day filled was $1,781 as compared with $1,600 in the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Overhead</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate overhead includes unallocated executive leadership and other centralized corporate functional support costs such as finance, IT, legal, human resources, and marketing, as well as public company expenses and corporate-wide projects. Corporate overhead increased to $17.6 million for the three months ended June&#160;30, 2022, from $14.1 million for the three months ended June&#160;30, 2021, primarily </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to increases in compensation and benefit expense, as well as IT and consulting expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As a percentage of consolidated revenue, corporate overhead was 2.3% for the three months ended June&#160;30, 2022 and 4.2% for the three months ended June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Segment Comparison - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"> compared to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:120%">Nurse and Allied Staffing</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenue increased $867.8 million, or 137.9%, to $1.5 billion for the six months ended June&#160;30, 2022, compared to $629.2 million for the six months ended June&#160;30, 2021, through strong performance driven by volume increases and higher bill rates</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution income increased $135.0 million, or 185.6%, to $207.7 million for the six months ended June&#160;30, 2022, compared to $72.7 million for the six months ended June&#160;30, 2021, driven by increased revenue and lower costs. As a&#160;percentage of segment revenue, contribution income margin was 13.9% for the six months ended June&#160;30, 2022, compared to 11.6% for the six months ended June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The average number of FTEs on contract during the six months ended June&#160;30, 2022 increased 89.9% from the six months ended June&#160;30, 2021, primarily due to headcount growth in travel nurse and allied, as well as additional headcount resulting from the WSG acquisition. The average revenue per FTE per day increased 25.3%, due to the increase in the average bill rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician Staffing</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue increased $13.4 million, or 42.0%, to $45.3 million for the six months ended June&#160;30, 2022, compared to $31.9 million for the six months ended June&#160;30, 2021, primarily due to an increase in volume in both primary care physicians and certified registered nurse anesthetists.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contribution income was $3.0 million for the six months ended June&#160;30, 2022, compared to $2.0 million for the six months ended June&#160;30, 2021. As a&#160;percentage of segment revenue, contribution income was 6.6% for the six months ended June&#160;30, 2022, compared to 6.2% for the six months ended June&#160;30, 2021, driven by higher revenue, partially offset by higher direct costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total days filled for the six months ended June 30, 2022 were 25,484, as compared with 19,244 in the prior year. Revenue per day filled was $1,776 as compared with $1,656 in the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Overhead</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate overhead increased to $33.8 million for the six months ended June 30, 2022, from $28.3 million for the six months ended June 30, 2021, primarily </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to increases in compensation and benefit expense, as well as IT and consulting expense, partially offset by decreases in legal and accounting expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As a percentage of consolidated revenue, corporate overhead was 2.2% for the six months ended June 30, 2022 and 4.3% for the six months ended June 30, 2021.</span></div><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2022, we reported $0.3 million in cash and cash equivalents, $123.9 million of term loan outstanding, at par, and $85.0 million of borrowings drawn under our ABL. Working capital increased by $141.2 million to $449.7 million as of June&#160;30, 2022, compared to $308.5 million as of December&#160;31, 2021, primarily due to an increase in accounts receivable, partially offset by the timing of disbursements. As of June 30, 2022, our days' sales outstanding, net of amounts owed to subcontractors, was 66 days, up</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 10 days year-over-year and up 4 days sequentially, primarily due to the timing of revenue recognized throughout the year.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of June 30, 2022, we do not have any off-balance sheet arrangements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating cash flow constitutes our primary source of liquidity and, historically, has been sufficient to fund our working capital, capital expenditures, internal business expansion, and debt service. This includes our commitments, both short-term and long-term, of interest expense on our debt and operating lease commitments, and future principal payments on our term loan and our ABL credit facility.&#160;We expect to meet our future needs from a combination of cash on hand, operating cash flows, and funds available through the ABL. See debt discussion which follows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an effective &#8220;shelf&#8221; registration statement on Form S-3 on file with the SEC that enables us, in one or more offerings, to sell up to an aggregate of 5,000,000 shares of common stock. Although we do not have any current plans to use the shelf registration statement, the proceeds from any offering could be used for working capital and other general corporate purposes, or to fund acquisitions of businesses, products, and technologies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $10.9 million in the six months ended June&#160;30, 2022, compared to $9.4 million in the six months ended June&#160;30, 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to the continued investment in net working capital associated with the revenue growth in our business, which resulted in a $215.2 million increase in receivables since the start of the year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $3.8 million in the six months ended June&#160;30, 2022, compared to $27.5 million in the six months ended June&#160;30, 2021. Net cash used in the six months ended June 30, 2022 was for capital expenditures, primarily related to multiple IT projects. Net cash used in the six months ended June 30, 2021 included $24.5 million related to the acquisition of WSG, as well as capital expenditures and the build-out of our corporate office.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities during the six months ended June&#160;30, 2022 was $14.0 million, compared to $53.4 million during the six months ended June&#160;30, 2021. During the six months ended June 30, 2022, we reported net borrowings of $75.8 million on our ABL, and used cash to repay borrowings of $50.4 million on our term loan, $2.4 million on our note payable, $5.3 million for income taxes on share-based compensation, $3.2 million in debt issuance costs, and an immaterial amount for other financing activities. During the six months ended June 30, 2021, we reported net borrowings of $100.0 million on our term loan, and used cash to repay borrowing on our ABL of $37.5 million, $2.4 million on our note payable, $4.5 million of debt issuance costs, $2.2 million for income taxes on share-based compensation, and an immaterial amount for other financing activities. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_118"></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Term Loan Credit Agreement</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As more fully described in Note 8 - Debt to our condensed consolidated financial statements, on June 8, 2021, we entered into a Term Loan Credit Agreement (Term Loan Agreement), which provides for a six-year second lien subordinated term loan in the amount of $100.0&#160;million (term loan). The term loan has an interest rate of one-month London Inter-Bank Offered Rate (LIBOR) plus 5.75% per annum, subject to a 0.75% LIBOR floor. The term loan was used to pay the cash consideration, as well as any costs, fees, and expenses in connection with the WSG acquisition (see Note 4 - Acquisitions to our condensed consolidated financial statements), with the remainder used to pay down a portion of the asset-based credit facility.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowings under the Term Loan Agreement generally bear interest at a variable rate based on either LIBOR or Base Rate (as defined in the Term Loan Agreement) and are subject to mandatory prepayments of principal payable in quarterly installments, commencing on September 30, 2021, with each installment being in the aggregate principal amount of $0.3 million (subject to adjustment as a result of prepayments) provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. The Term Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum net leverage ratio. The Company was in compliance with this covenant as of June 30, 2022. Obligations under the Term Loan Agreement are secured by substantially all the assets of the borrowers and guarantors under the Term Loan Agreement, subject to customary exceptions.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2021, we amended the Term Loan Agreement (Term Loan First Amendment), which provided the Company an incremental term loan in an aggregate amount equal to $75.0 million. Additionally, the Term Loan First Amendment increased the aggregate amount of all increases (as defined in the Term Loan Agreement) to be no greater than $115.0 million. The borrowings will be used primarily to fund organic growth. Commencing on December 31, 2021, installments of the mandatory prepayments will be in the aggregate principal amount of $0.4 million. All other terms, conditions, covenants, and pricing of the Term Loan Agreement remain the same.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aside from our scheduled payments, on June 23, 2022, we made an optional prepayment of $50.0&#160;million, and paid a prepayment premium of $0.5&#160;million pursuant to the Term Loan Agreement. As a result of the early prepayment, debt issuance costs of $1.4&#160;million were written off in the three months ended June 30, 2022. The prepayment premium and the write-off of debt issuance costs are included as loss on early extinguishment of debt in the condensed consolidated statements of operations. We were entitled to determine the application of the prepayment, which was applied to all future amortization payments, with the balance applied to the remaining balloon payment in 2027.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2019 Loan Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective October 25, 2019, our prior senior credit facility entered into in August 2017 was replaced by a $120.0&#160;million Loan Agreement, which provides for a five-year senior secured revolving credit facility. On June 30, 2020, we amended the Loan Agreement (First Amendment), which increased the current aggregate committed size of the ABL from $120.0&#160;million to $130.0&#160;million. All other terms, conditions, covenants, and pricing of the Loan Agreement remained the same. On March 8, 2021, we amended the Loan Agreement (Second Amendment), which increased the current aggregate committed size of the ABL from $130.0&#160;million to $150.0&#160;million, increased certain borrowing base sub-limits, and decreased both the cash dominion event and financial reporting triggers. On June 8, 2021, we amended the Loan Agreement (Third Amendment), which permits the incurrence of indebtedness and grant of security as set forth in the Loan Agreement and in accordance with the Intercreditor Agreement, and provides mechanics relating to a transition away from LIBOR as a benchmark interest rate to a replacement alternative benchmark rate or mechanism for loans made in U.S. dollars. On November 18, 2021, we amended the Loan Agreement (Fourth Amendment), whereby the permitted indebtedness (as defined in the Loan Agreement) was increased to $175.0 million. On March 21, 2022, we amended the Loan Agreement (Fifth Amendment), which increased the current aggregate committed size of the ABL from $150.0 million to $300.0 million, extended the credit facility for an additional five years, increased certain borrowing base sub-limits, and provided the option for all or a portion of the borrowings to bear interest at a rate based on the Secured Overnight Financing Rate (SOFR) or Base Rate, at the election of the borrowers, plus an applicable margin.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the interest rate spreads and fees under the Loan Agreement were based on SOFR plus 1.60% for the revolving portion of the borrowing base. The Base Rate (as defined by the Loan Agreement) margin would have been 0.50%  for the revolving portion</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The SOFR and Base Rate margins are subject to monthly pricing adjustments, pursuant to a pricing matrix based on the Company&#8217;s excess availability under the revolving credit facility. In addition, the facility is subject to an unused line fee, letter of credit fees, and an administrative fee. The Loan Agreement contains various restrictions and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">covenants, including a covenant to maintain a minimum fixed charge coverage ratio. We were in compliance with the fixed charge coverage ratio covenant as of June 30, 2022. Borrowing base availability under the ABL was $300.0&#160;million at June 30, 2022, with $85.0&#160;million of borrowings drawn as well as $17.5&#160;million of letters of credit outstanding, leaving $197.5&#160;million of excess availability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 - Debt to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Stockholders&#8217; Equity</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11 - Stockholders' Equity to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Critical Accounting Policies and Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our critical accounting policies and estimates remain consistent with those reported in our 2021 Form 10-K.</span></div><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Transactions with Related Parties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 15 - Related Party Transactions to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 16 - Recent Accounting Pronouncements to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to variable interest rate risk associated with our Term Loan Agreement entered into on June 8, 2021 and our Loan Agreement entered into on October 25, 2019. These agreements charge interest at a rate based on either SOFR, LIBOR, or Base Rate (as defined in the agreements) plus an applicable margin.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A 1% change in interest rates would have resulted in interest expense fluctuating approximately $1.0 million and $0.5 million for the six months ended June 30, 2022 and 2021, respectively. See Note 8 - Debt to our condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to our 2021 Form 10-K Item 1A. Risk Factors under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"The interest rates under our Term Loan Agreement and our ABL Credit Agreement may be impacted by the phase-out of LIBOR"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for discussion of the interest rate risk related to the continued phase-out of LIBOR.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our other exposures as disclosed in our 2021 Form&#160;10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_133"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our &#8220;disclosure controls and procedures&#8221; (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this report. Based upon the evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective. Disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, communicated to management, including the Chief Executive Officer and the Chief Financial Officer, and reported within the time periods specified in the SEC&#8217;s rules and forms. The disclosure controls and procedures are designed to ensure that information required to be disclosed by us in reports required under the Exchange Act of 1934, as amended, is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, in order to allow timely decisions regarding any required disclosure.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting as defined in Exchange Act Rules&#160;13a-15(f) that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not experienced any material impact to our internal controls over financial reporting despite the fact that most of our employees are working remotely </span><span style="background-color:#ffffff;color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">due to the COVID pandemic</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. &#8211; OTHER INFORMATION</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_139"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to certain legal proceedings is included in Part I, Item 1, Note 13 - Contingencies - </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Quarterly Report on Form 10-Q, and is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_142"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There are no material changes to our Risk Factors as previously disclosed in our 2021 Form 10-K.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;EXHIBITS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.265%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 #</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1141103/000162828022012463/ccrn20220331-10qex10x2.htm">Offer Letter by and between Cross Country Healthcare, Inc. and Daniel J. White, dated as of April 5, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1141103/000162828022012463/ccrn20220331-10qex10x2.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1141103/000162828022012463/ccrn20220331-10qex10x2.htm">(Previously filed as an exhibit to the Company's </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1141103/000162828022012463/ccrn20220331-10qex10x2.htm">Form </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1141103/000162828022012463/ccrn20220331-10qex10x2.htm">10-Q</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1141103/000162828022012463/ccrn20220331-10qex10x2.htm"> for the quarter ended March 31, 2022 and incorporated by reference herein)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ccrn20220630-10qex31x1.htm">Certification pursuant to Rule&#160;13a-14(a) and Rule&#160;15d-14(a) by John A. Martins,&#160;President, Chief Executive Officer, Director (Principal Executive Officer)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ccrn20220630-10qex31x2.htm">Certification pursuant to Rule 13a-14(a) and Rule 15d-14(a) by William J. Burns, Executive Vice President, Chief Financial Officer (Principal Accounting and Financial Officer)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ccrn20220630-10qex32x1.htm">Certification pursuant to 18 U.S.C. Section&#160;1350 by John A. Martins,&#160;President, Chief Executive Officer, Director (Principal Executive Officer)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ccrn20220630-10qex32x2.htm">Certification pursuant to 18 U.S.C. Section&#160;1350 by William J. Burns, Executive Vice President, Chief Financial Officer (Principal Accounting and Financial Officer)</a></span></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Represents a management contract or compensatory plan or arrangement</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="icbcc3b9b4b5d4dffac1c85669cdfe7d3_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.930%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CROSS&#160;COUNTRY&#160;HEALTHCARE,&#160;INC.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: August&#160;4, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ William J. Burns</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William J. Burns<br/>Executive Vice President &amp; Chief&#160;Financial&#160;Officer                         (Principal Accounting and Financial Officer)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ccrn20220630-10qex31x1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia1b3c5c9ac874a1b934695c80460a216_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, John A. Martins, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form&#160;10-Q of Cross Country Healthcare, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.361%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John A. Martins</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John A. Martins<br>President &#38; Chief&#160;Executive Officer<br>(Principal&#160;Executive&#160;Officer)</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ccrn20220630-10qex31x2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i38cd6903c12a48428703982278c33457_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, William J. Burns, certify that&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form&#160;10-Q of Cross Country Healthcare, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.361%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; William J. Burns</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William J. Burns<br>Executive Vice President &#38; Chief&#160;Financial&#160;Officer                                                                                    (Principal Accounting and Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ccrn20220630-10qex32x1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ifdf1fce63eef4268a958bdeaf16bd0ad_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the accompanying Quarterly Report on Form&#160;10-Q of Cross Country Healthcare, Inc. (the Company) for the quarterly period ended June&#160;30, 2022, (the &#34;Periodic Report&#34;), I, John A. Martins, President and Chief Executive Officer of the Company, hereby certify pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge the Periodic Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.961%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John A. Martins</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John A. Martins<br>President &#38; Chief&#160;Executive Officer<br>(Principal&#160;Executive&#160;Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&#160;906, has been provided to Cross Country Healthcare, Inc. and will be retained by Cross Country Healthcare, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification is provided solely for purposes of complying with the provisions of Section&#160;906 of the Sarbanes-Oxley Act of 2002.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>ccrn20220630-10qex32x2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3195355aa774462e8c13f2b2d33c3347_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the accompanying Quarterly Report on Form&#160;10-Q of Cross Country Healthcare, Inc. (the &#34;Company&#34;) for the quarterly period ended June&#160;30, 2022, (the &#34;Periodic Report&#34;), I, William J. Burns, Executive Vice President and Chief Financial Officer of the Company, hereby certify pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge the Periodic Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.361%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; William J. Burns</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William J. Burns<br>Executive Vice President &#38; Chief&#160;Financial&#160;Officer                                                                                    (Principal Accounting and Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&#160;906, has been provided to Cross Country Healthcare, Inc. and will be retained by Cross Country Healthcare, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification is provided solely for purposes of complying with the provisions of Section&#160;906 of the Sarbanes-Oxley Act of 2002.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ccrn-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5ab65a54-411a-4f77-8134-d4db92a3ff6c,g:6015d444-ff7a-4976-923c-b8be5a21a758-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ccrn="http://www.crosscountryhealthcare.com/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.crosscountryhealthcare.com/20220630">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ccrn-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.crosscountryhealthcare.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDBASISOFPRESENTATION" roleURI="http://www.crosscountryhealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION">
        <link:definition>2101101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2304301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails">
        <link:definition>2405401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails" roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails">
        <link:definition>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails" roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails">
        <link:definition>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restructuring (Benefits) Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITION" roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION">
        <link:definition>2108103 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONTables" roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables">
        <link:definition>2309302 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONDetails" roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails">
        <link:definition>2410404 - Disclosure - REVENUE RECOGNITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONS" roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONS">
        <link:definition>2111104 - Disclosure - ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSTables" roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSTables">
        <link:definition>2312303 - Disclosure - ACQUISITIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSAdditionalInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails">
        <link:definition>2413405 - Disclosure - ACQUISITIONS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>2414406 - Disclosure - ACQUISITIONS - Recognized Identified Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPREHENSIVEINCOME" roleURI="http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME">
        <link:definition>2115105 - Disclosure - COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPREHENSIVEINCOMEDetails" roleURI="http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOMEDetails">
        <link:definition>2416407 - Disclosure - COMPREHENSIVE INCOME (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE">
        <link:definition>2117106 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables">
        <link:definition>2318304 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails" roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails">
        <link:definition>2419408 - Disclosure - EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREAntidilutiveSecuritiesDetails" roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails">
        <link:definition>2420409 - Disclosure - EARNINGS PER SHARE - Anti-dilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS" roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS">
        <link:definition>2121107 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables">
        <link:definition>2322305 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails">
        <link:definition>2423410 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails" roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails">
        <link:definition>2424411 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Estimated Annual Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails">
        <link:definition>2425412 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.crosscountryhealthcare.com/role/DEBT">
        <link:definition>2126108 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://www.crosscountryhealthcare.com/role/DEBTTables">
        <link:definition>2327306 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTLongtermDebtDetails" roleURI="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails">
        <link:definition>2428413 - Disclosure - DEBT - Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT2021TermLoanCreditAgreementNarrativeDetails" roleURI="http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails">
        <link:definition>2429414 - Disclosure - DEBT - 2021 Term Loan Credit Agreement Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTMaturitiesofDebtDetails" roleURI="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails">
        <link:definition>2430415 - Disclosure - DEBT - Maturities of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT2019LoanAgreementDetails" roleURI="http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails">
        <link:definition>2431416 - Disclosure - DEBT - 2019 Loan Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.crosscountryhealthcare.com/role/LEASES">
        <link:definition>2132109 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.crosscountryhealthcare.com/role/LEASESTables">
        <link:definition>2333307 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESAdditionalInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/LEASESAdditionalInformationDetails">
        <link:definition>2434417 - Disclosure - LEASES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSupplementalBalanceSheetInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails">
        <link:definition>2435418 - Disclosure - LEASES - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESOperatingLeaseMaturityDetails" roleURI="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails">
        <link:definition>2436419 - Disclosure - LEASES - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESOperatingLeaseMaturityDetails_1" roleURI="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1">
        <link:definition>2436419 - Disclosure - LEASES - Operating Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESLeaseCostsDetails" roleURI="http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails">
        <link:definition>2437420 - Disclosure - LEASES - Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2138110 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2339308 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails">
        <link:definition>2440421 - Disclosure - FAIR VALUE MEASUREMENTS - Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails" roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails">
        <link:definition>2441422 - Disclosure - FAIR VALUE MEASUREMENTS - Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY">
        <link:definition>2142111 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>2343309 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYAdditionalInformationDetails" roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails">
        <link:definition>2444423 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYRestrictedStockActivityDetails" roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails">
        <link:definition>2445424 - Disclosure - STOCKHOLDERS' EQUITY - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTDATA" roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATA">
        <link:definition>2146112 - Disclosure - SEGMENT DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTDATATables" roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATATables">
        <link:definition>2347310 - Disclosure - SEGMENT DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTDATADetails" roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails">
        <link:definition>2448425 - Disclosure - SEGMENT DATA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONTINGENCIES" roleURI="http://www.crosscountryhealthcare.com/role/CONTINGENCIES">
        <link:definition>2149113 - Disclosure - CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.crosscountryhealthcare.com/role/INCOMETAXES">
        <link:definition>2150114 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails">
        <link:definition>2451426 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONS" roleURI="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS">
        <link:definition>2152115 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONSDetails" roleURI="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails">
        <link:definition>2453427 - Disclosure - RELATED PARTY TRANSACTIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECENTACCOUNTINGPRONOUNCEMENTS" roleURI="http://www.crosscountryhealthcare.com/role/RECENTACCOUNTINGPRONOUNCEMENTS">
        <link:definition>2154116 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ccrn_PaymentForDebtPrepayment" abstract="false" name="PaymentForDebtPrepayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_OperatingLeaseExpenseNonCash" abstract="false" name="OperatingLeaseExpenseNonCash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_TemporaryStaffingServicesMember" abstract="true" name="TemporaryStaffingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_NurseAndAlliedStaffingMember" abstract="true" name="NurseAndAlliedStaffingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_ShareBasedPaymentAwardsMember" abstract="true" name="ShareBasedPaymentAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_WorkforceSolutionsGroupIncMember" abstract="true" name="WorkforceSolutionsGroupIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_PaymentsForRestructuringAndAdjustments" abstract="false" name="PaymentsForRestructuringAndAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" abstract="false" name="BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_DeferredCompensationMember" abstract="true" name="DeferredCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_EarnoutNotesPayableMember" abstract="true" name="EarnoutNotesPayableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" abstract="true" name="ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="ccrn_SalesAllowanceBillingRelatedAdjustments" abstract="false" name="SalesAllowanceBillingRelatedAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_OmnibusPlanMember" abstract="true" name="OmnibusPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_LineOfCreditFacilityBorrowingBaseAvailability" abstract="false" name="LineOfCreditFacilityBorrowingBaseAvailability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_SegmentReportingUnallocatedCorporateExpenses" abstract="false" name="SegmentReportingUnallocatedCorporateExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_LineOfCreditSublimitAxis" abstract="true" name="LineOfCreditSublimitAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_BusinessCombinationContingentConsiderationTerm" abstract="false" name="BusinessCombinationContingentConsiderationTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" abstract="false" name="ProvisionForDoubtfulAccountsAndOtherAllowances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_SelectedIncMember" abstract="true" name="SelectedIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" abstract="true" name="HealthCareSystemAffiliatedWithABoardMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_AcquisitionAndIntegrationRelatedCosts" abstract="false" name="AcquisitionAndIntegrationRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" abstract="false" name="EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ccrn_StandbyLettersOfCreditSublimitMember" abstract="true" name="StandbyLettersOfCreditSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" abstract="false" name="OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" abstract="false" name="LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_RestrictedStockAndPerformanceSharesMember" abstract="true" name="RestrictedStockAndPerformanceSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_LongTermDebtMaturityAfterYearFour" abstract="false" name="LongTermDebtMaturityAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" abstract="false" name="ThresholdPeriodPastDueForPaymentOfServicesProvided" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ccrn_SeniorSecuredAssetBasedLoanMember" abstract="true" name="SeniorSecuredAssetBasedLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_LineOfCreditBorrowingBasePercentageOfAssets" abstract="false" name="LineOfCreditBorrowingBasePercentageOfAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_A2021TermLoanCreditAgreementMember" abstract="true" name="A2021TermLoanCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ccrn_SwingLoansSublimitMember" abstract="true" name="SwingLoansSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_DebtInstrumentVariableInterestRateFloor" abstract="false" name="DebtInstrumentVariableInterestRateFloor" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" abstract="false" name="LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" abstract="false" name="AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" abstract="true" name="A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_ExitCostsMember" abstract="true" name="ExitCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_OtherServicesMember" abstract="true" name="OtherServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_PhysicianStaffingMember" abstract="true" name="PhysicianStaffingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" abstract="true" name="A2021TermLoanCreditAgreementIncrementalTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ccrn_LineOfCreditSublimitDomain" abstract="true" name="LineOfCreditSublimitDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>ccrn-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5ab65a54-411a-4f77-8134-d4db92a3ff6c,g:6015d444-ff7a-4976-923c-b8be5a21a758-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ccrn-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1ad291d2-a7b9-4155-81a6-4eaa7d290afc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e86f637b-e650-48a0-b2fa-7222adcd9cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1ad291d2-a7b9-4155-81a6-4eaa7d290afc" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e86f637b-e650-48a0-b2fa-7222adcd9cbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_7b6e59aa-9402-4a57-9439-128baca6d3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1ad291d2-a7b9-4155-81a6-4eaa7d290afc" xlink:to="loc_us-gaap_TaxesPayableCurrent_7b6e59aa-9402-4a57-9439-128baca6d3f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_4da2fbcc-b347-4d91-b2e0-502c24a2b967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1ad291d2-a7b9-4155-81a6-4eaa7d290afc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_4da2fbcc-b347-4d91-b2e0-502c24a2b967" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_e6ee42b0-ca69-4442-8dbc-434bff8a3131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1ad291d2-a7b9-4155-81a6-4eaa7d290afc" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_e6ee42b0-ca69-4442-8dbc-434bff8a3131" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_39b70403-d413-4081-b103-e443121865ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1ad291d2-a7b9-4155-81a6-4eaa7d290afc" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_39b70403-d413-4081-b103-e443121865ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_e7264af0-ddab-4a5c-8347-e1c31ac1cf89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1ad291d2-a7b9-4155-81a6-4eaa7d290afc" xlink:to="loc_us-gaap_LongTermDebtCurrent_e7264af0-ddab-4a5c-8347-e1c31ac1cf89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_fe548e70-512a-43f3-8da5-0d6d50a4d476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1ad291d2-a7b9-4155-81a6-4eaa7d290afc" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_fe548e70-512a-43f3-8da5-0d6d50a4d476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2d1dd68b-9e0c-4c4b-8118-75e285333e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7066cfeb-ceb1-4083-8179-169a09133498" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2d1dd68b-9e0c-4c4b-8118-75e285333e19" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7066cfeb-ceb1-4083-8179-169a09133498" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b6d59333-1f93-4781-88bb-13d511ed2b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2d1dd68b-9e0c-4c4b-8118-75e285333e19" xlink:to="loc_us-gaap_CommonStockValue_b6d59333-1f93-4781-88bb-13d511ed2b4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_763a0651-884d-4e3f-8a13-45b6119a63c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2d1dd68b-9e0c-4c4b-8118-75e285333e19" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_763a0651-884d-4e3f-8a13-45b6119a63c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e04d97fb-5ea8-4d07-9ad3-e97abbb8c732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2d1dd68b-9e0c-4c4b-8118-75e285333e19" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e04d97fb-5ea8-4d07-9ad3-e97abbb8c732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c646fe2e-77e8-4912-af12-4985fc2a9d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9a8db79a-bcbb-441b-8f7e-86cd4c9b32d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c646fe2e-77e8-4912-af12-4985fc2a9d2b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9a8db79a-bcbb-441b-8f7e-86cd4c9b32d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_71bc35a4-f6ab-4835-a344-c3fdc1fe1bba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c646fe2e-77e8-4912-af12-4985fc2a9d2b" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_71bc35a4-f6ab-4835-a344-c3fdc1fe1bba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_17e00d27-ee39-42d8-9403-b4c97016ab0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c646fe2e-77e8-4912-af12-4985fc2a9d2b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_17e00d27-ee39-42d8-9403-b4c97016ab0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_63b7bbf2-0cc6-4c66-9aa8-bacbfe254032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c646fe2e-77e8-4912-af12-4985fc2a9d2b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_63b7bbf2-0cc6-4c66-9aa8-bacbfe254032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_36144815-030e-41ef-a750-e7e4835efbb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c646fe2e-77e8-4912-af12-4985fc2a9d2b" xlink:to="loc_us-gaap_Goodwill_36144815-030e-41ef-a750-e7e4835efbb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8044d34f-51c2-4293-a7e3-f4859692b855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c646fe2e-77e8-4912-af12-4985fc2a9d2b" xlink:to="loc_us-gaap_AssetsCurrent_8044d34f-51c2-4293-a7e3-f4859692b855" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_d389b93d-2a68-46af-b647-7d75b9895aab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c646fe2e-77e8-4912-af12-4985fc2a9d2b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_d389b93d-2a68-46af-b647-7d75b9895aab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_3354c0a5-058c-4e87-a4b1-cc7cfff4cb07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedTradeNames"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c646fe2e-77e8-4912-af12-4985fc2a9d2b" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_3354c0a5-058c-4e87-a4b1-cc7cfff4cb07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b00ff9d4-9e13-4210-ab9b-235527b23cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_9f1234b3-0af6-4473-bbc3-ba67ff6d36a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b00ff9d4-9e13-4210-ab9b-235527b23cf1" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_9f1234b3-0af6-4473-bbc3-ba67ff6d36a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3490e6af-cc01-4933-9f37-fb36f513fe42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b00ff9d4-9e13-4210-ab9b-235527b23cf1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3490e6af-cc01-4933-9f37-fb36f513fe42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_dde29d39-391a-4c00-aa45-b09eacdf9c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b00ff9d4-9e13-4210-ab9b-235527b23cf1" xlink:to="loc_us-gaap_LiabilitiesCurrent_dde29d39-391a-4c00-aa45-b09eacdf9c99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_0bd80086-d54c-43b8-8b56-90bef25e1af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b00ff9d4-9e13-4210-ab9b-235527b23cf1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_0bd80086-d54c-43b8-8b56-90bef25e1af9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_58252adc-af63-4f0f-b90e-178584749734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b00ff9d4-9e13-4210-ab9b-235527b23cf1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_58252adc-af63-4f0f-b90e-178584749734" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent_2a30e0db-0531-490f-aac2-60e6796eaf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b00ff9d4-9e13-4210-ab9b-235527b23cf1" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent_2a30e0db-0531-490f-aac2-60e6796eaf4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_c6dd1603-d005-4cb3-86ff-212415654351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b00ff9d4-9e13-4210-ab9b-235527b23cf1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_c6dd1603-d005-4cb3-86ff-212415654351" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8bea92e2-159c-4a70-9ea7-762376c6f0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e5cd8c77-58f7-4300-95b1-268a2454ea1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8bea92e2-159c-4a70-9ea7-762376c6f0ba" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e5cd8c77-58f7-4300-95b1-268a2454ea1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_88311d47-9b18-4ec5-a531-1a08755a91af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8bea92e2-159c-4a70-9ea7-762376c6f0ba" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_88311d47-9b18-4ec5-a531-1a08755a91af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_0093e893-4f89-4449-b0c6-2ad5c381bbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8bea92e2-159c-4a70-9ea7-762376c6f0ba" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_0093e893-4f89-4449-b0c6-2ad5c381bbe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_f1dfd30c-5264-49b7-821e-8dfa1ba205c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceSettlementsReceivableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8bea92e2-159c-4a70-9ea7-762376c6f0ba" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableCurrent_f1dfd30c-5264-49b7-821e-8dfa1ba205c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_bd2a2560-0646-4ec2-8ebd-89a6efd36125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8bea92e2-159c-4a70-9ea7-762376c6f0ba" xlink:to="loc_us-gaap_OtherAssetsCurrent_bd2a2560-0646-4ec2-8ebd-89a6efd36125" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_88dcda1f-a14e-4beb-8490-23da41deec00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_fa687a7a-916e-4707-b12f-2abfa504dee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_88dcda1f-a14e-4beb-8490-23da41deec00" xlink:to="loc_us-gaap_CommitmentsAndContingencies_fa687a7a-916e-4707-b12f-2abfa504dee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_93568b3f-d51b-4df4-a701-0ebe2ca9bd3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_88dcda1f-a14e-4beb-8490-23da41deec00" xlink:to="loc_us-gaap_StockholdersEquity_93568b3f-d51b-4df4-a701-0ebe2ca9bd3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_274ff98c-5b0b-437b-a79a-1ee9faad1d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_88dcda1f-a14e-4beb-8490-23da41deec00" xlink:to="loc_us-gaap_Liabilities_274ff98c-5b0b-437b-a79a-1ee9faad1d7a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ccrn-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_67568f08-88e3-4130-91d0-7de246a4a23b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_4106b514-77c1-4069-8b93-ec04ff4cdc13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_67568f08-88e3-4130-91d0-7de246a4a23b" xlink:to="loc_us-gaap_AssetImpairmentCharges_4106b514-77c1-4069-8b93-ec04ff4cdc13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e8d3a8a7-64a2-4bb1-bb42-79c8b196e406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_67568f08-88e3-4130-91d0-7de246a4a23b" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e8d3a8a7-64a2-4bb1-bb42-79c8b196e406" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9fc68670-197a-4cbe-8876-67f3b53d6b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_67568f08-88e3-4130-91d0-7de246a4a23b" xlink:to="loc_us-gaap_RestructuringCharges_9fc68670-197a-4cbe-8876-67f3b53d6b92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_a0bd98d1-fd2e-4731-b91b-b2b5ffbd71e7" xlink:href="ccrn-20220630.xsd#ccrn_AcquisitionAndIntegrationRelatedCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_67568f08-88e3-4130-91d0-7de246a4a23b" xlink:to="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_a0bd98d1-fd2e-4731-b91b-b2b5ffbd71e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_29ea9955-3012-4efa-a2ca-6a516bb7d225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_67568f08-88e3-4130-91d0-7de246a4a23b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_29ea9955-3012-4efa-a2ca-6a516bb7d225" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_62d8e4f3-27aa-4ea0-8786-b9360ae0567a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_67568f08-88e3-4130-91d0-7de246a4a23b" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_62d8e4f3-27aa-4ea0-8786-b9360ae0567a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectOperatingCosts_addc580f-ad00-4248-9942-ed95d443c73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectOperatingCosts"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_67568f08-88e3-4130-91d0-7de246a4a23b" xlink:to="loc_us-gaap_DirectOperatingCosts_addc580f-ad00-4248-9942-ed95d443c73d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_06b1fd17-fe65-4d1c-840c-76f39052917f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5cc63027-830a-4a10-95bb-19fc97ad3d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_06b1fd17-fe65-4d1c-840c-76f39052917f" xlink:to="loc_us-gaap_NetIncomeLoss_5cc63027-830a-4a10-95bb-19fc97ad3d2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_cccbda8d-6f26-45a1-9f03-49f1caccfdd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_06b1fd17-fe65-4d1c-840c-76f39052917f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_cccbda8d-6f26-45a1-9f03-49f1caccfdd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a520e09c-df09-4c58-a138-96597382a92e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6aff027f-592e-4842-8917-80f4079fdd94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a520e09c-df09-4c58-a138-96597382a92e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6aff027f-592e-4842-8917-80f4079fdd94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_34143136-8b22-43c6-b8b5-be5af2125c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a520e09c-df09-4c58-a138-96597382a92e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_34143136-8b22-43c6-b8b5-be5af2125c4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_519acdce-c4e3-4aac-a244-a50cdce16136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a520e09c-df09-4c58-a138-96597382a92e" xlink:to="loc_us-gaap_InterestExpense_519acdce-c4e3-4aac-a244-a50cdce16136" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7480acf4-fb47-4611-8e98-f392f9cd2232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a520e09c-df09-4c58-a138-96597382a92e" xlink:to="loc_us-gaap_OperatingIncomeLoss_7480acf4-fb47-4611-8e98-f392f9cd2232" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6a321681-b727-49f7-850a-604982f99c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4b5b2b20-0cd9-47af-9208-7009677f2b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6a321681-b727-49f7-850a-604982f99c2f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4b5b2b20-0cd9-47af-9208-7009677f2b6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1237853d-524d-443a-8a74-2e750d061399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6a321681-b727-49f7-850a-604982f99c2f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1237853d-524d-443a-8a74-2e750d061399" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_137bd6b2-17e1-4d58-b563-b430330719ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_0aa741af-5d13-4961-9bd1-6ae897a67455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_137bd6b2-17e1-4d58-b563-b430330719ce" xlink:to="loc_us-gaap_CostsAndExpenses_0aa741af-5d13-4961-9bd1-6ae897a67455" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_010d0aa1-e800-45b3-a1f3-ab08424450d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_137bd6b2-17e1-4d58-b563-b430330719ce" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_010d0aa1-e800-45b3-a1f3-ab08424450d7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ccrn-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_954dcb8e-c1b2-45ec-a998-3ff3bcf112c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_dbd3b4d1-4fe1-4737-8bd3-d1842cfd6843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_954dcb8e-c1b2-45ec-a998-3ff3bcf112c7" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_dbd3b4d1-4fe1-4737-8bd3-d1842cfd6843" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_244eb779-a42a-4906-8b0f-a5c410475fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_954dcb8e-c1b2-45ec-a998-3ff3bcf112c7" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_244eb779-a42a-4906-8b0f-a5c410475fa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_a58a4714-d6dc-4e1c-98eb-02a93a66a8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_954dcb8e-c1b2-45ec-a998-3ff3bcf112c7" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_a58a4714-d6dc-4e1c-98eb-02a93a66a8eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4be8f695-da32-4414-9361-f6b30efaee5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_954dcb8e-c1b2-45ec-a998-3ff3bcf112c7" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4be8f695-da32-4414-9361-f6b30efaee5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_69fe7caa-db58-4f03-92df-e09306997d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_954dcb8e-c1b2-45ec-a998-3ff3bcf112c7" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_69fe7caa-db58-4f03-92df-e09306997d57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_42a4c12f-fba1-4167-8073-61b53d2ea582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_954dcb8e-c1b2-45ec-a998-3ff3bcf112c7" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_42a4c12f-fba1-4167-8073-61b53d2ea582" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_ee43730e-f7ed-44db-a42a-4cc1c8cd52b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_954dcb8e-c1b2-45ec-a998-3ff3bcf112c7" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_ee43730e-f7ed-44db-a42a-4cc1c8cd52b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_17138556-2ea5-484b-a0de-c6c1f4eb00e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_954dcb8e-c1b2-45ec-a998-3ff3bcf112c7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_17138556-2ea5-484b-a0de-c6c1f4eb00e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3719166c-4fb3-40a5-a49c-9e80883eabc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0e10dad-0505-43cd-91dc-aed3f76b7fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3719166c-4fb3-40a5-a49c-9e80883eabc4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0e10dad-0505-43cd-91dc-aed3f76b7fbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ea842b16-c9b2-4200-be5f-69fc89cf448e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3719166c-4fb3-40a5-a49c-9e80883eabc4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ea842b16-c9b2-4200-be5f-69fc89cf448e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c24ebac1-fc8c-42b0-9e52-5e1618bc3fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3719166c-4fb3-40a5-a49c-9e80883eabc4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c24ebac1-fc8c-42b0-9e52-5e1618bc3fdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_65f56e5d-7fdf-4661-b684-165e2d2d2171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3719166c-4fb3-40a5-a49c-9e80883eabc4" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_65f56e5d-7fdf-4661-b684-165e2d2d2171" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_e36595a3-13d1-487b-8dbc-fd00812681aa" xlink:href="ccrn-20220630.xsd#ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_e36595a3-13d1-487b-8dbc-fd00812681aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_885a750e-0440-403f-8f46-fa48c7e08953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_us-gaap_NetIncomeLoss_885a750e-0440-403f-8f46-fa48c7e08953" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_1866c920-9edb-46c7-9830-b43036e16d03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_1866c920-9edb-46c7-9830-b43036e16d03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a7923c06-ab7d-40f8-9cf4-8cca5eceaf65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a7923c06-ab7d-40f8-9cf4-8cca5eceaf65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_159add72-8ef2-4de0-8e30-6e4ad2011b37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_159add72-8ef2-4de0-8e30-6e4ad2011b37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9db16e8d-fc10-4203-837a-440ef53b1ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9db16e8d-fc10-4203-837a-440ef53b1ef1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_813396e0-cfb6-4565-82d6-0f97ce3b7c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_us-gaap_ShareBasedCompensation_813396e0-cfb6-4565-82d6-0f97ce3b7c8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_521ab303-f6ff-453b-92cd-387410611cbf" xlink:href="ccrn-20220630.xsd#ccrn_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_521ab303-f6ff-453b-92cd-387410611cbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4cf41907-266d-4563-b621-b746dcfbc48a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4cf41907-266d-4563-b621-b746dcfbc48a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_efb8495e-0dc8-42fd-a0b5-e12fe1fb1ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_efb8495e-0dc8-42fd-a0b5-e12fe1fb1ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_b81d014e-8a32-4f6e-9fc0-17a8583c29a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_b81d014e-8a32-4f6e-9fc0-17a8583c29a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ff5c9c1d-71d3-4c3b-85bb-3916791f635a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ff5c9c1d-71d3-4c3b-85bb-3916791f635a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OperatingLeaseExpenseNonCash_6f1db7a8-1fa3-41a4-990b-d8a7c3e299b7" xlink:href="ccrn-20220630.xsd#ccrn_OperatingLeaseExpenseNonCash"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_ccrn_OperatingLeaseExpenseNonCash_6f1db7a8-1fa3-41a4-990b-d8a7c3e299b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_103c6385-4281-458e-a17f-60596fb058d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_us-gaap_AssetImpairmentCharges_103c6385-4281-458e-a17f-60596fb058d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bcf179b5-1501-4aeb-a993-97eb49ab0e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dcb2b1bc-0b29-4371-ac93-c27ee5284359" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bcf179b5-1501-4aeb-a993-97eb49ab0e74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_598f4cf8-204f-46e8-9441-67388b8c09d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0ef86123-fcbe-4559-973c-f7ad955d84b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_598f4cf8-204f-46e8-9441-67388b8c09d4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0ef86123-fcbe-4559-973c-f7ad955d84b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_db431cfa-37c8-4e2c-94c6-10593a25ecd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_598f4cf8-204f-46e8-9441-67388b8c09d4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_db431cfa-37c8-4e2c-94c6-10593a25ecd5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2e417af8-d284-44de-8ddf-46a13cef3c5b" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2dff21bc-136e-44fb-bce3-dccbe0d0e95a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2e417af8-d284-44de-8ddf-46a13cef3c5b" xlink:to="loc_us-gaap_Goodwill_2dff21bc-136e-44fb-bce3-dccbe0d0e95a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_54afaa4d-ea22-474a-86ad-3deaf49c533c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2e417af8-d284-44de-8ddf-46a13cef3c5b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_54afaa4d-ea22-474a-86ad-3deaf49c533c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_858c00f4-ea9a-4adb-b1fc-78f06839347c" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2e417af8-d284-44de-8ddf-46a13cef3c5b" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_858c00f4-ea9a-4adb-b1fc-78f06839347c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0cbec60d-8228-4e1f-ba7b-c2c3ca3a20f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2e417af8-d284-44de-8ddf-46a13cef3c5b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0cbec60d-8228-4e1f-ba7b-c2c3ca3a20f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_862b78c3-f981-439b-88a2-8034805bc64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2e417af8-d284-44de-8ddf-46a13cef3c5b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_862b78c3-f981-439b-88a2-8034805bc64d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_edf1a3c4-04c7-478a-a75c-65e67d740ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2e417af8-d284-44de-8ddf-46a13cef3c5b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_edf1a3c4-04c7-478a-a75c-65e67d740ec1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_fc819968-830a-4bcb-97f7-7e4c92f7f7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_2e417af8-d284-44de-8ddf-46a13cef3c5b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_fc819968-830a-4bcb-97f7-7e4c92f7f7cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9e7a0371-77f9-4ee8-9e36-882a0ab45227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_b4362fbf-6d98-467c-a13f-211f404d6231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9e7a0371-77f9-4ee8-9e36-882a0ab45227" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_b4362fbf-6d98-467c-a13f-211f404d6231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_c81b1661-4137-4a9c-bc74-b1ed3fd7cff9" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9e7a0371-77f9-4ee8-9e36-882a0ab45227" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_c81b1661-4137-4a9c-bc74-b1ed3fd7cff9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_15ede31a-171d-4df1-b332-ad5391c1b3c7" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9e7a0371-77f9-4ee8-9e36-882a0ab45227" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_15ede31a-171d-4df1-b332-ad5391c1b3c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_3a4fb9b4-2b1a-449d-bf33-b941db62449e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9e7a0371-77f9-4ee8-9e36-882a0ab45227" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_3a4fb9b4-2b1a-449d-bf33-b941db62449e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_97c49ffb-5fa9-459f-a572-5744d9822b6a" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_9e7a0371-77f9-4ee8-9e36-882a0ab45227" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_97c49ffb-5fa9-459f-a572-5744d9822b6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_df6e9d02-8c03-4273-8dd8-05d050794d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_621e65ba-b88c-4908-b7ab-f63c1424eabb" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_df6e9d02-8c03-4273-8dd8-05d050794d47" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_621e65ba-b88c-4908-b7ab-f63c1424eabb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c78b01f3-8b0a-40bd-b1d7-aabfe59b9650" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_df6e9d02-8c03-4273-8dd8-05d050794d47" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c78b01f3-8b0a-40bd-b1d7-aabfe59b9650" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_987b314a-faad-4d20-b7aa-6da0c33fab7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_099c19fb-9bfb-4551-8f99-a19884225016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_987b314a-faad-4d20-b7aa-6da0c33fab7c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_099c19fb-9bfb-4551-8f99-a19884225016" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8b111a94-6fc3-4337-bcec-17ab36e0fd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_987b314a-faad-4d20-b7aa-6da0c33fab7c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_8b111a94-6fc3-4337-bcec-17ab36e0fd7a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_81e16e54-e5bc-4223-8e5e-7ef360443074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a8ae45c7-8b96-45a1-b27b-7d0dd8e50d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_81e16e54-e5bc-4223-8e5e-7ef360443074" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a8ae45c7-8b96-45a1-b27b-7d0dd8e50d82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5bf1b5a9-d9a3-4de5-8203-310b1373e9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_81e16e54-e5bc-4223-8e5e-7ef360443074" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5bf1b5a9-d9a3-4de5-8203-310b1373e9a1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2b64a873-6c61-4cee-9eda-4f542e9bf96f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_722594aa-2ae0-454b-92a6-8c2066e852b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2b64a873-6c61-4cee-9eda-4f542e9bf96f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_722594aa-2ae0-454b-92a6-8c2066e852b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1ade0f23-1475-412a-92f9-3d33cb0dd238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2b64a873-6c61-4cee-9eda-4f542e9bf96f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1ade0f23-1475-412a-92f9-3d33cb0dd238" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7095d728-e301-4288-901b-213044d22e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2b64a873-6c61-4cee-9eda-4f542e9bf96f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7095d728-e301-4288-901b-213044d22e1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7a568c85-7ee6-464b-800c-d9163519a35e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2b64a873-6c61-4cee-9eda-4f542e9bf96f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7a568c85-7ee6-464b-800c-d9163519a35e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_d0c5e37b-203f-4157-9bf8-a4e7d9f26b64" xlink:href="ccrn-20220630.xsd#ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2b64a873-6c61-4cee-9eda-4f542e9bf96f" xlink:to="loc_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_d0c5e37b-203f-4157-9bf8-a4e7d9f26b64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3e40352d-c670-4507-851a-6aa1e34a4b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2b64a873-6c61-4cee-9eda-4f542e9bf96f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3e40352d-c670-4507-851a-6aa1e34a4b14" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#DEBTLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e87bb9dc-5a68-4541-858a-fd558564d063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a5e6b8d6-8249-4284-b572-99bfb98457d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e87bb9dc-5a68-4541-858a-fd558564d063" xlink:to="loc_us-gaap_LongTermDebtCurrent_a5e6b8d6-8249-4284-b572-99bfb98457d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6317ac20-d0d1-4c73-9066-d9a4d4cd12e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e87bb9dc-5a68-4541-858a-fd558564d063" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6317ac20-d0d1-4c73-9066-d9a4d4cd12e7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#DEBTMaturitiesofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_fb2cd793-7e8e-4532-938a-56f1f93dc05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_53ccdc6e-7a77-49ea-a4e1-cee5e58a48a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fb2cd793-7e8e-4532-938a-56f1f93dc05b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_53ccdc6e-7a77-49ea-a4e1-cee5e58a48a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_3ba9f2d0-1448-4777-a1cc-c9d1015e796d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fb2cd793-7e8e-4532-938a-56f1f93dc05b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_3ba9f2d0-1448-4777-a1cc-c9d1015e796d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_738cb258-4e3f-48e8-ac96-3fcbcd3d78ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fb2cd793-7e8e-4532-938a-56f1f93dc05b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_738cb258-4e3f-48e8-ac96-3fcbcd3d78ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LongTermDebtMaturityAfterYearFour_285f860e-4bab-46fb-9e8a-4da98510c5f1" xlink:href="ccrn-20220630.xsd#ccrn_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fb2cd793-7e8e-4532-938a-56f1f93dc05b" xlink:to="loc_ccrn_LongTermDebtMaturityAfterYearFour_285f860e-4bab-46fb-9e8a-4da98510c5f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_96546398-7817-4c13-88d3-8887a87e0d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fb2cd793-7e8e-4532-938a-56f1f93dc05b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_96546398-7817-4c13-88d3-8887a87e0d51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_e0a1d237-c8db-48b1-8f0a-031141544999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_fb2cd793-7e8e-4532-938a-56f1f93dc05b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_e0a1d237-c8db-48b1-8f0a-031141544999" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#LEASESOperatingLeaseMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ad38f57a-69ce-43a6-a0e3-6887a93d0551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0ffcfa34-a34b-4258-aea3-e98ebedd9f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ad38f57a-69ce-43a6-a0e3-6887a93d0551" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0ffcfa34-a34b-4258-aea3-e98ebedd9f93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_64b4ddef-053d-41f0-a7d4-64ee0e0456af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ad38f57a-69ce-43a6-a0e3-6887a93d0551" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_64b4ddef-053d-41f0-a7d4-64ee0e0456af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_61b750b2-36fe-4521-8746-94f928c4cca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ad38f57a-69ce-43a6-a0e3-6887a93d0551" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_61b750b2-36fe-4521-8746-94f928c4cca6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_173f1e51-e54a-450a-8e2b-6879dc63e31e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ad38f57a-69ce-43a6-a0e3-6887a93d0551" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_173f1e51-e54a-450a-8e2b-6879dc63e31e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_41a5d374-400a-4888-8886-effe89170a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d0b352ac-a457-42ae-8581-4db2aab73ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_41a5d374-400a-4888-8886-effe89170a23" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d0b352ac-a457-42ae-8581-4db2aab73ca3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c2c3630b-7a7b-4341-83a0-9085f93c62a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_41a5d374-400a-4888-8886-effe89170a23" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c2c3630b-7a7b-4341-83a0-9085f93c62a9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="ccrn-20220630.xsd#LEASESOperatingLeaseMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_07880307-deff-441c-97bb-287c8bd3d67f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9a0cd092-be3f-4085-a214-984ffbe6d7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_07880307-deff-441c-97bb-287c8bd3d67f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9a0cd092-be3f-4085-a214-984ffbe6d7ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b714422a-a010-4ff0-8c15-c6f853c2f351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_07880307-deff-441c-97bb-287c8bd3d67f" xlink:to="loc_us-gaap_OperatingLeaseLiability_b714422a-a010-4ff0-8c15-c6f853c2f351" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>ccrn-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5ab65a54-411a-4f77-8134-d4db92a3ff6c,g:6015d444-ff7a-4976-923c-b8be5a21a758-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ccrn-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="id271efa6ba1a4cb88b7702947ab646e1_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4a4b10d5-d1d1-4a87-a6f8-7a580cf5cb00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4a4b10d5-d1d1-4a87-a6f8-7a580cf5cb00" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_037b1ae2-9d24-40be-bb37-df4c0ccac455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_SharesOutstanding_037b1ae2-9d24-40be-bb37-df4c0ccac455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_49b59d5a-da9e-404f-922c-0578cebae84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_49b59d5a-da9e-404f-922c-0578cebae84b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_23c263cf-decb-4d91-9a5f-bc93abef4656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_23c263cf-decb-4d91-9a5f-bc93abef4656" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c9d8f597-6a72-489a-99f2-83e7e4d875e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c9d8f597-6a72-489a-99f2-83e7e4d875e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_655f25e8-660a-4ee3-9269-ed732d3f6a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_655f25e8-660a-4ee3-9269-ed732d3f6a47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3a391f24-7900-4b66-b01c-aabe52c85abc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3a391f24-7900-4b66-b01c-aabe52c85abc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f9d54f65-c2c1-4ca5-a900-695d1f56d726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f9d54f65-c2c1-4ca5-a900-695d1f56d726" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0a1d3972-e82d-47e7-a522-c92a8784b66f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0a1d3972-e82d-47e7-a522-c92a8784b66f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_78fcf649-acbf-490d-8b2b-95a4a700c079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_NetIncomeLoss_78fcf649-acbf-490d-8b2b-95a4a700c079" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e04bcf87-2886-4657-a089-bc7089552b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46405df7-f784-4c58-bf69-c9c8ac009a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b684d1bf-6670-4f5b-a581-07b7a8e7c431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4a4b10d5-d1d1-4a87-a6f8-7a580cf5cb00" xlink:to="loc_us-gaap_StatementTable_b684d1bf-6670-4f5b-a581-07b7a8e7c431" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a17fba4f-00d2-464e-8e11-f902fc67ce9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b684d1bf-6670-4f5b-a581-07b7a8e7c431" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a17fba4f-00d2-464e-8e11-f902fc67ce9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a17fba4f-00d2-464e-8e11-f902fc67ce9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a17fba4f-00d2-464e-8e11-f902fc67ce9d" xlink:to="loc_us-gaap_EquityComponentDomain_a17fba4f-00d2-464e-8e11-f902fc67ce9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a17fba4f-00d2-464e-8e11-f902fc67ce9d" xlink:to="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ab958f42-8766-429a-b5d4-0b19fcc931ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:to="loc_us-gaap_CommonStockMember_ab958f42-8766-429a-b5d4-0b19fcc931ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_df0c6c38-045c-45bd-8b4f-65e6205bcffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_df0c6c38-045c-45bd-8b4f-65e6205bcffd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_05ee259f-acb0-4184-8560-f1e0a1f6dd55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_05ee259f-acb0-4184-8560-f1e0a1f6dd55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f68adacc-9f1f-4831-b5f3-c542b5f29224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:to="loc_us-gaap_RetainedEarningsMember_f68adacc-9f1f-4831-b5f3-c542b5f29224" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_6b07e9b2-dff2-4948-a8d6-cfd2ab868668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:to="loc_us-gaap_NoncontrollingInterestMember_6b07e9b2-dff2-4948-a8d6-cfd2ab868668" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="extended" id="i0399a21e32d94586978fc8687c58bf48_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c58943e6-a73a-46b2-81fd-64cc441a4970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_838f7cff-599e-4018-ac4a-55c57bb02449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c58943e6-a73a-46b2-81fd-64cc441a4970" xlink:to="loc_us-gaap_UnbilledContractsReceivable_838f7cff-599e-4018-ac4a-55c57bb02449" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SalesAllowanceBillingRelatedAdjustments_755854b8-c49f-46d6-b0b6-db19627a69c2" xlink:href="ccrn-20220630.xsd#ccrn_SalesAllowanceBillingRelatedAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c58943e6-a73a-46b2-81fd-64cc441a4970" xlink:to="loc_ccrn_SalesAllowanceBillingRelatedAdjustments_755854b8-c49f-46d6-b0b6-db19627a69c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_d208fdc1-0040-44ab-91e9-26aa6f61ef43" xlink:href="ccrn-20220630.xsd#ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c58943e6-a73a-46b2-81fd-64cc441a4970" xlink:to="loc_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_d208fdc1-0040-44ab-91e9-26aa6f61ef43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_2a4a4871-d6ec-4345-aaa8-b81097b93351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c58943e6-a73a-46b2-81fd-64cc441a4970" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_2a4a4871-d6ec-4345-aaa8-b81097b93351" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6ce68f0f-8d2a-4730-8a25-50843bb06ef4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_2a4a4871-d6ec-4345-aaa8-b81097b93351" xlink:to="loc_srt_RangeAxis_6ce68f0f-8d2a-4730-8a25-50843bb06ef4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6ce68f0f-8d2a-4730-8a25-50843bb06ef4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6ce68f0f-8d2a-4730-8a25-50843bb06ef4" xlink:to="loc_srt_RangeMember_6ce68f0f-8d2a-4730-8a25-50843bb06ef4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6371f678-20fa-45db-a922-76e2382e453a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6ce68f0f-8d2a-4730-8a25-50843bb06ef4" xlink:to="loc_srt_RangeMember_6371f678-20fa-45db-a922-76e2382e453a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5feda9b5-5983-4f98-96ea-5dc85e83e711" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6371f678-20fa-45db-a922-76e2382e453a" xlink:to="loc_srt_MinimumMember_5feda9b5-5983-4f98-96ea-5dc85e83e711" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8acab170-7f06-44f9-8d56-f35109f95947" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6371f678-20fa-45db-a922-76e2382e453a" xlink:to="loc_srt_MaximumMember_8acab170-7f06-44f9-8d56-f35109f95947" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails" xlink:type="extended" id="i1d1f2166b9bf40be8519e1fb4996ff8d_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_fa4a623f-dc55-4a91-98cf-c9dd1f24a36a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_e14d02dc-60a7-4dc4-a32f-9f6e976b3cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fa4a623f-dc55-4a91-98cf-c9dd1f24a36a" xlink:to="loc_us-gaap_RestructuringReserveRollForward_e14d02dc-60a7-4dc4-a32f-9f6e976b3cfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_c18bf4d9-b7d5-4901-9e06-3ece70718fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e14d02dc-60a7-4dc4-a32f-9f6e976b3cfb" xlink:to="loc_us-gaap_RestructuringReserve_c18bf4d9-b7d5-4901-9e06-3ece70718fbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_26023b81-a5fc-4165-a347-2a83c8657c75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e14d02dc-60a7-4dc4-a32f-9f6e976b3cfb" xlink:to="loc_us-gaap_RestructuringCharges_26023b81-a5fc-4165-a347-2a83c8657c75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PaymentsForRestructuringAndAdjustments_61a26bf9-23bd-42c4-bc3f-1f9ec633faaf" xlink:href="ccrn-20220630.xsd#ccrn_PaymentsForRestructuringAndAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e14d02dc-60a7-4dc4-a32f-9f6e976b3cfb" xlink:to="loc_ccrn_PaymentsForRestructuringAndAdjustments_61a26bf9-23bd-42c4-bc3f-1f9ec633faaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_f4c94410-85fb-4fe1-b159-277c98b423a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e14d02dc-60a7-4dc4-a32f-9f6e976b3cfb" xlink:to="loc_us-gaap_PaymentsForRestructuring_f4c94410-85fb-4fe1-b159-277c98b423a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9160e880-e08a-4820-be5d-48a40fb66470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_2548f7ba-fd34-4c34-80bd-ed340ea8a694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fa4a623f-dc55-4a91-98cf-c9dd1f24a36a" xlink:to="loc_us-gaap_BusinessExitCosts1_2548f7ba-fd34-4c34-80bd-ed340ea8a694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7092ba41-186b-4cfc-8e90-826f8e18edc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fa4a623f-dc55-4a91-98cf-c9dd1f24a36a" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7092ba41-186b-4cfc-8e90-826f8e18edc3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_55d1a2f4-43f5-48cc-9725-ad953a676d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7092ba41-186b-4cfc-8e90-826f8e18edc3" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_55d1a2f4-43f5-48cc-9725-ad953a676d63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_55d1a2f4-43f5-48cc-9725-ad953a676d63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_55d1a2f4-43f5-48cc-9725-ad953a676d63" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_55d1a2f4-43f5-48cc-9725-ad953a676d63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_a4ee555c-13ec-4869-9288-7b19f129276f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_55d1a2f4-43f5-48cc-9725-ad953a676d63" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_a4ee555c-13ec-4869-9288-7b19f129276f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_4ee161b1-769c-41b4-aff9-27b00596e67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_a4ee555c-13ec-4869-9288-7b19f129276f" xlink:to="loc_us-gaap_EmployeeSeveranceMember_4ee161b1-769c-41b4-aff9-27b00596e67a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ExitCostsMember_2752b258-6f9a-49ed-9931-149622afd0ec" xlink:href="ccrn-20220630.xsd#ccrn_ExitCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_a4ee555c-13ec-4869-9288-7b19f129276f" xlink:to="loc_ccrn_ExitCostsMember_2752b258-6f9a-49ed-9931-149622afd0ec" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#REVENUERECOGNITIONDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails" xlink:type="extended" id="i8ca68972219a465692c337354c738263_REVENUERECOGNITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_87846dbb-5168-49c2-9bf5-1cab79356e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e5252c35-e492-417c-9e1c-dde8ff09ff3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_87846dbb-5168-49c2-9bf5-1cab79356e25" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e5252c35-e492-417c-9e1c-dde8ff09ff3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0ad0a2d8-aafa-40b0-8596-b9793d652ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_87846dbb-5168-49c2-9bf5-1cab79356e25" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0ad0a2d8-aafa-40b0-8596-b9793d652ffb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c28b9e37-7708-4f3c-b00e-6a6bd4ebe9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0ad0a2d8-aafa-40b0-8596-b9793d652ffb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c28b9e37-7708-4f3c-b00e-6a6bd4ebe9f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c28b9e37-7708-4f3c-b00e-6a6bd4ebe9f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c28b9e37-7708-4f3c-b00e-6a6bd4ebe9f4" xlink:to="loc_us-gaap_SegmentDomain_c28b9e37-7708-4f3c-b00e-6a6bd4ebe9f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dda68097-9f0e-48df-ba65-bd5e3b0877df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c28b9e37-7708-4f3c-b00e-6a6bd4ebe9f4" xlink:to="loc_us-gaap_SegmentDomain_dda68097-9f0e-48df-ba65-bd5e3b0877df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_5bc69625-3792-4da1-8f44-1fcb4492d7d0" xlink:href="ccrn-20220630.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_dda68097-9f0e-48df-ba65-bd5e3b0877df" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_5bc69625-3792-4da1-8f44-1fcb4492d7d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember_d52acd7e-2a11-421f-a4eb-8063bc0cea7b" xlink:href="ccrn-20220630.xsd#ccrn_PhysicianStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_dda68097-9f0e-48df-ba65-bd5e3b0877df" xlink:to="loc_ccrn_PhysicianStaffingMember_d52acd7e-2a11-421f-a4eb-8063bc0cea7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5545b109-f307-48f5-ab66-e1237f410f4b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0ad0a2d8-aafa-40b0-8596-b9793d652ffb" xlink:to="loc_srt_ProductOrServiceAxis_5545b109-f307-48f5-ab66-e1237f410f4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5545b109-f307-48f5-ab66-e1237f410f4b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5545b109-f307-48f5-ab66-e1237f410f4b" xlink:to="loc_srt_ProductsAndServicesDomain_5545b109-f307-48f5-ab66-e1237f410f4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3a5a07f-26a4-422b-898b-df476b020700" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5545b109-f307-48f5-ab66-e1237f410f4b" xlink:to="loc_srt_ProductsAndServicesDomain_b3a5a07f-26a4-422b-898b-df476b020700" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_TemporaryStaffingServicesMember_5db98161-487c-4f3b-8321-92e278f78a1f" xlink:href="ccrn-20220630.xsd#ccrn_TemporaryStaffingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3a5a07f-26a4-422b-898b-df476b020700" xlink:to="loc_ccrn_TemporaryStaffingServicesMember_5db98161-487c-4f3b-8321-92e278f78a1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OtherServicesMember_f064fc0c-48ba-4b97-91e9-f74f679f3115" xlink:href="ccrn-20220630.xsd#ccrn_OtherServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b3a5a07f-26a4-422b-898b-df476b020700" xlink:to="loc_ccrn_OtherServicesMember_f064fc0c-48ba-4b97-91e9-f74f679f3115" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#ACQUISITIONSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails" xlink:type="extended" id="i3b7cd2b08c464dd4a5661ef418c7d09f_ACQUISITIONSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e934833c-308f-425d-bd9c-f9076fb0d1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e934833c-308f-425d-bd9c-f9076fb0d1cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4d9f7bc1-7d42-4116-aaf4-740fc5d19ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4d9f7bc1-7d42-4116-aaf4-740fc5d19ddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_4da194e4-4f2e-4e81-b68e-7ac3cb068b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_4da194e4-4f2e-4e81-b68e-7ac3cb068b7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_20f4f8d2-db05-4441-9591-05de97225f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_20f4f8d2-db05-4441-9591-05de97225f31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_db25f864-1e20-48b3-bee8-d40c6aa57cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_db25f864-1e20-48b3-bee8-d40c6aa57cae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_db4c75d3-c799-49c8-8825-a441a8d6ab6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_db4c75d3-c799-49c8-8825-a441a8d6ab6a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2723a397-802f-41a2-8476-9c0d327916d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_Goodwill_2723a397-802f-41a2-8476-9c0d327916d4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_f52d42ff-1ead-428c-96bd-bf504ca6b3e7" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_f52d42ff-1ead-428c-96bd-bf504ca6b3e7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationTerm_c5c1346e-bc1e-4486-80b1-2e6c27126cd3" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationContingentConsiderationTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_ccrn_BusinessCombinationContingentConsiderationTerm_c5c1346e-bc1e-4486-80b1-2e6c27126cd3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_049fee2d-5aeb-43db-ab8a-592d7a72e70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_049fee2d-5aeb-43db-ab8a-592d7a72e70f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_36b56860-5147-4f1a-9926-f5fe2d37b912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_36b56860-5147-4f1a-9926-f5fe2d37b912" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e25a7ec-6b17-44ce-9c87-fb2c2e07b44b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e25a7ec-6b17-44ce-9c87-fb2c2e07b44b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0d3ff672-f72f-4d6b-9afe-72aed1a9c6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e25a7ec-6b17-44ce-9c87-fb2c2e07b44b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0d3ff672-f72f-4d6b-9afe-72aed1a9c6e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d3ff672-f72f-4d6b-9afe-72aed1a9c6e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0d3ff672-f72f-4d6b-9afe-72aed1a9c6e3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d3ff672-f72f-4d6b-9afe-72aed1a9c6e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_23d64354-790c-426d-91c5-087f143c8632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0d3ff672-f72f-4d6b-9afe-72aed1a9c6e3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_23d64354-790c-426d-91c5-087f143c8632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SelectedIncMember_95c411e4-0d5a-43ca-bc45-42beaa7e138e" xlink:href="ccrn-20220630.xsd#ccrn_SelectedIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_23d64354-790c-426d-91c5-087f143c8632" xlink:to="loc_ccrn_SelectedIncMember_95c411e4-0d5a-43ca-bc45-42beaa7e138e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_526f8418-3efc-4c25-ae02-c5002bd7aaba" xlink:href="ccrn-20220630.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_23d64354-790c-426d-91c5-087f143c8632" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_526f8418-3efc-4c25-ae02-c5002bd7aaba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24a21bae-587c-4a7d-bd97-43020b4352b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e25a7ec-6b17-44ce-9c87-fb2c2e07b44b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24a21bae-587c-4a7d-bd97-43020b4352b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_24a21bae-587c-4a7d-bd97-43020b4352b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24a21bae-587c-4a7d-bd97-43020b4352b7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_24a21bae-587c-4a7d-bd97-43020b4352b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75a0c54-0ca8-4427-90c0-d10a26c94485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24a21bae-587c-4a7d-bd97-43020b4352b7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75a0c54-0ca8-4427-90c0-d10a26c94485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_60772ade-16c4-423a-b474-93357e5ce8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75a0c54-0ca8-4427-90c0-d10a26c94485" xlink:to="loc_us-gaap_TradeNamesMember_60772ade-16c4-423a-b474-93357e5ce8e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_636526b0-677e-4851-90b4-bf8939842b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75a0c54-0ca8-4427-90c0-d10a26c94485" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_636526b0-677e-4851-90b4-bf8939842b98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_8945eb03-29c4-454a-a0e1-038c6df1ac47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75a0c54-0ca8-4427-90c0-d10a26c94485" xlink:to="loc_us-gaap_DatabasesMember_8945eb03-29c4-454a-a0e1-038c6df1ac47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7fa3dfe7-dbef-43aa-b6cd-71c799eb9251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75a0c54-0ca8-4427-90c0-d10a26c94485" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7fa3dfe7-dbef-43aa-b6cd-71c799eb9251" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="i1743038d6aa24e5b97c6469d9432923d_ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_aef5de6d-bc59-41c6-b023-1f9c1bd454b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_aef5de6d-bc59-41c6-b023-1f9c1bd454b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6b25fc46-4b82-4625-ad16-aa31d3cb1d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6b25fc46-4b82-4625-ad16-aa31d3cb1d01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_03d18529-c527-45e7-8bfb-d35538201006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_03d18529-c527-45e7-8bfb-d35538201006" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e13d883e-8aed-49e8-9551-abccd93919be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e13d883e-8aed-49e8-9551-abccd93919be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_4b27497a-fd3e-4aa8-a6ed-e1ebe4b62b95" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_4b27497a-fd3e-4aa8-a6ed-e1ebe4b62b95" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1e25380d-2eee-4bed-bc60-4580fd817366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_Goodwill_1e25380d-2eee-4bed-bc60-4580fd817366" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4f3ad37c-f371-4a53-80f1-b066492b325d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4f3ad37c-f371-4a53-80f1-b066492b325d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_722d4d4d-8974-44bf-af53-01f131e2a85d" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_722d4d4d-8974-44bf-af53-01f131e2a85d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0aa6f664-aa4d-472b-ba35-71622bbf7ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0aa6f664-aa4d-472b-ba35-71622bbf7ad2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_41f691d9-371e-4557-9976-818857fa5eed" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_41f691d9-371e-4557-9976-818857fa5eed" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_dd68adc1-bc88-494c-82ed-d26a27779e2e" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_dd68adc1-bc88-494c-82ed-d26a27779e2e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_85312cc3-5521-451d-9d3d-400ce800ab4b" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_85312cc3-5521-451d-9d3d-400ce800ab4b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_a01d9d75-3d8d-47a8-a6c4-de6fdce30898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_a01d9d75-3d8d-47a8-a6c4-de6fdce30898" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_91bdb4d5-aa4f-4f04-8e41-f85a2ca00d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_91bdb4d5-aa4f-4f04-8e41-f85a2ca00d4b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2d900402-0cf3-4394-b732-65392d72b370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2d900402-0cf3-4394-b732-65392d72b370" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0954bdb7-d9d9-42d2-932c-d334e758e70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0954bdb7-d9d9-42d2-932c-d334e758e70e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7c92f730-bf89-415f-999c-82e63d871cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0954bdb7-d9d9-42d2-932c-d334e758e70e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7c92f730-bf89-415f-999c-82e63d871cd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c92f730-bf89-415f-999c-82e63d871cd8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7c92f730-bf89-415f-999c-82e63d871cd8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c92f730-bf89-415f-999c-82e63d871cd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_486d25d5-99ac-459c-a303-27792ff113ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7c92f730-bf89-415f-999c-82e63d871cd8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_486d25d5-99ac-459c-a303-27792ff113ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_4d6fb75e-d418-4356-82e7-7ea853cdd7e5" xlink:href="ccrn-20220630.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_486d25d5-99ac-459c-a303-27792ff113ba" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_4d6fb75e-d418-4356-82e7-7ea853cdd7e5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#EARNINGSPERSHAREAntidilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="extended" id="icc7830f3b7af4c4182ed088107cd1c1d_EARNINGSPERSHAREAntidilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a4fb430-6989-4845-8d27-24f11dbdc63b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_94ce7fe5-5bf2-434e-a85e-e48f54220ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a4fb430-6989-4845-8d27-24f11dbdc63b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_94ce7fe5-5bf2-434e-a85e-e48f54220ca7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_baf64f82-25ef-4f38-be34-85e906ce0b53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a4fb430-6989-4845-8d27-24f11dbdc63b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_baf64f82-25ef-4f38-be34-85e906ce0b53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52138cdf-a31f-4188-8374-2d43faa2d10a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_baf64f82-25ef-4f38-be34-85e906ce0b53" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52138cdf-a31f-4188-8374-2d43faa2d10a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_52138cdf-a31f-4188-8374-2d43faa2d10a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52138cdf-a31f-4188-8374-2d43faa2d10a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_52138cdf-a31f-4188-8374-2d43faa2d10a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6bc98708-66f4-480c-8dde-8205df1c5327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52138cdf-a31f-4188-8374-2d43faa2d10a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6bc98708-66f4-480c-8dde-8205df1c5327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedPaymentAwardsMember_0487d3e1-d3ea-4df3-b11e-fca6500531e4" xlink:href="ccrn-20220630.xsd#ccrn_ShareBasedPaymentAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6bc98708-66f4-480c-8dde-8205df1c5327" xlink:to="loc_ccrn_ShareBasedPaymentAwardsMember_0487d3e1-d3ea-4df3-b11e-fca6500531e4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" xlink:type="extended" id="i8cd2fa5371ac4603b916b065eb7a3f75_GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8d7e178b-6dc9-4178-bd67-7dec837b50d4" xlink:href="ccrn-20220630.xsd#ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_92ab8639-42a7-45a4-80b1-6a1094ffcef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8d7e178b-6dc9-4178-bd67-7dec837b50d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_92ab8639-42a7-45a4-80b1-6a1094ffcef9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_210a9830-86a6-4e30-a660-ca33e460f4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_92ab8639-42a7-45a4-80b1-6a1094ffcef9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_210a9830-86a6-4e30-a660-ca33e460f4b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e9b1463e-306c-4d86-ae12-4ab2a0893eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_92ab8639-42a7-45a4-80b1-6a1094ffcef9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e9b1463e-306c-4d86-ae12-4ab2a0893eee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8185e398-e568-47a6-bbc0-476c966801ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_92ab8639-42a7-45a4-80b1-6a1094ffcef9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8185e398-e568-47a6-bbc0-476c966801ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_a7c90fc4-b102-49f7-a7df-1770b431a4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8d7e178b-6dc9-4178-bd67-7dec837b50d4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_a7c90fc4-b102-49f7-a7df-1770b431a4f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_fbf0b833-8837-43f4-aced-6e3d31d6f578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedTradeNames"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_a7c90fc4-b102-49f7-a7df-1770b431a4f0" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_fbf0b833-8837-43f4-aced-6e3d31d6f578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e3aca95e-7fcc-4f1e-ae0a-7b5ab307ba05" xlink:href="ccrn-20220630.xsd#ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8d7e178b-6dc9-4178-bd67-7dec837b50d4" xlink:to="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e3aca95e-7fcc-4f1e-ae0a-7b5ab307ba05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_000be185-a437-438a-81d5-b70e70034118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e3aca95e-7fcc-4f1e-ae0a-7b5ab307ba05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_000be185-a437-438a-81d5-b70e70034118" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_000be185-a437-438a-81d5-b70e70034118_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_000be185-a437-438a-81d5-b70e70034118" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_000be185-a437-438a-81d5-b70e70034118_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_000be185-a437-438a-81d5-b70e70034118" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_22b1a537-3a0a-490c-8e36-5fd45ba77b70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:to="loc_us-gaap_DatabasesMember_22b1a537-3a0a-490c-8e36-5fd45ba77b70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9e38234d-d0d4-4b1d-93a6-c0d861064b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9e38234d-d0d4-4b1d-93a6-c0d861064b73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_3575331a-e995-4fc7-9908-41485d9efb61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_3575331a-e995-4fc7-9908-41485d9efb61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_65628889-b015-4bc5-99e5-f4dcb203c711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:to="loc_us-gaap_TradeNamesMember_65628889-b015-4bc5-99e5-f4dcb203c711" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_191977f0-9927-401e-8517-4d33197839a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_191977f0-9927-401e-8517-4d33197839a8" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="extended" id="i34fb636316914cd3bd3f3eb68d1cb631_GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_928be4b3-d5a1-421d-9838-98c3ba58ec26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_928be4b3-d5a1-421d-9838-98c3ba58ec26" xlink:to="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_abfe6b8c-7170-486f-831d-732d9c8d67a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:to="loc_us-gaap_GoodwillGross_abfe6b8c-7170-486f-831d-732d9c8d67a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_48bbaabc-2fc8-4916-9009-820edfeed380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_48bbaabc-2fc8-4916-9009-820edfeed380" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8cd9f18f-74b5-4ecd-86cf-f78d9d2ccd2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:to="loc_us-gaap_Goodwill_8cd9f18f-74b5-4ecd-86cf-f78d9d2ccd2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_6d891a5c-f3fd-4f81-9a41-86a64df2f8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_6d891a5c-f3fd-4f81-9a41-86a64df2f8b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_aac7d3e4-7cca-4c57-8d38-d8b3a995e783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_ed69763f-fd6b-4516-8195-d27185581854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_faa8b27b-f5ef-4087-86f8-3ad85f2af15c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2f244e0a-f33b-44a4-8ff3-473eb6192c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_928be4b3-d5a1-421d-9838-98c3ba58ec26" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2f244e0a-f33b-44a4-8ff3-473eb6192c43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_91ae9598-4dda-45e2-b8d9-664a16c3d88f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2f244e0a-f33b-44a4-8ff3-473eb6192c43" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_91ae9598-4dda-45e2-b8d9-664a16c3d88f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_91ae9598-4dda-45e2-b8d9-664a16c3d88f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_91ae9598-4dda-45e2-b8d9-664a16c3d88f" xlink:to="loc_us-gaap_SegmentDomain_91ae9598-4dda-45e2-b8d9-664a16c3d88f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bec127f9-73a4-42ff-a193-589331e18398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_91ae9598-4dda-45e2-b8d9-664a16c3d88f" xlink:to="loc_us-gaap_SegmentDomain_bec127f9-73a4-42ff-a193-589331e18398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_5cc748a4-37aa-477d-b986-77a7e86ef42a" xlink:href="ccrn-20220630.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bec127f9-73a4-42ff-a193-589331e18398" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_5cc748a4-37aa-477d-b986-77a7e86ef42a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember_29c090c6-cd56-434c-a0c9-272f2b846650" xlink:href="ccrn-20220630.xsd#ccrn_PhysicianStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bec127f9-73a4-42ff-a193-589331e18398" xlink:to="loc_ccrn_PhysicianStaffingMember_29c090c6-cd56-434c-a0c9-272f2b846650" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_eb307c87-e25c-4e04-9994-4e9cd9cfca52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2f244e0a-f33b-44a4-8ff3-473eb6192c43" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_eb307c87-e25c-4e04-9994-4e9cd9cfca52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_eb307c87-e25c-4e04-9994-4e9cd9cfca52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_eb307c87-e25c-4e04-9994-4e9cd9cfca52" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_eb307c87-e25c-4e04-9994-4e9cd9cfca52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9158db38-74c8-42de-9ba5-3c0631c65449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_eb307c87-e25c-4e04-9994-4e9cd9cfca52" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9158db38-74c8-42de-9ba5-3c0631c65449" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_fcd4da23-8677-4700-a586-c804a97dfec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9158db38-74c8-42de-9ba5-3c0631c65449" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_fcd4da23-8677-4700-a586-c804a97dfec9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#DEBTLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails" xlink:type="extended" id="i03feeaea756e4e6aa4c8b3506835a154_DEBTLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_3b41e396-e685-400f-9e9f-6861056a466d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_3b41e396-e685-400f-9e9f-6861056a466d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e2b1930d-6b29-4e52-9efc-166ef34787b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e2b1930d-6b29-4e52-9efc-166ef34787b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a00a6937-4055-455c-abcb-bdca047d354c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a00a6937-4055-455c-abcb-bdca047d354c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_84714275-cc3d-4acb-b4be-5c8f0e392ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_84714275-cc3d-4acb-b4be-5c8f0e392ac9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a8db135a-d12d-4169-a233-03b476597c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:to="loc_us-gaap_LongTermDebtCurrent_a8db135a-d12d-4169-a233-03b476597c7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_845329db-ef67-4fe7-8285-2a00a6c618ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_845329db-ef67-4fe7-8285-2a00a6c618ac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7e8e4f1a-f5c4-4138-b571-e2afd6607d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:to="loc_us-gaap_DebtInstrumentTable_7e8e4f1a-f5c4-4138-b571-e2afd6607d22" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_704a1024-928e-4401-9a72-bf12c168b9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7e8e4f1a-f5c4-4138-b571-e2afd6607d22" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_704a1024-928e-4401-9a72-bf12c168b9c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_704a1024-928e-4401-9a72-bf12c168b9c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_704a1024-928e-4401-9a72-bf12c168b9c8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_704a1024-928e-4401-9a72-bf12c168b9c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5470d330-e663-4622-98f4-0b252c51844c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_704a1024-928e-4401-9a72-bf12c168b9c8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5470d330-e663-4622-98f4-0b252c51844c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_4eb1a25b-1264-4a62-bb3d-19049a8ba05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5470d330-e663-4622-98f4-0b252c51844c" xlink:to="loc_us-gaap_SecuredDebtMember_4eb1a25b-1264-4a62-bb3d-19049a8ba05d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_44b7cf2e-0227-409f-ab42-d07a4ae28d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5470d330-e663-4622-98f4-0b252c51844c" xlink:to="loc_us-gaap_LineOfCreditMember_44b7cf2e-0227-409f-ab42-d07a4ae28d12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_01792309-6a7c-4adf-8f31-521aa7232cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5470d330-e663-4622-98f4-0b252c51844c" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_01792309-6a7c-4adf-8f31-521aa7232cff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fcb32ed3-b9ac-4efc-b5ef-3bab87b7e922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7e8e4f1a-f5c4-4138-b571-e2afd6607d22" xlink:to="loc_us-gaap_DebtInstrumentAxis_fcb32ed3-b9ac-4efc-b5ef-3bab87b7e922" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fcb32ed3-b9ac-4efc-b5ef-3bab87b7e922_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_fcb32ed3-b9ac-4efc-b5ef-3bab87b7e922" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fcb32ed3-b9ac-4efc-b5ef-3bab87b7e922_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_605d2adb-08bc-406f-b6ec-5a8e0416e2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_fcb32ed3-b9ac-4efc-b5ef-3bab87b7e922" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_605d2adb-08bc-406f-b6ec-5a8e0416e2ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember_1ce2faba-b27b-4c44-8b80-52fcdca43569" xlink:href="ccrn-20220630.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_605d2adb-08bc-406f-b6ec-5a8e0416e2ed" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementMember_1ce2faba-b27b-4c44-8b80-52fcdca43569" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EarnoutNotesPayableMember_26cdc3b6-1ef9-4fdf-b0fe-f056abe71e09" xlink:href="ccrn-20220630.xsd#ccrn_EarnoutNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_605d2adb-08bc-406f-b6ec-5a8e0416e2ed" xlink:to="loc_ccrn_EarnoutNotesPayableMember_26cdc3b6-1ef9-4fdf-b0fe-f056abe71e09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_fc1202ba-f763-4cef-a2c4-df15b66e2146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7e8e4f1a-f5c4-4138-b571-e2afd6607d22" xlink:to="loc_us-gaap_CreditFacilityAxis_fc1202ba-f763-4cef-a2c4-df15b66e2146" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fc1202ba-f763-4cef-a2c4-df15b66e2146_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_fc1202ba-f763-4cef-a2c4-df15b66e2146" xlink:to="loc_us-gaap_CreditFacilityDomain_fc1202ba-f763-4cef-a2c4-df15b66e2146_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ff38e3e1-6642-4563-88ea-ba7a53ccfb10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_fc1202ba-f763-4cef-a2c4-df15b66e2146" xlink:to="loc_us-gaap_CreditFacilityDomain_ff38e3e1-6642-4563-88ea-ba7a53ccfb10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_86a3d29f-ed54-46d2-b5a8-17861b3fcf01" xlink:href="ccrn-20220630.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_ff38e3e1-6642-4563-88ea-ba7a53ccfb10" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_86a3d29f-ed54-46d2-b5a8-17861b3fcf01" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#DEBT2021TermLoanCreditAgreementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails" xlink:type="extended" id="i660cbad84a084c68a64ba94407b145a2_DEBT2021TermLoanCreditAgreementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PaymentForDebtPrepayment_1e45b5d3-deca-4c52-9e26-a27017a13547" xlink:href="ccrn-20220630.xsd#ccrn_PaymentForDebtPrepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_ccrn_PaymentForDebtPrepayment_1e45b5d3-deca-4c52-9e26-a27017a13547" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_6ccd9d03-117b-44e2-b8d2-8bf93aaf087b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_us-gaap_DebtInstrumentTerm_6ccd9d03-117b-44e2-b8d2-8bf93aaf087b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8072d55e-65af-470c-90ba-2852c90331cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8072d55e-65af-470c-90ba-2852c90331cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7305de09-cfd3-4551-99af-c2ded3170dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7305de09-cfd3-4551-99af-c2ded3170dad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DebtInstrumentVariableInterestRateFloor_4cae1c6a-dde9-48c2-b553-d7a72d12371e" xlink:href="ccrn-20220630.xsd#ccrn_DebtInstrumentVariableInterestRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_ccrn_DebtInstrumentVariableInterestRateFloor_4cae1c6a-dde9-48c2-b553-d7a72d12371e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_db2d39d5-8959-4112-9b98-a8e9f5043f96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_db2d39d5-8959-4112-9b98-a8e9f5043f96" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_33fb8610-e839-43b3-b6a7-ce0f807f35bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_33fb8610-e839-43b3-b6a7-ce0f807f35bf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_a4b90ab3-4905-4a65-87ed-4b8b268e01d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_a4b90ab3-4905-4a65-87ed-4b8b268e01d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1238faa3-9dee-4dc2-9c24-c850ddfb93fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_us-gaap_DebtInstrumentTable_1238faa3-9dee-4dc2-9c24-c850ddfb93fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1dd29e0a-a6be-4bd7-9ee6-c5c8e696d00e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1238faa3-9dee-4dc2-9c24-c850ddfb93fd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1dd29e0a-a6be-4bd7-9ee6-c5c8e696d00e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1dd29e0a-a6be-4bd7-9ee6-c5c8e696d00e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1dd29e0a-a6be-4bd7-9ee6-c5c8e696d00e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1dd29e0a-a6be-4bd7-9ee6-c5c8e696d00e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_672ba569-3421-4209-a7ea-a431574a2157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1dd29e0a-a6be-4bd7-9ee6-c5c8e696d00e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_672ba569-3421-4209-a7ea-a431574a2157" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_08f8371e-3d10-4dd4-8300-6980e86fcccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_672ba569-3421-4209-a7ea-a431574a2157" xlink:to="loc_us-gaap_SecuredDebtMember_08f8371e-3d10-4dd4-8300-6980e86fcccf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cd285914-52ba-42c1-a582-4a59497a29e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1238faa3-9dee-4dc2-9c24-c850ddfb93fd" xlink:to="loc_us-gaap_DebtInstrumentAxis_cd285914-52ba-42c1-a582-4a59497a29e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cd285914-52ba-42c1-a582-4a59497a29e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd285914-52ba-42c1-a582-4a59497a29e3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cd285914-52ba-42c1-a582-4a59497a29e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a4da6a79-4bf6-4395-9b4b-673f03187e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd285914-52ba-42c1-a582-4a59497a29e3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a4da6a79-4bf6-4395-9b4b-673f03187e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember_869770fa-faa9-4f8e-bf89-337540733686" xlink:href="ccrn-20220630.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a4da6a79-4bf6-4395-9b4b-673f03187e1e" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementMember_869770fa-faa9-4f8e-bf89-337540733686" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_daeef70c-1e7f-4d6d-a414-0e5adb97895e" xlink:href="ccrn-20220630.xsd#ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementMember_869770fa-faa9-4f8e-bf89-337540733686" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_daeef70c-1e7f-4d6d-a414-0e5adb97895e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_7f6fb156-3ff0-4ef6-a392-2de51d94b6e3" xlink:href="ccrn-20220630.xsd#ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementMember_869770fa-faa9-4f8e-bf89-337540733686" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_7f6fb156-3ff0-4ef6-a392-2de51d94b6e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_c8ceab25-e9fb-492f-9009-b5c93ce781b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1238faa3-9dee-4dc2-9c24-c850ddfb93fd" xlink:to="loc_us-gaap_VariableRateAxis_c8ceab25-e9fb-492f-9009-b5c93ce781b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c8ceab25-e9fb-492f-9009-b5c93ce781b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_c8ceab25-e9fb-492f-9009-b5c93ce781b9" xlink:to="loc_us-gaap_VariableRateDomain_c8ceab25-e9fb-492f-9009-b5c93ce781b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_71f9430c-966d-4898-9c18-3efd0c5c545b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_c8ceab25-e9fb-492f-9009-b5c93ce781b9" xlink:to="loc_us-gaap_VariableRateDomain_71f9430c-966d-4898-9c18-3efd0c5c545b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_bf6b5c3d-ff0d-4aa2-9852-af48ee531bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_71f9430c-966d-4898-9c18-3efd0c5c545b" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_bf6b5c3d-ff0d-4aa2-9852-af48ee531bd1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#DEBTMaturitiesofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails" xlink:type="extended" id="i751602d138ec46ed83746a27e39f0b96_DEBTMaturitiesofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_36ffcafe-38e1-4ab4-8681-629306d3e3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ffcafe-38e1-4ab4-8681-629306d3e3e5" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_11c81fd9-a108-4482-971c-496360693c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_11c81fd9-a108-4482-971c-496360693c9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_7acfc9f1-0845-48eb-aeb5-a932c4c2a9a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_7acfc9f1-0845-48eb-aeb5-a932c4c2a9a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4d089336-00f0-4c39-919f-de9978b40173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4d089336-00f0-4c39-919f-de9978b40173" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_8feff0f6-1ad7-40be-88d8-748f7589e9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_8feff0f6-1ad7-40be-88d8-748f7589e9e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e496acab-127c-4ca5-83d6-dff19f2cd8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e496acab-127c-4ca5-83d6-dff19f2cd8b4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LongTermDebtMaturityAfterYearFour_5d554ce9-cc3b-46c0-af25-a00d831fb99a" xlink:href="ccrn-20220630.xsd#ccrn_LongTermDebtMaturityAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_ccrn_LongTermDebtMaturityAfterYearFour_5d554ce9-cc3b-46c0-af25-a00d831fb99a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_012f35a3-c627-4211-a61e-056848663dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_012f35a3-c627-4211-a61e-056848663dc7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a1a2ed6f-0713-46cd-8c3e-a2ccab1ac300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ffcafe-38e1-4ab4-8681-629306d3e3e5" xlink:to="loc_us-gaap_DebtInstrumentTable_a1a2ed6f-0713-46cd-8c3e-a2ccab1ac300" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_72ec3bd5-b89e-4e02-b0d7-88ddb1d18f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a1a2ed6f-0713-46cd-8c3e-a2ccab1ac300" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_72ec3bd5-b89e-4e02-b0d7-88ddb1d18f5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_72ec3bd5-b89e-4e02-b0d7-88ddb1d18f5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_72ec3bd5-b89e-4e02-b0d7-88ddb1d18f5a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_72ec3bd5-b89e-4e02-b0d7-88ddb1d18f5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_44f02af4-c0bf-4de0-9836-a93d429a6966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_72ec3bd5-b89e-4e02-b0d7-88ddb1d18f5a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_44f02af4-c0bf-4de0-9836-a93d429a6966" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c5b6ff00-3066-460e-943c-a7c5dfd8ae50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_44f02af4-c0bf-4de0-9836-a93d429a6966" xlink:to="loc_us-gaap_SecuredDebtMember_c5b6ff00-3066-460e-943c-a7c5dfd8ae50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_73c89417-3827-4505-adbd-e2d53cf732b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_44f02af4-c0bf-4de0-9836-a93d429a6966" xlink:to="loc_us-gaap_LineOfCreditMember_73c89417-3827-4505-adbd-e2d53cf732b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c7a86880-bf13-49b7-a5f6-3f042f97ae56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a1a2ed6f-0713-46cd-8c3e-a2ccab1ac300" xlink:to="loc_us-gaap_DebtInstrumentAxis_c7a86880-bf13-49b7-a5f6-3f042f97ae56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c7a86880-bf13-49b7-a5f6-3f042f97ae56_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c7a86880-bf13-49b7-a5f6-3f042f97ae56" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c7a86880-bf13-49b7-a5f6-3f042f97ae56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d975a101-f013-4adc-b15e-c2b4e82ee8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c7a86880-bf13-49b7-a5f6-3f042f97ae56" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d975a101-f013-4adc-b15e-c2b4e82ee8e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember_1c5d85f1-4026-408a-98ce-930dc23ad129" xlink:href="ccrn-20220630.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d975a101-f013-4adc-b15e-c2b4e82ee8e2" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementMember_1c5d85f1-4026-408a-98ce-930dc23ad129" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_36d979cf-8f53-4509-b4a9-7b4905e6e481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a1a2ed6f-0713-46cd-8c3e-a2ccab1ac300" xlink:to="loc_us-gaap_CreditFacilityAxis_36d979cf-8f53-4509-b4a9-7b4905e6e481" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_36d979cf-8f53-4509-b4a9-7b4905e6e481_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_36d979cf-8f53-4509-b4a9-7b4905e6e481" xlink:to="loc_us-gaap_CreditFacilityDomain_36d979cf-8f53-4509-b4a9-7b4905e6e481_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3b834625-0d0e-499c-8425-e9d623a8a93d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_36d979cf-8f53-4509-b4a9-7b4905e6e481" xlink:to="loc_us-gaap_CreditFacilityDomain_3b834625-0d0e-499c-8425-e9d623a8a93d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_2fe49782-aebf-4e53-9b70-2bc291ca51e1" xlink:href="ccrn-20220630.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3b834625-0d0e-499c-8425-e9d623a8a93d" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_2fe49782-aebf-4e53-9b70-2bc291ca51e1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#DEBT2019LoanAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails" xlink:type="extended" id="id17717e511e945c6a42adf6528d80144_DEBT2019LoanAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_cf3b1d65-47a0-4cb1-a61d-0f609246691b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_cf3b1d65-47a0-4cb1-a61d-0f609246691b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b0217e64-20fe-4b61-a084-23f3ceb1182f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b0217e64-20fe-4b61-a084-23f3ceb1182f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_abb2bfdb-a851-47d8-b6b0-aefa5cd6a166" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_abb2bfdb-a851-47d8-b6b0-aefa5cd6a166" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_c9a695e4-1329-458b-80b1-12d6f7d51e2b" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_c9a695e4-1329-458b-80b1-12d6f7d51e2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_6866e860-baf5-46d4-85c8-e0ae48a15e05" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditBorrowingBasePercentageOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_6866e860-baf5-46d4-85c8-e0ae48a15e05" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_7b768c09-f06d-4ba9-b88c-c5430f87b0b4" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditFacilityBorrowingBaseAvailability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_7b768c09-f06d-4ba9-b88c-c5430f87b0b4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_23733fc6-9716-4206-a576-d1ae173b3411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_LineOfCredit_23733fc6-9716-4206-a576-d1ae173b3411" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_bd8ff86d-c6c1-4ff4-8412-b0277aa3048b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_bd8ff86d-c6c1-4ff4-8412-b0277aa3048b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_eafd81fe-bef1-411e-a9fb-98ab85ef0a41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_eafd81fe-bef1-411e-a9fb-98ab85ef0a41" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_851ade14-f4c0-4f44-804d-738e25aa21bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_851ade14-f4c0-4f44-804d-738e25aa21bb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_8f3ceac9-0a72-41c5-8299-321f44c5f647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_8f3ceac9-0a72-41c5-8299-321f44c5f647" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_917ab3d0-ba45-4588-90a6-093951cd402e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_917ab3d0-ba45-4588-90a6-093951cd402e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f9a59358-3ad9-4b8e-ae3c-866895f30fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_917ab3d0-ba45-4588-90a6-093951cd402e" xlink:to="loc_us-gaap_CreditFacilityAxis_f9a59358-3ad9-4b8e-ae3c-866895f30fe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f9a59358-3ad9-4b8e-ae3c-866895f30fe0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f9a59358-3ad9-4b8e-ae3c-866895f30fe0" xlink:to="loc_us-gaap_CreditFacilityDomain_f9a59358-3ad9-4b8e-ae3c-866895f30fe0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d4850712-e581-46b5-8b31-9557d6b32e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f9a59358-3ad9-4b8e-ae3c-866895f30fe0" xlink:to="loc_us-gaap_CreditFacilityDomain_d4850712-e581-46b5-8b31-9557d6b32e9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_894f951f-91e8-40f4-bf3e-5771cbed13e5" xlink:href="ccrn-20220630.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d4850712-e581-46b5-8b31-9557d6b32e9c" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_894f951f-91e8-40f4-bf3e-5771cbed13e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitAxis_9ba49871-ed10-499a-a893-8351ae679254" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditSublimitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_917ab3d0-ba45-4588-90a6-093951cd402e" xlink:to="loc_ccrn_LineOfCreditSublimitAxis_9ba49871-ed10-499a-a893-8351ae679254" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitDomain_9ba49871-ed10-499a-a893-8351ae679254_default" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditSublimitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ccrn_LineOfCreditSublimitAxis_9ba49871-ed10-499a-a893-8351ae679254" xlink:to="loc_ccrn_LineOfCreditSublimitDomain_9ba49871-ed10-499a-a893-8351ae679254_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitDomain_dbb573a6-9319-48db-b8f0-53394b4b6bf7" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditSublimitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ccrn_LineOfCreditSublimitAxis_9ba49871-ed10-499a-a893-8351ae679254" xlink:to="loc_ccrn_LineOfCreditSublimitDomain_dbb573a6-9319-48db-b8f0-53394b4b6bf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SwingLoansSublimitMember_46774584-991a-424b-ae49-ca77b8b1dd60" xlink:href="ccrn-20220630.xsd#ccrn_SwingLoansSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_LineOfCreditSublimitDomain_dbb573a6-9319-48db-b8f0-53394b4b6bf7" xlink:to="loc_ccrn_SwingLoansSublimitMember_46774584-991a-424b-ae49-ca77b8b1dd60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_StandbyLettersOfCreditSublimitMember_a3d876fd-d558-47b8-a2bb-73b149098e7b" xlink:href="ccrn-20220630.xsd#ccrn_StandbyLettersOfCreditSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_LineOfCreditSublimitDomain_dbb573a6-9319-48db-b8f0-53394b4b6bf7" xlink:to="loc_ccrn_StandbyLettersOfCreditSublimitMember_a3d876fd-d558-47b8-a2bb-73b149098e7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_aafc3b1c-106d-4f34-990b-33dfc65d6299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_917ab3d0-ba45-4588-90a6-093951cd402e" xlink:to="loc_us-gaap_VariableRateAxis_aafc3b1c-106d-4f34-990b-33dfc65d6299" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_aafc3b1c-106d-4f34-990b-33dfc65d6299_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_aafc3b1c-106d-4f34-990b-33dfc65d6299" xlink:to="loc_us-gaap_VariableRateDomain_aafc3b1c-106d-4f34-990b-33dfc65d6299_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d055ad4d-6a83-4958-a4e9-a3d38e48ce6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_aafc3b1c-106d-4f34-990b-33dfc65d6299" xlink:to="loc_us-gaap_VariableRateDomain_d055ad4d-6a83-4958-a4e9-a3d38e48ce6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_857f1a12-f10e-49bd-bb9f-dbb6ceaab4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_d055ad4d-6a83-4958-a4e9-a3d38e48ce6b" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_857f1a12-f10e-49bd-bb9f-dbb6ceaab4ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_9f1ef5bd-8c94-4a60-80d9-d3a3a9bd46c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_d055ad4d-6a83-4958-a4e9-a3d38e48ce6b" xlink:to="loc_us-gaap_BaseRateMember_9f1ef5bd-8c94-4a60-80d9-d3a3a9bd46c9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended" id="i9d47f862ef1c4f80996ea04709ac5ae3_FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ad0165d-04a8-45ff-b130-62e53afc66a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_44e26698-2dde-4064-a17d-5e500f172b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ad0165d-04a8-45ff-b130-62e53afc66a2" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_44e26698-2dde-4064-a17d-5e500f172b0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_af60c50d-25be-4e57-9897-5f13d1b85624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ad0165d-04a8-45ff-b130-62e53afc66a2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_af60c50d-25be-4e57-9897-5f13d1b85624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_433a5550-cc79-4f67-b345-a4949c119978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ad0165d-04a8-45ff-b130-62e53afc66a2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_433a5550-cc79-4f67-b345-a4949c119978" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_37a77043-deeb-4a46-bde2-1ad645ec431e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_433a5550-cc79-4f67-b345-a4949c119978" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_37a77043-deeb-4a46-bde2-1ad645ec431e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_37a77043-deeb-4a46-bde2-1ad645ec431e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_37a77043-deeb-4a46-bde2-1ad645ec431e" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_37a77043-deeb-4a46-bde2-1ad645ec431e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2cd1e736-24cc-4ed1-b647-39ec72b73158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_37a77043-deeb-4a46-bde2-1ad645ec431e" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2cd1e736-24cc-4ed1-b647-39ec72b73158" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DeferredCompensationMember_eb69a31c-7b96-4de0-8226-236810bd6dba" xlink:href="ccrn-20220630.xsd#ccrn_DeferredCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2cd1e736-24cc-4ed1-b647-39ec72b73158" xlink:to="loc_ccrn_DeferredCompensationMember_eb69a31c-7b96-4de0-8226-236810bd6dba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_83de1338-7b72-41c7-966a-7df875415533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_433a5550-cc79-4f67-b345-a4949c119978" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_83de1338-7b72-41c7-966a-7df875415533" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_83de1338-7b72-41c7-966a-7df875415533_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_83de1338-7b72-41c7-966a-7df875415533" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_83de1338-7b72-41c7-966a-7df875415533_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10d2cb38-9cca-43aa-9895-805090a766ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_83de1338-7b72-41c7-966a-7df875415533" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10d2cb38-9cca-43aa-9895-805090a766ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DeferredCompensationMember_1a4fe39e-6c22-47cc-96f0-fe82e412a550" xlink:href="ccrn-20220630.xsd#ccrn_DeferredCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10d2cb38-9cca-43aa-9895-805090a766ff" xlink:to="loc_ccrn_DeferredCompensationMember_1a4fe39e-6c22-47cc-96f0-fe82e412a550" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c1852ff6-c0d5-4b13-b14b-4dea3e9cc26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_433a5550-cc79-4f67-b345-a4949c119978" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c1852ff6-c0d5-4b13-b14b-4dea3e9cc26a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c1852ff6-c0d5-4b13-b14b-4dea3e9cc26a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c1852ff6-c0d5-4b13-b14b-4dea3e9cc26a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c1852ff6-c0d5-4b13-b14b-4dea3e9cc26a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b965b34-4059-4c34-9b98-c39ec4a683dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c1852ff6-c0d5-4b13-b14b-4dea3e9cc26a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b965b34-4059-4c34-9b98-c39ec4a683dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e2cebde1-b6f4-464b-bf49-59a894b7edea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b965b34-4059-4c34-9b98-c39ec4a683dc" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e2cebde1-b6f4-464b-bf49-59a894b7edea" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails" xlink:type="extended" id="ie1231c6b8f2f4febad9d0f260291a783_FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_557d37b3-f169-4f24-b53e-6ea29133d79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_710ce77b-fd83-4583-8b4d-4a44be123078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_557d37b3-f169-4f24-b53e-6ea29133d79e" xlink:to="loc_us-gaap_DebtInstrumentFairValue_710ce77b-fd83-4583-8b4d-4a44be123078" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure_f14a9a45-2dca-43cf-a7b8-d1516e535e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_557d37b3-f169-4f24-b53e-6ea29133d79e" xlink:to="loc_us-gaap_LinesOfCreditFairValueDisclosure_f14a9a45-2dca-43cf-a7b8-d1516e535e52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a8d7d87b-6cf7-46f0-a969-bac2c82e8c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_557d37b3-f169-4f24-b53e-6ea29133d79e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a8d7d87b-6cf7-46f0-a969-bac2c82e8c49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_557d37b3-f169-4f24-b53e-6ea29133d79e" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_08787f98-6e73-4a43-8c33-061329afd9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_08787f98-6e73-4a43-8c33-061329afd9e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_08787f98-6e73-4a43-8c33-061329afd9e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_08787f98-6e73-4a43-8c33-061329afd9e9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_08787f98-6e73-4a43-8c33-061329afd9e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3e035c3-f327-41a1-bc1f-107ee7619636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_08787f98-6e73-4a43-8c33-061329afd9e9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3e035c3-f327-41a1-bc1f-107ee7619636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a0c9462c-4531-4231-9bfc-b7167fb6574b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3e035c3-f327-41a1-bc1f-107ee7619636" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a0c9462c-4531-4231-9bfc-b7167fb6574b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_543ff8ed-edac-4c37-a21e-c3b68f7cff1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_543ff8ed-edac-4c37-a21e-c3b68f7cff1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_543ff8ed-edac-4c37-a21e-c3b68f7cff1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_543ff8ed-edac-4c37-a21e-c3b68f7cff1a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_543ff8ed-edac-4c37-a21e-c3b68f7cff1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_57471969-8a78-4520-a8c3-c0c0299c7b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_543ff8ed-edac-4c37-a21e-c3b68f7cff1a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_57471969-8a78-4520-a8c3-c0c0299c7b00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EarnoutNotesPayableMember_c8d54ec7-5aee-493f-be43-44072d839920" xlink:href="ccrn-20220630.xsd#ccrn_EarnoutNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_57471969-8a78-4520-a8c3-c0c0299c7b00" xlink:to="loc_ccrn_EarnoutNotesPayableMember_c8d54ec7-5aee-493f-be43-44072d839920" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_be285797-a1e3-47ab-8c13-fe7d58e53406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_57471969-8a78-4520-a8c3-c0c0299c7b00" xlink:to="loc_us-gaap_SecuredDebtMember_be285797-a1e3-47ab-8c13-fe7d58e53406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1be90e72-7a99-4e22-a422-a47f5944dab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:to="loc_us-gaap_CreditFacilityAxis_1be90e72-7a99-4e22-a422-a47f5944dab7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1be90e72-7a99-4e22-a422-a47f5944dab7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1be90e72-7a99-4e22-a422-a47f5944dab7" xlink:to="loc_us-gaap_CreditFacilityDomain_1be90e72-7a99-4e22-a422-a47f5944dab7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_70c8f9d5-6a83-4fd5-9ec2-67bfd129b79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1be90e72-7a99-4e22-a422-a47f5944dab7" xlink:to="loc_us-gaap_CreditFacilityDomain_70c8f9d5-6a83-4fd5-9ec2-67bfd129b79e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_f25b7cfe-8cf9-4a20-991d-5a4b3b18099e" xlink:href="ccrn-20220630.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_70c8f9d5-6a83-4fd5-9ec2-67bfd129b79e" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_f25b7cfe-8cf9-4a20-991d-5a4b3b18099e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_7d4494fd-6203-41b5-934a-8bad9481fae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_7d4494fd-6203-41b5-934a-8bad9481fae4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7d4494fd-6203-41b5-934a-8bad9481fae4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_7d4494fd-6203-41b5-934a-8bad9481fae4" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_7d4494fd-6203-41b5-934a-8bad9481fae4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_85b58fce-590b-45e6-9573-f876185c5084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_7d4494fd-6203-41b5-934a-8bad9481fae4" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_85b58fce-590b-45e6-9573-f876185c5084" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cc149583-c3cd-4883-8196-5fbc8704762b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_85b58fce-590b-45e6-9573-f876185c5084" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cc149583-c3cd-4883-8196-5fbc8704762b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b62deb86-e308-4f3b-b044-34bfed81fedf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cc149583-c3cd-4883-8196-5fbc8704762b" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b62deb86-e308-4f3b-b044-34bfed81fedf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_459febad-f2ac-4746-987a-199dc275ca63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cc149583-c3cd-4883-8196-5fbc8704762b" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_459febad-f2ac-4746-987a-199dc275ca63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4f0d0888-afea-4168-a0a7-0cadcf0790fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4f0d0888-afea-4168-a0a7-0cadcf0790fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f0d0888-afea-4168-a0a7-0cadcf0790fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4f0d0888-afea-4168-a0a7-0cadcf0790fd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4f0d0888-afea-4168-a0a7-0cadcf0790fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d75959c-d89c-492d-b671-a4f540d9f174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4f0d0888-afea-4168-a0a7-0cadcf0790fd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d75959c-d89c-492d-b671-a4f540d9f174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_8f66ce65-4490-4306-8dd3-e21a4b85d09d" xlink:href="ccrn-20220630.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d75959c-d89c-492d-b671-a4f540d9f174" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_8f66ce65-4490-4306-8dd3-e21a4b85d09d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SelectedIncMember_2a89afb1-c5d8-4e76-bf34-ee7976608b2e" xlink:href="ccrn-20220630.xsd#ccrn_SelectedIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d75959c-d89c-492d-b671-a4f540d9f174" xlink:to="loc_ccrn_SelectedIncMember_2a89afb1-c5d8-4e76-bf34-ee7976608b2e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#STOCKHOLDERSEQUITYAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails" xlink:type="extended" id="ifcf1fde84b1446b6918d365ad24c548f_STOCKHOLDERSEQUITYAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_934378a9-44de-4891-82de-5de2e0122c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_934378a9-44de-4891-82de-5de2e0122c13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_ca08f3a2-75a7-45cf-9e29-adee3f4aeb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_ca08f3a2-75a7-45cf-9e29-adee3f4aeb7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_eb996cfc-d6bc-4519-a7b6-bf68cef9ddd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_eb996cfc-d6bc-4519-a7b6-bf68cef9ddd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2f200f85-85b6-4e0d-8486-08aef9724eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2f200f85-85b6-4e0d-8486-08aef9724eb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_87ff0c01-666d-4a50-ad1b-1fcf6f1533f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_87ff0c01-666d-4a50-ad1b-1fcf6f1533f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_4dfebe49-08c3-437f-b541-54fdbcab06b9" xlink:href="ccrn-20220630.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_4dfebe49-08c3-437f-b541-54fdbcab06b9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_1b224f85-2db5-4112-9217-76ac2706dabe" xlink:href="ccrn-20220630.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_1b224f85-2db5-4112-9217-76ac2706dabe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dfe386b5-5922-4ba9-a0ba-6829f4627c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dfe386b5-5922-4ba9-a0ba-6829f4627c4d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_b3b2fee6-3d16-4f4e-8d41-560aeb24fc99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_b3b2fee6-3d16-4f4e-8d41-560aeb24fc99" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_cca2d5be-bb7c-4a98-b21d-22b297498df1" xlink:href="ccrn-20220630.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_cca2d5be-bb7c-4a98-b21d-22b297498df1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_633e5779-6f59-462a-9d95-7718326effcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_633e5779-6f59-462a-9d95-7718326effcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_633e5779-6f59-462a-9d95-7718326effcb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_633e5779-6f59-462a-9d95-7718326effcb" xlink:to="loc_us-gaap_EquityComponentDomain_633e5779-6f59-462a-9d95-7718326effcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7d28c86b-fe82-4421-a417-319c8daf0ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_633e5779-6f59-462a-9d95-7718326effcb" xlink:to="loc_us-gaap_EquityComponentDomain_7d28c86b-fe82-4421-a417-319c8daf0ffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3006dc58-1c6e-480f-822f-60fb7e532d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7d28c86b-fe82-4421-a417-319c8daf0ffa" xlink:to="loc_us-gaap_CommonStockMember_3006dc58-1c6e-480f-822f-60fb7e532d0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_014684f9-a5a6-4fb3-898d-6a75d925a176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:to="loc_us-gaap_PlanNameAxis_014684f9-a5a6-4fb3-898d-6a75d925a176" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_014684f9-a5a6-4fb3-898d-6a75d925a176_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_014684f9-a5a6-4fb3-898d-6a75d925a176" xlink:to="loc_us-gaap_PlanNameDomain_014684f9-a5a6-4fb3-898d-6a75d925a176_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_017fbb34-ca84-4777-a5f8-0cd6552e8d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_014684f9-a5a6-4fb3-898d-6a75d925a176" xlink:to="loc_us-gaap_PlanNameDomain_017fbb34-ca84-4777-a5f8-0cd6552e8d51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OmnibusPlanMember_c8a3b09f-e01a-49b0-93e0-c7f53265400e" xlink:href="ccrn-20220630.xsd#ccrn_OmnibusPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_017fbb34-ca84-4777-a5f8-0cd6552e8d51" xlink:to="loc_ccrn_OmnibusPlanMember_c8a3b09f-e01a-49b0-93e0-c7f53265400e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a6b8604c-bcad-445c-82f8-c71940c73271" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:to="loc_srt_RangeAxis_a6b8604c-bcad-445c-82f8-c71940c73271" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a6b8604c-bcad-445c-82f8-c71940c73271_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a6b8604c-bcad-445c-82f8-c71940c73271" xlink:to="loc_srt_RangeMember_a6b8604c-bcad-445c-82f8-c71940c73271_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_21dd763c-4205-4914-8827-858939bfd80e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a6b8604c-bcad-445c-82f8-c71940c73271" xlink:to="loc_srt_RangeMember_21dd763c-4205-4914-8827-858939bfd80e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fea03635-8228-4743-9ec9-ec929232d964" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_21dd763c-4205-4914-8827-858939bfd80e" xlink:to="loc_srt_MinimumMember_fea03635-8228-4743-9ec9-ec929232d964" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_f44c081d-ef2a-42bf-9688-ec44ce41f2ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:to="loc_srt_TitleOfIndividualAxis_f44c081d-ef2a-42bf-9688-ec44ce41f2ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_f44c081d-ef2a-42bf-9688-ec44ce41f2ce_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_f44c081d-ef2a-42bf-9688-ec44ce41f2ce" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_f44c081d-ef2a-42bf-9688-ec44ce41f2ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_82e1ceaa-5086-4c45-addb-5087026fe9b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_f44c081d-ef2a-42bf-9688-ec44ce41f2ce" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_82e1ceaa-5086-4c45-addb-5087026fe9b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_fa48269d-4852-46c8-9a71-569646ff8c80" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_82e1ceaa-5086-4c45-addb-5087026fe9b2" xlink:to="loc_srt_DirectorMember_fa48269d-4852-46c8-9a71-569646ff8c80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_786fd5d6-3f1b-4cc2-8dc0-e51c4b94966d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_786fd5d6-3f1b-4cc2-8dc0-e51c4b94966d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_786fd5d6-3f1b-4cc2-8dc0-e51c4b94966d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_786fd5d6-3f1b-4cc2-8dc0-e51c4b94966d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_786fd5d6-3f1b-4cc2-8dc0-e51c4b94966d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c1e8fab9-08b8-4246-95ba-45c71741e980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_786fd5d6-3f1b-4cc2-8dc0-e51c4b94966d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c1e8fab9-08b8-4246-95ba-45c71741e980" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_b4c5ef76-266f-4c91-957c-9d411d7a0571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c1e8fab9-08b8-4246-95ba-45c71741e980" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_b4c5ef76-266f-4c91-957c-9d411d7a0571" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0c8f8d13-54f0-45d2-bb7d-dc47cf8df784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:to="loc_us-gaap_AwardTypeAxis_0c8f8d13-54f0-45d2-bb7d-dc47cf8df784" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0c8f8d13-54f0-45d2-bb7d-dc47cf8df784_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0c8f8d13-54f0-45d2-bb7d-dc47cf8df784" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0c8f8d13-54f0-45d2-bb7d-dc47cf8df784_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5993b6b3-57bc-45b8-bb4e-8967215415c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0c8f8d13-54f0-45d2-bb7d-dc47cf8df784" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5993b6b3-57bc-45b8-bb4e-8967215415c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_RestrictedStockAndPerformanceSharesMember_d7bc50bf-1ea2-49c9-b827-c48294cc8df8" xlink:href="ccrn-20220630.xsd#ccrn_RestrictedStockAndPerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5993b6b3-57bc-45b8-bb4e-8967215415c7" xlink:to="loc_ccrn_RestrictedStockAndPerformanceSharesMember_d7bc50bf-1ea2-49c9-b827-c48294cc8df8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_b359245b-a159-4ed7-b810-c77d06ecde29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_RestrictedStockAndPerformanceSharesMember_d7bc50bf-1ea2-49c9-b827-c48294cc8df8" xlink:to="loc_us-gaap_PerformanceSharesMember_b359245b-a159-4ed7-b810-c77d06ecde29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_61b99897-96da-44a3-a7ee-cca09bd6abfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ccrn_RestrictedStockAndPerformanceSharesMember_d7bc50bf-1ea2-49c9-b827-c48294cc8df8" xlink:to="loc_us-gaap_RestrictedStockMember_61b99897-96da-44a3-a7ee-cca09bd6abfb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#STOCKHOLDERSEQUITYRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails" xlink:type="extended" id="ideca376835cd49e591c5fc23ba856b6e_STOCKHOLDERSEQUITYRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a0d4348-df44-4f78-ae29-8f9e08a540de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4815e421-8b1c-4d1d-b3ec-2f340aa05506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a0d4348-df44-4f78-ae29-8f9e08a540de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4815e421-8b1c-4d1d-b3ec-2f340aa05506" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f63987bf-e730-43a4-8abf-9023cd3fb51e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4815e421-8b1c-4d1d-b3ec-2f340aa05506" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f63987bf-e730-43a4-8abf-9023cd3fb51e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0c92c4d6-8abe-4292-aafb-2bf3c9b1fe2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4815e421-8b1c-4d1d-b3ec-2f340aa05506" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0c92c4d6-8abe-4292-aafb-2bf3c9b1fe2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_58ff26cc-de36-4e39-abb6-17465123c2db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4815e421-8b1c-4d1d-b3ec-2f340aa05506" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_58ff26cc-de36-4e39-abb6-17465123c2db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d99fa639-f03d-47a0-9e9c-3805ecb7feb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4815e421-8b1c-4d1d-b3ec-2f340aa05506" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d99fa639-f03d-47a0-9e9c-3805ecb7feb3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6286bf71-5c13-4f51-833f-17f989a62e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_093a386a-c5cf-48fa-bfdc-9258e41d3332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a0d4348-df44-4f78-ae29-8f9e08a540de" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_093a386a-c5cf-48fa-bfdc-9258e41d3332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_aa670cdc-8956-4b11-a787-dbdd0ed8eca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_093a386a-c5cf-48fa-bfdc-9258e41d3332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_aa670cdc-8956-4b11-a787-dbdd0ed8eca8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ae740fb7-411e-4f18-a55b-b71856cf515a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_093a386a-c5cf-48fa-bfdc-9258e41d3332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ae740fb7-411e-4f18-a55b-b71856cf515a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a555c691-9ca4-470a-9aff-c48b5217b292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_093a386a-c5cf-48fa-bfdc-9258e41d3332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a555c691-9ca4-470a-9aff-c48b5217b292" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_f40f248d-3d53-4739-8fae-fceb5e0304bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_093a386a-c5cf-48fa-bfdc-9258e41d3332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_f40f248d-3d53-4739-8fae-fceb5e0304bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5a33716c-b8da-4c7d-8c13-390426d32aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_761ed618-26e3-4fd3-af60-80b85cdd5bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a0d4348-df44-4f78-ae29-8f9e08a540de" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_761ed618-26e3-4fd3-af60-80b85cdd5bda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5d364250-6d30-4c27-af72-39e25dbfbc63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_761ed618-26e3-4fd3-af60-80b85cdd5bda" xlink:to="loc_us-gaap_AwardTypeAxis_5d364250-6d30-4c27-af72-39e25dbfbc63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d364250-6d30-4c27-af72-39e25dbfbc63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5d364250-6d30-4c27-af72-39e25dbfbc63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d364250-6d30-4c27-af72-39e25dbfbc63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70f4b24e-2bbe-4829-9b60-73229f32704f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5d364250-6d30-4c27-af72-39e25dbfbc63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70f4b24e-2bbe-4829-9b60-73229f32704f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_471e442d-4294-45be-aae6-a447fcabb689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70f4b24e-2bbe-4829-9b60-73229f32704f" xlink:to="loc_us-gaap_RestrictedStockMember_471e442d-4294-45be-aae6-a447fcabb689" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_95b0942f-ba8e-4fa7-85ff-0cce47901813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70f4b24e-2bbe-4829-9b60-73229f32704f" xlink:to="loc_us-gaap_PerformanceSharesMember_95b0942f-ba8e-4fa7-85ff-0cce47901813" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#SEGMENTDATADetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails" xlink:type="extended" id="ide4de4d2a8f54665bd6d63b145138c2d_SEGMENTDATADetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7cd1b247-c0ae-40ac-906c-8399583ff8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7cd1b247-c0ae-40ac-906c-8399583ff8d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_9525b630-bcfc-4630-8d97-f43f281c0332" xlink:href="ccrn-20220630.xsd#ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_9525b630-bcfc-4630-8d97-f43f281c0332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_38c629b8-ae4d-4ea9-9b00-e73db0999750" xlink:href="ccrn-20220630.xsd#ccrn_SegmentReportingUnallocatedCorporateExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_38c629b8-ae4d-4ea9-9b00-e73db0999750" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9c04d5e0-7d0b-4b4d-abb0-a4f9132c302e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9c04d5e0-7d0b-4b4d-abb0-a4f9132c302e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_42770361-da7b-4074-b1bd-c4d3aa977148" xlink:href="ccrn-20220630.xsd#ccrn_AcquisitionAndIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_42770361-da7b-4074-b1bd-c4d3aa977148" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9f159a37-1da1-4a1a-8631-b7b958c21ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_us-gaap_RestructuringCharges_9f159a37-1da1-4a1a-8631-b7b958c21ba6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_de8945d5-eb09-4934-9c9a-ea4e3d0c3eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_us-gaap_AssetImpairmentCharges_de8945d5-eb09-4934-9c9a-ea4e3d0c3eed" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5a7f1706-1119-4482-9d23-59fe78c19d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_us-gaap_OperatingIncomeLoss_5a7f1706-1119-4482-9d23-59fe78c19d6c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_5563ada1-6eb6-4819-a0a1-5c2ffe036480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_5563ada1-6eb6-4819-a0a1-5c2ffe036480" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c4bac737-b0cf-4cc6-b1fa-c832bff45374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_5563ada1-6eb6-4819-a0a1-5c2ffe036480" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c4bac737-b0cf-4cc6-b1fa-c832bff45374" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c4bac737-b0cf-4cc6-b1fa-c832bff45374_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c4bac737-b0cf-4cc6-b1fa-c832bff45374" xlink:to="loc_us-gaap_SegmentDomain_c4bac737-b0cf-4cc6-b1fa-c832bff45374_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_625a769e-326c-47f4-a7ac-2c85585afbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c4bac737-b0cf-4cc6-b1fa-c832bff45374" xlink:to="loc_us-gaap_SegmentDomain_625a769e-326c-47f4-a7ac-2c85585afbe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_0fb15d9d-02cd-4308-9dc4-92f9018be7c3" xlink:href="ccrn-20220630.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_625a769e-326c-47f4-a7ac-2c85585afbe5" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_0fb15d9d-02cd-4308-9dc4-92f9018be7c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember_ee91ea5b-f913-4898-beee-55b0b44d07c0" xlink:href="ccrn-20220630.xsd#ccrn_PhysicianStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_625a769e-326c-47f4-a7ac-2c85585afbe5" xlink:to="loc_ccrn_PhysicianStaffingMember_ee91ea5b-f913-4898-beee-55b0b44d07c0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#RELATEDPARTYTRANSACTIONSDetails"/>
  <link:definitionLink xlink:role="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="extended" id="i85e29882257c4fd49c7f36ca43db7ed5_RELATEDPARTYTRANSACTIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_f7d04b57-5861-4dcc-a75a-b1ee63a9731e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_6893a096-0da6-4cc9-a3d5-cf3502229fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f7d04b57-5861-4dcc-a75a-b1ee63a9731e" xlink:to="loc_us-gaap_RevenueFromRelatedParties_6893a096-0da6-4cc9-a3d5-cf3502229fbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9c540810-154a-4c44-a00c-d4c72905c7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f7d04b57-5861-4dcc-a75a-b1ee63a9731e" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9c540810-154a-4c44-a00c-d4c72905c7bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5f0b062f-eb89-4f0c-9e01-761d0460a638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9c540810-154a-4c44-a00c-d4c72905c7bb" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5f0b062f-eb89-4f0c-9e01-761d0460a638" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5f0b062f-eb89-4f0c-9e01-761d0460a638_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5f0b062f-eb89-4f0c-9e01-761d0460a638" xlink:to="loc_us-gaap_RelatedPartyDomain_5f0b062f-eb89-4f0c-9e01-761d0460a638_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f135c879-fade-4834-80f6-e350af6793e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5f0b062f-eb89-4f0c-9e01-761d0460a638" xlink:to="loc_us-gaap_RelatedPartyDomain_f135c879-fade-4834-80f6-e350af6793e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_6d51494f-9ff4-40fe-841e-c7ec314e7b52" xlink:href="ccrn-20220630.xsd#ccrn_HealthCareSystemAffiliatedWithABoardMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_f135c879-fade-4834-80f6-e350af6793e3" xlink:to="loc_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_6d51494f-9ff4-40fe-841e-c7ec314e7b52" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>ccrn-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5ab65a54-411a-4f77-8134-d4db92a3ff6c,g:6015d444-ff7a-4976-923c-b8be5a21a758-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_e114755b-55da-4303-88c2-d6891bedfc11_terseLabel_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement, Aggregate Amount of All Possible Increases</link:label>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_label_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement, Aggregate Amount Of All Possible Increases [Member]</link:label>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_documentation_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement, Aggregate Amount Of All Possible Increases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" xlink:href="ccrn-20220630.xsd#ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" xlink:to="lab_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_4aa3eb9b-9bb4-4e37-8779-a94f1d4d0d3e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fc48487c-9d14-409a-8cdf-35a7955c67ce_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_161c18df-b81c-4597-8996-ba1faedd9c9d_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_d063f85f-1dee-4423-a024-309425616bb7_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_41462e71-30cf-4e45-9cab-80631943d098_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_2a0a701b-718f-47ae-a2ab-064249d9820f_verboseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad Debt Expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationContingentConsiderationTerm_db46c753-4731-44ef-9246-079a262d5a97_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationContingentConsiderationTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability, term</link:label>
    <link:label id="lab_ccrn_BusinessCombinationContingentConsiderationTerm_label_en-US" xlink:label="lab_ccrn_BusinessCombinationContingentConsiderationTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Term</link:label>
    <link:label id="lab_ccrn_BusinessCombinationContingentConsiderationTerm_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationContingentConsiderationTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationTerm" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationContingentConsiderationTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationContingentConsiderationTerm" xlink:to="lab_ccrn_BusinessCombinationContingentConsiderationTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_c3f109eb-dcbb-4fc7-ac36-6f4c8bc8d4e2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_fccd32ea-0b21-40b5-9faa-568e05f68a53_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_cb09c9c1-78db-40df-bea0-cb0bb795b291_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditFairValueDisclosure_a758a843-b90c-4366-8139-8ad016a2333d_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Asset-Based Loan</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lines of Credit, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditFairValueDisclosure" xlink:to="lab_us-gaap_LinesOfCreditFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_f1f105f4-0e75-4616-8d1e-0a1775379ad1_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate, additional credit spread associated with SOFR</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_label_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Basis Spread On Variable Rate, Additional Credit Spread Associated With SOFR</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Basis Spread On Variable Rate, Additional Credit Spread Associated With SOFR</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" xlink:to="lab_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_f50734d7-3d71-47b5-a0b3-a03dceb94739_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early termination benefit</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_7c065f03-e324-4de1-9350-46e81796e3d7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedTradeNames_16ddfa39-8cc4-463c-8ac7-1a63ee9f8e15_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTradeNames" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedTradeNames_847555ce-1044-4111-8fd8-ffeb4d379e8f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTradeNames" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedTradeNames_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTradeNames" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Trade Names</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedTradeNames"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedTradeNames" xlink:to="lab_us-gaap_IndefiniteLivedTradeNames" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_DeferredCompensationMember_573afd28-ccba-41f0-94cc-2df7af78215c_terseLabel_en-US" xlink:label="lab_ccrn_DeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_ccrn_DeferredCompensationMember_label_en-US" xlink:label="lab_ccrn_DeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation [Member]</link:label>
    <link:label id="lab_ccrn_DeferredCompensationMember_documentation_en-US" xlink:label="lab_ccrn_DeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DeferredCompensationMember" xlink:href="ccrn-20220630.xsd#ccrn_DeferredCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DeferredCompensationMember" xlink:to="lab_ccrn_DeferredCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_c4a0749c-7689-42b0-8f79-8de8b60a6379_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_54e620ed-6c5a-4760-8d0f-42d95239f84d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c81a3f51-a532-4a22-85f0-b01a39221706_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_b442fd0d-3105-421a-96c4-1c9fefc5f05b_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note payable, fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_81c192ef-4e35-42ed-b90d-0e3c8cf51930_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_7beab4d7-fb13-4444-95f4-be0a617bb9c9_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_94459e28-3550-4cb3-ae39-800b47f57095_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_519ebdd0-5520-4892-914b-4fdb39cc7054_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign currency translation loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_e06f77d3-556a-45f1-bb21-39a715544060_terseLabel_en-US" xlink:label="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived And Indefinite Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="ccrn-20220630.xsd#ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_844ca7aa-74de-402b-929e-98990505187b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term accrued claims</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_cc3c66df-f99e-4027-8755-bf80665a6d2a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_SelectedIncMember_b868cf23-5320-4aef-8604-c4e3e946fc3a_terseLabel_en-US" xlink:label="lab_ccrn_SelectedIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected, Inc</link:label>
    <link:label id="lab_ccrn_SelectedIncMember_label_en-US" xlink:label="lab_ccrn_SelectedIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected, Inc [Member]</link:label>
    <link:label id="lab_ccrn_SelectedIncMember_documentation_en-US" xlink:label="lab_ccrn_SelectedIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SelectedIncMember" xlink:href="ccrn-20220630.xsd#ccrn_SelectedIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SelectedIncMember" xlink:to="lab_ccrn_SelectedIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_83f03cd4-248c-44a6-92d1-0b2413e84f13_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest margin percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_1b43acb6-f31e-4fb0-b17b-64779155bff6_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_094f9fc2-daf3-417e-8569-4e499a4ee201_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_SwingLoansSublimitMember_5b1c653a-82d4-4d3e-85f3-9d97f3079d35_terseLabel_en-US" xlink:label="lab_ccrn_SwingLoansSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swingline Sublimit</link:label>
    <link:label id="lab_ccrn_SwingLoansSublimitMember_label_en-US" xlink:label="lab_ccrn_SwingLoansSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swing Loans Sublimit [Member]</link:label>
    <link:label id="lab_ccrn_SwingLoansSublimitMember_documentation_en-US" xlink:label="lab_ccrn_SwingLoansSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swing Loans Sublimit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SwingLoansSublimitMember" xlink:href="ccrn-20220630.xsd#ccrn_SwingLoansSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SwingLoansSublimitMember" xlink:to="lab_ccrn_SwingLoansSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_47f8d4c8-d197-409a-b1f5-5649a96cb1ea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_07850856-17e2-4600-8268-bb91e4864206_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_fe5277c4-6a37-4427-a197-4d99752adef9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of WSG (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_ef21bb08-c6e6-49ac-82be-9328a4f15918_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash (benefits) costs</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_a7213ae2-fc43-4227-9159-9573522417ee_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_60083d6c-720e-45a3-99d3-05e74b632d7c_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_d21abc82-b1e3-46c7-8ea6-6ab96cf52838_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9c9694fc-378b-4013-9c9f-9c0739db428a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b92d63f7-d0eb-4aa1-94b0-073ffe45ce21_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares excluded from diluted weighted average shares (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_cf6aaa81-9cb2-498f-9ebd-bcb96e4428af_totalLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_label_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:to="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_aabaedaf-fffc-4d71-8bcb-6c3f50a59aa8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Aggregate Scheduled Maturities of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_5efbc940-fff5-49f9-ab44-b7f5488ba1c4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_0e778313-5ca3-4812-bed5-3a518d02536a_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_90619b60-f1ac-4742-ad16-04cca4a60aa5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation asset</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_9ce0e9aa-62aa-4a37-b040-0f5b7659f708_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_3c5251a1-a4a1-4ad6-8211-013784ceda6a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_f3384c4f-2b6b-43c5-ad5b-c97c938cbde5_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_34e7b063-31a3-445f-955c-c87588e93925_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets subject to amortization:</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_WorkforceSolutionsGroupIncMember_ef4379ad-01b8-4f5f-8be6-0fbdd8721116_terseLabel_en-US" xlink:label="lab_ccrn_WorkforceSolutionsGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce Solutions Group, Inc.</link:label>
    <link:label id="lab_ccrn_WorkforceSolutionsGroupIncMember_label_en-US" xlink:label="lab_ccrn_WorkforceSolutionsGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce Solutions Group, Inc. [Member]</link:label>
    <link:label id="lab_ccrn_WorkforceSolutionsGroupIncMember_documentation_en-US" xlink:label="lab_ccrn_WorkforceSolutionsGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce Solutions Group, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember" xlink:href="ccrn-20220630.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_WorkforceSolutionsGroupIncMember" xlink:to="lab_ccrn_WorkforceSolutionsGroupIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_3ace3c98-125c-4310-a52b-2b8e421fb67f_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_label_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-Of-Use Assets</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:to="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_066bcc9e-0fe6-4775-b154-9cebd287b7a2_terseLabel_en-US" xlink:label="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate overhead</link:label>
    <link:label id="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_label_en-US" xlink:label="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Unallocated Corporate Expenses</link:label>
    <link:label id="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses_documentation_en-US" xlink:label="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Unallocated Corporate Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:href="ccrn-20220630.xsd#ccrn_SegmentReportingUnallocatedCorporateExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:to="lab_ccrn_SegmentReportingUnallocatedCorporateExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_b1a2ec6d-6ce5-41d7-be1c-fac802d02765_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_b644fadc-c7a6-4379-9771-eb42d9bed5d0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_3c5ff397-23be-4e39-be04-ff2b7277d111_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_e44e9229-7b07-4cb2-96ae-e28b0d6bbc67_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_6ea50aed-8413-47a2-945f-a9174130c4db_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, carrying amount</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_80738c6c-29b2-4233-a439-dea6a7e49b3d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_32841878-bdb9-4ab7-ac5d-4b1fc18839e4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_fcd39806-a24e-422d-8c19-c84f9c9eec91_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_3d9df204-65c1-4b58-9c2c-1121195f0beb_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_034284f1-f37b-4948-8cb3-e329ef40ebff_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_4a905717-6672-493a-8e0b-a562277dd164_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities - current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_4f0436b6-7253-49bb-8a5c-ddd365d1f8f6_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: operating lease liabilities - current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_dd6439ab-a9a4-4e50-9b8a-efb192f28ae6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_81dfbefa-af90-4082-aaab-075749c525d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_91343636-1a9d-4e75-826c-6f04011321ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_45c9500a-9dc2-4540-a9a2-affe21f2abf4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_789665ea-5049-4191-8c85-e0dc571fb1dc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_a38ef5b0-efb0-454c-aa2a-42b3863d912f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_badbec29-c2df-4322-ad2f-f9296c24afdd_terseLabel_en-US" xlink:label="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution income:</link:label>
    <link:label id="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_label_en-US" xlink:label="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Loss Before D And A Acquisition And Integration Contingent Consideration Restructuring Legal Impairment And Corporate Overheard</link:label>
    <link:label id="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_documentation_en-US" xlink:label="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income Loss Before D And A Acquisition And Integration Contingent Consideration Restructuring Legal Impairment And Corporate Overheard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" xlink:href="ccrn-20220630.xsd#ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" xlink:to="lab_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_5187c3ec-206c-4fba-9062-3b519af1391a_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_de92d89b-273f-499c-b7c1-0b35da66388d_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a39ec451-25fc-4af0-a8f6-32a85c112b9e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ec0ed910-3520-42f2-a99a-75f70f34e5aa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_62ede8be-7ff7-48da-91bb-afea9efdb0c0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquisition adjustment - Selected</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c050be09-97a4-4973-9489-dc6d4df1e32e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d0dd643f-618d-4d17-9386-55079be87ed7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ab8f72a8-2b02-4711-9335-107c29ae7806_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c5c2bcf-5301-42f4-bdb6-96ab68e78a02_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_3a2aa8de-6a49-4cbb-a720-0469838af6a6_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_71eefa92-c0e1-40ef-8cae-86e2b9e5c004_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_252b979e-b911-4d1b-9294-f4d19f19b787_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c7452c2c-15b0-49b2-8fd5-73da75e7d9f1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_41882f48-ce03-4237-a080-52e196d1e419_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_60600ba7-5fbc-4a4c-b650-555759034258_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock_3400b3c8-5e16-45fd-83a0-520b0b4544b7_terseLabel_en-US" xlink:label="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Balance Sheet Information</link:label>
    <link:label id="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock_label_en-US" xlink:label="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Leases [Table Text Block]</link:label>
    <link:label id="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock_documentation_en-US" xlink:label="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:href="ccrn-20220630.xsd#ccrn_AssetsAndLiabilitiesLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:to="lab_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_092cdde9-51dc-4069-b977-fb3cb568627f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock awards, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_06ab651a-56d0-482c-94c6-022d2f28c374_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock awards, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_cfc12448-7f76-47f8-abb2-fbee88a31b39_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_b74c15be-b1db-4b0e-91a6-831dd635c91e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_9895431d-f174-4a79-afc6-de73a41ff366_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_803a1f86-db66-4dd2-9241-458c58578635_terseLabel_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested in period, net (shares)</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_label_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other than Options, Vested In Period, Net</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_documentation_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other than Options, Vested In Period, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" xlink:href="ccrn-20220630.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" xlink:to="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_56d003c5-ba4e-4f9a-8bd1-93657ea43b5d_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_2c7b7533-afc6-4eb4-831b-0a914132feda_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_02906e81-2312-436e-9c21-29469b96944a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6a9ff898-6541-45dd-8fa3-06855d726918_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c698d0f1-9851-4223-94a0-71011c8dbfa9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity consideration for acquisition (shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_95bf0b82-a7ab-4457-aede-78fa50ba07e3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_EarnoutNotesPayableMember_7a02e630-5575-47c1-b7d6-a477da561ef9_terseLabel_en-US" xlink:label="lab_ccrn_EarnoutNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Notes Payable</link:label>
    <link:label id="lab_ccrn_EarnoutNotesPayableMember_label_en-US" xlink:label="lab_ccrn_EarnoutNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Notes Payable [Member]</link:label>
    <link:label id="lab_ccrn_EarnoutNotesPayableMember_documentation_en-US" xlink:label="lab_ccrn_EarnoutNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EarnoutNotesPayableMember" xlink:href="ccrn-20220630.xsd#ccrn_EarnoutNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_EarnoutNotesPayableMember" xlink:to="lab_ccrn_EarnoutNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5d026ffa-dc45-4f6a-9fb9-fff8755d4ea0_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_95e3ba02-e37c-484f-8c9f-bba7d37cddd7_terseLabel_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement, Incremental Term Loan</link:label>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_label_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement, Incremental Term Loan [Member]</link:label>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_documentation_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement, Incremental Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" xlink:href="ccrn-20220630.xsd#ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" xlink:to="lab_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_f36dab82-c91a-445f-aecb-f5084a322aef_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_775e7152-6c8f-4dea-af5f-d58c572c9b95_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-Offs, net of Recoveries</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_c8dc2fd7-ce55-4fc5-88e0-f1bb504e3ffd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_773fb318-c1d1-4f7d-9af4-4c64ec7489dc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_69e9e19c-55de-4948-bdc5-314613c1800f_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, net</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d13905da-b51e-40a1-a548-4255655caa98_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_9ce7099b-6470-4e77-9055-3b7d8359193d_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock Awards</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e1ff7e14-f75a-4684-841d-568e6faed050_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivableCurrent_a46cf677-ab25-43de-8c56-5194f072ff78_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance recovery receivable</link:label>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Settlements Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceSettlementsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:to="lab_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee6d800e-2a4e-4c63-92f0-c766a17ea54c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_14fbba50-a5c0-4103-9c4a-569aaa853c35_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_320061a1-00f2-4e70-8bcd-0a67bbced535_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_3f9ce628-25ac-46ef-82ad-2b228430d919_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_271c79ed-5f61-47f2-82a7-3e6c0308337f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_b42589f0-bbb1-41eb-a28a-80426e0a309e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_f3ed8573-2296-4e06-8663-65323b9caba9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable and other lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_0eae7c04-44d3-4471-913a-d2a6005cea8d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Asset-Based Loan</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3127349d-a132-43f3-8ee7-b429ad3611c6_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_1539ff19-b37e-4b27-973d-a90f4cbd9f49_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ShareBasedPaymentAwardsMember_08aefbc8-417e-4be5-9736-e1b161436c16_terseLabel_en-US" xlink:label="lab_ccrn_ShareBasedPaymentAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Awards</link:label>
    <link:label id="lab_ccrn_ShareBasedPaymentAwardsMember_label_en-US" xlink:label="lab_ccrn_ShareBasedPaymentAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Awards [Member]</link:label>
    <link:label id="lab_ccrn_ShareBasedPaymentAwardsMember_documentation_en-US" xlink:label="lab_ccrn_ShareBasedPaymentAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedPaymentAwardsMember" xlink:href="ccrn-20220630.xsd#ccrn_ShareBasedPaymentAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ShareBasedPaymentAwardsMember" xlink:to="lab_ccrn_ShareBasedPaymentAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_10642d83-7891-4dde-832e-2cb7d98ae144_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_72fa97a4-7226-41ae-9706-e291dc7cb89e_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_0cfcd8eb-907b-42bf-890d-b29097f227d1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_61c54a35-044b-4d5b-963b-01cedf845aa5_terseLabel_en-US" xlink:label="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_documentation_en-US" xlink:label="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:href="ccrn-20220630.xsd#ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:to="lab_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_28901e04-a592-47fe-bbe3-7d2160516486_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_9cd12781-6362-4bd7-b3eb-8cd6af67f332_periodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate goodwill acquired, beginning balance</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_938d6dc1-bcbf-4cc5-bfc9-53840ebdb4c3_periodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate goodwill acquired, ending balance</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_e2b0bcf5-49fb-4966-8736-cd0cd1d8bab3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of business</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_5722b54c-9c38-439b-91ee-5fe93f5a5a0e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cf2b8a83-7d5e-479c-b8a6-4e11c711c62e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_8068ee05-ba22-4c9a-8416-0b794d241e7a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:to="lab_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_35031c8d-4055-4f93-a41c-d42a631ff220_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_3deed9e6-fcbb-45cf-b560-2dd446209df5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_064f77e6-e43a-425b-8a16-e9ac845c0f44_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration, gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LineOfCreditSublimitAxis_80867b9a-dacf-45ab-8f9a-60c21bcbc6d4_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditSublimitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Sublimit [Axis]</link:label>
    <link:label id="lab_ccrn_LineOfCreditSublimitAxis_label_en-US" xlink:label="lab_ccrn_LineOfCreditSublimitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Sublimit [Axis]</link:label>
    <link:label id="lab_ccrn_LineOfCreditSublimitAxis_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditSublimitAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Sublimit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitAxis" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditSublimitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditSublimitAxis" xlink:to="lab_ccrn_LineOfCreditSublimitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_e3fd0535-dd74-4962-8c1f-0af1f7920d3b_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectOperatingCosts_76880cc5-0354-43eb-8e44-1d863d78e3c0_terseLabel_en-US" xlink:label="lab_us-gaap_DirectOperatingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct operating expenses</link:label>
    <link:label id="lab_us-gaap_DirectOperatingCosts_label_en-US" xlink:label="lab_us-gaap_DirectOperatingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Operating Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectOperatingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectOperatingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectOperatingCosts" xlink:to="lab_us-gaap_DirectOperatingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_5e4a73f3-0e6d-484a-9881-41b448728c47_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_3a8060a9-2758-45e6-93d9-8a0ea3fba429_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_a4518514-c560-42a2-87a8-3707e44b9d7d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_e4458f0b-763d-42a6-abdb-04515b51da0d_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1cb75fd8-510e-4160-a054-500c64a5260c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_07d769f6-4660-426a-aff5-b27137390498_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_19330f11-d91d-4e55-a54c-0966602b857d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1d377958-ad63-4247-be7b-80643d4be14b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d32c9a3d-b966-4299-b076-210b937625c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_b455d891-7a25-4318-8c10-a0339316fa20_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liability</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_1d0e0e66-6b76-41fe-abcd-fba5054b0ac4_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Business</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_e6e83471-302b-4b18-ab1b-7ea40b8ef92d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_PhysicianStaffingMember_77e92485-cedf-4054-8cd2-b1e05787c294_terseLabel_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician Staffing</link:label>
    <link:label id="lab_ccrn_PhysicianStaffingMember_label_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician Staffing [Member]</link:label>
    <link:label id="lab_ccrn_PhysicianStaffingMember_documentation_en-US" xlink:label="lab_ccrn_PhysicianStaffingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician staffing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember" xlink:href="ccrn-20220630.xsd#ccrn_PhysicianStaffingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PhysicianStaffingMember" xlink:to="lab_ccrn_PhysicianStaffingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_fa64381f-66b3-44fd-811a-bed561673a4e_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_d8b5fc3b-6547-4eb4-a172-44e810896c5c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_73df3cb6-7e32-412b-8bf5-fa6e29898b89_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_e7e47a48-fe67-477a-bf79-35208863ddaf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from term loan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_416e1c34-a7ec-40fb-afa1-4b53175834e9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_dd59b029-f178-4961-809b-534bd5e38825_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_c181f04c-056b-44dd-b8b1-ee340ffecb21_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0ce1fe58-4dea-43ca-8191-2ed7c71c7bcb_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a7160690-d0e1-4e99-a40f-a90699180c83_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_2602a552-7310-4a08-9283-f5da13992bd3_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability - non-current</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_label_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Noncurrent</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" xlink:to="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_59aa473f-ae36-40a5-97bf-99c2f4d03ec7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_97ff1453-280c-4332-a7c6-bfd6aca27ada_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly installment amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2f7a1079-1399-4c33-bea9-56d1865dd0ea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_1890ee77-fa40-445b-b418-bc0e81ce12ae_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_64ea4808-3fde-493b-908b-6c22f3fdd611_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f788faed-315b-4baa-9774-bfb5a2df0e81_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_60e99181-fe36-4424-a86f-858079f4b722_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_04bfeee6-3d23-49e3-88eb-36559db838ea_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_e0bc6dff-b1ff-4ab1-b14a-19005c74d7e2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_6dcafefe-93a1-4bf3-a521-92c62f18f4a9_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_80e1db07-f891-4c3a-9d69-25b37999e538_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_5c0ebdbc-0119-410f-8962-31008ab0b484_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Option, Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Option, Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:to="lab_us-gaap_FairValueOptionQuantitativeDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d271d588-e1ed-4abb-bfd4-12acb144a867_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_7da4be74-0869-42b5-999f-40a0e3bd0e65_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_448a19b2-50ea-4161-801c-4d502766a55e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from related parties</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties" xlink:to="lab_us-gaap_RevenueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_5752bf30-2fa1-49fb-8126-a22099f62534_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment premium paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_94d2c725-8933-4457-970b-f56b2d50412a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_e2d92676-145e-430d-863e-239baa4d02e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Carrying Amount of Goodwill by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_ea8d67db-c781-46c1-98e5-1df9a97c5cec_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to common stockholders - Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax_5aa81cbc-2c79-483b-88a9-46875b579e67_negatedTerseLabel_en-US" xlink:label="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on currency fluctuations</link:label>
    <link:label id="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Before Tax</link:label>
    <link:label id="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax_documentation_en-US" xlink:label="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" xlink:href="ccrn-20220630.xsd#ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" xlink:to="lab_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9055ccc7-a71c-49cd-b07d-e840b4da9a10_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_5ab4da2a-62d0-4319-80e7-62d8c412afbb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_10dd9bb6-60fb-4a18-a3ea-51c20a34b63c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_b1763e1e-cc94-4c06-9737-c011b059fc60_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_46e39f53-a660-48e0-b4df-08a62efb7ae3_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_26d5ee28-a9bf-4f05-b1a6-bf648242a23d_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Member of the Board of Directors</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_TemporaryStaffingServicesMember_1b99b6af-19f5-45cb-b4e0-46d569e3dfa4_terseLabel_en-US" xlink:label="lab_ccrn_TemporaryStaffingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Staffing Services</link:label>
    <link:label id="lab_ccrn_TemporaryStaffingServicesMember_label_en-US" xlink:label="lab_ccrn_TemporaryStaffingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Staffing Services [Member]</link:label>
    <link:label id="lab_ccrn_TemporaryStaffingServicesMember_documentation_en-US" xlink:label="lab_ccrn_TemporaryStaffingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Staffing Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_TemporaryStaffingServicesMember" xlink:href="ccrn-20220630.xsd#ccrn_TemporaryStaffingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_TemporaryStaffingServicesMember" xlink:to="lab_ccrn_TemporaryStaffingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_05c7e583-e192-4c44-84eb-68c300507a28_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_e128a077-b625-4530-a46f-a1f7c9becc1e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_aa0afff9-fab7-4226-b17c-f6e3b2ea99d2_terseLabel_en-US" xlink:label="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate, excluding discrete items</link:label>
    <link:label id="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_label_en-US" xlink:label="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate, Continuing Operations, Excluding Discrete Items</link:label>
    <link:label id="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_documentation_en-US" xlink:label="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate, Continuing Operations, Excluding Discrete Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:href="ccrn-20220630.xsd#ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:to="lab_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_199366db-b1cf-4ef7-88e9-176456fc27ee_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f8888bc0-4d62-4ced-9767-9c9da39fd01d_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_e8d987a9-0a51-47eb-b2ae-060af9921bd3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15072fdc-aa49-4afc-bf22-ab10249c5b71_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_981c9b09-093f-4b61-b1af-4bbcaeb30ea7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_120a2690-1aba-4361-bded-446ab73756da_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_707f3b12-9be2-4f1d-abdc-0a5c4c151ef9_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_e9268bac-c476-4c11-baf0-5e6f7541e608_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5f2ddf85-cfb9-44fc-b2b0-5f43174e0173_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_9ca76c79-612e-4f68-8e50-67b4916326fe_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_1b4b48cc-bf9b-4dc0-bb98-bafa29a817e8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_acc32eb2-01d0-4668-9293-4c6c7dcfb641_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_ba5e1db1-03c0-4862-888d-5ce6397dd925_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_baa3bc85-3c63-4184-bf91-1004252ab464_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_58934d5d-11b0-4e71-9f57-309a77f50218_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_50aaa2fd-72c2-4673-aa8b-2066ca0845c8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of WSG</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_PaymentForDebtPrepayment_a388752d-e9df-429a-b692-5fa70e9e3005_terseLabel_en-US" xlink:label="lab_ccrn_PaymentForDebtPrepayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for debt prepayment</link:label>
    <link:label id="lab_ccrn_PaymentForDebtPrepayment_label_en-US" xlink:label="lab_ccrn_PaymentForDebtPrepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Debt Prepayment</link:label>
    <link:label id="lab_ccrn_PaymentForDebtPrepayment_documentation_en-US" xlink:label="lab_ccrn_PaymentForDebtPrepayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Debt Prepayment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PaymentForDebtPrepayment" xlink:href="ccrn-20220630.xsd#ccrn_PaymentForDebtPrepayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PaymentForDebtPrepayment" xlink:to="lab_ccrn_PaymentForDebtPrepayment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_7bdad2d9-a9a1-4f68-a921-fb4b634bd050_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_ecd588cb-1511-44f3-b05e-0dba8068826d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_8beb3f72-12ca-44fa-b453-206929e10743_terseLabel_en-US" xlink:label="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Liabilities</link:label>
    <link:label id="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="ccrn-20220630.xsd#ccrn_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_b8cdecce-8b43-40c3-ae42-624b34716225_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities - non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f558d986-aa8e-45f3-b9f6-f37e216bcd04_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities - non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_8b7e8822-95b6-4614-aeee-c2f8e8284a57_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_76cdcf7b-34cd-4773-8b6f-a09f30037344_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_30cb80c9-ee71-4a03-9e1d-b5cbf0025611_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances of $11,896 in 2022 and $6,881 in 2021</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7169982e-b4df-4ec8-9b4a-56f087692f4e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_ba45fbe1-495e-45f9-86ef-808f582dae6c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_64af4638-211d-44b3-9922-ea3b582e51d0_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_872c3d9c-ee12-45d0-859e-885b0e63f020_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_cf5ac229-619e-44cf-b633-1fee0bba6a62_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_7ffbcde5-e23c-48aa-9e69-3002dc822fd2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f48da422-e308-4e64-8994-02dba740e88b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock awards, beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d4960899-e7b7-4890-b540-5a364afe2a4f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested restricted stock awards, ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_dc285e0e-75a6-41d4-a60e-9a34d0ff6867_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of earnout liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_0ad0f170-2890-4dc6-9e09-c5d7c12f4a75_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of earnout liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_15743374-9e55-42bf-aca0-4dd5bed838f9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_3f12160d-364b-4e0c-a11d-c71edf021bf5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_3f2d7363-ccc3-4e84-8100-349f09af4c67_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_69d80f2f-c67d-44c7-88b5-ee4f3e76833e_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_6d3e50e0-133b-4a5b-97e5-989827ef1fbc_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING PRONOUNCEMENTS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_17e530e6-fe0c-45ab-80a5-d168523c979e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_34211caf-8512-43f7-84f3-00c4c93c0403_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss, net</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_fe1a95a7-962e-4c13-85c5-06930e0216dd_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_7f10ac18-d337-46e1-bfbe-3eb665968b41_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_20b998b4-5c17-455f-8cb1-7e6864576de2_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_96c5566e-c253-4787-9452-dd4c4d0d2682_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_b1730da3-ea00-4fd0-a276-797ceeec3d09_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_b90eb19a-0aaf-4867-a25f-a15619a871b7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a8923b4c-ad21-42e7-9f45-34dc013a4923_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Accounting Pronouncement</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_8ad486e8-1da3-42b1-93fd-0aba8e4a822f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of diluted shares:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_19eb3e6b-bbb7-4a0e-909b-3ded258e8148_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing base availability</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_label_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Borrowing Base Availability</link:label>
    <link:label id="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Borrowing Base Availability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditFacilityBorrowingBaseAvailability" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditFacilityBorrowingBaseAvailability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditFacilityBorrowingBaseAvailability" xlink:to="lab_ccrn_LineOfCreditFacilityBorrowingBaseAvailability" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LineOfCreditSublimitDomain_8c66ef95-4f6a-47a7-881a-4f38aa534b21_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditSublimitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Sublimit [Domain]</link:label>
    <link:label id="lab_ccrn_LineOfCreditSublimitDomain_label_en-US" xlink:label="lab_ccrn_LineOfCreditSublimitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Sublimit [Domain]</link:label>
    <link:label id="lab_ccrn_LineOfCreditSublimitDomain_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditSublimitDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Line Of Credit Sublimit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitDomain" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditSublimitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditSublimitDomain" xlink:to="lab_ccrn_LineOfCreditSublimitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6437225e-4491-44fe-971a-e5554efb0bb4_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LongTermDebtMaturityAfterYearFour_eea0517e-782e-40fc-a112-cf7c6a673145_terseLabel_en-US" xlink:label="lab_ccrn_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ccrn_LongTermDebtMaturityAfterYearFour_label_en-US" xlink:label="lab_ccrn_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, After Year Four</link:label>
    <link:label id="lab_ccrn_LongTermDebtMaturityAfterYearFour_documentation_en-US" xlink:label="lab_ccrn_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LongTermDebtMaturityAfterYearFour" xlink:href="ccrn-20220630.xsd#ccrn_LongTermDebtMaturityAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LongTermDebtMaturityAfterYearFour" xlink:to="lab_ccrn_LongTermDebtMaturityAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_7ca3fb2d-c283-4429-b8cc-f11224a43b7a_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_37cf2f95-7fe2-4cb8-b131-2fde089f09c5_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net of impairment loss, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_57b2e206-a031-48d1-8b32-7e9b5b40bfb0_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net of impairment loss, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_868487ff-ab4f-4d3b-9868-9549ff93d804_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_2b378e9e-34d4-499e-a578-e92cc9f65a32_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_203e1812-cdd6-4288-b241-cd204d827e60_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_OperatingLeaseExpenseNonCash_13e00585-9db4-4bf2-a27f-4a54609e6f1e_terseLabel_en-US" xlink:label="lab_ccrn_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_ccrn_OperatingLeaseExpenseNonCash_label_en-US" xlink:label="lab_ccrn_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Expense, Non-Cash</link:label>
    <link:label id="lab_ccrn_OperatingLeaseExpenseNonCash_documentation_en-US" xlink:label="lab_ccrn_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Expense, Non-Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OperatingLeaseExpenseNonCash" xlink:href="ccrn-20220630.xsd#ccrn_OperatingLeaseExpenseNonCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OperatingLeaseExpenseNonCash" xlink:to="lab_ccrn_OperatingLeaseExpenseNonCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_62353956-f76d-4065-966b-e59459f9e227_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_RestrictedStockAndPerformanceSharesMember_896f657f-3c3c-4509-8d0b-89e883d8bad4_terseLabel_en-US" xlink:label="lab_ccrn_RestrictedStockAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock And Performance Shares</link:label>
    <link:label id="lab_ccrn_RestrictedStockAndPerformanceSharesMember_label_en-US" xlink:label="lab_ccrn_RestrictedStockAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock And Performance Shares [Member]</link:label>
    <link:label id="lab_ccrn_RestrictedStockAndPerformanceSharesMember_documentation_en-US" xlink:label="lab_ccrn_RestrictedStockAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock And Performance Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_RestrictedStockAndPerformanceSharesMember" xlink:href="ccrn-20220630.xsd#ccrn_RestrictedStockAndPerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_RestrictedStockAndPerformanceSharesMember" xlink:to="lab_ccrn_RestrictedStockAndPerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_fcbc65be-7e42-4e2e-8240-bb9ac79f592e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_8d608346-0686-4746-93ab-c1814e9c336d_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements, impairment loss</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_c7fd0406-d48a-43be-84c2-49bbf5d61762_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_f4a26ec0-e88c-41ca-82a0-f1ec624d1080_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationPeriod_db114123-36ac-49f7-a120-513a5074c399_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit term</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_303281ac-ff9c-4533-9c6c-41d369533a67_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1932d0d5-dc8f-47d5-abe2-e0999dad8b38_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares - Diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90f4948b-9e1a-4ff6-9cac-6de72a972e06_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_DebtInstrumentVariableInterestRateFloor_5a032fbd-6352-4ded-bd64-ea026bba6f97_terseLabel_en-US" xlink:label="lab_ccrn_DebtInstrumentVariableInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest margin floor percentage</link:label>
    <link:label id="lab_ccrn_DebtInstrumentVariableInterestRateFloor_label_en-US" xlink:label="lab_ccrn_DebtInstrumentVariableInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Interest Rate Floor</link:label>
    <link:label id="lab_ccrn_DebtInstrumentVariableInterestRateFloor_documentation_en-US" xlink:label="lab_ccrn_DebtInstrumentVariableInterestRateFloor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Interest Rate Floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DebtInstrumentVariableInterestRateFloor" xlink:href="ccrn-20220630.xsd#ccrn_DebtInstrumentVariableInterestRateFloor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_DebtInstrumentVariableInterestRateFloor" xlink:to="lab_ccrn_DebtInstrumentVariableInterestRateFloor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_a2c57982-33df-4982-a192-538c450f07b7_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_57ad68df-309f-405a-8aec-416ac8079af7_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_ccb9c77e-5629-45d0-bdbc-88830521a3c6_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_0cb52363-86a0-49b1-96bf-57ef9a58004a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_03a368ac-6e84-4cad-aed1-c57071fea6ab_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_0ee4a094-9ba5-4f9a-9600-97d8ffd9d95a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_c387faef-7e39-4382-9858-bc5366ca9962_terseLabel_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance attainment percentage</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_label_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Attainment Percentage</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_documentation_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Target Attainment Level, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" xlink:href="ccrn-20220630.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" xlink:to="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_dfaf00c9-75bd-46f7-a5de-c1be9291e6a8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_b2392baa-7b67-41c9-811f-59d05f21dac5_verboseLabel_en-US" xlink:label="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for allowances</link:label>
    <link:label id="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_label_en-US" xlink:label="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision For Doubtful Accounts And Other Allowances</link:label>
    <link:label id="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_documentation_en-US" xlink:label="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision For Doubtful Accounts And Other Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" xlink:href="ccrn-20220630.xsd#ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" xlink:to="lab_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_321ef32b-9b12-474e-b1c4-ba05e0acbb4b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_03e14f7f-a14e-4926-b9e4-715877783c9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_31b1a463-1f81-46ea-9d4c-148ebabd581e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_7906b26f-2aa3-4bda-909b-4e47bd5c92ca_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease expense</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_37819067-37f8-4ea9-9b14-33a2c8e27be4_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_51c7193e-ea72-4be3-b0a3-ead4ae6014ff_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_a437ab75-a6d2-4ed9-a274-189a5bc9fec6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_36c50fc3-c003-417e-91e2-2c1bd0e773e0_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_b4da61d2-c507-4790-9bd3-60fb4b4e7993_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment loss, beginning balance</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c62fe944-3af6-4fa5-926a-df6b9b1e765f_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment loss, ending balance</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_98d42963-68c2-4caa-abb4-408355969904_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_75e49e4b-6d59-4ac5-b5fe-9898784c037c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to common stockholders - Basic and Diluted - Basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_0686ca16-f640-46ad-a213-1b6c1d1c1ee2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_c2ad05d4-f78d-494d-a324-64ee9fdbce19_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ef3bb585-7568-4cff-8acc-8d3ad3d6c6c6_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_62fe3037-1c46-4019-9776-c3cc39059ce9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_ba49f6ae-2f82-48ae-a373-7af729edd11b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_94e24747-fece-457a-ac88-f72f9de7b76e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_37cf409d-4775-499a-8347-58da13b7a05b_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under Senior Secured Asset-Based revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-Term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_4109c897-3032-4bd1-811f-05c16d52c422_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_SeniorSecuredAssetBasedLoanMember_45bc02ac-6c84-492d-b242-b2328d86e87e_terseLabel_en-US" xlink:label="lab_ccrn_SeniorSecuredAssetBasedLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Asset-Based Loan</link:label>
    <link:label id="lab_ccrn_SeniorSecuredAssetBasedLoanMember_label_en-US" xlink:label="lab_ccrn_SeniorSecuredAssetBasedLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Asset-Based Loan [Member]</link:label>
    <link:label id="lab_ccrn_SeniorSecuredAssetBasedLoanMember_documentation_en-US" xlink:label="lab_ccrn_SeniorSecuredAssetBasedLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Asset-Based Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember" xlink:href="ccrn-20220630.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SeniorSecuredAssetBasedLoanMember" xlink:to="lab_ccrn_SeniorSecuredAssetBasedLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3c629310-5ab4-438a-8006-d7f825cf92a7_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_66a2cecb-ca09-4346-97ad-2940c18acffc_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_067909a2-14e1-47a5-9200-fb16a6087910_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_fef7eb24-4b79-4770-ba2d-0e2c2ff615a5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_549f766f-6e2c-468f-ba99-942aa0774475_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_33fe44c5-e9d5-427b-83b1-ee548015e61c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_03d6712e-4c98-4679-b133-68a7ff2c8260_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_SalesAllowanceBillingRelatedAdjustments_c90807f0-18ff-4b59-96c6-cc9a6a929bba_terseLabel_en-US" xlink:label="lab_ccrn_SalesAllowanceBillingRelatedAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales allowance, billing-related adjustments</link:label>
    <link:label id="lab_ccrn_SalesAllowanceBillingRelatedAdjustments_label_en-US" xlink:label="lab_ccrn_SalesAllowanceBillingRelatedAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Allowance, Billing-Related Adjustments</link:label>
    <link:label id="lab_ccrn_SalesAllowanceBillingRelatedAdjustments_documentation_en-US" xlink:label="lab_ccrn_SalesAllowanceBillingRelatedAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Allowance, Billing-Related Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SalesAllowanceBillingRelatedAdjustments" xlink:href="ccrn-20220630.xsd#ccrn_SalesAllowanceBillingRelatedAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_SalesAllowanceBillingRelatedAdjustments" xlink:to="lab_ccrn_SalesAllowanceBillingRelatedAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_ed1ffac1-2e15-4617-be88-d2a3db6f5d4d_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_93d3b618-277c-4bc4-9763-68eb4837672f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_56f9b0d1-9f14-4caa-b8f8-02df4e3e75f5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly commitment fee on the average daily unused portion percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_e2eee38e-0ac2-448b-9558-e3d713e7006d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on note payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_fd033611-8371-4409-96e7-83701682ffd6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Termination</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_508918e5-99da-4b5d-8b8d-dc7f4e2c7a01_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, impairment loss</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_58a2bf81-bfcf-4cf9-9db9-95011bb92800_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Fair Value of Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a445191b-818f-487a-83b5-49d24ad7ebb3_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_27a240a2-871f-4021-aefc-4350b9126540_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5a11081b-87ce-46bf-a37c-3ee42760af4d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_42a7dd51-7941-488d-bcf5-47055377191c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_78919bd5-2571-4e6b-bfee-f022cd8f7d86_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3fd0647e-879c-4a92-a3e4-20d26b114ac5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_f8bccb56-703c-490d-a946-9cc32d4b2bc8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net of accumulated depreciation of $19,240 in 2022 and $17,729 in 2021</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_98875ff8-530a-401a-81ce-21936498e4d8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0fc11827-f7ab-4717-8c2e-6a922c5bd1f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Annual Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_3898addb-d30c-47b1-99a4-652c641ca39f_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_f871868d-d778-4844-9516-a6797ed83f9a_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DatabasesMember_8f7efdc5-e987-44b9-9f10-4994c257091a_terseLabel_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Databases</link:label>
    <link:label id="lab_us-gaap_DatabasesMember_label_en-US" xlink:label="lab_us-gaap_DatabasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Database Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DatabasesMember" xlink:to="lab_us-gaap_DatabasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a5ce981a-9f37-47e0-8a14-ff3f92fc5e4d_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7e9a05ba-e07f-4c57-a450-3adc049b0604_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e2c79036-b923-4724-9fb7-a00e13ea7069_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_e040b099-8a22-4f02-a53b-4dc81a33c7d8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current earnout liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_93837858-79cc-49da-a76a-e1bf52ea9675_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_c454df0b-e2d4-4fcb-9192-3ede85332647_terseLabel_en-US" xlink:label="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold period, past due for payment of services provided</link:label>
    <link:label id="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_label_en-US" xlink:label="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold Period, Past Due For Payment Of Services Provided</link:label>
    <link:label id="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_documentation_en-US" xlink:label="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold Period, Past Due For Payment Of Services Provided</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" xlink:href="ccrn-20220630.xsd#ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" xlink:to="lab_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_f2db418e-5769-4cc9-9128-0589c85fa784_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b6905cf1-b8d1-4037-8e02-249c8845586c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f953d703-08a4-4d99-ac39-275c69a33479_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_b0a807c6-1f7c-464d-a27a-06a957513260_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_9a4ffcf3-1a01-489e-a1bc-54726de541b2_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_c9673ea9-229b-4dcc-b7bd-60c30c583b8b_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_1aa10860-2556-4adb-b638-7c6ec76cf8c5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_b8b136e8-98a7-4d85-9ee3-3889c83f6d3f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_5ad52a92-ca4c-4e5c-9efe-d5da54d37b2d_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_b16c8350-3f3d-4157-9119-feb2fdf2e1cd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_e8ddc5fe-00bf-46bd-883e-3a6a52c5959c_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_768c255c-945d-499e-b537-2a346123ae9e_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_66ee0951-5687-422c-8b97-f4c7cdd1b388_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_f3c0fe46-25f8-419e-83ca-3ff2ef41e498_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_dfb3fd73-7a1a-482d-8f72-3c601dde172d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_f7dd5bd9-3fa9-45db-a5f4-122b778b1b0b_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_53d84bcd-c077-4ee9-80a1-b51c4f4dee9b_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased and retired (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebtNoncurrent_45d2a357-7df5-4092-abb6-62a034e40222_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebtNoncurrent" xlink:to="lab_us-gaap_OtherLongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_7bb2db9e-4b7c-41e3-8e41-739635f5b922_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_888ad0b8-aefb-433a-812c-d4634c74d50e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1372328c-7163-46ab-ac91-6f8c0b8cd9ae_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ORGANIZATION AND BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_fb8b737b-02c0-4cbc-8008-a72538c6c3d1_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_d5974284-2209-454d-890d-c6bef057d8bf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_a5de1165-43d9-416d-81f4-a442cd36d8d7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_9287f93c-04a6-49d8-90b4-21f8fde4a738_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_43380673-c231-463a-a080-75334cc8fabf_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_70a23909-458c-4f9e-880e-adaf4b37d765_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT DATA</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_8975990a-55f5-4f5f-bfe8-a7964cdd6732_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_1b03f251-dfba-4e8b-8ff4-d886c5e8ad31_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fe7e9924-a64f-4dd8-9471-117261a885f6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8270e649-e5a7-4c71-975c-049d1257adc9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c5c599f3-a7cf-457a-8b6e-85bfc31f5054_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_PaymentsForRestructuringAndAdjustments_69483da2-fc73-419a-9781-3680a9a2b471_negatedTerseLabel_en-US" xlink:label="lab_ccrn_PaymentsForRestructuringAndAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments and adjustments</link:label>
    <link:label id="lab_ccrn_PaymentsForRestructuringAndAdjustments_label_en-US" xlink:label="lab_ccrn_PaymentsForRestructuringAndAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Restructuring And Adjustments</link:label>
    <link:label id="lab_ccrn_PaymentsForRestructuringAndAdjustments_documentation_en-US" xlink:label="lab_ccrn_PaymentsForRestructuringAndAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Restructuring And Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PaymentsForRestructuringAndAdjustments" xlink:href="ccrn-20220630.xsd#ccrn_PaymentsForRestructuringAndAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_PaymentsForRestructuringAndAdjustments" xlink:to="lab_ccrn_PaymentsForRestructuringAndAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_dd55ef52-50df-4407-b566-e6818b44d220_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_d469ab6f-2c39-40a1-b76f-b7ba2bc6c928_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8d166ae5-cec5-45ab-8151-b2a89d9b49c3_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_659068e4-c765-41cf-af11-41c112300032_terseLabel_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of vesting installments</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_label_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Installments</link:label>
    <link:label id="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_documentation_en-US" xlink:label="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:href="ccrn-20220630.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:to="lab_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_6b7fc839-70bb-42ca-93ad-a10a3ce31526_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring (benefits) costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_7636ed31-177f-429e-8c1b-87d292be3607_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_929696b1-9bdd-4949-8c59-7c3bd2ea8057_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_040f5c74-8dab-4cd4-89bc-7f341fa05910_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_defdca1b-ab46-46c1-a7eb-7b32596c1326_terseLabel_en-US" xlink:label="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:label id="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="ccrn-20220630.xsd#ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_3c290699-705b-4ae6-ac27-0c4f78665488_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_f43bb7c9-11f0-4a26-9ec7-eea44c9f7249_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e1c10f92-3303-43e6-adc1-d8ad4eb1228f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_44dca098-929f-4db3-ab6f-d1a0614c33bd_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares - Basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_a3258ea7-c1a6-4344-ba6d-f4e3ebb74022_verboseLabel_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nurse And Allied Staffing</link:label>
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_2e8f9a73-5a94-4382-88c8-4c3e440a9f22_terseLabel_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nurse And Allied Staffing</link:label>
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_label_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nurse And Allied Staffing [Member]</link:label>
    <link:label id="lab_ccrn_NurseAndAlliedStaffingMember_documentation_en-US" xlink:label="lab_ccrn_NurseAndAlliedStaffingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nurse and allied staffing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember" xlink:href="ccrn-20220630.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_NurseAndAlliedStaffingMember" xlink:to="lab_ccrn_NurseAndAlliedStaffingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_45cedccf-dd31-4579-a5fd-a7eadb15480d_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_91dff9d0-581b-4e93-aa0f-6e2b27c544a6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_4471dfb0-e301-45b4-af1a-b27249427aef_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_5fb5ab42-cf7f-4089-af59-39a5f2cec3af_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets not subject to amortization:</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_81835b58-ba29-490f-92db-872762152d05_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_4ef128b9-b782-4be9-9b13-ed80e742ae0c_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_009da77b-91af-4cfb-b766-28951467424c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ec2c8fb7-aaee-4f82-bd38-90cf4e6b5f3b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from services</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_7a407042-c8d5-42fc-9bd8-48f0f3a987a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_2510f178-4c27-446f-8a09-893decdc11cb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity consideration for acquisition, value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_3da9c2dd-4e6f-4a5b-9f4a-97e701780c02_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares reserved for share-based payments (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_dc9fe690-0a65-4566-b051-2bbda6ab18d5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_dacd43e5-ba45-4a1a-ad8b-b488b35ff670_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_00fd5dbd-5486-4dc3-b48a-9cd329373008_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_af473c37-f2d1-41ba-a1fe-15c306ec1498_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE RECOGNITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_c62a6d29-e7b2-497b-8b31-f0d128471927_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_StandbyLettersOfCreditSublimitMember_2973b632-38cf-4e19-ba81-2d8c1b5cf0d2_terseLabel_en-US" xlink:label="lab_ccrn_StandbyLettersOfCreditSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters Of Credit Sublimit</link:label>
    <link:label id="lab_ccrn_StandbyLettersOfCreditSublimitMember_label_en-US" xlink:label="lab_ccrn_StandbyLettersOfCreditSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters Of Credit Sublimit [Member]</link:label>
    <link:label id="lab_ccrn_StandbyLettersOfCreditSublimitMember_documentation_en-US" xlink:label="lab_ccrn_StandbyLettersOfCreditSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters Of Credit Sublimit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_StandbyLettersOfCreditSublimitMember" xlink:href="ccrn-20220630.xsd#ccrn_StandbyLettersOfCreditSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_StandbyLettersOfCreditSublimitMember" xlink:to="lab_ccrn_StandbyLettersOfCreditSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_de1b6f7b-9568-409e-890a-ed607e8688a5_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Subsidiary</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b1d0107b-171d-48d0-afa5-b1f89b6e4fcf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for shares withheld for taxes</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_add14051-1488-4168-aaf4-ed2da8be2807_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_94ea41c6-14ed-446d-899d-fccde1ad4bec_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_57d99772-808b-4565-989e-81d805302013_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_c6f91ce2-c0f9-4238-bfdf-1e588bf2530b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_0abb3136-f021-42e6-9d65-09c5894be66a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_74000993-7ef8-4c1b-9b15-c4e0672886a0_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments on Senior Secured Asset-Based revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_e68b6462-6acb-4f80-98b8-a777faafbe14_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of indebtedness permitted from other sources</link:label>
    <link:label id="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_label_en-US" xlink:label="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit, Amount Of Indebtedness Permitted By Senior Secured Asset Based Loan To Be Borrowed From Other Sources</link:label>
    <link:label id="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit, Amount Of Indebtedness Permitted By Senior Secured Asset Based Loan To Be Borrowed From Other Sources</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" xlink:to="lab_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e1feea46-ceff-4983-a83b-ba4bc7e00de5_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards (shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_04b564ff-dd4f-4ac2-b500-7ad152cb1ca2_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_ExitCostsMember_c8fb7903-e2bd-4558-99e1-293cc47e63eb_terseLabel_en-US" xlink:label="lab_ccrn_ExitCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease-Related</link:label>
    <link:label id="lab_ccrn_ExitCostsMember_label_en-US" xlink:label="lab_ccrn_ExitCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit Costs [Member]</link:label>
    <link:label id="lab_ccrn_ExitCostsMember_documentation_en-US" xlink:label="lab_ccrn_ExitCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ExitCostsMember" xlink:href="ccrn-20220630.xsd#ccrn_ExitCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_ExitCostsMember" xlink:to="lab_ccrn_ExitCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_36e62422-9475-49cc-b66e-9415d9a17fdd_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_f647d864-4ee7-431b-a8b5-94faafeef70e_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Information on Operating Segments and Reconciliation to Income from Operations</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_71cf6cfd-f79a-4a4f-a81d-e1330cfc02c7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_89008ba7-308d-4d2d-af08-552653331656_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_7bf53e43-4bae-42f9-b922-edc174d454fe_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability - current</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_label_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Current</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" xlink:to="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e003fc9d-9acf-479f-8f94-b1da1cabc8bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amount of lease payments representing interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_1bd97784-5375-4375-83c7-18adc5751586_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to common stockholders - Basic and Diluted - Diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_07ee5d35-6980-418e-b7b8-76acc3e09be6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_OtherServicesMember_0e841c61-a510-40c8-b157-76b205a55187_terseLabel_en-US" xlink:label="lab_ccrn_OtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Services</link:label>
    <link:label id="lab_ccrn_OtherServicesMember_label_en-US" xlink:label="lab_ccrn_OtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Services [Member]</link:label>
    <link:label id="lab_ccrn_OtherServicesMember_documentation_en-US" xlink:label="lab_ccrn_OtherServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OtherServicesMember" xlink:href="ccrn-20220630.xsd#ccrn_OtherServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OtherServicesMember" xlink:to="lab_ccrn_OtherServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_2bddf56a-081d-4489-a8c8-ac6af5f8512a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to common stockholders - Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_8fc68a94-c640-47a2-a3b1-2eef8b02c7bc_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_label_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Compensation And Benefits</link:label>
    <link:label id="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Compensation And Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" xlink:to="lab_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_995a3638-7bb5-472e-829d-188bed2aa206_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d29e8af-3a37-4c95-beb4-f5c27837cf5f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ab057df2-5263-4eb8-82e4-69eb7badbc5c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c07fd6fc-1929-4367-9655-a1bf3aecab21_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_aadd1d06-43b6-485c-a6f6-abf697c7e2a9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_50fe2d3f-58b0-4fce-a7f5-31690aeba3bd_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_e94e2b9d-5d8c-4fa1-984b-9e525c185094_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_5d405147-7d28-4fc5-b121-b619d2f4e729_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses (income):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_OmnibusPlanMember_029e603d-571b-4e95-89a0-ff539d2777c8_terseLabel_en-US" xlink:label="lab_ccrn_OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omnibus Plan</link:label>
    <link:label id="lab_ccrn_OmnibusPlanMember_label_en-US" xlink:label="lab_ccrn_OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omnibus Plan [Member]</link:label>
    <link:label id="lab_ccrn_OmnibusPlanMember_documentation_en-US" xlink:label="lab_ccrn_OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Omnibus Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OmnibusPlanMember" xlink:href="ccrn-20220630.xsd#ccrn_OmnibusPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_OmnibusPlanMember" xlink:to="lab_ccrn_OmnibusPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_605b7941-1462-4ba5-a06c-bbf7c596c128_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a98b9b1a-9eb9-4ba1-a7c0-7ad25e28d5f7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c2e96cb2-4aa8-49dc-8c99-002e859a217f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_07914b22-cde4-4036-87b4-6c5abb19d075_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_e47b577c-d35b-4c95-b268-e7bbfcd9eefc_terseLabel_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net working capital adjustment</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_label_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Net Working Capital Adjustment</link:label>
    <link:label id="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_documentation_en-US" xlink:label="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Net Working Capital Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:to="lab_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_8c620118-4f29-4442-ba7f-455178a14790_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled contracts receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_369de174-5b65-47d5-bca8-671f9be3925f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_6c325ee6-2288-4171-9f9f-11eb899a25fc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing availability</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_01d56e14-a920-41c5-bad7-24e7eb0be28c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_a5695e5f-57fc-48cd-88d3-d796c845fff9_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_a204a6ef-bd30-4739-9d09-9a8ed313c1a0_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_AcquisitionAndIntegrationRelatedCosts_8309c191-12c9-46fe-943f-3e023e3f2119_terseLabel_en-US" xlink:label="lab_ccrn_AcquisitionAndIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and integration-related costs</link:label>
    <link:label id="lab_ccrn_AcquisitionAndIntegrationRelatedCosts_label_en-US" xlink:label="lab_ccrn_AcquisitionAndIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition And Integration-Related Costs</link:label>
    <link:label id="lab_ccrn_AcquisitionAndIntegrationRelatedCosts_documentation_en-US" xlink:label="lab_ccrn_AcquisitionAndIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and integration-related costs include costs for prior acquisitions, costs incurred for potential transactions, and accretion and valuation adjustments on contingent consideration liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AcquisitionAndIntegrationRelatedCosts" xlink:href="ccrn-20220630.xsd#ccrn_AcquisitionAndIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_AcquisitionAndIntegrationRelatedCosts" xlink:to="lab_ccrn_AcquisitionAndIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_c6bd4868-cf75-4f36-9bcf-f050802a9f8b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_ea7a593d-6a67-43e6-8437-48c9f915cc89_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_21e06456-3c2e-47cb-aa14-7864d30c3742_terseLabel_en-US" xlink:label="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing base, percentage of assets</link:label>
    <link:label id="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_label_en-US" xlink:label="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit, Borrowing Base, Percentage Of Assets</link:label>
    <link:label id="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_documentation_en-US" xlink:label="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit, Borrowing Base, Percentage Of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditBorrowingBasePercentageOfAssets" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditBorrowingBasePercentageOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_LineOfCreditBorrowingBasePercentageOfAssets" xlink:to="lab_ccrn_LineOfCreditBorrowingBasePercentageOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5837b7d6-5e47-4dae-9629-e6b0734f043f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_90bede8a-a03b-4445-8fdc-770bea75f4ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b076e078-9f76-4e40-a87c-153306f48bfe_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_1e9f5c9f-1f54-42f2-a673-30f8a6eeddb2_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring (Benefits) Costs</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_0c94e07f-e245-4a6d-8d52-4d024de220db_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_e44e730c-7a8d-4e22-95f2-9fe05ea3719b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_4f813bde-8aa2-43cb-8ddd-b37a8413288a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_b2b6b904-dd00-47ff-8f57-8e9cafad0e7a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_9c5a0033-1841-44d3-9bba-eb15fca4309f_terseLabel_en-US" xlink:label="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care System Affiliated with a Board Member</link:label>
    <link:label id="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_label_en-US" xlink:label="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care System Affiliated With A Board Member [Member]</link:label>
    <link:label id="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_documentation_en-US" xlink:label="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care System Affiliated With A Board Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" xlink:href="ccrn-20220630.xsd#ccrn_HealthCareSystemAffiliatedWithABoardMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" xlink:to="lab_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0ef966de-0259-429f-b378-aa7601c4504a_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_e3d2f281-47c7-4079-b40a-dc9bb04640f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c267d5fa-0463-4043-93a0-5276065a5a1a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_22e12f7d-3437-428a-9f82-53a894829c64_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_f1231d69-9fef-4a20-a3eb-76dc06950213_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_75bed255-644e-46b5-b1aa-6612d26a2d9c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6704ec99-5394-4edb-93ad-cf4f0c648f07_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_d9642067-eecb-45cb-b6c0-efa485eb22b8_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program common stock authorized to be purchased (up to)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ed912cac-6afb-4ba5-b371-a4e9a472f852_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_4246f46e-fa70-42ab-9d9d-93a69a0b230b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_49e0f7e1-deec-44f5-b664-2078789cb976_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_bf130cd1-de4f-4ccf-babc-91c9a564eeff_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d12e72c8-2936-400b-af2e-f9812dbbf9e5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_2c0a102c-364f-41cd-a411-6cae25585102_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares left remaining to repurchase under the plan (up to) (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_6c558239-70b0-47bc-8056-3ad742701340_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a8a0074c-815d-45b8-8c23-dd19da07d69d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_f62abd16-a7ac-456b-8dca-0219e305b29f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_044341d2-52ec-40dc-a8e7-119b50557deb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_41feadd4-f77e-4d95-ac2c-7128cd9875fa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_f8101e2c-b119-462a-8dc6-e75ed1612ca8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_5c73f38d-195d-4e7b-a4d9-1b76e38ffe81_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0624b3d5-cb02-4a00-bbe2-d61832f7a59f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_a7d9767b-c04b-4bed-ae96-b9445a1b1e2a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_7f7630b7-1e2e-445a-a7a1-7470cd90b21c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementMember_f5313266-69f0-43f8-816d-29905266b355_terseLabel_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement</link:label>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementMember_label_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement [Member]</link:label>
    <link:label id="lab_ccrn_A2021TermLoanCreditAgreementMember_documentation_en-US" xlink:label="lab_ccrn_A2021TermLoanCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember" xlink:href="ccrn-20220630.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementMember" xlink:to="lab_ccrn_A2021TermLoanCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d57c67eb-474b-49f4-916d-87bd4e270953_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5dbed4bd-eb87-41fb-ad6b-7827f1e2acd8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2618a267-9b00-44a5-ae14-d63b105b91e6_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets acquired under operating lease</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_35b8e5ea-4bab-4244-8a7c-31ae1c824c1d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Option, Quantitative Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Option, Quantitative Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:to="lab_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>ccrn-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:5ab65a54-411a-4f77-8134-d4db92a3ff6c,g:6015d444-ff7a-4976-923c-b8be5a21a758-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/Cover" xlink:type="simple" xlink:href="ccrn-20220630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5d44f97d-79bb-4719-bd8f-cf9260c19e96" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_DocumentType_5d44f97d-79bb-4719-bd8f-cf9260c19e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_a0c9f677-3cde-4911-a5e7-a0522356edd9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_DocumentQuarterlyReport_a0c9f677-3cde-4911-a5e7-a0522356edd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_cadfe532-ddfa-433a-8e71-bc1c73655a74" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_DocumentPeriodEndDate_cadfe532-ddfa-433a-8e71-bc1c73655a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_1f99026c-cd2c-4b3b-979d-13c398a9af1a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_DocumentTransitionReport_1f99026c-cd2c-4b3b-979d-13c398a9af1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c0fcdcb9-22b3-4be2-a089-52f2f37550ed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityRegistrantName_c0fcdcb9-22b3-4be2-a089-52f2f37550ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_fd444a49-b9c7-43a0-a90c-8c4487e1dcac" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityIncorporationStateCountryCode_fd444a49-b9c7-43a0-a90c-8c4487e1dcac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_91a9e56e-a452-4ceb-87e3-454a308858a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityFileNumber_91a9e56e-a452-4ceb-87e3-454a308858a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ef22ea36-2bc5-48ee-9dd3-b7aba8506c34" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityTaxIdentificationNumber_ef22ea36-2bc5-48ee-9dd3-b7aba8506c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_278f2921-0910-4a65-81b8-c48c868abaea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityAddressAddressLine1_278f2921-0910-4a65-81b8-c48c868abaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_346414ee-8c21-4aff-8f06-5c384fc8cc1f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityAddressCityOrTown_346414ee-8c21-4aff-8f06-5c384fc8cc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_1097ee4b-6ca0-45e3-9e8f-7fd824545189" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityAddressStateOrProvince_1097ee4b-6ca0-45e3-9e8f-7fd824545189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_57c55682-aaa4-4b5c-820e-400a2550455f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityAddressPostalZipCode_57c55682-aaa4-4b5c-820e-400a2550455f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_41d81add-8d9c-4c6c-a97d-36b0911984c8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_CityAreaCode_41d81add-8d9c-4c6c-a97d-36b0911984c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f498f0d3-d639-4b5d-92c3-891a22f2a3d3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_LocalPhoneNumber_f498f0d3-d639-4b5d-92c3-891a22f2a3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a4d98c0f-5377-496e-ba22-2ba16675d303" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_Security12bTitle_a4d98c0f-5377-496e-ba22-2ba16675d303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_174b5231-055c-45c4-8dd7-d3fcd17a93e7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_TradingSymbol_174b5231-055c-45c4-8dd7-d3fcd17a93e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_27ef2e48-55b0-4134-8aae-298906b66d24" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_SecurityExchangeName_27ef2e48-55b0-4134-8aae-298906b66d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_35274f5e-f1c8-43b5-968d-f9ee8abec750" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityCurrentReportingStatus_35274f5e-f1c8-43b5-968d-f9ee8abec750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f0cc2722-ec7b-4b7d-ae2f-479f8a87317b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityInteractiveDataCurrent_f0cc2722-ec7b-4b7d-ae2f-479f8a87317b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_f089bbe8-c064-41bf-83cd-773e979d0c91" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityFilerCategory_f089bbe8-c064-41bf-83cd-773e979d0c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_cec61280-cd9c-43a2-bb80-0ad70bcf74e0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntitySmallBusiness_cec61280-cd9c-43a2-bb80-0ad70bcf74e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4b8ce483-b11a-4146-bb75-8492dc2b7a18" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityEmergingGrowthCompany_4b8ce483-b11a-4146-bb75-8492dc2b7a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_5a57ec5f-1707-4464-95db-66d22846b99b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityShellCompany_5a57ec5f-1707-4464-95db-66d22846b99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_1bcc9c11-e549-4518-8038-31b84b823779" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_1bcc9c11-e549-4518-8038-31b84b823779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_25143b61-6c10-4f68-840f-ce57758e54f6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_EntityCentralIndexKey_25143b61-6c10-4f68-840f-ce57758e54f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_d578f107-a5ca-4d60-9578-196201ad1854" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_CurrentFiscalYearEndDate_d578f107-a5ca-4d60-9578-196201ad1854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_3ba5b179-f543-45a8-866c-0b9e7803132c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_DocumentFiscalYearFocus_3ba5b179-f543-45a8-866c-0b9e7803132c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_61ce2663-de6f-4b3a-b301-6f35fd9ac564" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_DocumentFiscalPeriodFocus_61ce2663-de6f-4b3a-b301-6f35fd9ac564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6ac389d3-dcb9-45ca-9617-e3e04e1e11a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da67de7e-9e41-4341-aa65-accb5e8e5121" xlink:to="loc_dei_AmendmentFlag_6ac389d3-dcb9-45ca-9617-e3e04e1e11a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ccrn-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_390ba9f2-ae34-4cd9-9051-5b737702930f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_99a0f3da-afca-4690-8679-6348384b312c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_390ba9f2-ae34-4cd9-9051-5b737702930f" xlink:to="loc_us-gaap_AssetsAbstract_99a0f3da-afca-4690-8679-6348384b312c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_a99197c2-87b5-4464-9add-d5307c65c316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99a0f3da-afca-4690-8679-6348384b312c" xlink:to="loc_us-gaap_AssetsCurrentAbstract_a99197c2-87b5-4464-9add-d5307c65c316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e99f03fb-bafd-418b-9293-fe813b2903d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a99197c2-87b5-4464-9add-d5307c65c316" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e99f03fb-bafd-418b-9293-fe813b2903d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cb9be9f5-9118-464e-9c64-18e79d3c8394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a99197c2-87b5-4464-9add-d5307c65c316" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_cb9be9f5-9118-464e-9c64-18e79d3c8394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_e6a24528-34f8-43ac-bd66-82ed278f1c79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a99197c2-87b5-4464-9add-d5307c65c316" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_e6a24528-34f8-43ac-bd66-82ed278f1c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_8ba37776-c672-4e08-a448-5636e15c8bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceSettlementsReceivableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a99197c2-87b5-4464-9add-d5307c65c316" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableCurrent_8ba37776-c672-4e08-a448-5636e15c8bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_5c2d5b3d-10d9-40f6-b9e1-7785992d4798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a99197c2-87b5-4464-9add-d5307c65c316" xlink:to="loc_us-gaap_OtherAssetsCurrent_5c2d5b3d-10d9-40f6-b9e1-7785992d4798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ca584c0e-43e3-4fe2-8c07-764004943e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a99197c2-87b5-4464-9add-d5307c65c316" xlink:to="loc_us-gaap_AssetsCurrent_ca584c0e-43e3-4fe2-8c07-764004943e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b3e8b7a1-7b94-49fd-a7bd-be5d08941dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99a0f3da-afca-4690-8679-6348384b312c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b3e8b7a1-7b94-49fd-a7bd-be5d08941dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7be8ea60-4475-44b8-a721-ce4e339f71fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99a0f3da-afca-4690-8679-6348384b312c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7be8ea60-4475-44b8-a721-ce4e339f71fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_abe65be3-fcdc-48af-b48f-261f947e4415" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99a0f3da-afca-4690-8679-6348384b312c" xlink:to="loc_us-gaap_Goodwill_abe65be3-fcdc-48af-b48f-261f947e4415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_a6eef489-a4d5-46d0-b4fb-11996ebd59ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedTradeNames"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99a0f3da-afca-4690-8679-6348384b312c" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_a6eef489-a4d5-46d0-b4fb-11996ebd59ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b8eb3c2e-cff1-4945-82d8-f4d108b01a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99a0f3da-afca-4690-8679-6348384b312c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b8eb3c2e-cff1-4945-82d8-f4d108b01a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_00f84afa-108b-4d41-8d9c-ce2c746b3667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99a0f3da-afca-4690-8679-6348384b312c" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_00f84afa-108b-4d41-8d9c-ce2c746b3667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e2f26c9c-27f4-486b-ae21-0392f2dbd7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99a0f3da-afca-4690-8679-6348384b312c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e2f26c9c-27f4-486b-ae21-0392f2dbd7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f5bc78ff-60dd-42ad-8c1c-2dba25a27ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_99a0f3da-afca-4690-8679-6348384b312c" xlink:to="loc_us-gaap_Assets_f5bc78ff-60dd-42ad-8c1c-2dba25a27ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aed23f53-3bba-432c-8467-7994138d04d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_390ba9f2-ae34-4cd9-9051-5b737702930f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aed23f53-3bba-432c-8467-7994138d04d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_24e0171e-6b5b-4e01-a128-d6303621ab5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aed23f53-3bba-432c-8467-7994138d04d7" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_24e0171e-6b5b-4e01-a128-d6303621ab5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_2d15d0cd-7913-4b3f-958e-18528afcba99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_24e0171e-6b5b-4e01-a128-d6303621ab5b" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_2d15d0cd-7913-4b3f-958e-18528afcba99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_dd1547ec-29a5-4762-b706-454d3cbc53d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_24e0171e-6b5b-4e01-a128-d6303621ab5b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_dd1547ec-29a5-4762-b706-454d3cbc53d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_9fc71ad8-182d-4242-a7a9-196ebf46b7be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_24e0171e-6b5b-4e01-a128-d6303621ab5b" xlink:to="loc_us-gaap_LongTermDebtCurrent_9fc71ad8-182d-4242-a7a9-196ebf46b7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2d3042f6-e7fc-413e-924d-48283046050d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_24e0171e-6b5b-4e01-a128-d6303621ab5b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2d3042f6-e7fc-413e-924d-48283046050d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_c848157d-d98b-4d9e-a400-4f88a6658b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_24e0171e-6b5b-4e01-a128-d6303621ab5b" xlink:to="loc_us-gaap_TaxesPayableCurrent_c848157d-d98b-4d9e-a400-4f88a6658b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_2d65a824-1c12-4590-bacc-1a9a6b2b8002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_24e0171e-6b5b-4e01-a128-d6303621ab5b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_2d65a824-1c12-4590-bacc-1a9a6b2b8002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_a44fc9c5-b91e-4341-be3f-185178c77c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_24e0171e-6b5b-4e01-a128-d6303621ab5b" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_a44fc9c5-b91e-4341-be3f-185178c77c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d0028e68-1c1e-4513-8d94-1c2d21253c71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_24e0171e-6b5b-4e01-a128-d6303621ab5b" xlink:to="loc_us-gaap_LiabilitiesCurrent_d0028e68-1c1e-4513-8d94-1c2d21253c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent_98d05d63-e3a8-4946-88cb-e5848182bcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aed23f53-3bba-432c-8467-7994138d04d7" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent_98d05d63-e3a8-4946-88cb-e5848182bcfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4ec70a83-3815-4a2f-a0e4-2820da6f1b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aed23f53-3bba-432c-8467-7994138d04d7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4ec70a83-3815-4a2f-a0e4-2820da6f1b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ebf24424-519b-48bd-a5c2-45a2780c7b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aed23f53-3bba-432c-8467-7994138d04d7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ebf24424-519b-48bd-a5c2-45a2780c7b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_997c22a3-010f-4055-9d17-7f46d01b8103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aed23f53-3bba-432c-8467-7994138d04d7" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_997c22a3-010f-4055-9d17-7f46d01b8103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0123f0df-6e6b-4dc9-899a-8506c0e96b70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aed23f53-3bba-432c-8467-7994138d04d7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_0123f0df-6e6b-4dc9-899a-8506c0e96b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_fc82b081-c3ad-456d-b932-504ad6bbceeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aed23f53-3bba-432c-8467-7994138d04d7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_fc82b081-c3ad-456d-b932-504ad6bbceeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_14d12417-cfa4-42bc-ba43-024c997d5a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aed23f53-3bba-432c-8467-7994138d04d7" xlink:to="loc_us-gaap_Liabilities_14d12417-cfa4-42bc-ba43-024c997d5a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c0b28641-4d32-447f-9ca6-f322ffbfb391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aed23f53-3bba-432c-8467-7994138d04d7" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c0b28641-4d32-447f-9ca6-f322ffbfb391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_86b5eb20-9a55-4bd6-9213-a1e776e7d8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aed23f53-3bba-432c-8467-7994138d04d7" xlink:to="loc_us-gaap_StockholdersEquityAbstract_86b5eb20-9a55-4bd6-9213-a1e776e7d8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_37ab3434-c589-4fc9-bea3-61d058ed8aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_86b5eb20-9a55-4bd6-9213-a1e776e7d8e9" xlink:to="loc_us-gaap_CommonStockValue_37ab3434-c589-4fc9-bea3-61d058ed8aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9e5dc58e-0b5a-4a8a-8cd9-39d8384eba03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_86b5eb20-9a55-4bd6-9213-a1e776e7d8e9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9e5dc58e-0b5a-4a8a-8cd9-39d8384eba03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5c044ea3-b178-4e28-bf97-cf99c1ca1640" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_86b5eb20-9a55-4bd6-9213-a1e776e7d8e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5c044ea3-b178-4e28-bf97-cf99c1ca1640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1ecd842c-6e2b-423c-80a4-38bd7f65123d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_86b5eb20-9a55-4bd6-9213-a1e776e7d8e9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1ecd842c-6e2b-423c-80a4-38bd7f65123d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4150d485-6e6c-4dfd-9514-9c82d80e1479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_86b5eb20-9a55-4bd6-9213-a1e776e7d8e9" xlink:to="loc_us-gaap_StockholdersEquity_4150d485-6e6c-4dfd-9514-9c82d80e1479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_62ef5268-ae99-420f-8c27-a2fdcae3a53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_aed23f53-3bba-432c-8467-7994138d04d7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_62ef5268-ae99-420f-8c27-a2fdcae3a53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ccrn-20220630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a722cfeb-680e-490b-ba70-4429703dc3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b8b6061d-89df-4faa-83db-9ba892242c14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a722cfeb-680e-490b-ba70-4429703dc3a5" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b8b6061d-89df-4faa-83db-9ba892242c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_223d0183-0a3f-4d3a-a8d6-1784357e7c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a722cfeb-680e-490b-ba70-4429703dc3a5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_223d0183-0a3f-4d3a-a8d6-1784357e7c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ccrn-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_06719d5a-1940-493c-87e6-7e1da8ac9169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_204fe620-d173-4345-8795-2c0409ecfc42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06719d5a-1940-493c-87e6-7e1da8ac9169" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_204fe620-d173-4345-8795-2c0409ecfc42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8fff8e5e-944c-40d8-9e94-fffc5c5f7a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06719d5a-1940-493c-87e6-7e1da8ac9169" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8fff8e5e-944c-40d8-9e94-fffc5c5f7a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_87b21e16-8671-4dc6-a2da-5c5d02f49525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06719d5a-1940-493c-87e6-7e1da8ac9169" xlink:to="loc_us-gaap_OperatingExpensesAbstract_87b21e16-8671-4dc6-a2da-5c5d02f49525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectOperatingCosts_86d07147-a02f-439c-a96f-8e2d871bce13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DirectOperatingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87b21e16-8671-4dc6-a2da-5c5d02f49525" xlink:to="loc_us-gaap_DirectOperatingCosts_86d07147-a02f-439c-a96f-8e2d871bce13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4d9ba356-d9e7-44cb-8538-ef4c4a16d850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87b21e16-8671-4dc6-a2da-5c5d02f49525" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4d9ba356-d9e7-44cb-8538-ef4c4a16d850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_67b1e900-1a7d-4a43-8e15-46b51650538c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87b21e16-8671-4dc6-a2da-5c5d02f49525" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_67b1e900-1a7d-4a43-8e15-46b51650538c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_123d9dc9-19d0-409e-b98e-8c36310fde80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87b21e16-8671-4dc6-a2da-5c5d02f49525" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_123d9dc9-19d0-409e-b98e-8c36310fde80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_98a56f50-f35b-41e2-bbd9-dfd37b07318d" xlink:href="ccrn-20220630.xsd#ccrn_AcquisitionAndIntegrationRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87b21e16-8671-4dc6-a2da-5c5d02f49525" xlink:to="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_98a56f50-f35b-41e2-bbd9-dfd37b07318d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_624b0653-3434-4e78-b71a-b4dd5af69def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87b21e16-8671-4dc6-a2da-5c5d02f49525" xlink:to="loc_us-gaap_RestructuringCharges_624b0653-3434-4e78-b71a-b4dd5af69def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_3c9c3558-08eb-41e9-a4a3-e0cc05539ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87b21e16-8671-4dc6-a2da-5c5d02f49525" xlink:to="loc_us-gaap_AssetImpairmentCharges_3c9c3558-08eb-41e9-a4a3-e0cc05539ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_8ec44010-e799-4022-a9f5-6fe8eb5821cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_87b21e16-8671-4dc6-a2da-5c5d02f49525" xlink:to="loc_us-gaap_CostsAndExpenses_8ec44010-e799-4022-a9f5-6fe8eb5821cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c5f29573-bb74-4f86-9223-94de4b5b8e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06719d5a-1940-493c-87e6-7e1da8ac9169" xlink:to="loc_us-gaap_OperatingIncomeLoss_c5f29573-bb74-4f86-9223-94de4b5b8e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d67b7b98-83da-45ea-a7e6-02f169df2f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06719d5a-1940-493c-87e6-7e1da8ac9169" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d67b7b98-83da-45ea-a7e6-02f169df2f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8b9e2121-b0ff-4fdd-a825-687d49738088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d67b7b98-83da-45ea-a7e6-02f169df2f02" xlink:to="loc_us-gaap_InterestExpense_8b9e2121-b0ff-4fdd-a825-687d49738088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0f64784d-2a7b-44a3-bb6f-0fae0b614d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d67b7b98-83da-45ea-a7e6-02f169df2f02" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0f64784d-2a7b-44a3-bb6f-0fae0b614d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_67789ad3-fac0-45a9-9e1f-da20022de2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d67b7b98-83da-45ea-a7e6-02f169df2f02" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_67789ad3-fac0-45a9-9e1f-da20022de2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_daf178fc-1667-49ec-aa4e-e07769c9255a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06719d5a-1940-493c-87e6-7e1da8ac9169" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_daf178fc-1667-49ec-aa4e-e07769c9255a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f5089d0f-a0c4-46f1-9cc0-aae044baa0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06719d5a-1940-493c-87e6-7e1da8ac9169" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f5089d0f-a0c4-46f1-9cc0-aae044baa0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2c12a41d-047a-4a2b-9ad8-ffb2e2b1e525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06719d5a-1940-493c-87e6-7e1da8ac9169" xlink:to="loc_us-gaap_NetIncomeLoss_2c12a41d-047a-4a2b-9ad8-ffb2e2b1e525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7dc834da-c5f8-43c1-9661-f3ff54acef12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06719d5a-1940-493c-87e6-7e1da8ac9169" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7dc834da-c5f8-43c1-9661-f3ff54acef12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_7b12dc7c-bed6-4b52-bba5-567940af5615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7dc834da-c5f8-43c1-9661-f3ff54acef12" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_7b12dc7c-bed6-4b52-bba5-567940af5615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5eb658ac-823b-4172-a50b-ce89ccd0ba8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7dc834da-c5f8-43c1-9661-f3ff54acef12" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_5eb658ac-823b-4172-a50b-ce89ccd0ba8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_46f31957-c600-4143-aae6-8dfea3e7fd82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06719d5a-1940-493c-87e6-7e1da8ac9169" xlink:to="loc_us-gaap_EarningsPerShareBasic_46f31957-c600-4143-aae6-8dfea3e7fd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_50fc0528-6a52-46ed-a89f-13b036754f70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06719d5a-1940-493c-87e6-7e1da8ac9169" xlink:to="loc_us-gaap_EarningsPerShareDiluted_50fc0528-6a52-46ed-a89f-13b036754f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ca33ece4-cc78-4d7f-999a-b45becc9b868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_06719d5a-1940-493c-87e6-7e1da8ac9169" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ca33ece4-cc78-4d7f-999a-b45becc9b868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_752dc840-b59c-4b06-8cbf-642b00a1ed77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ca33ece4-cc78-4d7f-999a-b45becc9b868" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_752dc840-b59c-4b06-8cbf-642b00a1ed77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_18e34d79-c29f-4381-9475-67391146a3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ca33ece4-cc78-4d7f-999a-b45becc9b868" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_18e34d79-c29f-4381-9475-67391146a3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ccrn-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a8fb9f19-860f-49cd-b0e1-b4cc5d274152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b684d1bf-6670-4f5b-a581-07b7a8e7c431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a8fb9f19-860f-49cd-b0e1-b4cc5d274152" xlink:to="loc_us-gaap_StatementTable_b684d1bf-6670-4f5b-a581-07b7a8e7c431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a17fba4f-00d2-464e-8e11-f902fc67ce9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b684d1bf-6670-4f5b-a581-07b7a8e7c431" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a17fba4f-00d2-464e-8e11-f902fc67ce9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a17fba4f-00d2-464e-8e11-f902fc67ce9d" xlink:to="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ab958f42-8766-429a-b5d4-0b19fcc931ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:to="loc_us-gaap_CommonStockMember_ab958f42-8766-429a-b5d4-0b19fcc931ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_df0c6c38-045c-45bd-8b4f-65e6205bcffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_df0c6c38-045c-45bd-8b4f-65e6205bcffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_05ee259f-acb0-4184-8560-f1e0a1f6dd55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_05ee259f-acb0-4184-8560-f1e0a1f6dd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f68adacc-9f1f-4831-b5f3-c542b5f29224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:to="loc_us-gaap_RetainedEarningsMember_f68adacc-9f1f-4831-b5f3-c542b5f29224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_6b07e9b2-dff2-4948-a8d6-cfd2ab868668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dbe8d94a-38e1-4cfe-a716-1a1d5a22a6a7" xlink:to="loc_us-gaap_NoncontrollingInterestMember_6b07e9b2-dff2-4948-a8d6-cfd2ab868668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4a4b10d5-d1d1-4a87-a6f8-7a580cf5cb00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b684d1bf-6670-4f5b-a581-07b7a8e7c431" xlink:to="loc_us-gaap_StatementLineItems_4a4b10d5-d1d1-4a87-a6f8-7a580cf5cb00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4a4b10d5-d1d1-4a87-a6f8-7a580cf5cb00" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_037b1ae2-9d24-40be-bb37-df4c0ccac455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_SharesOutstanding_037b1ae2-9d24-40be-bb37-df4c0ccac455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_49b59d5a-da9e-404f-922c-0578cebae84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_49b59d5a-da9e-404f-922c-0578cebae84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_23c263cf-decb-4d91-9a5f-bc93abef4656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_23c263cf-decb-4d91-9a5f-bc93abef4656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c9d8f597-6a72-489a-99f2-83e7e4d875e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_c9d8f597-6a72-489a-99f2-83e7e4d875e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_655f25e8-660a-4ee3-9269-ed732d3f6a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_655f25e8-660a-4ee3-9269-ed732d3f6a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3a391f24-7900-4b66-b01c-aabe52c85abc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3a391f24-7900-4b66-b01c-aabe52c85abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f9d54f65-c2c1-4ca5-a900-695d1f56d726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f9d54f65-c2c1-4ca5-a900-695d1f56d726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0a1d3972-e82d-47e7-a522-c92a8784b66f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0a1d3972-e82d-47e7-a522-c92a8784b66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_78fcf649-acbf-490d-8b2b-95a4a700c079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_NetIncomeLoss_78fcf649-acbf-490d-8b2b-95a4a700c079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e04bcf87-2886-4657-a089-bc7089552b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_SharesOutstanding_e04bcf87-2886-4657-a089-bc7089552b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46405df7-f784-4c58-bf69-c9c8ac009a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_82d949d8-a1e3-467d-a6d6-cbd7b3f82897" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_46405df7-f784-4c58-bf69-c9c8ac009a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ccrn-20220630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_15c04857-0ee0-4d0a-9298-634a3ae71419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fbf7ed17-268c-431a-8a4c-550a0bb05299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_15c04857-0ee0-4d0a-9298-634a3ae71419" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fbf7ed17-268c-431a-8a4c-550a0bb05299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c7ce3777-dfab-429d-9b05-0ca7976a3f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fbf7ed17-268c-431a-8a4c-550a0bb05299" xlink:to="loc_us-gaap_NetIncomeLoss_c7ce3777-dfab-429d-9b05-0ca7976a3f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b8840a46-5272-46dd-a4f3-b4010ea3a33e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fbf7ed17-268c-431a-8a4c-550a0bb05299" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b8840a46-5272-46dd-a4f3-b4010ea3a33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6efaf4df-3679-4d0b-ac8e-ccc1e1df081f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b8840a46-5272-46dd-a4f3-b4010ea3a33e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6efaf4df-3679-4d0b-ac8e-ccc1e1df081f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_7e19a410-55c0-4de5-b4f2-fb343243c18e" xlink:href="ccrn-20220630.xsd#ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b8840a46-5272-46dd-a4f3-b4010ea3a33e" xlink:to="loc_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances_7e19a410-55c0-4de5-b4f2-fb343243c18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c63426dd-7a92-4776-a72a-ba168004b52a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b8840a46-5272-46dd-a4f3-b4010ea3a33e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c63426dd-7a92-4776-a72a-ba168004b52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OperatingLeaseExpenseNonCash_ad58b5cc-2ac1-45dc-8569-f202c1070778" xlink:href="ccrn-20220630.xsd#ccrn_OperatingLeaseExpenseNonCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b8840a46-5272-46dd-a4f3-b4010ea3a33e" xlink:to="loc_ccrn_OperatingLeaseExpenseNonCash_ad58b5cc-2ac1-45dc-8569-f202c1070778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_1f295097-7bf9-4c53-b336-895e9533fb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b8840a46-5272-46dd-a4f3-b4010ea3a33e" xlink:to="loc_us-gaap_AssetImpairmentCharges_1f295097-7bf9-4c53-b336-895e9533fb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_475effad-ab3c-4c4e-bf93-ce7358655ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b8840a46-5272-46dd-a4f3-b4010ea3a33e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_475effad-ab3c-4c4e-bf93-ce7358655ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_29b2b989-7b6e-4c74-b772-c27623e2e1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b8840a46-5272-46dd-a4f3-b4010ea3a33e" xlink:to="loc_us-gaap_ShareBasedCompensation_29b2b989-7b6e-4c74-b772-c27623e2e1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_f0e78239-01cc-4a25-b05b-630e87f2fae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b8840a46-5272-46dd-a4f3-b4010ea3a33e" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_f0e78239-01cc-4a25-b05b-630e87f2fae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b20d2124-b4f6-4e0d-836d-685fa8e393b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b8840a46-5272-46dd-a4f3-b4010ea3a33e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b20d2124-b4f6-4e0d-836d-685fa8e393b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a73cd2d8-d9ad-49ae-9176-cb41b2afaa52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b20d2124-b4f6-4e0d-836d-685fa8e393b6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a73cd2d8-d9ad-49ae-9176-cb41b2afaa52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3f0ca463-10c0-4722-ad89-e6346f04dd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b20d2124-b4f6-4e0d-836d-685fa8e393b6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3f0ca463-10c0-4722-ad89-e6346f04dd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_9545824e-a68f-4d46-ac69-7d12d2b7bbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b20d2124-b4f6-4e0d-836d-685fa8e393b6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_9545824e-a68f-4d46-ac69-7d12d2b7bbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_630765d9-9d5a-4b33-a40a-e2b381b6310f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b20d2124-b4f6-4e0d-836d-685fa8e393b6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_630765d9-9d5a-4b33-a40a-e2b381b6310f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_388ec223-32a3-45ff-82e4-f97209557e08" xlink:href="ccrn-20220630.xsd#ccrn_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b20d2124-b4f6-4e0d-836d-685fa8e393b6" xlink:to="loc_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities_388ec223-32a3-45ff-82e4-f97209557e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_5d3be85b-2d44-4fed-8476-e5c0f9e15056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b20d2124-b4f6-4e0d-836d-685fa8e393b6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_5d3be85b-2d44-4fed-8476-e5c0f9e15056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f320ffe0-1cdc-422e-be9f-25e55f74cd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fbf7ed17-268c-431a-8a4c-550a0bb05299" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f320ffe0-1cdc-422e-be9f-25e55f74cd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4f7a782e-c5a1-4408-97eb-583c3ad8d47a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_15c04857-0ee0-4d0a-9298-634a3ae71419" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4f7a782e-c5a1-4408-97eb-583c3ad8d47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_df0e92a1-4194-4101-8a53-280d13dfd126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4f7a782e-c5a1-4408-97eb-583c3ad8d47a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_df0e92a1-4194-4101-8a53-280d13dfd126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_beb5c772-8f77-4e8c-b435-e38a38239e12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4f7a782e-c5a1-4408-97eb-583c3ad8d47a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_beb5c772-8f77-4e8c-b435-e38a38239e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_20d3cc12-207a-4a1d-8f12-044b5b88d07e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4f7a782e-c5a1-4408-97eb-583c3ad8d47a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_20d3cc12-207a-4a1d-8f12-044b5b88d07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_672f025f-cab8-44bd-8501-89286c6c37ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_15c04857-0ee0-4d0a-9298-634a3ae71419" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_672f025f-cab8-44bd-8501-89286c6c37ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_1778ba55-e40f-4a41-89d6-d52c18ff61c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_672f025f-cab8-44bd-8501-89286c6c37ba" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_1778ba55-e40f-4a41-89d6-d52c18ff61c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_c7817f79-8cf2-44b3-b3c9-b32de37aa738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_672f025f-cab8-44bd-8501-89286c6c37ba" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_c7817f79-8cf2-44b3-b3c9-b32de37aa738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f10a8048-eb92-4386-9b3d-dd77758147ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_672f025f-cab8-44bd-8501-89286c6c37ba" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f10a8048-eb92-4386-9b3d-dd77758147ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_6f1c1cd6-958d-4916-a44d-a5dff8012c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_672f025f-cab8-44bd-8501-89286c6c37ba" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_6f1c1cd6-958d-4916-a44d-a5dff8012c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_17e47b28-55bd-42ec-b73b-03138b0e378f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_672f025f-cab8-44bd-8501-89286c6c37ba" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_17e47b28-55bd-42ec-b73b-03138b0e378f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a6c95593-9e45-4609-aeee-0d5224220b54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_672f025f-cab8-44bd-8501-89286c6c37ba" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a6c95593-9e45-4609-aeee-0d5224220b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_014591e0-5b27-43b3-8ca9-47f86cfbf5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_672f025f-cab8-44bd-8501-89286c6c37ba" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_014591e0-5b27-43b3-8ca9-47f86cfbf5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_898be769-a1ca-4b85-92a1-3ebd30577021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_672f025f-cab8-44bd-8501-89286c6c37ba" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_898be769-a1ca-4b85-92a1-3ebd30577021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f58323ae-fd6d-4c0e-8372-f27b86f5bf1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_672f025f-cab8-44bd-8501-89286c6c37ba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f58323ae-fd6d-4c0e-8372-f27b86f5bf1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bbd8b02f-01ee-4e55-bc77-f3859c333fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_15c04857-0ee0-4d0a-9298-634a3ae71419" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bbd8b02f-01ee-4e55-bc77-f3859c333fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_05bb06d8-e330-4ea1-9400-1836940200d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_15c04857-0ee0-4d0a-9298-634a3ae71419" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_05bb06d8-e330-4ea1-9400-1836940200d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_654f5d83-0d02-449d-9441-192b06fee1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_15c04857-0ee0-4d0a-9298-634a3ae71419" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_654f5d83-0d02-449d-9441-192b06fee1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_da286622-f3a0-47ab-be8e-d50ade27e717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_15c04857-0ee0-4d0a-9298-634a3ae71419" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_da286622-f3a0-47ab-be8e-d50ade27e717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION" xlink:type="simple" xlink:href="ccrn-20220630.xsd#ORGANIZATIONANDBASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_91d001e3-2321-4572-ac8d-cbd4cc516031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_d5a6ec9b-e275-4962-8982-5bf805263887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_91d001e3-2321-4572-ac8d-cbd4cc516031" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_d5a6ec9b-e275-4962-8982-5bf805263887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="ccrn-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_65ebc026-f57d-43a8-86df-0c2a38d7fcf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_305e9c4c-5832-445e-9fdc-66d4159ba74d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65ebc026-f57d-43a8-86df-0c2a38d7fcf8" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_305e9c4c-5832-445e-9fdc-66d4159ba74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="ccrn-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2b3b3898-1e23-4985-b8ce-3b0a4668cda9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_782f4aad-e14a-45a6-a6b9-8b883bc2d2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2b3b3898-1e23-4985-b8ce-3b0a4668cda9" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_782f4aad-e14a-45a6-a6b9-8b883bc2d2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_88fd2ebe-c37d-42b2-b765-e901ab357d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2b3b3898-1e23-4985-b8ce-3b0a4668cda9" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_88fd2ebe-c37d-42b2-b765-e901ab357d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_064f00a8-061b-4b21-8ef5-70e9fd546de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2b3b3898-1e23-4985-b8ce-3b0a4668cda9" xlink:to="loc_us-gaap_UseOfEstimates_064f00a8-061b-4b21-8ef5-70e9fd546de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_5ff66679-9899-4d5f-9ee9-90dbb1c2dcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2b3b3898-1e23-4985-b8ce-3b0a4668cda9" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_5ff66679-9899-4d5f-9ee9-90dbb1c2dcfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_5f1134f7-ec84-4ac5-851f-52f51bf5cb32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2b3b3898-1e23-4985-b8ce-3b0a4668cda9" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_5f1134f7-ec84-4ac5-851f-52f51bf5cb32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b72e2960-0da8-43a1-a919-5f729e35ebae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2b3b3898-1e23-4985-b8ce-3b0a4668cda9" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b72e2960-0da8-43a1-a919-5f729e35ebae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="ccrn-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0b1f0b11-be82-4c65-853b-af16586bd1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_302be4ef-18fc-40bc-b2ea-e546c3df28c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b1f0b11-be82-4c65-853b-af16586bd1c0" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_302be4ef-18fc-40bc-b2ea-e546c3df28c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_61b22bee-c7bc-45c8-bd9a-178a54025885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0b1f0b11-be82-4c65-853b-af16586bd1c0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_61b22bee-c7bc-45c8-bd9a-178a54025885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7f936576-5b17-4b30-a9ae-0abb3e194c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_2a4a4871-d6ec-4345-aaa8-b81097b93351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7f936576-5b17-4b30-a9ae-0abb3e194c2f" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_2a4a4871-d6ec-4345-aaa8-b81097b93351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6ce68f0f-8d2a-4730-8a25-50843bb06ef4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_2a4a4871-d6ec-4345-aaa8-b81097b93351" xlink:to="loc_srt_RangeAxis_6ce68f0f-8d2a-4730-8a25-50843bb06ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6371f678-20fa-45db-a922-76e2382e453a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6ce68f0f-8d2a-4730-8a25-50843bb06ef4" xlink:to="loc_srt_RangeMember_6371f678-20fa-45db-a922-76e2382e453a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5feda9b5-5983-4f98-96ea-5dc85e83e711" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6371f678-20fa-45db-a922-76e2382e453a" xlink:to="loc_srt_MinimumMember_5feda9b5-5983-4f98-96ea-5dc85e83e711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8acab170-7f06-44f9-8d56-f35109f95947" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6371f678-20fa-45db-a922-76e2382e453a" xlink:to="loc_srt_MaximumMember_8acab170-7f06-44f9-8d56-f35109f95947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c58943e6-a73a-46b2-81fd-64cc441a4970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_2a4a4871-d6ec-4345-aaa8-b81097b93351" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c58943e6-a73a-46b2-81fd-64cc441a4970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_838f7cff-599e-4018-ac4a-55c57bb02449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c58943e6-a73a-46b2-81fd-64cc441a4970" xlink:to="loc_us-gaap_UnbilledContractsReceivable_838f7cff-599e-4018-ac4a-55c57bb02449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SalesAllowanceBillingRelatedAdjustments_755854b8-c49f-46d6-b0b6-db19627a69c2" xlink:href="ccrn-20220630.xsd#ccrn_SalesAllowanceBillingRelatedAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c58943e6-a73a-46b2-81fd-64cc441a4970" xlink:to="loc_ccrn_SalesAllowanceBillingRelatedAdjustments_755854b8-c49f-46d6-b0b6-db19627a69c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_d208fdc1-0040-44ab-91e9-26aa6f61ef43" xlink:href="ccrn-20220630.xsd#ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c58943e6-a73a-46b2-81fd-64cc441a4970" xlink:to="loc_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided_d208fdc1-0040-44ab-91e9-26aa6f61ef43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c3afa61c-b612-4ff9-871d-57269b4f262e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_85667d6b-0ac4-431d-9e59-8b229a33d09b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c3afa61c-b612-4ff9-871d-57269b4f262e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_85667d6b-0ac4-431d-9e59-8b229a33d09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_67ad826a-4e9c-4672-bdc1-b33380d53cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_85667d6b-0ac4-431d-9e59-8b229a33d09b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_67ad826a-4e9c-4672-bdc1-b33380d53cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_ffd2a160-8703-4b3c-b90c-bfa272530597" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_85667d6b-0ac4-431d-9e59-8b229a33d09b" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_ffd2a160-8703-4b3c-b90c-bfa272530597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_a44b3298-c0e2-445a-83ff-27de2d401348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_85667d6b-0ac4-431d-9e59-8b229a33d09b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_a44b3298-c0e2-445a-83ff-27de2d401348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_d5721579-9e8c-4071-8c35-5bb8da01c26f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_85667d6b-0ac4-431d-9e59-8b229a33d09b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_d5721579-9e8c-4071-8c35-5bb8da01c26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_892f55d8-3fc0-48a7-bcae-6c624982fcdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7092ba41-186b-4cfc-8e90-826f8e18edc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_892f55d8-3fc0-48a7-bcae-6c624982fcdc" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7092ba41-186b-4cfc-8e90-826f8e18edc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_55d1a2f4-43f5-48cc-9725-ad953a676d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7092ba41-186b-4cfc-8e90-826f8e18edc3" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_55d1a2f4-43f5-48cc-9725-ad953a676d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_a4ee555c-13ec-4869-9288-7b19f129276f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_55d1a2f4-43f5-48cc-9725-ad953a676d63" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_a4ee555c-13ec-4869-9288-7b19f129276f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_4ee161b1-769c-41b4-aff9-27b00596e67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_a4ee555c-13ec-4869-9288-7b19f129276f" xlink:to="loc_us-gaap_EmployeeSeveranceMember_4ee161b1-769c-41b4-aff9-27b00596e67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ExitCostsMember_2752b258-6f9a-49ed-9931-149622afd0ec" xlink:href="ccrn-20220630.xsd#ccrn_ExitCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_a4ee555c-13ec-4869-9288-7b19f129276f" xlink:to="loc_ccrn_ExitCostsMember_2752b258-6f9a-49ed-9931-149622afd0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_fa4a623f-dc55-4a91-98cf-c9dd1f24a36a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7092ba41-186b-4cfc-8e90-826f8e18edc3" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_fa4a623f-dc55-4a91-98cf-c9dd1f24a36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_e14d02dc-60a7-4dc4-a32f-9f6e976b3cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fa4a623f-dc55-4a91-98cf-c9dd1f24a36a" xlink:to="loc_us-gaap_RestructuringReserveRollForward_e14d02dc-60a7-4dc4-a32f-9f6e976b3cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_c18bf4d9-b7d5-4901-9e06-3ece70718fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e14d02dc-60a7-4dc4-a32f-9f6e976b3cfb" xlink:to="loc_us-gaap_RestructuringReserve_c18bf4d9-b7d5-4901-9e06-3ece70718fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_26023b81-a5fc-4165-a347-2a83c8657c75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e14d02dc-60a7-4dc4-a32f-9f6e976b3cfb" xlink:to="loc_us-gaap_RestructuringCharges_26023b81-a5fc-4165-a347-2a83c8657c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PaymentsForRestructuringAndAdjustments_61a26bf9-23bd-42c4-bc3f-1f9ec633faaf" xlink:href="ccrn-20220630.xsd#ccrn_PaymentsForRestructuringAndAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e14d02dc-60a7-4dc4-a32f-9f6e976b3cfb" xlink:to="loc_ccrn_PaymentsForRestructuringAndAdjustments_61a26bf9-23bd-42c4-bc3f-1f9ec633faaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_f4c94410-85fb-4fe1-b159-277c98b423a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e14d02dc-60a7-4dc4-a32f-9f6e976b3cfb" xlink:to="loc_us-gaap_PaymentsForRestructuring_f4c94410-85fb-4fe1-b159-277c98b423a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_9160e880-e08a-4820-be5d-48a40fb66470" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e14d02dc-60a7-4dc4-a32f-9f6e976b3cfb" xlink:to="loc_us-gaap_RestructuringReserve_9160e880-e08a-4820-be5d-48a40fb66470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_2548f7ba-fd34-4c34-80bd-ed340ea8a694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fa4a623f-dc55-4a91-98cf-c9dd1f24a36a" xlink:to="loc_us-gaap_BusinessExitCosts1_2548f7ba-fd34-4c34-80bd-ed340ea8a694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION" xlink:type="simple" xlink:href="ccrn-20220630.xsd#REVENUERECOGNITION"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2004ac60-8212-465c-bb9d-63c2c67da9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a72b57ea-435a-4183-b269-c46f4ebd7c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2004ac60-8212-465c-bb9d-63c2c67da9a6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a72b57ea-435a-4183-b269-c46f4ebd7c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables" xlink:type="simple" xlink:href="ccrn-20220630.xsd#REVENUERECOGNITIONTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_90251437-bef1-4b74-8821-d925c79479e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_f4ae00c2-b060-4507-bc1b-34bac8bf00b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_90251437-bef1-4b74-8821-d925c79479e9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_f4ae00c2-b060-4507-bc1b-34bac8bf00b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#REVENUERECOGNITIONDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7e48ea79-3a64-4e28-bbf2-9bed0f8c1d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0ad0a2d8-aafa-40b0-8596-b9793d652ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7e48ea79-3a64-4e28-bbf2-9bed0f8c1d09" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0ad0a2d8-aafa-40b0-8596-b9793d652ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c28b9e37-7708-4f3c-b00e-6a6bd4ebe9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0ad0a2d8-aafa-40b0-8596-b9793d652ffb" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c28b9e37-7708-4f3c-b00e-6a6bd4ebe9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dda68097-9f0e-48df-ba65-bd5e3b0877df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c28b9e37-7708-4f3c-b00e-6a6bd4ebe9f4" xlink:to="loc_us-gaap_SegmentDomain_dda68097-9f0e-48df-ba65-bd5e3b0877df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_5bc69625-3792-4da1-8f44-1fcb4492d7d0" xlink:href="ccrn-20220630.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_dda68097-9f0e-48df-ba65-bd5e3b0877df" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_5bc69625-3792-4da1-8f44-1fcb4492d7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember_d52acd7e-2a11-421f-a4eb-8063bc0cea7b" xlink:href="ccrn-20220630.xsd#ccrn_PhysicianStaffingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_dda68097-9f0e-48df-ba65-bd5e3b0877df" xlink:to="loc_ccrn_PhysicianStaffingMember_d52acd7e-2a11-421f-a4eb-8063bc0cea7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5545b109-f307-48f5-ab66-e1237f410f4b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0ad0a2d8-aafa-40b0-8596-b9793d652ffb" xlink:to="loc_srt_ProductOrServiceAxis_5545b109-f307-48f5-ab66-e1237f410f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b3a5a07f-26a4-422b-898b-df476b020700" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5545b109-f307-48f5-ab66-e1237f410f4b" xlink:to="loc_srt_ProductsAndServicesDomain_b3a5a07f-26a4-422b-898b-df476b020700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_TemporaryStaffingServicesMember_5db98161-487c-4f3b-8321-92e278f78a1f" xlink:href="ccrn-20220630.xsd#ccrn_TemporaryStaffingServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3a5a07f-26a4-422b-898b-df476b020700" xlink:to="loc_ccrn_TemporaryStaffingServicesMember_5db98161-487c-4f3b-8321-92e278f78a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OtherServicesMember_f064fc0c-48ba-4b97-91e9-f74f679f3115" xlink:href="ccrn-20220630.xsd#ccrn_OtherServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b3a5a07f-26a4-422b-898b-df476b020700" xlink:to="loc_ccrn_OtherServicesMember_f064fc0c-48ba-4b97-91e9-f74f679f3115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_87846dbb-5168-49c2-9bf5-1cab79356e25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0ad0a2d8-aafa-40b0-8596-b9793d652ffb" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_87846dbb-5168-49c2-9bf5-1cab79356e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e5252c35-e492-417c-9e1c-dde8ff09ff3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_87846dbb-5168-49c2-9bf5-1cab79356e25" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e5252c35-e492-417c-9e1c-dde8ff09ff3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONS" xlink:type="simple" xlink:href="ccrn-20220630.xsd#ACQUISITIONS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_85759a93-3151-459e-9ac8-555c1820b594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_307583ec-bc0b-4d42-be54-de7790baf20e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_85759a93-3151-459e-9ac8-555c1820b594" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_307583ec-bc0b-4d42-be54-de7790baf20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSTables" xlink:type="simple" xlink:href="ccrn-20220630.xsd#ACQUISITIONSTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_38fc8679-fff1-4740-91e1-cae6d2ff91aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_bac64f5f-47fa-439a-844d-1b541590b423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_38fc8679-fff1-4740-91e1-cae6d2ff91aa" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_bac64f5f-47fa-439a-844d-1b541590b423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#ACQUISITIONSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_303de2c4-b80b-4317-970b-990a87e2228f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e25a7ec-6b17-44ce-9c87-fb2c2e07b44b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_303de2c4-b80b-4317-970b-990a87e2228f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e25a7ec-6b17-44ce-9c87-fb2c2e07b44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0d3ff672-f72f-4d6b-9afe-72aed1a9c6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e25a7ec-6b17-44ce-9c87-fb2c2e07b44b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0d3ff672-f72f-4d6b-9afe-72aed1a9c6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_23d64354-790c-426d-91c5-087f143c8632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0d3ff672-f72f-4d6b-9afe-72aed1a9c6e3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_23d64354-790c-426d-91c5-087f143c8632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SelectedIncMember_95c411e4-0d5a-43ca-bc45-42beaa7e138e" xlink:href="ccrn-20220630.xsd#ccrn_SelectedIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_23d64354-790c-426d-91c5-087f143c8632" xlink:to="loc_ccrn_SelectedIncMember_95c411e4-0d5a-43ca-bc45-42beaa7e138e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_526f8418-3efc-4c25-ae02-c5002bd7aaba" xlink:href="ccrn-20220630.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_23d64354-790c-426d-91c5-087f143c8632" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_526f8418-3efc-4c25-ae02-c5002bd7aaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24a21bae-587c-4a7d-bd97-43020b4352b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e25a7ec-6b17-44ce-9c87-fb2c2e07b44b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24a21bae-587c-4a7d-bd97-43020b4352b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75a0c54-0ca8-4427-90c0-d10a26c94485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24a21bae-587c-4a7d-bd97-43020b4352b7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75a0c54-0ca8-4427-90c0-d10a26c94485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_60772ade-16c4-423a-b474-93357e5ce8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75a0c54-0ca8-4427-90c0-d10a26c94485" xlink:to="loc_us-gaap_TradeNamesMember_60772ade-16c4-423a-b474-93357e5ce8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_636526b0-677e-4851-90b4-bf8939842b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75a0c54-0ca8-4427-90c0-d10a26c94485" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_636526b0-677e-4851-90b4-bf8939842b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_8945eb03-29c4-454a-a0e1-038c6df1ac47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75a0c54-0ca8-4427-90c0-d10a26c94485" xlink:to="loc_us-gaap_DatabasesMember_8945eb03-29c4-454a-a0e1-038c6df1ac47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7fa3dfe7-dbef-43aa-b6cd-71c799eb9251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b75a0c54-0ca8-4427-90c0-d10a26c94485" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7fa3dfe7-dbef-43aa-b6cd-71c799eb9251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e25a7ec-6b17-44ce-9c87-fb2c2e07b44b" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e934833c-308f-425d-bd9c-f9076fb0d1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e934833c-308f-425d-bd9c-f9076fb0d1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4d9f7bc1-7d42-4116-aaf4-740fc5d19ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4d9f7bc1-7d42-4116-aaf4-740fc5d19ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_4da194e4-4f2e-4e81-b68e-7ac3cb068b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_4da194e4-4f2e-4e81-b68e-7ac3cb068b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_20f4f8d2-db05-4441-9591-05de97225f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_20f4f8d2-db05-4441-9591-05de97225f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_db25f864-1e20-48b3-bee8-d40c6aa57cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_db25f864-1e20-48b3-bee8-d40c6aa57cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_db4c75d3-c799-49c8-8825-a441a8d6ab6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_db4c75d3-c799-49c8-8825-a441a8d6ab6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2723a397-802f-41a2-8476-9c0d327916d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_Goodwill_2723a397-802f-41a2-8476-9c0d327916d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_f52d42ff-1ead-428c-96bd-bf504ca6b3e7" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment_f52d42ff-1ead-428c-96bd-bf504ca6b3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationContingentConsiderationTerm_c5c1346e-bc1e-4486-80b1-2e6c27126cd3" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationContingentConsiderationTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_ccrn_BusinessCombinationContingentConsiderationTerm_c5c1346e-bc1e-4486-80b1-2e6c27126cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_049fee2d-5aeb-43db-ab8a-592d7a72e70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_049fee2d-5aeb-43db-ab8a-592d7a72e70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_36b56860-5147-4f1a-9926-f5fe2d37b912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_55481c04-7e39-4c34-86f5-55ca8a8190de" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_36b56860-5147-4f1a-9926-f5fe2d37b912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_aaafde54-f158-4d34-b47f-6a9bdfd4207a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0954bdb7-d9d9-42d2-932c-d334e758e70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_aaafde54-f158-4d34-b47f-6a9bdfd4207a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0954bdb7-d9d9-42d2-932c-d334e758e70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7c92f730-bf89-415f-999c-82e63d871cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0954bdb7-d9d9-42d2-932c-d334e758e70e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7c92f730-bf89-415f-999c-82e63d871cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_486d25d5-99ac-459c-a303-27792ff113ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7c92f730-bf89-415f-999c-82e63d871cd8" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_486d25d5-99ac-459c-a303-27792ff113ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_4d6fb75e-d418-4356-82e7-7ea853cdd7e5" xlink:href="ccrn-20220630.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_486d25d5-99ac-459c-a303-27792ff113ba" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_4d6fb75e-d418-4356-82e7-7ea853cdd7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0954bdb7-d9d9-42d2-932c-d334e758e70e" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_aef5de6d-bc59-41c6-b023-1f9c1bd454b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_aef5de6d-bc59-41c6-b023-1f9c1bd454b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6b25fc46-4b82-4625-ad16-aa31d3cb1d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6b25fc46-4b82-4625-ad16-aa31d3cb1d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_03d18529-c527-45e7-8bfb-d35538201006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_03d18529-c527-45e7-8bfb-d35538201006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e13d883e-8aed-49e8-9551-abccd93919be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_e13d883e-8aed-49e8-9551-abccd93919be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_4b27497a-fd3e-4aa8-a6ed-e1ebe4b62b95" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets_4b27497a-fd3e-4aa8-a6ed-e1ebe4b62b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1e25380d-2eee-4bed-bc60-4580fd817366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_Goodwill_1e25380d-2eee-4bed-bc60-4580fd817366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4f3ad37c-f371-4a53-80f1-b066492b325d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4f3ad37c-f371-4a53-80f1-b066492b325d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_722d4d4d-8974-44bf-af53-01f131e2a85d" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill_722d4d4d-8974-44bf-af53-01f131e2a85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0aa6f664-aa4d-472b-ba35-71622bbf7ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0aa6f664-aa4d-472b-ba35-71622bbf7ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_41f691d9-371e-4557-9976-818857fa5eed" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits_41f691d9-371e-4557-9976-818857fa5eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_dd68adc1-bc88-494c-82ed-d26a27779e2e" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent_dd68adc1-bc88-494c-82ed-d26a27779e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_85312cc3-5521-451d-9d3d-400ce800ab4b" xlink:href="ccrn-20220630.xsd#ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent_85312cc3-5521-451d-9d3d-400ce800ab4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_a01d9d75-3d8d-47a8-a6c4-de6fdce30898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability_a01d9d75-3d8d-47a8-a6c4-de6fdce30898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_91bdb4d5-aa4f-4f04-8e41-f85a2ca00d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_91bdb4d5-aa4f-4f04-8e41-f85a2ca00d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2d900402-0cf3-4394-b732-65392d72b370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e5ef0d88-e84c-4d52-b387-af0765862f9d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2d900402-0cf3-4394-b732-65392d72b370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME" xlink:type="simple" xlink:href="ccrn-20220630.xsd#COMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3921e392-f26c-448d-8def-8a3d02c62eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_69b95c74-73f9-461a-9b51-f36b7ac7c2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3921e392-f26c-448d-8def-8a3d02c62eb4" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_69b95c74-73f9-461a-9b51-f36b7ac7c2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOMEDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#COMPREHENSIVEINCOMEDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOMEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6ef3dec2-76e5-4c86-a940-81685fc871dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax_cf514a95-c611-4d98-809b-e77cfa799e2b" xlink:href="ccrn-20220630.xsd#ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6ef3dec2-76e5-4c86-a940-81685fc871dd" xlink:to="loc_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax_cf514a95-c611-4d98-809b-e77cfa799e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="ccrn-20220630.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d96c4098-8dec-4411-8273-3d05e72aa819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_84778292-b546-45cd-8475-58315c8ddc15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d96c4098-8dec-4411-8273-3d05e72aa819" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_84778292-b546-45cd-8475-58315c8ddc15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="ccrn-20220630.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_738e5ee0-aba2-40c4-b5c5-838efc5da69f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_130058bc-86b5-490b-aebe-898f1546b9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_738e5ee0-aba2-40c4-b5c5-838efc5da69f" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_130058bc-86b5-490b-aebe-898f1546b9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c00f5a67-af2b-4e93-9644-e108947d9939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_738e5ee0-aba2-40c4-b5c5-838efc5da69f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c00f5a67-af2b-4e93-9644-e108947d9939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_cd08e9c7-31c2-4fb7-a56e-aff2111b7e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_4f59dcd0-4855-4c97-bfdb-3f6fe815a0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cd08e9c7-31c2-4fb7-a56e-aff2111b7e77" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_4f59dcd0-4855-4c97-bfdb-3f6fe815a0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2ab0e1d3-1502-40e8-921d-fb629237e03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_4f59dcd0-4855-4c97-bfdb-3f6fe815a0b9" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2ab0e1d3-1502-40e8-921d-fb629237e03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_1ea84c70-b851-42e6-8790-86f76d73c119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_4f59dcd0-4855-4c97-bfdb-3f6fe815a0b9" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_1ea84c70-b851-42e6-8790-86f76d73c119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6e310051-30d0-4fe2-b2ce-4b11e97b1a80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cd08e9c7-31c2-4fb7-a56e-aff2111b7e77" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6e310051-30d0-4fe2-b2ce-4b11e97b1a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8359a878-8de3-4561-a980-999c922762af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6e310051-30d0-4fe2-b2ce-4b11e97b1a80" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8359a878-8de3-4561-a980-999c922762af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_eb52bb64-ef7b-4134-beeb-af1dfa80ca12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6e310051-30d0-4fe2-b2ce-4b11e97b1a80" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_eb52bb64-ef7b-4134-beeb-af1dfa80ca12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1504cd48-6745-43c8-8675-532f2b7ece65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_eb52bb64-ef7b-4134-beeb-af1dfa80ca12" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1504cd48-6745-43c8-8675-532f2b7ece65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2e8e5566-f753-4f11-9466-54a02cd03672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_6e310051-30d0-4fe2-b2ce-4b11e97b1a80" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2e8e5566-f753-4f11-9466-54a02cd03672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f491023b-24f1-437e-9ffc-66f10baab4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cd08e9c7-31c2-4fb7-a56e-aff2111b7e77" xlink:to="loc_us-gaap_EarningsPerShareBasic_f491023b-24f1-437e-9ffc-66f10baab4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_ac70443a-933c-4feb-af25-d8b14b4160ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_cd08e9c7-31c2-4fb7-a56e-aff2111b7e77" xlink:to="loc_us-gaap_EarningsPerShareDiluted_ac70443a-933c-4feb-af25-d8b14b4160ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#EARNINGSPERSHAREAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_df95baf6-4661-40eb-8966-6ae81ecec15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_baf64f82-25ef-4f38-be34-85e906ce0b53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df95baf6-4661-40eb-8966-6ae81ecec15e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_baf64f82-25ef-4f38-be34-85e906ce0b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52138cdf-a31f-4188-8374-2d43faa2d10a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_baf64f82-25ef-4f38-be34-85e906ce0b53" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52138cdf-a31f-4188-8374-2d43faa2d10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6bc98708-66f4-480c-8dde-8205df1c5327" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_52138cdf-a31f-4188-8374-2d43faa2d10a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6bc98708-66f4-480c-8dde-8205df1c5327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedPaymentAwardsMember_0487d3e1-d3ea-4df3-b11e-fca6500531e4" xlink:href="ccrn-20220630.xsd#ccrn_ShareBasedPaymentAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6bc98708-66f4-480c-8dde-8205df1c5327" xlink:to="loc_ccrn_ShareBasedPaymentAwardsMember_0487d3e1-d3ea-4df3-b11e-fca6500531e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a4fb430-6989-4845-8d27-24f11dbdc63b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_baf64f82-25ef-4f38-be34-85e906ce0b53" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a4fb430-6989-4845-8d27-24f11dbdc63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_94ce7fe5-5bf2-434e-a85e-e48f54220ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7a4fb430-6989-4845-8d27-24f11dbdc63b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_94ce7fe5-5bf2-434e-a85e-e48f54220ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="ccrn-20220630.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9be3bb09-603c-4f2f-b381-21cf3661acf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_75459a4a-94a7-4c85-b9ed-25fafc944964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9be3bb09-603c-4f2f-b381-21cf3661acf6" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_75459a4a-94a7-4c85-b9ed-25fafc944964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="ccrn-20220630.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2d3a61b2-2f8f-429b-8400-7e20f6a20242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_bed01790-fefa-41e8-888f-a36ba38bd6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2d3a61b2-2f8f-429b-8400-7e20f6a20242" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_bed01790-fefa-41e8-888f-a36ba38bd6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_4e8da02f-6d98-43a3-9723-1d1552ba6977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2d3a61b2-2f8f-429b-8400-7e20f6a20242" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_4e8da02f-6d98-43a3-9723-1d1552ba6977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_b1c0a11c-f1b9-46bd-a87e-35083cbb8b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2d3a61b2-2f8f-429b-8400-7e20f6a20242" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_b1c0a11c-f1b9-46bd-a87e-35083cbb8b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_371515cf-b637-4323-9580-ebd580abc4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e3aca95e-7fcc-4f1e-ae0a-7b5ab307ba05" xlink:href="ccrn-20220630.xsd#ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_371515cf-b637-4323-9580-ebd580abc4fd" xlink:to="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e3aca95e-7fcc-4f1e-ae0a-7b5ab307ba05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_000be185-a437-438a-81d5-b70e70034118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e3aca95e-7fcc-4f1e-ae0a-7b5ab307ba05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_000be185-a437-438a-81d5-b70e70034118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_000be185-a437-438a-81d5-b70e70034118" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DatabasesMember_22b1a537-3a0a-490c-8e36-5fd45ba77b70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DatabasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:to="loc_us-gaap_DatabasesMember_22b1a537-3a0a-490c-8e36-5fd45ba77b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9e38234d-d0d4-4b1d-93a6-c0d861064b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9e38234d-d0d4-4b1d-93a6-c0d861064b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_3575331a-e995-4fc7-9908-41485d9efb61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_3575331a-e995-4fc7-9908-41485d9efb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_65628889-b015-4bc5-99e5-f4dcb203c711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:to="loc_us-gaap_TradeNamesMember_65628889-b015-4bc5-99e5-f4dcb203c711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_191977f0-9927-401e-8517-4d33197839a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5efcf96-6d3e-49fd-a21f-b6423eb7c5d6" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_191977f0-9927-401e-8517-4d33197839a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8d7e178b-6dc9-4178-bd67-7dec837b50d4" xlink:href="ccrn-20220630.xsd#ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable_e3aca95e-7fcc-4f1e-ae0a-7b5ab307ba05" xlink:to="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8d7e178b-6dc9-4178-bd67-7dec837b50d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_92ab8639-42a7-45a4-80b1-6a1094ffcef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8d7e178b-6dc9-4178-bd67-7dec837b50d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_92ab8639-42a7-45a4-80b1-6a1094ffcef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_210a9830-86a6-4e30-a660-ca33e460f4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_92ab8639-42a7-45a4-80b1-6a1094ffcef9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_210a9830-86a6-4e30-a660-ca33e460f4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e9b1463e-306c-4d86-ae12-4ab2a0893eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_92ab8639-42a7-45a4-80b1-6a1094ffcef9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e9b1463e-306c-4d86-ae12-4ab2a0893eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8185e398-e568-47a6-bbc0-476c966801ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_92ab8639-42a7-45a4-80b1-6a1094ffcef9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8185e398-e568-47a6-bbc0-476c966801ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_a7c90fc4-b102-49f7-a7df-1770b431a4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8d7e178b-6dc9-4178-bd67-7dec837b50d4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_a7c90fc4-b102-49f7-a7df-1770b431a4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedTradeNames_fbf0b833-8837-43f4-aced-6e3d31d6f578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedTradeNames"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_a7c90fc4-b102-49f7-a7df-1770b431a4f0" xlink:to="loc_us-gaap_IndefiniteLivedTradeNames_fbf0b833-8837-43f4-aced-6e3d31d6f578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cab2d53c-d83e-474c-8eda-ab0fabb14cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_1b21ebda-d2d8-412d-8bc8-2768fdd40d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cab2d53c-d83e-474c-8eda-ab0fabb14cae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_1b21ebda-d2d8-412d-8bc8-2768fdd40d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8854acd8-150b-4e3f-b505-00dfa4e3a06a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cab2d53c-d83e-474c-8eda-ab0fabb14cae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8854acd8-150b-4e3f-b505-00dfa4e3a06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_674bced0-abd5-4228-a30b-141b9f719ede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cab2d53c-d83e-474c-8eda-ab0fabb14cae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_674bced0-abd5-4228-a30b-141b9f719ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e25f8fb5-0e0f-4707-9cb5-a9158f281b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cab2d53c-d83e-474c-8eda-ab0fabb14cae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e25f8fb5-0e0f-4707-9cb5-a9158f281b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dc1bbd24-52b8-45b8-95c2-06be1a3900cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cab2d53c-d83e-474c-8eda-ab0fabb14cae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dc1bbd24-52b8-45b8-95c2-06be1a3900cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_5d962cd0-790d-43ae-b6d2-01fd27a51562" xlink:href="ccrn-20220630.xsd#ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cab2d53c-d83e-474c-8eda-ab0fabb14cae" xlink:to="loc_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_5d962cd0-790d-43ae-b6d2-01fd27a51562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_306d1185-3dca-43b9-844f-617de65ae0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cab2d53c-d83e-474c-8eda-ab0fabb14cae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_306d1185-3dca-43b9-844f-617de65ae0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b7c7e80a-da25-49f9-87a3-e22cd945b24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2f244e0a-f33b-44a4-8ff3-473eb6192c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b7c7e80a-da25-49f9-87a3-e22cd945b24a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2f244e0a-f33b-44a4-8ff3-473eb6192c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_91ae9598-4dda-45e2-b8d9-664a16c3d88f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2f244e0a-f33b-44a4-8ff3-473eb6192c43" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_91ae9598-4dda-45e2-b8d9-664a16c3d88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bec127f9-73a4-42ff-a193-589331e18398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_91ae9598-4dda-45e2-b8d9-664a16c3d88f" xlink:to="loc_us-gaap_SegmentDomain_bec127f9-73a4-42ff-a193-589331e18398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_5cc748a4-37aa-477d-b986-77a7e86ef42a" xlink:href="ccrn-20220630.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bec127f9-73a4-42ff-a193-589331e18398" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_5cc748a4-37aa-477d-b986-77a7e86ef42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember_29c090c6-cd56-434c-a0c9-272f2b846650" xlink:href="ccrn-20220630.xsd#ccrn_PhysicianStaffingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bec127f9-73a4-42ff-a193-589331e18398" xlink:to="loc_ccrn_PhysicianStaffingMember_29c090c6-cd56-434c-a0c9-272f2b846650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_eb307c87-e25c-4e04-9994-4e9cd9cfca52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2f244e0a-f33b-44a4-8ff3-473eb6192c43" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_eb307c87-e25c-4e04-9994-4e9cd9cfca52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_9158db38-74c8-42de-9ba5-3c0631c65449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_eb307c87-e25c-4e04-9994-4e9cd9cfca52" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_9158db38-74c8-42de-9ba5-3c0631c65449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_fcd4da23-8677-4700-a586-c804a97dfec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_9158db38-74c8-42de-9ba5-3c0631c65449" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_fcd4da23-8677-4700-a586-c804a97dfec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_928be4b3-d5a1-421d-9838-98c3ba58ec26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2f244e0a-f33b-44a4-8ff3-473eb6192c43" xlink:to="loc_us-gaap_GoodwillLineItems_928be4b3-d5a1-421d-9838-98c3ba58ec26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_928be4b3-d5a1-421d-9838-98c3ba58ec26" xlink:to="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_abfe6b8c-7170-486f-831d-732d9c8d67a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:to="loc_us-gaap_GoodwillGross_abfe6b8c-7170-486f-831d-732d9c8d67a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_48bbaabc-2fc8-4916-9009-820edfeed380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_48bbaabc-2fc8-4916-9009-820edfeed380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8cd9f18f-74b5-4ecd-86cf-f78d9d2ccd2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:to="loc_us-gaap_Goodwill_8cd9f18f-74b5-4ecd-86cf-f78d9d2ccd2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_6d891a5c-f3fd-4f81-9a41-86a64df2f8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_6d891a5c-f3fd-4f81-9a41-86a64df2f8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_aac7d3e4-7cca-4c57-8d38-d8b3a995e783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:to="loc_us-gaap_GoodwillGross_aac7d3e4-7cca-4c57-8d38-d8b3a995e783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_ed69763f-fd6b-4516-8195-d27185581854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_ed69763f-fd6b-4516-8195-d27185581854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_faa8b27b-f5ef-4087-86f8-3ad85f2af15c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_09e942e7-2069-4d28-971c-11a077bf5239" xlink:to="loc_us-gaap_Goodwill_faa8b27b-f5ef-4087-86f8-3ad85f2af15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBT" xlink:type="simple" xlink:href="ccrn-20220630.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f5d5fb7e-b680-423d-805a-2135676fe093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_5c47ab06-4bf7-49d1-97e3-3c6ec950ed45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f5d5fb7e-b680-423d-805a-2135676fe093" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_5c47ab06-4bf7-49d1-97e3-3c6ec950ed45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTTables" xlink:type="simple" xlink:href="ccrn-20220630.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_951e3bb6-e487-4cdd-abef-ddc32b8a9c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_4a2680a0-6c96-4a04-aafb-79edbd54e8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_951e3bb6-e487-4cdd-abef-ddc32b8a9c83" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_4a2680a0-6c96-4a04-aafb-79edbd54e8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_2dd0a406-6899-4216-ba7f-c0af2369cbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_951e3bb6-e487-4cdd-abef-ddc32b8a9c83" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_2dd0a406-6899-4216-ba7f-c0af2369cbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#DEBTLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_50944dcf-3ba2-42bb-a7c3-a31a91c7ebee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7e8e4f1a-f5c4-4138-b571-e2afd6607d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_50944dcf-3ba2-42bb-a7c3-a31a91c7ebee" xlink:to="loc_us-gaap_DebtInstrumentTable_7e8e4f1a-f5c4-4138-b571-e2afd6607d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_704a1024-928e-4401-9a72-bf12c168b9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7e8e4f1a-f5c4-4138-b571-e2afd6607d22" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_704a1024-928e-4401-9a72-bf12c168b9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5470d330-e663-4622-98f4-0b252c51844c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_704a1024-928e-4401-9a72-bf12c168b9c8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5470d330-e663-4622-98f4-0b252c51844c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_4eb1a25b-1264-4a62-bb3d-19049a8ba05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5470d330-e663-4622-98f4-0b252c51844c" xlink:to="loc_us-gaap_SecuredDebtMember_4eb1a25b-1264-4a62-bb3d-19049a8ba05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_44b7cf2e-0227-409f-ab42-d07a4ae28d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5470d330-e663-4622-98f4-0b252c51844c" xlink:to="loc_us-gaap_LineOfCreditMember_44b7cf2e-0227-409f-ab42-d07a4ae28d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_01792309-6a7c-4adf-8f31-521aa7232cff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5470d330-e663-4622-98f4-0b252c51844c" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_01792309-6a7c-4adf-8f31-521aa7232cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fcb32ed3-b9ac-4efc-b5ef-3bab87b7e922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7e8e4f1a-f5c4-4138-b571-e2afd6607d22" xlink:to="loc_us-gaap_DebtInstrumentAxis_fcb32ed3-b9ac-4efc-b5ef-3bab87b7e922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_605d2adb-08bc-406f-b6ec-5a8e0416e2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_fcb32ed3-b9ac-4efc-b5ef-3bab87b7e922" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_605d2adb-08bc-406f-b6ec-5a8e0416e2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember_1ce2faba-b27b-4c44-8b80-52fcdca43569" xlink:href="ccrn-20220630.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_605d2adb-08bc-406f-b6ec-5a8e0416e2ed" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementMember_1ce2faba-b27b-4c44-8b80-52fcdca43569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EarnoutNotesPayableMember_26cdc3b6-1ef9-4fdf-b0fe-f056abe71e09" xlink:href="ccrn-20220630.xsd#ccrn_EarnoutNotesPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_605d2adb-08bc-406f-b6ec-5a8e0416e2ed" xlink:to="loc_ccrn_EarnoutNotesPayableMember_26cdc3b6-1ef9-4fdf-b0fe-f056abe71e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_fc1202ba-f763-4cef-a2c4-df15b66e2146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7e8e4f1a-f5c4-4138-b571-e2afd6607d22" xlink:to="loc_us-gaap_CreditFacilityAxis_fc1202ba-f763-4cef-a2c4-df15b66e2146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ff38e3e1-6642-4563-88ea-ba7a53ccfb10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_fc1202ba-f763-4cef-a2c4-df15b66e2146" xlink:to="loc_us-gaap_CreditFacilityDomain_ff38e3e1-6642-4563-88ea-ba7a53ccfb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_86a3d29f-ed54-46d2-b5a8-17861b3fcf01" xlink:href="ccrn-20220630.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_ff38e3e1-6642-4563-88ea-ba7a53ccfb10" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_86a3d29f-ed54-46d2-b5a8-17861b3fcf01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7e8e4f1a-f5c4-4138-b571-e2afd6607d22" xlink:to="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_3b41e396-e685-400f-9e9f-6861056a466d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_3b41e396-e685-400f-9e9f-6861056a466d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e2b1930d-6b29-4e52-9efc-166ef34787b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e2b1930d-6b29-4e52-9efc-166ef34787b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a00a6937-4055-455c-abcb-bdca047d354c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a00a6937-4055-455c-abcb-bdca047d354c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_84714275-cc3d-4acb-b4be-5c8f0e392ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_84714275-cc3d-4acb-b4be-5c8f0e392ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a8db135a-d12d-4169-a233-03b476597c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:to="loc_us-gaap_LongTermDebtCurrent_a8db135a-d12d-4169-a233-03b476597c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_845329db-ef67-4fe7-8285-2a00a6c618ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5d3dc15-2716-4ddf-a78e-9b026279b3fb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_845329db-ef67-4fe7-8285-2a00a6c618ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#DEBT2021TermLoanCreditAgreementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_607467de-950b-4857-9929-848d6d6a7d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1238faa3-9dee-4dc2-9c24-c850ddfb93fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_607467de-950b-4857-9929-848d6d6a7d8b" xlink:to="loc_us-gaap_DebtInstrumentTable_1238faa3-9dee-4dc2-9c24-c850ddfb93fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1dd29e0a-a6be-4bd7-9ee6-c5c8e696d00e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1238faa3-9dee-4dc2-9c24-c850ddfb93fd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1dd29e0a-a6be-4bd7-9ee6-c5c8e696d00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_672ba569-3421-4209-a7ea-a431574a2157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1dd29e0a-a6be-4bd7-9ee6-c5c8e696d00e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_672ba569-3421-4209-a7ea-a431574a2157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_08f8371e-3d10-4dd4-8300-6980e86fcccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_672ba569-3421-4209-a7ea-a431574a2157" xlink:to="loc_us-gaap_SecuredDebtMember_08f8371e-3d10-4dd4-8300-6980e86fcccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cd285914-52ba-42c1-a582-4a59497a29e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1238faa3-9dee-4dc2-9c24-c850ddfb93fd" xlink:to="loc_us-gaap_DebtInstrumentAxis_cd285914-52ba-42c1-a582-4a59497a29e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a4da6a79-4bf6-4395-9b4b-673f03187e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cd285914-52ba-42c1-a582-4a59497a29e3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a4da6a79-4bf6-4395-9b4b-673f03187e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember_869770fa-faa9-4f8e-bf89-337540733686" xlink:href="ccrn-20220630.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a4da6a79-4bf6-4395-9b4b-673f03187e1e" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementMember_869770fa-faa9-4f8e-bf89-337540733686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_daeef70c-1e7f-4d6d-a414-0e5adb97895e" xlink:href="ccrn-20220630.xsd#ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementMember_869770fa-faa9-4f8e-bf89-337540733686" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember_daeef70c-1e7f-4d6d-a414-0e5adb97895e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_7f6fb156-3ff0-4ef6-a392-2de51d94b6e3" xlink:href="ccrn-20220630.xsd#ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_A2021TermLoanCreditAgreementMember_869770fa-faa9-4f8e-bf89-337540733686" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember_7f6fb156-3ff0-4ef6-a392-2de51d94b6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_c8ceab25-e9fb-492f-9009-b5c93ce781b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1238faa3-9dee-4dc2-9c24-c850ddfb93fd" xlink:to="loc_us-gaap_VariableRateAxis_c8ceab25-e9fb-492f-9009-b5c93ce781b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_71f9430c-966d-4898-9c18-3efd0c5c545b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_c8ceab25-e9fb-492f-9009-b5c93ce781b9" xlink:to="loc_us-gaap_VariableRateDomain_71f9430c-966d-4898-9c18-3efd0c5c545b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_bf6b5c3d-ff0d-4aa2-9852-af48ee531bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_71f9430c-966d-4898-9c18-3efd0c5c545b" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_bf6b5c3d-ff0d-4aa2-9852-af48ee531bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1238faa3-9dee-4dc2-9c24-c850ddfb93fd" xlink:to="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PaymentForDebtPrepayment_1e45b5d3-deca-4c52-9e26-a27017a13547" xlink:href="ccrn-20220630.xsd#ccrn_PaymentForDebtPrepayment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_ccrn_PaymentForDebtPrepayment_1e45b5d3-deca-4c52-9e26-a27017a13547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_6ccd9d03-117b-44e2-b8d2-8bf93aaf087b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_us-gaap_DebtInstrumentTerm_6ccd9d03-117b-44e2-b8d2-8bf93aaf087b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_8072d55e-65af-470c-90ba-2852c90331cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_8072d55e-65af-470c-90ba-2852c90331cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7305de09-cfd3-4551-99af-c2ded3170dad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7305de09-cfd3-4551-99af-c2ded3170dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DebtInstrumentVariableInterestRateFloor_4cae1c6a-dde9-48c2-b553-d7a72d12371e" xlink:href="ccrn-20220630.xsd#ccrn_DebtInstrumentVariableInterestRateFloor"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_ccrn_DebtInstrumentVariableInterestRateFloor_4cae1c6a-dde9-48c2-b553-d7a72d12371e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_db2d39d5-8959-4112-9b98-a8e9f5043f96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_db2d39d5-8959-4112-9b98-a8e9f5043f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_33fb8610-e839-43b3-b6a7-ce0f807f35bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_33fb8610-e839-43b3-b6a7-ce0f807f35bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_a4b90ab3-4905-4a65-87ed-4b8b268e01d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67a575f3-02c3-437e-953f-4c2eda04a23c" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_a4b90ab3-4905-4a65-87ed-4b8b268e01d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#DEBTMaturitiesofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cdba1379-f48d-469f-9bef-8c36aa1a3279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a1a2ed6f-0713-46cd-8c3e-a2ccab1ac300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cdba1379-f48d-469f-9bef-8c36aa1a3279" xlink:to="loc_us-gaap_DebtInstrumentTable_a1a2ed6f-0713-46cd-8c3e-a2ccab1ac300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_72ec3bd5-b89e-4e02-b0d7-88ddb1d18f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a1a2ed6f-0713-46cd-8c3e-a2ccab1ac300" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_72ec3bd5-b89e-4e02-b0d7-88ddb1d18f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_44f02af4-c0bf-4de0-9836-a93d429a6966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_72ec3bd5-b89e-4e02-b0d7-88ddb1d18f5a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_44f02af4-c0bf-4de0-9836-a93d429a6966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c5b6ff00-3066-460e-943c-a7c5dfd8ae50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_44f02af4-c0bf-4de0-9836-a93d429a6966" xlink:to="loc_us-gaap_SecuredDebtMember_c5b6ff00-3066-460e-943c-a7c5dfd8ae50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_73c89417-3827-4505-adbd-e2d53cf732b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_44f02af4-c0bf-4de0-9836-a93d429a6966" xlink:to="loc_us-gaap_LineOfCreditMember_73c89417-3827-4505-adbd-e2d53cf732b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c7a86880-bf13-49b7-a5f6-3f042f97ae56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a1a2ed6f-0713-46cd-8c3e-a2ccab1ac300" xlink:to="loc_us-gaap_DebtInstrumentAxis_c7a86880-bf13-49b7-a5f6-3f042f97ae56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d975a101-f013-4adc-b15e-c2b4e82ee8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c7a86880-bf13-49b7-a5f6-3f042f97ae56" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d975a101-f013-4adc-b15e-c2b4e82ee8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_A2021TermLoanCreditAgreementMember_1c5d85f1-4026-408a-98ce-930dc23ad129" xlink:href="ccrn-20220630.xsd#ccrn_A2021TermLoanCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d975a101-f013-4adc-b15e-c2b4e82ee8e2" xlink:to="loc_ccrn_A2021TermLoanCreditAgreementMember_1c5d85f1-4026-408a-98ce-930dc23ad129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_36d979cf-8f53-4509-b4a9-7b4905e6e481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a1a2ed6f-0713-46cd-8c3e-a2ccab1ac300" xlink:to="loc_us-gaap_CreditFacilityAxis_36d979cf-8f53-4509-b4a9-7b4905e6e481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3b834625-0d0e-499c-8425-e9d623a8a93d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_36d979cf-8f53-4509-b4a9-7b4905e6e481" xlink:to="loc_us-gaap_CreditFacilityDomain_3b834625-0d0e-499c-8425-e9d623a8a93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_2fe49782-aebf-4e53-9b70-2bc291ca51e1" xlink:href="ccrn-20220630.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3b834625-0d0e-499c-8425-e9d623a8a93d" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_2fe49782-aebf-4e53-9b70-2bc291ca51e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_36ffcafe-38e1-4ab4-8681-629306d3e3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a1a2ed6f-0713-46cd-8c3e-a2ccab1ac300" xlink:to="loc_us-gaap_DebtInstrumentLineItems_36ffcafe-38e1-4ab4-8681-629306d3e3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_36ffcafe-38e1-4ab4-8681-629306d3e3e5" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_11c81fd9-a108-4482-971c-496360693c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_11c81fd9-a108-4482-971c-496360693c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_7acfc9f1-0845-48eb-aeb5-a932c4c2a9a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_7acfc9f1-0845-48eb-aeb5-a932c4c2a9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4d089336-00f0-4c39-919f-de9978b40173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4d089336-00f0-4c39-919f-de9978b40173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_8feff0f6-1ad7-40be-88d8-748f7589e9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_8feff0f6-1ad7-40be-88d8-748f7589e9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e496acab-127c-4ca5-83d6-dff19f2cd8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e496acab-127c-4ca5-83d6-dff19f2cd8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LongTermDebtMaturityAfterYearFour_5d554ce9-cc3b-46c0-af25-a00d831fb99a" xlink:href="ccrn-20220630.xsd#ccrn_LongTermDebtMaturityAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_ccrn_LongTermDebtMaturityAfterYearFour_5d554ce9-cc3b-46c0-af25-a00d831fb99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_012f35a3-c627-4211-a61e-056848663dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_89fba66a-a20c-4c66-9623-21c6bda4d34a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_012f35a3-c627-4211-a61e-056848663dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#DEBT2019LoanAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6279114d-825d-4f21-ab93-de8baeee5c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_917ab3d0-ba45-4588-90a6-093951cd402e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6279114d-825d-4f21-ab93-de8baeee5c18" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_917ab3d0-ba45-4588-90a6-093951cd402e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f9a59358-3ad9-4b8e-ae3c-866895f30fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_917ab3d0-ba45-4588-90a6-093951cd402e" xlink:to="loc_us-gaap_CreditFacilityAxis_f9a59358-3ad9-4b8e-ae3c-866895f30fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d4850712-e581-46b5-8b31-9557d6b32e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f9a59358-3ad9-4b8e-ae3c-866895f30fe0" xlink:to="loc_us-gaap_CreditFacilityDomain_d4850712-e581-46b5-8b31-9557d6b32e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_894f951f-91e8-40f4-bf3e-5771cbed13e5" xlink:href="ccrn-20220630.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d4850712-e581-46b5-8b31-9557d6b32e9c" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_894f951f-91e8-40f4-bf3e-5771cbed13e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitAxis_9ba49871-ed10-499a-a893-8351ae679254" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditSublimitAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_917ab3d0-ba45-4588-90a6-093951cd402e" xlink:to="loc_ccrn_LineOfCreditSublimitAxis_9ba49871-ed10-499a-a893-8351ae679254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditSublimitDomain_dbb573a6-9319-48db-b8f0-53394b4b6bf7" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditSublimitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_LineOfCreditSublimitAxis_9ba49871-ed10-499a-a893-8351ae679254" xlink:to="loc_ccrn_LineOfCreditSublimitDomain_dbb573a6-9319-48db-b8f0-53394b4b6bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SwingLoansSublimitMember_46774584-991a-424b-ae49-ca77b8b1dd60" xlink:href="ccrn-20220630.xsd#ccrn_SwingLoansSublimitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_LineOfCreditSublimitDomain_dbb573a6-9319-48db-b8f0-53394b4b6bf7" xlink:to="loc_ccrn_SwingLoansSublimitMember_46774584-991a-424b-ae49-ca77b8b1dd60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_StandbyLettersOfCreditSublimitMember_a3d876fd-d558-47b8-a2bb-73b149098e7b" xlink:href="ccrn-20220630.xsd#ccrn_StandbyLettersOfCreditSublimitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_LineOfCreditSublimitDomain_dbb573a6-9319-48db-b8f0-53394b4b6bf7" xlink:to="loc_ccrn_StandbyLettersOfCreditSublimitMember_a3d876fd-d558-47b8-a2bb-73b149098e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_aafc3b1c-106d-4f34-990b-33dfc65d6299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_917ab3d0-ba45-4588-90a6-093951cd402e" xlink:to="loc_us-gaap_VariableRateAxis_aafc3b1c-106d-4f34-990b-33dfc65d6299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d055ad4d-6a83-4958-a4e9-a3d38e48ce6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_aafc3b1c-106d-4f34-990b-33dfc65d6299" xlink:to="loc_us-gaap_VariableRateDomain_d055ad4d-6a83-4958-a4e9-a3d38e48ce6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_857f1a12-f10e-49bd-bb9f-dbb6ceaab4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_d055ad4d-6a83-4958-a4e9-a3d38e48ce6b" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_857f1a12-f10e-49bd-bb9f-dbb6ceaab4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_9f1ef5bd-8c94-4a60-80d9-d3a3a9bd46c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_d055ad4d-6a83-4958-a4e9-a3d38e48ce6b" xlink:to="loc_us-gaap_BaseRateMember_9f1ef5bd-8c94-4a60-80d9-d3a3a9bd46c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_917ab3d0-ba45-4588-90a6-093951cd402e" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_cf3b1d65-47a0-4cb1-a61d-0f609246691b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_cf3b1d65-47a0-4cb1-a61d-0f609246691b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b0217e64-20fe-4b61-a084-23f3ceb1182f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b0217e64-20fe-4b61-a084-23f3ceb1182f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_abb2bfdb-a851-47d8-b6b0-aefa5cd6a166" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources_abb2bfdb-a851-47d8-b6b0-aefa5cd6a166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_c9a695e4-1329-458b-80b1-12d6f7d51e2b" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR_c9a695e4-1329-458b-80b1-12d6f7d51e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_6866e860-baf5-46d4-85c8-e0ae48a15e05" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditBorrowingBasePercentageOfAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_ccrn_LineOfCreditBorrowingBasePercentageOfAssets_6866e860-baf5-46d4-85c8-e0ae48a15e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_7b768c09-f06d-4ba9-b88c-c5430f87b0b4" xlink:href="ccrn-20220630.xsd#ccrn_LineOfCreditFacilityBorrowingBaseAvailability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_ccrn_LineOfCreditFacilityBorrowingBaseAvailability_7b768c09-f06d-4ba9-b88c-c5430f87b0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_23733fc6-9716-4206-a576-d1ae173b3411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_LineOfCredit_23733fc6-9716-4206-a576-d1ae173b3411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_bd8ff86d-c6c1-4ff4-8412-b0277aa3048b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_bd8ff86d-c6c1-4ff4-8412-b0277aa3048b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_eafd81fe-bef1-411e-a9fb-98ab85ef0a41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_eafd81fe-bef1-411e-a9fb-98ab85ef0a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_851ade14-f4c0-4f44-804d-738e25aa21bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_851ade14-f4c0-4f44-804d-738e25aa21bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_8f3ceac9-0a72-41c5-8299-321f44c5f647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_54346980-6dbb-45c6-a3b6-fca26cea7808" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_8f3ceac9-0a72-41c5-8299-321f44c5f647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASES" xlink:type="simple" xlink:href="ccrn-20220630.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_96a0f782-65bf-4a87-8b39-2c770df522be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_17d5fa1c-a96f-4dac-bb83-f0265a30974b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_96a0f782-65bf-4a87-8b39-2c770df522be" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_17d5fa1c-a96f-4dac-bb83-f0265a30974b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESTables" xlink:type="simple" xlink:href="ccrn-20220630.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9b7c4e10-fcbc-4532-aee0-6def340c6752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock_834e4451-f0c1-4b45-8f10-833dd0d82b1e" xlink:href="ccrn-20220630.xsd#ccrn_AssetsAndLiabilitiesLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9b7c4e10-fcbc-4532-aee0-6def340c6752" xlink:to="loc_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock_834e4451-f0c1-4b45-8f10-833dd0d82b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_88b173ef-6baa-4df4-8c3f-3a0cdf9948ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9b7c4e10-fcbc-4532-aee0-6def340c6752" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_88b173ef-6baa-4df4-8c3f-3a0cdf9948ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_5b9637b1-f3dc-4530-b8fc-1f3a5bebb5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9b7c4e10-fcbc-4532-aee0-6def340c6752" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_5b9637b1-f3dc-4530-b8fc-1f3a5bebb5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#LEASESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2d0b9a88-b56e-432a-905c-3da022252f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3171f4f7-58ca-4f17-8488-c0095ddd3b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2d0b9a88-b56e-432a-905c-3da022252f6d" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3171f4f7-58ca-4f17-8488-c0095ddd3b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_6edf4870-d707-471f-b3f5-09822b43c529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2d0b9a88-b56e-432a-905c-3da022252f6d" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_6edf4870-d707-471f-b3f5-09822b43c529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#LEASESSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_90ca8de1-ee4d-4bfd-a18d-96ddb1ec78df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4c26fc58-034f-4e78-a634-c26d920d4538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_90ca8de1-ee4d-4bfd-a18d-96ddb1ec78df" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4c26fc58-034f-4e78-a634-c26d920d4538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8a4dc119-e5b0-444c-a09e-464f5237d7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_90ca8de1-ee4d-4bfd-a18d-96ddb1ec78df" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8a4dc119-e5b0-444c-a09e-464f5237d7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_791f7816-cf19-45b9-9119-ecec23f863d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_90ca8de1-ee4d-4bfd-a18d-96ddb1ec78df" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_791f7816-cf19-45b9-9119-ecec23f863d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_514af28a-3953-49b1-94d8-d14824d6762d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_90ca8de1-ee4d-4bfd-a18d-96ddb1ec78df" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_514af28a-3953-49b1-94d8-d14824d6762d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a69ea5de-be4d-4a5a-9a62-329096f2dc63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_90ca8de1-ee4d-4bfd-a18d-96ddb1ec78df" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a69ea5de-be4d-4a5a-9a62-329096f2dc63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#LEASESOperatingLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_34108832-51a3-40f4-9a5c-759ffb12384c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_c196a343-b817-4297-82a1-a701d430df48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34108832-51a3-40f4-9a5c-759ffb12384c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_c196a343-b817-4297-82a1-a701d430df48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c717a756-c463-470e-bfa4-31776b3fe972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34108832-51a3-40f4-9a5c-759ffb12384c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c717a756-c463-470e-bfa4-31776b3fe972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5e450feb-51d7-4d1a-aaa4-ff895ddf3695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34108832-51a3-40f4-9a5c-759ffb12384c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_5e450feb-51d7-4d1a-aaa4-ff895ddf3695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e3c95684-0dd5-4122-a5bd-cebf87132bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34108832-51a3-40f4-9a5c-759ffb12384c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e3c95684-0dd5-4122-a5bd-cebf87132bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_34a99cf1-7433-4fe2-99a1-6950d6d15d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34108832-51a3-40f4-9a5c-759ffb12384c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_34a99cf1-7433-4fe2-99a1-6950d6d15d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f6642f6e-675c-416c-a6cb-7d236d16665d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34108832-51a3-40f4-9a5c-759ffb12384c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f6642f6e-675c-416c-a6cb-7d236d16665d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c54a467c-bbec-4c3a-9063-6af26fa5a002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34108832-51a3-40f4-9a5c-759ffb12384c" xlink:to="loc_us-gaap_OperatingLeaseLiability_c54a467c-bbec-4c3a-9063-6af26fa5a002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_33bf72fe-120a-4231-af9d-90b8358c8a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34108832-51a3-40f4-9a5c-759ffb12384c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_33bf72fe-120a-4231-af9d-90b8358c8a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1e0c9079-abca-4154-925e-f1bfaa80e656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34108832-51a3-40f4-9a5c-759ffb12384c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1e0c9079-abca-4154-925e-f1bfaa80e656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1" xlink:type="simple" xlink:href="ccrn-20220630.xsd#LEASESOperatingLeaseMaturityDetails_1"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#LEASESLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3ed2d053-4f81-4892-af9b-2541196e71ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_ca01a1dd-44d7-48ef-ab90-70bcc904cae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3ed2d053-4f81-4892-af9b-2541196e71ed" xlink:to="loc_us-gaap_OperatingLeasePayments_ca01a1dd-44d7-48ef-ab90-70bcc904cae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ba7e276b-ca49-439c-879b-55d97269e366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3ed2d053-4f81-4892-af9b-2541196e71ed" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ba7e276b-ca49-439c-879b-55d97269e366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_f79bbb14-e242-45ef-8342-dcbd170ed645" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3ed2d053-4f81-4892-af9b-2541196e71ed" xlink:to="loc_us-gaap_OperatingLeaseCost_f79bbb14-e242-45ef-8342-dcbd170ed645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_421eab20-825d-4118-a955-fbfa05122461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3ed2d053-4f81-4892-af9b-2541196e71ed" xlink:to="loc_us-gaap_ShortTermLeaseCost_421eab20-825d-4118-a955-fbfa05122461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_fee634e9-35fd-4968-80d2-ebbd7faa0c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3ed2d053-4f81-4892-af9b-2541196e71ed" xlink:to="loc_us-gaap_VariableLeaseCost_fee634e9-35fd-4968-80d2-ebbd7faa0c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="ccrn-20220630.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7d5d20b3-dcf9-4f21-bb55-0eccfc1114df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_74e66ac2-77e3-4f63-a78e-27b2683aa4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7d5d20b3-dcf9-4f21-bb55-0eccfc1114df" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_74e66ac2-77e3-4f63-a78e-27b2683aa4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="ccrn-20220630.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6a3306d1-da3c-4ab7-905f-83d2e23f1b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_7abbc9e5-4c83-47e8-9f5d-a632283a3cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6a3306d1-da3c-4ab7-905f-83d2e23f1b72" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_7abbc9e5-4c83-47e8-9f5d-a632283a3cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_023817e3-79fc-41ab-a57f-51a33e972927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6a3306d1-da3c-4ab7-905f-83d2e23f1b72" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_023817e3-79fc-41ab-a57f-51a33e972927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5595ff71-4053-4081-96a6-d1f823baa988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_433a5550-cc79-4f67-b345-a4949c119978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5595ff71-4053-4081-96a6-d1f823baa988" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_433a5550-cc79-4f67-b345-a4949c119978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_37a77043-deeb-4a46-bde2-1ad645ec431e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_433a5550-cc79-4f67-b345-a4949c119978" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_37a77043-deeb-4a46-bde2-1ad645ec431e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2cd1e736-24cc-4ed1-b647-39ec72b73158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_37a77043-deeb-4a46-bde2-1ad645ec431e" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2cd1e736-24cc-4ed1-b647-39ec72b73158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DeferredCompensationMember_eb69a31c-7b96-4de0-8226-236810bd6dba" xlink:href="ccrn-20220630.xsd#ccrn_DeferredCompensationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2cd1e736-24cc-4ed1-b647-39ec72b73158" xlink:to="loc_ccrn_DeferredCompensationMember_eb69a31c-7b96-4de0-8226-236810bd6dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_83de1338-7b72-41c7-966a-7df875415533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_433a5550-cc79-4f67-b345-a4949c119978" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_83de1338-7b72-41c7-966a-7df875415533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10d2cb38-9cca-43aa-9895-805090a766ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_83de1338-7b72-41c7-966a-7df875415533" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10d2cb38-9cca-43aa-9895-805090a766ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_DeferredCompensationMember_1a4fe39e-6c22-47cc-96f0-fe82e412a550" xlink:href="ccrn-20220630.xsd#ccrn_DeferredCompensationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10d2cb38-9cca-43aa-9895-805090a766ff" xlink:to="loc_ccrn_DeferredCompensationMember_1a4fe39e-6c22-47cc-96f0-fe82e412a550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c1852ff6-c0d5-4b13-b14b-4dea3e9cc26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_433a5550-cc79-4f67-b345-a4949c119978" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c1852ff6-c0d5-4b13-b14b-4dea3e9cc26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b965b34-4059-4c34-9b98-c39ec4a683dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c1852ff6-c0d5-4b13-b14b-4dea3e9cc26a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b965b34-4059-4c34-9b98-c39ec4a683dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e2cebde1-b6f4-464b-bf49-59a894b7edea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b965b34-4059-4c34-9b98-c39ec4a683dc" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e2cebde1-b6f4-464b-bf49-59a894b7edea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ad0165d-04a8-45ff-b130-62e53afc66a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_433a5550-cc79-4f67-b345-a4949c119978" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ad0165d-04a8-45ff-b130-62e53afc66a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_44e26698-2dde-4064-a17d-5e500f172b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ad0165d-04a8-45ff-b130-62e53afc66a2" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_44e26698-2dde-4064-a17d-5e500f172b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_af60c50d-25be-4e57-9897-5f13d1b85624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3ad0165d-04a8-45ff-b130-62e53afc66a2" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_af60c50d-25be-4e57-9897-5f13d1b85624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8d9bc834-811c-41ad-a8d7-647a365b798d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8d9bc834-811c-41ad-a8d7-647a365b798d" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_08787f98-6e73-4a43-8c33-061329afd9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_08787f98-6e73-4a43-8c33-061329afd9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3e035c3-f327-41a1-bc1f-107ee7619636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_08787f98-6e73-4a43-8c33-061329afd9e9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3e035c3-f327-41a1-bc1f-107ee7619636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a0c9462c-4531-4231-9bfc-b7167fb6574b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c3e035c3-f327-41a1-bc1f-107ee7619636" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a0c9462c-4531-4231-9bfc-b7167fb6574b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_543ff8ed-edac-4c37-a21e-c3b68f7cff1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_543ff8ed-edac-4c37-a21e-c3b68f7cff1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_57471969-8a78-4520-a8c3-c0c0299c7b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_543ff8ed-edac-4c37-a21e-c3b68f7cff1a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_57471969-8a78-4520-a8c3-c0c0299c7b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EarnoutNotesPayableMember_c8d54ec7-5aee-493f-be43-44072d839920" xlink:href="ccrn-20220630.xsd#ccrn_EarnoutNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_57471969-8a78-4520-a8c3-c0c0299c7b00" xlink:to="loc_ccrn_EarnoutNotesPayableMember_c8d54ec7-5aee-493f-be43-44072d839920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_be285797-a1e3-47ab-8c13-fe7d58e53406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_57471969-8a78-4520-a8c3-c0c0299c7b00" xlink:to="loc_us-gaap_SecuredDebtMember_be285797-a1e3-47ab-8c13-fe7d58e53406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1be90e72-7a99-4e22-a422-a47f5944dab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:to="loc_us-gaap_CreditFacilityAxis_1be90e72-7a99-4e22-a422-a47f5944dab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_70c8f9d5-6a83-4fd5-9ec2-67bfd129b79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1be90e72-7a99-4e22-a422-a47f5944dab7" xlink:to="loc_us-gaap_CreditFacilityDomain_70c8f9d5-6a83-4fd5-9ec2-67bfd129b79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SeniorSecuredAssetBasedLoanMember_f25b7cfe-8cf9-4a20-991d-5a4b3b18099e" xlink:href="ccrn-20220630.xsd#ccrn_SeniorSecuredAssetBasedLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_70c8f9d5-6a83-4fd5-9ec2-67bfd129b79e" xlink:to="loc_ccrn_SeniorSecuredAssetBasedLoanMember_f25b7cfe-8cf9-4a20-991d-5a4b3b18099e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_7d4494fd-6203-41b5-934a-8bad9481fae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_7d4494fd-6203-41b5-934a-8bad9481fae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_85b58fce-590b-45e6-9573-f876185c5084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_7d4494fd-6203-41b5-934a-8bad9481fae4" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_85b58fce-590b-45e6-9573-f876185c5084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cc149583-c3cd-4883-8196-5fbc8704762b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_85b58fce-590b-45e6-9573-f876185c5084" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cc149583-c3cd-4883-8196-5fbc8704762b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b62deb86-e308-4f3b-b044-34bfed81fedf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cc149583-c3cd-4883-8196-5fbc8704762b" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_b62deb86-e308-4f3b-b044-34bfed81fedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_459febad-f2ac-4746-987a-199dc275ca63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cc149583-c3cd-4883-8196-5fbc8704762b" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_459febad-f2ac-4746-987a-199dc275ca63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4f0d0888-afea-4168-a0a7-0cadcf0790fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4f0d0888-afea-4168-a0a7-0cadcf0790fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d75959c-d89c-492d-b671-a4f540d9f174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4f0d0888-afea-4168-a0a7-0cadcf0790fd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d75959c-d89c-492d-b671-a4f540d9f174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_WorkforceSolutionsGroupIncMember_8f66ce65-4490-4306-8dd3-e21a4b85d09d" xlink:href="ccrn-20220630.xsd#ccrn_WorkforceSolutionsGroupIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d75959c-d89c-492d-b671-a4f540d9f174" xlink:to="loc_ccrn_WorkforceSolutionsGroupIncMember_8f66ce65-4490-4306-8dd3-e21a4b85d09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SelectedIncMember_2a89afb1-c5d8-4e76-bf34-ee7976608b2e" xlink:href="ccrn-20220630.xsd#ccrn_SelectedIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0d75959c-d89c-492d-b671-a4f540d9f174" xlink:to="loc_ccrn_SelectedIncMember_2a89afb1-c5d8-4e76-bf34-ee7976608b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_557d37b3-f169-4f24-b53e-6ea29133d79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionQuantitativeDisclosuresLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresTable_66d7217a-2da5-471e-9d70-84762a1e3c9d" xlink:to="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_557d37b3-f169-4f24-b53e-6ea29133d79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_710ce77b-fd83-4583-8b4d-4a44be123078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_557d37b3-f169-4f24-b53e-6ea29133d79e" xlink:to="loc_us-gaap_DebtInstrumentFairValue_710ce77b-fd83-4583-8b4d-4a44be123078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure_f14a9a45-2dca-43cf-a7b8-d1516e535e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_557d37b3-f169-4f24-b53e-6ea29133d79e" xlink:to="loc_us-gaap_LinesOfCreditFairValueDisclosure_f14a9a45-2dca-43cf-a7b8-d1516e535e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a8d7d87b-6cf7-46f0-a969-bac2c82e8c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems_557d37b3-f169-4f24-b53e-6ea29133d79e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a8d7d87b-6cf7-46f0-a969-bac2c82e8c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ccrn-20220630.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_fbd0c561-69d1-4363-adae-6f4462fc210c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_52558cb3-9991-4765-a87c-b75edaa444cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fbd0c561-69d1-4363-adae-6f4462fc210c" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_52558cb3-9991-4765-a87c-b75edaa444cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="ccrn-20220630.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7622ed43-72ea-4b1c-bd5f-8cfe7d23e6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_e0397135-1e99-4c81-99b0-0980f98dedd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7622ed43-72ea-4b1c-bd5f-8cfe7d23e6f3" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_e0397135-1e99-4c81-99b0-0980f98dedd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#STOCKHOLDERSEQUITYAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_59640d11-283a-4229-84b3-44e52ee6b5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_59640d11-283a-4229-84b3-44e52ee6b5d5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_633e5779-6f59-462a-9d95-7718326effcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_633e5779-6f59-462a-9d95-7718326effcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7d28c86b-fe82-4421-a417-319c8daf0ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_633e5779-6f59-462a-9d95-7718326effcb" xlink:to="loc_us-gaap_EquityComponentDomain_7d28c86b-fe82-4421-a417-319c8daf0ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3006dc58-1c6e-480f-822f-60fb7e532d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7d28c86b-fe82-4421-a417-319c8daf0ffa" xlink:to="loc_us-gaap_CommonStockMember_3006dc58-1c6e-480f-822f-60fb7e532d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_014684f9-a5a6-4fb3-898d-6a75d925a176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:to="loc_us-gaap_PlanNameAxis_014684f9-a5a6-4fb3-898d-6a75d925a176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_017fbb34-ca84-4777-a5f8-0cd6552e8d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_014684f9-a5a6-4fb3-898d-6a75d925a176" xlink:to="loc_us-gaap_PlanNameDomain_017fbb34-ca84-4777-a5f8-0cd6552e8d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OmnibusPlanMember_c8a3b09f-e01a-49b0-93e0-c7f53265400e" xlink:href="ccrn-20220630.xsd#ccrn_OmnibusPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_017fbb34-ca84-4777-a5f8-0cd6552e8d51" xlink:to="loc_ccrn_OmnibusPlanMember_c8a3b09f-e01a-49b0-93e0-c7f53265400e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a6b8604c-bcad-445c-82f8-c71940c73271" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:to="loc_srt_RangeAxis_a6b8604c-bcad-445c-82f8-c71940c73271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_21dd763c-4205-4914-8827-858939bfd80e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a6b8604c-bcad-445c-82f8-c71940c73271" xlink:to="loc_srt_RangeMember_21dd763c-4205-4914-8827-858939bfd80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fea03635-8228-4743-9ec9-ec929232d964" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_21dd763c-4205-4914-8827-858939bfd80e" xlink:to="loc_srt_MinimumMember_fea03635-8228-4743-9ec9-ec929232d964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_f44c081d-ef2a-42bf-9688-ec44ce41f2ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:to="loc_srt_TitleOfIndividualAxis_f44c081d-ef2a-42bf-9688-ec44ce41f2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_82e1ceaa-5086-4c45-addb-5087026fe9b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_f44c081d-ef2a-42bf-9688-ec44ce41f2ce" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_82e1ceaa-5086-4c45-addb-5087026fe9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_fa48269d-4852-46c8-9a71-569646ff8c80" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_82e1ceaa-5086-4c45-addb-5087026fe9b2" xlink:to="loc_srt_DirectorMember_fa48269d-4852-46c8-9a71-569646ff8c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_786fd5d6-3f1b-4cc2-8dc0-e51c4b94966d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_786fd5d6-3f1b-4cc2-8dc0-e51c4b94966d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c1e8fab9-08b8-4246-95ba-45c71741e980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_786fd5d6-3f1b-4cc2-8dc0-e51c4b94966d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c1e8fab9-08b8-4246-95ba-45c71741e980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_b4c5ef76-266f-4c91-957c-9d411d7a0571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c1e8fab9-08b8-4246-95ba-45c71741e980" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_b4c5ef76-266f-4c91-957c-9d411d7a0571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0c8f8d13-54f0-45d2-bb7d-dc47cf8df784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:to="loc_us-gaap_AwardTypeAxis_0c8f8d13-54f0-45d2-bb7d-dc47cf8df784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5993b6b3-57bc-45b8-bb4e-8967215415c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0c8f8d13-54f0-45d2-bb7d-dc47cf8df784" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5993b6b3-57bc-45b8-bb4e-8967215415c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_RestrictedStockAndPerformanceSharesMember_d7bc50bf-1ea2-49c9-b827-c48294cc8df8" xlink:href="ccrn-20220630.xsd#ccrn_RestrictedStockAndPerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5993b6b3-57bc-45b8-bb4e-8967215415c7" xlink:to="loc_ccrn_RestrictedStockAndPerformanceSharesMember_d7bc50bf-1ea2-49c9-b827-c48294cc8df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_b359245b-a159-4ed7-b810-c77d06ecde29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_RestrictedStockAndPerformanceSharesMember_d7bc50bf-1ea2-49c9-b827-c48294cc8df8" xlink:to="loc_us-gaap_PerformanceSharesMember_b359245b-a159-4ed7-b810-c77d06ecde29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_61b99897-96da-44a3-a7ee-cca09bd6abfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ccrn_RestrictedStockAndPerformanceSharesMember_d7bc50bf-1ea2-49c9-b827-c48294cc8df8" xlink:to="loc_us-gaap_RestrictedStockMember_61b99897-96da-44a3-a7ee-cca09bd6abfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eeeebfd0-a8d3-487f-9ac1-d0391aac246d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_934378a9-44de-4891-82de-5de2e0122c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_934378a9-44de-4891-82de-5de2e0122c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_ca08f3a2-75a7-45cf-9e29-adee3f4aeb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_ca08f3a2-75a7-45cf-9e29-adee3f4aeb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_eb996cfc-d6bc-4519-a7b6-bf68cef9ddd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_eb996cfc-d6bc-4519-a7b6-bf68cef9ddd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2f200f85-85b6-4e0d-8486-08aef9724eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2f200f85-85b6-4e0d-8486-08aef9724eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_87ff0c01-666d-4a50-ad1b-1fcf6f1533f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_87ff0c01-666d-4a50-ad1b-1fcf6f1533f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_4dfebe49-08c3-437f-b541-54fdbcab06b9" xlink:href="ccrn-20220630.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments_4dfebe49-08c3-437f-b541-54fdbcab06b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_1b224f85-2db5-4112-9217-76ac2706dabe" xlink:href="ccrn-20220630.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage_1b224f85-2db5-4112-9217-76ac2706dabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dfe386b5-5922-4ba9-a0ba-6829f4627c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dfe386b5-5922-4ba9-a0ba-6829f4627c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_b3b2fee6-3d16-4f4e-8d41-560aeb24fc99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_b3b2fee6-3d16-4f4e-8d41-560aeb24fc99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_cca2d5be-bb7c-4a98-b21d-22b297498df1" xlink:href="ccrn-20220630.xsd#ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6fd076c5-fb87-436c-b390-5288413ca8a3" xlink:to="loc_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet_cca2d5be-bb7c-4a98-b21d-22b297498df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#STOCKHOLDERSEQUITYRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_156ffbf3-acd8-4f93-8e16-5edb0979d10f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_761ed618-26e3-4fd3-af60-80b85cdd5bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_156ffbf3-acd8-4f93-8e16-5edb0979d10f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_761ed618-26e3-4fd3-af60-80b85cdd5bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5d364250-6d30-4c27-af72-39e25dbfbc63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_761ed618-26e3-4fd3-af60-80b85cdd5bda" xlink:to="loc_us-gaap_AwardTypeAxis_5d364250-6d30-4c27-af72-39e25dbfbc63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70f4b24e-2bbe-4829-9b60-73229f32704f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5d364250-6d30-4c27-af72-39e25dbfbc63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70f4b24e-2bbe-4829-9b60-73229f32704f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_471e442d-4294-45be-aae6-a447fcabb689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70f4b24e-2bbe-4829-9b60-73229f32704f" xlink:to="loc_us-gaap_RestrictedStockMember_471e442d-4294-45be-aae6-a447fcabb689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_95b0942f-ba8e-4fa7-85ff-0cce47901813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_70f4b24e-2bbe-4829-9b60-73229f32704f" xlink:to="loc_us-gaap_PerformanceSharesMember_95b0942f-ba8e-4fa7-85ff-0cce47901813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a0d4348-df44-4f78-ae29-8f9e08a540de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_761ed618-26e3-4fd3-af60-80b85cdd5bda" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a0d4348-df44-4f78-ae29-8f9e08a540de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4815e421-8b1c-4d1d-b3ec-2f340aa05506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a0d4348-df44-4f78-ae29-8f9e08a540de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4815e421-8b1c-4d1d-b3ec-2f340aa05506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f63987bf-e730-43a4-8abf-9023cd3fb51e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4815e421-8b1c-4d1d-b3ec-2f340aa05506" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f63987bf-e730-43a4-8abf-9023cd3fb51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0c92c4d6-8abe-4292-aafb-2bf3c9b1fe2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4815e421-8b1c-4d1d-b3ec-2f340aa05506" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0c92c4d6-8abe-4292-aafb-2bf3c9b1fe2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_58ff26cc-de36-4e39-abb6-17465123c2db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4815e421-8b1c-4d1d-b3ec-2f340aa05506" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_58ff26cc-de36-4e39-abb6-17465123c2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d99fa639-f03d-47a0-9e9c-3805ecb7feb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4815e421-8b1c-4d1d-b3ec-2f340aa05506" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d99fa639-f03d-47a0-9e9c-3805ecb7feb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6286bf71-5c13-4f51-833f-17f989a62e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4815e421-8b1c-4d1d-b3ec-2f340aa05506" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6286bf71-5c13-4f51-833f-17f989a62e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_093a386a-c5cf-48fa-bfdc-9258e41d3332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7a0d4348-df44-4f78-ae29-8f9e08a540de" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_093a386a-c5cf-48fa-bfdc-9258e41d3332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_aa670cdc-8956-4b11-a787-dbdd0ed8eca8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_093a386a-c5cf-48fa-bfdc-9258e41d3332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_aa670cdc-8956-4b11-a787-dbdd0ed8eca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ae740fb7-411e-4f18-a55b-b71856cf515a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_093a386a-c5cf-48fa-bfdc-9258e41d3332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ae740fb7-411e-4f18-a55b-b71856cf515a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a555c691-9ca4-470a-9aff-c48b5217b292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_093a386a-c5cf-48fa-bfdc-9258e41d3332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a555c691-9ca4-470a-9aff-c48b5217b292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_f40f248d-3d53-4739-8fae-fceb5e0304bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_093a386a-c5cf-48fa-bfdc-9258e41d3332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_f40f248d-3d53-4739-8fae-fceb5e0304bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5a33716c-b8da-4c7d-8c13-390426d32aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_093a386a-c5cf-48fa-bfdc-9258e41d3332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5a33716c-b8da-4c7d-8c13-390426d32aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATA" xlink:type="simple" xlink:href="ccrn-20220630.xsd#SEGMENTDATA"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SEGMENTDATA" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_531a9713-034d-473f-b5f4-80121965d567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_ff7a279b-0d13-4153-91a5-ced7bb772dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_531a9713-034d-473f-b5f4-80121965d567" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_ff7a279b-0d13-4153-91a5-ced7bb772dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATATables" xlink:type="simple" xlink:href="ccrn-20220630.xsd#SEGMENTDATATables"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SEGMENTDATATables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1713f415-ded2-4250-bfa6-b043bd04884c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_4cbad5fd-7d35-4ece-b5be-cd4cc8fce507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1713f415-ded2-4250-bfa6-b043bd04884c" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_4cbad5fd-7d35-4ece-b5be-cd4cc8fce507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#SEGMENTDATADetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_65502a04-eb32-4b42-bf73-c061bebcda73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_5563ada1-6eb6-4819-a0a1-5c2ffe036480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_65502a04-eb32-4b42-bf73-c061bebcda73" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_5563ada1-6eb6-4819-a0a1-5c2ffe036480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c4bac737-b0cf-4cc6-b1fa-c832bff45374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_5563ada1-6eb6-4819-a0a1-5c2ffe036480" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c4bac737-b0cf-4cc6-b1fa-c832bff45374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_625a769e-326c-47f4-a7ac-2c85585afbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c4bac737-b0cf-4cc6-b1fa-c832bff45374" xlink:to="loc_us-gaap_SegmentDomain_625a769e-326c-47f4-a7ac-2c85585afbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_NurseAndAlliedStaffingMember_0fb15d9d-02cd-4308-9dc4-92f9018be7c3" xlink:href="ccrn-20220630.xsd#ccrn_NurseAndAlliedStaffingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_625a769e-326c-47f4-a7ac-2c85585afbe5" xlink:to="loc_ccrn_NurseAndAlliedStaffingMember_0fb15d9d-02cd-4308-9dc4-92f9018be7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_PhysicianStaffingMember_ee91ea5b-f913-4898-beee-55b0b44d07c0" xlink:href="ccrn-20220630.xsd#ccrn_PhysicianStaffingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_625a769e-326c-47f4-a7ac-2c85585afbe5" xlink:to="loc_ccrn_PhysicianStaffingMember_ee91ea5b-f913-4898-beee-55b0b44d07c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable_5563ada1-6eb6-4819-a0a1-5c2ffe036480" xlink:to="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7cd1b247-c0ae-40ac-906c-8399583ff8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7cd1b247-c0ae-40ac-906c-8399583ff8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_9525b630-bcfc-4630-8d97-f43f281c0332" xlink:href="ccrn-20220630.xsd#ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard_9525b630-bcfc-4630-8d97-f43f281c0332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_38c629b8-ae4d-4ea9-9b00-e73db0999750" xlink:href="ccrn-20220630.xsd#ccrn_SegmentReportingUnallocatedCorporateExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_ccrn_SegmentReportingUnallocatedCorporateExpenses_38c629b8-ae4d-4ea9-9b00-e73db0999750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9c04d5e0-7d0b-4b4d-abb0-a4f9132c302e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9c04d5e0-7d0b-4b4d-abb0-a4f9132c302e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_42770361-da7b-4074-b1bd-c4d3aa977148" xlink:href="ccrn-20220630.xsd#ccrn_AcquisitionAndIntegrationRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_ccrn_AcquisitionAndIntegrationRelatedCosts_42770361-da7b-4074-b1bd-c4d3aa977148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_9f159a37-1da1-4a1a-8631-b7b958c21ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_us-gaap_RestructuringCharges_9f159a37-1da1-4a1a-8631-b7b958c21ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_de8945d5-eb09-4934-9c9a-ea4e3d0c3eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_us-gaap_AssetImpairmentCharges_de8945d5-eb09-4934-9c9a-ea4e3d0c3eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5a7f1706-1119-4482-9d23-59fe78c19d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems_fbb65799-375f-49a0-b4ad-ff3974590d09" xlink:to="loc_us-gaap_OperatingIncomeLoss_5a7f1706-1119-4482-9d23-59fe78c19d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/CONTINGENCIES" xlink:type="simple" xlink:href="ccrn-20220630.xsd#CONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/CONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_46e50285-eb79-4e3a-8f72-b378e8cabe95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f5808744-6bf0-4885-8352-40592de33299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_46e50285-eb79-4e3a-8f72-b378e8cabe95" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f5808744-6bf0-4885-8352-40592de33299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/INCOMETAXES" xlink:type="simple" xlink:href="ccrn-20220630.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_cdc19e85-dfc6-48d8-9ad9-85926fe7af8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_b93e0808-280b-45f9-9203-fe53c412b462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cdc19e85-dfc6-48d8-9ad9-85926fe7af8d" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_b93e0808-280b-45f9-9203-fe53c412b462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a1380d9e-86f6-4182-80a9-5c6b1a7167be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_40f0f7bb-31cd-4661-ba69-6d8358c0b122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a1380d9e-86f6-4182-80a9-5c6b1a7167be" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_40f0f7bb-31cd-4661-ba69-6d8358c0b122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_984f3869-4f82-426a-8b8a-ace41906c281" xlink:href="ccrn-20220630.xsd#ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a1380d9e-86f6-4182-80a9-5c6b1a7167be" xlink:to="loc_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems_984f3869-4f82-426a-8b8a-ace41906c281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="simple" xlink:href="ccrn-20220630.xsd#RELATEDPARTYTRANSACTIONS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_f6f37088-2b34-4846-96ff-3fbe1d65feb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_266a1311-3e65-4f69-a153-d26991f96fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_f6f37088-2b34-4846-96ff-3fbe1d65feb2" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_266a1311-3e65-4f69-a153-d26991f96fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="simple" xlink:href="ccrn-20220630.xsd#RELATEDPARTYTRANSACTIONSDetails"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_ca79d2a7-c0ae-4679-995d-046f9cdbc7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9c540810-154a-4c44-a00c-d4c72905c7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_ca79d2a7-c0ae-4679-995d-046f9cdbc7b9" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9c540810-154a-4c44-a00c-d4c72905c7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5f0b062f-eb89-4f0c-9e01-761d0460a638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9c540810-154a-4c44-a00c-d4c72905c7bb" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5f0b062f-eb89-4f0c-9e01-761d0460a638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f135c879-fade-4834-80f6-e350af6793e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5f0b062f-eb89-4f0c-9e01-761d0460a638" xlink:to="loc_us-gaap_RelatedPartyDomain_f135c879-fade-4834-80f6-e350af6793e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_6d51494f-9ff4-40fe-841e-c7ec314e7b52" xlink:href="ccrn-20220630.xsd#ccrn_HealthCareSystemAffiliatedWithABoardMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_f135c879-fade-4834-80f6-e350af6793e3" xlink:to="loc_ccrn_HealthCareSystemAffiliatedWithABoardMemberMember_6d51494f-9ff4-40fe-841e-c7ec314e7b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_f7d04b57-5861-4dcc-a75a-b1ee63a9731e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9c540810-154a-4c44-a00c-d4c72905c7bb" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_f7d04b57-5861-4dcc-a75a-b1ee63a9731e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_6893a096-0da6-4cc9-a3d5-cf3502229fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_f7d04b57-5861-4dcc-a75a-b1ee63a9731e" xlink:to="loc_us-gaap_RevenueFromRelatedParties_6893a096-0da6-4cc9-a3d5-cf3502229fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.crosscountryhealthcare.com/role/RECENTACCOUNTINGPRONOUNCEMENTS" xlink:type="simple" xlink:href="ccrn-20220630.xsd#RECENTACCOUNTINGPRONOUNCEMENTS"/>
  <link:presentationLink xlink:role="http://www.crosscountryhealthcare.com/role/RECENTACCOUNTINGPRONOUNCEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_25ef1460-132b-4594-87c6-5fa8702e4b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_dbcfb4ab-8bd9-4bfe-8331-f90ad137d36a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_25ef1460-132b-4594-87c6-5fa8702e4b3f" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_dbcfb4ab-8bd9-4bfe-8331-f90ad137d36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ccrn-20220630_g1.jpg
<TEXT>
begin 644 ccrn-20220630_g1.jpg
M_]C_X1#?17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    D    <@$R  (    4
M    EH=I  0    !    K    -@ +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-#(#(P,3D@*$UA8VEN=&]S:"D ,C Q.3HP-CHQ-R Q-#HT-CHR
M,@     #H $  P    $  0  H ( !     $   Z<H , !     $   7=
M      8! P #     0 &   !&@ %     0   28!&P %     0   2X!*  #
M     0 "   " 0 $     0   38" @ $     0  #Z$         2     $
M  !(     ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4 9(     !_]L A  ,
M" @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,
M# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,
M#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" !
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M4')I;G0 .$))300E       0UPI0%;\,*P7ZOCQ>"-2! 3A"24T$.@
MY0   !     !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0
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M;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP
M $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/
M8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M1W)N(&1O=6) ;^            !";" @9&]U8D!OX            $)R9%15
M;G1&(U)L=                $)L9"!5;G1&(U)L=                %)S
M;'15;G1&(U!X;$!RP           "G9E8W1O<D1A=&%B;V]L 0    !09U!S
M96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M    5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M       08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M
M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12
M:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M
M   0 2P    !  $!+     $  3A"24T$)@      #@             _@
M.$))300-       $    'CA"24T$&0      !    !XX0DE- _,       D
M          $ .$))32<0       *  $          3A"24T#]0      2  O
M9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:
M!@       0 U     0 M    !@       3A"24T#^       <   ________
M_____________________P/H     /____________________________\#
MZ     #_____________________________ ^@     ________________
M_____________P/H   X0DE-!         (  #A"24T$ @       @  .$))
M300P       ! 0 X0DE-!"T       8  0    (X0DE-! @      !     !
M   "0    D      .$))300>       $     #A"24T$&@     #60    8
M            !=T   Z<    $@!# $, 2 !? $8 :0!N &$ ; !? $P ;P!G
M &\ 7P!2 $( 1P    $                          0             .
MG   !=T                      0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P  !=T     4F=H=&QO;F<   Z<    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   .G     -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$%       !     (X0DE-! P
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MQ $_   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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MDTFLUL%=I-=;+6V_V_\ 1KJ$DDB;32DDDD%/_]D .$))300A      !=
M 0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    %P!! &0
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M(
M    $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0
M  ($    %')865H   (8    %&=865H   (L    %&)865H   )     %&1M
M;F0   )4    <&1M9&0   +$    B'9U960   -,    AG9I97<   /4
M)&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P    #')44D,   0\
M   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P>7)I9VAT
M("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C
M !)S4D="($E%0S8Q.38V+3(N,0              $G-21T(@245#-C$Y-C8M
M,BXQ
M          !865H@        \U$  0    $6S%A96B
M    6%E:(        &^B   X]0   Y!865H@        8ID  +>%   8VEA9
M6B         DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N
M:65C+F-H               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                                     &1E<V,
M        +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E
M("T@<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@
M8V]L;W5R('-P86-E("T@<U)'0@                            !D97-C
M         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y
M-C8M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N
M(&EN($E%0S8Q.38V+3(N,0                                  =FEE
M=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6
M %    !7'^=M96%S          $                        "CP    )S
M:6<@     $-25"!C=7)V        !      %  H #P 4 !D '@ C "@ +0 R
M #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0": )\
MI "I *X L@"W +P P0#& ,L T #5 -L X #E .L \ #V /L! 0$' 0T!$P$9
M 1\!)0$K 3(!. $^ 44!3 %2 5D!8 %G 6X!=0%\ 8,!BP&2 9H!H0&I ;$!
MN0'! <D!T0'9 >$!Z0'R ?H" P(, A0"'0(F B\". )! DL"5 )= F<"<0)Z
M H0"C@*8 J("K *V L$"RP+5 N "ZP+U P #"P,6 R$#+0,X T,#3P-: V8#
M<@-^ XH#E@.B ZX#N@/' ],#X /L _D$!@03!" $+00[!$@$501C!'$$?@2,
M!)H$J 2V!,0$TP3A!/ $_@4-!1P%*P4Z!4D%6 5G!7<%A@66!:8%M07%!=4%
MY07V!@8&%@8G!C<&2 99!FH&>P:,!IT&KP; !M$&XP;U!P<'&0<K!ST'3P=A
M!W0'A@>9!ZP'OP?2!^4'^ @+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC["1 )
M)0DZ"4\)9 EY"8\)I FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*\PL+
M"R(+.0M1"VD+@ N8"[ +R OA"_D,$@PJ#$,,7 QU#(X,IPS #-D,\PT-#28-
M0 U:#70-C@VI#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/>@^6
M#[,/SP_L$ D0)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$<D1Z!('$B82
M11)D$H02HQ+#$N,3 Q,C$T,38Q.#$Z03Q1/E% 84)Q1)%&H4BQ2M%,X4\!42
M%3055A5X%9L5O17@%@,6)A9)%FP6CQ:R%M86^A<=%T$791>)%ZX7TA?W&!L8
M0!AE&(H8KQC5&/H9(!E%&6L9D1FW&=T:!!HJ&E$:=QJ>&L4:[!L4&SL;8QN*
M&[(;VAP"'"H<4AQ['*,<S!SU'1X=1QUP'9D=PQWL'A8>0!YJ'I0>OA[I'Q,?
M/A]I'Y0?OQ_J(!4@02!L()@@Q"#P(1PA2"%U(:$ASB'[(B<B52*"(J\BW2,*
M(S@C9B.4(\(C\"0?)$TD?"2K)-HE"24X)6@EER7')?<F)R97)H<FMR;H)Q@G
M22=Z)ZLGW"@-*#\H<2BB*-0I!BDX*6LIG2G0*@(J-2IH*ILJSRL"*S8K:2N=
M*]$L!2PY+&XLHBS7+0PM02UV+:LMX2X6+DPN@BZW+NXO)"]:+Y$OQR_^,#4P
M;#"D,-LQ$C%*,8(QNC'R,BHR8S*;,M0S#3-&,W\SN#/Q-"LT932>--@U$S5-
M-8<UPC7]-C<V<C:N-NDW)#=@-YPWUS@4.% XC#C(.04Y0CE_.;PY^3HV.G0Z
MLCKO.RT[:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B ^8#Z@/N _(3]A/Z(_XD C
M0&1 ID#G02E!:D&L0>Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:1=Y&
M(D9G1JM&\$<U1WM'P$@%2$M(D4C721U)8TFI2?!*-TI]2L1+#$M32YI+XDPJ
M3'),NDT"34I-DTW<3B5.;DZW3P!/24^33]U0)U!Q4+M1!E%049M1YE(Q4GQ2
MQU,34U]3JE/V5$)4CU3;52A5=57"5@]67%:I5O=71%>25^!8+UA]6,M9&EEI
M6;A:!UI66J9:]5M%6Y5;Y5PU7(9<UETG77A=R5X:7FQ>O5\/7V%?LV %8%=@
MJF#\84]AHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUGDV?I
M:#]HEFCL:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>;WAO
MT7 K<(9PX'$Z<95Q\')+<J9S 7-=<[AT%'1P=,QU*'6%=>%V/G:;=OAW5G>S
M>!%X;GC,>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^ 7YB?L)_(W^$?^6
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M 1$  A$! Q$!_\0!00 !  (" P$! 0$           0* PD'" L&!0(! 0$
M  <! 0$              0(#! 4&!P@)"A    ,' 00%"0D! 0$  P$! 0($
M #$#!08'"" P0!$)$#05-0I0(4$3%!8V.!E@<!(R,Q<W&#F &D+0(B0E(Q$
M 00! @(% @\*" P$ @$5 @$#! 4&$0< $B A@1,(,100,$#P05%Q(A75EK9W
MMSA0D;'!M7;6-Y=X8:'A,B,6-IA@<-'Q0M(STR34%X> E"4U4C2G8D-3E;AR
M@I,F9B<8T&-S@T1T158)$@ "  ($!@P)!0T%" (" @,! A$# "$Q!"!!47$2
M!3! 88&1H;'1(C)R$Q#!0E*2LM(S!E!B(W,48/#A@J+"D[,T=)0U!W" 0R05
M\5-CH\/3U-7B@T2T%M E5,3_V@ , P$! A$#$0   +_
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                             !^;/#\:K+)EC]%1F
M                     'SM:6--#]6G-^M3B                 (TT/G:
MTH^DH3YX                 !\Q7EQQA^K3F_6IQ
M
M
M            '1/;,?J,Z-A=:N\8OH[M6/ZNY^TXKR%'^0?9VL_:+ WG>S4\
MALYT3*[C>:9SNYJU^                              !^/5EU:[[B=3?
M0\-KJW3&=,-GL>N&;M?E;B0#DVPJ]G\%=]X]4R&RK1\IMZYQF^^&I9
M       =(=JL-1_1<+K7W?%]'MKQ_5S/6G$&2HQ9H"9+'F7&5^U6OW?>+5,A
MLFTC*;:N=YGNMJ]^           !PKE*&H?HV%UB[WB>@VWX[J/L=EP-E[?\
M*K*!R38U>R>$NNZ6KW^Q#3,EM2T#,;.]$RO[%*8
M
M
M     #C:^I5X^RZU7?[-K/2':K      #8/IV2L?\3VC?WQ_8_HJ,P     %
M';U5H/7[,6P       _L^HMYON[2KSOB;CM9KUYWSU+([+M&RG,&-K@
M    =7,_:5J>X:MH"Z_K?"65H      =X-5O[%_%MGL-\:V7[FTJ
M #CV\I5Z>RZW7<[-K/1?;,>      .\.JW]@+CVR6&^-;+S+C*X        '
M\1:<^E8.MSVW5]0O1\+^74@     !S!C:^]3D^P6.N*;/WUU'(@
M
M
M               ?GSPK@=LU>JGZ U#A?*4        .U6OWEN[SEN>\OE.P
M     #S2?<?+.J6P68          GR1V>:)EK!/'=DWU\CV'Z2A.       .
M.KVE5)]!:?6Y[=J_SM:4       #GW#W-M+SQN-@_CFRY8       !BBKS]E
MUJI=Z'TW@K+6X        Y"LJMEWAVTVAN#;;]]9U       !KJW3&4V_2^C
MZU=XQ8        S0;K>79ZV_YUW/NCK%\
M
M                                                        .K&?
MLZ/7JG0=9&]XH         #=_P KS]TOS#O7+..K    #S2?<?+.J6P68
M        ':K7[RXUYJW;<_S'.@     #7-NN,HV>K- ZD;%9          ;B
M.:YN[EY:WWFG%UP     !Q5D*-(3U/H6FSIF#          ':O7[RZ_Y=WO:
MSS[,      ?X5A.[ZG4O]$:=^14E          ^FH3VM//NWV?N#[9+EB
M
M
M                  !K8W?%T-O6W/.#,M;@          =Q]9OK[/D?HG</
M6KT   #S2?<?+.J6P68            _N"TSP/;K8WGG<?\ 0    #2QT_!4
M=O56@_&75,          #N'K5[?L\A]&[::[>     #A;*4//^]@<XZ#;?C@
M          !^E)&WAYQW2S#PW:@    /\*=GI32:V';]6            W+\
MSSEXGRKOW(=E5
M
M                                  UO;MBZ _K_ )SQK?4@
M   .QV$NO0(\?='[FZQ?   #S2?<?+.J6P68             MK>=]RM&\$V
MT    :>^DX2A[ZUY[^%5E            [5:_>>A5XWZ3V/PET    /P:TOG
M[^P><:PM\Q(            %J#@.W6P_/6X@   "KSWG4JD7HK30
M    -F^B96_%Y%Z+R58U0
M
M                                        .L>=M/.P]G\SX'R]N
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M8\=WM/J9L-EKBW7&:>>E83K)G;0    ;<^<YJ^UY&Z)^M3B
M
M
M     !$FAY^GL+G&K+?\0  !+EC8!X_L=HC@NV]S]8O@  !_AJNW_$5./0VG
M:M=^Q    VZ\YS5^?R'T7/   /-)]Q\LZI;!9@ "\3Y5WX     <39&CT9VO
M'Z:NF8/J5L5F   -R_,\Y?,\D=#   _-GAYYGLKFNN'=L6  !*EC8"X_L=IC
M@6W=O];O0  !_$6J3H.'J8>A]-UD[UB@  !:0X)MMM/SON0   ZWYNU\UGW!
MRWY*XD  $N6-A3C>R6@N#;;W"UN]    ^!O*>A;K>NU@>\:GU!V2R   '[-*
M;T&_'72-E^C94  #S^?8/.-470L.  !LFTC*6Q?/6X[<><YK/    ,$6IWH>
M&K$]VU33WTG"    6D.";;;3\[[D
M
M                                              !70[3K%,OTUHX
M '8##W-Y#RIO^U/G^7     &**N%VO5Z@'I'2OG:TH  %S[S'O-B7C&S  #S
M2?<?+.J6P68  ]6/Y^=?      $.:%?SL.N4X?2VD?$W5,  3)8^FIX7ZKV#
MPUR  *YG:M8IG^F='   YBQE>\CY4W_;ASK,@    "--"KUWG4ZF7H;3H\T
M !^]1F]'?Q3T_N=K%\  !4_]":=5<[_J(  ^]LZEZ;RAT'<!S?-      ?@5
MI:S7<]5JF^@M/^2N)  !RC85KW/DSH.UGGV8  &O[<,;YSOM/F0  %G#A6UV
MY/.FYSY(@     :CNBX:F1Z;T;J)L=D  /Z+2_ MNME>>=Q
M
M
M     'PUW3\U'W#RW@/+VP  ['82Z]!WQUTCMQKEZ      !J:Z'AJ'WK3GO
MP5Y3  '.>)N/2N\/=2Y"LZH 'FD^X^6=4M@LP !ZL?S\Z^       -+/3\%1
M$]:<]_D  %WWROON^;DFQ  ?-UY/-.]P\MZXYNU  '*N/K>@=X\Z/L T_)
M     5S^TZQ3.]-:/_(  -]G(]BN[^6-]   \WWVSR_H]M5@  +N7EG?=^/(
MMB       '0G;L=11]8\^Z@;)9 #LY@KN^KY'Z'WRU'(@  5/_0FG57._P"H
M@ #=IRW/7KO)W0?]       ..KVE2L]0:+HTZMKX _4IQN1^:-XL6<7V8
M
M
M               "N!VS5Z;?I?2  !^Q2F]"'QSTC95H^5        TY]*PE
M#CUMSS\^>   N%^;=VLL<.VD #S2?<?+.J6P68  ]6/Y^=?        \^[V)
MS?5;O^(  %IC@6W6R_/.X@ :$NN:[2)]3Z$  !>T\F]!W7\NSP       %,S
MTUH]<_M.L  #]NE-Z8GAKJG83#7( '%60H^7K[RY-CB  [;:[>>E1X?ZGE@
M       X1RMO0C]<\[US;KC!L T_)7TO(_0^R.$N@  !0(]?\YU)]$PP  ]%
M3Q?TS8?IF3        Q15"O1VEUENZ:H.0K*K>4\J;_N-YIFP
M
M           !^/2ONB&F^A>%,7O6W'I?C/\ U    =.>*>ANM?,.R?S&'^31
M_F9_,8_S%_,S^9H_S%_,T?XB_F=_,8_Q%_,T?YG?Q&/\S1_B9_,T?XF?S&/\
M3OYF?Q&/\3OYFC_$8_Q._4N;*55HR:U#Z*^Q7VF1P').7U/FO8-!YCSFBYYJ
M8                              \Z#VES+7WN.-  %F;AFU6_?-^Z@
M      54/0.H52_06G@#]"2.[GEF>M,\"V[8#I^2  \TGW'RSJEL%F  /5C^
M?G7P       *M7?-1J8^A].  %B;C&S7/?,>\@ 4'?7?.]/W2,(  -T?,,[?
M \E]"        '&-_2\U?V_RSA+*T  !<%\W;K9>X;M0 &O;<L;YTOM'F0
MWB<JS]Y_RCT         #B;(T?/N]A\W["8:YO.^4N@<DV-4   #S4O</+.I
M.Q68 'Z]./J@^ NNRY8@       #_"GSZ2TK15UC7KYODCH>P_3,F
M
M               !PEAM^K:^>_J7HLX]] ^)[;;H]Q"QQWCYA6L?0_R$_P!0
M   XYUG;ZJOR2^YO4_DW<OXJ38JK%/-AGFQ5&*M'#4CAGCAJ38J[!4FPSL%6
M?#78*DV&>."O'%5FC5(X:LV&O&/4CAJ38*Z/6FP5)L%:."M-@J31ZS!7FP5)
MHU6.&XC^_D,7VGW/C?>+H?GS8WTWRWM1ZOX^YFS6B@
M         =.=EL?-B]O<N  'U5O/Z8GAKJG.N)N         /Q:LOG3^T>9]
M#MMQWUUM/8"X_LEG#A6U]P]:O0  /-)]Q\LZI;!9@ #U8_GYU\       "O9
MV36J5_I_10 !8%X]LEU[R[O8 ^(NJ?E[>\N3?.5Y0 !Z&/C7I6S+1LJ
M   !5+]!:?50] Z@  -MO.LS?V\@]&  U8[_ (CSZO8G-P !N+YKF[['D;H@
M         X(RUOR_CJW[%*8    >8[[KY3U^S%L !(ECZCW@GK7WMI4
M    C30X%RUOV#P]R
M                                       !IBXY[LJ/^5?M#Q3:;;@N
M(1[F,>XA@N%CONGS"M:^@_D)_J   ''.M;A51^2GW+ZH<G[KBJL4\V&>;%48
MJT<-2.&>.&I-BKL%2;#.P59\-=@J389XX*\<56:-4CAJS8:\8]2.&I-@KH]:
M;!4FP5HX*TV"I-'K,%>;!4FC58X;B,>K/'J,%Q&/5GDW-MM)ZSY"L&>@?FML
M[Z7Y-                           KB]KUBFMZ8T<  ;PN59^]#Y1Z
M       !J/Z+AM4G0</9.XCM'/N'N0   /-)]Q\LZI;!9@ #U8_GYU\
M  "OUV'6Z4/J+1  !8)X[LEUKR]O8 U1]!P_G\>PN<  #M[KE[Z4OA_J7^@
M       '3K9;'S8?;W+@ !]U:5/47\%=:_2DB -=^YXSSK/:',P !]G:S^E1
MX@ZGV(PMR              !YHWN/EG578+,  72_,.]6&.-;*
M
M                      /\1K0>9_JY6=\X?5R+7C@N&"XA'N8Q[B&"X1[E
M8_[A\PK7/?OD)_J   ''&M;A50^2_P!S.IO*>Z8IYL,\V*HQ5HX:D<,\<-2;
M%78*DV&=@JSX:[!4FPSQP5XXJLT:I'#5FPUXQZD<-2;!71ZTV"I-@K1P5IL%
M2:/68*\V"I-&JQPW$8]6>/48+B,>K/'JQP5XQZT^SSI_DJV-ZF^.':[9^.@
M                        4G?4>AU_NP:X  +J?E_>["''-D
M      \TGW'RSJEL%F  /5C^?G7P       *]?9-:I8>G]%  %DGB.T7&O-6
M[@"MAV_5J=?I320 !8FXQLUSWS'O(         'F@>Y.5]6\_:  #TF/$74>
MY>LWP X9R=#S!/>')_Y  !M)T'+WU/(_0^1K*J              //Z]@\XU
M0]"PX  Y6Q];T /'_1MANF9,
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MO[G?F3>=J?/\N             !4[]"Z=5@[]J(  'V]I4MJ^>-RL><3V?\
M;I3
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M(            Z/[58><%[8Y?AB   ';'7KRROP[:=_7(-CYAQM<
M
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M.7,=6
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MWR/Y2XD  ^KMY_4X\"=<                'FD^X^6=4M@LP !ZL?S\Z^
M    !U)V*RH(^O>==0-DL@ !;I\Y[G9ZX1M@ %';U5H.B7K.O  "^_Y%Z+N$
MYMF@         *>_I+2JTG<=5  %U[R[O=@7CVR  #3!T[!41_6?/H<T
M !RYCJVX7FV;W,\RSFXCFN;YAQM<         #@[*V_G6>T.9]8,]:     #
M]FE-M#T/+;FN99S<US+.=T]7OP
M                                                 !$DKU)/%7VQ
MTB\'^@<>NPW"/<,-S"-<1P7$,%PP7$(]S&/<0P7"/<H]RP7$,%P_R(6BNU?*
M*T-VKY2   #BK5=XJ;?*7[J=6N:=JPSQPU)L5=@J389V"K/AKL%2;#/'!7CB
MJS1JD<-6;#7C'J1PU)L%='K38*DV"M'!6FP5)H]9@KS8*DT:K'#<1CU9X]1@
MN(QZL\>K'!7C'K3QZD8]S&/5FP5)HUS&/5CO=[%\^+>_I3XOS)J
M              'EC^^^1_*7$@ 'U=O/ZG'@3K@                \TGW'
MRSJEL%F  /5C^?G7P    !$FATAVJPT2=9UZM3W#5N-KZD  -KW/<Q?N\A=%
M_7IS  4=O56@Z)>LZ\  +[_D7HNX3FV:          I[^DM*K2=QU4  77O+
MN]V!>/;(  !7C[+K5,CTWHWY\\      !^M3CM'T'+[MN6Y[>#RO/]C\)=
M       ='MJQ] _U]SKK;F[4      #NCK%]NSY;GMX_*M@V*Z7D_P"X
M
M                  /SJ5U4@\1_;?2MPCWU@N$>NPW"/<,-S"-<1P7$,%PP
M7$(]S&/<0P7"/<H]RP7$,%P_R("TYVWY,6=.S_*X   <5:MO%3'Y3?=7JSS7
MM6&I-BKL%2;#.P59\-=@J389XX*\<56:-4CAJS8:\8]2.&I-@KH]:;!4FP5H
MX*TV"I-'K,%>;!4FC58X;B,>K/'J,%Q&/5GCU8X*\8]:>/4C'N8QZLV"I-&N
M8QZL8]2?=9UGPE<B]+?$G]JK8@                     #RQ_??(_E+B0
M#ZNWG]3CP)UP                >:3[CY9U2V"S  ':W7[P    #\6I+PME
M*'RMQ(   -T_+\[=Y\L[[R'950 !1V]5:#HEZSKP  OO^1>B[A.;9H
M   "GOZ2TJM)W'50 !=>\N[W8%X]L@   U"]'PM)?U)H?7[,6P       F2Q
MVO<]S%A;C>R[O^5Y[Z2A.       !ULSEK2(]3:%JFZ#AP       .Y.LWU@
M7CVQV$>.;+V$PUR
M                                   /S:-W43\,_<'37PSW?@KL%PCU
MV&X1[AAN81KB."XA@N&"XA'N8Q[B&"X1[E'N6"XA@N'^1 "TYVWY,6=.S_*X
M   <4ZMO%2WY4_=;JQS;M>*NP5)L,[!5GPUV"I-AGC@KQQ59HU2.&K-AKQCU
M(X:DV"NCUIL%2;!6C@K38*DT>LP5YL%2:-5CAN(QZL\>HP7$8]6>/5C@KQCU
MIX]2,>YC'JS8*DT:YC'JQCU)\%Q';STOQ==1]-?#+Z6OBP
M       /+']]\C^4N)  /J[>?U./ G7                !YI/N/EG5+8+,
M           #O9J>0M-<"V[>UR;8?[@   H[>JM!T2]9UX  7W_(O1=PG-LT
M         !3W]):56D[CJH  NO>7=[L"\>V0   #B/(T:J/H'3ZY_:=9^6N)
M        .P6'N;+_  W:K(_$=H^[M*@       CS0K[]AURJ%Z$T[K3G+4
M     #Z&C-OKY'L5IC@6W=O];O0
M                                             /Q[>^J ^#/NAJ)X
MG[>PW$,%=@N$>NPW"/<,-S"-<1P7$,%PP7$(]S&/<0P7"/<H]RP7$,%P_P B
M  M.=M^3%G3L_P K@  !Q3JV\5*/E9]U^K'.NU8*DV&=@JSX:[!4FPSQP5XX
MJLT:I'#5FPUXQZD<-2;!71ZTV"I-@K1P5IL%2:/68*\V"I-&JQPW$8]6>/48
M+B,>K/'JQP5XQZT\>I&/<QCU9L%2:-<QCU8QZD^"XC'JQVD]!\EW=O3GP>^X
MNL"                     /+']]\C^4N)  /J[>?U./ G7
M    !YI/N/EG5+8+,          ?KTYMOO-\U: X/MFT[0,O_H   !1V]5:#
MHEZSKP  OO\ D7HNX3FV:          I[^DM*K2=QU4  77O+N]V!>/;(
M !URS=K6^[9J]?'L>M]>,S;        =CL)=7 /-^Z[U>3[        !\S7D
MT+]<UZN3VK6-<&[8L       #]ZC-96X?M-KGSYN'VUK4
M
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M+NCK%\
M                      /F[/+4^OG]]V=57%?9N"X8+AAN(8*[!<(]=AN$
M>X8;F$:XC@N(8+A@N(1[F,>XA@N$>Y1[E@N(8+A_D0  _P!0MA=T^0EDWL'S
M#   '%&K[Q4@^6GW9ZJ<X[5@JSX:[!4FPSQP5XXJLT:I'#5FPUXQZD<-2;!7
M1ZTV"I-@K1P5IL%2:/68*\V"I-&JQPW$8]6>/48+B,>K/'JQP5XQZT\>I&/<
MQCU9L%2:-<QCU8QZD^"XC'JQC59\%S'OKMWGB];Z;^ O,N0TD
M         >6/[[Y'\I<2  ?5V\_J<>!.N                #S2?<?+.J6P
M68            &ZKE^=NY>6=]Y'LJH  H[>JM!T2]9UX  7W_(O1=PG-LT
M        !3W]):56D[CJH  NO>7=[L"\>V0       1IH:[=SQNH#I&$U$]&
MPNLO>L5^!6E      VM<^S%]GR-T3["VG         '6/.VFGSI.%U$=&PNI
M?HF&X:R=      #FG%U_0!\?]'[\ZAD0
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MR<,O:>F_@#V%RW.                    /+']]\C^4N)  /J[>?U./ G7
M               !YI/N/EG5+8+,  7!_-NZ@    ?/5Y> <O;=#]MQ^K;?L
M1\A<R   ;8>>YB_AY!Z-^E)$ "CMZJT'1+UG7@ !??\ (O1=PG-LT
M  !3W]):56D[CJH  NO>7=[L"\>V0         <?7E/5/T'#Z>^DX33-TW!]
M4M@LP    -^'(MBNY^6=]           @SPUX;GC-/O2,+IMZ9@]:^[XN+-
M    =F\%=^B_XMZ;S3BZX
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MS\_W:/-\G                   'EC^^^1_*7$@ 'U=O/ZG'@3K@
M         \TGW'RSJEL%F  /5C^?G7P     !Q'D:-5KO^H5H.Y:K_$0  N/
M^:=WLB<2V@ "CMZJT'1+UG7@ !?7\C=$W&<US8         %/#TGI-:ON&K
M "Z]Y=WNP+Q[9           /XBUU;IC-"77-=T ]@USA_)4    +Z'DCH>Y
M/F><            '7C,VVBGK&O5XNS:UT6VS'@   6%^-[+=,\P;T
M
M       !\/B]CIT?./[VZY.1^K<%>&"O'#7A@N&"X8;B&"NP7"/78;A'N&&Y
MA&N(X+B&"X8+B$>YC'N(8+A'N4>Y8+B&"X?Y$   !_J%L;NGR"LD]@^8H
MXFUG>*B7R_\ NWU0YWVW#/'!7CBJS1JD<-6;#7C'J1PU)L%='K38*DV"M'!6
MFP5)H]9@KS8*DT:K'#<1CU9X]1@N(QZL\>K'!7C'K3QZD8]S&/5FP5)HUS&/
M5C'J3X+B,>K&-5GP7,8]2/\ D0[)9CF-[KTY^?[N)L'%@
M   /,)]W<HX2RMN  /5 \!]=^CH3                >:3[CY9U2V"S  'J
MQ_/SKX       J0^BM,J]=YU,  =O=<O?2C\0=2_N  4J?4&B5\NQZV  +SG
ME'H&\?E6?          I:>GM%KS]EUH  7D?*>_[TN4;             /@;
MRG6L[?JU6;ONH_#7=,  #9[HF6]";QOTD             8XM,?3<%4']'Z7
MTTV:Q   _6IQ]+;PYU3LO@[H
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MTU\!.]FS\                   'G&^UN8]#MMQP  ])#Q)U#NGJ]^
M          !YI/N/EG5+8+,  >K'\_.O@      #X"\I^8Y[KY1Q]>4P !Z1
M/B7J'=K5K\ 5$/1NEUB^[:H  +AOFS=K*W#]I          H2^N>=Z=NE80
M 7]_('1MMG.\R             .C^U6%![UUSKJ[G[0  ?W!Z9OAGJO9/!W0
M             'Q-U3I$^IM"TD=3P(  %Q3S7NUD_B&T@
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MG@  !=W\L;[OLY'L0               'FD^X^6=4M@LP !ZL?S\Z^
M !06]><ZU"]'PH  O*^4]_WG<HV  5Q.UZQ37],:.  +"?&]DNH>8-[
M     \ROW1RKKAF[4  >E3X?ZEVZUR]              U_;AC?.S]G\S_)J
M0  %[#R=T'=GRW/              #YRO+YVWL[F?0C;L<  -^'(MBNY^6=]
M
M            XOP&YTX/F=]^^BW+O2&&M+AKQPW#!7A@KQPUX8+A@N&&XA@K
ML%PCUV&X1[AAN81KB."XA@N&"XA'N8Q[B&"X1[E'N6"XA@N'^1     #(EMS
M=Z^.-B;K7S7   '"VJ="I_\ S)^\'6'1>Q1JD<-6;#7C'J1PU)L%='K38*DV
M"M'!6FP5)H]9@KS8*DT:K'#<1CU9X]1@N(QZL\>K'!7C'K3QZD8]S&/5FP5)
MHUS&/5C'J3X+B,>K&-5GP7,8]2/^1  <C7>M7A_2GP9VA[KY2
M      %6KOFHU,?0^G  #?-R38;OOE??@         -;.[XNJSW_ %"T9P7;
M=H&AY8   #S2?<?+.J6P68  ]6/Y^=?        ID>FM&KI]IUD  7'?-.[V
M1N);0 -8&^8GSV_8_-@ !VEP%WZ77ASJF2         #HWM>/\X#VQS   <G
M6%7U#/!O69,L0             !0\]:\]TO].P0  N/>:=WLB\2V@
M       "OUV'6Z4/J+1  !MEYYF;_P!X_P"C
M                                               #BS7MUII?,']
MW2[FWH+!7CAK2X:\<-PP5X8*\<->&"X8+AAN(8*[!<(]=AN$>X8;F$:XC@N(
M8+A@N(1[F,>XA@N$>Y1[E@N(8+A_D0     'T];%>BAZU_-=V9S/+0  !PMJ
MO0J?7S,^\75W1>PX:LV&O&/4CAJ38*Z/6FP5)L%:."M-@J31ZS!7FP5)HU6.
M&XC'JSQZC!<1CU9X]6."O&/6GCU(Q[F,>K-@J31KF,>K&/4GP7$8]6,:K/@N
M8QZD?\B  'UU?#W<O2/PEVX;YXY                 UD;UBO/3]D\U  'V
M=K/Z8_AKJO-.+K@        "A!ZZYWI[Z3A!M-T#+VB>#;;N*YKF_P"X  !Y
MI/N/EG5+8+,  >K'\_.O@       4^_2.E5H.Y:J  +@_FW=;+G#MJ 'RMQ)
MY??O'D_Q5U3  'H&^/.C[5N?Y@        "I/Z)TVKIWK4@ !N/YIF[ZGD?H
M@   U4=!P^S31<M]'0F          J;^AM.JR=]U$  7#O-F[65>'[2   .H
MFQV7\1=OM;O0         -=NYXSSKO:',P !M9Y]F/0*\>]'
M                                                           X
M>UC?J;'R]_0+T[YSWO%7A@KQPUI<->.&X8*\,%>.&O#!<,%PPW$,%=@N$>NP
MW"/<,-S"-<1P7$,%PP7$(]S&/<0P7"/<H]RP7$,%P_R(     ?MU+&[-Z/\
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M\3YZ_LCFP  W7<NSU[7R;T$
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MMEN+SIN8
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M=M?/Z]@\XZ<[+8@ #NSJU_Z.GBGI_P"M3B !YI/N/EG5+8+,  >K'\_.O@
M     56._P"H50_0FG@ "V[YUW*T-P;;0 /RZD/-E]N\MZE;%9@ #D2RJ^@%
MX_Z-L=TG*       5H^Y:K3X](Z4  !8DXQLUS_S'O(  X1RMOYXGLOFO478
M[( 2Y8V7.&[3;#\][C]S:5       !KRW/&>=A[/YG@B  Y.L*OI\^$.L?N4
MI@ /\*57J#1*^78];  VCZ#E[I_F#>NYNLWP       _#JR^<;[6YCTJVBP
M %]3R/T3<?S3-@
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MXFCEZJT#K9G+4  ?T7X/(G1-P/-\V  /-)]Q\LZI;!9@ #U8_GYU\
M"KSWG4JD7HK30 !:T\^[A:O\_;>  -!?7M=I(>I="   Y1L*UWGRQONYGF6<
M     'Y\\*J'H'4*K_?M0QQ  #[*VG](_P 1]1[18&[  ^5N)* OK_G.L#?,
M2  !VCP%W;3\\;EOAY)L,R6(     '!V5M_/J]B<WZ1;58  "P;QS9+JWE_>
MP !5R[WJ52GT1IH  'T]">RWPW:;0'!]LYAQM<     "/-"FGZ8T>NAVG60
M!SABKCTT?"_5?HJ,P
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M^;0               '%M_1\X3VQS#K3G+4  #^C=QRS/6CN";=L;TK)@
M=2=BLJN7>]2KV]CUN#/   "P[QG9;HWF+>@  /-)]Q\LZI;!9@ #U8_GYU\
M      "LWW/5:@'I#2@ !:@X#MUL/SUN(  Q1>?U[!YQJFZ#AP  ,D&^CDFQ
M6HN ;=W5U>_   &*+41T;"U,/0^FZY]UQ@   MK^=MRM&<%VT  5$/1NEUB^
M[:H    .Y6LWUC_B>T;WN2[!SYB+D   #'%I@Z=@J<WI72.K&?M  !.DCZ-'
MBSIW>W4L@ !K&WO$^>[[&YO'F@   !R38U;!G'=DL%<=V38'IV2_T    Z;;
M-8T\O26DZ<NEX0  "V7YYW&TQP+;@
M                                     .N6@==IO?*']"'7W3^HX:K'
M68:[#58:[%7A@KQPUI<->.&X8*\,%>.&O#!<,%PPW$,%=@N$>NPW"/<,-S"-
M<1P7$,%PP7$(]S&/<0P7"/<H]RP7$,%P_P B   _;J6-UKT;\,MS?0_$0
M      X1UCH=-SYR?>?JOI?8\%2;!6C@K38*DT>LP5YL%2:-5CAN(QZL\>HP
M7$8]6>/5C@KQCUIX]2,>YC'JS8*DT:YC'JQCU)\%Q&/5C&JSX+F,>I'_ "(
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MZ=]M:U
M              !PGI_2*8GR/_1%U[TOJN*O##58ZS#78:K#78J\,%>.&M+A
MKQPW#!7A@KQPUX8+A@N&&XA@KL%PCUV&X1[AAN81KB."XA@N&"XA'N8Q[B&"
MX1[E'N6"XA@N'^1  #].>UNF^BOASNPZ/X7          '".L=#II?.?[U=6
MM,[%@K1P5IL%2:/68*\V"I-&JQPW$8]6>/48+B,>K/'JQP5XQZT\>I&/<QCU
M9L%2:-<QCU8QZD^"XC'JQC59\%S&/4C_ )$     +_?J?\[FQ7;?-0
M          KW]CUNEAZ?T3'$           !W.UB^]!CQWTCGW#W(   \TGW
M'RSJEL%F  /5C^?G7P       -1_1<-0,]?<Y  ',^,K^EOX<ZGR+950  -7
M6^XF@EZ]YS\=<R            =V-6O_ $(O'/2>:<77   'YL\*I?H+3ZMW
M?-2AS0             V':9D_0C\<=)^RMIP  !I^Z1A:27J70N"LM;@
M        ?:VM3T%O'?2-C&E9,
M                                 1Z=6G-\F?T(:^^(>J<-6.*O##58
MZS#78:K#78J\,%>.&M+AKQPW#!7A@KQPUX8+A@N&&XA@KL%PCUV&X1[AAN81
MKB."XA@N&"XA'N8Q[B&"X1[E'N6"XA@N'^1  ?ISVMT'T1\0-WG2?"
M      X U/IM,[YU?>OK1JG6,%:;!4FCUF"O-@J31JL<-Q&/5GCU&"XC'JSQ
MZL<%>,>M/'J1CW,8]6;!4FC7,8]6,>I/@N(QZL8U6?!<QCU(_P"1     "UG
MW'Y&67>Q_+H                "O/V76J97IK1OR:D           -BFEY.
M^AY(Z'S_ (>Y    \TGW'RSJEL%F  /5C^?G7P       .*,A1\P?W?R?\NI
M   ;RN4[!=]\K[[^Y2F   U,]#PU$[UES[C.^I           =]=1R-^+R)T
M3L9A;H    #5;O\ B*4OJ+1.I&Q60           '>S4\A?]\?\ 1^>L1<
M  #K_F+:E_Z<T;2YT_!            ?96T]ZCR?T'<3S7-@
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M        HK^L.?:1.IX$  "PQQK9;I?F'>@  !T9VO'T9O5N@=&]KQX
M    &\GE.?NH>8-[Y*L:H     'PUW3JQ=]U&LYW/5?E;B0          ;E^
M9YR[GY9WWEG'5@     -&W5M?J$^CM+ZMY^T          ':; 7=YGRET#9)
MI&4
M            P25:/'QB_2UULT'K^.JPU8XJ\,-5CK,-=AJL-=BKPP5XX:TN
M&O'#<,%>&"O'#7A@N&"X8;B&"NP7"/78;A'N&&YA&N(X+B&"X8+B$>YC'N(8
M+A'N4>Y8+B&"X?Y$!^G/:W0?1'Q W>=)\(             #K]JO3:8GSS^]
MO6;4^M1ZS!7FP5)HU6.&XC'JSQZC!<1CU9X]6."O&/6GCU(Q[F,>K-@J31KF
M,>K&/4GP7$8]6,:K/@N8QZD?\B     &WS?O&=Y3TM\$P
M  .(LC1J9^A]-KN]FUK\>K*       !W4U>^N">;MVW%\US8     \TGW'RS
MJEL%F  /5C^?G7P       !U-V&S\\GV7S3@3+VX  W7\NSU[3R;T$   #Y.
MXDJT=]U&LCW75/C;F0       #L]@;NW=YRW3>OR?8        .JNP6=6/ON
MHZ!>OZY\Y7E        '8/#7-M3SON5@CCVR9(       /D;F2N'VO6*R/==
M3ZZ9JV        '[=*:QGQ79[8GGK<.4;"L
M                                            .@G"O5%-SY(_H7_B
MK#'58:L<5>&&JQUF&NPU6&NQ5X8*\<-:7#7CAN&"O#!7CAKPP7#!<,-Q#!78
M+A'KL-PCW##<PC7$<%Q#!<,%Q"/<QCW$,%PCW*/<L%Q#!</\B'Z<]K=!]$?$
M#=YTGP@              .ONJ]-I??/;[X=9=6ZO@KS8*DT:K'#<1CU9X]1@
MN(QZL\>K'!7C'K3QZD8]S&/5FP5)HUS&/5C'J3X+B,>K&-5GP7,8]2/^1
M  #;_OWC&\CZ6^"H                  '4C8K*MEV_5]!_7==X0RMN
M /[@V7Z-E;(G$]HWK\FV']:G$     "DYZCT/@/+VP  OO\ D7HH
M'6'/6E5[OVHZA^CX7@/+VV*(#=#S'.WE_*6_@    =>,S;5MNW:M7S['K?7C
M,VP     &P;3LE8TXKL]@'C^Q_46\X         Z_9BVKW=DUO0=UW7.C^U6
M       V":=DK$?&=FL#<=V/[:UJ         ?.UI='W5<!7W[#K>I[H>'_(
MJ2@     <\8BXWY<BV.R7Q':.UVO7@
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MO'5[2']P<IV%;M-@+OO=J61V>Z'E=Q/-LYVSUV\
M          _/GAK,WK%:E^AX;7'NV+Z8;-8];<Y:_"7=,9H.5\?6[08"[[T:
MID-E^C97<!S?-]S]8O@           !TVV:QU.="P^M?>,5T;VNPZL9^SX1R
MMO\ DU(#]"2/-.+K]I\!>=Y-4R&RC1\IMUYSFNX6MWH           '$61HZ
MF>B8;61O6)Z#;?CNHFQV77O,VWQUS(/[@Y.L:W9'!W7=/6+[8EI>3VL\_P Q
MLST7*_H21
M                    %47Y=_=/4WY@]V?Q5ACJL-6.*O##58ZS#78:K#78
MJ\,%>.&M+AKQPW#!7A@KQPUX8+A@N&&XA@KL%PCUV&X1[AAN81KB."XA@N&"
MXA'N8Q[B&"X1[E'N6"XA@N$R>A<R]#?$C>CTSP*                .OFK=
M-I9> ?OCUDU7K4:K'#<1CU9X]1@N(QZL\>K'!7C'K3QZD8]S&/5FP5)HUS&/
M5C'J3X+B,>K&-5GP7,8]2/\ D0     MH]V^/EC_ *]\R@
M        /S9X?C59?W*4T^2(
M_(J0_+J2_049I<L0                 /F:\N.,/JK><
M  #\>K+^9/#]^C-,EB
M                                *>OR6_03KKX+ZV_BK#'58:L<5>&&
MJQUF&NPU6&NQ5X8*\<-:7#7CAN&"O#!7CAKPP7#!<,-Q#!78+A'KL-PCW##<
MPC7$<%Q#!<,%Q"/<QCW$,%PCW*/<L%Q#+=4+DGH3XG[W^G_/X
M      =>]7Z=2N\!_?+K!J_6<-Q&/5GCU&"XC'JSQZL<%>,>M/'J1CW,8]6;
M!4FC7,8]6,>I/@N(QZL8U6?!<QCU(_Y$     /09]6?G,[[[1YZ
M
M
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M/\VG]H
M
M
M   "K=\SOMQIR\F_0?\ BK#'58:L<5>&&JQUF&NPU6&NQ5X8*\<-:7#7CAN&
M"O#!7CAKPP7#!<,-Q#!78+A'KL-PCW##<PC7$<%Q#!<,%Q"/<QCW$,%PCW++
M=T+C/I'XG;V^I?/X                   =>=8Z=2C\&_?3J_K/6X]1@N(Q
MZL\>K'!7C'K3QZD8]S&/5FP5)HUS&/5C'J3X+B,>K&-5GP7,8]2/^1     7
M!._?&&P9U;YR@
M
M
M          :.?%GTPK3_ #O^Q_\ %6&.JPU8XJ\,-5CK,-=AJL-=BKPP5XX:
MTN&O'#<,%>&"O'#7A@N&"X8;B&"NP7"/78;A'N&&YA&N(X+B&"X8+B$>YC'N
M(8+AENZ%Q3TO\3M['5?G\                    .O&L].I.^$/OMU>UGK.
M"XC'JSQZL<%>,>M/'J1CW,8]6;!4FC7,8]6,>I/@N(QZL8U6?!<QCU(_Y$
M  .X^P<5]"SU?^<']VKCP
M
M
M                  .M?.^QT=_C#^EO%48ZK#5CBKPPU6.LPUV&JPUV*O#!
M7CAK2X:\<-PP5X8*\<->&"X8+AAN(8*[!<(]=AN$>X8;F$:XC@N(8+A@N(1[
MF,>XAENZ%Q#TW\3MZO6?G\                     .NFL]0I$>#_O_ -<,
M%T^/5GCU8X*\8]:>/4C'N8QZLV"I-&N8QZL8]2?!<1CU8QJL^"YC'J1_R(
M #]>I9WT?4'Y\ME&X>8                      !Q;?T>D6U6'5_/6G#63
MH?+UY/T9)N6L=6[/X&[[U:GD.:,97              AS0Z@[)9=/-ELNO\
MF+;CJ]I18P^RMJG-6+K]K=?O.[FJW_V]K4
M
M                                              IY?)O]!&NO@OK;
M'58:L<5>&&JQUF&NPU6&NQ5X8*\<-:7#7CAN&"O#!7CAKPP7#!<,-Q#!78+A
M'KL-PCW##<PC7$<%Q#!<,%Q"/<Q7-*WYZ>^*V^;L'SS
M     '635>LTDO#7WWZW8#J,>K'!7C'K3QZD8]S&/5FP5)HUS&/5C'J3X+B,
M>K&-5GP7,8]2/^1   #_ %"X-W_XP6">J_.<                    #'%J
MZWW$:.NJX#41T;"])]IL,,0  ']P=T]8O]QG-,WOBY+L.Q_2<H
M!Q'D:.C/J^OZ5^GX+5MOV(XUOJ0   _3IQV"Z=DMQ'-LWO>Y+L/>75,@
M  ./KRGPIE+<  <EV-7F'&UP        ..;VEPSDZ   Y+L:O,.-K@")-#J]
MGK0  =I<!>9X         !UXS-M\U7D  E2Q[18&[ XNOZ/$F1H@
M       <MXZMRC85@/F:\G7G,VP        _4DCRGCZW(ME5     ' >7MOC
M[F0  #L5A;KZ*C,         !QU>TN&,G0   [#8:Y^FH3@
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M$  !:"X-MEN'SKN8         %!SUWSK3_TC"@ #NUJU_P"C/XKZ=]%1F
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MJ,WHR^+.G=X-5OP        -,73L'0Y]:\\  &:#T"O'O2-J?/\ +@
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MG60*O/>=2J1>BM-                MN^==RM#<&VT#6CO.*\\KV5S4
M        ?34)[9?GG<;-W"MKR0 #J7L5GYQ/M;F'PUW3  &VCG>9O]>0.C?Z
M        ?/UI?.(]K\PZ9[-8@ "P;QS9+JWE_>P
M          /G;#+U ?E?]^-=_$?5^&JQUF&NPU6&NQ5X8*\<-:7#7CAN&"O#
M!7CAKPP7#!<,-Q#!78+A'KL-PCW##<PC7$?]NJ5MOU=\7=]/</G6
M                   /@['8M;//O4G1C3^_]>\+TGX6EGL4\<4\V*JQ3QQ3
MQQ58XIXSIZ'*5[J7;7/<>V4;AY@[U;/P'^T                    !CBI^
M^D-*K1=RU4           2)8V^?.&Z68N&[4    !P[DJ% CU_SG7KN6-
M        'WMG4OB>2NA[8N>Y@   5^NPZW2A]1:(  ++?#MJN$>;=U
M   KG]IUFF9Z:T8  66^';5<(\V[J .*,A1\O/WGR8   ;_>/['=F\N;X
M     //*]E<UUH[SB@ .5L?6]0WP9UD"KSWG4JD7HK30               +
M;OG7<K0W!MM UH[SBO/*]E<U             %C+BNSW+O,^\?W  *QG=M4J
M'^C=+   O&^5-_WK<GV        "L=W75*AOH[2P !S?BKCTB_$O4.:<77
M                              'P>$VBFW\I_P!!O2GE7HG'68:[#58:
M[%7A@KQPUI<->.&X8*\,%>.&O#!<,%PPW$,%=@N$>NPW"/<,-S#^;J2VQZS^
M+N^;N?SJ
M     %33T-IU6?ONH@    ??V=3L;A;K[:TJ?*W$G6C.VG'UY3    ']%P_S
M7NUE+B&T@   ?,5Y//\ ?8/.=8N]XD    ?W!SQB;CG/$W$^2/%^0I=;,W:_
MBU90   !R)95?0>\<](V Z?D@  *_78=;I0^HM$  %EOAVU7"/-NZ@
M  5S^TZS3,]-:,  ++?#MJN$>;=U '%&0H^7G[SY,   !=U\L[[ONY%L0
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M]^]?-\
M   :,>KZ_1L]6:!_(  !_1M8Y]F-]G(]BVS<[S';/7KW) !BBZ7[/8::^F8.
MO%V76ND6U6    G21OC>2NA[C^:9L   4VO2^CUP>V:P   /VZ4V\+E6?WM<
MFV#:=H.8Y>QM8 ?/UI=>FY8S2QU#!5[>QZWP!F+8   =M]=O?1A\6=-Y+L:H
M  K]=AUNE#ZBT0  66^';5<(\V[J        !7/[3K-,STUHP  LM\.VJX1Y
MMW4 <49"CY>?O/DP   ')5C5]%KQ=TWM_K=Z       //*]E<UUH[SB@ .5L
M?6]0WP9UD"KSWG4JD7HK30               +;OG7<K0W!MM UH[SBO/*]E
M<U  '[U&;[BUJ     ?E5)>/KRF    /L[6?TG/$74NRF#N@!KKW3&>>'[+Y
MI^94@  +./"MKMY><=T       I<>G=%KQ]FUH  ;7>>YCT O'_1\D
M                            '7;1>LTN_E+^A[@S6.CX:K#78J\,%>.&
MM+AKQPW#!7A@KQPUX8+A@N&&XA@KL%PCUV&X8[F6U?ZV^-U@/T%\UP
M                                                  !UWS-MYOOM
MGE_$V1H@  ; =/R5RKS/N^SC1,L    (\T-!O7==J#>C]+X/RMN  !S;BJ_H
M]>*.G\^8BY  &J7H.'\_KV#SC'$  !N YOFKD_F?>.WFN7H    ^-N9*OO>=
M2JT]\U+\:K*  !8[XIL]RCS/O   K]=AUNE#ZBT0  66^';5<(\V[J
M  !7/[3K-,STUHP  LM\.VJX1YMW4 <49"CY>?O/DP    V0:3E/0E\<=)_>
MHS       >>5[*YKK1WG%  <K8^MZAO@SK('%U_1XDR-$     #SD_:O,>-+
MZD !R78U?1L\5=.      Y;QU;E&PK :T=YQ7GE>RN:@ #>UR;8;Q/E7?@
M  !QK?4M;^[8O0?UW7=!/7M<_,J0   M!<&VRW#YUW, "H-Z/TNLKW35  !^
MW2F]&+Q9TWO-JF0      UY[EC/.T]G\TAS0  ^GH3^C3XKZ;W3U>_
M                             Z@\Q[W3'^6'Z$^+\-N&&NQ5X8*\<-:7
M#7CAN&"O#!7CAKPP7#!<,-Q#!78+A'KOXN9;5?KKXWV /0WS6
M                                               I+>I-#T"]?UP
M #?QR#8[HOF+>?IJ$X     '7+-VM$SUCS[6YN^+   W\\@V.[5Y;WP #!%Y
MU'M'F6OK<<:  !:%X-MEM;SON4B6(     &J7H.'H@>M.>\:WU(  ?H21]''
MQ3T[O%JN0  K]=AUNE#ZBT0  66^';5<(\V[J        !7/[3K-,STUHP
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MV6?Q5X8*\<-:7#7CAN&"O#!7CAKPP7#!<,-Q#!78+ACN);5'K_XW[_/1/S6
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M*YKK1WG%  <K8^MZAO@SK(       'EY>\^3<4Y"B !RMCZWJ&^#.L@
M  :T=YQ7GE>RN:@ #>UR;8;Q/E7?@      !7N['K=*WU!H@  'IS^$^K<^8
MBY  T\])PE"3UUSO^0  7?/+&^[Y^1[$    !HLZQK]&_P!5Z   .Z&L7WHU
M^*^G?46\X                                    U]<8]3U#?FQ]X.)
M<+NV"O'#6EPUXX;A@KPP5XX:\,%PP7##<0P5WZ=_C[6OLCXR[T?0/SN
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M7-=:.\XH #E;'UO4-\&=9        \O+WGR;BG(40 .5L?6]0WP9UD
M #6CO.*\\KV5S4  ;VN3;#>)\J[\       /Q*LOF&>[N4<59"B  /0Q\:]*
MV9:-E0 !2!]4:#H:ZWKP  [%X6Z]([Q)U#DJQJ@   ?&75/S=?;7+^K.?M
M/[@O]>0.C;9N>9D                                     <#:ATVKW
MX)^S&J7@?MC!6AAKQPW#!7A@KQPUX8+A@N&&XAWDZ7YTM@>T/BYWNZ)YR
M                                                       'X-:7
MS&O=?*>'\E0  %XSRKO^]?DVP         :P=\Q/GR^Q>;Q)H#^C;?SK,V@.
M#[;MOYUF?[@ XOOZ/F%>[N4?@UI0 !?$\E="W/\ ,<Z        /@KNGYI/N
M/EG!^5MP !=B\N;Y8!X_L8 K]=AUNE#ZBT0  66^';5<(\V[J        !7/
M[3K-,STUHP  LM\.VJX1YMW4 <49"CY>?O/DP     &X?FV;OJ^1NB9X
M !YY7LKFNM'><4 !RMCZWJ&^#.L@       >7E[SY-Q3D*( '*V/K>H;X,ZR
M       !K1WG%>>5[*YJ  -[7)MAO$^5=^        \^+V-S;5SON)  %^;R
M'T7;[SC-  #@C+6_F[^VN7\-Y.@  +,'#=JN!^;MU    JK>@-0JB^@]/  &
M_KD&QW:?+>^                                       =&.4>DM(?E
M[Z*ZN.'^R>O^M]-P5X8*\<->'(^P:?LM[/Y'W7^A_GWM4[/XSSS4P
M                                                   -3O0L/Y_W
ML'G   [38"[]*[P]U.?)$         4L_3^BU^NPZWO%Y3G[/_"-LV&Z9DP
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M==GYQEC(
M        *H_H/3ZJGH#4  !9TX3M=N_SEN@         ' F7M_@KREVXUR]
M  %3/T-IU6CONH@ "S+PS:K?WF_=0        !K4WC%>>/[+YJ  .X^M7WI.
M>(>H@"OUV'6Z4/J+1  !9;X=M5PCS;NH        %<_M.LTS/36C  "RWP[:
MKA'FW=0!Q1D*/EY^\^3  #:MS_,=%=LQW">4H  #Z&C-Z%?C;I6Q?2\F
M!YY7LKFNM'><4 !RMCZWJ&^#.L@       >7E[SY-Q3D*( '*V/K>H;X,ZR
M      !K1WG%>>5[*YJ  -[7)MAO$^5=^        H0>NN=:>^DX4  7[O(7
M1=NO.<T  !CBH">O^<:F^AX<  ;4- R_H'>/.D98  !2!]4:#H:ZWKP  NG>
M8-ZL*\;V4
M                                                     4._6O/=
M,'3L$  +Z7D?H>Y'FF<               HO>KN?Z/>JX   7G?*/0-XW*L^
M         /Q:LOEN>]^2_,UY  )\D?4T\"]<^@HS 5^NPZW2A]1:(  ++?#M
MJN$>;=U         KG]IUFF9Z:T8  66^';5<(\V[J .*,A1\O/WGR8  ;VN
M3;#O+Y3GZ+7J_GX  '<;6K[T6/%W3.1;*J    //*]E<UUH[SB@ .5L?6]0W
MP9UD       #R\O>?)N*<A1  Y6Q];U#?!G60       -:.\XKSRO97-0 !O
M:Y-L-XGRKOP       'G]>P><:H>A8<  >B/XQZ7L<TK*   #ISLMCYR/M7F
M/R%S(  +M?EO?-_'(-C  UB;WB?/=]C\VPQ  ;3= R_H(^/.D98
M
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MP$::'G@>S.::Y-UQ@ 'T-&;T8/%G3>\6JY
M
M                   #R^?>/)N(LE1  D2Q]4OP#UW]"2(
M 'G!>V.8=&=KQX  ],CPSU3LW@KL         #SSO9/-=9N]8H  >CQXHZ?W
MKU/( 5^NPZW2A]1:(  ++?#MJN$>;=U         KG]IUFF9Z:T8  66^';5
M<(\V[J .*,A1\O/WGR8  ;VN3;#>)\J[]Q=?T?.4]J\QZL9^T   NY>6=]WX
M\BV(   #SRO97-=:.\XH #E;'UO4-\&=9        \O+WGR;BG(40 .5L?6]
M0WP9UD       #6CO.*\\KV5S4  ;VN3;#>)\J[\       -;^[8OSO/9O-
M !L%T[)>B]XMZ:    /Q*LOG6>T.9]"MNQP  LJ\/VFX=YLW8"OGV+6Z5'J'
M1  !:;X%MULCSSN(                                         'Y\
M\.),C1_2DCRICZV6
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MGVYR[KWF;8 #N#K=[Z.?BGI_U]M.
M        .@^WXZOYV#6]171L-TCVK'_D5(#[6UJ;!M.R6Y+F>;L#\>V3L?A+
MH
M>6/[[Y'\I<2  ?5V\_J<>!.N               #S=/;?+^D^T6   ].+PIU
M;L#A[D         #S]?87.-4W0<.  /1@\6]-V!Z=D@*_78=;I0^HM$  %EO
MAVU7"/-NZ@        5S^TZS3,]-:,  ++?#MJN$>;=U '%&0H^7G[SY,  -
M[7)MAO$^5=^ JG>@=/JF^@M0   V.:5E/0I\;])_>HS   >>5[*YKK1WG%
M<K8^MZAO@SK(       'EY>\^3<4Y"B !RMCZWJ&^#.L@       :T=YQ7GE
M>RN:@ #>UR;8;Q/E7?@     !UPS=K2K]0:)I_Z1A0 !W8U:_P#1A\6]-^JM
MYP    !3J]*:36Q[?JP  V@Z'EO0=\<])J2^B=,J]]YU, #^B_9Y"Z+MUYSF
M@                                       .LN=M*=OI/2=)?4L#_$0
M   ^BHS63.(;3:[\^;A]U:5
M                     !Y8_OOD?REQ( !]7;S^IQX$ZX
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M&I_,UY  -\W)-AN^^5]^
MU+]#PU&3U=H'#^2H     #O)JF0OD>2>A=M]=O0
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M>YBZYY=WOM/@+P      #2YT_!4/_6G/0    !RYCJWI%^).H<^8BY
M                                 &FOIF#HK>L.?_,UY      !V.PE
MUZ _C[H_<[6+X
M          >6/[[Y'\I<2  ?5V\_J<>!.N               #S=/;?+^D^T
M6   ].+PIU;L#A[D         #S]?87.-4W0<.  /1@\6]-V!Z=D@*_78=;I
M0^HM$  %EOAVU7"/-NZ@        5S^TZS3,]-:,  ++?#MJN$>;=U '%&0H
M^7G[SY,  -[7)MAO$^5=^  U3=!P] ?U_P Y_-G@  .?\/<^C3XKZ=SWB+@
M#SRO97-=:.\XH #E;'UO4-\&=9        \O+WGR;BG(40 .5L?6]0WP9UD
M      #6CO.*\\KV5S4           ?76T^X'F^;L7<6V;<+S;-_Z
M 49?5O/]&W5L     !<[\R;S8HXOLP
M         U%]&PM#[UISWY&YD       '8["77H#^/NC]SM8O@
M                                              /+']]\C^4N)  /
MJ[>?U./ G7               !YNGMOE_2?:+   >G%X4ZMV!P]R
M !Y^OL+G&J;H.'  'HP>+>F[ ].R0%?KL.MTH?46B  "RWP[:KA'FW=0
M    *Y_:=9IF>FM&  %EOAVU7"/-NZ@#BC(4?+S]Y\F  &]KDVPWB?*N_  "
MK'WW4:G'H;3@  -P?-LW?9\C=$SP #SRO97-=:.\XH #E;'UO4-\&=9
M   \O+WGR;BG(40 .5L?6]0WP9UD       #6CO.*\\KV5S4          #F
M+&5]YO*<_MMYUFMPO-LUR%9U0       !UZS-MYN_MKE_%.0H@   ;/=#RWH
M.^.ND298@                                      :B^C86B#ZTY[\
M=<R        #L=A+KT!_'W1^YVL7P
M                         \L?WWR/Y2XD  ^KMY_4X\"=<
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M       !78[/K-,/TYHP   _;I3>BQXNZ9WPU+(@
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M8;Q/E7?@  .#LK;^=#[2YEUKSEJ  /H:,WH5^-NE;%]+R8'GE>RN:ZT=YQ0
M'*V/K>H;X,ZR       !Y>7O/DW%.0H@ <K8^MZAO@SK(       &M'><5YY
M7LKFH             V-Z5D[]'D/HO,&-K@      #!%Y]OL3F^K7?L0  !:
M'X-MMMSSKN0                                      &HOHV%H@^M.
M>_'7,@          ['82Z] ?Q]T?N=K%\
M                            /+']]\C^4N)  /J[>?U./ G7
M       !YNGMOE_2?:+   >G%X4ZMV!P]R         !Y^OL+G&J;H.'  'H
MP>+>F[ ].R0%?KL.MTH?46B  "RWP[:KA'FW=0        *Y_:=9IF>FM&
M%EOAVU7"/-NZ@#BC(4?+S]Y\F  &]KDVPWB?*N_   #5UON)\_CV%SC\BI*
M .XVM7WHM^+>F<A6=4>>5[*YKK1WG%  <K8^MZAO@SK(       'EY>\^3<4
MY"B !RMCZWJ&^#.L@       :T=YQ7GE>RN:@ #>7RG8+MOEK?    !@BXXO
MJ76#/6FMG=\5H,Z[KNLW>L4  !N+YKF[Z_D;HG^@       Z#[?CO.4]J<Q
M '8'#W/I6^'NI?:VM0                                      :JN@
M8>A%ZZYW\=<R           #L'AKF_UY Z-WFU3(
M        <4Y"CUBSUIQ%DJ/RU>3^X1RP?Z#\FI*!+EC]-0GY.L*O/>(N.P6'
MN94L0                 !Y:WOCDGPMW3  _:I3>J3X!ZZ
M  /-]]L\OZ/;58  #TSO#'5>RN#N@         //5]D<VUC;WB0 !Z.?BGI_
M?#4L@!7Z[#K=*'U%H@  LM\.VJX1YMW4        "N?VG6:9GIK1@ !9;X=M
M5PCS;NH XHR%'R\_>?)@ !O:Y-L-XGRKOP   %7[O&IU'?1>F   6).,;-<_
M\Q[R//*]E<UUH[SB@ .5L?6]0WP9UD       #R\O>?)N*<A1  Y6Q];U#?!
MG60       -:.\XKSRO97-0 !O:Y-L-XGRKOP      _PK<]MU>G/Z5TC'$
M +[WD7HFX7FV;       '%&0H^7G[SY,  -@6G9+T8?%O30
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M$NZ?G(>U>8]1MCL@            !SWB+CT O'W1^\VJ9
M          8(M4?0L/IHZ9@_EKB2=)-.EA,DC.DC.A&;)&;)-,E9)0    ER
MQV=:+EMLG/,Q,EB                //5]D<UUC;WB@ !Z%GC;I6S?1<J
M            !1(]9\]TI]0P0  O?^2^A;I.89T         0YH>7%[VY+\+
M=TP ,\'J7>!NN?76TX%?KL.MTH?46B  "ROP[:;AGFW=@        *Y_:=9I
MF>FM&  %GSA&V6Y_.>Y@#BC(4?+S]Y\F  &]KDVPWB?*N_    #AK)T/.D]H
M\RZN9^T  '83#7/HZ^*>GT-/6W/-:.\XH #E;'UO4-\&=9        \O+WGR
M;BG(40 .5L?6]0WP9UD       #6CO.*\\KV5S4  ;VN3;#>)\J[\
M-<.[8OSNO9O-  !V'PUSZ;GA7JP       XHR%'R\_>?)@ !L"T[)>C#XMZ:
M                                     !5+]!:?50] Z@
M    .>\1<>@%X^Z/WFU3(                       #CN]I5S>TZQTMVBP
MG233)(S81GR33983:<9TL9LL9LD9TDTJ5_<     '<'6[[>YR?8/V*4P
M           %+ST[HM=_LVM  "W-YTW.S[P?;          /E;B3K_F+;M5K
M]X   *BWHS3*PO=]3  %I7@>W6SO/&X@        #H+M^.\Y;VIS$  =J=?O
M/2Z\.=3 &BSK&OT;_5>@  "P#Q_8[L7ES?         *Q?=M4J(>C=+  %K#
MS]M]K/S[N  XHR%'R\_>?)@ !O:Y-L-XGRKOP    &LS>L5Y]GL3F_X564
M;QN59_K/G+76CO.*  Y6Q];U#?!G60       /+R]Y\FXIR%$ #E;'UO4-\&
M=9        UH[SBO/*]E<U  &]KDVPWB?*N_       #\FI#RR???(OR*D
M!ZEO@;K?VUK4       XHR%'R\_>?)@ !L"T[)>C#XMZ:
M                      /D[B3S*O='*N'<G0               Y[Q%QZ
M7C[H_>;5,@                      .),C1JY=ZU+@?+VTZ6,V6,VG&;+-
M-E3I9ITD)LD9TL9LLTV1.DFD2OZ@     [R:KD-Y_*-@_H
M %>KLFM4L?3^B@ #8_I.4]$3QETL         "N?VG6*<_I72=\/)=AM!\&V
MSO)JF0  &C3JVOT9_5N@  #OIJ.1]&_Q5TX         57^_:C4\]"Z<  -X
MO*L_>>\H]  &JKH&'\_'V'S@  ;/]#RWH2>..D@        4W_2VD5O.VZN
M +FOF7>;%W%MF '%&0H^7G[SY,  -[7)MAO$^5=^     %9GN>JU O2&E
M?4V\_P M<2  <K8^MZAO@SK(       'EY>\^3<4Y"B !RMCZWJ&^#.L@
M    :T=YQ7GE>RN:@ #>UR;8;Q/E7?@       /,3]V\HX(RUN  /3B\*=6[
M X>Y       XHR%'R\_>?)@ !L"T[)>C#XMZ:
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MX7ZKV-PET      !Q1D*/EY^\^3  #8%IV2]&'Q;TT
M                   5$?1NEUBN[:H                .=\3<7[/(71=@
M&GY(                    </Y*A5+]!:AP%E[:;",V2,^G&=*FRQFRS3:<
M9TL9LL9LL9TD)U.:;",V6,VG&;+'-*     ^TMJEEOAVT_34)P
M    !YZOLCFNL;>\4  -E>CY7T*/&_2?T)(@       "F%Z<T:NSV?60 !;;
M\[;E:(X+MH H!>P.<ZF>AX8  ;2M!R_H)>.^D9X        *VG;M7IS^E=(
M 'ZE./IF>&.J]@\/<@ >99[HY5UOS=J  +LWES?-_O']C        ZJ;!9^:
MC[AY;%F@ !^I3CZ@O@[K/)5C5 '%&0H^7G[SY,  -[7)MAO$^5=^      XE
MR-'SI_:/,NIVPV8    '*V/K>H;X,ZR       !Y>7O/DW%.0H@ <K8^MZAO
M@SK(       &M'><5YY7LKFH  WM<FV&\3Y5WX       #S5?<'+>HVQV0
M]+?PYU/M9K]X      !Q1D*/EY^\^3  #8%IV2]&'Q;TT
M                      43/67/M)_4<"                !S3BZ]_KR!
MT;8!I^2                   '%.0HU+?1&F]?LQ;S9$V6,Z6,V2,^G&;+&
M=!-DFF21G2QG233I83)(SY(S81FR1FR33)624    !MUYUFMH&AY8
M        : NP:Y29]1Z&  !:0X)MMM/SON0       %=CL^LTP_3FC  "1+'
MT:O%?3>^.I9$ :(.M:]1[]4Z"  !;Q\X[I9RX5M8       Z/[58>=][,YIQ
M[>T@ !NVY;GKUOD[H(  I2>H=$K[]BUL  =Q=:O?1O\ %73_ *^VG
M%,OTUH]=#M.L  #:5H.7]!GQUT@ #BC(4?+S]Y\F  &]KDVPWB?*N_
M#7!NV+\][V-S;YRO*    .5L?6]0WP9UD       #R\O>?)N*<A1  Y6Q];U
M#?!G60       -:.\XKSRO97-0 !O:Y-L-XGRKOP       'FZ>V^7])]HL
M !Z6_ASJ?:S7[P      #BC(4?+S]Y\F  &P+3LEZ,/BWIH
M                        \_SV#SC4_P!"PX                 YIQ=>
M_P!>0.C; -/R0                  XGR-&I7Z'T[K7G+.;+--DC-E398SI
M9IM-.DC.EC-E3I)IDD9T(SI)ILL)M.,Z6,V6,V2,Z2:5*_N     <P8ZO94X
M?M/^@              'XE67S;/;G+^I6Q60  _HMD>>=QM+<#V[^X
M!74[1K--7TQH\&>   W[<AV.[;Y:WP #\FI#S=?;7+NGFRV0  G21NL>7][W
M^\?V,      =/]DLO/\ O8'..KN?M  !_<'H:>->E;+-'RH  U!=(PM!GUWS
MH  #?UR#8[L/EW>Y$L0     !IFZ;@Z'_K3GL6:   N;^9-YL6<7V8 #BC(4
M?+S]Y\F  &]KDVPWB?*N_       5K^WZM3L]*:2    .5L?6]0WP9UD
M   #R\O>?)N*<A1  Y6Q];U#?!G60       -:.\XKSRO97-0 !O:Y-L-XGR
MKOP       'G,>U.8] ]OQP  ])CQ%U'N7K-\      !Q1D*/EY^\^3  #8%
MIV2]&'Q;TT                                     4.O6O/-,/3L&
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M^).H=V-7OP      .*,A1\O/WGR8  ; M.R7HP^+>F@
M                   "G5Z4TFMCV_5@                 !S3BZ]_KR!T
M;8!I^2                '$>1HU!_1^E=8<]:3I)ILB;+-/D38)M.:;+&;+
M&;)&?33I8S98SI9IDB=)-.EC-EC.DA-DFFRITLTR2,Z2.>#_ &    #<7S;-
M[*M'RH               %%OU?S_ $@=4P    ^QMI]]_(MCW[<@V+9KHV5_
M8I3  #I-M-AH%Z_KE<SM.L<19*B  !F@O7>3N@[K^79X   48?5W/]'75<
M  .QV$NK)?$=HWP<EV'M5K]X  ./;REIKZ9A*V?;]6U?;YB0  !SGB;CT;_%
M73NP.'N0  !I+ZE@:*'K'GP   Y?QM:QSQ3:-\?)-A[RZKD/[@  ''5[2T[]
M)PE;+M^KZMM^Q    N0>:=WLA\2V@  <49"CY>?O/DP  WM<FV&\3Y5WX
M    <77]'SKO:',^GVR60   Y6Q];U#?!G60       /+R]Y\FXIR%$ #E;'
MUO4-\&=9        UH[SBO/*]E<U  &]KDVPWB?*N_        >>W['YMK W
MS$@ #T2/&/2]C>E90      #BC(4?+S]Y\F  &P+3LEZ,/BWIH
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M]I1ZC@0 !<Z\R;S8IXOLP      '%&0H^7G[SY,  -@6G9+T8?%O30
M                              !\!>4_,I]T<IXQOZ0
M     '-.+KWXO(G1=C&EY,              <67]&G3Z5TGJ+LEG/IPFR1FR
MS381FTXSY)ILL)TLTZ2,R1.EC-EC-DC/IQFRQG039)ILD9LL9TDTZ6$R2,^2
M,V$9LD9LDTR5DE   #NIK%_OAY+L(                ZI[!9^?=[$YOU9S
M]H           !9[X1MEN?SGN?\ H    .INPV?GX>P^;]7<_:
M "=)&[!Y=WS?KR'8@    .,KZEY[GL?FW0S;L<           !VZUR]]"SQO
MTGGW#W(  '%&0H^7G[SY,  -[7)MAO$^5=^        %<OM6L4T/3.C@  <K
M8^MZAO@SK(       'EY>\^3<4Y"B !RMCZWJ&^#.L@       :T=YQ7GE>R
MN:@ #>UR;8;Q/E7?@       *D/HK3*O7>=3  '>C4\AZ*/C#IGU5O.
M .*,A1\O/WGR8  ; M.R7HP^+>F@
M     5.?0NG58N_:B                   .6<=6OW^0NB[&]*R@
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MFXIR%$ #E;'UO4-\&=9        UH[SBO/*]E<U  &]KDVPWB?*N_
M :F.AX:@'[ YR  !N%YMF[OWE??>8,;7      XHR%'R\_>?)@ !L"T[)>C#
MXMZ:                                     !\-=T_.B]H\RZ9;/8@
M                 #EG'5K]_D+HNQO2LH            .*<A1IB^F]&Z>;
M+939(SI)IL$V5/IQFR1G2QFRS39$V2;]"1,@G4YILL9D$Z2:=33I8SI8S98S
M:<9TLTV5-EFG20FTXSI8S8339$Z2:1*_J   =Z]4R.\KE.?
M    'R%S)4=]%:96Y[=J\.:         '<G6;ZZWY>WO9_H>6       ^"NZ
M=/[TCI5>#LVLX8@        -@^G9*[AY9WWO9J>0       X^O*=-/TSH^@G
MKVN          ;R^4[!= \Q;SRQCZP   '%&0H^7G[SY,  -[7)MAO$^5=^
M        XYO:7G9^S^9]+MGL0 .5L?6]0WP9UD       #R\O>?)N*<A1  Y
M6Q];U#?!G60       -:.\XKSRO97-0 !O:Y-L-XGRKOP       $>:'G;>S
MN::[=SQ@  %U[R[O=@7CVR      <49"CY>?O/DP  V!:=DO1A\6]-
M                                '1+;<?Y\7L7FW$V1H@
M        #EG'5K]_D+HNQO2LH           .)\C1I:>G=%Z;[-83I9ILD9L
MD9TLTV5.EA-ISSI8S94Z2:;(FRS?H2)D$VG-.EC,EC-DC/IITL9LL9TLTR1.
MDFG2QFPC.IPFR3394Z6:9)&=)'/!_L  &T70\OMPYUF0
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MK.A)ZYYWTKVBP  %U[R[O=@7CVR      <49"CY>?O/DP  V!:=DO1A\6]-
M                                      UR;KBZ"'KWG7$V1H@
M             #EG'5K]_D+HNQO2LH          .,[ZE2E]1:)TAVC'SY(S
M81G21FR33)4Z6:;+&?)";)&=+-,E3J<TZ2,V"?)--E3:<9LL9L(S9(SZ<9TJ
M;+&;+--IQG2QFRQFRQGTX39)IL$V6:;3C-ECFE  ;T^4;!WBU7(
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M/&=.=ELNO^8MN.;VECB^JMYN;<5<=K]?O.^.HY'8/IV2^@HS
M ?Q%T\V2QU_[ACNH>R677O,6W&U]2@3PGR1Y*L:O83#7/;S7+WO_ *?D>X6M
MWV2
M                                                         :_]
MPQM CU_SGA/*4                   !RSCJU]WR-T39;HV5        '&%
M_2I#^I] Z);78381G2QFR1GTTV6,Z6:;*FTYITL9DL9L'Z%*,R5.EFFRQFTX
MSI9I\D)LLTV2,V5-EC.EFFTTZ2,Z6,V5.DFFR338)TDTZ2$V2,V6,V6,Z2,V
M2:5*_N =Y=5R&]#E&P
M
M
M                   =&=KQ_G^^P><<"9>W                   ')5C5
MOQ>1>B[-]$RH       XNOZ-'7U5H/0_;L=-D39)ILL9LL9TDT^FFP39)ITL
M9DD9TDTV";*GTXS9(SI8S99ILB;+-^A33()U.:;+&9!.DFG4TZ6,Z6,V6,VG
M&=+--E399ITD)U.,V6,V$TV2,Z2,B5DA&Q+QC9>QV%N@
M
M
M                                            !TCVFPH#>O\ G/7'
M-VH                   Y*L:M^+R+T79OHF5      ''5[2HP^KM U^[AC
MI\B;!-DC-DC.DC-A&;3F_0D394V6:;)&;)&=+--E3I83:<\Z6,V5.DFFR)LL
MWZ$B9!.I3381F2QFR1GTTZ6,V6,Z6:9(G233I8S81G4X3I)IDJ=+--DC-DCL
M%T[);N.6YX
M
M
M            =,=GL: GK_G/67.V@                   Y*L:M^+R+T79
MOHF5     ''-[2HO>K^?ZZ=TQDZ2:;+&?)"9+&=)--D3I9ILL9M-/DC.A&;)
M&;)-,E3I9ILL9\D)LD9TLTR5.IS3I(S8)\DTV5-IQFRQFPC-DC/IQG2ILL9L
MLTVG&=+&;+&;+&?3A-DFFP399N9,77L@<3VC[&VG
M
M
M                                           ZD;%9>?K["YQU=S]H
M                   .2K&K?B\B]%V;Z)E0   !QQ>TJ)WK'GVN/=L7.EFF
MR)LDTV6,^2$V$9M.:;+&=+&=)&;33I8SI9ILJ=3FFRQF0C-EC^A3A,DC.EFF
MRQFR1G233I83I9ILD9LB;+&=+&9)&?3C.EC-E399ILD9TL9LLT^2$R2,Z2/W
MEK4L6<6V?L)AKD
M
M
M                 #JSG[3S^?87..I&Q60                   Y*L:M^
M+R+T79OHF5    I$^I]"TE=2P$ZG--E399ILD9LL9TD9\L)DL9M.:=+&;",Z
MG-.IPG0C-EFFR1FR1G2S394V5/IQFRILLTZ2,R2,Z6:?)";+&;)--EC-E399
MIU-.DC.EC-EC-DC.DFF2ITLT^2')5A5L/\:V;LU@KL
M
M
M                                              #J[GK2@7Z^YSTR
MV>Q                   ')5C5OJ>1^B;1="RP   ZF[#9T&/7O.NN&:M)L
MDTZ6,V6,VG--E3I8SI$V6,V2,Z6,V6,VG-/D394Z6:;+&;3C.EFFP394ZE&;
M+&=+&=+-,IITLT^1,@G4YIDL9L$Z2:=3398SI8SI8S:<9LLTV5S;B[BQSQ39
M^=\1<
M
M
M           =<<U:^?\ >P><]*]HL                   !][9U+Z/DCH>
MU7G^8   '4W8K.@UZ\YWUQS-I-EC-DC-A&=3FFRQG2)LJ=)&;+&=)&;+&;)&
M?)&;+&=+&;)-,D3I9ILJ=+"=3FFRS394Z2:;)&;+&?(FRIM.:;",V6,V2/Z%
M-,EC.EC-EFFR.RF#N[)7$=HY7Q]8
M
M
M                                  #@7+V_G^^P><=&-KQX
M           ^]LZE]'R1T/:KS_,   #J=L5G0<]=\ZZX9FUFRQG2QFRQFR33
M9(SY8398S:<TV5.EFG2QFTTZ2,Z6,V6,Z2:9+&;+&=+&=)";3C.EFFP3:<TZ
M2,V"?)--E3:<9LL9L(S*<?T)(S94V6/<;6;^R;Q':/NK2H
M   !JSS%@ !^K+'9OB;X  #X&I)KQREF !RG1J=^<;=@ :TLK8_@3P
M YRMZO=K'W0    '2+(6O"%Q2  ^EDCLGQ5\    !QO5DU]Y.S  Y>H5.]V.
MNP     -;N5LOE9Y0       !LCQ5[]3),!K2RMC^!/  #:%B+^5   /P)I=
M:66L@ /M*<VQC%WH   '$]:GIISN,U>9:PZ8W]KPO7I0XPY'I5.TEG<;$L9>
M[EL'DN\&/NP      -8^6L?RYH  <_VU;N;87(    'RT\NMS*V0    'TLD
M>P-M6[/6EQ(@    _ FEUI9:R       ';&RN.S=I7
M                                     '!66MZ"/KWG6O\ W#&@
M              #[VSJ7T?)'0]JO/\P   .IVPV=!_UWSKKAFK6;+&=+--DC
M,DC.EC/DA-A&;3FFRQFRQG21G4TZ6,Z6:;*FTYILL9LL9L$^G&;(G2S398S)
M(SI)ITL)TLTV2,V1-EC.EC,DC^A3CL U#)60.)[1])0F
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M;%&L9H
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M-]O5    '6RZH>?OTG3P      /NZ<]Q+1]DVG8C(  #A&XI>>ETO30
M !9SU/.V*-8S0
M         XFR-&@AZ]YUKDW7%@                  #[VSJ7T?)'0]JO/\
MP   .I^PV=!3UYSGK_F+>=+&;+&;3FFRITL9TB;+&;)&=+&;+&;3FGR)LJ=+
M--EC-IQG2S38)LJ=2C-EC.EC-EFF2)TLWZ%-,@G4YYLK<GS3.;_>/['E@
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MGG;%&L9H
M    #C*^I4(/77.M9&]XH                   ?>V=2^5Y)Z'M<Y]F   !
MTYV6QH4>N>=\"9>WFR1FPC.IS398SI(398SI(S98SI(S98S9(SY(S98SI8S9
M)IDB=+--E3I83J<TV6:;*G2339(S98SY$Z5OKY%L>\'E>?
M      'FR=3T@ #DJE/Z*/,=T   Z17]I1!Z)J8 &R?%7UW30=I  \]/I>F\
M(7%(      #<K@\G<&TC9    !2VWO6-5N8QX  '*=&IZ'/,]RGPB   !K]R
M5G1FZ#J@ &TS#W]T_1-H      \_CI&G]:[N@        /0(YMN'9.UK@>>G
MTO3>$+BD !Z.W+]V^EDB  .$;BEYZ72]-  [<V5Q?BYSMX %>39L-5_VW @
M "?",",   +&&KYJS7JF=    ^:GE\[SIFF?&5)0  -Q.#R5Q+2-E    '6R
MZH>?OTG3P       -[&O9:V'INP@ <(W%+STNEZ:       +.>IYVQ1K&:
M                                                       '&M]2
MH:>MN>:L=_Q                    ^QMI[WWDOH6W3G.:   '3K9;&A3ZX
MYYP)E[:=+&;+&;3FG2QG2PFRQFTYILJ=+-.EC-IITD9TL9LL9TDTR6,Z6,V6
M,^2$RG&=+--@FTYITD?UY(V0.);1M\YQF@                    /-DZGI
M  ')5*?T4>8[H  !TBO[2B#T34P -D^*OKNF@[2 !YZ?2]-X0N*0 &TS#WX
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M#*[C<'DP
M     /@KNG0U];\\U1]!PX                   ^QMI[WWDOH6W3G.:
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MV^EDB  .$;BEYZ72]-  [<V5Q?BYSMX U"YO&TWMXUH #G.WJWR^=[=R[0J
M 4_-VUO3/G<8 !?;YUMW<"QN0  !5GV_ 5_-DPX   %WK0-JV0XN]    ZV7
M5#S]^DZ> !W=Q]U>^YYMH '"E>EY_?2=/^3GE  ]&SE^Z_7R3 #A&XI>>ETO
M30 .[N/NKWW/-M
M                  ^/N9*('K3GNHOHV%                   'V-M/>^
M\E]"VZ<YS0   Z=[+94+?6_.^!<O;399ILD9TL9LD9\L)DL9M.:=+&;",ZG-
M.IPG0C-EFFR1G21FRS394V5/IQFRN1+*M:[\^;AL$T[)
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M2J #A&XI>>ETO30 .[N/NKWW/-M
M                               'Q]S)1@]7<_TU],P8
M       ^QMI[WWDOH6W3G.:   '3O9;*A?ZWYWP-E[>;+&;3FFRITL9TJ;)&
M;)&=)&;",VG-/D394Z6:;+&;3C.EFFP397,V*N+=?G/<^Y>LWP
M            \V3J>D  <E4I_11YCN@  '2*_M*(/1-3  V3XJ^NZ:#M( 'G
MI]+TWA"XI  >DWRS=P        !0"Z1I_6&[H #=E@,II-S^+ &0]!_FFX\\
M6]8   :_<E9T9N@ZH !M,P]_=/T3:         --6<QE/G=];  L":UF+2^H
MY\    >>GTO3>$+BD !Z.W+]V^EDB  .$;BEYZ72]-  [<V5Q?BYSMX IG[S
MK.I3-8X "YUHNS;8<-D0 !TBO[2B#T34P +E6C;-MQPN1   ZN7=O0'Z1J
M^RIS;4<1D-/F;QH [HV%U?*YWMH   '6RZH>?OTG3P .[N/NKWW/-M  %&;H
M.J:_<E9@ >BCS'<^2J50 <(W%+STNEZ: !W=Q]U>^YYMH
M                                                 'S->2C-ZMT#
M2WT_!                   #[&VGO?>2^A;=.<YH   =/-ELJ&/K;G? N7M
MYTL9LDTV6,Z2$V6,Z2,V6,Z2:;*FR1GR1FRQG2QFR339$V6;LEA+FX1YMW7L
MU@KL                      #S9.IZ0 !R52G]%'F.Z   =(K^TH@]$U,
M#9/BKZ[IH.T@ >>GTO3>$+BD !Z3?+-W         ZFWMO06Z-J  ^FDFO>\
M\VR@YT;40 +:6F;%O)U_*@  #7[DK.C-T'5  -IF'O[I^B;0        !IJS
MF,I\[OK8 %@36LQ:7U'/@   #ST^EZ;PA<4@ /1VY?NWTLD0 !PC<4O/2Z7I
MH ';FRN+\7.=O %+#>]7U9YBP  NZ:#M.R?%7P  Z4W]K1?Z#J8 %Q'2-EVR
MX;(@  :!]CP]5S<,  -HV(O]O^$R53K<M> ']'H)<UW'L/;5@  !ULNJ'G[]
M)T\ #N[C[J]]SS;0 !1FZ#JFOW)68 'HP\PW3[JG. .$;BEYZ72]-  [NX^Z
MO?<\VT
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M^ZO?<\VT
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M4@ ._6.O)$   _'FAT5R%H !VYLKB_%SG;P!2PWO5]6>8L  +NF@[3LGQ5\
M       !\E/+YW?3=,^5GE %Z?GNV=\\==^>]TK3N!KFB -MF%R-R_1MF
M'6RZH>?OTG3P .[N/NKWW/-M '\FBC8<34]W+7@ + 6MYBTSJ&?  X1N*7GI
M=+TT #]66/+5&H  !<AT?9MA>,O
M                             !^74A2C]0Z'H,Z]KH
M     ^FH3WJ?)_0-RG,\X   .GNR6-#?UMSW@;+V\Z2,V6,V2,^5,E3J<9LL
MTV$9U.:=3AM4T#,6]_..Z_8VTX                        \V3J>D
M     ;)\5?7=-!VD #ST^EZ;PA<4@    !:7U#/V!-;S     ^+J2^=WTS3/
MG)Y0!>3Y]M>PC&WFD7/XJH]NFN@ 7;]!VG99BKX  #7[DK.C-T'5  -IF'O[
MI^B;0        !IJSF,I\[OK8 %@36LQ:7U'/@   #ST^EZ;PA<4@
M!VYLKB_%SG;P!2PWO5]6>8L  +NF@[3LGQ5\        !JIS&/I=;WK  Y+H
MS^B%S/<YT(U ]VUO3!G<8 /N:<_HA<RW/Z"6(  '6RZH>?OTG3P /L:<W=&Q
MN@/Y. KBCU\NJ( '>3'W=W/0=IY$I3@ <(W%+STNEZ:     !=TT':=D^*O@
M
M  (4\*6'I[1:_'8M;                   'TU">]3Y/Z!N4YGG   !T]V2
MRH<^MN><#Y>WFTYILJ=+&=*FR1FR1G21_5EFL0<7V:R[P[:?T)(@
M                >;)U/2         -D^*OKNF@[2 !YZ?2]-X0N*0
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M:#M.R?%7P
M            CS0J?^A-/JW=[U*+-                   #Z:A/>I\G] W
M*<SS@   Z>[)94//6O/>!\O;39)ILL9TD)LL9TD>[>K7]K_SWN.R#2<H
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M!VG9/BKX
M            :P=\Q-2[T/INJ[?\1_$0                  ^FH3WJ?)_0
M-RG,\X   .GVR65#WUKSW@?+VTVG-^I)-LITC)6"..[)N;YEG9TD0
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MFZ/HFS@  <W4*OTLDP
M                       ZF[#9ZK>@8?IQLME\%>4P
M /IJ$UIC@6W<E6-4   =/MDLM%76=>[NZKD-G&B97L#A[D
M             #S9.IZ0 !]]2GO2\^VP  #J)>VU-?>=9  V3XJ^NZ:#M( '
MGI]+TWA"XI  >DWRS=P       .GE];4)^BZB !=UT#:>[EA= :8<[C*IFXZ
M^ !:VT[8-\NNY<  :_<E9T9N@ZH !M,P]_=/T3:         --6<QE/G=];
M L":UF+2^HY\    >>GTO3>$+BD !?#YYMOT$DP  XBKTJ/._P"J@ =N;*XO
MQ<YV\ 4L-[U?5GF+  "[IH.T[)\5?        "OMLN'JV[=@ !RU0J7\N<;?
ME *E6YZ]J#S>-  O]\WV_M!:7   ZV75#S]^DZ> !W/L+F\%H&U #B2M3KX;
M-A]#&Q8@ #8OB[V\)H&U  <(W%+STNEZ: !W=Q]U>^YYMH
M
M                                                  'FR=3T@ #D
MJE/Z*/,=T   Z17]I1!Z)J8 &R?%7UW30=I  \]/I>F\(7%( #TF^6;N
M   !7IV;#5>MMP(      &V+#9"YSHNS@ #7[DK.C-T'5  -IF'O[I^B;0
M      !IJSF,I\[OK8 %@36LQ:7U'/@   #ST^EZ;PA<4@ /1VY?NWTLD0 !
MPC<4O/2Z7IH ';FRN+\7.=O %+#>]7U9YBP  NZ:#M.R?%7P  UUY.RIA;WK
M  %U_0MH[Y8Z\  I2[YJ^K[+V       %J;3]@WZZYEP !ULNJ'G[])T\ #N
M[C[J]]SS;0 ,10DZ-J/42]M@!G@]%+F6Z<A4IP!PC<4O/2Z7IH '=W'W5[[G
MFV@
M
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MA&XI>>ETO30 .[N/NKWW/-M
M
M                            \V3J>D  <E4I_11YCN@  '2*_M*(/1-3
M  V3XJ^NZ:#M( 'GI]+TWA"XI  >DWRS=P      !\'4D\[SINF?AS0
M  %U30]HVCXB_  U^Y*SHS=!U0 #:9A[^Z?HFT         ::LYC*?.[ZV !
M8$UK,6E]1SX    \]/I>F\(7%( #T=N7[M]+)$  <(W%+STNEZ: !VYLKB_%
MSG;P!5,W'7]"^Q8@ "SSJ6=L1:SF@ !I]S>-IS;QK0 %Z'GNU]^L=> #4SF<
M=3*WK60      !]1)-Z(W,MS^MDF  ZV75#S]^DZ> !W=Q]U>^YYMH  J/;I
MKND7/XH "_'SG;^W%E< #A&XI>>ETO30 .[N/NKWW/-M
M
M                                                 \V3J>D  <E4
MI_11YCN@  '2*_M*(/1-3  V3XJ^NZ:#M( 'GI]+TWA"XI  >DWRS=P
M !J)S6.IM;SK(       &_[6\Q:=U#/@ :_<E9T9N@ZH !M,P]_=/T3:
M     --6<QE/G=];  L":UF+2^HY\    >>GTO3>$+BD !Z.W+]V^EDB  .$
M;BEYZ72]-  [<V5Q?BYSMX TG9[%U%=UUP #L=:U[Y/.]MY$I3@ 4^-VUO37
MG<8 !Z"?-MQ[$6M8 52-QU[0WL6)        NAZ)L^UC#Y  #K9=4//WZ3IX
M '=W'W5[[GFV@ "H]NFNZ1<_B@ +\?.=O[<65P .$;BEYZ72]-  [NX^ZO?<
M\VT
M
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MN+*X '"-Q2\]+I>F@ ?523=L[*X    &_P!UO,;P<!E0
M
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MW<"QN0!PC<4O/2Z7IH       LYZGG;%&L9H
M
M                                   >;)U/2  .2J4_HH\QW0  #I%?
MVE$'HFI@ ;)\5?7=-!VD #ST^EZ;PA<4@      -RN#R=P;2-D '2R_M:&_1
M-2  N/:/LNWW"9(  "J%N.O:(=BQ( %IS4,_O_UO, #7[DK.C-T'5
M!<&TC9-RN#R8   TU9S&4^=WUL "P)K68M+ZCGP   !YZ?2]-X0N*0 'H[<O
MW;Z62(  X1N*7GI=+TT #MS97%^+G.W@ ? 5)*)?0]3ZKWEN      .QMK7O
MG<ZVWD"G. *\^S8:KYMN! 'Z,(^A_P RW/DNE.  !Y_G2-/ZSW=  "^]SG;N
MWME<@#K9=4//WZ3IX '=W'W5[[GFV@ "K-M^ K^[)AP +F>B[-MHPV1 '"-Q
M2\]+I>F@      "SGJ>=L4:QF@
M
M                        !YLG4](  Y*I3^BCS'=   .D5_:40>B:F !L
MGQ5]=TT':0 //3Z7IO"%Q2       W*X/)W!M(V0 5VMGPM8G;,$ /TY8^B#
MS/<^1Z4X  &H#-XVG'O&M  ;1L1?W5=#V@ :_<E9T9N@ZH       +@VD;)N
M5P>3   &FK.8RGSN^M@ 6!-:S%I?4<^    //3Z7IO"%Q2  ]';E^[?2R1
M'"-Q2\]+I>F@ =N;*XOQ<YV\  =5[RWI.;[J_6^ZH     #EBC4NRZ%M/=['
MW0 %)7?=6UG9:Q &Q#&7MXOG^U   "IYN6O:)]AQ( %HO4<]80UK,@#K9=4/
M/WZ3IX '=W'W5[[GFV@ #2WGL74(W77  -G^(O[J^A[1E .$;BEYZ72]-
M    %G/4\[8HUC-
M
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M.G@ =W<?=7ON>;:  /F)Y:)W0M3Z>7UL !=GT+:=FF)O@.$;BEYZ72]-
M   %G/4\[8HUC-
M
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MS.8SBVM3 &XW!Y/LW:5P/EIY=-V<Q@       [UXZ[[GV-T
M
M
M                                                           (
M<7&-6G#C#DBE4_>EB
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MZ0G 3^S<\EX*4RE'&W"7RY=-55*6<2I@3IDZ2#N,YD$HJ!-5MHIE*@$!*.X
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M!$ ";7#I"3BOOC+R,JO54\5HMUZYB#^Y5;L6YE<$,FN[6L 4%\5Y1E=W:1F
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M?[NG-<Z[X\0$1$C$<1Q'E>5BOM[<$4NQJZD9#7,ANW:*?6GGP= ,5@8' X'
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MBL1B.(XCRO*Q7E>&B'#B1HE#T/#D4/?JPH^35M)JTHJ<T+.2L5@># X'@Q7
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M5RM9-UDBD*.0HQ#CT.86$&<P@P@Q@XL(<>AS"#"#<&%A!A 6'S[2M9?^"+Y
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M\JSJ)ZR::I3"]5+?(,P[PW>JHG FJE8?"'HJH_&/JI:'P3;K44/\$SU4^?\
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M;'7PI6]]*BP.Z >Q6%@<#"P/;T WI!P.%X/!PL#RL+F*P]!>DK>GT@X'^GT
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M>C_Y8&!@<#P8' P,#@=M#D)$)F'AX>CC["V-SJLM)5EE[TTG>ZDP<#"P/;T
MWI!P.%X/!PL#RL+F*P]!>DK>GT@X'^GT \&%X.!VFL*/INO:;R=Q?J&PL_\
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MO!P.VG,MJHBNL?)XE S>KAL  7[%B4IF]7#8   \B_@(+>KA^1A*4S>KAL
M ?<M@RGA0<8!<#S/%P.%O0#>EO0# YA<+N@'@]A86%[>C_Y8&!@<#P8' P,#
ME*E,B39>Y>J;HJ?(EI;M5=9JKK-WCI&]E)%87,5AZ"])6]/I!P/]/H!X,+P<
M#MIE371;A7[_ .9,$5H*L91<#S/%P.%O0#>EO0# YA<+N@'@]A86%[>C_P"6
M!@8' \&!P,#*%*9$FR\R]4W04>1K2W:JZS57V:O'2-[*1%S%8>@O25O3Z0<#
M_3Z >#"\' [9Y$W+AVFLZ8QCF_YDY<$]"865%P/,\7 X6] -Z6] ,#F%PNZ
M>#V%A87MZ/\ Y8&!@<#P8' RA2F1)\O,O5-T%'DBTMVJNLU5UG+R4A>RD&*P
M]!>DK>GT@X'^GT \&%X.!VSYAMX2U/6__,O+3K B"N1<#S/%P.%O0#>EO0#
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M8L># +VA+V[0E[=H2]NT)>W:$O;M"7MVA+V)$)%)Y=Q,OB-D+J08L*/#,\7
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M,Q@^68BB!"8\T2E89L1NUC"/:IF[5,W:IF[5,W:L1NU8C=JQ&":G8)J#%FD
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M;%A$CPY@AB2]3Y(3J(J6++)G"F,+>E"B$FA+UT5?$ >@!8!X,(<&>P"SNE[
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M6]=TJ/U]I)_T]E,XGJTNB&08D0  H,HA^M@:9/%X'US#J>F6=<W.;=5TR?\
M5V2C]?<DG6M$SZYIEO4MSF\7\471*X?XU71-X?XH&F6Q?6)=:KJVV@IXT<8$
MI !(0L,NI1^AM9;U+[@! !";4^("(" ^1R'/"/)YP1>38+D,%?!5I(R*,SV
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M=_K5Y,6Q\E5Y\<::#^./(6=_SP[WRXN<G>/#]?:.[MM[[V\U>(?^?G5R(_\
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MM7AIOYQT7X_@[5RAL;+>Y;9#9%6!N'C!>752=5U)0E3\LW/.FL\L?MGSA_\
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MS&'8W.#$C)&'JN-=NUEGY+D?X@##2T4/,#FZ9B9@0]AC=CU<;*:\^+>-]O\
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M\<KG\N?F,6PS[MAOEZ;TVZQ_MUF=FG</,:XI#\6(=B'X,4S$/Q8AVAQ&(?\
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M#,;#FT>:]HLL,3KNX:W=AG:$?@Q#\&AGXM#B-"B,0[0SM#/Q:'$XM#/P$A^
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M-&?!^K)GY;]. _SJZ/$ UY'6W9T\@2RR,R75SD[=(JZP2T\FF;#,L MAG)>
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M :Q.(^BBJ3FU>5EDE8&55CA7IY$-XAJ_&W8<T[Y ]/)H^?S<^>A\E6GP_O\
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MA1E'V^IW[A+Z8*8@Y*#<SPY^&U4Q:J\,U44$_P#YIKXM_P"::^+?^::^+?\
MFFOBW_FFOBW_ )IKXM_YIKXM_P"::^+?^::^+?\ FFOBW_FFOBW_ )IKXM_Y
MIKXM_P"::^+?^::^+?\ FFOBW_FFOBW_ )IKXM_YIKXM_P"::^+?^::^+?\
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M_-I^PZS_ $-T_P#-I^PZS_0W7_S:?L.L_P!#=?\ S:?L.L_T-U_\VG[#K/\
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MFD^5B5R>E4&Z5;?*=PN_^[N\E>"6HQ8<Z]$Q[V8[QRZ3$XZ\>/Y"U9^Z7?\
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M-;]9JH*,$88PDU%KJ9D63-8[PEN?48]DGJ[#.^'/B.3WLB;6"(!Y3B.C-E-
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M)8^:H7D V%KCJXK>;]9H@Q25NS"#ULDL'2\[1!$7O^L9AFSIABS-:<@R  5
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MY5)4U$TG:JOZZ,R2T#D(M5ERJP@1N'+_ &+SM;ZWG+(NTA2SNQ@ !QDDP"J
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MM<:X;0E)%;O=U),N1+)ZHLTG: ,R80"Y J5%1%VH,,;,LB0I=W("J!$DFH
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MG .C,EM Z++'=# E6!4D%M5:U73E/%I$]00DY ;1;HNL0)DLDE"165*LU!M
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M(8T9[S=S-DC_ !949B0RF TD_'5=B"ZINS3%QS"-&6,L9C06(R EL@-%O?Q
MXODT5]V 1)4[L>E,_&"J;"AH)<I0JJ(  0  L  J &38#\.ZM?\ S-X7Z4@U
MRY1Q;CS!4,82)JTE.P:L_=+O^I3;%_2-1E(=\.8<IP]63<0-X&^1)(]4X893
M BPT"WAO\Y=@$G#&WFS1N.!7D<,(0A'#@:P:->]3$7*\&LJ!&2QW4%<L[J=$
M>8370_ZG=F$L634Z<HY.FM2QQ!]%MS80JB)-@HLV?+^QR#Y<T$,1\V54YR@M
MH*18U!,NB=[>(5SID"]E83%+4UU+614S-#81\*:O:*H0UX(L+"M97XM3O\[1
M%JL,-]>":LZ^Q*E<=W4U6$1TI@B2XZ.CT%,0\=B__P K=U:9" F+T9@R=,5D
M#$&TEW*-.^'[PMX7%+FP29F#CH,=T]V."ON];769(Q LIT3V7$5;\4G8H"LF
MBWB_*;E=C7I3!](P^9+J->(OHB%8TK*?8M52]&,--S7,F$8W: CC@!!5B=$"
M)PVFS"%5022:@ *R2<0 MI.UDONA]'*!Q2TC YV)+D8BQ&+"EW;7,U4EKTEE
MM5W[@B$N-@RD1BP&BHK) 1   ( "H "P 9-B-TUE)2?+/DNH81RB-A&(B!&(
MT,_X>GF[,?\ #F1>7F#==1G[S>H3>[HSRQ_B2OI$AE)6)4=L*>'8PNJ[N3+C
M S6Z,I<L7(@88U72;(IHM]O1%ZO@\LCH2S_PU,8'YYZ631!(V"5\+W5JDA-G
MP\XCZ-#F!+D65H;1_88^O=>O%C%9$A2.]O$V$0B V 5%W(T9:UF)*JTSX@^(
M)D6/1E2ECW4B5&*RY:FP"UF/2=HLQ).V!AC8UD2%+NY 50(DDU  "TF@O]_
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MK59&!J&U7U?JDK>;[88&,N4?GD'I,/,4U>45J!>_ZRFM.FS#$LQX@+ !B4
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ME!WLV9=R?]Y*;EE]X!G)A0=QK&[UXFFJAX'*GBH/L\^7,CYKJUMEA-OA+,8
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M]R#BR:9'6/DCH@UL3\A/JC7"1!KES!#3E/"IT.(C&+&$58$&C:JUJL08F5-
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M2F'3@=U00N]_=EUI-K^FEW1Z[*KI)E]'*/H^&(Q;<&&/ )<L%F8@  1))J
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M0 &8?W9M:_#:+I3ITAFDC'W\HB;) .+2F(JDCR6(K!()5A C;8PEERP69C
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M<918^4J]V_I2]%CODT,S4E[>2V))H$Q<P9=%E&Z0YH9EYNQFRE_Q)/TB0RF
MTU&ZZJ-L?9M5W=Y[XPBDPW6-BC=8@;M!,US/2Z*;57Z69F,"$&<.T,F4-/E/
M>W&.:Y(]!-!"-Q@U.[U==Y<A<DM%0?D@;"9<Y0ZFT, 0<X-5"9]Q26Q\J5&4
M0<L)952>TIRVT,S4-\(.))XB/TB $?HSGH7UC=6[H?XB=.7#*66.C^/HG<V<
MR-6R)EX<#2*RD:8P4$ L0H) !($;(D#'3^67O^'G>Q3^67O^'G>Q3^67O^'G
M>Q3^67O^'G>Q3^67O^'G>Q3^67O^'G>Q19FLKI.NZL8*9LIY8)M@"ZB)W!M0
MR=6W>9>'41*RD:80(PB0H) B0(V1-/Y9>_X>=[%/Y9>_X>=[%/Y9>_X>=[%/
MY9>_X>=[%/Y9>_X>=[%/Y9>_X>=[%%F:RNDZ[JQ@IFRGE@FV +J(G<&")<L%
MF8@  1))J  %I.(4_EE[_AYWL4_EE[_AYWL4_EE[_AYWL4_EE[_AYWL4_EE[
M_AYWL4_EE[_AYWL4*L($5$&T':JWJYW"\393]5TD365JX5,JD&L$5&T4_EE[
M_AYWL4_EE[_AYWL4_EE[_AYWL4_EE[_AYWL4_EE[_AYWL4,R9JV]*J@DDW>:
M  *R22E0&,X#+JR[3;P4AI"5+>9HQC".@#",#"-L#3^67O\ AYWL4_EE[_AY
MWL4_EE[_ (>=[%/Y9>_X>=[%/Y9>_P"'G>Q3^67O^'G>Q3^67O\ AYWL4_EE
M[_AYWL4_EE[_ (>=[%/Y9>_X>=[%/Y9>_P"'G>Q3^67O^'G>Q3^67O\ AYWL
M4_EE[_AYWL4_EE[_ (>=[%/Y9>_X>=[%/Y9>_P"'G>Q3^67O^'G>Q3^67O\
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M5 4#,!5\EIK?XG4I),"DBM7<8C,QHAQ*(,UI*CK+=[LBRY: !54!54"P "H
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MF[38)/48T)J8#SI9Z0RC26(TC19TE@R. RD&(((B"#C!%8.&OQ3<4Z<H!)X
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MNG\SO?\ $3O;I_,[W_$3O;I_,[W_ !$[VZ?S.]_Q$[VZ7>9,)9FE2R23$DE
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MBH/]0OLF4/\ AJ\P_E"4([]!,OQF7QQB=M%/02!WF9A1;M<I2R9:V*BA5&8
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M)E@U&'G-UFW3"P#[D/M5ZC*N,H]-["Y'^'+W?.:Q1E) I+N5REB5*E *JJ(
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M1JBZV2EZ30@7<UNYW6:)W!!; /"4< @B!!K!!M!&2C3[@/L,\UQEB,LG=E1
M'XA3=C1IMYD]]=U_QI722&5AUDW2RA8U!C@W76B?X$U'.ZH8:0_&6(WZ+-E$
M,K $$6$$1!&X1ASI<M82+P>^E9(.3I*.P\0!;HZ)-NTTNUW4O,F,%51:68P
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M\Y6'19?G*2-_94UCK]6NUTM"'HS9HQ5&N6AQL>D1U0 0X2YW.6LJ5+$%51
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M>JT2%&U6N.J2M[OE8,#&5*-G38=9@?(4XCI,M0+ZPUG-,V:]I.(8@!8JC$H
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M6&(Y#8PK%6''P1\$#L%>!$;!&D:1P(&#SV'12/Y39%XVL&,AKU?'+NV/(,0
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M7QS,FS#%F-I/B L %0$   /N&F_B^NN%+["\@V67V3R[&LI;6( WS"@EK8H
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M !634*77^J']59"S-<D+,N=Q< K<":UG3P:FO@$"B=6ZFLZ5X@9&S7K^K?\
M22Z_2]*;K'5TI?>6L][NB*/>6M/D*/I*YLH=YI+,V"[?%WPC>3=KY=C4;4F(
M8:<F<D0)DJ8!!T.XRE756'^JZLA=M8W4(M]N9,6D3&!@R&K3D3=%C*F0Q%'
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M@RF)E3I1(TY$](CO)4R TEB""%=&68J.HUWJ0B1?9 5;Y<V8&;=II&]WDF9
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M4Y0?&+#PX\-DQ,AX00>2/]B5W^#_ (*N;7R_7F,%$ J(O7FS7:"2I2 Q9W(
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M%2C(.<XSXH4$Z0VBPX]PC&*"6W0FXUR[JY<UHW;=JS3E '"P&&&\U6/B\?\
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MP[#]NG#HIU=ULN9>7-AP-#>+@-TI[/L\&2D#41LD)$UE&2,1P&(XJ0FJKC-
M\1AQ4^EDD9B#RA:5Z:YUYB:>]A^*_LT]\.!N:GO?R6/YM.CI-F7G(I"1)WV/
MB \=(:>@,B5<=;<=(FLG8%D)9:QR#&?$-VBRI8@JB &X/["[I\#?"4K2GW@Q
MF36![J[2%([V\3B.K+E@V=9W*RI8:8Z*9'P=\(R8*H#WB\,!WU[GP >?.86D
MP@B Z$I(2T 4;(,$^$;6G:RUE.2[W>[HTR;-F,$ERY: L[N[$*J*H+,S$  $
MDPHWP/\  TUY/PQ='.DW21M934(T9TQ3 K=I9$;O):!8_3SE[SNDD;6D?%_P
MA/[J?*Z,R6T3)O$DD%Y$] 1IRW@,89&"S);+,56"?$WPX>ZG2]&7>[JY!FW6
M>1$HQ@-.6T"TF< %F(#4LQ9DM#X!X1X1M$;/K_5MV30NU]FB_P @"H:%]43I
M@48E2\-.EJ!4 @ J$/D,WN[#Z06CSA[0X[,E(';7=2J@.LV(#GR#'FB:"1($
M .$G&3NG[ZMAG_6/ZQVQ,(M4J>, \1.&EX2U"#GRC?%5%G2C%6$1]^7+N[!5
M5,7JG\T[AXC7E!,J:-%EJ(.VA*EU*.LV(#G.(8\T:+(DB"KQY2=T["581!M!
ML-#/U>*L:>SS<&(4T6J(VYH"I%ZS9!D&Z<7#BHLJ4(*H@!N;"9J=";EQ'M<]
MN>RADWA=$\1&4'&-N"5*&DS& %-"UVK8[N0;@_#C_L+2ZW5&F39C!$1 69V8
M@*JJ 2S,2   220 (T0ZTEJWQ!K54G7^:*S+J)E7-&\R[AH/ PF3S,>)3NPN
MR#!/A&U9VLM93DN]WNZ-,FS9C!)<N6@+.[NQ"JBJ"S,Q  !),*3?@+X"FO=_
MAB[O"9,$4F:RF(8B9,!@RW56&E(D- N0)TX:?=RY.V)/Q;\)3M%U@L^0Q/<W
MJ3$%I,Y0:U-JL.G+>#H0PI+^*?A:9HNL$O-V<COKI.A$RY@%JFLRIH&A-2L0
M8.BT'A'A&T1L_P +_&LI(F\7>]7&8V("[S$GR%/:^U7@CLFRJ/R&;S= !,QK
M8&YFY<==="KB!%H-HVQ!.B@ZS8AN#*=SAH)$@0 X2<I.,_?9L4_ZQ_6.V'D'
MRU(X1"A5JB*CA_9Y]<ICZ)RYLHWQNAT((-8(L.P::]&:HJ.7<;<R'%Q4,F<N
MBRVC[\6[MC1EU(.LV(<YR#Q4$B0( 6G&3E.[]XV33ZDSSAC[0Q\N[BIH7A8#
M$16IS'Q&O<VUH2ZE'6;$!XSD'BH)$@0 X2<IRD_?5L?=7A=(8LH.4'$:&;)^
MDEY1:,X\8JRPVT)4H%F:H 4[V;TIK6G$HR#QGQ?V&3?ZK:^DZ>KOA]PMU# %
M9NLF4,C5@@BYRV$[$5G3+LZGHL-F&"?"-J3M9:RG)=[O=T:9-FS&"2Y<M 6=
MW=B%5%4%F9B  "284F_ 7P%->[_#%W>$R8(I,UE,0Q$R8#!ENJL-*1(:!<@3
MIPT^[ER=M2?BWX2G:+K!)\AB>YO4DD%I,Y0:U-JL.G+>#H0PI+^*?A:9HNL$
MO-V<COKI.A$RY@%JFLRIH&A-2L08.BCPCPC:(V?5VM5'3N6MI%<(PES;M>T8
M1Q1?NC$U5 6D?(O>+T)N)LNXV7/:.*G=7A8'$<1W0<?WQVL)]\BDO$/*;F''
MRT$J4H518!L<_P"L?UCMDSU'0FU_C>4/'O[FP?9=(]V03#%$8QDW86[#HS1!
MA8PM'.-SD-=-&<(J;&%AYCN'C%>UA.O$4E?E-FR#=.]&@DR5"J,0^^W=V8RI
MRAE-H-=#-U>8CS":]XX\QX30RYJE6%H(@=KB;-BDK+C;L\]F>@DR%T5&+QG*
M=T[,9EW^BF;G5.<8LXWP::%X6&0XCF/WG*-K]U=UCE.(9S]Y.(4Z/2F&UCR#
M(.7'_88EVNZEYDQ@JJHBS,Q@J@"LDD@ "TTU-\#RE GW>2)E[85]Y?)WTEY;
M2M8":Q2639*26MBC9A@GPC:<[66LIR7>[W=&F39LQ@DN7+0%G=W8A515!9F8
M@  DF%)OP%\!37N_PQ=WA,F"*3-93$,1,F P9;JK#2D2&@7($Z<-/NY<G;DG
MXM^$IVBRP6?(8GN;U)B"TF<H-:FU6'3EO!T(84E?%/PM,T76"7F[.1WUTG0B
M9<P"U3694T#0FI6(,'1? /"-HC9]937)!DWJX.L,9-Y27759HS":H5@5PB#\
MBF5>%#*<OBQ@[HH9ER/>+YIZPS8CQ'<-"C@@BT&HC:4)"U8V-2C?\0B:"8_T
MDS*14.R/&:\D-EG_ %C^L=LF[S,X.0XCS[E#(GB!' 1E&4'[Z\,=EMB,N: R
MFT&L4,W5YC\PGU2>0\-#+FJ586@B!VEH7="V4XAG-GCR4$V\?23/R1F&/.>
M;2T;P@.0V$9C;O6;E"]T/>+D-3#Q'B.Y0I,!4BT$0.T^[NR%CQ#.;!03;W"8
MXQ>2/:WZMRD!M RYJAE-H(B*&9<6T#YK5C>-HWX[U-"\(5W<1S&P[3"("2;
M*R=Z@FWXZ"^:.L<YL'&<U!*D*%48A]]9W37_ &&ZEDWE-.[:J+ZSG8X"YZ+2
M(@U%3>VNRL#:I(H-F&"?"-I3M9:RG)=[O=T:9-FS&"2Y<M 6=W=B%5%4%F9B
M  "284F_ 7P%->[_  Q=WA,F"*3-93$,1,F P9;JK#2D2&@7($Z<-/NY<G;T
MGXM^$IVBZP6?(8GN;U)B"TF<H-:FU6'3EO!T(84E_%/PM,T76"7F[.1WUTG0
MB9<P"U3694T#0FI6(,'1:#PC:(V?6,HB/?WNX)')"\+,CN^[AOQQ?)$+P@)R
MV,-^W>LW*%KF^F/-:H\-AWX4T;PA0[HJ.8V'>V8%4T%/E-4."T[PH'O![UMV
MI>#'OF&Y0*@@!8!4-FFS9: JSL1TEL+$C'3J#TEYZ=0>DO/3J#TEYZ=0>DO/
M3J#TEYZ=0>DO/M3N[PL<AQC,?O!QBA:Z,)@R'HMQU'/$9J0F27'XI(X152!4
M\!IU3P4ZIX*=4\% 2".BVR:%Y0,.,9C:*%[D\?FM;O,/&!GI"\2RNZ15O$5'
M>.S RY9"GRFZ(XZSO T#WMN\.05+SGBS4$N6H518 (#:NC>$#9[1F-HWC0M<
MYD/FM9Z0KX0<]"9TLP&,5CA%F_#9XRY9 RMT1QV[P- ][;O#D%2\YXLU!+E*
M%48@(#BVH4F ,#B(B. T+2"93;E:\!\1 W*$JO>+E6OBMX ::+@@C$:MFT;N
MA?,*M\V#?H&OKZ(\U:SPV#>C2%W0 XS:3G)KWK-S^P_XI^.9R5C[+<)+PQ'O
M+Q>5CO74PW*[10;,,$^$;1G:RUE.2[W>[HTR;-F,$ERY: L[N[$*J*H+,S$
M $DPI-^ O@*:]W^&+N\)DP129K*8AB)DP&#+=58:4B0T"Y G3AI]W+D_($GX
MM^$IVBZP6?(8GN;U)B"TF<H-:FU6'3EO!T(84E_%/PM,T76"7F[.1WUTG0B9
M<P"U3694T#0FI6(,'11X1M$;/JG4H/TE\UM+>&67(NMZ+0_'FRJ\D1C^2M%A
M$'$:1[O0.53#BZO%2-WF[S#QCFIT55^RP_.T:=*2^\I/)&D'1AG!&!T$8YE)
M\5.C)89QH^M"D9A5!NF)XA#CI&\3&?<$%'C/&*?02PIRVGA,3Q_<!HL(@Y:1
M,O0.5>CQ6<5(W>;O,/&.:G157[+#\[1ITI+[RD\8C3IJ1G!'A@*="6S9E)\5
M.C)89QH^M"GTA5,YB>($<=(WB8S9@%'C/)2,F4H.4UGA,3P;;C.E*2<8$#PB
M!I&0[)G@P\1XZ1E.CC?!Y(<=*Y).8@\A-.G*<9U;FITA#PP C3H2G;,K'Q4Z
M,DC/!>4BD9K*@SDGB$..D9\QGS04>,\=(R)2@C'")X3$\>VM&>BOG /^RD9>
ME+.X8C@:/$13Z":K=H%>32I5+##<8<A(/%3IR7]$GC ITU(S@C Z",<P)\5.
MC)??$.6%.F%3.T?5TJ1O$V.XHAQF/)2(EZ9RMTN*SBIHJ( 9/[$3?M&!UAK.
M^3XPM")(NP@3:!]G-D #&J,21LPP3X1M"9?+Y,63)DJSN[L%1$4%F=V8A555
M!+,2  "284?^GG]/I[R_AN[.>^G*2IUG-0C18BIA=);",F68=ZT)TQ8K*67\
MA2?BWX2G:+K!9\AB>YO4F(+29R@UJ;58=.6\'0AA25\4_"TS1=8)>KJY'?72
M=")ES +5-9E30-":E8@P=%\ VB-G^&_@N4\3<;I/ODP"R-\FK*32^<%N;$ U
MA7C8PC\G](1IU1P4@!#[B^D(TZHX*0%7R-$@<%.J.#Y&Z0!IU1P4@*O[%_AR
M9+$#-;6+MNL-:7U([G1115DC::#9A@GPC9YE\ODQ9,F2K.[NP5$1069W9B%5
M54$LQ(  ))A2=_3G^G,YI/PY);1GSUBKZR=3O,MS5A&7+,#.($R8(:"+\B2?
MBWX2G:+K!9\AB>YO4F(+29R@UJ;58=.6\'0AA27\4_"TS1=8)>KJY'?72=")
MES +5-9E30-":E8@P=%H-HC9_B+7EW</=I-X^QR"#%3*N2B[!D.-9KRWG#$3
M,)%4!_=EU%(!4_9INL)=1B1'6%YG=*NIOI8PJZ)4PKB1LPP3X1LTR^7R8LF3
M)5G=W8*B(H+,[LQ"JJJ"68D  $DPI._IS_3F<TGX<DMHSYZQ5]9.IWF6YJPC
M+EF!G$"9,$-!%^1I/Q=\(SM%U@L^0Q/<WJ3$%I,Y0:U-JL.G+>#H0PI+^*?A
M:9HNL$O5U<COKI.A$RY@%JFLRIH&A-2L08.B#:(V;7?QBCZ%Z209%TK@QO=X
M^AD%;">[9N^8"ONY3D64+,8DUDFTG*?[LNL=2.8OJ_6LZ R2I]WNTQ<=IFB=
MB A"TQH-F&"?"-EF7R^3%DR9*L[N[!41%!9G=F(55502S$@  DF%)W].?Z<S
MFD_#DIM&?/6*OK)U.\RW-6$9<LP,X@3)@ T$7Y(D_%WPC.T76"SY#$]S>I,0
M6DSE!K4VJPZ<MX.A#"DKXI^%IFBZP2]75R.^NDXB)ES +5-9E30-":E8@P=$
MV@-FNO\ 2?4\S2N>H?IKT08A[_.2I#:#]FN[:,08B9/G(PB@_NS?$/P//> U
ME<Y-ZE@FHS+E-*,J_.:7>RQ M642>K0;,,$^$;),OE\F+)DR59W=V"HB*"S.
M[,0JJJ@EF)  !),*3OZ<_P!.9S2?AR4VC/GK%7UDZG>9;FK",N68&<0)DP0"
M(OR5)^+OA&=HNL%GR&)[F]28@M)G*#6IM5ATY;P="&%)?Q5\*S-%U@EZNKD=
M]=)T(F7, M4UF5- T)J5B#!T79QLM^^,[V5>]P[FXR6/O[Y,#=TD(@E$@TZ=
M @B3+>!TH1O.NM;SFO%[ODV9.G37,7F39K%YCL<;,[%CNG^[-J#XUF/H7>[7
MI4O)C5]DO ,B\DCRM&3,=U!JTT4U$ @.AB#6"*P0<8V88)\(V.9?+Y,63)DJ
MSN[L%1$4%F=V8A555!+,2  "284G?TY_IS.:3\.26T9\]8J^LG0[S+<U81ER
MS SB!,F"&@B_)DCXN^%9I!4A;Q=V)$F]R(@O(FBNHVH\"TIX3$Z0KD_%WPC.
MTD:"SY#$=]=9T(M)G*#4PM5AT)B0="5.SC9)^M=:3DN]VNTMYLV;,8*DN7+4
ML[NQ@%55!9B:@ 2:->K@S)J+5FG)U=*,1I*2.\O<Q39-O)53" T)22I9&DKL
MWR=],ZIG('+2N<#F!/("*5:;9E'C(IT9;G/HCQFGNFX13I2F&^#S4Z2NN\/$
MU(=[ [H8<<(<=/H9BOF8'DV]$U"G3G)O$$\ B:=%RV93XX4Z*.=Y1^=2J4W"
M*>Z;A%.E+<>B?SA3I:2YUYB:=&<HSQ7U@*1E,&&X0>3^X5<KM?INGK34(6X7
ML$Q=EE+"ZSSC/>W<*K.:WG2IQQ;,,$^$;$\^>P26@+,S$*JJHB68F   $234
M!6:3/Z9_TVO++J"0Q6]WE#H_ZE,4B"H1TOL<MA%:X7AX.5[M)9;Y.E_%7PK,
MTD:"7JZN3W-[DQB9<P"QA694T#3E/6(J71Y/Q=\(SM)&@L^0Q'?76="+29R@
MU,+58="8D'0E3LPV.)J I-_I1_3F\$ZDN\R%^O2$@7^=+:J5+(/2N<IP&+$0
MO$U5=?HI:/-^2XFA!?3;(M?'9QTA=I8096K/!4!QT^DFM#(#HC@$!2)V'Z*:
MT,A,1P&(H%O4L,,JU'@,0>*@5'T6/DM4>8[Q.V-.>X0;IAP9=ZA6[(9ARGHC
MQGB%(*PECYH\9B>"%(SG9SNDGEV'24P.Y3HS21D;I<L3P$4A>Y>^G,>>@$F8
M-(^2:CP&W>CL^G.<(#5%B (Y(FGOY?IKST]_+]->>GOY?IKST]_+]->>GOY?
MIKST]_+]->>A$B8KD6Z+ PX#M32GNJ U18@<M/?R_37GI[^7Z:\]/?R_37GI
M[^7Z:\]/?R_37GI[^7Z:\]")$Q7(MT6!AP'!B:@*>_E^FO/3W\OTUYZ>_E^F
MO/3W\OTUYZ>_E^FO/3W\OTUYZ1&U3+F345A:"R@C>)I[^7Z:\]/?R_37GI[^
M7Z:\]/?R_37GI[^7Z:\]("?+)/SUY\ &>ZI&S2($<T33W\OTUYZ>_E^FO/3W
M\OTUYZ>_E^FO/3W\OTUYZ>_E^FO/3W\OTUYZ>_E^FO/3W\OTUYZ>_E^FO/3W
M\OTUYZ>_E^FO/3W\OTUYZ>_E^FO/3W\OTUYZ>_E^FO/3W\OTUYZ>_E^FO/3W
M\OTUYZ>_E^FO/3W\OTUYZ>_E^FO/3W\OTUYZ>_E^FO/3W\OTUYZ>_E^FO/3W
M\OTUYZ>_E^FO/3W\OTUYZ>_E^FO/3W\OTUYZ>_E^FO/3W\OTUYZ$R'5X6Z)!
MAG@< S)C!5%I)@!OFGOY?IKST]_+]->>GOY?IKST]_+]->>GOY?IKST]_+]-
M>>GOY?IKST]_+]->>GOY?IKST]_+]->>GOY?IKST]_+]->>GOY?IKST]_+]-
M>>GOY?IKST]_+]->>GOY?IKST]_+]->>G1G2S^.O/3H.IS$'9>[FS45AB+*#
MP$T]_+]->>GOY?IKST]_+]->>GOY?IKST]_+]->>GOY?IKST]_+]->>@>60R
MFP@Q!S$;6TI[J@-46( COT]_+]->>GOY?IKST]_+]->>GOY?IKST]_+]->>G
MOY?IKST]_+]->>@F2V#*;"#$'?'R](UCK.81J76@6Z:P%9"2V:,J\P ,6NLP
MZ9@"QDM.11I."%G26#HX#*RD%64B(((J((K!%1&RC!/A&PM/GL$1 69F("JH
M$2S$P   B2:@*S2\?TQ_IC>"FH4)2]WM"0VL64P,N61 BY VFV\FL_0P$SY0
ME_%/PA/*UJMXN[$F1>Y0,3*GH#6*SH.(/*8Z4M@8Q_U/X:F]S?I*J;W<)C#O
M[LQ B;%[V06JEST4*]C"7,TI:[(-BFW_ %A-21(D(SS)DQE27+1 69W=B%5%
M4$LS$  $D@4G_P!./Z1WAY.ISI2[W?UTDF7X$:+29$0'EW0Q(F,83+QU8))T
MA.^2BS& &,T*74=ZV6Q1OVG>JW:?3N='S14O!CWXG: "/I+YK5C>QC>- DWZ
M)\AL.9N>&Y':FG>'"Y!C.86G[XT*7,=VN4UMS#CST,R:Q9CC)B>/: 72[Q,C
M5\!M'&-R@2/=N?);Q&P\1W-E3ZP>J^'-[(Y=J2^W^:<.;V1RX+]EN0X8N$\]
M)>H<H\W.,6Y5BVK.SCU1A)VEY1@2<[?F_(4[.OYV!.S#UAM7Z-V7,2.2G1G,
M>UTO6C2$Y%<;ZGBB.*D)P:6?2'"*^*FE(<.-PQX<F_L'VJ4.G+%>ZN/?%HW]
MS8#<)IJ-:9\8W[1NQR[6T$/T<N(&Z<9W\6X,-9 ZMK'(HMWS8-TT$M!!5$ ,
M@'R_)_HC\;7B%^N:$:JFS#[^[(L3<R3;-NR@F0(]*[@H(=P-+9!@GPC8&O%X
M8)+0%F9B%5541+,3   "))J K-+Q_3'^F-X*:A0E+W>T)5M8L# RY9$"+D"*
MS;>C6?H8"9\I2/B7X3OLVX7Z[&,N=*;1895(K5T85/+<,CJ2KJRDBDGX:_JX
M9>IM:0"K?1T;A>&LC,))^QS"($Z9-W)TB)DJ*2J+/D,'1P&5E(*LI$0RD1!!
M!B"*B*QL8V$ZV^.K^LF8ZDR;K+A,O=Y(B(29 (8B(T3-?0DH2.\F)$4?4\K2
MU3\/(T4N,IR3.T3%9E]F#1[]H@,LJ D2R%*HTQ>];Y*A,.D^)1;OY!GW@:?2
MM!,2BH;^4[IWH;4$MCWDOS3B[)Q9JQN4[R[M&%H-HSCQV9#M")J H9-P@S8W
M-@S9<]F>AFSF+,<9VH)5XC,E[O6&8X\QWB*"==VTE/"-PC$=C3ZP>J^'-[(Y
M=J2^W^:<.;V1RX+]EN0X8F(8,IB#D(H)ECK4PW<HW#BWQBVI.SCU1A)VEY1@
M2<[?F_(4[.OYV!.S#UAMD/+8J1C!@>$4"7H=ZN6QN&P[XCNTC=VB<:FIAG'C
M$1NX>G+'T<RL;AQKO8MS-AAT,"#$'(119XZUC#(PMX;1N':G=2S]),J&X,9\
M0W3'%AP%!ICZ1ZVW,B[W+'[@).M-637D7F[.DV5,1BKRYB,&1T85JRL 016"
M(TE_"OQ9-21\57.6>\6 1+_+3_\ )NZBKO L#>9*PT6C-EJ))*RMC&"?",-I
M\]@DM 69F("JH$2S$P   B2:@*S2\?TP_IC>"FH4)2]WM"0VL6!KERR($7($
M5FV\FL_0P$SY52Z_#=_-YU:IB;A>]*==8$Q/=J6$R[DDDDW=Y<6K</927<?C
M9)OPW?F@"9L9]R9OFWF6H=(UD]_)E(H@.]8T36OP_?)-^NLSJSKO-2=*;'T7
MELRFHBPX]A&&_P#_ #77EWN]X3_\66W?WLG$/LTG3FKI5 /,5)8M9P 2)VI_
MZ0:O_P!*D."OVZ]A)M\@?*E2%+7>0V0S&O.4!&@1.U[\27R=?[[>#I3)\^8T
MV:YL&D[DL8  *(P4     ?)9N]Q(+8WM W!B)W;!NXB[DDFLDUD[6$Z0Q5AC
M'WUC<H),^"3>)LV0[G!'%LIG3V"J,9^^LY!0RI70E9,;;K<UF>W:XG7=H'&,
M1&0C']\*='HS!:OC&4<F/8D^L'JOAS>R.7:DOM_FG#F]D<N"_9;D.P">E8L8
M91C'C&[19THQ5A$'[^/:<[./5&$G:7E&!)SM^;\A3LZ_G8$[,/6&VQ,EDJPL
M(J(H+O?S!K ^(]K(=VS+"VD1@M=WM-8.1A8>?<C1I,T093 C-A@.?HYE3;F1
MM['N$[3,QS *"2<@%M&GFRQ1D46<YW2</[9-'0EFK=;_ .-N>&[]P5U^(OA^
M\/=+[<IBSI,Z68/+F(8JPM!W5(*L(JP*D@_8M9%+M\2:OEC[;=P-%)JQT1>[
ML"3&2Y($Q(Z4B:=!AH-*>9L0P3X1A//GL$EHI9F8@*J@1+,3   "))J K-+Q
M_3#^F-X*:A0E+W>T)#:Q8&!ERR($7($5FV]&L_0P$SY8_P!0^$]97K5D^KZ2
MZSYLAC#$3*92PK(@8@@D$0)HLF^W^[:XEI""WZZHS0R&;=C=IK=IYCMNPJHJ
M?$GPG*G&%;W:_/)$86B5-N\^()A49HT17%H0,;]\/ZSEM&R6UUF"$!7%ILHQ
MC&K1Q QK@/Y5KW^&N'_LZ?RK7O\ #7#_ -G3^5:]_AM7_P#LZ?RK7O\ #:O_
M /9T_E6O?X;5_P#[.G\JU[_#:O\ _9TA_I6O?X;5_P#[.G\JU[_#:O\ _9TC
M=-3Z[=XV/(N*"&7276$PQW-'?%&_T3X6OEX.+O[W)N\:L?=RKS"NJH&JNNRC
M2_A;46KM7!O*GM/OCJ/FE6NJ:4<;2V$*M''1Y&OOB6]2Y$R(,FZ%;E**FK09
M;JLHS$@:Q-,R..,*%F,2:R3:3E/R7$T-TN1Z%C,/*W!N93CS6[8B*"Z7T]*Q
M6/E;AW<AQXZ[=C:?.,%7[X#=--)ZD'57$-TY3N\&V1-E'19:P131>"S5M&7=
M&YE&+@V%/K!ZKX<WLCEVI+[?YIPYO9'+@OV6Y#L/V2<?HW-1\UN8X]VO+M.=
MG'JC"3M+RC DYV_-^0IV=?SL"=F'K#;HNE[,99J5CY.X?F\F:S!^WRA6M3[H
MQ'>L.Y#)L'V>8>G*XUQ'>L.]EVD+A+-;5MFQ#?MS#=PUN\JUCP92=P"NBW>4
M.BHX<I.Z36?N#N?Q?\)WEKI?[C,$R7,4G,R.(@/*F+%)LMNBZ,RL"":+K.Z:
M%UUQ= JW^Y!HM)<U";*TND]VG0C+>O1,93L70D[",$^$8+SY[!$0%F9B JJ!
M$LQ,   (DFH"LTO'],/Z87@IJ%"4O=[0D-K%@8&7+(@1<@16;;T:S]# 3/NT
M-PNIJL=AC^:/'P98[']&A;,">2E4A]]2.44]RU*Y#[RD\D:?2H5S@CEV07*]
MGI^2Q\K<.[DRY[=A,R88*HB2<0I55+7JCQG=/$*LL=CC+E.V92?%2J2W!#EI
M'N6X*=*2X_%;FI!P0=VK8UG23!E,0:=X*G6IAD.7,<7!BV!/K!ZKX<WLCEVI
M+[?YIPYO9'+@OV6Y#L7V6<?I$%1\Y><6'>.7:4[./5&$G:7E&!)SM^;\A3LZ
M_G8$[,/6&WOL$\])1T#E \G.,6YFP2C"(-1&X:&6.HU:G<R9Q8=XX\-;Q+\D
MUC*,8WQST6=*,581'W\NT'O$RQ1PG$-\U4:?-,68Q/WY!8-S#^US1TY@JW%Q
M<-N:'W"W;XU^#;P9%[NY@RF)E3Y+$&9=YZ1&G)F:(TEJ*L%F(5F(CK*^+/AM
MNZG)"7>[H[!IUTGPB9;PAI2VK:3-T56:E<%=9DM-@&"?", S)A"JH)))@ !6
M22; ,9I._I7_ $OO1&I999+_ 'R6T!K!P0.XDL*_L:$'3<&%Z:SZ!09_W:?9
MY)^E<>BN7.;!PXAL0;1[M3C:K@%O%#=I&\,TPY!T1Q1/'3Z*4H(QPB>$Q/'2
M P(&GTLI8Y0('A$#0M=)A4Y&K'"*QQTC/3H^<*UX<6_ ["&4P(IW<T_2I;\X
M>=S[N?8?L,@]!3TCE;)F7ES;"$0$DV 5D[U T\B4N[6W /&0=R@,P&8?G&K@
M$..-/H9:IF ')@Z+@,,A$:=*4%.5>CR5<(H6N<R.XU1X15Q"FA>4*G=L.8V'
M>.PB?+S$91C'-D-%GRC%6$1]^46'=PT^L'JOAS>R.7:DOM_FG#F]D<N"_9;D
M.Q+.E&#*8C[\F6@GRZC8PR'&/&-S:,[./5&$G:7E&!)SM^;\A3LZ_G8$[,/6
M&'! 2=P1IU&]$\U.HWHGFIU&]$\U.HWHGFIU&]$\U.HWHGFIU&]$\U.HWHGF
MIU&]$\U.HWHGFIU&]$\U.DA&\=C6;+,&4@@[HHEY3RA6,AQC>."98ZZUJ=W)
MF-G <5"K"!%1&0X9N$TU-6FX<8W[1NQQG: N<L]&7;NM_P#&S.3AQ<?1I6V[
MD7?Q[D:0'W#2?C'X5?2A]'>;LY(DWN[D@O)FPLLTI<P M*F!7 (!5KO\;?!T
M[O+O.Z$R6T!-NT]0IF7>>HCHS9>D#C5T9)DLM+=&.&,$^$>%IDPA541))@ !
M622; ,9I>?Z5?TJO)75"EI=^OTMH&_$5-=[NPLN8LF3!^U=5?\M$S_NT:\3+
M%%F4X@,YYZ-/FF+,8_@&X+!L'T0@@M8V#-E.X-^% RKIOYS6[PL&]7NG8X&A
MF73Z)\GDG>Q;U6Y0R;PI5N7=!L(V!;Q*,&4\.4'<-%O$JQAP'&#F.&= _2/4
MNYE.]BW84B=@$U_HY64VGLC'GLSV4T;NL#C8UL<Y\0@-S8S+FJ&4V@B(H9VK
M_0/YI/(>'%0HX@1:#:-@^PS3T7ZNXV3\;ESX:?6#U7PYO9'+M27V_P TX<WL
MCEP7[+<AV,.:T:IAN9<XYQCH'0Q!$01C!VA.SCU1A)VEY1@ 3T5X6:0!AFB*
M>XE^@O-3W$OT%YJ>XE^@O-3W$OT%YJ>XE^@O-3W$OT%YJ>XE^@O-3W$OT%YJ
M>XE^@O-3W$OT%YJ>XE^@O-3W$OT%YJ>XE^@O-1P*@&/+A(#6"PY:>XE^@O-3
MW$OT%YJ>XE^@O-3W$OT%YJ>XE^@O-3W$OT%YJ>XE^@O-3W$OT%YJ>XE^@O-3
MW$OT%YJ>XE^@O-3W$OT%YJ>XE^@O-0B0BI&W1 $<\!@3LP]889[#<J[+]*BM
MG /+0P30.53#BK'%0O=3WJY+&X+#O&.Y0JP@1:#:-@>YL:CTESBH\(@=XX7V
M^4*FJ?<.([]AW<^&'0P(,0<A%%G#K"IAD86[QM&S--'7:I<YQ[UO%CII&LG"
M$N6(LQ@!E)HLA;;6.5C;S#<'W$)KW51:\:MO!5+_ '$MHR[S*$8,(Q"7B5$M
M(F@14Q1HRIDQ&NGQG\(7E;U<;Z@9&$-)&\N5-4$]W.E-%)DLUJP(K$"<(8)\
M(\!F3"%50223  "LDDV 8S2\_P!*OZ57DKJA2TN_7Z6T#?B*FN]W867,&J9,
M'[56J_Y:)O'W:_999Z$JW=;'P69X[ +Q>@5E8AC;F&[CQ9:"7+ 518!4!LW<
MWA8C$<8.4'$?O,13I=*6>JWB.0\N+<P_LDP]";9N-BX;,\,*)HTT=05+F&/?
MMXM@%[OHJM5#CW6W,@QXZK8#9M->C-%C9=QLHW;1Q4,F<-%EM'WXLAPPRF!%
M8HL_RK&[0MX;1N'"3ZP>J^'-[(Y=J2^W^:<.;V1RX+]EN0[(+A/-1ZAR'S=_
M%NU8]H3LX]482=I>4;2?M-RG"3M+RC:4[,/6&&>PW*NT-(06:+&\391QC%DH
MTF<-%EJ(^_BPY4[$&$<QJ/$3A-)FB*L($4:[OBK!R@V'GW8C#&F?HWJ;<R-O
M<D=F)0_1I4N[E.^>*&'_ *A-&XG(6\0W]S[BH3B]Y^'[^Z_;[H(,1Y(O5W!*
MA;Q+6T1"SY8[N9 B5,E77XI^%KTE]N%]03),Z68JRFH@@P*LI!5T8*\MU9'5
M64@8(P3X10S)A"JH)))@ !622; ,9I>?Z5?TJO)75"EI=^OTMH&_$5-=[NPL
MN8LF3!^U=5?\M$WC[M7G^5""]HV<%N84TC63A_:)X^B4^D<F88^#- 5 ;0,J
M<-)6M!I57+;JGQ'='&*\H&%$42<>M8W:%O#;OX)EH>E-Z(S>4>"K?V 7V\CH
M ]$'RB,9W!QG<%>T-)*IJ#HG+\TY\60[]"C"!%1&0C#-V<]&;9VA9PB(SPPD
M^L'JOAS>R.7:DOM_FG#F]D<N"_9;D.R1%1%-"8?I4ZVZ,3<^[G&SSLX]482=
MI>4;2?M-RG"3M+RC:4[,/6&&>PW*NT?MDL=.7;NK_P#&W-'8)4XVLJG?($<+
M3ECZ276-T8U\8W<^P?99AZ<H5;JXN"P[V79/L\L].;5F7&=^P;^3#60MEK'(
MHMW\0W:"7+$%40 R ?<6UTG*^L/AZ^.#>KEI=)&J!O-T+$*EX""#*2LN>H5)
MA4K+FRI/Q9\#WY+]<YU45,'E. "TJ=+,'DS5B-*6X!@0PBC*QP!@GPSM<:YO
M$NZW2[(TR;.FNJ2Y:*(L[NQ"JH%I)I>?Z=_TLF/=M0MI2[S>ZTG:P6PH@,&D
MW0P(*F$V\*83 DLM*?[MENBFJ6(GM&S@'+AK=TJC:<@%IYMV HLF4(*H@!]_
M'M)I$X15N+(1NBAD3,5ARC$>?(<-])#W3B()J&D,D;8BV&08)EJ>C*&COVMQ
MU;V&LD5**V.11;OFP9Z"7+$%40 &(#:7^H21;4_B;?L.[#*<-9B&!4@C.*Z)
M/2QP#PXMZS!3ZP>J^'-[(Y=J2^W^:<.;V1RX+]EN0[*MXE6KQC&#GHMXDFIN
M$'&#NC9IV<>J,).TO*-I/VFY3A)VEY1M*=F'K##/8;E7:)1A$$0.8T>0?(8C
M@,,.2=PC@8CQ8?VF4/HYAX&QC,;1OY,-;Q+M4UC*,8WQST6?*,581'WY18=W
M8FFS#!5!).X*->'QV#(!8/OQQ.'&8/I)E;;F1=['ND_<:/B+X#OS7:8VB)TI
MNG=[RBF/=WB22%F+60&&C,EQ)E3$8Z5)6I/BMT^'==M!>ZO#@72\/9_EKTT%
M4L80DS^[F18)+,\@M2(K!\(P3X)EVU]?!?=;*O0U==669>8D17OJ]"[(8@Z4
MXJQ4Z4M)EE#*UW-^PZHEMI2=6W=CW"P/1><Q@UYG"KZ28 BF)DRI08@_=L7:
MH*"3F%'GM:Y)X<6\*L/[0XZ<VO,N+AMWQDVH0H^D2M3RKF/+ T@:B, ,P[M,
MK>(6GB&[0,P[QQC;Q"P;\3NX+SVL0$\ C0NU98DG.<,36'3F](YO)'!7O[3:
M3,$580._1[N]J&&<8COB!PVD&V6W$U8X]+!3ZP>J^'-[(Y=J2^W^:<.;V1RX
M+]EN0[-W<P_1/;N'$W/N9A2(V6=G'JC"3M+RC:3]IN4X2=I>4;2G9AZPPSV&
MY5VE- QP/"H/+AR\[>L<-KO-L8<!Q$9C1KO-$&4PYCF(KPS<)IZ+5KN-C&_B
MW<^Q"X2CNOXAXSO8?VN:.A+-6ZV+T;<\-W[D)5PU%K+[=JV74+C?@UXNZK5T
M91TEG2 *X+(FRY<22R-1+M_4/5UZU%># --E#[;=+8%B9:I>5Q-H"[S8"(TV
M(!9!\'_$5POTQZQ)2\RQ>/QKLY6\+'%I2Q'%08!G_%^N;EJQ0(_YF\R9)-40
M%68ZLQ.(*"3B!H]W^%S>?B*\B( NTMI%W##$]XO(0Z)Q/)DSU-HI,U=J.>OP
MWJ]XCN[@SB\LO_$OK0G1Q1NXNRL*F4UQ:?/8O,<EF9B2S,3$LQ,2228DFLFL
M_=P\+7@@W[?R0<.7=\3&O,*SQ T"K4!M47R6.C,MW&_^0KS@T"J(DXA0/>/H
MEW:VX,6^1FH&E+%AY35G>Q#> PR@MF$+XSR8<N[XF->85GB%(#:DN^+Y71.<
M5CA$>##,HV3%(WQ7R1P4^L'JOAS>R.7:DOM_FG#F]D<N"_9;D.SBX3STEZAR
MCS<XQ;E6+99V<>J,).TO*-I/VFY3A)VEY1M*=F'K##/8;E7:3YE]48:9V]8[
M!]KE#IRQ7NKSK;FCN88=3 @Q!R$46=Y0J89"/$;1L#7A_)%0RG$-\\5=&G33
M%F,2<^$MWE"+,8<YS 5T6[RK%'"<9.Z37]R8E?#>O]9:O5:@+M?KU( %8@!*
MFH!42-\T,N5\7ZQ()CTY_>&P#K3 S 56 PM,(DT,I_B[6 #5'1FJAWF50PS@
M@T:7KSXHUM>D:U)FL+TTNN$0)9FZ !T02 H!(!-=&FS6+,Q)))B23622:R2:
MR3;]W<F[C=8\@\>',O1\D!1OUGB X=K-=YW5;):,A&[2%W0 Y;6._;O6;FPR
M9 Q!F._ #D.',O)\D!1G-9XAQ[5FKC4:0_%K/%$8<F9\X YB8'B."GU@]5\.
M;V1R[4E]O\TX<WLCEP7[+<APWN\VQD:O(8B!&:C7><(,IX<A&X<,3$,"#$$8
MC0/8ZU,-W+F.+?&+9)V<>J,).TO*-I/VFY3A)VEY1M*=F'K##/8;E7:3YE]4
M8<LY2WK'8(&D4'T;UKN95WL6Y##!<_1O4VYD;>Y(TB,/[-+/0E<;8^"SARX?
MVR:.G,%6XO\ \K<T-W^U-E\Q57BTOSL-6QN2W' <0^0-'S54<I\>'I^>Q/!T
M?$=JE&L(@=^C2S:I(X*L(,+10.,8!X<!/K!ZKX<WLCEVI+[?YIPYO9'+@OV6
MY#AGL-RK3OY0^DECTEQC.+1OC'L GI6+&&49/&-VBSI1BK"(/W\>QSLX]482
M=I>4;2?M-RG"3M+RC:4[,/6&&>PW*NTINYHC\D8<E=R/"2?'L+2&MM4Y&%A\
M1W*-*F"#*2"-T8?V6:>G+%6ZN+@LS0PBRGIO4N?&=[EA2)P@''T:5MNY%W^2
M-(#^U.<WSV' 8>+#DR\B+PP$>/Y G'= X% \6')7YL>&OQ[6G+\]CPF/CPY+
M943U1@)]8/5?#F]D<NU)?;_-.'-[(Y<%^RW(<,]AN5?!]KDCZ.8:_FMS&T;L
M1DV#[)//T;FH^:W,<>[ Y=CG9QZHPD[2\HVD_:;E.$G:7E&TIV8>L,,]AN5=
MI39PL9C#-&KBPH"DN3YB@<  V+_4)0K%3YK V]8=R&0X:WB7:ILRC&-\46?*
M,581'WY18=W B:@*&8.HM2YLN_;P#%A"6@B6, ,I-%DCK6L<K&W>%@W/[5)C
MY68\).% 4"C%\@3B?//%5AR5R2T]4;6G9QZHPY)^8.*K 3ZP>J^'-[(Y=J2^
MW^:<.;V1RX+]EN0X9[#<J^!I$T15A _?E%HW:-=YF*PY1B//D,1L'V6>?I$%
M1\Y><6'<@<NQ3LX]482=I>4;2?M-RG"3M+RC:4[,/6&&>PW*NT7<'I-T5SGF
M$3O8<J7B!TCF6OCLW]C*.(@B!&4&AD^2:U.4<XL/#CPS<9IZ+UKN-C&_BW<^
M!]DEGIS+=Q?_ )69HX?^H319$)R%O$-_[EHL84Z4Q1^,.>G1F*8Y&'/2(^[Q
MLYPESCY!G]MN7#E=A?5&UIOXOJ+AR>S@)]8/5?#F]D<NU)?;_-.'-[(Y<%^R
MW(<,]AN5?#%!](E:[N5=_%N[]-%JB,-9THP93$'[^.@GRZC8PR'&/&-S89V<
M>J,).TO*-I/VFY3A)VEY1M*=F'K##/8;E7:!=S "LDV 4BE4M*E'*<YY(8;7
MUQ6]2]D&L[YY-D*+UUK4[N,9C9G@<5"K5$8093 BL'(:+-/7%3#=RYC:.#%X
M&GS3!5$3]_)1[Q,M8V9!B&\,);NM0M8Y%%I\0W2*+*EB"J  -P?<G"<\6\U:
MSP8M^%(766%&5JSP" ''3ISFS Z(_)A2+$D[OAC+8KF)')2J:6&1NEQFOCIH
MWN7#=3V3SFFE=G#;F,9P:Q]W+9SA+G'R#/[;<N'*["^J-K3?Q?47#D]G 3ZP
M>J^'-[(Y=J2^W^:<.;V1RX+]EN0X9[#<JX!UA=QVP/6Y^'+L&F:T:IAN9<XY
MQCH'0Q!$01C!V"=G'JC"3M+RC:3]IN4X2=I>4;2G9AZPPSV&Y5V?O+PX7(,9
MS"T_?&G=)T)0Q8SNMS6#=MPQ)6I;6.0<YL&[N4$N6(*H  W!LOVZ4.B_6W&R
M_C8]W/AAG/T;U-XCO<D:1%!<)1J$"^?$-ZT[L,F'I3!]),@6W!B7>Q[N;[DN
M\O#0R#&<P^\9:%)'T2;G6.<^(0W8[$'EDJ1808'AH)5_&D//%HSC'O5YZ";)
M8,IL(^[=LYPESCY!G]MN7#E=A?5&UIOXOJ+AR>S@)]8/5?#F]D<NU)?;_-.'
M-[(Y<%^RW(<,]AN5< JPB#;32ECZ)^J<GS3FQ91F.P"X3S4>H<A\W,<6[5C&
MP3LX]482=I>4;2?M-RG"3M+RC:4[,/6&&9UX,%T2+":R1DS4ZY]%N:G7/HMS
M4ZY]%N:G7/HMS4ZY]%N:G7/HMS4ZY]%N:G7/HMS4ZY]%N:G7/HMS4ZY]%N:E
M18YE/CA3Z&4S9R%Y-*FC*A+&X(GA/B H9DUBS'&3$\>&)$@1)X ,I.(??;3N
MI=9-;-C)YAB&+/'9FDS1%6$#]_)NT:[S,5ARC$?OQQ&&Z3C&9*$$!\H&I?1-
MOS84,R88LQ))RDX7VJ:.A+-6ZV(;UIWLOW):"P::;%R;K9!D%IXZ&=/8LQ^^
M R#<&RZ4HQ4VJ;#S'=\5.]DG.#:#N^(X_NV;.<)<X^09_;;EPY787U1M:;^+
MZBX<GLX"?6#U7PYO9'+M27V_S3AS>R.7!?LMR'#/8;E7!:[SA4W"#B(W11KO
M.M&/$1B(W#^##B*:$P_2IUMT8FY]W.,.=G'JC"3M+RC:3]IN4X2=I>4;2G9A
MZPVX'(T)?G''V1CSV;M.ZNXAE.,G*3]X&+:'>RQ])+K&Z,8\8W:L>RK=Y0BS
M&'X<P%9HMWE6*.$XR<Y^Y'NI5<XV#$HRGQ#?-5IF3#%C62;2=G$^08$6C$1D
M.Y_M%.]E5$=9<8/-D.//$?=JV<X2YQ\@S^VW+ARNPOJC:TW\7U%PY/9P$^L'
MJOAS>R.7:DOM_FG#F]D<N"_9;D.&>PW*N%%/>IU3E^:<^+(=^A5A BHC(<-;
MQ*M7@(Q@[AHMXDFIN$'&#NC"G9QZHPD[2\HVD_:;E.$G:7E&TIV8>L-LZ$I2
MQR $GBH#- E+\ZW@'CA0.X[UQC:S>6SAB=W:?VB4/HYAX&QC?M&^,6R?;9HZ
M4P='<7+^-;FAE/W(Z"=*:U@R;I\0QYJ&;-.DS&))Q[1$^08$6C$1D.Y_M%.]
ME5$=9<8/-D.//$?=HV<X2YQ\@S^VW+ARNPOJC:TW\7U%PY/9P$^L'JOAS>R.
M7:DOM_FG#F]D<N"_9;D.&>PW*N&=87<5^6!ZWM<.4[!H3#]$]NX<3<^YF%(C
M!G9QZHPD[2\HVD_:;E.$G:7E&TIV8>L-L:6@K]H1'!&FB9" ?,Z'%72$S2EG
M=$1PB/&!33DL'&4$'DVFUWFV,+<AQ$9J-(FB#*8'GS&T;$%8?1I6WB&_R1I
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M'U:>J-H/V6Y#AR>U]QI'FJH\?C^1!/D&##CW#E!III4XZRY.<'$?'\DF;-,
M./<&[3O'J L&(#[[3CX*0\$<&K K\,*5TCLQD'%6/']^[\@B\H.E*M[)MX#
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MW<V"M3E4V<QW0<,,I@107:]&$T5 XG_^6YCQ9-G[V<:\2XV.YXSBH9\\YAB
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MHZ++6"*:+=&:MHR[HW.3@)V R9PS'&#E'C&.ADSA7B.(C*/OJI X-?@B*0I
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MJ;41U6Q@\V48\\#3Z2=P+XR1R4C,+/G,!Q0/'3Z"6J[H%?#;Q_+Z@Y13W:\
MI[M> 4]VO *>[7@%/=KP"GNUX!3W:\ H[*@! M@,)-_U3A/VCRG:[OCA 9S5
MA(I81A$UC'73K#A%.L.$4ZPX10,I!*G+B-7-A-*/DF.\?PC#?>Y1A+O\AVH.
MT.0X3YAR[&_:/*<(?1KP"GNUX!3W:\ I[M> 4]VO *>[7@%/=KP"CL$4$*<0
MR84OM#EP6WN082;_ *QVFLH8S$[W^WBP50V$BG6'"*=8<(IUAPBG6'"*::$'
M2 LRBKFPDF917G%1X\.9V6Y#A(#773JC@%.J. 4ZHX!3JC@%.D@X(<8KH9LB
MM1:,8S91A+&QJCOV<>$_9/(<*7G_ +@*YQR[!,S82;_JG"?M'E.UUDC&8G>L
MY=H!<3"'C&&^]RC"7?Y#M0=H<APGS#EV-^T>4X0PW[)Y#A2^T.7!;>Y!A)O^
ML<-R*K/6%.L>$TZQX33K'A-.L>$TZQX31":[>4X1&):N?CV@TH^28[Q_"./#
MF=EN0X4O/AM+%D:LQKP8BBOE /",%^R>0X4O/_<!7..78)F;"3?]4X3]H\IV
MNV1:N"WCCM .MH,>"@<6$1X<)][E&$N_R':@[0Y#A/F'+L;]H\IPAAOV3R'"
ME]H<N"3E Y,)1D)Y2<-][UAA)O\ *<$NU@!/!0L;28[0 -C5>,<8PYG9;D.%
M+SX8.51RD84OLCDP7[)Y#A2\_P#<!7..78)F;"3?]4X3]H\IVL9AL4$\%"QM
M->T0,:U<W$<)][E&$N_R':@[0Y#A/F'+L;]H\IPAAOV3R'"E]H<N"KY1#@/X
M<)Y)Q&/#4?%AZ/G$#Q^+"3,>4X)46L0/&>3:(=;00>"@=;" >'"F=EN0X4O/
MAKV1RMA2^R.3!?LGD.%+S_W 5SCEV"9FPDW_ %3A/VCRG:VB+6('C.TFE'&(
M\'^WBPGWN482[_(=J#M#D.$^8<NQOVCRG"&&_9/(<*7VARX(F#R3Q&KEAA":
MN*W=&.@F2S$'"[M;$Y<?-A(F11R8*RAY(COG\ &T@#:IAXQQ84SLMR'"EY\-
M>R.5L*7V1R8+]D\API>?^X"N<<NP3,V$F_ZIPG[1Y3A>\-/>&GO#3WAI[PT]
MX:>\-/>&GO#3WAH5F,2('Q82RAY(XS^"&"LO*:\V/BIU.,\].IQGGIU.,\].
MIQGGIU.,\].IQGGHW=I!H&%9MX<)'Q1KS&HX3[W*,+3EF!%.OQ#FIU^(<U.O
MQ#FIU^(<U.OQ#FIU^(<U.OQ#FIU^(<U.OQ#FIU^(<U"\TQ,3R#81VAR'"?,.
M78W[1Y3A##?LGD.%+[0Y<%I;>4(4*-:# X71K4VC[[#3K:)R&KCLI$>",Q@N
M<T,N[8[6YN?"67E->;'Q83S,IXL7%@L9HBJCC/\ L-.IQGGIU.,\].IQGGIU
M.,\].IQGGIU.,\]!,DK"!@;<>?":4?*$=\?@.%,[+<API>?#7LCE;"E]D<F"
M_9/(<(.A@13WAI[PT]X:>\-/>&GO#3WAI[PT]X:>\-'[UBT(0CO_ -NRYQR[
M!,S82;_JG"?M'E.T#V3RC":9E)X,7%@M,/DCC/X([ \O(>(UCBPD?'"O.*C@
MOO<HVB>T>0;".T.0X3YAR[&_:/*<(8;]D\API?:'+A"\+8U1SXCO_?;L'1)&
M8PI NW":1.&;PV8>,^+AP7?'" SFK"TS:Q)WK,-TW*LXK&$DS(:\QJ/%A3.R
MW(<*7GPU[(Y6PI</-&"_9/(=HS-[Q_V[+G'+L$S-A)O^J<)^T>4[0/9/*,%V
MQP@,YJPM(VL2=ZS8%FCRAQC\$,)I1Q&.\?\ 9QX+[W*-HGM'D&PCM#D.$^8<
MNQOVCRG"&&_9/(<*7VARX1EO6#0RVWCE&SB6F^<@RT$M+!@I*&,Q.]9RX,!C
MHLL>2 -@>7D/$:QQ82/CA YQ4<&9V6Y#A2\^&CY01P'\.$%QJ2/&.7!?LGD.
MT9F]X_[=ESCEV"9FPDW_ %3A/VCRG:![)Y1@I)&.L\@\>" +3198\D <&P:0
MM4@[UGCP@,35<W'@OO<HVB>T>0;".T.0X3YAR[&_:/*<(8;]D\API?:'+AZ#
M[QR&FA,&8XCFV42Y8B331%;&T_?BPFR+5P6\<<%0;!7P?AAL*S!Y0XQ^"&$T
MDXC$;_\ LX\&9V6Y#A2\^&)@\@\1JYL*#]5JCN9#]^+!?LGD.T9F]X_[=ESC
MEV"9FPDW_5.$_:/*=H'LGE&"T+%JX+>.."H-@KX+..&PM+/E BD#BP0ZV@QX
M*!UL(CPX#[W*-HGM'D&PCM#D.$^8<NQOVCRG"&&_9/(<*7VAR[!H3!$??90M
M*Z:\8WL>]L<8:*Y3XLO)31EC.<9PFF'R03P4+&TUX+SCF'*?%L.F/)(.]9X\
M)<C5<-G'#!F=EN0X4O/AE&K!$#0HUF(Y1SY<)23&WE. _9/(=HS-[Q_VX]9N
M$>S3K-PCV:=9N$>S3K-PCV:=9N$>S0,&:K='-L!E-8<E.LW"/9IUFX1[-.LW
M"/9IUFX1[-.LW"/9H)J%B1&TB%8ADPBY9HDDVC'O4ZS<(]FG6;A'LTZS<(]F
MG6;A'LTZS<(]FG6;A'LTZS<(]FG6;A'LTZS<(]FG6;A'LTZS<(]FG6;A'LTZ
MS<(]FG6;A'LTZS<(]FG>2R280KAS#!+%FB=T<U.LW"/9IUFX1[-.LW"/9IUF
MX1[-"TLDDB%</$!L1F$L"3&HB%>]3K-PCV:=9N$>S3K-PCV:=9N$>S3K-PCV
M:"4I) RVX!E/&!R4ZS<(]FG6;A'LTZS<(]FG6;A'LTZS<(]FG6;A'LTZS<(]
MFG6;A'LTZS<(]FG6;A'LTZS<(]FG6;A'LTZS<(]FG6;A'LTZS<(]FG6;A'LT
M[N621&-?^P;#W<PD",:O]AIUFX1[-.LW"/9IUFX1[-.LW"/9IUFX1[-"TLDQ
MJKAX@-C+EFB23:,>]3K-PCV:=9N$>S3K-PCV:=9N$>S3K-PCV:0PRAL((X:=
M9N$>S3K-PCV:=9N$>S3K-PCV:=9N$>S03%+14QM'-L476O**C^'?I&2P.X:C
M]_!3I(=ZODC2#"&!T$)WJN&RD9I"CA/%5QTB1I'*>:S8#*8D Y+?'3K-PCV:
M=9N$>S3K-PCV:=9N$>S3K-PCV:=U+C#=M\6PF6UC"%.LW"/9IUFX1[-.LW"/
M9IUFX1[-.LW"/9H&#-$5VCV<%I;6,".&JG6;A'LTZS<(]FG6;A'LTZS<(]FG
M6;A'LT$Q2T5KK(YM@T)@B*1EL5X_OX:>\XOPT]YQ?AI[SB_#3WG%^&@E QA&
MNRTQP"AL((X:=9N$>S3K-PCV:=9N$>S3K-PCV:=9N$>S3K-PCV:=9N$>S3K-
MPCV:=9N$>S3K-PCV:=9N$>S3K-PCV:=9N$>S3K-PCV:=9N$>S3K-PCV:$2R3
MI0MABS ?W@ZZ5H#O"D0B\ IT1#_^UE__V@ ( 0$!!C\ _P#VGVMOW%K6U+#K
MG<M/64Z+!:<=Y5/NFW)1 BEHBKRHNNB*O']L\4^451_ON&H5?E&.SICZJ+$2
M'=ULJ2\0BID+3##I&2H**JHB>1%7_ MV%891CL&8PJ"_$F7=;%DLD0H8BZP^
MZ)BJBJ*B*GD5%X_MGBGRBJ/]]P_\"W-3;^:]UYS\%V,.?YOWW-W/?^:&?)S\
MA\O-IKRKIY%^XKLVPEQH,-A$)^7,?:BQF1(D 2=??40%%)41%5?*J)Q_;/%/
ME%4?[[C^V>*?**H_WW#,N'(8EQ9#8O1Y,9UM^.^T:<P.LO-*HD*IUH0JJ+]Q
M76'\NQAA]APV7F7K^J;=9=;)0<:=;-U%$A5%0A5-47J7C^V>*?**H_WW#_P+
M<U-OYKW7G/P78PY_F_?<W<]_YH9\G/R'R\VFO*NGD7_P8RX>X_B*P(\@AJZT
M_B.$S7MQLL9EM*B>96%'@P3W(+I:IR_"/FXZ=:D@HJ\2X6QWAYS_ #XFU-F/
M=[B9)2;=5QF)<J2V*ND;OY+S*]9 #IQG%33F1M=422UA$#9S:2"7O8;F.81)
MR:[8#5"YI4_/9MG#><\H\P5S0\J_S.9.97W;[Q;;PP"D&9N)A%^UMFT*N.(Z
M2,,[<,U0-)JF@BT(H*:BB(*JG!.9;O+NME)F;;AGD>XF7W9D;2*C1D5G,=55
M%")!5?)JNGEX(B)2(E4B(E52(E752)5\JK[*^BTN(YYF>*K' VV%QS*+RC5D
M')"3' :^#'VN5">1'51--31"7WW7PTF,^+3?3N6-.XA9'GUUF]:P*$!HVS5Y
MJY81Q#4$]X+2#UDFFAGS,!F5AM5O'#!1&1_77;^+0V+C2 @*C$W;5ZC: ^KF
M0W(SB:JNHJG4D:!O[X>LVP5PC;9<R+;+(ZG<"L,C70ILJAR *.5%:#5.8&9,
MUS1%(4)50.(<':?Q 81.R2<K;3&$Y1*D8'F[TH@0G(D'%\T;@RII-JO*;E>#
M[6O\UPDT7_ ";D&4WM/C5#6M*_8W=_9PJ>HKV$717IME8FVRT&O^DX:)Q,A,
M[NO[PW\1#7X"V2I7LV;?T%>3S?,'SA8XXA$G+_1W)*G4JB@JB\/1-BO#%5P1
M%7/-\@W9S67:D^*JJ-(]A^'L0^Z5-$(E&]<UU440>7F*2E1N=B&UL&4J<U;M
MSMMBK;;3:?\ UJ-9YNS=V+::Z+S!-0^K3FY55%/^L_BR\0<UAU>9R!#W6S*D
MJ3+75"*FHI<:(JI_HKW/5UZ::KPXN49CE62*\K1.K?Y#;W"NDP/*P3GPB\YS
M*"=0*OD3R= 7\2W:W-Q=X%4A>QW/,JI'1)65C*0N5DMI456R)O77^:JCY%TX
M8<H?%OO5,6.NK3>99;(W&C_Z2(+D7<(;1LQ3G703!430=$]X.C#>;#M#O#$$
M&VY3F6X'_5NW=$$3G>C3-N95/%:=)4ZU. XVFJZ-)[WEAP=]_#MF^$$2 U*R
M#;3)J?/H!/+U++.@R!NCD1V473F!N7*<1-5'G70>(<+;CQ#X,SD4WNFVL/SF
M5(VXRQR6XB*L"!3YPW!*>Z.OOO@TI =2J)JB*OJN;$W1\1. 1<@KW'(\K#L4
MGN[@9G'F-KR^93\8P9NPEPS)>I%G-L@GE(Q%%5),/9'8/<G<F0WWC+=MG=[1
M;8TAN:*C<R(S6AD$U]I%T+NWV(IEHH_T?47#S.#8SLGM;!7G2,]5XE<95?-(
M:*@K(GY;8R83BCU**C6 FOE14ZN'/AWQ8;FP.]11+^I)T&VNB*VK2]W_ -.8
M-5R+HNJ*&BHOOOYR(O#Q9GOWO3EQ2.^[]<GW2SF^5_S@D.1WRVLYWF[PA13Y
MM>9415UTX=FV$N3.F/JA/RYC[LJ2\0B@"3K[ZD9*@HB(JKY$1/1";63IE;,;
M0Q;EP)3\.2V+@J#@@_'(31"%5141>M.I>&5PSQ"[XXBL<&6V%QC=G/:!6 CL
MK'C@S\%6#7*@-DK8(.G**J*:(NG#)4WBHSZV;:,")C.8F+[BMO@)$I-/.9W7
MV+NA(9(1 X):<JH2* *,=C<+!]D]TJX %)#[V/7V&9(^8K_/;L\>L/@]OF37
MF3X(+KY5'E1%0HT/>C8K=';"0]RMN66'6U!NA0QG-="?FG*2@G@UHFND>#(-
M%5!Y234^(,7:WQ&;=6-Y8*TW%Q+)+-S \R?DNJ(>:1,5SENNFR3$R0%6(RZ"
MK_-(D5%7U3\*;U[Q;=;8QR8\XC,9?E=14VMBUS]W_P"CT;[OGLTM=?>1([A:
M(JZ:(JI+@;8U6Z.^EFSS#%FX_C8X5B#[@)UB_<YV<2R!->H3:I'17151=.52
MD,;0; [3[?17%<!J5F]QE&Y5LTTJZ-/,'5GCL4743K5'8KP>QRKY>'FW?$-+
MQ&O=UY:W L*P+%A8U=1W^AMX=85G_HB/OYQ>]14_TCYG?ZX>*+Q!9$TZG*42
MSWAS^17""J"JVS6+8>;MBJM@1"VTB*2(2HI=?'?Y'D-Y?OJ^_)5Z[MI]JZLF
M47/)D=Y.<<7G<7K</74EZU5>@C^+;J[DXT^)MN"]09SD],Z+C(J#)HY72FU1
M00E05UZD543R\-?U?\7&^KS;*MJS'RC/;C.HC(M" -LM0\X.Q:%H4;%$:0$!
M$YDY="+5C^LV3;8;MLMKHXWGNV=16..MJ:ER]_MBYCJH2"O*)JB^1%)#7FYH
ML/?+PP3(PHH>>Y%M1G#$XE%57O%BX;E\:/HJ)IHAWRZ^RHZ:K$A!O:UM9>2^
M[_\ 1=Z:>9@#<;O%0?\ B\MD=_CH:*NA:W/5UE_-12XA9!BU[3Y+0V32/UUW
M06<*XJ+!A5T1Z%95QN,NAK_I-FJ?^"B7G>\.X6([;8C#-&G;[,+R#20G91BI
M-0(2S#$I,ES14:BQQ-UQ>H )>KBRQGPC;:2=S;9I'X[&YFYK=CC&"-2 -1:F
M5.%Q":N;-@AT+_C)%4:+_H$GEGQMVM[\J>Q6<XXJ[>8E(3"MOVHY(0MPWL9Q
MSN&IHMB1 #MF4E[15YG2557TZ! V]WENLBPR C;3>V^YYR,_P<8;2HHP*Z%<
M.^>5;.J:J---AJNJZE[XM:S%/$UB5AL!ELDV8J9E5N2LPVHG2"% 5^;(9;2V
MIN]=7E!MZ+,CM"BF_/ 4XJ\NP?)J#,<5O(PS:7)<7N*^^H;:(:Z#)KK:K<=8
M>!514YFW%35%3RIZ=XF-M\(\1'P)A>WWB!WFPC$*;_I)L99?!&+XIN-94-!6
M?"-OC,B7(\WB1VFN^E/N.GR\SCAFI$OVF_\ Z%_#W^B?'VF__H7\/?Z)\?:;
M_P#H7\/?Z)\?:;_^A?P]_HGQ]IO_ .A?P]_HGQ]IO_Z%_#W^B?'VF_\ Z%_#
MW^B?'VF__H7\/?Z)\?:;_P#H7\/?Z)\?:;_^A?P]_HGQ]IO_ .A?P]_HGQ]I
MO_Z%_#W^B?'VF_\ Z%_#W^B?'VF__H7\/?Z)\?:;_P#H7\/?Z)\?:;_^A?P]
M_HGP!EXEP=$#$B:<V8\/Z-N(*ZJV:M8J):+Y%Y21?:5%Z^/UOXI^R/;3XLX(
MY<[9F\$FD;1JTVT)EL#0D7OQ6EL(9<ZZ*FBDHZ*OO==%1%S7878/(&>=5)O%
MUW#P]Q6^\!4%';:XO$1>1'!YN14U(2TT!1-AK<[PJ9ACXC[V3-P3<JES%7-&
MQ_IF*O(*RBY.8N=.Z*8?*B(O>$JJ@QHUQN#FVTDZ7R"S$W0V]NH[:/&J)W,F
MWP5;VN8T15577Y@-)HO])KHB^?[-[P[:[GL"PDA\<'S3'\CEPFM41?A*OK'W
M)$4D4D0@D- 0JJ(J(J^IOA[?G=*@Q&1(C.2:7$FG2N,[R5 50%,?PVK1V<^!
M.)W12E:&,T2IWS[0^^XM,;\(^V-=MW3$KT:+N5NBS$R?-WF5YD:L*G"X;ATU
M<\B\JH,YZU;5-=6T54Y5R'?'=O.MS;$7RD16\HOIDRIJW#0A(:+'VU"!7AH1
M(C4*,T":KH/6OIT*+M+O=E#6*PS;UV]RYX<WP!R,"AWD2/C62I(;@(X("!O5
M917^5-!='BKQ?Q:[>S-I;QY6(SVY.WS5CEFW;SI*B.3K;%S[V[JFDUZ@BK:K
MU:J0)U)6YYM;F^+[A8;< I5V2XA=U]]42#$4)Z,LRN-P0?:YD%^.XHNM%J#@
M"2*B>I+#/=V\\Q7;K#JM/^+R'+KF%2UR.J"FU#C.3#%7Y+O*J,16!-YTO>M@
M1*B<66,^$O;:7NW:L]XPQN5N*%IB.WPOCUMRZK$6T9O;-A?YI#+<J#1=5'G'
M12G1=TM\\K#%9W>-EM[A,E<$P)(AKS#"F8[C/FXV !_H.6IRG4_^R+Z?7Q=J
M]^<R;QBN5H&\!R^6F=X%YH!H3D"+C.5I*9@@XB<IN5GFSVG\UT5T7BOQSQ;[
M22<+F.*PP]N7M'YU?8QSD""[*N,"N'2LX;(*BF1P9]BX7,@C''EYB9S78W=#
M$-S,=<;8.1(QJU:D3ZDY*$3,3(J)_NY]9))!)?-;&*P\B)JH)ZD-UTP;:; G
M'''"0&VVP3F,S,M$1$1-55?)Q9XOB-Q(\1.Y<#O67,:VNL(+N)5DYH^0HF1[
MF.H]7M*BH8.-UC=@^T8J#S#:JG%A58EET#P]X1*5QIFAVC:>@9*<4N86OA/<
M:P5VV5]!-1-RL<@-%HB]PBIKQ.O<CN+2_O+-]9-E<W=A+M;6PDD*"4B=8SC<
M>=-41$4W#5=$3K].'(]E-U\]VQME?8?DNX=DMG3Q+,HZZM,WE5'<2)/9]@H\
MUAUHDZB!4ZN(%%XFMO<;WOH6T;9?S'% B;>;C-)JB.S9D."T=#8*(I[R.S K
ME5552D::(D*NVHW3A5N=2P'7:O< &,-W&![ND><CP:::Z;%HK8KJZY2RYK0=
M?,XFB_\ @DL;R]LZ^EI:>%*L[:XMIL:NJZNM@LE)FV%C83"!IAAEL2<===,1
M 44B5$15XN]N/!K45NZN8,C(KY>\60M2$VRHY76PX[B50!-2;YYI>96Y3AL0
M>9 <!9[)$*O[@[Z;D9)N/E+J.-QY=[+'S&HBNGWA5V.T<(6H-;%YD0O-8$9E
MK7WW)S*J^HDR+8?<RXQF+)D _>8;-+X:P#*$1$ PR'#K%3ANN*VG=C,;!N6T
M*KW$AHEYN*C;W?$*OP];SS%8A1/ABU3_ *5YK8.:--MXUEEBH+72GW->[K+<
MAU4FV8\R8\7*GIGC+_>L\0_UNW'J>);4MC/J+6O?"3 LZN9(@6$*2WUMR(DV
M(0.-&/L&!(J>WQ#CL[Q2]W<6B]V+F(;X,O[@Q'VF@[IIMO*)#S.0QT 5T (]
MP#>J)S-F@HG%9C/B+Q6Z\/65RE9C+D[#K^;;6RI1EW2.2+6 PW:5B.$HJ@R:
M]Z.R*DKTU!'G6KS# \IQW-,3NV%DTV38I=5V0T%K'%PF3>KK>I<=CO")B0$K
M;BZ$BBO6BIZAM]R-W<WQW;[!Z)M#LLBR6P:@0@<(2)B%%$M7),I[E48\.,#C
M[Q>\:;,E1.+K;SP4U+^W^+*LFOD;UY96Q9&=W3/,3#DC"\7FH]%IV'1129ES
M@?FJ!B8LU[X=5IEV;Y-?YAE5Y)*;=9)E%O87U];2S30I-C;6CCK[QJB(G,XX
MJZ(B>1/436<;#;FY)M_<*XP5G$K9??XYDD>.2D$#*\6G([7V;":KRMS(SG(J
M\[:@X@DE/MOXJX=-L5N=)1J'#SV/)>;V<RR;Y/\ BYEB;C^-ON=7*%@^]#54
M)5G-&;<=6945YJ3&DM-OQY##@/,/L/ CC+S+S:J) 0JA"0JJ*BZIU>H7I4IY
MJ-&C-./R)#[@,L,,,@KCSSSSBH(@(HI$1*B(B:KU<76VGA/A4^]^Y<3OH,[<
M28\Z[L[BTU/>$E9(KW6W\CD-Z%S>9NLPA50(9DA4<8%_/M]]R<BW"R$U>&"E
MI(!BEH8KQ]X5=C&.0!:@5L;5$5684=L27WQ(1JI+ZBK\]VESS*MNLQJU_P"#
MR'$;J;2V*-*:&[#D.0S%'XSO*B/Q7T-ET?>N 0JJ<56!>.'&_A&(1LQ&=]MO
M:=MJ?%%2!KSK/=NZT1;?!-7'7IM"(&(B(-U;QJKG%/N+M1FN.;@81?M$[59+
MBUG&M:R0K:\DB,;L=55J0R>K<B*\(/,N(K;H 8J*>H'H.<71YONY*A#*Q_9;
M#9<.1ELD9+2G L<GDNJK%'7.+RKYW-U=<#F*'&ED! EG39-EK^W.T<IQYN)L
M[M[.G5.,R*\B_HF<RL&R"5?.\J KGGY>;=XG>,1(^O*GJ)F5%>=C28SK;\>0
MPX;+[#[)HXR\R\VJ$)B2(0D*HJ*FJ=?%1BF[$USQ(;41%9BN5N;V3S>Y%)7C
MHWKCNXQB](?5M-%&/=-S!411IIR,*\XK9[+9TP>4088R\CVPR9(]'N/C(:B#
MKT_'3=<\YB@9@'PA7NR(G,2!WR.:@G_@@>W'WNRH*QN3YS'Q3$*I&;#-L\MX
MS2.%4XI0DXV3RCS-I(E/&W%C(8%)?:0P4IM):3W]M=BXTSO,?V9QBSD%62@C
MR._A6>?VX"RY>SQ46R%7FPB,$"%%BLN*XX[ZEH]K]ZWKO>CP]-'&@1HLV9YY
MN'MG '^B%S";FQ-%F0&0Y42DGO=T @(PWH:<XNTFZNS&:T^=X/? J1;:H>57
M(<UIL')=-=5[R#(@SX_."284MMMYO5.8$0A5?2O&7^]9XA_K=N/53>2;$[E7
M&-Q'982KS"ISAW&WN5H(HTXUDF'326(\9-ZM#+;%N6R*JL>0R>A)2;;;D#7[
M)>(29YO!CXO93U7"=P+$F^52V]R*:J*,AXT50I; DDHI"W'=G*AFGIP?UHD)
MF^\600'I.#[.T4YEN[L&^MIJ^RJ;HX-13HZG)YV^V3KY(80V)!-/]T6;;UY:
M[,@0'9*8?@-.4BOP+!84E41R+C= 3ABCK@B"29\@G9<CE!'GB$&Q#U+3[?9T
M[;[P^&\'&HKF!SYP.Y-@$,W5)Z=M?<6!(C(AS*XM+*=2$ZJ*C:PG73D\4V[6
MR6:5F:X9<\S*R89$S8TMJRV#DW'\EIW^617V$=#!7HDEL3Y2!T>9IQMP_3LA
MW8WCS"KPC!,98!RQN;,S579#Q=W"JZN#'0WYDV2?]'&AQFS==+J$5T72ZVYV
MY<NMH_#7W[L5G#HTU(^6;BPFG/Z*?N?8UKA ;3JBCH4<9PHC*JB.N37&PD)Z
MF#-MC<VDTS4M^,6487:=[9X%F\2,JH,'*L:,P;>5 (P:ELDU+80B6/(:)558
M6(R3C[4^(*+!5RWVJO;)DX^1E&:5R9:[9W;_ '?PK'0!)YV$0!-C"CBFRXPV
MDMSTTB(D$112(B5$$11-5(E7R(GLKQD.PO@GNJ^ZR=L'JK,/$#$6-9T>//KJ
MU-J=KP<%QB=,#K!RZ-#C,KKYH+SG+(9M<ER>YM,BR*]GR;2ZO;N?*M+>VLIC
MJORY]E8S2-Y]YTU4C<<-2)5U5?4U-FF!Y-?8;EV.SF;*BR;&;6;2WE1/8+F:
ME5]G7FV\T:>34235-475%5.*'9[QR2*^AN'?-:J@\0T"&U H+22:]TPWNM2P
M1%FM<,N45NH#0P_?(4J/$:;=EE"M*N;$LJVRB1I]=8P)+,R#/@S&4D1)L*7'
M4FW6G6R$VW )1(50A545%_\  \BV7FV:;X975RG]M=J8TKD>E<IK$#*<QD,*
MIP*5EY"3O%1'9;C9L1450?=CWF[N]>6S,KRVZ<)M@#4V*7'*<7C>@XUBM0A$
MW!KHO.2,QV^M54G72=?<<=/U.UGFTMX;]%:.P6,_VVMY$@\,W IHK_/YI;P0
M549F- 3J0+1@4D15,T B9=?9=8W'VGM%C6U8D"#N#M[:O-IE6WV0RXO?K66K
M H/?Q75%WS"S9#N)0@?)R.MOLL^D^,O]ZSQ#_6[<>JP=:,VW6S%QMQLE!QMP
M%Y@,#'145%35%3R<8SX:O&=DYS:Z6[&I-N/$!?S=956^XJ,5V,;KV$G_ &L8
MRY6HN0.GSLKRC/4V2*7'$A)"$D0A(511(535"%4\J+["^F3MI-J7*S,O$]?T
MZN1H1$Q.H-HH5BPA0,FS5GK1Z>XV??UE,O68\DF7R129"7D>XVY.4W&:9QEM
MF_;Y%DM]+.9964Z0OOC<,M!!L!06V&&A%IEL0:: &P$4]3QMQ=I[A7Z>P<A1
M-P-NK1XRQ+</'X\CO3K+:/H?F\IM%-8%I'%)$4R+E4V7'V'H.ZNTMF;;T<V:
MW-\&M78Z97M]DA-*XY2W\5@E0FW$$G(,YO\ H932<P*A@ZTUZ9DV\N\N31\8
MPO&(^KCB\K]I=VCXE\&8UC59S"<VQFF*MQHS:IKH3CA-LMN. F49FXN,[<8R
M_-C[8[5ULMYVDQ.LD.<I6-@9:).N9;8AY_8F \VB-,@S' &A]45E]06MC1WM
M+/B6M/=4\Z366U39P'QE0;&LL81 \P^RZ(N-/-&)@2(0JBHB\8UX<_&-=0JC
M<.0<*BV]WNF&Q I<ZD$"1H./;AKH#,&X<)!&/:(0QYQFC;PL2D$YGI9$1((B
MBD1$J((BB:J1*OD1/97C(_"WX4\GE0-JX3\JEW3W7HI;L67N;)9-8\_$<0L(
MZB;>.@2$W-F-DBVBZMMK\'<RS_5-3MGN6Y=[F^&25+()&*H\$S*=M5F/=Y(N
M=MY%@X =PAJ3TBC>>",\2F;)QGS<<<QS=':?+J?.<#RR$D^CR*CD=_$DMH:M
M2(S[9H+L>3'=$V)420 /,.B;3S8. 0I_X&RMS2MRC>W-8TR)M'MQ(>>1NQF,
M$#$W*\G6(J.,4U;WB./:$#DMWEB,&"FX_'RK=G=G*K',L]S*Q.RO+RR,5-PU
M%&HT*%&:06HT2,T(1X<.. ,L,@#30" HB>J:'>39N^6LO*Q4AW5+,5Y[&LUQ
MIYX';+$\LK6C#SB%(Y!7J(7671;D1W&I#3;@Q=S-M97P9?U7F5;N3MS82FG\
MCV\R:2P3B5\_D0/.(4GNW7*NS;;%N4T!>]:D-28['I'C+_>L\0_UNW'JVA\$
MF_\ D*OW<*&D+P]YO<2![RUK:^,IKM-=3GE12DQF04Z!UU55UH2@<R&W":>]
M*'!-O7Z^[\2^XU/)+#ZIY E1-O*"2CL$MR<CBF)MN*V\!-U,![09+XD;B%'C
MO Y=Y=EUW:9+E&2VDV[R#(+N;(LK>YM[*04J?964^41.///.$1F9DJJJ^JJ+
M>':RP,UCFW7YEALN6^QCNX6).O(=CC&0--<R:&B=Y$E=V1Q9 MOMHI HEB^]
MNTUIYU2W;0Q+RCE&"7N$Y9%C-.WF&Y+'#_9S(1.CJ0ZMOM$U)8)QAYIPO2K_
M #'+KFOQW%L6I['(,BOK:2W#K*:EJ(AS[.SGRG506VF60-PR7R(B\2'JB194
MFP&WT^=6[18:\X^PLV.A+&D[A91"4N1;:T%.<04?^"C*$0%,QD/R/5>(^$3Q
M6Y(X] ><@8SLGO!=R2<=KW7"&%3[<9]8/JJE&)5"/3VKI:LKR19)=QW3K'I5
MSX(MA<@=C9#90FVO$'FM/)1MRFI[&,C[.TU1-97G23-8,'KYUHA1N.3<'F,G
MYK3'JONW/A',M@\RL8Q;F;9C)%3;-1&+_7;"?.B%J-=1FA%"%2!F<R QI)"H
MQI,7%=V=ILJKLRP+,JX+*CO*TR4' 4E:DPIL9U!=C2XSHG'F0Y  \P\!M.@)
MBJ)_X&<NWQW+D\\*D:"OQG&XS[35QG&9V+9CC^(T@.:JKL@P)Q]U!)(\9M^4
MXG=LGQF&]^[=PMKE663-68C"N-TV,4,55;I,3QJ$:DD>! 95&F0U4S+G??-V
M0\\ZYZ0TPPTX^^^X#+++($XZ\ZX2 VTTV"*I$2JB"*)JJ]2<1++%MA,BQ#&9
M:@HY9NP['VSJ>X<'G:FQ8&4*S:S6#3^:]75T@5\NNG7Q$E[W>)S%<><10.=0
M[783;9<CH+HILQ\JRN32]T2=:(95#J:_Z*IPRYD^2;\[@2DT62%QFV.4E8Z2
M+_-8B8K2PI#8*FFJ%-,M=50D31$9<_\ U<?AF4SWR>=7VZ>\ECWJ/:IRO0/Z
MP!#+E1= 7S;5-$77F]]Q]EC%/E9N7\=\%WGAJC5;_<=PU*HMS=XJ@V$YU/O1
MBQ<@2,9]:IS/,&NG5Y$322>'Y)OEMM/)#6&E3F5%D5,RX3BDB2H&5U,N4\ B
MO*@A8-%U"JFJ\W-)G;$^(O",Y44)UF@W*Q:XV]FB(K_\HS>X^]?L2'5%-1-V
M+%!27E+D1.?B3/W?V'S"MQF+S$YG&-LQLXP<&4$C!Z9E&(.38L/F$2(6YYL.
MZ(NH)HOI6/[Q[93#D-1S"MS;"Y4R3'Q_<#$)#B+98Y>-,+IKI_309*@919(-
M/B)\A >&[W[36Z6F*9? 1PXKRM!<8U>1M&KO%,CAMD7F\^ _S,OMZJ))RO,D
MXPZTZ?3\9?[UGB'^MVX]6U.0T%E-IKVALX%U27%9)=AV55;U<H)U;95\QA1-
MI]AYL'6G )"$A0D5%3C%]PK*1#;W3Q)P<%WCJ(H#'"/FE5%!P+Z)$_T8=S$)
MFQ8Y$[MMPWXHD11C7TG(]WLK6+:Y-(1V@VOP8Y'<R\XSR7%-RLK?>+WC<&.@
MK+M)0I_0Q@+DYWS8:<S+=_=/(9>49YG=P]<WUO+(E0G" 8\.O@L*JHQ#AQVV
MHD&*WH#$=IMEM$ !1/2(U?71),^?-?;C0X4)AV5+ER7C1MF/&C,(1N&9*@B
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MYNGC^T.R^(S\RSC(G#6/!B\C,*MKHZCY_?7]H^HL0:^*)"4B7(,0'4012<,
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MR226O6I6-7(DUXII[ U">[['$6'NKB6X>S5@[R>=3RA-[A8C$YB02_\ 5,9
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M.ZH4;;[*G$8B7B*J+W;  Q.444BA *<R^K?#GXDJ^)S1IM??[)97-1M11B5
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M5.;S.:YRZHA:+U>HFLWV&W(O,*G&_'.ZI&WO/\/RR-'542ORW$YO/!GM*!&
M&ZUWS/,IQW674%P:?;7?EJGV$WME]Q"@R)ED0;5Y[8$(@(8[D%F2%53'SYD;
MJ[1TD)>1N/-DO&C2>H;+$,]Q7',UQ2X:1BVQK+*2MR&ALV1)#%N?46S;T=U$
M)$(4-M=%1%3K3BQR;PX9/;^'K+Y"O24QF0$K-=JYT@E-Y6FJJ>^%I5*ZX2"K
MD6P>CL@B(U ZM%GV.8;0V.=81!5\BW'VB\ZW Q,8C"_TEA9LUS 6M6PB<O\
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M=OH+V\+PG;Z"\)Q][A>$X7L_!PO9^'A."[>$]WCL]$NWH=G"^[Z-=NML[>I
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MT\ID ++;9Z2=TKBJ@..NMF7>JY$AQW$->54$A;4=0U7U86+[H4P5.:5$20.
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M[>.:$A1KV^QF/D-]'7F55_HYLM\$7JUTUT'R)ZMO\"D0ZZ'NIB[$W)MF,RD
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MBFW$@0F$2?EV"B\O,A"J*[/J54G(R+WC9O1T,VON'OU50HA2K_;VFA[Q8[R
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M,)EP8K^[F,QF9"BJ-.R(F&B[)9 _(I-B\T1)["&/MIZ3<;P;DN+932<6GP+
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MISNIZ1CF[&S^7VV$9WBTM)-7=5+W*IM%[V766<1Q"9F0I0:LRX4ELV7FU4'
M(5TXI=M=RW*?:+Q)I'CQ#Q67.2/B.Y<T 1MZ?MG9V!\RR'2172H)+A2VD548
M<G-M.OAZ98WE[9U]+2T\*59VUQ;38U=5U=;!9*3-L+&PF$#3##+8DXZZZ8B
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MV2T<CR6E%UEQ!<:,'!$DM]Q/ [;.7]4BOSI6P^:W+87T%O4G"C;>YO:$+<T
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M]2H=LW_!KQ&G[W[V;E;KRF59=*GQ&LI]KL:?-.M^+/1P[NR>:\HH<:PB&O\
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M414YFWLB>;)0E2@51B"I1XY*2O/.?<RXVNW)K@('VWIF+9/'8;.]PC)ACDU
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MG#N+!62[OF+E 74YD0>;1>9/LS[K?*[$?]3@QN/#IO-!C(T2@]6W>$6KY/\
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M6_!=;"?71.9J0E@VB:HBDJH8R_Z_^)W=4Z^:KGG&/XCD#FW>,.LF7,,9_',
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M26;953QNY;/']U3A[J5TB(PNK< 9><MS;"*TG4*>838YB*( D@)R\0ZOQ/\
MA_AS8ZJP$K,]D+1R%+9;'0'G%P#-I#K;YE_/4@R!@45%%&]"3E@U^TN]6.%F
M$[NP#;G,3+"=P%DN&H)$@X[D/<E8FFB<QU+DIM.844]5T]/BY/N]N9M]M5C4
M^V8H8.0[D9GCF#4<R\E0W["-31;;)Y,6.Y+<CQ9+[<<'%<)METT%1;-4^V7X
M4_[P^T7QQQ]LOPI_WA]HOCCC[9?A3_O#[1?'''VR_"G_ 'A]HOCCC[9?A3_O
M#[1?'''VR_"G_>'VB^..+.KV=WRV>W8LJ6(S/N:[;3<S"L[G5,&0]YNQ-LXF
M+393C#1N>\!QT1%2]ZBJO5ZD@7N\&Z6W.U%':6"5-9<[E9OC."U5C:K&.8E9
M L<HE167I'<M..]RV:GR 1:<HJJ?;+\*?]X?:+XXX^V7X4_[P^T7QQQ]LOPI
M_P!X?:+XXX^V7X4_[P^T7QQQ]LOPI_WA]HOCCC[9?A3_ +P^T7QQQ9U>SN^6
MSV[%E2Q&9]S7;:;F85G<ZI@R'O-V)MG$Q:;*<8:-SW@..B(J7O455ZNC-M+2
M;$K:VMB29]C8SY+,.# @PV5D2YLV7(46VFFFQ(W'#)!$44B5$15X^V7X4_[P
M^T7QQQ]LOPI_WA]HOCCC[9?A3_O#[1?'''VR_"G_ 'A]HOCCC[9?A3_O#[1?
M'''VR_"G_>'VB^..(\R'(8EPY;#4F+*C.MOQI,9]M'6)$=]I5$P,50@,55%1
M45%T]2VN&;@>)[P\8-F%$ZTQ=XIF.]6VV,Y+3/R(P36&;6BNK-B5',V76W@%
MYH54#$DU$D5?ME^%/^\/M%\<<?;+\*?]X?:+XXX^V7X4_P"\/M%\<<?;+\*?
M]X?:+XXX^V7X4_[P^T7QQQ"K*SQ?>%VQLK&7'@5]? W_ -J)DZ?.F/)'B0H4
M2/;$XZZZX0@VV J1$J"**JHG0J)6\F[^UVTL;('9C%#(W-S_ !/ V+M^N!MR
MP9J'LIEQ!DFP+S1/"RI*"&"EHA)K]LOPI_WA]HOCCC[9?A3_ +P^T7QQQ]LO
MPI_WA]HOCCC[9?A3_O#[1?'''VR_"G_>'VB^../ME^%/^\/M%\<<?;+\*?\
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M=9B^FY)NON_F%1@^"8K#.7:75O(1L3<Y5\UJZR*.KTR=*-$9AP8P&^^ZHMM
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M8&"HHJB*BHJ<8QX7/%OD3#.XQMPZ+:O>:YE*V.XLA%\W@XCN!.DERC?&G(W
MLS5!LBT:?5+ @<G^EY=O1N]D#>.X/AL#SJ=(0$D6-E->-&*N@H8',)2K"<^0
M1XD<23F,D4R!L3,7+C)I$G%MH\:L99[7[2PY?>5.-Q#!8H7-XZT@)874AK7S
MF<Z*HWSFS%%EA5 O5&+[H;7Y1:89GF&6C-QCN14[R-3(,QI% P,#0FWF'FR-
MB5%? V7V3-EX#:,P61096%'AGB.PB&#F<8-!?-BNR:I!09#/\%BSG''R@..&
M+4V(KKKD%]1!PR:>C//>D;5_O68/]46<]/Q+_11B7SO+U)L3^\"U]7-WT_$O
M]%&)?.\NCO-]%&XGS0F>DM>&+=V\[G8_=R^:_JE<6<DDA[9[FV2A#BO=ZZJB
MS579(W&G(NC;,GN96K8%,-SU%XI_SKQ/ZM*3I;-?2MMY\[H?0\(WYU[P?DC'
M_N%XN?SKV?\ R1D'0\4_YJ8G]9=)ZMQKPP>)_)W[/92T?A46W&Y%_.5R3L[*
M(!AUM!>V$LO?8N>@--N.%_Z6JHNOF/,D8'6C!QIP!<;<;)#;<;-.8# QU145
M%U14\O1B>-[;&GY\DPR%7XYOO706#.1<X:TH0,8S]6VE]\[3DHU]@?(1%"<C
MN$0,P#5>FNP>?7*R]Y?#U5P*R.]->)RPS#:1"&OQ3(%==)2>?JB4::>2(N@#
M!><,G91:>H:7P3[?6O)?YW'K,RWJEP9&CU9A<:7YWBF$O$UUBY:RF1L98*0D
MD6.P)(;,TDZ>WVQ>VT+SG*<_OH]6W+=:?=KZ"J!%E7N472QT(PA5D,'ILHA1
M2[MM1!",A%=O]C=M(/F6);?T+%3%><;8"?<V!D4N[R2X*.(@<VRF./S99B*(
MKKA<J"*"*?X!9)MON'1Q<AQ+*JYVNM*^4V!$*&G-'GP7B158E1G$!^+);T-I
MT <!4(4X=HK%)M_MOD+K\K;K/BBHW'NH :&[3VI,?T3-I"0D"4RG*C@\LAL4
M:<01X[/Q\)Z"=OH]G"]GX/0[>%]Q>%]Q>%X^_P =GH+V^@GN\=GX^%[.(\*%
M'?F3)C[,6)$BLN2),J3(<1IB/'8:13-PS5! !15551$157BC\17B*HV)F],Q
MAJQP/ [%IN1&VFC2&^=BWMV#U \C,%U$5U2N1=$UEJ11_P##3*O!7X<<A5JH
MBK-Q[Q![A5+R<UQ)_P#E[':?&YS?\V*U[]K()+1:OGK $A9"6,CTM$P#;7/\
MY4E(13#\-R+)E4A%PB%$I8S_ %HC3JJGM ?_ ,*Z-'7^#_Q%M"])"(V5QM+F
M6.BKCB H.DN01(O*S[\=9!:-)[[4TY2T^R9NO_\ :ZL_YKA[X0\('B!D=QW/
M/\ [9Y+E/-W^G)W/]6&)G>::IS]WS<G7S::+H@;B;9[@8$:GW:!FF&9'BQJ>
M@KR(-Y&8770P73_ZI/;3TL2$E$A5"$A54(21=4(53R*GL+Q1>$GQ-90K^ZL)
M@*_9[<J]E-BYN/61&$"/@^4V4DT)W(6!%4@2SU*Q:3NW56>"'.])R3/<ZOJ[
M%\.P^EL,AR;(;=](U;3TU7&*7.G2W5U7E !5>444B7010B5$5QRO=LL>V"P*
M?-B;3X*ZXXP4EM=8TC/<LB@:MN7%@"+R#HHPHQ#%:4B\X?D^E TT!N.N&+;;
M;8J;CCAKR@  .JJJJNB(GEX;D8)X<=^,SCNIS-R<5VBW R",8((&KB2*JO=#
ME07&R4N;1$(55=%3AXHOA&WK:1A0$_A/$WZ4B4T51[D;DF%<3J756T5$ZM=-
M4U>D.>$O=PFV&G'C%BGARGR!H%,D9BQ9!NN&J)[UML"(EZA155$X)W(?"5XC
MZ^, -F<Y=F-PI5:'>*J !V<*O<CB:\J^\5SF3RJFBIP59DU#=8[9 G,5?>U<
MZHG"/,H\Q1+!MMQ$U14UY?+Z7B.[&UV1S<3SS!KB/>8[>0%!7(TMC4'&),=U
M":D1I#1''EQ7P)I]DW&70-LR%8N=580,?W/Q)85#O#MZQ*5UW&<D=9(HEO6@
M_HZ=/;@T[)K7RYD11?BDXX_$>7TC:O\ >LP?ZHLYZ?B7^BC$OG>7J38G]X%K
MZN;OI^)?Z*,2^=Y='>;Z*-Q/FA,]*;\-V[U\+V_&T-&R&/6UI*(['=+;2O0(
MD2U<D/KS/VU.BMQ++55<?85B8JNN+,-OU#XI_P Z\3^K2DZ6S7TK;>?.Z'T/
M"-^=>\'Y(Q_[A>+G\Z]G_P D9!T/%/\ FIB?UETGJYCP5;TWRR\TP^F>F;$9
M):2D.;E&%TT97K/;J6\^O.]-I8X+*K%0C)RN%YI4;&O!7NA<8WD%;#N:'(*N
MPI+NHL6 E5]K46L0X%E6SHSJ*+C+[+AM.MDFA"2HO4O&0X#$8FR=J,P\ZS/9
M>_D^</\ GF&3)I N-SK!U.5VRI'?^ F^^YW 2/+(&QEMCT]N]^<&(WY^&7#9
M75&LA8T3+<1GIYGE.)SW.4T%N=#)QH'5;)67>[D *N-!I@V[VW%J%UA&X>.5
MV38]/3NQ>6'8,\YPYS+9&C,N*ZCD69'4E)E]MQHO? OJ#<C?C/WM*#;_ !^1
M9-5S;S;,W([Z00P<:Q6K)SJ\YLI[L>&RI>]!7.\-1; R3/MY=QK+X5S7<;)K
M')[Z2".#&:?G._\ #UM:RX1JU#A,"U#A,<RHTPTVVBZ G3=\4.X])YONUOO3
MQBP^-/CB,W#]FWR;L:A&Q<%#:D9"X#5G(T)46($ = -'A7_ 2]VMW-I@ML>N
M01Z-(;Y&K7'[IAHPK<DQ^:J*L>;%5PE;<1%$A(V71<8==;.=MWF[7G]=)%RR
MPO,HD5]BES/'N]Y&K"%WO,C4AI5%J?"5PBCN]7,XT;3SO9^/A/03M]'LX7L_
M!Z';PON+PON+PO'W^.ST%[?03W>.S\? ,,-N///. TRRT!..NNN$@-MMMAJI
M$2JB(B)JJ]2<5/B3\1F.,'NS/8C6&V> V\?O'-KH3S:N#D=_$>U!,@D"0+'8
M(>:M#K)4FF0P_P##0=BMH;U8WB(W>HY*E:ULA6Y^U.W<PCKIF7 ^TJ&S:V!"
M_#I%!4-E0?F\S9QXZ/$1$I$2J1$2JI$2KJI$J^55]E?2!$14B)4$1%%4B)5T
M011/*J^PG%=?MX QLS@%@C;[.;;SNS<429#-I) R*7#VF'[R4+K9"49]:]N(
MZJII*%.8AAV&^VXVX>]URV#)2J>H<9VPP=UQ44I#+D2G<EW+B(N@@ZW=L*J(
MI*VBDB!$_P"F?AFV>H)T'3S6_EX;5Y-EC/*G*FF8Y8,ZU7^'FF+JO6O7PTPP
MTVPPPV#+++("VTRTV* VTTV"(@B*(B"*)HB=2=!Z+*9:DQI+3C$B.^V#S#[#
MP*V\R\RXBB0$*J)"2*BHNB]7$L=Q?#)M3+GS>99.0XSCK6W^5NN+IRNO97@)
M5EBXHZ)RH[))/*BHJ*J+87'A@WHR/ KA0-Z'A>Z\=K+\1D2.3E"#&RJC:C6E
M<PJZ$KK\6S<1>9.545.1^1O+M/;,X>#O=Q=S,1-,NVYF"1HVT;N25*%\'FX2
MJ+4:W:B2#T5194=%7TBON*>PFU-O4S8EG56M9+?@65990'QE0;"OG12!UE]E
MT!<:=;)" D0A5%1%X>P+<FSB->)+:>LAMYBT7F\4]Q,5YA@UVY57#:$![Q7%
M"+=,L!R,22:=1&VIC#0^D3/!OL[?]YMEMO<(N\5Y52T*+G.XU6\BAB(NL+HY
M7XZ\*C)%2Y7;)#Y@_P"!9</TBKQ?$,?N\JR:\EMP*7'<;JI]Y>V\YW56H574
M5C;LB0Z6B\K;39$OL)Q6Y#O+88_X;<0F=V\L7)FERO<IV(YH0NLX+3/M,QE5
M-4)JTM8CX+IS,+Q!FYO09GOSD48&W'INXV3RX&/I-%-''8>)85\&QU875>6/
M8N343V2)41>&6MI=F-K-M$8:5D'<%P'%L6E$!-]TXK\REBLNNFXBKWKCAD1J
MJJ:DJJJ]!ZCS'&<?RVDD?_,4^34U;?5;_P#_ !J^U;=9+_\ "!>)16_AXQ?!
M;>1WA-Y!M"<K;";$>=UYY#=5BQ,U+QZJI:2ZUX=>OEXGWGA3WOCY$VWW[T;;
M_>>(U4VY- 2&W'A[@XNPL20^8J0B$BFAMH0HI/HAJH)B^_FTV7;;V+SKS-=,
MN((2,<O5C_[8\;RZJ.1560!_IG F.H/^DJ+Z3BN]6"N.S848TI,_Q!9!,5^=
MX%826W+W&IJIJ(N+W;<F#((2[B6TP\HF($V>#;Q[97 7N"[AX_#R/'K!!%M_
MS:4BA(@6$82+N)D-\'8DZ,1*3,AIUH_? O3VK_>LP?ZHLYZ?B7^BC$OG>7J3
M8G]X%KZN;OI^)?Z*,2^=Y='>;Z*-Q/FA,]*PO=[;&\?Q[.<"O(E]063*FK??
MQU49$&>P)"C\26R3D69&)>5YAQQHO>DO&+;SX8<>OMG02CW%PP9229N"9] C
MMG=8_)(D0C8+G"77R"%._B.LN*@.*;8>H/%/^=>)_5I2=+9KZ5MO/G=#Z'A&
M_.O>#\D8_P#<+Q<_G7L_^2,@Z'BG_-3$_K+I.F55B>.7V46@QW)95N.U%A=S
MQB,D(.RBAUK;KB-B1@A'RZ(I(BKUIQ^IK=;]GF7?\GQ^IK=;]GF7?\GQ^IK=
M;]GF7?\ )\?J:W6_9YEW_)\?J:W6_9YEW_)\?J:W6_9YEW_)\?J:W6_9YEW_
M "?'ZFMUOV>9=_R?'ZFMUOV>9=_R?'ZFMUOV>9=_R?'ZFMUOV>9=_P GPV[=
M[9[@4[3W>=TY:X9D=>#O=(A.]V<N,"%RHJ*6GDU37TO#]R\#MY%#F6"9'495
MC5O%(A<A6]+-"=#<(15.=M2! >:+WKC:D!HHDJ+M9OYC/F\<,YQQAW(*:.ZK
MO]6<TK#*JS+&CYU5S2'8LR&F#<1"=8[I]$Y715>A?X/"C0(^[>%)+S'9?()2
M-M+#RV+&_P"*QF9-5.9N!>,!YC*Z^0'/-I9 X44!6VQZ_K9M->T-G/I;NGLX
MSL.RJK>KE'!LJVPAOH)M/L/-FTZV8H0D*BJ(J=.S\$NY-WW>-YQ+LLKV-F6,
MG2/49LC*S,HP-AY[J;:MV6RL(+7.#:36I  )R+!$+T^N\)^ VRO[=["VCTS<
M%^(^BP\BWG<C'!E030%(3#&XCKM>BKRD,V18-&*HRT:]*$_E]4Y)V)V><K,P
MW5>=:+S+('2D&>*[=(YY%*X?8<66**BI!8EJA"XK6K3##3;###8,LLL@+;3+
M38H#;338(B"(HB((HFB)U)_@-:;9[@QB94B6QQ;*(3++EWAN1M-*W#NZHG=$
M)-%5J5&(D!]DC;)151,+K:W<RK\RN*U$F5=E'YW*?*,>D/N-5F34$LT3O8LC
MNS1-40VW <8=$'FG %/03M]'LX7L_!Z';PON+PON+PO'W^.ST%[?03W>&V66
MW'GGC!IIIH"<===<+D;;;;#52(E5$1$355ZDXH/$IXD\?;>W0>"/;[:[:V\<
M7&MMVG!1Z'E.40WD5"OR14.)$--*U-'#3S_1(7^&FX6_.X+J'4874$Y64K<A
MN/89;E,\TA8SB52IH2J_/EFVTIH!(RUWDAQ$99<(<ZWIW0MSN<VW OI5Y;/H
MKR0X3;FC-=25##YN$Q KXP,PH,?G7NF&FPU7EU7IBFW5$F+[7UMB,'+=Y<LC
MRHV%TA-HCLROIT!$=N+0&U11KH&O(1M>=O1&71>XJ+REQ)K=+=^"#+TG=_<>
M%"M;N+9"*$X_A=$:' HFQ/G[@H;93$;+NWILC3F7TJ5 GQ8\V#-CO1)D.6RW
M)B2XDEM69$65'>0@<;< E P-%0D545%1>+;.?#$53X>]U7 =D_U888?39C*9
MA&IDW+H8+;KU X2*@B_3-K&!$ZZXS)74L-K]\\$M\%RR"BOQVIPMR*F]K2-0
M9N\9O89.1+&$XJ*@R(KQB)(39\CH& ]/ ]\=L;%8&5X)=,V+4=QQ\*Z]JW/^
M'N\8NVV"$G8-C%)V)*;147D-2!1<$"' -]=MY8.X_F].U*E5A2 D6&+Y#&_X
M;(L2N>00TEUTL78SB\@BX@B\WJRZV1=*<F&V;<7?+>!;#"MJQ;,5ET )'#^M
M>X*-ZHJ)417@2(?6GG[\3F VD=1'7WW7'WWW#>>>>,G'7G7"4W'77#55(B55
M4B5=57K7TBJW"R@I.S'A\D.=\&X%Y6&]D&;1FB1'&=ML:D*TLMHU_HUMI)-P
M@5#[HI3K1Q^!H]C=N:^JN9$1N+?[B7J,WNY65J( CI7N72&Q=1HR!'?,(01X
M+9J1,Q6U)=?2K7!MRL.QO/,.O&%CVV,Y93P+VFG-JBH).P;$' YP5>9IT40P
M+0@(21%2ZW0\#$J0:L@]/L?#WD]J4EPP%2<>';/-+EWO"41Y$;J[IXR+WY!8
M*2M1EM\8RFDML;R2@L)53>4%[7RZFYI[2"\L>;76=9.!MYA]HQ4'&G0$A5%1
M41?2)/@YW&N#' -W[-ZTVGE37G#9QG=8F1%_&V3<+E9B9#':Y6P3J2P:9%L.
M>:\?3VK_ 'K,'^J+.>GXE_HHQ+YWEZDV)_>!:^KF[Z?B7^BC$OG>71WF^BC<
M3YH3/2X&3S'["PV9SPZ_&]YL4C*X\DFB&07F&75D)-4*SI3=<D1N5.9UDI$7
MF%)"D-!F.(W-?D6+933UV08[?5,EN967-+;Q GUEG E-*HN-/,F#@$GE14]0
M>*?\Z\3^K2DZ6S7TK;>?.Z'T*B+O)M!M=NU&Q]V8_0Q]S< Q//&*1^Q!MNP>
MJ&<IB2QC&^++0O$R@J: "%J@II]C3PI_W>-HOB?C[&GA3_N\;1?$_'V-/"G_
M '>-HOB?C[&GA3_N\;1?$_'V-/"G_=XVB^)^/L:>%/\ N\;1?$_'V-/"G_=X
MVB^)^/L:>%/^[QM%\3\?8T\*?]WC:+XGX^QIX4_[O&T7Q/Q]C3PI_P!WC:+X
MGX^QIX4_[O&T7Q/Q]C3PI_W>-HOB?C=BLK(42NK:[<O.X%?7P([,.# @P\IE
M1XD*%$CH+;3338B#;8"@B*((HB(B=+:>LLX42QK;'<O!(%A7SX[,R#/@S,IB
MQY<*;$D(3;K3K9$#C9BHD*J)(J*J<?8T\*?]WC:+XGX^QIX4_P"[QM%\3\?8
MT\*?]WC:+XGX^QIX4_[O&T7Q/Q]C3PI_W>-HOB?C[&GA3_N\;1?$_'V-/"G_
M '>-HOB?C[&GA3_N\;1?$_'V-/"G_=XVB^)^/L:>%/\ N\;1?$_'V-/"G_=X
MVB^)^/L:>%/^[QM%\3\?8T\*?]WC:+XGXMXNS>T&UVTL;('8;]]'VRP#$\#8
MNWZX'&Z]ZW9Q:)$&2; O.BR3R$H(9H.B$NOH^*?\U,3^LNDZ=Q^[]N)\Y<?]
M-?:W*VHVUW":DMDS);SC!<7RQN0T3*1R:?"^BR$,5;$04214Y41/(B)Q.>A;
M2S-GL@F(?)D6SF13\7\U-5Y@\WQ*Q\_Q\11==4"H%5151"305&TR[PYY+ \1
M6(0T?EGBJ0VL3W9@PPU=4(M(^\[7W*LMIH2PIC4I\]$8KR4N5+*@R&ILZ&]I
MILFLN*2Z@2JNWJK*&ZK$ROLJV<#;S#[1B0.-.@)"2*A(BIZ1N_X2K^P0:S+(
M'_6+;IA\^46\FI&X]!GE9%U55-V;7?!TP6T1$$*]\^M27I,>-S;&E4,5SJ?7
MT&^E?7QQ&-0YR\(P<>STVF>IMB[$0A3W.012>#3AF;]BO3H<NQ:VFT.38O<5
MN08]=UKQ1K&HNJ>8%A5V<&0'6#K#S8.-DGD)$7C#=VXQP(F=5[88ENWC<(^5
M,?W$IXK?PL3$8E4FX5B!M6=>BD?*P^+1.&ZT[IZ;EFX4"5%7=++$>P;9NJ>%
MA]7\WMH;BAD$B$]JCD2ECHY92$(5!PFV8Q**R 7B=:VDR38V=G,DV%C837W)
M,R=/FOE)F3)<EY5-QUUPB-PR55(E5575>EB^ X533,BR_-+^IQC&:*O;[V;;
M7MY."NK($<5T3F=>< =25!374E1$5>,,V:ITASLI)M,GW1R>*WR_UKW&N(K2
M7T\'"03*+&%MJOKD)$5(L=GG3O%<(O\  >3B.0A&I<VI@?F[=Y^$-'['%;D^
M4G&'D!1-^NF<@LSX:EH0\KH<K[3+@9'MAN31OT.68Q.<B3(S@N+%FQU76%<5
M$HQ%),*6WRO19()RN-DB]2ZHG"=OH]G"]GX/0[>%]Q>%]Q>%X^_QV>@O;Z#3
M++9O//. TTTT!..NNN+R-MMMAJI$2JB(B)JJ\8_XD_$GC[;VZ#S<>VVUVUMX
MXN-;;M."CT/*,HAO(J%?DBH<2(::5J:&XGG^B0O\-8_AHP:Y\XVN\/,Z3'R5
M8,A3@Y+O+(86-D3SZ!H)IC[)%3,H0\S<I;+12!P%3ITN_?B2KKC$O#HG<66)
MXR+SM5DV]/(^J(3#K)#)KL?7D7O; 4!^8)(,$A EEMT6$8'C5)A^'XS7LU6/
M8SCE;%J*2FKH^O=1*^NA"#38(JJ2\H]9*I%J2JJ^FS=K]\\-BY+3.)(?HKJ,
MK<'+L)N7F>Z;R+#,A0#<A2V]!4DY38?$>YE,R(Y&R3(W)NYQLME5@_&V\W:@
M0"BQ)SPLK*7&<M@MDZ-;<--H9(R3BM2FP-^*9(#[<?IGX9,YMG&]J_$+:1HV
M,^=/(D+%MY^Y"%02VD<70 OV6VZ:0@"I')&N5>4&W%7HR)DR0Q$AQ&'9,J5)
M=;8C1HS#:NOR)#[JH(  HI&9*B(B*JKIQG&Y5=-G'MECAI@FT%;*5QMN+@U"
M\8-7'F9KHT_<2BD6KZ*G./?@P2JC :=/&?$_XP\9?_JQ*6'>[5['73!,)D\(
MFU?K\QW+@.HCB5SBJV_74Y\OG8HCLP5B&+$F+ @18\*#"CLQ(<.(RW&B1(D9
MM&8\6+'900;;; 4  !$041$1$1/3I645 5>W?B/HZU6\4W.9AF,7)&8<=1A8
MAN1'A^^F0#5 ;8GH!RX&B$QWK/>Q'\JVFW9Q6QPW/<-L3K;RCL@%#;-!1V--
MA26E)J3$DM$$B',CF;+[)@ZT9 2*O2K+VEGRZJYI;"%;5-I ?<C3JVSKI(S(
M$^%):5";=9= '&S%4421%1=4XVXWB<D1%S9J(6&[KU\4661K-R\99:CY"21&
M$0&&K #CV\1D>H(\MH%7F%43H[5_O68/]46<]/Q+_11B7SO+U)L3^\"U]7-W
MT_$O]%&)?.\NCO-]%&XGS0F>F0?!!O/?$F,9'/D/>'_([64(LX]DL]XI5AM@
M^^^J(,6T>)R54)JG)-)V,B'YXR+7I_BG_.O$_JTI.ELU]*VWGSNA^HMY?I6W
M#^=TSI;-?2MMY\[H?J+Q3_FIB?UETG3N/W?MQ/G+C_J";>Q(U5MSXAZN" 8I
MNU"KU1+48O\ L<;W%AP>4K*O,4[MJ02%*A*J''(FD=BR,MVDW6QF?B&?X1:'
M4Y#0V" KD=_NAE19460RI-2(LJ.XU*ARV#)I]AQMYHR;,27I>'?=Y9:P:W&-
MS:"+DTA'>Z0<+RETL1S="->K1:B?-30NK7373RIT<RVLW%I8^181GN/V.,Y+
M3R=1&766;"L.JR\'OV7VE47H\AM4<9=$'6R$P%4SK8K,%?FL4LD;?",G<CK&
M8S7;ZW></%LIC FH(3K;9QYC39$+$QF3'0R5E27I5B9;:K%V-WA6NPC==I]S
ME@T2E)),4W#7540"II3Q^=&NJ>8/S$0"=[I0!UHP<:< 7&W&R0VW&S3F P,=
M45%1=45/+Z8;KI@VTV!....$@-MM@G,9F9:(B(B:JJ^3B[E8O:G+V4VD.PP+
M:1EET3@6T6-+0<FS]KNU436\ELH['<ZE\Q:A 8HX!Z]*=XYMSZ35MOX5Q3P^
MUUE%ZB=U<J\SW-9;?#_0T=I:MX#5-5L2(=1CN?X%*4485%O+B,"46W>8NJ;#
M#O,2R7,2R<V0<)VLE.:J)(!.17B[]G42?9?R# ,_Q^PQ?+\7L':R[I+-I&Y,
M22VB&)"8*0.LN@0O1Y#)$T\T0.M&;9B2IV^CV<+V?@]#MX7W%X7W%X7C[_'9
MZ"]O#;++;CSSS@---- 3CKKKA(#;;;8:J1$JHB(B:JO&/^)'Q)8^V]N>Z$>W
MVUVVMXXN-;;MN"CT/*,HAO(J%?DBH<2(::5J:.&GG^B0O\-=UMYPDL-Y=&J%
MQ;;*(\T$A)^Y65 =;BJ+&<T%UJ&:N6DMLB3FC17D34M$6=:VDR38V=G,DV%C
M837W),R=/FOE)F3)<EY5-QUUPB-PR55(E5575>F6]N]-/,;\->WENC UCR/P
MTW?S&%H]_56)) @<2IA*K;EQ):75Q5&$T2&;[D:)75T2- KX$9B% @0F&HL.
M%#BM(Q%B1(K""#;38"(-M@*"(HB(B(GJ#)]L-TL5J<TP3,*QZIR#';ECOHDR
M*\FH.M. HN,2&307HLJ.8/,.B#K+@. ))S5R6>4>'[.["2>U6X$H6G93)BSY
MY*P3,2C"+;-O!'G[MU !N='%)3(@:28T7I19\"5(A3H4AF7#F1'G(TN)+C.(
M]'E19#*B;;C9BA@8*BBJ(J*BIQMAN]-EQG\YBPW,&W6CQD$$B;DXDRU%O7W&
M 1!92R9<B73+ ZHVS-:#55%>C<X7C=D<#<7Q&39.UM <60+,^OPXHB3-SKYH
M5]\3:5Q-TY$VJ&V[9,NBOO/2*[Q?[_8^DO:K%;=Q-H<'N(0.0=QLMIY2"]E]
MU&E(HOT=4^!-,1U!0F307O"[B(XS*]0'?XC#KZCQ(;:U4^3MKD9(S$3+*\=9
MTK;+)YA* G$F.(2ULA\M(,LU<$@8?F ]<XSD=9-I,AQVVL:*]IK..Y$L:BYJ
M)AU]I66$1Y$-I^.^V;3K9(BB0JBIJG3N/#WDEDD?"?$;5C%IAE25:B5NZF(Q
M7[/&W&E>+NVULX*SZTA$>=^2L!M%7D$5Z.U?[UF#_5%G/3\2_P!%&)?.\O4F
MQ/[P+7U<W?3\2_T48E\[RZ.\WT4;B?-"9Z9$L:Z7)@6$"2Q-@3X3[L69"F17
M4?BRXDIA1-MULQ$VW )"$D145%3A,6SRSCCXB]H:^OJ]PXSIL,R,XHM$ATVY
M]=$#E14E*@Q[8&AY69J*7*TS*B@OIWBG_.O$_JTI.ELU]*VWGSNA^HMY?I6W
M#^=TSI;-?2MMY\[H?J+Q3_FIB?UETG3N/W?MQ/G+C_J$?%?A%2PWNAL- $,W
M.(R RLOV??F)Y]YX0IJX]CLATK*.9$*##<L$7G+N!'I^'O="5(.3/S_9;;++
M+1YP>5U;B[PV'.N0=3R<X2C> ^551515%5315Z+V88%3>>;^;'Q+3)<%"#&
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M$1$5(B5!$115(B5=$$43RJOL)Q79#;8L&PNV,T&)29ONS$G5=I9P'M"1[%<
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MQYLES3ZC.QK)&(_,7(S:5KT2Q8%254;?#7KZ>9[+V<Y9-OL!N+(:K(ZKJL+
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M($E7:_*]X'6UA93:$H:"XW2 I4D75%Y7DL' ,FI Z=)_Q7[D4W<;H[Y4C+&
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MX=G D"B*3$V!(&5%>%%ZM1,!)-?:XQG+((\D+)\?I<AAAJX7+%NJUNRCCS/
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M"@ #=;7(0CK'8%P@%UUU5_QI[VY(CK#Z9!N[N3>(]&$AC/);9E-G]['$E54
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M9[JNR)+Y(B"*>06VFQ%ML$%ML ;$13U!0[R;-WRUEY6*D.ZI9BO/8UFN-//
M[98GEE:T8><0I'(*]1"ZRZ+<B.XU(:;<&)N5MK+2LR&L2)7;D;;V,ME[)=O<
ME>94U@SD! \X@R.1QRLLVVQ:E-"7O6I#4B.Q_AGF?YUY%^5WNEAGYUX[^5V?
MN#XO_P!X'<SYRO\ 3\,_[OVS7U<UOJ;Q-_\ 9?\ ^Y[Q/I^$SZ*8'Y4E=#:O
M]ZS!_JBSGI^)?Z*,2^=Y>I-B?W@6OJYN^GXE_HHQ+YWET=YOHHW$^:$SIW'[
MOVXGSEQ_IVOCFV2H/^.@1V$\16*U$;59D!@1BP]WH4-A->\C @1LA[M%164:
ML"$>ZGOGT_ZF[@6K_P#^KGO!90*_/F7W'GHV!Y&@>94FYM=%3F0$9U"+<BVB
M*]"T<)'7849OB/,AR&)<.6PU)BRHSK;\:3&?;1UB1'?:51,#%4(#%5145%1=
M.CXI_P Z\3^K2DZ6S7TK;>?.Z'ZBWE^E;</YW3.ELU]*VWGSNA^HO%/^:F)_
M672>J/AK_I/L[N?)1]MT(N[^)6&:U -M@H^:_ GG\:(0$JJ1*;)&J_Z>B(B0
ML;M/!EX?Z_&6E$'ZG89RPV1KP 1[MIZ-3.Q[^-S-HJKR:"A?S4)M%U2'6;@.
M;C;#V\CD:=?SC&/ZP8HDIS1 :C9%@;ED\C:JNBOSJ^* ]:FHBG-PSE^TNXF%
M[E8P\H -[@^2U&35K3YMH[YI*DU#SJ,OBBIWD=[E<!=1,!5%3U'N#L/N&PB4
MV:5!M5URW'9D6.*9-"+SO&\MI^^3WLF!+%MU$0D1UOO&'%5IUP2SW9;<RK^"
M<VV\R"707+ *X<.5W.CT"XJGW1 GH4^,;,V$^H#WC#K9Z)S:)Z355.0U\DMD
M]KEKLVWBLA%UN-.K6Y:_ & M2@%4&3?2&C9(><#2$U->;)'&118E=71(T"O@
M1F(4"!"8:BPX4.*TC$6)$BL((-M-@(@VV H(BB(B(B?X(.89ACE3F/B8S&I-
MW$,0=-)5;A%;*0F6<\SQEDD(8XDA+7UZD+DUP51%".#KHY+N-N-DMMF.<9C;
M2;O)<ENY*RK*ULI2^_>>/J$0$4%MEEL1;:;$&F@!L!%/45#O)LW?+67E8J0[
MJEF*\]C6:XT\\#MEB>65K1AYQ"D<@KU$+K+HMR([C4AIMP8FY6VLM*S(:Q(E
M=N1MO8RV7LEV]R5YE36#.0$#SB#(Y''*RS;;%J4T)>]:D-2(['^&69_G7D7Y
M7>Z6&?G7COY79^X/B_\ W@=S/G*_T_#/^[]LU]7-;ZF\3?\ V7_^Y[Q/I^$S
MZ*8'Y4E=#:O]ZS!_JBSGI^)?Z*,2^=Y>I-B?W@6OJYN^GXE_HHQ+YWET=YOH
MHW$^:$SIW'[OVXGSEQ_IS:NTA1+*MLHDF!8UT^,S,@SX,QE8\N%-B2$)MUIU
MLB!QLQ42%5$D5%5./ZZ;?5<D_#?NY:39F!20%V0S@62&!3[;;"SEEJJ(R*.2
M:4W5YGH2*WS//0Y3B].!X(=Y[Y"R[%*Y]SP_Y#:2B*1DV)5S#DRQVSD/R%4B
METS('(J$YEYZ\7(XHV,!I'NAXI_SKQ/ZM*3I;-?2MMY\[H?J+>7Z5MP_G=,Z
M6S7TK;>?.Z'ZB\4_YJ8G]9=)ZKBYOL_N)F.VN61.40O,-O[&AF/,":&4&>L!
MP!DQG--'8LD39<%5%P"%51:G /'!C[%A7NK'A,;[8#3C%L82_P PIF?X#6CW
M,@%5>9V91-LDV(Z#7/D2F-%GVW654.;87DT$+&AR?&K*+;4UI$-5!7(LV(1
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ML:V?$?1#:>8> VW )$42147IXOO)B!2K*C14HMR,*"3YO#SK Y[PE;4KZEJ
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M9)N]-OPB[LWC<;:?=J\[[;.YLWR2/@^ZUF01F:-7C71JNR(D!C1?>-6",&B
M,J4ZGH>*?\Z\3^K2DZ6S7TK;>?.Z'ZBWE^E;</YW3.ELU]*VWGSNA^HO%/\
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M_P"SQK[?L_R<?B_EXU]KV?Y./Q?R\+K]_P#DXT^]^/TN+95<Z76V,)X)$.?
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M^5B$M<>?$$\I-3DCNBGMBG3PG<7&GO-LCP'+L;S6@D:JG<76+7+-Y5/:I_\
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M1T<EPS?41(U@O30; G3;TCS(<AB7#EL-28LJ,ZV_&DQGVT=8D1WVE43 Q5"
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MP_-_.-;+#<T@PXDC)-O\LCAI R.@=DI__)FQN<!E1C<8(@YT,+7:C>"B<CN
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M$-\T0VZ^ !H[+>3D#E;%YYK$MD-I*E:[&,7C<TJPE(RY>95D,H!6ZR[)IC
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M +(<A)_']O<??EQ]NMN8\LG:['*YXN0K&Q,$$9=K+$1*9,4?:::0&0$..O\
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M4U3O$70D>/ _%EE]"WJ91X^7;54V6GR\[A T],IKJD3515H5<%CJ43+D5"0
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M\7\?K1R7]F.X'Q?Q^M')?V8[@?%_'ZT<E_9CN!\7\/;;;.9K<9!EK%!89,Y
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M4T8:<ZHD;E9$1=.2X]Z=BV\.!/FX_4O>89-CIRG(U;FF'S7@6]Q6V44-.[D
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MKQEMJ[%*;#D11DM(B*KD=7Q'G'WP]8ZIUI[?I&<>%#)[#6!>,3MR=K_.7?\
M8W<!IMC-\:B(6JKYS$%JT9:'E /-9KBZF[U^DY7G&0O^;4&&8U>Y7>2=03S>
MGQVK=M[)_5Q1%.1EDR]\2)U=:HG&<;C9 7/>9[EV1YC;KWANBEEDMN]<3 !P
M^M1%QXA'7V$3J3TA, GRE9I][,)O,3!LS1N,F48ZW_7''I3Q$2)SJS#L(3**
MBJ1RD%$U)/2_%;^[9OI]5]IZBR_P^V\TDH-Y,?D7N-1G#(@9S_!8;MFZW&:T
MY0\\I?A I#G,G,L..&B]6G1\07T([K_,.?ZA\3WYR[6_DN\_PURK:;=G%:[,
ML"S*N.MO*.R E!P%)'8TV%):478TN,Z(2(<R.8/,/ #K1B8HJ-6]:]9YYX>L
MOL'&,$W).&(RZB>8E(3!\]"(G=1K1IL2*/($08GM 3S MN!)BQON1C6XVW.2
MVV'9QAUM&N\:R6DDK%LJJRBK[QYD^L2 A4FWF7!)MULC:= VS(5;PS,W*G#O
M$QAU2#N7X@T:1:W-ZV*@LO9Y@;+Q*11R)16PKT(G(3A(BJ<<VG2](E[<[C1$
MK,@K$EV&W6XM?$9>R/ ,C>90$FPE-0\X@R.1MNRK7'!;DMB/OFI#4>0S>[/[
MP4:UEW6JLNFN8B//8[F6.//&W6Y5BMDX()(AR.0DZQ%QEP7&'VVGVG&Q]>G'
MEZT\G7U\:??]KLX]>O'EZOXN/9_'V\:>Q_%V<:+KZ_;X3K33^'R=G&J*O9Y>
M/8U_B[.$\OX^WA/)^+LXUU7\?;PGD_%V<>S^/MXZ_O?Y..OR>OR\:^7U^QQU
MKZ_X>/7_ !<?Y?Q\>7J_@_%QJGWO\O'E^]^+B)75T23/L)\EB% @PV'94R;,
ME.HQ%B18K"$;CKAD(-M@*D1*B(BJO%/O'OG71;+=!%8LL3PYTFY=9M]S-=XQ
M86HIJW(N14M01%)J&2(3:G(07&?NAM3])."_.B+Z1XF?HVF_E&-TO#U_W9^H
M[)NEX@OINW7^?D_I?JNQK]IVW_QAQ^J[&OVG;?\ QAQ^J[&OVG;?_&''ZKL:
M_:=M_P#&''ZKL:_:=M_\8<?JNQK]IVW_ ,8<?JNQK]IVW_QAQ^J[&OVG;?\
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MMM]YD2<E370$UC0(PDX:IS&K3*&\$";FV.2-]\U:9:6==;BZ'BZ2Q)#>^"<
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M^$JVI:05ZM7-=>K1>@#C9DVXV0FVX!*!@8+S"8$/6BHO6BIQLINYYP$F=F6
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MDQ#0X,94T)*EHTDGKI**-R''=KJ2CK:^FI:B%%K*FHJH<>NJZNM@LC&A5]=
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MJ/DEE_\ K<?:7VH^267_ .MQ]I?:CY)9?_K<?:7VH^267_ZW'VE]J/DEE_\
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MS7?\J<W(EZVO)SKR\VN@\^I='&\4.0CMUL[EN68'8@9?\24"=9EFM!)(-?\
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MMIKN8[8*Y+L[:8<^?*<5<.55)QUPS7^%>/UD>)/Y8;7_ *'<?K(\2?RPVO\
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1:*9$:II_.55\J_\ [5E__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980251855936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 21, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CROSS COUNTRY HEALTHCARE, INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-33169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-4066229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6551 Park of Commerce Boulevard, N.W.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boca Raton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">998-2232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CCRN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,231,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001141103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980253121648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 279<span></span>
</td>
<td class="nump">$ 1,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $11,896 in 2022 and $6,881 in 2021</a></td>
<td class="nump">701,926<span></span>
</td>
<td class="nump">493,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">6,774<span></span>
</td>
<td class="nump">7,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceSettlementsReceivableCurrent', window );">Insurance recovery receivable</a></td>
<td class="nump">5,750<span></span>
</td>
<td class="nump">5,041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">3,594<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">718,323<span></span>
</td>
<td class="nump">508,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation of $19,240 in 2022 and $17,729 in 2021</a></td>
<td class="nump">18,241<span></span>
</td>
<td class="nump">15,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">5,058<span></span>
</td>
<td class="nump">7,488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">113,360<span></span>
</td>
<td class="nump">119,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Trade names, indefinite-lived</a></td>
<td class="nump">5,900<span></span>
</td>
<td class="nump">5,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">42,863<span></span>
</td>
<td class="nump">42,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Non-current deferred tax assets</a></td>
<td class="nump">8,096<span></span>
</td>
<td class="nump">11,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">27,120<span></span>
</td>
<td class="nump">21,956<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">938,961<span></span>
</td>
<td class="nump">732,809<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">189,805<span></span>
</td>
<td class="nump">109,753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">65,409<span></span>
</td>
<td class="nump">65,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities - current</a></td>
<td class="nump">4,145<span></span>
</td>
<td class="nump">4,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income tax payable</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">7,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Current portion of earnout liability</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">1,769<span></span>
</td>
<td class="nump">1,364<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">268,658<span></span>
</td>
<td class="nump">199,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">205,376<span></span>
</td>
<td class="nump">176,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities - non-current</a></td>
<td class="nump">7,017<span></span>
</td>
<td class="nump">10,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Non-current deferred tax liabilities</a></td>
<td class="nump">222<span></span>
</td>
<td class="nump">190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Long-term accrued claims</a></td>
<td class="nump">26,869<span></span>
</td>
<td class="nump">25,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Non-current earnout liability</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">12,508<span></span>
</td>
<td class="nump">13,788<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">528,150<span></span>
</td>
<td class="nump">435,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">320,000<span></span>
</td>
<td class="nump">321,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,335)<span></span>
</td>
<td class="num">(1,293)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (accumulated deficit)</a></td>
<td class="nump">92,142<span></span>
</td>
<td class="num">(22,735)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">410,811<span></span>
</td>
<td class="nump">297,528<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 938,961<span></span>
</td>
<td class="nump">$ 732,809<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceSettlementsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceSettlementsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980251846832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for credit losses</a></td>
<td class="nump">$ 11,896<span></span>
</td>
<td class="nump">$ 6,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
<td class="nump">$ 19,240<span></span>
</td>
<td class="nump">$ 17,729<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254505072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList', window );">Revenue from Contract with Customer, Product and Service [Extensible List]</a></td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">$ 753,561<span></span>
</td>
<td class="nump">$ 331,827<span></span>
</td>
<td class="nump">$ 1,542,293<span></span>
</td>
<td class="nump">$ 661,068<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DirectOperatingCosts', window );">Direct operating expenses</a></td>
<td class="nump">583,156<span></span>
</td>
<td class="nump">259,237<span></span>
</td>
<td class="nump">1,197,094<span></span>
</td>
<td class="nump">517,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">86,009<span></span>
</td>
<td class="nump">50,344<span></span>
</td>
<td class="nump">162,822<span></span>
</td>
<td class="nump">96,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">3,192<span></span>
</td>
<td class="nump">466<span></span>
</td>
<td class="nump">5,561<span></span>
</td>
<td class="nump">970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,481<span></span>
</td>
<td class="nump">2,199<span></span>
</td>
<td class="nump">6,200<span></span>
</td>
<td class="nump">4,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_AcquisitionAndIntegrationRelatedCosts', window );">Acquisition and integration-related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">924<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">924<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring (benefits) costs</a></td>
<td class="num">(1,114)<span></span>
</td>
<td class="nump">835<span></span>
</td>
<td class="num">(634)<span></span>
</td>
<td class="nump">2,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
<td class="nump">1,741<span></span>
</td>
<td class="nump">2,070<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">674,724<span></span>
</td>
<td class="nump">315,926<span></span>
</td>
<td class="nump">1,372,824<span></span>
</td>
<td class="nump">624,173<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">78,837<span></span>
</td>
<td class="nump">15,901<span></span>
</td>
<td class="nump">169,469<span></span>
</td>
<td class="nump">36,895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expenses (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">3,857<span></span>
</td>
<td class="nump">1,196<span></span>
</td>
<td class="nump">7,378<span></span>
</td>
<td class="nump">1,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">1,912<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,912<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="num">(1,084)<span></span>
</td>
<td class="num">(204)<span></span>
</td>
<td class="num">(1,092)<span></span>
</td>
<td class="num">(241)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">74,152<span></span>
</td>
<td class="nump">14,909<span></span>
</td>
<td class="nump">161,271<span></span>
</td>
<td class="nump">35,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">21,258<span></span>
</td>
<td class="nump">3,361<span></span>
</td>
<td class="nump">46,394<span></span>
</td>
<td class="nump">4,273<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to common stockholders</a></td>
<td class="nump">52,894<span></span>
</td>
<td class="nump">11,548<span></span>
</td>
<td class="nump">114,877<span></span>
</td>
<td class="nump">30,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Unrealized foreign currency translation loss, net of tax</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 52,863<span></span>
</td>
<td class="nump">$ 11,524<span></span>
</td>
<td class="nump">$ 114,835<span></span>
</td>
<td class="nump">$ 30,966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share attributable to common stockholders - Basic (in dollars per share)</a></td>
<td class="nump">$ 1.41<span></span>
</td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="nump">$ 3.08<span></span>
</td>
<td class="nump">$ 0.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share attributable to common stockholders - Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 3.03<span></span>
</td>
<td class="nump">$ 0.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (shares)</a></td>
<td class="nump">37,471<span></span>
</td>
<td class="nump">36,625<span></span>
</td>
<td class="nump">37,251<span></span>
</td>
<td class="nump">36,404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (shares)</a></td>
<td class="nump">37,757<span></span>
</td>
<td class="nump">37,203<span></span>
</td>
<td class="nump">37,866<span></span>
</td>
<td class="nump">37,120<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_AcquisitionAndIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition and integration-related costs include costs for prior acquisitions, costs incurred for potential transactions, and accretion and valuation adjustments on contingent consideration liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_AcquisitionAndIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectOperatingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate direct operating costs incurred during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectOperatingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980248886528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss, net</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Noncontrolling Interest in Subsidiary</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 154,909<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 310,388<span></span>
</td>
<td class="num">$ (1,280)<span></span>
</td>
<td class="num">$ (154,737)<span></span>
</td>
<td class="nump">$ 534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Vesting of restricted stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Vesting of restricted stock</a></td>
<td class="num">(2,230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">3,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes</a></td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Acquisition of WSG (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition of WSG</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">30,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">192,131<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">316,644<span></span>
</td>
<td class="num">(1,310)<span></span>
</td>
<td class="num">(123,741)<span></span>
</td>
<td class="nump">534<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">173,674<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">309,711<span></span>
</td>
<td class="num">(1,286)<span></span>
</td>
<td class="num">(135,289)<span></span>
</td>
<td class="nump">534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Vesting of restricted stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Vesting of restricted stock</a></td>
<td class="num">(204)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(204)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">2,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes</a></td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Acquisition of WSG (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Acquisition of WSG</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">11,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">192,131<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">316,644<span></span>
</td>
<td class="num">(1,310)<span></span>
</td>
<td class="num">(123,741)<span></span>
</td>
<td class="nump">534<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">297,528<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">321,552<span></span>
</td>
<td class="num">(1,293)<span></span>
</td>
<td class="num">(22,735)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Vesting of restricted stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Vesting of restricted stock</a></td>
<td class="num">(5,267)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,267)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">3,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes</a></td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">114,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">410,811<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">320,000<span></span>
</td>
<td class="num">(1,335)<span></span>
</td>
<td class="nump">92,142<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="nump">356,073<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">318,125<span></span>
</td>
<td class="num">(1,304)<span></span>
</td>
<td class="nump">39,248<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Vesting of restricted stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Vesting of restricted stock</a></td>
<td class="num">(239)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(239)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Equity compensation</a></td>
<td class="nump">2,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes</a></td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">52,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="nump">$ 410,811<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 320,000<span></span>
</td>
<td class="num">$ (1,335)<span></span>
</td>
<td class="nump">$ 92,142<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980253124192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Consolidated net income</a></td>
<td class="nump">$ 114,877<span></span>
</td>
<td class="nump">$ 30,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">6,200<span></span>
</td>
<td class="nump">4,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances', window );">Provision for allowances</a></td>
<td class="nump">7,213<span></span>
</td>
<td class="nump">1,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax expense</a></td>
<td class="nump">3,476<span></span>
</td>
<td class="nump">2,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OperatingLeaseExpenseNonCash', window );">Non-cash lease expense</a></td>
<td class="nump">1,005<span></span>
</td>
<td class="nump">1,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">1,741<span></span>
</td>
<td class="nump">2,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">1,912<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity compensation</a></td>
<td class="nump">3,715<span></span>
</td>
<td class="nump">3,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash (benefits) costs</a></td>
<td class="num">(301)<span></span>
</td>
<td class="nump">772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(215,230)<span></span>
</td>
<td class="num">(76,274)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(424)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="num">(9,021)<span></span>
</td>
<td class="nump">479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">78,438<span></span>
</td>
<td class="nump">22,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(2,674)<span></span>
</td>
<td class="num">(3,365)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other</a></td>
<td class="num">(1,824)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(10,897)<span></span>
</td>
<td class="num">(9,422)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(24,470)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(3,848)<span></span>
</td>
<td class="num">(3,002)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(3,848)<span></span>
</td>
<td class="num">(27,472)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Principal payments on term loan</a></td>
<td class="num">(50,438)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="num">(3,159)<span></span>
</td>
<td class="num">(4,465)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Borrowings under Senior Secured Asset-Based revolving credit facility</a></td>
<td class="nump">900,112<span></span>
</td>
<td class="nump">273,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Repayments on Senior Secured Asset-Based revolving credit facility</a></td>
<td class="num">(824,312)<span></span>
</td>
<td class="num">(311,400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Cash paid for shares withheld for taxes</a></td>
<td class="num">(5,267)<span></span>
</td>
<td class="num">(2,230)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payments on note payable</a></td>
<td class="num">(2,426)<span></span>
</td>
<td class="num">(2,426)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(523)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">13,987<span></span>
</td>
<td class="nump">53,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash and cash equivalents</a></td>
<td class="num">(757)<span></span>
</td>
<td class="nump">16,527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">1,036<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 279<span></span>
</td>
<td class="nump">$ 18,127<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_OperatingLeaseExpenseNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Expense, Non-Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_OperatingLeaseExpenseNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision For Doubtful Accounts And Other Allowances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980255949440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION AND BASIS OF PRESENTATION</a></td>
<td class="text">ORGANIZATION AND BASIS OF PRESENTATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). In the opinion of management, all adjustments necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. All such adjustments consisted of all normal recurring items, including the elimination of all intercompany transactions and balances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (U.S. GAAP) for interim financial information and with the instructions to Form&#160;10-Q and Article 10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021 included in the 2021 Form 10-K. The December&#160;31, 2021 condensed consolidated balance sheet included herein was derived from the December&#160;31, 2021 audited consolidated balance sheet included in the 2021 Form&#160;10-K.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation. See the condensed consolidated statements of cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254929280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Management has assessed various accounting estimates and other matters, including those that require consideration of forecasted financial information, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in context of the unknown future impacts of the global pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> using information that is reasonably available to the Company at the time. Significant estimates and assumptions are used for, but not limited to: (i) the valuation of accounts receivable; (ii) goodwill, trade names, and other intangible assets; (iii) other long-lived assets; (iv) revenue recognition; (v) accruals for health, workers&#8217; compensation, and professional liability claims; (vi) valuation of deferred tax assets; (vii) legal contingencies; and (viii) income taxes. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. As additional information becomes available to the Company, its future assessment of these estimates</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including management's expectations at the time regarding the duration, scope, and severity of the pandemic, as well as other factors,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> could materially and adversely impact the Company's consolidated financial statements in future reporting periods. Actual results could differ from those estimates.  </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prioritizes the mental health and well-being of its employees, especially in response to the COVID pandemic. While operating primarily through a remote workforce, the Company's offices remain open with stringent safety guidelines and procedures in place. Business travel, including visits to healthcare clients, continues to be somewhat limited at the request of the Company's clients who are continuing to cope with the pandemic twenty-four hours a day/seven days a week.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2022, average bill rates were down in the mid-single digits as expected, but volumes were stronger as the Company continued to experience high demand across a wide range of specialties spanning the healthcare continuum. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in people and technology, along with other improvements the Company has made during the pandemic, have allowed it to quickly respond to high demand levels that it is continuing to see across a wide range of specialties, including operating room, emergency room, pediatrics, labor and delivery, and medical and surgical services, not all of which are directly related to COVID needs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the pandemic, the Company worked collaboratively with clients on adjusting bill rates in order to adapt to the rapidly changing market conditions. One of the Company's core values is to act ethically and responsibly, and it has been especially important during this pandemic to be transparent and build trust with its clients to re-enforce long-lasting relationships as both demand and bill rates increased to unprecedented levels.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The timing of revenue recognition, billings, and collections results in billed and unbilled accounts receivable from customers, which are classified as accounts receivable on the condensed consolidated balance sheets and are presented net of allowances for doubtful accounts and sales allowances. Estimated revenue for the Company employees', subcontracted employees', and independent contractors&#8217; time worked but not yet billed at June 30, 2022 and December 31, 2021 totaled $217.3&#160;million and $140.0&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts is established for losses expected to be incurred on accounts receivable balances. Accounts receivable are written off against the allowance for doubtful accounts when the Company determines amounts are no longer collectible. Judgment is required in the estimation of the allowance and the Company evaluates the collectability of its accounts receivable and contract assets based on a combination of factors. The Company bases its allowance for doubtful account estimates on its historical write-off experience, current conditions, an analysis of the aging of outstanding receivable and customer payment patterns, and specific reserves for customers in adverse condition adjusted for current expectations for the customers or industry. Based on the information currently available, the Company also considered current expectations of future economic condition</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, including the impact of COVID, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">when estimating its allowance for doubtful accounts.</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The opening balance of the allowance for doubtful accounts is reconciled to the closing balance for expected credit losses as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,091&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(426)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,857&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,329&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the allowance for doubtful accounts, the Company maintains a sales allowance for billing-related adjustments which may arise in the ordinary course of business and adjustments to the reserve are recorded as contra-revenue. The balance of this allowance as of June 30, 2022 and December 31, 2021 was $1.0&#160;million and $0.8&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s contract terms typically require payment between 30 to 60 days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's customers are U.S. based healthcare systems with a significant percentage in acute-care facilities. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single customer accounted for more than 10% of the Company&#8217;s revenue for the three and six months ended June 30, 2022 and 2021, or the accounts receivable balance as of June 30, 2022 and December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring (Benefits) Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring (benefits) costs on the condensed consolidated statements of operations primarily include employee termination costs and lease-related exit costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation of the employee termination costs and lease-related exit costs (benefits) beginning and ending liability balance is presented below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:50.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.593%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.742%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Termination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease-Related</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,620&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Restructuring (benefits) costs in the condensed consolidated statements of operations for the six months ended June 30, 2022 include a benefit of $1.4&#160;million associated with the early termination of one of the Company's corporate offices which was previously restructured. Other costs were immaterial for the six months ended June 30, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980255008352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGNITION</a></td>
<td class="text">REVENUE RECOGNITION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues from customer contracts are generated from temporary staffing services and other services. Revenue is disaggregated by segment in the following table. Sales and usage-based taxes are excluded from revenue.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.961%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,353&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,264&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,669&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,236&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">  Six Months ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,504,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,486&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,445&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> Six Months ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,096&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629,196&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     </span></div>See Note 12 - Segment Data.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980253118624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS</a></td>
<td class="text">ACQUISITIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selected</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2021, the Company purchased and acquired substantially all of the assets and assumed certain liabilities of Selected, Inc. (Selected) for a purchase price of $3.5&#160;million in cash, subject to adjustment, and $1.5&#160;million in shares (or 59,429 shares) of the Company's common stock. The transaction was treated as a purchase of assets for income tax purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sellers were eligible to receive up to an additional $1.5&#160;million in earnout cash consideration, based on Selected's revenues for each of the twelve-month periods ending on the first and second anniversaries of the first day after the closing date. In the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">second quarter of 2022, the Company determined that the contingent consideration earnout related to the Selected acquisition would not be achieved for 2022 and 2023 and, as a result, the entire liability was reversed. See Note 10 - Fair Value Measurements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assigned the following values to other identifiable intangible assets: (i) an immaterial amount to trade names with a weighted average estimated useful life of 2 years; (ii) $1.7&#160;million to software with a weighted average estimated useful life of 5 years; and (iii) $2.9&#160;million to a database, consisting of education professionals, with a weighted average estimated useful life of 5 years, for a total of $4.6&#160;million in definite life intangible assets with a weighted average estimated useful life of 5 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining excess purchase price over the fair value of net assets acquired of $0.4&#160;million was recorded as goodwill on the Company's condensed consolidated balance sheets. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition was not significant and has been accounted for using the acquisition method of accounting. Associated immaterial acquisition-related costs incurred have been included in acquisition and integration-related costs on the Company's condensed consolidated statements of operations for the six months ended June 30, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cross Country Workforce Solutions Group (CCWSG)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 8, 2021, the Company purchased and acquired substantially all of the assets and assumed certain liabilities of Workforce Solutions Group, Inc. (WSG) for a purchase price of $25.0&#160;million in cash and $5.0&#160;million in shares (or 307,730 shares) of the Company's common stock. The parties agreed to a final net working capital reduction of $1.1&#160;million which was received in the fourth quarter of 2021. The transaction was treated as a purchase of assets for income tax purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sellers are also eligible to receive an earnout based on the business' performance through three years after the acquisition date that could provide up to an additional $15.0&#160;million in cash. The current portion of the liability of $7.5&#160;million is included in current portion of earnout liability and the non-current portion of $7.5&#160;million is included in non-current earnout liability on the condensed consolidated balance sheets. See Note 10 - Fair Value Measurements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the assets acquired and liabilities assumed on June 8, 2021:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,361&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,027&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assigned a value to other identifiable intangible assets of $14.2&#160;million in customer relationships with a weighted average estimated useful life of 11.5 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining excess purchase price over the fair value of net assets acquired of $22.1&#160;million was recorded as goodwill on the Company's condensed consolidated balance sheets. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets. </span></div>The acquisition was not significant and has been accounted for using the acquisition method of accounting. The pro-forma impact on the Company's consolidated revenue from services and net income, including the pro forma effect of events that are directly attributable to the acquisition, was not significant.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254928736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">COMPREHENSIVE INCOME</a></td>
<td class="text">COMPREHENSIVE INCOME<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total comprehensive income includes net income or loss and foreign currency translation adjustments, net of any related deferred taxes, and is included within the accompanying condensed consolidated statements of operations. Certain of the Company&#8217;s foreign subsidiaries use their respective local currency as their functional currency. Assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying condensed consolidated balance sheets and was an unrealized loss of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1.4&#160;million at June 30, 2022 and $1.3 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> at December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254924800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.115%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(amounts in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common stockholders - Basic and Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,894&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,877&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,996&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares - Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of diluted shares:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares - Diluted</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,757&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,203&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,866&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,120&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Diluted</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.84&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the share-based awards that could potentially dilute net income per share attributable to common stockholders in the future that were not included in the computation of diluted net income per share attributable to common stockholders because to do so would have been anti-dilutive for the periods presented.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254900304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had the following acquired intangible assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets subject to amortization:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Databases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets not subject to amortization:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names, indefinite-lived</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, estimated annual amortization expense is as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:80.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,863&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The changes in the carrying amount of goodwill by reportable segment are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.447%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate goodwill acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,851&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269,874)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,598)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,472)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net of impairment loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes to aggregate goodwill in 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquisition adjustment - Selected </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of business</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269,874)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net of impairment loss</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,553&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,360&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Represents an adjustment to the fair value of the identifiable net assets acquired, with a corresponding offset to goodwill, made during the measurement period related to the acquisition of Selected. See Note 4 - Acquisitions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Goodwill, Trade Names, and Other Intangible Assets Impairment </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests reporting units&#8217; goodwill and intangible assets with indefinite lives for impairment annually during the fourth quarter and more frequently if impairment indicators exist. The Company performs quarterly qualitative assessments of significant events and circumstances such as reporting units&#8217; historical and current results, assumptions regarding future performance, strategic initiatives and overall economic factors,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> including COVID,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and macro-economic developments, to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of reporting units or intangible assets is less than their carrying value. If indicators of impairments are identified a quantitative impairment test is performed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022 and 2021, the Company performed a qualitative assessment of each of its reporting units and determined it was not more likely than not that the fair value of its reporting units dropped below their carrying value. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lthough management believes that the Company's current estimates and assumptions utilized in its qualitative testing are reasonable and supportable, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including its assumptions on the impact and timing related to COVID,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> there can be no assurance that the estimates and assumptions management used for purposes of its qualitative assessment as of June 30, 2022 will prove to be accurate predictions of future performance.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For its long-lived assets and definite-lived intangible assets, the Company reviews for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. As of June 30, 2022, the Company performed a qualitative assessment of its trade names and other intangible assets and determined it was not more likely than not that their carrying value may not be recoverable. During the six months ended June 30, 2021, the Company wrote off a discontinued software development project, resulting in an immaterial impairment charge.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254494576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's long-term debt consists of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, interest of 7.39% and 6.50% at June 30, 2022 and December 31, 2021, respectively</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,396)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Asset-Based Loan, interest of 3.12% and 1.60% at June 30, 2022 and December 31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,848)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(991)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Payable, interest of 2.00% per annum at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,347)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,387)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion - Note Payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion - Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,875&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,347)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,762&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,387)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the current portion of the term loan and the note payable are included in current portion of debt on the condensed consolidated balance sheets. The final installment of the note payable, related to contingent consideration assumed as part of a prior period acquisition, was paid in the first quarter of 2022. The Company has elected to present the debt issuance costs associated with its revolving line-of-credit as an asset, which is included in other non-current assets on the condensed consolidated balance sheets. As a result, the long-term debt in the above table will not agree to long-term debt, net of current portion on the condensed consolidated balance sheets herein.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Late in the second quarter of 2022, the Company made an optional prepayment of $50.0&#160;million on its term loan. The Company was entitled to determine the application of the prepayment, which was applied to all future amortization payments, with the balance applied to the remaining balloon payment in 2027. As of June 30, 2022, the aggregate schedule for maturities of debt are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Secured Asset-Based Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Through Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Term Loan Credit Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 8, 2021, the Company entered into a Term Loan Credit Agreement (Term Loan Agreement) with</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> certain lenders identified therein (collectively, the Lenders) and Wilmington Trust</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, National Association as administrative agent and collateral agent, pursuant to which the Lenders extended to the Company a six-year second lien subordinated term loan in the amount of $100.0&#160;million (term loan). The term loan has an interest rate of one-month London Inter-Bank Offered Rate (LIBOR) plus 5.75% per annum, subject to a 0.75% LIBOR floor. The term loan was used to pay the cash consideration, as well as any costs, fees, and expenses in connection with the WSG acquisition (see Note 4 - Acquisitions), with the remainder used to pay down a  of the asset based credit facility. Fees paid in connection with the Term Loan Agreement have been included as debt issuance costs and as a reduction to the carrying amount of the term loan and are expected to be amortized to interest expense over the term of the Term Loan Agreement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The borrowings under the Term Loan Agreement generally bear interest at a variable rate based on either LIBOR or Base Rate (as defined in the Term Loan Agreement) and are subject to mandatory prepayments of principal payable in quarterly installments, commencing on September 30, 2021, with each installment being in the aggregate principal amount of $0.3 million (subject to adjustment as a result of prepayments) provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. The Term Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum net leverage ratio. The Company was in compliance with this covenant as of June 30, 2022. Obligations under the Term Loan Agreement are secured by substantially all the assets of the borrowers and guarantors under the Term Loan Agreement, subject to customary exceptions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2021, the Company amended its Term Loan Agreement (Term Loan First Amendment), which provided the Company an incremental term loan in an aggregate amount equal to $75.0&#160;million. Additionally, the Term Loan First Amendment increased the aggregate amount of all increases (as defined in the Term Loan Agreement) to be no greater than $115.0&#160;million. The borrowings will be used primarily to fund organic growth. Commencing on December 31, 2021, installments of the mandatory prepayments will be in the aggregate principal amount of $0.4&#160;million. All other terms, conditions, covenants, and pricing of the Term Loan Agreement remain the same. In conjunction with the Term Loan First Amendment, the Company entered into the Term Loan First Amendment to the Intercreditor Agreement, effective as of November 18, 2021, which sets forth the lien priority, relative rights, and other creditors&#8217; rights issues in respect of the collateral lenders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aside from its scheduled payments, on June 23, 2022, the Company made an optional prepayment of $50.0&#160;million to reduce interest costs, and paid a prepayment premium of $0.5&#160;million pursuant to the Term Loan Agreement. As a result of the early prepayment, debt issuance costs of $1.4&#160;million were written off in the three months ended June 30, 2022. The prepayment premium and the write-off of debt issuance costs are included as loss on early extinguishment of debt in the condensed consolidated statements of operations. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term loan is secured by a second-priority security interest in the collateral as defined in the ABL Credit Agreement (Loan Agreement) (as described below), and Wells Fargo Bank, National Association as agent, as amended by the First Amendment, Second Amendment, Third Amendment, Fourth Amendment, and Fifth Amendment to the Loan Agreement (as described below). The lien priority, relative rights, and other creditors&#8217; rights issues in respect of the collateral lenders are set forth in the Intercreditor Agreement, by and among Wells Fargo Bank, National Association, as first lien agent, and Wilmington Trust, National Association, as second lien agent, as amended, restated, amended and restated, supplemented or otherwise modified from time to time in accordance with the terms thereof dated June 8, 2021 (Intercreditor Agreement).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Loan Agreement</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective October 25, 2019, the Company terminated its commitments under its prior senior credit facility entered into in August 2017 and entered into a Loan Agreement, by and among the Company and certain of its domestic subsidiaries, as borrowers or guarantors, Wells Fargo, PNC Bank N.A., as well as other Lenders (as defined) from time to time parties thereto. The Loan Agreement provides for a five-year revolving senior secured asset-based credit facility (ABL) in the aggregate principal amount of up to $120.0&#160;million (as described below), including a sublimit for swing loans up to $15.0&#160;million and a $35.0&#160;million sublimit for standby letters of credit.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2020, the Company amended its Loan Agreement (First Amendment), which increased the current aggregate committed size of the ABL from $120.0&#160;million to $130.0&#160;million. All other terms, conditions, covenants, and pricing of the Loan Agreement remained the same. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2021, the Company amended its Loan Agreement (Second Amendment), which increased the current aggregate committed size of the ABL from $130.0&#160;million to $150.0&#160;million, increased certain borrowing base sub-limits, and decreased both the cash dominion event and financial reporting triggers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 8, 2021, the Company amended its Loan Agreement (Third Amendment), which permits the incurrence of indebtedness and grant of security as set forth in the Loan Agreement and in accordance with the Intercreditor Agreement, and provides mechanics relating to a transition away from LIBOR as a benchmark interest rate to a replacement alternative benchmark rate or mechanism for loans made in U.S. dollars.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 18, 2021, the Company amended its Loan Agreement (Fourth Amendment), whereby the permitted indebtedness (as defined in the Loan Agreement), was increased to $175.0 million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 21, 2022, the Company amended its Loan Agreement (Fifth Amendment), which increased the current aggregate committed size of the ABL from $150.0 million to $300.0 million, extended the credit facility for an additional five years, and increased certain borrowing base sub-limits. In addition, the agreement provides the option for all or a portion of the borrowings to bear interest at a rate based on the Secured Overnight Financing Rate (SOFR) or Base Rate, at the election of the </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">borrowers, plus an applicable margin. The applicable margin will increase 10 basis points due to the credit spread associated with the transition to SOFR.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amendments were treated as modifications of debt and, as a result, the associated fees and costs were included in debt issuance costs and will be amortized ratably over the remaining term of the Loan Agreement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Availability of the ABL commitments is subject to a borrowing base of up to 85% of secured eligible accounts receivable, subject to adjustment at certain quality levels, minus customary reserves and subject to customary adjustments. Revolving loans and letters of credit issued under the Loan Agreement reduce availability under the ABL on a dollar-for-dollar basis. Availability under the ABL will be used for general corporate purposes. At June 30, 2022, borrowing base availability under the ABL was $300.0&#160;million and the Company had $85.0&#160;million of borrowings drawn, as well as $17.5&#160;million of letters of credit outstanding related to workers' compensation and professional liability policies, leaving $197.5&#160;million of excess availability.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the interest rate spreads and fees under the Loan Agreement were based on SOFR plus 1.60% for the revolving portion of the borrowing base. The Base Rate (as defined by the Loan Agreement) margin would have been 0.50%  for the revolving portion</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The SOFR and Base Rate margins are subject to monthly pricing adjustments, pursuant to a pricing matrix based on the Company&#8217;s excess availability under the revolving credit facility. In addition, the facility is subject to an unused line fee, letter of credit fees, and an administrative fee. The unused line fee is 0.375% of the average daily unused portion of the revolving credit facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum fixed charge coverage ratio. The Company was in compliance with this covenant as of June 30, 2022. Obligations under the ABL are secured by substantially all the assets of the borrowers and guarantors, subject to customary exceptions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980256003808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's lease population of its right-of-use asset and lease liabilities is substantially related to the rental of office space. The Company enters into lease agreements as a lessee that may include options to extend or terminate early. Some of these real estate leases require variable payments of property taxes, insurance, and common area maintenance, in addition to base rent. Certain of the leases have provisions for free rent months during the lease term and/or escalating rent payments and, particularly for the Company&#8217;s longer-term leases for its corporate offices, it has received incentives to enter into the leases, such as receiving up to a specified dollar amount to construct tenant improvements. These leases do not include residual value guarantees, covenants, or other restrictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the second quarter of 2020, in connection with the continuing developments from COVID, the Company expedited restructuring plans and either reduced or fully vacated leased office space. The Company is in the process of seeking to sublet some of the space where possible. The Company did not record any lease-related impairment charges for the three months ended June 30, 2022. The decision and change in the use of space resulted in a right-of-use asset impairment charge of $1.5&#160;million for the three months ended March 31, 2022 and $1.7&#160;million for the three months ended June 30, 2021. This loss was determined by comparing the fair value of the impacted right-of-use assets to the carrying value of the assets as of the impairment measurement date. The fair value of the right-of-use assets was based on the estimated sublease income for the space taking into consideration the time period it will take to obtain a subtenant, the applicable discount rate, and the sublease rate. For the three months ended March 31, 2022 and June 30, 2021, the Company wrote off an immaterial amount of leasehold improvements and other property and equipment related to these locations. The measurement of the right-of-use asset impairments, using the assumptions described, is a Level 3 fair value measurement. See Note 10 - Fair Value Measurements for a description of Level 3 inputs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the lease-related assets and liabilities included on the condensed consolidated balance sheets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification on Condensed Consolidated Balance Sheets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - current</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles the undiscounted cash flows for each of, and total of, the remaining years to the operating lease liabilities (which do not include short-term leases) recorded on the condensed consolidated balance sheets as of June 30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:75.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amount of lease payments representing interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,014)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: operating lease liabilities - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,017&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information regarding supplemental cash flows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets acquired under operating lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Included in Condensed Consolidated Statements of Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable and other lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Included in Condensed Consolidated Statements of Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable and other lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense, short-term lease expense, and variable and other lease costs are included in selling, general and administrative expenses, direct operating expenses, and restructuring (benefits) costs in the condensed consolidated statements of operations, depending on the nature of the leased asset. Operating lease expense is reported net of sublease income, which is not material. Variable and other lease costs for the three and six months ended June 30, 2022 include a benefit associated with the early termination of one of the Company's corporate offices which was previously restructured.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the Company does not have any material operating leases which have not yet commenced. The Company has an immaterial</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount of finance lease contracts related to other equipment rentals which are not included in the above disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254926384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy was established which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Quoted prices in active markets for identical assets or liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items Measured at Fair Value on a Recurring Basis:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial assets/liabilities required to be measured on a recurring basis were its: (i) deferred compensation asset included in other non-current assets; and (ii) deferred compensation liability included in other long-term liabilities on its condensed consolidated balance sheets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company utilizes Level 1 inputs to value its deferred compensation assets and liabilities. The Company&#8217;s deferred compensation assets and liabilities are measured using publicly available indices, as per the plan documents.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s financial assets and liabilities measured on a recurring basis is as follows:&#160;</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation asset</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="9" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,457&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items Measured at Fair Value on a Non-Recurring Basis:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's non-financial assets, such as goodwill, trade names, other intangible assets, right-of-use assets, and property and equipment, are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The six months ended June 30, 2022 and 2021 included impairment charges to right-of-use assets along with related property and equipment in connection with leases that were vacated. Accordingly, as of June 30, 2022 and 2021, these assets were recorded at fair value using Level 3 inputs. See Note 9 - Leases for more information about these fair value measurements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Fair Value Disclosures:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financial instruments not measured or recorded at fair value in the condensed consolidated balance sheets consist of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses. The estimated fair value of accounts receivable and accounts payable and&#160;accrued expenses approximate their carrying amount due to the short-term nature of these instruments. Other financial instruments not measured or recorded at fair value include: (i) note payable, (ii) ABL, (iii) term loan, and (iv) and (v) earnout liabilities, as discussed below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(i) The Company paid the third and final installment on its note payable in the first quarter of 2022. Due to its relatively short-term nature, the carrying value of the note payable approximated its fair value. (ii) The carrying amount of the Company's ABL approximates fair value because the interest rates are variable and reflective of market rates. (iii) The estimated fair value of the Company's term loan was calculated applying an interest rate lattice model using Level 2 inputs from available market information. (iv) Potential earnout payments related to the WSG acquisition are contingent upon meeting certain performance requirements based on 2021 through 2023 performance. The Company performed an analysis using multiple forecasted scenarios to determine the fair value of the earnout liability. The earnout liability's carrying amount approximates fair value and is included in current portion of earnout liability and non-current earnout liability on the condensed consolidated balance sheets. (v) Potential earnout payments related to the Selected acquisition were contingent upon meeting certain performance requirements based on 2022 and 2023 revenues. The earnout liability's carrying amount approximates fair value and was included in current portion of earnout liability and non-current earnout liability on the condensed consolidated balance sheets. In the second quarter of 2022, the Company determined that the contingent consideration earnout related to the Selected acquisition would not be achieved for 2022 and 2023 and, as a result, the entire liability was reversed. See Note 4 - Acquisitions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and estimated fair value of the Company&#8217;s significant financial instruments that were not measured at fair value are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Asset-Based Loan</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, net</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,386&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,312&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,845&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout Liability (WSG)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout Liability (Selected)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk:</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See discussion of credit losses and allowance for doubtful accounts in Note 2 - Summary of Significant Accounting Policies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, based on the large number of customers in differing geographic areas, primarily throughout the United States and its territories, the Company believes the concentration of credit risk is limited.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254489440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February 28, 2008, our Board of Directors authorized our most recent stock repurchase program whereby we may purchase up to 1.5&#160;million of our common shares, subject to the terms of our current credit agreements. The shares may be repurchased from time-to-time in the open market and the repurchase program may be discontinued at any time at our discretion. During the six months ended June 30, 2022 and 2021, the Company did not repurchase any shares of its common stock. As of June&#160;30, 2022, the Company has 510,004 shares of common stock under the current share repurchase program available to repurchase, subject to certain conditions in the Company's Loan Agreement and Term Loan Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Payments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2020, the Company's stockholders approved the Cross Country Healthcare, Inc. 2020 Omnibus Incentive Plan (2020 Plan), which replaced the 2017 Omnibus Incentive Plan (2017 Plan), and applies to awards granted after May 19, 2020. The remaining shares available for grant under the 2017 Plan were cancelled and no further awards will be granted under that plan. The 2020 Plan generally mirrors the terms of the 2017 Plan and includes the following provisions: (i) an aggregate share reserve of 3,000,000 shares; (2) annual dollar and share limits of awards granted to employees and consultants, as well as non-employee directors, based on type of award; (3) awards granted generally will be subject to a minimum one-year vesting schedule; and (4) awards may be granted under the 2020 Plan until March 24, 2030.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan and the 2020 Plan (Plans) for the six months ended June&#160;30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Target <br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards, January&#160;1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards, June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,912&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509,884&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock awards granted under the Company&#8217;s Plans entitle the holder to receive, at the end of a vesting period, a specified number of shares of the Company&#8217;s common stock. Share-based compensation expense is measured by the market value of the Company&#8217;s stock on the date of grant. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards granted to non-employee directors under the 2017 Plan, prior to the adoption of the 2020 Plan, vest in three equal installments on the first, second, and third anniversaries of the grant date, while restricted shares granted under the 2020 Plan on and subsequent to June 2020 will vest on the first anniversary of such grant date, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or earlier subject to retirement eligibility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, effective in the three months ended June 30, 2020, the Company implemented modified guidelines that provide for accelerated vesting of restricted stock grants on the last date of service when a retirement-eligible director retires.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Plans, the number of target shares that are issued for performance-based stock awards are determined based on the level of attainment of the targets. During the first quarter of 2022, the Company's Compensation Committee of the Board of Directors approved a 120% level of attainment for the 2019 performance-based share awards, resulting in the issuance of 170,278 performance shares that vested on March 31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three and six months ended June 30, 2022, $2.1 million and $3.7&#160;million, respectively, was included in selling, general and administrative expenses related to share-based payments, and a net of 80,200 and 499,700 shares, respectively, of common stock were issued upon the vesting of restricted and performance stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June 30, 2021, $2.1 million and $3.5&#160;million, respectively, was included in selling, general and administrative expenses related to share-based payments, and a net of 159,025 and 476,630 shares, respectively, of common stock were issued upon the vesting of restricted stock.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254944224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT DATA<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT DATA</a></td>
<td class="text">SEGMENT DATA<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s segments offer services to its customers as described below:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nurse and Allied Staffing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added total talent solutions including: temporary and permanent placement of travel and local nurse and allied professionals, managed services programs (MSP) services, education healthcare services, in-home care services, and outsourcing services. In addition, Nurse and Allied Staffing provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. Its clients include: public and private acute-care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public schools and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and many other healthcare providers throughout the United States.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9679;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Physician Staffing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Physician Staffing provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates performance of each segment primarily based on revenue and contribution income. The Company defines contribution income as income (loss) from operations before depreciation and amortization, acquisition and integration-</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related costs, restructuring (benefits) costs, legal settlement charges, impairment charges, and corporate overhead. The Company does not evaluate, manage, or measure performance of segments using asset information; accordingly, total asset information by segment is not prepared or disclosed. The information in the following table is derived from the segments&#8217; internal financial information as used for corporate management purposes. Certain corporate expenses are not allocated to and/or among the operating segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information on operating segments and a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reconciliation to income from operations for the periods indicated are as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,561&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,827&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,293&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,068&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate overhead </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring (benefits) costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(634)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,837&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,901&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,469&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,895&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Corporate overhead includes unallocated executive leadership and other centralized corporate functional support costs such as finance, IT, legal, human resources, and marketing, as well as public company expenses and corporate-wide projects (initiatives).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254917168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">CONTINGENCIES</a></td>
<td class="text">CONTINGENCIES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in various litigation, claims, investigations, and other proceedings that arise in the ordinary course of its business. These matters primarily relate to employee-related matters that include individual and collective claims, professional liability, tax, and payroll practices. The Company establishes reserves when available information indicates that a loss is probable and an amount or range of loss can be reasonably estimated. These assessments are performed at least quarterly and are based on the information available to management at the time and involve significant management judgment to determine the probability and estimated amount of potential losses, if any. Based on the available information considered in its reviews, the Company adjusts its loss contingency accruals and its disclosures as may be required. Actual outcomes or losses may differ materially from those estimated by the Company's current assessments, including available insurance recoveries, which would impact the Company's profitability. Adverse developments in existing litigation claims or legal proceedings involving the Company or new claims could require management to establish or increase litigation reserves or enter into unfavorable settlements or satisfy judgments for monetary damages for amounts in excess of current reserves, which could adversely affect the Company's financial results. The Company believes the outcome of any outstanding loss contingencies as of June 30, 2022 will not have a material adverse effect on its business, financial condition, results of operations, or cash flows.</span></div>Sales and Other State Non-Income Tax Liabilities The Company's sales and other state non-income tax filings are subject to routine audits by authorities in the jurisdictions where it conducts business in the United States which may result in assessments of additional taxes. The Company accrues sales and other non-income tax liabilities based on the Company's best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company's business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions. The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised. The expense is included in selling, general and administrative expenses in the Company's condensed consolidated statements of operations and the liability is reflected in sales tax payable within other current liabilities in its condensed consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980255043376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and six months ended June 30, 2022, the Company calculated its effective tax rate estimating its annual effective tax rate, as opposed to the three and six months ended June 30, 2021 whereby the Company calculated its effective tax rate based on year-to-date results. The Company&#8217;s effective tax rate for the three and six months ended June 30, 2022 was 28.7% and 28.8%, respectively, including the impact of discrete items, and 28.9% and 29.5%, respectively, excluding discrete items. The Company's effective tax rate for the three and six months ended June 30, 2021 was 22.5% and 12.1%, respectively, including the impact of discrete items, and 9.5% and 6.6%, respectively, excluding discrete items. The effective tax rate for the three and six months ended June 30, 2022 was primarily impacted by federal and state taxes. As a result of the Company's valuation allowance on substantially all of its domestic deferred tax assets, the effective tax rate for the three and six months ended June 30, 2021 was primarily impacted by international taxes, state taxes, and additional valuation allowance required as a result of the WSG acquisition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company concluded that it was more likely than not that a benefit from a substantial portion of its United States federal and state deferred tax assets would be realized and released the majority of its valuation allowance. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022 and December 31, 2021, the Company had an immaterial amount of valuation allowance on its deferred tax assets related to state net operating losses not expected to be realized before expiration.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax years 2012 through 2021 remain open to examination by certain taxing jurisdictions to which the Company is subject to tax.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980256063280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text">RELATED PARTY TRANSACTIONS<div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has entered into an arrangement for digital marketing services provided by a firm that is related to Mr. Clark, the Company's non-executive Chairman of the Board since April 1, 2022, and the Company's Co-Founder &amp; Chief Executive Officer through March 31, 2022. Mr. Clark is a minority shareholder in the firm's parent company and is a member of the parent company's Board of Directors. Management believes the terms of the arrangement are equivalent to those prevailing in an arm's-length transaction and have been approved by the Company through its related party process. The digital marketing firm manages a limited number of digital publishers covering various Company brands for a monthly management fee. During the three and six months ended June 30, 2022 and 2021, the Company incurred an immaterial amount in expenses. The Company had an immaterial payable balance at June 30, 2022 and December 31, 2021.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides services to entities which are affiliated with certain members of the Company&#8217;s Board of Directors. Management believes the services were conducted on terms equivalent to those prevailing in an arm's-length transaction. Revenue related to these transactions was $0.5&#160;million and $0.9 million, respectively, for the three and six months ended June 30, 2022. Revenue was immaterial for the three and six months ended June 30, 2021. Accounts receivable due from these entities was an immaterial amount at June 30, 2022 and December 31, 2021.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the WSG acquisition on June 8, 2021, the Company continues to rent WSG's headquarters. The Chief Executive Officer and Founder of WSG, and currently a business unit president with the Company, is an agent of the lessor. The lease term is from January 1, 2020 through December 31, 2024. The Company paid an immaterial amount in rent expense for these premises for the three and six months ended June 30, 2022 and the month ended June 30, 2021. The Company had an immaterial payable balance at June 30, 2022 and no payable balance at December 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254905968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING PRONOUNCEMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text">RECENT ACCOUNTING PRONOUNCEMENTS<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities such as deferred revenue acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Generally, this amendment will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically such amounts were recognized by the acquirer at fair value in acquisition accounting. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The Company is currently in the process of evaluating this standard and expects to adopt this standard in its first quarter of 2023.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980249646640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Nature of Business</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). In the opinion of management, all adjustments necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. All such adjustments consisted of all normal recurring items, including the elimination of all intercompany transactions and balances.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (U.S. GAAP) for interim financial information and with the instructions to Form&#160;10-Q and Article 10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021 included in the 2021 Form 10-K. The December&#160;31, 2021 condensed consolidated balance sheet included herein was derived from the December&#160;31, 2021 audited consolidated balance sheet included in the 2021 Form&#160;10-K.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of Estimates<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Management has assessed various accounting estimates and other matters, including those that require consideration of forecasted financial information, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in context of the unknown future impacts of the global pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> using information that is reasonably available to the Company at the time. Significant estimates and assumptions are used for, but not limited to: (i) the valuation of accounts receivable; (ii) goodwill, trade names, and other intangible assets; (iii) other long-lived assets; (iv) revenue recognition; (v) accruals for health, workers&#8217; compensation, and professional liability claims; (vi) valuation of deferred tax assets; (vii) legal contingencies; and (viii) income taxes. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. As additional information becomes available to the Company, its future assessment of these estimates</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including management's expectations at the time regarding the duration, scope, and severity of the pandemic, as well as other factors,</span> could materially and adversely impact the Company's consolidated financial statements in future reporting periods. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable, net</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The timing of revenue recognition, billings, and collections results in billed and unbilled accounts receivable from customers, which are classified as accounts receivable on the condensed consolidated balance sheets and are presented net of allowances for doubtful accounts and sales allowances. Estimated revenue for the Company employees', subcontracted employees', and independent contractors&#8217; time worked but not yet billed at June 30, 2022 and December 31, 2021 totaled $217.3&#160;million and $140.0&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts is established for losses expected to be incurred on accounts receivable balances. Accounts receivable are written off against the allowance for doubtful accounts when the Company determines amounts are no longer collectible. Judgment is required in the estimation of the allowance and the Company evaluates the collectability of its accounts receivable and contract assets based on a combination of factors. The Company bases its allowance for doubtful account estimates on its historical write-off experience, current conditions, an analysis of the aging of outstanding receivable and customer payment patterns, and specific reserves for customers in adverse condition adjusted for current expectations for the customers or industry. Based on the information currently available, the Company also considered current expectations of future economic condition</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s, including the impact of COVID, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">when estimating its allowance for doubtful accounts.</span></div>In addition to the allowance for doubtful accounts, the Company maintains a sales allowance for billing-related adjustments which may arise in the ordinary course of business and adjustments to the reserve are recorded as contra-revenue. The balance of this allowance as of June 30, 2022 and December 31, 2021 was $1.0&#160;million and $0.8&#160;million, respectively.The Company&#8217;s contract terms typically require payment between 30 to 60 days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's customers are U.S. based healthcare systems with a significant percentage in acute-care facilities.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Restructuring (Benefits) Costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring (Benefits) Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring (benefits) costs on the condensed consolidated statements of operations primarily include employee termination costs and lease-related exit costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Accounting Pronouncement</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 28, 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities such as deferred revenue acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Generally, this amendment will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically such amounts were recognized by the acquirer at fair value in acquisition accounting. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The Company is currently in the process of evaluating this standard and expects to adopt this standard in its first quarter of 2023.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254749136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Schedule of Allowance for Doubtful Accounts</a></td>
<td class="text"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The opening balance of the allowance for doubtful accounts is reconciled to the closing balance for expected credit losses as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,091&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad Debt Expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-Offs, net of Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(426)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,857&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,329&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring and Related Costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliation of the employee termination costs and lease-related exit costs (benefits) beginning and ending liability balance is presented below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:50.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.593%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.742%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Termination</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease-Related</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,620&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Restructuring (benefits) costs in the condensed consolidated statements of operations for the six months ended June 30, 2022 include a benefit of $1.4&#160;million associated with the early termination of one of the Company's corporate offices which was previously restructured. Other costs were immaterial for the six months ended June 30, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254971408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenues from customer contracts are generated from temporary staffing services and other services. Revenue is disaggregated by segment in the following table. Sales and usage-based taxes are excluded from revenue.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.961%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,353&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,264&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,669&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,236&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">  Six Months ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,504,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,486&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,445&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> Six Months ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Segments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary Staffing Services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,096&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629,196&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980255006272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Summary of Fair Value of Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of the assets acquired and liabilities assumed on June 8, 2021:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,361&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability - non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,027&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254818736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.115%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(amounts in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to common stockholders - Basic and Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,894&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,877&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,996&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares - Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of diluted shares:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares - Diluted</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,757&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,203&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,866&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,120&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to common stockholders - Diluted</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.03&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.84&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the share-based awards that could potentially dilute net income per share attributable to common stockholders in the future that were not included in the computation of diluted net income per share attributable to common stockholders because to do so would have been anti-dilutive for the periods presented.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980255322512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Acquired Intangible Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had the following acquired intangible assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.846%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets subject to amortization:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Databases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets not subject to amortization:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names, indefinite-lived</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Annual Amortization Expense</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, estimated annual amortization expense is as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:80.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,863&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Changes in Carrying Amount of Goodwill by Segment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The changes in the carrying amount of goodwill by reportable segment are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.447%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nurse<br/>And Allied<br/>Staffing</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Physician<br/>Staffing</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate goodwill acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,851&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269,874)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,598)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,472)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net of impairment loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes to aggregate goodwill in 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquisition adjustment - Selected </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances as of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate goodwill acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of business</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,889)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269,874)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(310,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net of impairment loss</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,553&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,360&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Represents an adjustment to the fair value of the identifiable net assets acquired, with a corresponding offset to goodwill, made during the measurement period related to the acquisition of Selected. See Note 4 - Acquisitions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980252522768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's long-term debt consists of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Debt Issuance Costs</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, interest of 7.39% and 6.50% at June 30, 2022 and December 31, 2021, respectively</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,499)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,396)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Asset-Based Loan, interest of 3.12% and 1.60% at June 30, 2022 and December 31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,848)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(991)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Payable, interest of 2.00% per annum at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,875&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,347)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,387)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion - Note Payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion - Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,875&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,347)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,762&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,387)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Aggregate Scheduled Maturities of Debt</a></td>
<td class="text">As of June 30, 2022, the aggregate schedule for maturities of debt are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term Loan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Secured Asset-Based Loan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Through Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980255322512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock', window );">Schedule of Supplemental Balance Sheet Information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the lease-related assets and liabilities included on the condensed consolidated balance sheets:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Classification on Condensed Consolidated Balance Sheets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - current</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.853%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles the undiscounted cash flows for each of, and total of, the remaining years to the operating lease liabilities (which do not include short-term leases) recorded on the condensed consolidated balance sheets as of June 30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:75.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December&#160;31:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amount of lease payments representing interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,014)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: operating lease liabilities - current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,017&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Costs</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information regarding supplemental cash flows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,189&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets acquired under operating lease</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Included in Condensed Consolidated Statements of Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable and other lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Included in Condensed Consolidated Statements of Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable and other lease costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_AssetsAndLiabilitiesLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Leases [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_AssetsAndLiabilitiesLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980251852944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis</a></td>
<td class="text">The estimated fair value of the Company&#8217;s financial assets and liabilities measured on a recurring basis is as follows:&#160;<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.412%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.403%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation asset</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="9" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,274&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,457&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and estimated fair value of the Company&#8217;s significant financial instruments that were not measured at fair value are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Level 2)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note Payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Asset-Based Loan</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,200&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan, net</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,875&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,386&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,312&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174,845&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout Liability (WSG)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnout Liability (Selected)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254893472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Restricted Stock Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan and the 2020 Plan (Plans) for the six months ended June&#160;30, 2022:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.741%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Target <br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards, January&#160;1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,877)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards, June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712,912&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509,884&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980253118624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Schedule of Information on Operating Segments and Reconciliation to Income from Operations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information on operating segments and a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reconciliation to income from operations for the periods indicated are as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.057%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from services:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,561&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,827&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542,293&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,068&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and Allied Staffing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician Staffing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate overhead </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and integration-related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring (benefits) costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(634)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,837&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,901&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,469&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,895&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Corporate overhead includes unallocated executive leadership and other centralized corporate functional support costs such as finance, IT, legal, human resources, and marketing, as well as public company expenses and corporate-wide projects (initiatives).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254531680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled contracts receivable</a></td>
<td class="nump">$ 217.3<span></span>
</td>
<td class="nump">$ 140.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SalesAllowanceBillingRelatedAdjustments', window );">Sales allowance, billing-related adjustments</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided', window );">Threshold period, past due for payment of services provided</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided', window );">Threshold period, past due for payment of services provided</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_SalesAllowanceBillingRelatedAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales Allowance, Billing-Related Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_SalesAllowanceBillingRelatedAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold Period, Past Due For Payment Of Services Provided</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55302-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980248782912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning balance</a></td>
<td class="nump">$ 8,091<span></span>
</td>
<td class="nump">$ 6,087<span></span>
</td>
<td class="nump">$ 3,221<span></span>
</td>
<td class="nump">$ 3,416<span></span>
</td>
<td class="nump">$ 6,087<span></span>
</td>
<td class="nump">$ 3,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad Debt Expense</a></td>
<td class="nump">3,192<span></span>
</td>
<td class="nump">2,369<span></span>
</td>
<td class="nump">466<span></span>
</td>
<td class="nump">504<span></span>
</td>
<td class="nump">5,561<span></span>
</td>
<td class="nump">970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-Offs, net of Recoveries</a></td>
<td class="num">(426)<span></span>
</td>
<td class="num">(365)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="num">(699)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending balance</a></td>
<td class="nump">$ 10,857<span></span>
</td>
<td class="nump">$ 8,091<span></span>
</td>
<td class="nump">$ 3,329<span></span>
</td>
<td class="nump">$ 3,221<span></span>
</td>
<td class="nump">$ 10,857<span></span>
</td>
<td class="nump">$ 3,329<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980252260608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restructuring (Benefits) Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to restructuring</a></td>
<td class="num">$ (1,114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 835<span></span>
</td>
<td class="num">$ (634)<span></span>
</td>
<td class="nump">$ 2,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Early termination benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to restructuring</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_PaymentsForRestructuringAndAdjustments', window );">Payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(160)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at end of period</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ccrn_ExitCostsMember', window );">Lease-Related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at beginning of period</a></td>
<td class="nump">2,620<span></span>
</td>
<td class="nump">2,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charged to restructuring</a></td>
<td class="num">(1,379)<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_PaymentsForRestructuringAndAdjustments', window );">Payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(192)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at end of period</a></td>
<td class="nump">$ 1,039<span></span>
</td>
<td class="nump">$ 2,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_PaymentsForRestructuringAndAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Restructuring And Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_PaymentsForRestructuringAndAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ccrn_ExitCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ccrn_ExitCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980247850464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">$ 753,561<span></span>
</td>
<td class="nump">$ 331,827<span></span>
</td>
<td class="nump">$ 1,542,293<span></span>
</td>
<td class="nump">$ 661,068<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ccrn_TemporaryStaffingServicesMember', window );">Temporary Staffing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">733,297<span></span>
</td>
<td class="nump">323,591<span></span>
</td>
<td class="nump">1,504,848<span></span>
</td>
<td class="nump">644,972<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ccrn_OtherServicesMember', window );">Other Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">20,264<span></span>
</td>
<td class="nump">8,236<span></span>
</td>
<td class="nump">37,445<span></span>
</td>
<td class="nump">16,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse And Allied Staffing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">731,443<span></span>
</td>
<td class="nump">316,188<span></span>
</td>
<td class="nump">1,497,023<span></span>
</td>
<td class="nump">629,196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse And Allied Staffing | Temporary Staffing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">712,090<span></span>
</td>
<td class="nump">308,519<span></span>
</td>
<td class="nump">1,461,537<span></span>
</td>
<td class="nump">614,494<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse And Allied Staffing | Other Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">19,353<span></span>
</td>
<td class="nump">7,669<span></span>
</td>
<td class="nump">35,486<span></span>
</td>
<td class="nump">14,702<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">22,118<span></span>
</td>
<td class="nump">15,639<span></span>
</td>
<td class="nump">45,270<span></span>
</td>
<td class="nump">31,872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing | Temporary Staffing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">21,207<span></span>
</td>
<td class="nump">15,072<span></span>
</td>
<td class="nump">43,311<span></span>
</td>
<td class="nump">30,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing | Other Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">$ 911<span></span>
</td>
<td class="nump">$ 567<span></span>
</td>
<td class="nump">$ 1,959<span></span>
</td>
<td class="nump">$ 1,394<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ccrn_TemporaryStaffingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ccrn_TemporaryStaffingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ccrn_OtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ccrn_OtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980247730864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 16, 2021</div></th>
<th class="th"><div>Jun. 08, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119,490<span></span>
</td>
<td class="nump">$ 113,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Current portion of earnout liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Non-current earnout liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember', window );">Selected, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration, gross</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Equity consideration for acquisition, value</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Equity consideration for acquisition (shares)</a></td>
<td class="nump">59,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liabilities</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember', window );">Selected, Inc | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember', window );">Selected, Inc | Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember', window );">Selected, Inc | Databases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember', window );">Workforce Solutions Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Equity consideration for acquisition, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Equity consideration for acquisition (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment', window );">Net working capital adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationContingentConsiderationTerm', window );">Contingent consideration liability, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Current portion of earnout liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Non-current earnout liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember', window );">Workforce Solutions Group, Inc. | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Net Working Capital Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationContingentConsiderationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationContingentConsiderationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980247770432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS - Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 08, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 113,360<span></span>
</td>
<td class="nump">$ 119,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember', window );">Workforce Solutions Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,066<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits', window );">Accrued compensation and benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent', window );">Lease liability - current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent', window );">Lease liability - non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability', window );">Earnout liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,027<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Compensation And Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980248839184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax', window );">Loss on currency fluctuations</a></td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980251966096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to common stockholders - Basic and Diluted - Basic</a></td>
<td class="nump">$ 52,894<span></span>
</td>
<td class="nump">$ 11,548<span></span>
</td>
<td class="nump">$ 114,877<span></span>
</td>
<td class="nump">$ 30,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income attributable to common stockholders - Basic and Diluted - Diluted</a></td>
<td class="nump">$ 52,894<span></span>
</td>
<td class="nump">$ 11,548<span></span>
</td>
<td class="nump">$ 114,877<span></span>
</td>
<td class="nump">$ 30,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares - Basic (shares)</a></td>
<td class="nump">37,471<span></span>
</td>
<td class="nump">36,625<span></span>
</td>
<td class="nump">37,251<span></span>
</td>
<td class="nump">36,404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of diluted shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Share-based awards (shares)</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">578<span></span>
</td>
<td class="nump">615<span></span>
</td>
<td class="nump">716<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares - Diluted (shares)</a></td>
<td class="nump">37,757<span></span>
</td>
<td class="nump">37,203<span></span>
</td>
<td class="nump">37,866<span></span>
</td>
<td class="nump">37,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share attributable to common stockholders - Basic (in dollars per share)</a></td>
<td class="nump">$ 1.41<span></span>
</td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="nump">$ 3.08<span></span>
</td>
<td class="nump">$ 0.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share attributable to common stockholders - Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 3.03<span></span>
</td>
<td class="nump">$ 0.84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980253153472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Anti-dilutive Securities (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ccrn_ShareBasedPaymentAwardsMember', window );">Share-based Payment Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Shares excluded from diluted weighted average shares (shares)</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ccrn_ShareBasedPaymentAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ccrn_ShareBasedPaymentAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980248957680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 83,202<span></span>
</td>
<td class="nump">$ 78,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">40,339<span></span>
</td>
<td class="nump">36,228<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">42,863<span></span>
</td>
<td class="nump">42,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Intangible assets not subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Trade names, indefinite-lived</a></td>
<td class="nump">5,900<span></span>
</td>
<td class="nump">5,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember', window );">Databases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">33,430<span></span>
</td>
<td class="nump">30,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">20,217<span></span>
</td>
<td class="nump">18,375<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">13,213<span></span>
</td>
<td class="nump">12,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">47,738<span></span>
</td>
<td class="nump">47,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">19,626<span></span>
</td>
<td class="nump">17,581<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">28,112<span></span>
</td>
<td class="nump">30,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">304<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">272<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets subject to amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,515<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DatabasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980253138448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Estimated Annual Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 4,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">8,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">7,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">6,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">5,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">10,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 42,863<span></span>
</td>
<td class="nump">$ 42,344<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite Lived Intangible Asset, Expected Amortization, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980252220384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning balance</a></td>
<td class="nump">$ 439,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning balance</a></td>
<td class="num">(310,472)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, beginning balance</a></td>
<td class="nump">119,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill acquisition adjustment - Selected</a></td>
<td class="num">(6,130)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, ending balance</a></td>
<td class="nump">433,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, ending balance</a></td>
<td class="num">(310,472)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, ending balance</a></td>
<td class="nump">113,360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning balance</a></td>
<td class="nump">9,889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, ending balance</a></td>
<td class="nump">9,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse And Allied Staffing</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning balance</a></td>
<td class="nump">396,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning balance</a></td>
<td class="num">(269,874)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, beginning balance</a></td>
<td class="nump">116,683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill acquisition adjustment - Selected</a></td>
<td class="num">(6,130)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, ending balance</a></td>
<td class="nump">390,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, ending balance</a></td>
<td class="num">(269,874)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, ending balance</a></td>
<td class="nump">110,553<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse And Allied Staffing | Sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning balance</a></td>
<td class="nump">9,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, ending balance</a></td>
<td class="nump">9,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning balance</a></td>
<td class="nump">43,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, beginning balance</a></td>
<td class="num">(40,598)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, beginning balance</a></td>
<td class="nump">2,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill acquisition adjustment - Selected</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, ending balance</a></td>
<td class="nump">43,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss, ending balance</a></td>
<td class="num">(40,598)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net of impairment loss, ending balance</a></td>
<td class="nump">2,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing | Sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, beginning balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Aggregate goodwill acquired, ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980247820496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 208,875<span></span>
</td>
<td class="nump">$ 185,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs</a></td>
<td class="num">(7,347)<span></span>
</td>
<td class="num">(6,387)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 208,875<span></span>
</td>
<td class="nump">$ 181,762<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term Loan | 2021 Term Loan Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate percentage</a></td>
<td class="nump">7.39%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 123,875<span></span>
</td>
<td class="nump">$ 174,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs</a></td>
<td class="num">(3,499)<span></span>
</td>
<td class="num">(5,396)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Senior Secured Asset-Based Loan | Senior Secured Asset-Based Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate percentage</a></td>
<td class="nump">3.12%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 85,000<span></span>
</td>
<td class="nump">$ 9,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs</a></td>
<td class="num">(3,848)<span></span>
</td>
<td class="num">$ (991)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Note Payable | Earnout Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 2,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,426<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_EarnoutNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_EarnoutNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980247862880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - 2021 Term Loan Credit Agreement Narrative (Details) - Term Loan - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 23, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 08, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Nov. 18, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">2021 Term Loan Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_PaymentForDebtPrepayment', window );">Payment for debt prepayment</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Quarterly installment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Prepayment premium paid</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">2021 Term Loan Credit Agreement | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_DebtInstrumentVariableInterestRateFloor', window );">Interest margin floor percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">2021 Term Loan Credit Agreement, Incremental Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">2021 Term Loan Credit Agreement, Aggregate Amount of All Possible Increases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_DebtInstrumentVariableInterestRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Variable Interest Rate Floor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_DebtInstrumentVariableInterestRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_PaymentForDebtPrepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment For Debt Prepayment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_PaymentForDebtPrepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980247337024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Maturities of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 208,875<span></span>
</td>
<td class="nump">$ 185,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term Loan | 2021 Term Loan Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">123,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">123,875<span></span>
</td>
<td class="nump">174,312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Senior Secured Asset-Based Loan | Senior Secured Asset-Based Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">85,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 85,000<span></span>
</td>
<td class="nump">$ 9,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LongTermDebtMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LongTermDebtMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ccrn_A2021TermLoanCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980249624048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - 2019 Loan Agreement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 21, 2022</div></th>
<th class="th"><div>Oct. 25, 2019</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Nov. 18, 2021</div></th>
<th class="th"><div>Mar. 08, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources', window );">Amount of indebtedness permitted from other sources</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember', window );">Senior Secured Asset-Based Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Line of credit term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="nump">$ 120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">$ 130,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR', window );">Basis spread on variable rate, additional credit spread associated with SOFR</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineOfCreditBorrowingBasePercentageOfAssets', window );">Borrowing base, percentage of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_LineOfCreditFacilityBorrowingBaseAvailability', window );">Borrowing base availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit, carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Borrowing availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Quarterly commitment fee on the average daily unused portion percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember', window );">Senior Secured Asset-Based Loan | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember', window );">Senior Secured Asset-Based Loan | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest margin percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember', window );">Senior Secured Asset-Based Loan | Swingline Sublimit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember', window );">Senior Secured Asset-Based Loan | Standby Letters Of Credit Sublimit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit, Amount Of Indebtedness Permitted By Senior Secured Asset Based Loan To Be Borrowed From Other Sources</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditBorrowingBasePercentageOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit, Borrowing Base, Percentage Of Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditBorrowingBasePercentageOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Basis Spread On Variable Rate, Additional Credit Spread Associated With SOFR</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditFacilityBorrowingBaseAvailability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Borrowing Base Availability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditFacilityBorrowingBaseAvailability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditSublimitAxis=ccrn_SwingLoansSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditSublimitAxis=ccrn_SwingLoansSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_LineOfCreditSublimitAxis=ccrn_StandbyLettersOfCreditSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_LineOfCreditSublimitAxis=ccrn_StandbyLettersOfCreditSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254466112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Leasehold improvements, impairment loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Operating lease, impairment loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980252206880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 5,058<span></span>
</td>
<td class="nump">$ 7,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities - current</a></td>
<td class="nump">4,145<span></span>
</td>
<td class="nump">4,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities - non-current</a></td>
<td class="nump">$ 7,017<span></span>
</td>
<td class="nump">$ 10,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">6.29%<span></span>
</td>
<td class="nump">6.39%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254566976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Operating Lease Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 2,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">5,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">3,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">1,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">12,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: amount of lease payments representing interest</a></td>
<td class="num">(1,014)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of future minimum lease payments</a></td>
<td class="nump">11,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: operating lease liabilities - current</a></td>
<td class="num">(4,145)<span></span>
</td>
<td class="num">$ (4,090)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities - non-current</a></td>
<td class="nump">$ 7,017<span></span>
</td>
<td class="nump">$ 10,853<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980247378192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Lease Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,135<span></span>
</td>
<td class="nump">$ 3,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets acquired under operating lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 645<span></span>
</td>
<td class="nump">$ 938<span></span>
</td>
<td class="nump">1,447<span></span>
</td>
<td class="nump">1,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease expense</a></td>
<td class="nump">1,241<span></span>
</td>
<td class="nump">641<span></span>
</td>
<td class="nump">2,385<span></span>
</td>
<td class="nump">1,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable and other lease costs</a></td>
<td class="num">$ (1,110)<span></span>
</td>
<td class="nump">$ 751<span></span>
</td>
<td class="num">$ (353)<span></span>
</td>
<td class="nump">$ 1,220<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980249688560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis (Details) - Level 1 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=ccrn_DeferredCompensationMember', window );">Deferred compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Deferred compensation liability</a></td>
<td class="nump">$ 2,274<span></span>
</td>
<td class="nump">$ 2,457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=ccrn_DeferredCompensationMember', window );">Deferred compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Deferred compensation asset</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">$ 1,398<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=ccrn_DeferredCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=ccrn_DeferredCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=ccrn_DeferredCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=ccrn_DeferredCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980249545120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 16, 2021</div></th>
<th class="th"><div>Jun. 08, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember', window );">Workforce Solutions Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember', window );">Selected, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Carrying Amount | Workforce Solutions Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liability</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Carrying Amount | Selected, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value | Workforce Solutions Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liability</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value | Selected, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Earnout liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Senior Secured Asset-Based Loan | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditFairValueDisclosure', window );">Senior Secured Asset-Based Loan</a></td>
<td class="nump">85,000<span></span>
</td>
<td class="nump">9,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Senior Secured Asset-Based Loan | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditFairValueDisclosure', window );">Senior Secured Asset-Based Loan</a></td>
<td class="nump">85,000<span></span>
</td>
<td class="nump">9,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Earnout Notes Payable | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Note payable, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Earnout Notes Payable | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Note payable, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Term Loan | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Note payable, fair value</a></td>
<td class="nump">123,875<span></span>
</td>
<td class="nump">174,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Term Loan | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems', window );"><strong>Fair Value, Option, Quantitative Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Note payable, fair value</a></td>
<td class="nump">$ 118,386<span></span>
</td>
<td class="nump">$ 174,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionQuantitativeDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionQuantitativeDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_WorkforceSolutionsGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ccrn_SelectedIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=ccrn_SeniorSecuredAssetBasedLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ccrn_EarnoutNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ccrn_EarnoutNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980249565296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>installment </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 19, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2008 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock repurchase program common stock authorized to be purchased (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Common shares left remaining to repurchase under the plan (up to) (shares)</a></td>
<td class="nump">510,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage', window );">Performance attainment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ccrn_RestrictedStockAndPerformanceSharesMember', window );">Restricted Stock And Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet', window );">Vested in period, net (shares)</a></td>
<td class="nump">80,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">499,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">575,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet', window );">Vested in period, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">476,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation | $</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember', window );">Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for share-based payments (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember', window );">Omnibus Plan | Member of the Board of Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments', window );">Number of vesting installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember', window );">Omnibus Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased and retired (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Target Attainment Level, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other than Options, Vested In Period, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ccrn_RestrictedStockAndPerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ccrn_RestrictedStockAndPerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ccrn_OmnibusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980247854864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Restricted Stock Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, beginning balance (shares)</a></td>
<td class="nump">1,039,455<span></span>
</td>
<td class="nump">1,039,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(575,051)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,117)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, ending balance (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">712,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 9.75<span></span>
</td>
<td class="nump">$ 9.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, ending balance (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, beginning balance (shares)</a></td>
<td class="nump">522,166<span></span>
</td>
<td class="nump">522,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (shares)</a></td>
<td class="num">(170,278)<span></span>
</td>
<td class="num">(170,278)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,877)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested restricted stock awards, ending balance (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 8.64<span></span>
</td>
<td class="nump">$ 8.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested restricted stock awards, ending balance (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.54<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980252005712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT DATA (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">$ 753,561<span></span>
</td>
<td class="nump">$ 331,827<span></span>
</td>
<td class="nump">$ 1,542,293<span></span>
</td>
<td class="nump">$ 661,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard', window );">Contribution income:</a></td>
<td class="nump">98,787<span></span>
</td>
<td class="nump">35,846<span></span>
</td>
<td class="nump">210,653<span></span>
</td>
<td class="nump">74,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_SegmentReportingUnallocatedCorporateExpenses', window );">Corporate overhead</a></td>
<td class="nump">17,583<span></span>
</td>
<td class="nump">14,066<span></span>
</td>
<td class="nump">33,837<span></span>
</td>
<td class="nump">28,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,481<span></span>
</td>
<td class="nump">2,199<span></span>
</td>
<td class="nump">6,200<span></span>
</td>
<td class="nump">4,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_AcquisitionAndIntegrationRelatedCosts', window );">Acquisition and integration-related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">924<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring (benefits) costs</a></td>
<td class="num">(1,114)<span></span>
</td>
<td class="nump">835<span></span>
</td>
<td class="num">(634)<span></span>
</td>
<td class="nump">2,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,921<span></span>
</td>
<td class="nump">1,741<span></span>
</td>
<td class="nump">2,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">78,837<span></span>
</td>
<td class="nump">15,901<span></span>
</td>
<td class="nump">169,469<span></span>
</td>
<td class="nump">36,895<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember', window );">Nurse And Allied Staffing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">731,443<span></span>
</td>
<td class="nump">316,188<span></span>
</td>
<td class="nump">1,497,023<span></span>
</td>
<td class="nump">629,196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard', window );">Contribution income:</a></td>
<td class="nump">97,567<span></span>
</td>
<td class="nump">35,284<span></span>
</td>
<td class="nump">207,668<span></span>
</td>
<td class="nump">72,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember', window );">Physician Staffing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems', window );"><strong>Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from services</a></td>
<td class="nump">22,118<span></span>
</td>
<td class="nump">15,639<span></span>
</td>
<td class="nump">45,270<span></span>
</td>
<td class="nump">31,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard', window );">Contribution income:</a></td>
<td class="nump">$ 1,220<span></span>
</td>
<td class="nump">$ 562<span></span>
</td>
<td class="nump">$ 2,985<span></span>
</td>
<td class="nump">$ 1,990<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_AcquisitionAndIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition and integration-related costs include costs for prior acquisitions, costs incurred for potential transactions, and accretion and valuation adjustments on contingent consideration liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_AcquisitionAndIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Income Loss Before D And A Acquisition And Integration Contingent Consideration Restructuring Legal Impairment And Corporate Overheard</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_SegmentReportingUnallocatedCorporateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Unallocated Corporate Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_SegmentReportingUnallocatedCorporateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_NurseAndAlliedStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ccrn_PhysicianStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980254513600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">28.70%<span></span>
</td>
<td class="nump">22.50%<span></span>
</td>
<td class="nump">28.80%<span></span>
</td>
<td class="nump">12.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems', window );">Effective tax rate, excluding discrete items</a></td>
<td class="nump">28.90%<span></span>
</td>
<td class="nump">9.50%<span></span>
</td>
<td class="nump">29.50%<span></span>
</td>
<td class="nump">6.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate, Continuing Operations, Excluding Discrete Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ccrn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139980248878160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ccrn_HealthCareSystemAffiliatedWithABoardMemberMember', window );">Health Care System Affiliated with a Board Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ccrn_HealthCareSystemAffiliatedWithABoardMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ccrn_HealthCareSystemAffiliatedWithABoardMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>ccrn-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ccrn="http://www.crosscountryhealthcare.com/20220630"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ccrn-20220630.xsd" xlink:type="simple"/>
    <context id="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i226685b20fe64fcdbefcd85507b14d38_I20220721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2022-07-21</instant>
        </period>
    </context>
    <context id="ib8c3eb7e773141eeacba6e9a970bc860_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib1b4fd715e5f4320a19dcfe134293e02_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i531629651f344ec6a65beff4a5deca32_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i449c5e6731f340f7b56a94edc4b9d609_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i14bf0f7b08e64965a1a24ab1083597f2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i46f7ed285cae40089dae6c224378c0dc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i537dd183eaec41c087e74135b134f4bf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if9d2332650c84b7e8d003bddf5a15b05_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i31dcc4001be54470acb6bfeafeab8e86_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8356e77d185d42a595240bb06077cf3b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i206b5bfd38994bada2f7ed528b90c58c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5890a7c02b9f453b81942f2d23ca6ee1_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2818c901fa294008b0ac70a7926b7750_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if5c162997fa542aaaa564c877f405887_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie7ad72ba2a404b11bce5d4ba287b2050_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i500e0f29c7f04d4abc254b61775901d9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3e41c385e2a54c60ac848e6147a19f67_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8f6433f078ee4dd6a65f2bc4bf4d7164_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i604483a0fb4648eead96a92019de1c64_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if7728dd1404d4128a2d0f589c4c7d344_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i760e91ed75f744d1bfb84b6d6b15c919_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i59307db96ef44b038e0df4fa3bf234ea_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i90078daa01da46fa9dc40d6cdc958040_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2224a68f821e43b997df6840a0be749e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i987aabb9817140daad5b016172020182_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i90bd49deece64987b9a9f7ed50a970cd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7fa7d8c493de45b58bafdfed07b02f38_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id0235582b9294676b1724db099df1dbf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifccfe432a49541508ac24bf9eba96187_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3ebafd2e0fb647129b868a2a74277f49_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaf69140622c542a2a5dbade330bed92f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i73fb24814a2c4f2dbce0205fa38c054e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id2ddb987bb1248dfb24dea790e19f923_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1299054e8f31469fb1fada07913bbe8c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i57bb4502177a4191a1ce7b5ac9398fca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaacba8aeb0b5485c8876a3714cb90244_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if7c2dc5236e64eada06aea8f7ef16bc5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d8a1a73be9c419f95a1bb64e4383005_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8e54d79ab9284085bcf0c45bcd9c139a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic34a4d1e4be64eceb08f27f939e04b69_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ia32b475baddb40bb9ed523ad5ff77137_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie2cc9574c5784fdba767ee2f4418cd46_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2f3bea820d5244fd87508196dd2090f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i44e8f4bbd7df49c8b09fc53f08598fee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf4dd3e30f8e4cfc9b12d4d8ae0ab312_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0eeb9206ba354b3889aeee34d83cfee0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8163ebc66fb43e29c1f37f64b2ca55b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i681334a1907145ebba1a62d2883f0d2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25f9ce0742594c3b883c445ec9f65431_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i265e0b6608b74677b7e23b6bf871bc6a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7cf3b0130dbb44d58977a9439465a5c4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i135d7bd16c8c4b9c9ec3f80f3ad82fd8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i901eb837ca884f56bf62787429027b0d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i65d90e4671ee4c59a461a36fb4feb935_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6b1af1a6ef9b4991a2becb162f578c28_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3442c709c0ae4842936f9b013f384d0b_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6f2b21ab37dd434787d065fd619cd08e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i56adbc127d1b4228a9fb7d5d917ebda6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc7b147a6f3c4703ad97384ca78b4e51_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id41486ab11b34eedb4414956313b30ba_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i24f024b630474e2eba6a4f4bcaa226b9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i86e3eb14987b43ce8e00a87a48966e2a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i77211dc7914343a3b578681823086312_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic88b4cd36ee341d99b6656eabb36c7e7_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id2b2bf1c40f44f96806300198d700199_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i37eea076df3941df808a4bb9a9957bf9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ccrn:ExitCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iec98b500e7134221858e7e81d469419a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icd0f16019530428fa69ea61f71c26e30_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibec9a7eb25a8452ab4f07a8f19d5a7ca_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie19fee64a40e4a429338db3ef66cb9e8_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i81d0bf790acc4fbf9d552dc8c5ccd7f8_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0637eaa261ae423fbb4cfefcf4952957_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="icd91226911de469ebcf68a20f0c11784_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i48182d1c2a094a3da085fb747d293f3e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i796e252f03f54d9bab2ef196b1644ea2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i491217535f4143388e3f0a3eb3413c6e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i551d5f3fb9c24cf798e78e30f611b1d0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id9e70abbbf7c43c7911d3bd4476e4fff_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i85c04ae276924053a85cf7f653efd272_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia2898ec216b2457c81230fdf865b2026_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3ccb0817428f4985b0301b681c4ab64a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iee0a4262a80f406a86e3cfc6a645adae_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9ef77dfdd3394746b59eef004634995d_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if1db1376854a41a8923d1dd5d7564232_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i35ea3df9e838469981abd5e5723b5fc5_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i61ed7a3d39b74440a4a96aaf98594c7c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie38297005b1e41d9b478ecea2d5d91e8_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6779ceb8952242a1b84e123a93be0258_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie0d06303bf64411ebac22da90bae8bc6_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="iababccf169c64eb497cc9f14a300ad39_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i19e1810adf8a4e9c8ff08ecbfcd00221_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifa24deb39bf0450eba559976b6616ac0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1d0f582d5c5c480b9e485784c87df1a9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:TemporaryStaffingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if4a09364018146ecb6ada9bb466c7e10_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idda00ec1c753498c8a69045746a652ca_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia2eb18fd6b6844a0907cdf3d269c615b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ccrn:OtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6d6e818748004cac8bd53aeb8e5fcb4a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6936f0dd73f149a284028ca151da158a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i81ed68aa78894c6b82beb72c410707bf_D20211216-20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-16</startDate>
            <endDate>2021-12-16</endDate>
        </period>
    </context>
    <context id="id353cd1c4a224e5ca74c740f0046d0e9_I20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-16</instant>
        </period>
    </context>
    <context id="i60247132b56844b7b090215e36d1bcd5_I20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-16</instant>
        </period>
    </context>
    <context id="i9c13f3c9c6d5496795d1db28f45e48bf_D20211216-20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-16</startDate>
            <endDate>2021-12-16</endDate>
        </period>
    </context>
    <context id="ib3ea81fad99645bf83db89997adc7652_I20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-16</instant>
        </period>
    </context>
    <context id="ibfc8232348364f31b8fab71bfb70b6e5_D20211216-20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-16</startDate>
            <endDate>2021-12-16</endDate>
        </period>
    </context>
    <context id="ic62e27dff65649e6b35f5937f91d27d5_I20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-16</instant>
        </period>
    </context>
    <context id="if26f3065692a439ea180f58828581dab_D20211216-20211216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-16</startDate>
            <endDate>2021-12-16</endDate>
        </period>
    </context>
    <context id="idff5fc97df814ca3a4732c20943377d7_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="id1d9b43633a64c3b89445a5e452d6ea7_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1671691aefa34321882545ccf2019faf_I20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-08</instant>
        </period>
    </context>
    <context id="i2a281909e341489e93181970ce395c4b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia1c9b2c7cc8a4a979b20f24f8720ad94_I20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-08</instant>
        </period>
    </context>
    <context id="ib19a69210f684fa48653b01303c034bf_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="i7a171810dfba45719542dcd325b21e11_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i12dc2febc4c84d4288a4906fe94e7c1b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i10b1ca7fabaa4095b85f6b18a5b65654_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib72123a2c3914fce9452ab74a8a3a3ba_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ccrn:ShareBasedPaymentAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i539c9e6b43fb478fae6799603240e6dc_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i207e780bad744a04ae7391b8036f801f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DatabasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d386cdc5efb4d9582172fa5148def89_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i32f84c71196b460ab5a3ae5a4826c77e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic36e0417ede14c6988b1777707b1f8f9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifca6652933cd479d898cbf242f81426d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieabbbda1a0c74a69bcac845525179f61_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9f1314ae8d2a4bef96916b457d74c9c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia8f0cc98b9f24950a7b4b12b08aefbd3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibc74fefee46742279f8b45d775c187b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i50b7d147bfc6416cabda9cebd8aef26b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04576ab71ad14259b8dde82aaf1a434d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic64dfa83d28e423e96e7ed34d4fd500c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76c278957a754512b8adac480fa3184b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1105535cc021464682c0f1266a44a41f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8742261c00d64b76a788ed6c05a3ad95_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic3e8f0444e0d4d5eb1c366333ffac9d3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie958469fcde64897ae4e65a0e3c3dca4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:NurseAndAlliedStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4278c04c7f5f4845bcc68a5828e1da06_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ccrn:PhysicianStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i09567f48a192498ab1e23194314c8143_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i59183c7b0a0d42569a396d37e5f31cf2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8adc557041bd46c1aad7c9618f831b96_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5a27e7c144ff4f158da5313fe7ca7cf6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e98009a6e864c61960639454ed150b9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifefa74c81dd046a4a182bdbcbbcd35d9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i192f55a490bc4b13a11411bf8375331d_D20220623-20220623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-23</startDate>
            <endDate>2022-06-23</endDate>
        </period>
    </context>
    <context id="i50264a0fdd1a433d9a8447d69f0035fd_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="i68be6e52da804315993d34ceb671e045_I20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-08</instant>
        </period>
    </context>
    <context id="i13740719146d46bfa5f350cbdd53411e_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="ided7cff52c6e4850b72dad17899abe6e_D20210930-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-30</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iab471474c53b443eb54c1499c93e0f21_I20211118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementIncrementalTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-18</instant>
        </period>
    </context>
    <context id="i54b8d8616dab4fadae7e75406657ca20_I20211118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-18</instant>
        </period>
    </context>
    <context id="i5c3977ce54064bf697411bb87b1c135b_D20211231-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i292cd5b0d4684b41981daf8445d9f078_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ccrn:A2021TermLoanCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i15fbcb21001e48dbbc8416ff64ed2806_D20191025-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-25</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="if2408cf0e0744cf0a51dbfcd008b71e2_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i83732e8193cb492394faa19420b680d4_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ccrn:LineOfCreditSublimitAxis">ccrn:SwingLoansSublimitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i3c0d2cadfb0a4cfb9357b9111fdacb7a_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ccrn:LineOfCreditSublimitAxis">ccrn:StandbyLettersOfCreditSublimitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i82b501029b6b4759a00e12cfe8165a29_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if24ce204b488479499da054c091fc827_I20210308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-08</instant>
        </period>
    </context>
    <context id="i522e12765bc4480e83302783fd04656b_I20211118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2021-11-18</instant>
        </period>
    </context>
    <context id="i7f0de89c6ea44abd90a514fbdcf1d0c8_I20220321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-21</instant>
        </period>
    </context>
    <context id="ia26394bf64ed4410939d860acc9b1d9d_D20220321-20220321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-21</startDate>
            <endDate>2022-03-21</endDate>
        </period>
    </context>
    <context id="i217e4a8af4e34fdba46527b4d110ea93_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id1e947347db04c70921aea757a478098_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i79663bc76cf8454ea92834abe34d819f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i744622b84e6e4593840fc16870ce088e_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib11f714337624b81b95fbf29632b3e86_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iec21b6d449de4e3c8935b693d4938157_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ife18debf13894b69a0178110599379d5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib2384a0e875f4fe2ab84ead51c98f914_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">ccrn:DeferredCompensationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia801d6ec97434f77b5185c504d4dd03d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i8757da1f937e4835a03d88e39ffd3134_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if30c1a9abfaa4b8591cc814cac5da11b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia28c4adf56ef473b81222066e0f6bab4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ccrn:EarnoutNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2b289aa8b0f4bb297cf5af62491dd19_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib938672d8ae84dcaaf92e08eb3bd8e91_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i34f90c0620cd48ca9ad8a72c38f6bd27_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd2145204d454b038df9969fda6aba63_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">ccrn:SeniorSecuredAssetBasedLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc259a1981dd4d899a03b46cd1bd6311_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i400cb6bbb3d8415c9ce00409549a9981_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7d0a8e32b5d9415ea6ddc671aea7986c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id739059325464c648e732b5b9492ad1b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib1337e8b15554efd83e0ffd2872603fa_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ide48511e0c344631b47d7e4c4b0171bd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6df7ed8d4d9942dfa095df93b4a7ae83_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie33c5b897ac646ec9c437ba3d4e036bd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:WorkforceSolutionsGroupIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2fbdf4e4242e42b081d7c65a199e7f48_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1d26b10494d9470ca481d6bcf4a4096c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4875239875ba43d69f254dacac91eda3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifca25155201b4bddafc6f616f359148c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ccrn:SelectedIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf0b19c2fa5d44578370990b5584d68a_I20080228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
        </entity>
        <period>
            <instant>2008-02-28</instant>
        </period>
    </context>
    <context id="ie26d32fbbb214db89f00ca5ce7718efc_I20200519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-19</instant>
        </period>
    </context>
    <context id="if3a6eab5e44b46c9aa104ee3b7965107_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if4eba8a27a3045758fc0c06e41d5704b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i956eb0b29bb74ffdb6756b06306769ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ieff115cae5e34e28b5383a9a88245810_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0ab71c9c84ee4815b1628aa855d13c01_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i343cbe120aa04706a172fc551f526ec0_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ccrn:OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i488f7313d7ea4152874fdd22f4842f51_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i45d3569daa544f6ba38c9b4d1d64b515_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie37e701f5bf845919892f1792910aac5_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id12cc7870c3344898d8faa6c6deb3e69_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ccrn:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9a976517796d4a5a90410a85dfa2fcd2_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ccrn:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i272ddda01d4c4d8ab777088cc19278c1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7aac8a7b75f44c50bf673b0750cb5e38_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4d1a96b65b9a4f4cb322a36a20b6c8a2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i88fe5a3577e44e7f93025fcc20ad13e0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i91fdc80f57044a50afa1d6033fa5183f_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1e0108cb028149ccb9de91110e533b39_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i2612021a1b9a4426b3de852fbbf51315_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i48c021a3ed524ae4a24a7c9d9e8eca04_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141103</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ccrn:HealthCareSystemAffiliatedWithABoardMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="installment">
        <measure>ccrn:installment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180L2ZyYWc6Nzg2YjA1YzFiYWRhNGU1YzlhZjUxZjA5MGEzMzgxZDkvdGFibGU6Yzk4N2RjZGU5NDY1NDg3OTlkNGQ2NjVjMjBjYjhiNzIvdGFibGVyYW5nZTpjOTg3ZGNkZTk0NjU0ODc5OWQ0ZDY2NWMyMGNiOGI3Ml8zLTEtMS0xLTM5MzMx_703e5471-e7a2-4857-b5a8-2b8d18a56c02">0001141103</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180L2ZyYWc6Nzg2YjA1YzFiYWRhNGU1YzlhZjUxZjA5MGEzMzgxZDkvdGFibGU6Yzk4N2RjZGU5NDY1NDg3OTlkNGQ2NjVjMjBjYjhiNzIvdGFibGVyYW5nZTpjOTg3ZGNkZTk0NjU0ODc5OWQ0ZDY2NWMyMGNiOGI3Ml80LTEtMS0xLTM5MzMx_4f09dfd4-9b93-4bc3-9417-e318e1407e14">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180L2ZyYWc6Nzg2YjA1YzFiYWRhNGU1YzlhZjUxZjA5MGEzMzgxZDkvdGFibGU6Yzk4N2RjZGU5NDY1NDg3OTlkNGQ2NjVjMjBjYjhiNzIvdGFibGVyYW5nZTpjOTg3ZGNkZTk0NjU0ODc5OWQ0ZDY2NWMyMGNiOGI3Ml81LTEtMS0xLTM5MzMx_1d202324-b3b6-4c2b-8bda-dad8ec2ccc72">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180L2ZyYWc6Nzg2YjA1YzFiYWRhNGU1YzlhZjUxZjA5MGEzMzgxZDkvdGFibGU6Yzk4N2RjZGU5NDY1NDg3OTlkNGQ2NjVjMjBjYjhiNzIvdGFibGVyYW5nZTpjOTg3ZGNkZTk0NjU0ODc5OWQ0ZDY2NWMyMGNiOGI3Ml82LTEtMS0xLTM5MzMx_bee120b2-2d3c-432b-8b08-ab9f66148c99">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180L2ZyYWc6Nzg2YjA1YzFiYWRhNGU1YzlhZjUxZjA5MGEzMzgxZDkvdGFibGU6Yzk4N2RjZGU5NDY1NDg3OTlkNGQ2NjVjMjBjYjhiNzIvdGFibGVyYW5nZTpjOTg3ZGNkZTk0NjU0ODc5OWQ0ZDY2NWMyMGNiOGI3Ml83LTEtMS0xLTM5MzMx_3fa4770d-8ead-4468-b091-78ecb87746a7">false</dei:AmendmentFlag>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0wLTEtMS0zOTMzMQ_33870ac4-7a5d-4666-b864-06e3c6e8fa8f">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0wLTEtMS0zOTMzMQ_4df3da1c-5136-4a23-a756-78c13d836a34">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0wLTEtMS0zOTMzMQ_62909d48-4125-45af-9432-4ba33e5741cc">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0wLTEtMS0zOTMzMQ_eccdff06-1bc8-40b8-9d1b-0325ebbdf6bd">http://fasb.org/us-gaap/2022#ServiceMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <dei:DocumentType
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzk0_5c8b01ef-894f-431b-8e21-0d2a3b3803ce">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzg4_751deaf2-d2e7-475a-811c-0eda1a601c89">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl83Mjc1_b0516099-0455-45bf-b7eb-0bb9220dca7b">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzg5_fe4f7291-e5fc-475b-8fab-13faa22486fc">false</dei:DocumentTransitionReport>
    <dei:EntityRegistrantName
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzc3_9039c7f4-f726-46b7-815f-4e13b57650e5">CROSS COUNTRY HEALTHCARE, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGFibGU6ZDU3NjdlMzM2Nzk2NGFkMDljZDJmYTc5OGE2ZWIwZDcvdGFibGVyYW5nZTpkNTc2N2UzMzY3OTY0YWQwOWNkMmZhNzk4YTZlYjBkN18wLTAtMS0xLTM5MzMx_bd5bdafc-494d-44ec-bd8a-f0e75116f51b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGFibGU6ZDU3NjdlMzM2Nzk2NGFkMDljZDJmYTc5OGE2ZWIwZDcvdGFibGVyYW5nZTpkNTc2N2UzMzY3OTY0YWQwOWNkMmZhNzk4YTZlYjBkN18wLTEtMS0xLTM5MzMx_8033af61-2019-49f2-9f51-a04bf0f89b0f">0-33169</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGFibGU6ZDU3NjdlMzM2Nzk2NGFkMDljZDJmYTc5OGE2ZWIwZDcvdGFibGVyYW5nZTpkNTc2N2UzMzY3OTY0YWQwOWNkMmZhNzk4YTZlYjBkN18wLTItMS0xLTM5MzMx_7a342b46-37de-4faa-a959-e013f5c10b12">13-4066229</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzc4_af9e8899-cbcd-4ab8-9d51-920913f128e9">6551 Park of Commerce Boulevard, N.W.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzkx_965f6029-7a35-4acb-bb50-bfc06721849e">Boca Raton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzcw_4c7ad0f0-0c6e-4f3e-86df-44a4b916a212">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzc5_a5e31428-fede-4890-871e-6f52f8f9ab2c">33487</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzcx_6a1d49a8-da64-4771-89c9-7f71087541d6">561</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzcy_c1a2c3f6-d5d9-4a8a-9fd9-67c8ec8d24e0">998-2232</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGFibGU6NmE4MTQ5OWVjZjRlNDhlMWI0MWI0ZDE3N2I0NGU5OWUvdGFibGVyYW5nZTo2YTgxNDk5ZWNmNGU0OGUxYjQxYjRkMTc3YjQ0ZTk5ZV8xLTAtMS0xLTM5MzMx_4fcca47d-5fbd-4e69-aa9d-048cac5e0717">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGFibGU6NmE4MTQ5OWVjZjRlNDhlMWI0MWI0ZDE3N2I0NGU5OWUvdGFibGVyYW5nZTo2YTgxNDk5ZWNmNGU0OGUxYjQxYjRkMTc3YjQ0ZTk5ZV8xLTEtMS0xLTM5MzMx_d96042ce-68db-4e34-aaa6-d08ce6661674">CCRN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGFibGU6NmE4MTQ5OWVjZjRlNDhlMWI0MWI0ZDE3N2I0NGU5OWUvdGFibGVyYW5nZTo2YTgxNDk5ZWNmNGU0OGUxYjQxYjRkMTc3YjQ0ZTk5ZV8xLTItMS0xLTM5MzMx_74b426da-71c3-432b-9b0f-79429e070b3f">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzgw_9ce1c77d-f1c4-40cf-9e25-4cc4e8ac9a1d">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzcz_393240d4-dfda-4e97-a6da-3b01b1ff6a05">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzc0_387458d4-4fd3-4599-9e39-bf24377f11ee">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzc1_448a9021-ba07-4a30-889b-61f5adc02ad4">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzc2_388da574-3379-4285-980b-77dabff4c926">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl85Mzg2_c8959893-1677-4f37-b5e5-ddd2c1ff0b5f">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i226685b20fe64fcdbefcd85507b14d38_I20220721"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xL2ZyYWc6ZTYzNzFlYzQzOTNhNDg4YmE2NmJjZDQ3NmEyM2Q4NzYvdGV4dHJlZ2lvbjplNjM3MWVjNDM5M2E0ODhiYTY2YmNkNDc2YTIzZDg3Nl8zODQ4MjkwNzA2NjE3_89f7c9d2-b734-4cc3-8c7d-cdba99c446c2"
      unitRef="shares">38231338</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNC0xLTEtMS0zOTMzMQ_a40c6eb2-8708-4909-bcbb-a704de8b79cb"
      unitRef="usd">279000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNC0zLTEtMS0zOTMzMQ_5511d36b-fbb1-41d9-a2ea-46157fbaf97f"
      unitRef="usd">1036000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNS0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOjc2ODQwM2Y2N2I3NTQ2MjA4OTdkZGFkYTU3Y2MwNTA0XzQ3_6837d920-c636-483b-a947-229162750031"
      unitRef="usd">11896000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNS0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOjc2ODQwM2Y2N2I3NTQ2MjA4OTdkZGFkYTU3Y2MwNTA0XzYz_c1a73bb7-5df7-4ca3-9efc-56b7dbd607b0"
      unitRef="usd">6881000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNS0xLTEtMS0zOTMzMQ_0bfe95d3-1982-4e6c-b149-a10b62fb1a13"
      unitRef="usd">701926000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNS0zLTEtMS0zOTMzMQ_4149bd2b-6382-4cd2-9647-5004b1a737fd"
      unitRef="usd">493910000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNi0xLTEtMS0zOTMzMQ_afa6afb1-a286-4a6f-8832-cb3ac56be72c"
      unitRef="usd">6774000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNi0zLTEtMS0zOTMzMQ_d0c68e3b-27a4-4f55-9be5-1ecba3aa4e20"
      unitRef="usd">7648000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:InsuranceSettlementsReceivableCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNy0xLTEtMS0zOTMzMQ_c3df4604-1c8b-4d47-81c7-ee83834c915c"
      unitRef="usd">5750000</us-gaap:InsuranceSettlementsReceivableCurrent>
    <us-gaap:InsuranceSettlementsReceivableCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNy0zLTEtMS0zOTMzMQ_b6961811-85f1-4912-9040-d4813eb12dee"
      unitRef="usd">5041000</us-gaap:InsuranceSettlementsReceivableCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfOC0xLTEtMS0zOTMzMQ_c1f36198-2ef4-40a2-860f-f317144da6ab"
      unitRef="usd">3594000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfOC0zLTEtMS0zOTMzMQ_2a578b55-9842-4c3f-8672-ee578b22ea2e"
      unitRef="usd">638000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfOS0xLTEtMS0zOTMzMQ_6675070a-6bba-4e7f-badc-8424cccee4f6"
      unitRef="usd">718323000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfOS0zLTEtMS0zOTMzMQ_ba8eae15-7b44-46ab-aad7-07d884e575db"
      unitRef="usd">508273000</us-gaap:AssetsCurrent>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTAtMC0xLTEtMzkzMzEvdGV4dHJlZ2lvbjo1MDg1NTM3MTAzNTI0OWFhYjMwMjZkMDI4MzBlYzM0Zl82NA_f770a47c-81c5-44f6-b4e6-ecc392015cac"
      unitRef="usd">19240000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTAtMC0xLTEtMzkzMzEvdGV4dHJlZ2lvbjo1MDg1NTM3MTAzNTI0OWFhYjMwMjZkMDI4MzBlYzM0Zl84MA_57db5e31-8340-4e3b-8306-59d1bfc9b749"
      unitRef="usd">17729000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTAtMS0xLTEtMzkzMzE_cb1160df-f8c4-47c7-bf48-582ef660acdc"
      unitRef="usd">18241000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTAtMy0xLTEtMzkzMzE_2681bbcd-7228-49cb-8248-7173ed6e6a63"
      unitRef="usd">15833000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTEtMS0xLTEtMzkzMzE_1dcd425a-e792-4c5d-a21a-2dd71a73244c"
      unitRef="usd">5058000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTEtMy0xLTEtMzkzMzE_57f9e90d-4bb3-4d8c-a08e-790bb94191e9"
      unitRef="usd">7488000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTItMS0xLTEtMzkzMzE_b6a6d569-3e35-412b-a759-56500943bd33"
      unitRef="usd">113360000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTItMy0xLTEtMzkzMzE_9edbc6eb-5e27-4930-b818-acdde085968e"
      unitRef="usd">119490000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTMtMS0xLTEtMzkzMzE_df3b863d-b03a-4f27-a2de-1bce0952da1f"
      unitRef="usd">5900000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTMtMy0xLTEtMzkzMzE_4a51a2f6-aff8-4839-8b34-2adc508718b0"
      unitRef="usd">5900000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTQtMS0xLTEtMzkzMzE_6cafae18-65ef-48de-8a60-4ee991de64f0"
      unitRef="usd">42863000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTQtMy0xLTEtMzkzMzE_9483b609-937d-4e74-81e6-e08e4308c571"
      unitRef="usd">42344000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTUtMS0xLTEtMzkzMzE_5f62993d-625a-4753-8beb-f21153b715dd"
      unitRef="usd">8096000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTUtMy0xLTEtMzkzMzE_a06d41b6-ab2c-41dd-848e-0acff3b0d0c7"
      unitRef="usd">11525000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTYtMS0xLTEtMzkzMzE_f4852748-bad6-4f49-932d-9fd3e46b7006"
      unitRef="usd">27120000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTYtMy0xLTEtMzkzMzE_ebdf6a6b-110b-46c6-9827-c9274c6b14fa"
      unitRef="usd">21956000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTctMS0xLTEtMzkzMzE_16ffa9eb-08a7-45a9-aaa9-f0d92d16bece"
      unitRef="usd">938961000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMTctMy0xLTEtMzkzMzE_7fd7571b-c81d-430b-b600-6efc9a69e646"
      unitRef="usd">732809000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjEtMS0xLTEtMzkzMzE_4f3a3c96-21a8-4488-b995-6fb7f0e158a5"
      unitRef="usd">189805000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjEtMy0xLTEtMzkzMzE_1b664a42-d485-4269-985b-03cedb9fb748"
      unitRef="usd">109753000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjItMS0xLTEtMzkzMzE_dc0597d6-8758-4c49-828d-f291e04e4e25"
      unitRef="usd">65409000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjItMy0xLTEtMzkzMzE_d660f337-2cf3-43ee-86cf-fd7a661bbd26"
      unitRef="usd">65580000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjMtMS0xLTEtMzkzMzE_30dd5343-b6c6-4511-8b1d-52df3e841b57"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjMtMy0xLTEtMzkzMzE_06aed4a8-6d04-473e-9113-85d54b554c77"
      unitRef="usd">4176000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjQtMS0xLTEtMzkzMzE_4bd34f6d-cdd7-4626-bdaf-697cc50621ef"
      unitRef="usd">4145000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjQtMy0xLTEtMzkzMzE_82eea03f-b543-4034-acd0-7f0a89e67753"
      unitRef="usd">4090000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjUtMS0xLTEtMzkzMzE_5be9121e-462c-408b-bc20-62087752c453"
      unitRef="usd">30000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjUtMy0xLTEtMzkzMzE_71f3c463-d6f2-4827-be77-7d5555f103f2"
      unitRef="usd">7307000</us-gaap:TaxesPayableCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjYtMS0xLTEtMzkzMzE_61be3043-5bc1-4182-bed1-b8f4e1c4a6b9"
      unitRef="usd">7500000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjYtMy0xLTEtMzkzMzE_7ca8ad05-61c7-4e95-9432-3f1e90fb7ab9"
      unitRef="usd">7500000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjctMS0xLTEtMzkzMzE_e6aa699b-966e-4b12-981a-13f2b288161e"
      unitRef="usd">1769000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjctMy0xLTEtMzkzMzE_79b68b59-0973-4a56-8865-6aafce1e4837"
      unitRef="usd">1364000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjgtMS0xLTEtMzkzMzE_e6ea1b5d-4dfb-40da-93d2-d5fae1363ea0"
      unitRef="usd">268658000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjgtMy0xLTEtMzkzMzE_73ecf31d-0a39-4635-a6dd-1a41a595ebbe"
      unitRef="usd">199770000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjktMS0xLTEtMzkzMzE_9f4508b3-21d6-44db-bfda-2d4beada2a70"
      unitRef="usd">205376000</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:OtherLongTermDebtNoncurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMjktMy0xLTEtMzkzMzE_27ff041f-fba4-4bda-b07e-7919b2250bd7"
      unitRef="usd">176366000</us-gaap:OtherLongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzAtMS0xLTEtMzkzMzE_da456a4c-ccf9-44bc-9eb8-448e5496e19d"
      unitRef="usd">7017000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzAtMy0xLTEtMzkzMzE_c5e3a65a-2463-4fc6-b25d-faec24dc4ef1"
      unitRef="usd">10853000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzEtMS0xLTEtMzkzMzE_40a1e0f7-facc-4444-9819-c022feeca91f"
      unitRef="usd">222000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzEtMy0xLTEtMzkzMzE_aaa603d8-a066-4841-8e51-fdbd329699e9"
      unitRef="usd">190000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzItMS0xLTEtMzkzMzE_1c498cc4-c5c9-44cf-aaa8-c38126a7ec19"
      unitRef="usd">26869000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzItMy0xLTEtMzkzMzE_fbecb373-9d65-48f9-a320-c57d79d0946d"
      unitRef="usd">25314000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzMtMS0xLTEtMzkzMzE_8dd593d9-e8dc-4757-a4a5-09a98301898a"
      unitRef="usd">7500000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzMtMy0xLTEtMzkzMzE_a9369df8-2a53-4720-a458-8ead1d5ebc5c"
      unitRef="usd">9000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzQtMS0xLTEtMzkzMzE_e3e786dc-8d4c-4da5-ad0e-0af738fba2a5"
      unitRef="usd">12508000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzQtMy0xLTEtMzkzMzE_673870f1-e063-4776-8d2a-66d329fdd01f"
      unitRef="usd">13788000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzUtMS0xLTEtMzkzMzE_9cf2e555-b7da-4fa3-991e-05022e4d6c0c"
      unitRef="usd">528150000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzUtMy0xLTEtMzkzMzE_ea916977-80bb-45bf-99a5-5341cb9b2ecc"
      unitRef="usd">435281000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzctMS0xLTEtMzkzMzE_dced551a-bc77-4ed3-835a-53f1b9ee9058"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfMzctMy0xLTEtMzkzMzE_a1ee82cb-3d8b-42ae-9a7a-daed8b27442c"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDAtMS0xLTEtMzkzMzE_c3cdde0f-9f2f-4649-bf0e-638430e48181"
      unitRef="usd">4000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDAtMy0xLTEtMzkzMzE_a755849f-b20c-4c0b-81a9-5e3c27d94227"
      unitRef="usd">4000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDEtMS0xLTEtMzkzMzE_338b784e-bf0e-4f4d-bdc7-422bb9de3331"
      unitRef="usd">320000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDEtMy0xLTEtMzkzMzE_93ac8de8-7c8f-47e4-97ce-6ad9672a3c84"
      unitRef="usd">321552000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDItMS0xLTEtMzkzMzE_122a5404-b1b2-4f06-a703-859398cdce5f"
      unitRef="usd">-1335000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDItMy0xLTEtMzkzMzE_14d69348-dcd3-4f56-832e-12faef0813f4"
      unitRef="usd">-1293000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDMtMS0xLTEtMzkzMzE_6ffd61ee-a88a-41c9-a5f0-33cd6da5771d"
      unitRef="usd">92142000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDMtMy0xLTEtMzkzMzE_cd2b3f7c-fbf2-4a99-8eff-b19ae7d2219a"
      unitRef="usd">-22735000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDYtMS0xLTEtMzkzMzE_1d0e6c67-a8c6-4999-9ea5-4adbb38e5ef3"
      unitRef="usd">410811000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDYtMy0xLTEtMzkzMzE_2580ccb4-702c-4a70-bad9-76c9cf48d756"
      unitRef="usd">297528000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDctMS0xLTEtMzkzMzE_a3a96981-0997-4a10-8c50-2c619467fca0"
      unitRef="usd">938961000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18xOS9mcmFnOjE3ODhjNDU2MjMzYjRkMTNiNmQ0Y2UxNDRiZGI0OWExL3RhYmxlOjIxYmEwY2QxNGIyZjRjMGY4OTNiZTYwNzliNTMzMTJkL3RhYmxlcmFuZ2U6MjFiYTBjZDE0YjJmNGMwZjg5M2JlNjA3OWI1MzMxMmRfNDctMy0xLTEtMzkzMzE_5485fe7d-7e67-4c2c-8cad-299640b589e5"
      unitRef="usd">732809000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0xLTEtMS0zOTMzMQ_fd38ba6d-6bed-42bd-aafc-19080a325e3f"
      unitRef="usd">753561000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC0zLTEtMS0zOTMzMQ_b5951de5-be1d-4ea8-a428-5158e7f576a0"
      unitRef="usd">331827000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC01LTEtMS0zOTMzMQ_5a9f7bb0-28ed-42e3-a141-0a4a1efe75fa"
      unitRef="usd">1542293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNC03LTEtMS0zOTMzMQ_a9bb6891-88d9-464b-b3d0-e63c0ea09a7a"
      unitRef="usd">661068000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DirectOperatingCosts
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNi0xLTEtMS0zOTMzMQ_ee13de4f-7363-40e1-a9b7-b4e8a74829c5"
      unitRef="usd">583156000</us-gaap:DirectOperatingCosts>
    <us-gaap:DirectOperatingCosts
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNi0zLTEtMS0zOTMzMQ_2f41e015-1f92-4e98-9ebc-5f5f2ce844ab"
      unitRef="usd">259237000</us-gaap:DirectOperatingCosts>
    <us-gaap:DirectOperatingCosts
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNi01LTEtMS0zOTMzMQ_1a956aae-97de-4599-a6f2-90fad881f1f7"
      unitRef="usd">1197094000</us-gaap:DirectOperatingCosts>
    <us-gaap:DirectOperatingCosts
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNi03LTEtMS0zOTMzMQ_7cdf18c0-23a6-4a97-9698-8e3d6361da7c"
      unitRef="usd">517013000</us-gaap:DirectOperatingCosts>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNy0xLTEtMS0zOTMzMQ_3edb0a26-a78d-434d-ab43-b6c39d53cca1"
      unitRef="usd">86009000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNy0zLTEtMS0zOTMzMQ_ea053cef-ee72-41ad-a4e9-367f9a390643"
      unitRef="usd">50344000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNy01LTEtMS0zOTMzMQ_0e67ada4-b0aa-415b-9d5a-4098c7a55869"
      unitRef="usd">162822000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfNy03LTEtMS0zOTMzMQ_94d08d35-a797-4d18-83b3-b106917cda33"
      unitRef="usd">96671000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOC0xLTEtMS0zOTMzMQ_8b9a27c0-d491-46ce-84de-425c841d2c24"
      unitRef="usd">3192000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOC0zLTEtMS0zOTMzMQ_92115f99-8381-41a8-8ec5-1fdf830f761e"
      unitRef="usd">466000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOC01LTEtMS0zOTMzMQ_5580326d-7d41-4402-bcb6-3dd84ee0a92a"
      unitRef="usd">5561000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOC03LTEtMS0zOTMzMQ_bef60045-5e26-49bc-98ae-e5d582905482"
      unitRef="usd">970000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOS0xLTEtMS0zOTMzMQ_6eb0212c-77d8-47b7-ac9a-1cf34c248531"
      unitRef="usd">3481000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOS0zLTEtMS0zOTMzMQ_aceffee7-5cf7-4355-a014-87bfec052994"
      unitRef="usd">2199000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOS01LTEtMS0zOTMzMQ_0491c614-721b-4d9e-b831-188bfda239bb"
      unitRef="usd">6200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfOS03LTEtMS0zOTMzMQ_6c22ba90-738f-4b03-9c83-13dffa02e58d"
      unitRef="usd">4452000</us-gaap:DepreciationDepletionAndAmortization>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTAtMS0xLTEtMzkzMzE_d37a4aa8-abaa-4371-95dc-8f29e075273c"
      unitRef="usd">0</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTAtMy0xLTEtMzkzMzE_214e6f44-b86c-4c04-ba40-c139bbd44cab"
      unitRef="usd">924000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTAtNS0xLTEtMzkzMzE_477dbcae-e03a-41e4-a52b-ce805622256f"
      unitRef="usd">40000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTAtNy0xLTEtMzkzMzE_55545450-d0c7-4aa6-a401-514f35c323ce"
      unitRef="usd">924000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <us-gaap:RestructuringCharges
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTEtMS0xLTEtMzkzMzE_9175ce51-b181-4810-8655-d92741d874e4"
      unitRef="usd">-1114000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTEtMy0xLTEtMzkzMzE_0170e515-02fd-495e-b48a-ce4bd49d4fa8"
      unitRef="usd">835000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTEtNS0xLTEtMzkzMzE_7e4cd63c-d341-46c6-bd5d-32a44d3a920a"
      unitRef="usd">-634000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTEtNy0xLTEtMzkzMzE_ade835df-4246-4263-b585-23280792c58e"
      unitRef="usd">2073000</us-gaap:RestructuringCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTItMS0xLTEtMzkzMzE_a3a356bb-c330-433c-8548-3f323baa33d6"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTItMy0xLTEtMzkzMzE_d966caa6-50a8-4a9d-9e3d-cad5a8c0645f"
      unitRef="usd">1921000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTItNS0xLTEtMzkzMzE_63fa2c28-dac0-4871-b93d-cc52868ead2c"
      unitRef="usd">1741000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTItNy0xLTEtMzkzMzE_6bee77a2-5262-46e6-8c7c-c01911a8ba47"
      unitRef="usd">2070000</us-gaap:AssetImpairmentCharges>
    <us-gaap:CostsAndExpenses
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTMtMS0xLTEtMzkzMzE_db4f24e4-af8e-44e9-9932-467e46ef2f27"
      unitRef="usd">674724000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTMtMy0xLTEtMzkzMzE_b98857c0-568d-4878-8d1d-3a1ca7277fc1"
      unitRef="usd">315926000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTMtNS0xLTEtMzkzMzE_9cc5a356-93cc-40c5-a0d3-7f02d7d01a8e"
      unitRef="usd">1372824000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTMtNy0xLTEtMzkzMzE_0d6842ea-8728-4d3d-9df6-dad531cf459e"
      unitRef="usd">624173000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTQtMS0xLTEtMzkzMzE_c2e8fe15-194b-47aa-ba11-9f330359fca7"
      unitRef="usd">78837000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTQtMy0xLTEtMzkzMzE_899b89e4-a58a-48f2-a7e8-5e9ef2376d3d"
      unitRef="usd">15901000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTQtNS0xLTEtMzkzMzE_6f952527-c64d-4e3b-85b9-afc687d367fa"
      unitRef="usd">169469000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTQtNy0xLTEtMzkzMzE_e3c43b4c-c5f3-4e76-934d-804e03e14073"
      unitRef="usd">36895000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTYtMS0xLTEtMzkzMzE_dc57b222-2361-45b1-967c-9134b5fcd4b1"
      unitRef="usd">3857000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTYtMy0xLTEtMzkzMzE_99c43d9e-f302-4ed2-9e78-9e2fd80e7533"
      unitRef="usd">1196000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTYtNS0xLTEtMzkzMzE_93574f72-19de-4432-b0fc-d367b7996147"
      unitRef="usd">7378000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTYtNy0xLTEtMzkzMzE_ec2f5b90-9892-4c82-98c9-5ccd43e768f8"
      unitRef="usd">1867000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctMS0xLTEtNDMzNDI_229d7f64-3d8f-4a6e-b748-2537bde47228"
      unitRef="usd">-1912000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctMy0xLTEtNDMzNDU_2e31fcec-4016-4847-bff2-095a5c3e46d2"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctNS0xLTEtNDMzMzY_1095e31b-0929-4190-8532-f6e5f875069e"
      unitRef="usd">-1912000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctNy0xLTEtNDMzMzk_0b6c3318-a77b-4b64-8da4-a902b334d1dd"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctMS0xLTEtMzkzMzE_f5a03e2c-3f3b-48d6-b85b-a175ab0748ab"
      unitRef="usd">1084000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctMy0xLTEtMzkzMzE_296c9495-5a4a-48d9-a472-e80d6a523ee1"
      unitRef="usd">204000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctNS0xLTEtMzkzMzE_41e911f6-d6d9-4722-8bc2-c83ba88dd3c7"
      unitRef="usd">1092000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTctNy0xLTEtMzkzMzE_0031121b-9d75-4604-836f-76d959d78c98"
      unitRef="usd">241000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTgtMS0xLTEtMzkzMzE_fd7d7009-f2b3-411e-8f3f-21d02f79d761"
      unitRef="usd">74152000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTgtMy0xLTEtMzkzMzE_1fc6cc7b-0878-4475-998c-b1b4b4dc6b8c"
      unitRef="usd">14909000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTgtNS0xLTEtMzkzMzE_62f2ff20-22be-4d52-aa31-972851952f57"
      unitRef="usd">161271000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTgtNy0xLTEtMzkzMzE_acdcdd9f-d77d-4a36-b75d-2a2abac90e3d"
      unitRef="usd">35269000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTktMS0xLTEtMzkzMzE_512d3242-8b86-4cb0-a67a-91b669c2d788"
      unitRef="usd">21258000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTktMy0xLTEtMzkzMzE_ef760ebe-ed4b-4c4b-b0d3-7f540f211345"
      unitRef="usd">3361000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTktNS0xLTEtMzkzMzE_d8dfa5ac-7658-44b9-b4eb-230d0ac65fb5"
      unitRef="usd">46394000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMTktNy0xLTEtMzkzMzE_5809e4d6-27b8-4c35-9d1a-ded5179dd44e"
      unitRef="usd">4273000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjItMS0xLTEtMzkzMzE_58460700-ee09-488e-985a-2d56438b6226"
      unitRef="usd">52894000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjItMy0xLTEtMzkzMzE_825ebb46-d1ad-47fe-b1f9-ad58a8cbd9ec"
      unitRef="usd">11548000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjItNS0xLTEtMzkzMzE_4d6a79bc-6ab7-4305-ad94-9f60679ae574"
      unitRef="usd">114877000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjItNy0xLTEtMzkzMzE_6cef8223-8ab3-4e08-a484-db8cbbf0edf6"
      unitRef="usd">30996000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjUtMS0xLTEtMzkzMzE_ee72a1e2-a96d-49f4-8641-eff0f2e9a8c1"
      unitRef="usd">-31000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjUtMy0xLTEtMzkzMzE_ab9315e7-be7b-4ddf-8556-d96abba4f925"
      unitRef="usd">-24000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjUtNS0xLTEtNDA4MDQ_05885003-b2ec-453c-b1a3-0b88e46b01b9"
      unitRef="usd">-42000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjUtNy0xLTEtNDA4MDQ_f5c4fedd-dc84-465b-b8ee-4b9889a5367c"
      unitRef="usd">-30000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjYtMS0xLTEtMzkzMzE_735bff1e-5f71-4f70-b034-5e40fbf7b222"
      unitRef="usd">52863000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjYtMy0xLTEtMzkzMzE_0b352df7-d9f6-4c27-9c8f-774b2de2201d"
      unitRef="usd">11524000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjYtNS0xLTEtNDEzODk_297e8181-71b3-4253-9fbb-ef2d451229b4"
      unitRef="usd">114835000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjYtNy0xLTEtNDEzODk_ec216047-690a-4b9b-bea1-33636208c162"
      unitRef="usd">30966000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjgtMS0xLTEtMzkzMzE_0aa4ac6f-fb28-454d-8919-ba255078212a"
      unitRef="usdPerShare">1.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjgtMy0xLTEtMzkzMzE_eedd0d69-fc6a-4023-b61b-29b8d39a0621"
      unitRef="usdPerShare">0.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjgtNS0xLTEtMzkzMzE_bececd0b-7f50-464c-a4d6-d631878dc19f"
      unitRef="usdPerShare">3.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMjgtNy0xLTEtMzkzMzE_6bcdda43-f2ab-410b-b9b8-f61d17b68ede"
      unitRef="usdPerShare">0.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzAtMS0xLTEtMzkzMzE_0d12d27e-0786-44fb-9758-1f7458cc2700"
      unitRef="usdPerShare">1.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzAtMy0xLTEtMzkzMzE_548c31c6-afeb-4c59-83dd-13509d21da6e"
      unitRef="usdPerShare">0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzAtNS0xLTEtMzkzMzE_754e918d-cb90-45ed-8402-c1feef3393b0"
      unitRef="usdPerShare">3.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzAtNy0xLTEtMzkzMzE_26fb2db1-5067-45d4-a914-e692cf9bd21f"
      unitRef="usdPerShare">0.84</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzMtMS0xLTEtMzkzMzE_59f33e88-f3fb-4cf5-a594-524c85c06411"
      unitRef="shares">37471000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzMtMy0xLTEtMzkzMzE_5c942686-39da-4195-975a-0cf92c7dc2ee"
      unitRef="shares">36625000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzMtNS0xLTEtMzkzMzE_08b457f2-3aa2-45f5-9117-5513f4554893"
      unitRef="shares">37251000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzMtNy0xLTEtMzkzMzE_f8b65cf2-f6de-4326-8bfc-84b779239d65"
      unitRef="shares">36404000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzQtMS0xLTEtMzkzMzE_2a541b50-6307-48a0-8532-cc6f8f25b0ba"
      unitRef="shares">37757000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzQtMy0xLTEtMzkzMzE_9c83ce26-6aa5-460e-955d-71332ae36f61"
      unitRef="shares">37203000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzQtNS0xLTEtMzkzMzE_48b35b07-917f-431a-8317-fdc3033608ae"
      unitRef="shares">37866000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yMi9mcmFnOmQwYzE5YTZhNzdiODQyNWE5YzQzY2E0ZjhiNjFiY2U0L3RhYmxlOjk4NjE1MjQwNTZiNDQwZTNhOWU3YTA4OTczMzgxNzU2L3RhYmxlcmFuZ2U6OTg2MTUyNDA1NmI0NDBlM2E5ZTdhMDg5NzMzODE3NTZfMzQtNy0xLTEtMzkzMzE_3ce7838f-1eb3-47b6-91f3-be5055430fe6"
      unitRef="shares">37120000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i531629651f344ec6a65beff4a5deca32_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi0xLTEtMS0zOTMzMQ_fab4ddbb-f186-4101-838c-84550ca98bf3"
      unitRef="shares">37443000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i531629651f344ec6a65beff4a5deca32_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi0zLTEtMS0zOTMzMQ_69ed3f6d-6fe8-4d37-b873-cbf3e96a2549"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i449c5e6731f340f7b56a94edc4b9d609_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi01LTEtMS0zOTMzMQ_8f1e2515-e1c5-4b77-8a58-9ece1e493962"
      unitRef="usd">318125000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i14bf0f7b08e64965a1a24ab1083597f2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi03LTEtMS0zOTMzMQ_38024879-2a9d-43e6-a921-5a208d0fe036"
      unitRef="usd">-1304000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i46f7ed285cae40089dae6c224378c0dc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi05LTEtMS0zOTMzMQ_58598565-6346-489d-b333-b8e8de7ff5a7"
      unitRef="usd">39248000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i537dd183eaec41c087e74135b134f4bf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi0xMS0xLTEtMzkzMzE_dcadc6c9-8312-4d61-830f-f2f69eda82e5"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if9d2332650c84b7e8d003bddf5a15b05_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMi0xMy0xLTEtMzkzMzE_a9c087b7-5ebe-4b61-adb7-df52e72fc5d0"
      unitRef="usd">356073000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i31dcc4001be54470acb6bfeafeab8e86_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMy0xLTEtMS0zOTMzMQ_2e0adc61-0ec5-429e-97ad-ffb7a0017d15"
      unitRef="shares">80000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8356e77d185d42a595240bb06077cf3b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMy01LTEtMS0zOTMzMQ_3b44f5cb-6cde-456b-87f4-4d94d2171cb9"
      unitRef="usd">-239000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMy0xMy0xLTEtMzkzMzE_71780a54-a126-4307-aa2c-ed625a9ab080"
      unitRef="usd">-239000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8356e77d185d42a595240bb06077cf3b_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfNC01LTEtMS0zOTMzMQ_ce793045-493f-4615-8d71-129bcba4b00b"
      unitRef="usd">2114000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfNC0xMy0xLTEtMzkzMzE_305aec30-8ba3-4f1e-aec6-d7cf2e78e667"
      unitRef="usd">2114000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i206b5bfd38994bada2f7ed528b90c58c_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfNS03LTEtMS0zOTMzMQ_e82464b4-71c7-481b-aff8-eb84905b89f6"
      unitRef="usd">-31000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfNS0xMy0xLTEtMzkzMzE_fedb0df8-a4b6-44e7-ba1e-0402ddc535f7"
      unitRef="usd">-31000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i5890a7c02b9f453b81942f2d23ca6ee1_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOC05LTEtMS0zOTMzMQ_c2a28c88-d7a8-4ad4-a792-2983d3523c76"
      unitRef="usd">52894000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOC0xMy0xLTEtMzkzMzE_64c10ddd-e49f-4ac7-8731-06c42ba4746a"
      unitRef="usd">52894000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i2818c901fa294008b0ac70a7926b7750_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS0xLTEtMS0zOTMzMQ_49a328a8-5ad8-4278-87c1-4e51f75ace89"
      unitRef="shares">37523000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2818c901fa294008b0ac70a7926b7750_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS0zLTEtMS0zOTMzMQ_7b4a7567-2d3a-4e85-931e-8ae3425666d9"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if5c162997fa542aaaa564c877f405887_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS01LTEtMS0zOTMzMQ_2b10ecf2-0fff-459c-b3c1-3d794a6a7215"
      unitRef="usd">320000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie7ad72ba2a404b11bce5d4ba287b2050_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS03LTEtMS0zOTMzMQ_78886692-e0d1-4094-8989-a658652ed737"
      unitRef="usd">-1335000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i500e0f29c7f04d4abc254b61775901d9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS05LTEtMS0zOTMzMQ_2a84489f-ae6b-493d-83e1-c2dad4e95878"
      unitRef="usd">92142000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e41c385e2a54c60ac848e6147a19f67_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS0xMS0xLTEtMzkzMzE_539d5d12-52bf-437c-a2d1-cf7b0d6e6982"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfOS0xMy0xLTEtMzkzMzE_eeaa33d4-2043-4ac6-9053-8c273e9c46f9"
      unitRef="usd">410811000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i8f6433f078ee4dd6a65f2bc4bf4d7164_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtMS0xLTEtMzkzMzE_1d80024f-b911-45cc-8640-91a4b8ec64b1"
      unitRef="shares">36495000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8f6433f078ee4dd6a65f2bc4bf4d7164_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtMy0xLTEtMzkzMzE_58de9f59-782a-46f3-be45-031fcd13d5c6"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i604483a0fb4648eead96a92019de1c64_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtNS0xLTEtMzkzMzE_90a245fe-45b8-4d7f-bd34-b26bf7ff6f03"
      unitRef="usd">309711000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7728dd1404d4128a2d0f589c4c7d344_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtNy0xLTEtMzkzMzE_fbf035ad-ee8b-44bc-8aee-5a132bf29a29"
      unitRef="usd">-1286000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i760e91ed75f744d1bfb84b6d6b15c919_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtOS0xLTEtMzkzMzE_7c30867e-b6ca-48d1-a8c1-3e1ace0c9200"
      unitRef="usd">-135289000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i59307db96ef44b038e0df4fa3bf234ea_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtMTEtMS0xLTM5MzMx_54348d94-ae99-4bdc-86f4-887acbfe6221"
      unitRef="usd">534000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90078daa01da46fa9dc40d6cdc958040_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTMtMTMtMS0xLTM5MzMx_49903a2d-dc12-45b0-9ccb-85ee9d6b6259"
      unitRef="usd">173674000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i2224a68f821e43b997df6840a0be749e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTQtMS0xLTEtMzkzMzE_d34cc94f-f1aa-498f-ad97-716e7875748b"
      unitRef="shares">159000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i987aabb9817140daad5b016172020182_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTQtNS0xLTEtMzkzMzE_c9d7600e-1cdf-44dc-a4b2-284755adf318"
      unitRef="usd">-204000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTQtMTMtMS0xLTM5MzMx_690024e5-0c55-41bf-9f5e-1b4d267032ab"
      unitRef="usd">-204000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i987aabb9817140daad5b016172020182_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTUtNS0xLTEtMzkzMzE_d0a01cb7-190d-470c-bdb2-751a7a7100fb"
      unitRef="usd">2137000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTUtMTMtMS0xLTM5MzMx_300f5c2c-e2f1-49ca-9c3d-3671160c0f7a"
      unitRef="usd">2137000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i90bd49deece64987b9a9f7ed50a970cd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTYtNy0xLTEtMzkzMzE_f1ae9e99-2cf0-47bb-b05a-116b2bd219b2"
      unitRef="usd">-24000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTYtMTMtMS0xLTM5MzMx_c4c67e6c-ed3d-4ae0-bb27-8d0760424a51"
      unitRef="usd">-24000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i2224a68f821e43b997df6840a0be749e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTctMS0xLTEtMzkzMzE_5d260e3e-8f9c-4145-82a4-20a62ff81fda"
      unitRef="shares">308000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i987aabb9817140daad5b016172020182_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTctNS0xLTEtMzkzMzE_611f258c-d960-45aa-bffe-6db7b4f7250a"
      unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTctMTMtMS0xLTM5MzMx_feb56c1e-0043-4256-a3d8-9684b52fdd5f"
      unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:NetIncomeLoss
      contextRef="i7fa7d8c493de45b58bafdfed07b02f38_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTgtOS0xLTEtMzkzMzE_77497417-4ebc-470e-bcf5-ec00cda06efe"
      unitRef="usd">11548000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTgtMTMtMS0xLTM5MzMx_ae87e237-8484-4727-8fa1-9ff9dd8c0789"
      unitRef="usd">11548000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="id0235582b9294676b1724db099df1dbf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktMS0xLTEtMzkzMzE_914c9603-69bd-4018-9a52-5fea6655712c"
      unitRef="shares">36962000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0235582b9294676b1724db099df1dbf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktMy0xLTEtMzkzMzE_5ad106dc-174e-4893-b761-d00b3b6cee82"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifccfe432a49541508ac24bf9eba96187_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktNS0xLTEtMzkzMzE_c13d6ac1-6be3-43fe-a306-e2d678316bfb"
      unitRef="usd">316644000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ebafd2e0fb647129b868a2a74277f49_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktNy0xLTEtMzkzMzE_2ddbcbcf-4ea3-44aa-85fa-087e966bc501"
      unitRef="usd">-1310000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaf69140622c542a2a5dbade330bed92f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktOS0xLTEtMzkzMzE_0cc73def-986e-4d43-b0cb-83ea86cf62ab"
      unitRef="usd">-123741000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73fb24814a2c4f2dbce0205fa38c054e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktMTEtMS0xLTM5MzMx_dec2c686-9d0a-4feb-8c3a-aacc72b9714a"
      unitRef="usd">534000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id2ddb987bb1248dfb24dea790e19f923_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yNS9mcmFnOjRiM2U5OTIzMmQ4OTQzNTVhYWI0M2JjZmMwMDFiOWEwL3RhYmxlOjdjNjRiYTc4YjU5NTRiYjFiNmY3OGY5YjIyYjc0YzdiL3RhYmxlcmFuZ2U6N2M2NGJhNzhiNTk1NGJiMWI2Zjc4ZjliMjJiNzRjN2JfMTktMTMtMS0xLTM5MzMx_aabbec9c-22bf-4937-aafb-e5361d9b3db6"
      unitRef="usd">192131000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i1299054e8f31469fb1fada07913bbe8c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi0xLTEtMS0zOTMzMQ_4623551c-130a-4bc4-b62c-029471001084"
      unitRef="shares">37024000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1299054e8f31469fb1fada07913bbe8c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi0zLTEtMS0zOTMzMQ_fe0a761d-42db-47c8-979e-f38588120201"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i57bb4502177a4191a1ce7b5ac9398fca_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi01LTEtMS0zOTMzMQ_9a8891a6-58d0-46dd-84a0-48133068773a"
      unitRef="usd">321552000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaacba8aeb0b5485c8876a3714cb90244_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi03LTEtMS0zOTMzMQ_d505ea0b-3cfc-48d8-9123-3e8b271ed775"
      unitRef="usd">-1293000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7c2dc5236e64eada06aea8f7ef16bc5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi05LTEtMS0zOTMzMQ_9ca5ddec-9c0d-430b-b69c-e4df83579284"
      unitRef="usd">-22735000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d8a1a73be9c419f95a1bb64e4383005_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi0xMS0xLTEtMzkzMzE_5f53755f-75d5-440b-aa52-5bd1b42dcd9a"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMi0xMy0xLTEtMzkzMzE_c8cc4584-1391-46f1-a2db-7312f7d23d66"
      unitRef="usd">297528000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i8e54d79ab9284085bcf0c45bcd9c139a_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMy0xLTEtMS0zOTMzMQ_038192c5-48b6-4343-bb3e-061bb0867e4b"
      unitRef="shares">499000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic34a4d1e4be64eceb08f27f939e04b69_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMy01LTEtMS0zOTMzMQ_631a813c-3245-4d42-828c-917dd11cd91c"
      unitRef="usd">-5267000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMy0xMy0xLTEtMzkzMzE_22723723-dd8b-49e5-b4f7-7dbcce5b09bf"
      unitRef="usd">-5267000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic34a4d1e4be64eceb08f27f939e04b69_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfNC01LTEtMS0zOTMzMQ_697def5e-60e8-4534-8180-5e64fafeedce"
      unitRef="usd">3715000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfNC0xMy0xLTEtMzkzMzE_aa074ddd-e31a-47a4-8677-f090345f1f75"
      unitRef="usd">3715000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia32b475baddb40bb9ed523ad5ff77137_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfNS03LTEtMS0zOTMzMQ_01c515f5-4afc-4150-b6c8-7d81d949daac"
      unitRef="usd">-42000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfNS0xMy0xLTEtMzkzMzE_15f66352-1593-411b-bc23-7ec75ef03ab4"
      unitRef="usd">-42000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ie2cc9574c5784fdba767ee2f4418cd46_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfOS05LTEtMS0zOTMzMQ_2ff1785b-f314-4ecd-aa70-e70bf3e0e547"
      unitRef="usd">114877000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfOS0xMy0xLTEtMzkzMzE_5f36e1e5-ea86-4002-9a1c-99aee7da525a"
      unitRef="usd">114877000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i2818c901fa294008b0ac70a7926b7750_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtMS0xLTEtMzkzMzE_8725ab1e-5811-435a-b6cc-36ba34066f1f"
      unitRef="shares">37523000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2818c901fa294008b0ac70a7926b7750_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtMy0xLTEtMzkzMzE_b7cb128c-384f-4098-ac48-2fbe31109986"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if5c162997fa542aaaa564c877f405887_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtNS0xLTEtMzkzMzE_7ea0f159-2f77-4659-8625-3bea53ec1ecf"
      unitRef="usd">320000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie7ad72ba2a404b11bce5d4ba287b2050_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtNy0xLTEtMzkzMzE_5f80eead-56e7-4fe2-9f7d-0251456a5d3c"
      unitRef="usd">-1335000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i500e0f29c7f04d4abc254b61775901d9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtOS0xLTEtMzkzMzE_de2939ce-d462-4083-a3a5-8d8c7be75647"
      unitRef="usd">92142000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e41c385e2a54c60ac848e6147a19f67_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtMTEtMS0xLTM5MzMx_6a5afd99-976b-4280-a5c1-fccdeef0817f"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTAtMTMtMS0xLTM5MzMx_1fd5a0da-ac1a-42ce-8329-4128a506abbf"
      unitRef="usd">410811000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i2f3bea820d5244fd87508196dd2090f4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtMS0xLTEtMzkzMzE_5ccfa0b9-bea7-4f1a-836f-7d9bb374b415"
      unitRef="shares">36177000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2f3bea820d5244fd87508196dd2090f4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtMy0xLTEtMzkzMzE_1a870f17-0bd9-49e4-bad4-a51e77ec8c5e"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i44e8f4bbd7df49c8b09fc53f08598fee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtNS0xLTEtMzkzMzE_25d7b0dc-5f29-4bd8-ac7a-9e477cf3c8c1"
      unitRef="usd">310388000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icf4dd3e30f8e4cfc9b12d4d8ae0ab312_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtNy0xLTEtMzkzMzE_472add39-b3e0-40e3-8bba-422bd4e39b14"
      unitRef="usd">-1280000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0eeb9206ba354b3889aeee34d83cfee0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtOS0xLTEtMzkzMzE_28b7f4f2-a0bc-445c-b25f-fa57669b56a5"
      unitRef="usd">-154737000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib8163ebc66fb43e29c1f37f64b2ca55b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtMTEtMS0xLTM5MzMx_8bf51c99-0d7c-464d-ae1c-e0727a50f18d"
      unitRef="usd">534000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i681334a1907145ebba1a62d2883f0d2e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTQtMTMtMS0xLTM5MzMx_12396954-3ebf-4107-964a-53766dc2f283"
      unitRef="usd">154909000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i25f9ce0742594c3b883c445ec9f65431_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTUtMS0xLTEtMzkzMzE_0e3d4067-b4b7-49b7-bfb5-a9dcdf888275"
      unitRef="shares">477000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i265e0b6608b74677b7e23b6bf871bc6a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTUtNS0xLTEtMzkzMzE_c377aed8-2f43-4e1a-ba3d-363a51b5394b"
      unitRef="usd">-2230000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTUtMTMtMS0xLTM5MzMx_4ddb31de-3a21-47dc-8859-9c0f02e36a84"
      unitRef="usd">-2230000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i265e0b6608b74677b7e23b6bf871bc6a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTYtNS0xLTEtMzkzMzE_3f893f8f-609c-4423-b337-e395dc3d1a6c"
      unitRef="usd">3486000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTYtMTMtMS0xLTM5MzMx_94366e59-d485-4618-b06d-698922ea64b8"
      unitRef="usd">3486000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i7cf3b0130dbb44d58977a9439465a5c4_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTctNy0xLTEtMzkzMzE_ddf81694-f8c9-4e37-a838-b59a080a6c14"
      unitRef="usd">-30000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTctMTMtMS0xLTM5MzMx_5a647f9d-5931-4885-8de0-ff55f862ab4a"
      unitRef="usd">-30000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i25f9ce0742594c3b883c445ec9f65431_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTgtMS0xLTEtMzkzMzE_bdd3bc58-0f69-43a7-ad40-fcd2044da2ed"
      unitRef="shares">308000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i265e0b6608b74677b7e23b6bf871bc6a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTgtNS0xLTEtMzkzMzE_9776b218-c128-491f-925b-0f8de9a628fb"
      unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTgtMTMtMS0xLTM5MzMx_d5e75efd-2dac-4d09-9b08-a26043dbfc39"
      unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:NetIncomeLoss
      contextRef="i135d7bd16c8c4b9c9ec3f80f3ad82fd8_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTktOS0xLTEtMzkzMzE_9f6f7058-3a04-4621-9332-754257e709f4"
      unitRef="usd">30996000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMTktMTMtMS0xLTM5MzMx_56456a02-515d-4358-9c62-ed373c087b8d"
      unitRef="usd">30996000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="id0235582b9294676b1724db099df1dbf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtMS0xLTEtMzkzMzE_4ddd2da7-7aa9-4a27-bdf6-344a3d6c84e3"
      unitRef="shares">36962000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0235582b9294676b1724db099df1dbf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtMy0xLTEtMzkzMzE_7a2501e3-fee7-43d5-bc39-5b9e881de092"
      unitRef="usd">4000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifccfe432a49541508ac24bf9eba96187_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtNS0xLTEtMzkzMzE_6cae219b-9f56-4d34-a3ca-390612a5903b"
      unitRef="usd">316644000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ebafd2e0fb647129b868a2a74277f49_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtNy0xLTEtMzkzMzE_7ef5558b-fa9a-4cf2-9a0a-df28e65ce2fc"
      unitRef="usd">-1310000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaf69140622c542a2a5dbade330bed92f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtOS0xLTEtMzkzMzE_b0bb1157-c842-4837-b69e-d7871e2cc761"
      unitRef="usd">-123741000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73fb24814a2c4f2dbce0205fa38c054e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtMTEtMS0xLTM5MzMx_3337b497-a7c7-4890-9ba6-9fce97418374"
      unitRef="usd">534000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id2ddb987bb1248dfb24dea790e19f923_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18yOC9mcmFnOjFmZjI5MWIzMTA2OTQ0YjhiZWVkNjMyYzE5ZDUyNDU3L3RhYmxlOmZkMjliNTRkMGU5YjRjMTBhMGQwZjQ0ZmU4Zjg5NjBkL3RhYmxlcmFuZ2U6ZmQyOWI1NGQwZTliNGMxMGEwZDBmNDRmZThmODk2MGRfMjAtMTMtMS0xLTM5MzMx_3502f672-f34a-4624-88d7-470c372adb4a"
      unitRef="usd">192131000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNC0xLTEtMS0zOTMzMQ_20f35d8a-faed-40e7-be2b-6255969cf674"
      unitRef="usd">114877000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNC0zLTEtMS0zOTMzMQ_e27d42a5-56cc-4660-a9db-544c64179076"
      unitRef="usd">30996000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNi0xLTEtMS0zOTMzMQ_7d364953-c5d7-470b-b9ea-440cfdd32c51"
      unitRef="usd">6200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNi0zLTEtMS0zOTMzMQ_b89598d4-ff83-40e3-b8ca-bf8a574e98b3"
      unitRef="usd">4452000</us-gaap:DepreciationDepletionAndAmortization>
    <ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNy0xLTEtMS0zOTMzMQ_e9d4e874-b6bb-490a-9bf0-a8c0a9101a80"
      unitRef="usd">7213000</ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances>
    <ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNy0zLTEtMS0zOTMzMQ_5414b408-3c0c-40f1-aea4-e1f36a80692c"
      unitRef="usd">1927000</ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfOC0xLTEtMS0zOTMzMQ_69aafc47-ccf7-4f98-a7f3-f6c38f444cc8"
      unitRef="usd">3476000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfOC0zLTEtMS0zOTMzMQ_0dc51452-042b-4440-8e87-84b680ec1b35"
      unitRef="usd">2923000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <ccrn:OperatingLeaseExpenseNonCash
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfOS0xLTEtMS0zOTMzMQ_e6e64c28-e34e-4f1d-aaae-aba7b2351c8d"
      unitRef="usd">1005000</ccrn:OperatingLeaseExpenseNonCash>
    <ccrn:OperatingLeaseExpenseNonCash
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfOS0zLTEtMS0zOTMzMQ_685746c3-af50-421c-a123-5ec5be042548"
      unitRef="usd">1284000</ccrn:OperatingLeaseExpenseNonCash>
    <us-gaap:AssetImpairmentCharges
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTAtMS0xLTEtMzkzMzE_654776a6-4aa9-4557-87f8-9060c39f1979"
      unitRef="usd">1741000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTAtMy0xLTEtMzkzMzE_63f2c9da-6e2a-4a33-9cba-db08e1c1e127"
      unitRef="usd">2070000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTEtMS0xLTEtNDQ0MDQ_2cf13d58-57d4-41eb-ae6f-1ecd94db1df6"
      unitRef="usd">-1912000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTEtMy0xLTEtNDQ0MDQ_beb607d8-d66e-4324-9845-9ec926b5da72"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTEtMS0xLTEtMzkzMzE_a2c1f1b7-9143-4a73-93a0-bee2773769af"
      unitRef="usd">3715000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTEtMy0xLTEtMzkzMzE_ed1414f6-6a1d-4915-ac84-a69b252b0a2f"
      unitRef="usd">3486000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTItMS0xLTEtMzkzMzE_5039fef9-98b8-4c19-8a4f-e1cbbf37293d"
      unitRef="usd">301000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTItMy0xLTEtMzkzMzE_b4bd5660-5f56-4a8c-83e6-d8fd6e81c365"
      unitRef="usd">-772000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTQtMS0xLTEtMzkzMzE_5a3190b5-df52-4691-9904-9595d41d63d9"
      unitRef="usd">215230000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTQtMy0xLTEtMzkzMzE_c9049ca4-9efe-465d-baf6-d4ebadf5d79c"
      unitRef="usd">76274000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTUtMS0xLTEtMzkzMzE_4e3bd0f0-e786-4e7e-8910-a8a808e3b2f6"
      unitRef="usd">424000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTUtMy0xLTEtMzkzMzE_924b5398-8b86-4009-a40f-2f029b8504c7"
      unitRef="usd">64000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTYtMS0xLTEtMzkzMzE_30dba9a7-4e6a-4dfb-af39-3244b41f6bc0"
      unitRef="usd">-9021000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTYtMy0xLTEtMzkzMzE_e1d475ad-2f64-42eb-b995-a611fd44ca9c"
      unitRef="usd">479000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTctMS0xLTEtMzkzMzE_ae890074-b34a-412d-a255-8d91e3cc587f"
      unitRef="usd">78438000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTctMy0xLTEtMzkzMzE_80541cd5-afba-4f57-8afd-038ad4ae7cea"
      unitRef="usd">22014000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <ccrn:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTgtMS0xLTEtMzkzMzE_f808afde-935f-4bf9-9aa0-b216593b0522"
      unitRef="usd">-2674000</ccrn:IncreaseDecreaseInOperatingLeaseLiabilities>
    <ccrn:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTgtMy0xLTEtMzkzMzE_0496a7e6-929a-43f0-8df9-e6a03444f514"
      unitRef="usd">-3365000</ccrn:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTktMS0xLTEtMzkzMzE_3454808a-0aa3-44f9-b5ce-6dea6d92dd1a"
      unitRef="usd">-1824000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMTktMy0xLTEtMzkzMzE_c19b6a5f-c371-4d14-981f-46ac850b41f3"
      unitRef="usd">-122000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjAtMS0xLTEtMzkzMzE_88b69c3a-6d2d-4f66-a24a-fb62de9a3462"
      unitRef="usd">-10897000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjAtMy0xLTEtMzkzMzE_f78e84e5-40df-4c4a-af44-5e50da9c85a3"
      unitRef="usd">-9422000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjMtMS0xLTEtMzkzMzE_86181db0-b919-4eb2-b568-8e53e6f770fc"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjMtMy0xLTEtMzkzMzE_35abe9de-c134-4651-b6a4-f990ad257ce1"
      unitRef="usd">24470000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjQtMS0xLTEtMzkzMzE_d319ac4e-176a-4cf3-86a7-2944601ab3a3"
      unitRef="usd">3848000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjQtMy0xLTEtMzkzMzE_a63bd334-a817-45a9-92e1-24ea0b89ef44"
      unitRef="usd">3002000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjUtMS0xLTEtMzkzMzE_a47dc582-9b7e-4025-95d6-466b559dc1d1"
      unitRef="usd">-3848000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjUtMy0xLTEtMzkzMzE_6d399c6f-6f94-4227-8c42-b43299cd1715"
      unitRef="usd">-27472000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjgtMS0xLTEtMzkzMzE_83383b1e-7312-441b-b250-8e8372032a05"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjgtMy0xLTEtMzkzMzE_c5db7f44-90c6-495e-b169-1ae2b6ee52f9"
      unitRef="usd">100000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjktMS0xLTEtMzkzMzE_b01c2dfc-1bed-49e1-8054-2bee9900ca25"
      unitRef="usd">50438000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMjktMy0xLTEtMzkzMzE_f1b4f9c9-efc2-46e9-8685-c8e8f2037836"
      unitRef="usd">0</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzAtMS0xLTEtMzkzMzE_eee3e5d5-0af1-4ab6-bef2-454a3adfa5d2"
      unitRef="usd">3159000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzAtMy0xLTEtMzkzMzE_a08f88bf-3b42-4bbd-bac4-f5f37db90b2d"
      unitRef="usd">4465000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzEtMS0xLTEtMzkzMzE_8f0eff44-380b-4cd5-81c7-090c544b0ef1"
      unitRef="usd">900112000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzEtMy0xLTEtMzkzMzE_995a96a5-d802-4bc4-a97b-319b33d557a0"
      unitRef="usd">273981000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzItMS0xLTEtMzkzMzE_d2ae7084-1d1c-42ce-9f97-3d4bbf975717"
      unitRef="usd">824312000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzItMy0xLTEtMzkzMzE_bba7dc80-f76e-49f5-94b2-391c8ce19d20"
      unitRef="usd">311400000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzMtMS0xLTEtMzkzMzE_f5c0efe9-93b7-4a6e-bb2a-367a76f93008"
      unitRef="usd">5267000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzMtMy0xLTEtMzkzMzE_6892fa38-60ac-4bc3-acb3-787ec844d70c"
      unitRef="usd">2230000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzQtMS0xLTEtMzkzMzE_dab24e46-27fd-4eaf-a839-452739daef7d"
      unitRef="usd">2426000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzQtMy0xLTEtMzkzMzE_0b64ac09-56c4-44e4-8c30-2732eb35ae90"
      unitRef="usd">2426000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzYtMS0xLTEtMzkzMzE_c7e63469-7302-490b-8116-b1dc7991abc2"
      unitRef="usd">-523000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzYtMy0xLTEtMzkzMzE_db338f20-40d3-4b31-9bcf-705ca2f62e33"
      unitRef="usd">-22000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzctMS0xLTEtMzkzMzE_33aea0fb-9ab3-434e-994a-62e8b96ed5e3"
      unitRef="usd">13987000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzctMy0xLTEtMzkzMzE_29ebfebe-2a75-476b-af6b-b1598eb001c6"
      unitRef="usd">53438000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzktMS0xLTEtMzkzMzE_ef2b004d-6ad2-44ee-90e7-65d5532fab1e"
      unitRef="usd">1000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfMzktMy0xLTEtMzkzMzE_edd74cf7-9e7d-4cf1-80fb-2e4550588a4c"
      unitRef="usd">-17000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNDAtMS0xLTEtMzkzMzE_6c09a055-ceae-4c6c-9140-c8ed6145bb28"
      unitRef="usd">-757000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNDAtMy0xLTEtMzkzMzE_38a20734-c951-48b5-bd8c-bb629892c9f8"
      unitRef="usd">16527000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNDEtMS0xLTEtMzkzMzE_19605f74-df6d-40a1-8750-5ad732eb5745"
      unitRef="usd">1036000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i681334a1907145ebba1a62d2883f0d2e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNDEtMy0xLTEtMzkzMzE_9629476d-0be5-402d-bc45-5be0af5f91ed"
      unitRef="usd">1600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNDItMS0xLTEtMzkzMzE_12c74b4a-352a-4422-835c-88b75932b50f"
      unitRef="usd">279000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id2ddb987bb1248dfb24dea790e19f923_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zMS9mcmFnOjQyNWU1YzM4NzliZjQ4ODJiYjMyZDNkNDdkNDQwNzNjL3RhYmxlOjAzNGM2MDM4MDZmNzQ3ZDk5YjUwZjJlNGI5NmI2MWQ5L3RhYmxlcmFuZ2U6MDM0YzYwMzgwNmY3NDdkOTliNTBmMmU0Yjk2YjYxZDlfNDItMy0xLTEtMzkzMzE_8020b11b-6af5-4e3f-866a-326cd24f0051"
      unitRef="usd">18127000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zNy9mcmFnOmU1MTVjMjg4NDk4YzQ0NGY4ZWU0MDYxOWU4ODY5YjJhL3RleHRyZWdpb246ZTUxNWMyODg0OThjNDQ0ZjhlZTQwNjE5ZTg4NjliMmFfMTY5OA_1fcb363d-2c12-421e-9f2e-597256aba169">ORGANIZATION AND BASIS OF PRESENTATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Business&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). In the opinion of management, all adjustments necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. All such adjustments consisted of all normal recurring items, including the elimination of all intercompany transactions and balances.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (U.S. GAAP) for interim financial information and with the instructions to Form&#160;10-Q and Article 10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021 included in the 2021 Form 10-K. The December&#160;31, 2021 condensed consolidated balance sheet included herein was derived from the December&#160;31, 2021 audited consolidated balance sheet included in the 2021 Form&#160;10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation. See the condensed consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zNy9mcmFnOmU1MTVjMjg4NDk4YzQ0NGY4ZWU0MDYxOWU4ODY5YjJhL3RleHRyZWdpb246ZTUxNWMyODg0OThjNDQ0ZjhlZTQwNjE5ZTg4NjliMmFfMTcwMA_3c200846-89b2-45c5-ae1d-0afe37d8f87d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Business&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements include the accounts of Cross Country Healthcare, Inc. and its direct and indirect wholly-owned subsidiaries (collectively, the Company). In the opinion of management, all adjustments necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. All such adjustments consisted of all normal recurring items, including the elimination of all intercompany transactions and balances.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM18zNy9mcmFnOmU1MTVjMjg4NDk4YzQ0NGY4ZWU0MDYxOWU4ODY5YjJhL3RleHRyZWdpb246ZTUxNWMyODg0OThjNDQ0ZjhlZTQwNjE5ZTg4NjliMmFfMTcwOQ_82ad0bc5-8c0b-42ec-9fa8-d9a52aafded6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (U.S. GAAP) for interim financial information and with the instructions to Form&#160;10-Q and Article 10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These operating results are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021 included in the 2021 Form 10-K. The December&#160;31, 2021 condensed consolidated balance sheet included herein was derived from the December&#160;31, 2021 audited consolidated balance sheet included in the 2021 Form&#160;10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNjc2NA_90bfce6a-1c47-4981-bacb-8153f62322b1">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Management has assessed various accounting estimates and other matters, including those that require consideration of forecasted financial information, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in context of the unknown future impacts of the global pandemic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; using information that is reasonably available to the Company at the time. Significant estimates and assumptions are used for, but not limited to: (i) the valuation of accounts receivable; (ii) goodwill, trade names, and other intangible assets; (iii) other long-lived assets; (iv) revenue recognition; (v) accruals for health, workers&#x2019; compensation, and professional liability claims; (vi) valuation of deferred tax assets; (vii) legal contingencies; and (viii) income taxes. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. As additional information becomes available to the Company, its future assessment of these estimates&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, including management's expectations at the time regarding the duration, scope, and severity of the pandemic, as well as other factors,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; could materially and adversely impact the Company's consolidated financial statements in future reporting periods. Actual results could differ from those estimates.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;COVID&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company prioritizes the mental health and well-being of its employees, especially in response to the COVID pandemic. While operating primarily through a remote workforce, the Company's offices remain open with stringent safety guidelines and procedures in place. Business travel, including visits to healthcare clients, continues to be somewhat limited at the request of the Company's clients who are continuing to cope with the pandemic twenty-four hours a day/seven days a week.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2022, average bill rates were down in the mid-single digits as expected, but volumes were stronger as the Company continued to experience high demand across a wide range of specialties spanning the healthcare continuum. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Investments in people and technology, along with other improvements the Company has made during the pandemic, have allowed it to quickly respond to high demand levels that it is continuing to see across a wide range of specialties, including operating room, emergency room, pediatrics, labor and delivery, and medical and surgical services, not all of which are directly related to COVID needs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Throughout the pandemic, the Company worked collaboratively with clients on adjusting bill rates in order to adapt to the rapidly changing market conditions. One of the Company's core values is to act ethically and responsibly, and it has been especially important during this pandemic to be transparent and build trust with its clients to re-enforce long-lasting relationships as both demand and bill rates increased to unprecedented levels.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable, net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The timing of revenue recognition, billings, and collections results in billed and unbilled accounts receivable from customers, which are classified as accounts receivable on the condensed consolidated balance sheets and are presented net of allowances for doubtful accounts and sales allowances. Estimated revenue for the Company employees', subcontracted employees', and independent contractors&#x2019; time worked but not yet billed at June 30, 2022 and December 31, 2021 totaled $217.3&#160;million and $140.0&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts is established for losses expected to be incurred on accounts receivable balances. Accounts receivable are written off against the allowance for doubtful accounts when the Company determines amounts are no longer collectible. Judgment is required in the estimation of the allowance and the Company evaluates the collectability of its accounts receivable and contract assets based on a combination of factors. The Company bases its allowance for doubtful account estimates on its historical write-off experience, current conditions, an analysis of the aging of outstanding receivable and customer payment patterns, and specific reserves for customers in adverse condition adjusted for current expectations for the customers or industry. Based on the information currently available, the Company also considered current expectations of future economic condition&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s, including the impact of COVID, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;when estimating its allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The opening balance of the allowance for doubtful accounts is reconciled to the closing balance for expected credit losses as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad Debt Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-Offs, net of Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad Debt Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-Offs, net of Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the allowance for doubtful accounts, the Company maintains a sales allowance for billing-related adjustments which may arise in the ordinary course of business and adjustments to the reserve are recorded as contra-revenue. The balance of this allowance as of June 30, 2022 and December 31, 2021 was $1.0&#160;million and $0.8&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s contract terms typically require payment between 30 to 60 days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's customers are U.S. based healthcare systems with a significant percentage in acute-care facilities. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No single customer accounted for more than 10% of the Company&#x2019;s revenue for the three and six months ended June 30, 2022 and 2021, or the accounts receivable balance as of June 30, 2022 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring (Benefits) Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring (benefits) costs on the condensed consolidated statements of operations primarily include employee termination costs and lease-related exit costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliation of the employee termination costs and lease-related exit costs (benefits) beginning and ending liability balance is presented below:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Termination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease-Related&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Restructuring (benefits) costs in the condensed consolidated statements of operations for the six months ended June 30, 2022 include a benefit of $1.4&#160;million associated with the early termination of one of the Company's corporate offices which was previously restructured. Other costs were immaterial for the six months ended June 30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNjc1Mg_afc69d92-fbf1-418a-9b70-039b183d7a58">Use of Estimates&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Management has assessed various accounting estimates and other matters, including those that require consideration of forecasted financial information, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in context of the unknown future impacts of the global pandemic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; using information that is reasonably available to the Company at the time. Significant estimates and assumptions are used for, but not limited to: (i) the valuation of accounts receivable; (ii) goodwill, trade names, and other intangible assets; (iii) other long-lived assets; (iv) revenue recognition; (v) accruals for health, workers&#x2019; compensation, and professional liability claims; (vi) valuation of deferred tax assets; (vii) legal contingencies; and (viii) income taxes. Accrued insurance claims and reserves include estimated settlements from known claims and actuarial estimates for claims incurred but not reported. As additional information becomes available to the Company, its future assessment of these estimates&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, including management's expectations at the time regarding the duration, scope, and severity of the pandemic, as well as other factors,&lt;/span&gt; could materially and adversely impact the Company's consolidated financial statements in future reporting periods. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNjc2Ng_a73428c4-16a8-4b17-9d13-4de673cc1d63">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable, net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The timing of revenue recognition, billings, and collections results in billed and unbilled accounts receivable from customers, which are classified as accounts receivable on the condensed consolidated balance sheets and are presented net of allowances for doubtful accounts and sales allowances. Estimated revenue for the Company employees', subcontracted employees', and independent contractors&#x2019; time worked but not yet billed at June 30, 2022 and December 31, 2021 totaled $217.3&#160;million and $140.0&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally does not require collateral and mitigates its credit risk by performing credit evaluations and monitoring at-risk accounts. The allowance for doubtful accounts is established for losses expected to be incurred on accounts receivable balances. Accounts receivable are written off against the allowance for doubtful accounts when the Company determines amounts are no longer collectible. Judgment is required in the estimation of the allowance and the Company evaluates the collectability of its accounts receivable and contract assets based on a combination of factors. The Company bases its allowance for doubtful account estimates on its historical write-off experience, current conditions, an analysis of the aging of outstanding receivable and customer payment patterns, and specific reserves for customers in adverse condition adjusted for current expectations for the customers or industry. Based on the information currently available, the Company also considered current expectations of future economic condition&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s, including the impact of COVID, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;when estimating its allowance for doubtful accounts.&lt;/span&gt;&lt;/div&gt;In addition to the allowance for doubtful accounts, the Company maintains a sales allowance for billing-related adjustments which may arise in the ordinary course of business and adjustments to the reserve are recorded as contra-revenue. The balance of this allowance as of June 30, 2022 and December 31, 2021 was $1.0&#160;million and $0.8&#160;million, respectively.The Company&#x2019;s contract terms typically require payment between 30 to 60 days from the date of invoice and are considered past due based on the particular negotiated contract terms. The majority of the Company's customers are U.S. based healthcare systems with a significant percentage in acute-care facilities.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:UnbilledContractsReceivable
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfMzU2OQ_9f27ad59-e1b2-4058-975b-26961a8e9473"
      unitRef="usd">217300000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:UnbilledContractsReceivable
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfMzU3Ng_53e801aa-d9e8-4ae3-99a8-6d8b4e312806"
      unitRef="usd">140000000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNjc1Mw_ad248e62-da17-4d86-9914-606eca70418f">&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The opening balance of the allowance for doubtful accounts is reconciled to the closing balance for expected credit losses as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad Debt Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-Offs, net of Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad Debt Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-Offs, net of Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNC0xLTEtMS0zOTMzMQ_8baabf2f-7035-4be0-a7ea-60a1f78feba8"
      unitRef="usd">6087000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i681334a1907145ebba1a62d2883f0d2e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNC0zLTEtMS0zOTMzMQ_98ac80d9-7a18-4838-bfb2-af797f01188b"
      unitRef="usd">3416000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i901eb837ca884f56bf62787429027b0d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNS0xLTEtMS0zOTMzMQ_771f39ad-76bb-4570-ac4f-6191031b1478"
      unitRef="usd">2369000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i65d90e4671ee4c59a461a36fb4feb935_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNS0zLTEtMS0zOTMzMQ_af34c3f2-5800-4fac-ac0e-8b5fe4bb1941"
      unitRef="usd">504000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i901eb837ca884f56bf62787429027b0d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNi0xLTEtMS0zOTMzMQ_aad574eb-5071-4892-aaeb-0b49e243fb2d"
      unitRef="usd">365000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i65d90e4671ee4c59a461a36fb4feb935_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNi0zLTEtMS0zOTMzMQ_da417dc7-a049-4fc6-9821-1f9e781b66f7"
      unitRef="usd">699000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="if9d2332650c84b7e8d003bddf5a15b05_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNy0xLTEtMS0zOTMzMQ_12fbc0ba-8c31-4307-8242-75c3af3154d2"
      unitRef="usd">8091000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i90078daa01da46fa9dc40d6cdc958040_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfNy0zLTEtMS0zOTMzMQ_7c8d1122-30ec-48dc-a751-4ff5ece52028"
      unitRef="usd">3221000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfOC0xLTEtMS0zOTMzMQ_33dce108-7c05-4177-bf79-c34b8c9ad056"
      unitRef="usd">3192000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfOC0zLTEtMS0zOTMzMQ_eb95bddb-0056-48bf-9ee0-7c0213c941b7"
      unitRef="usd">466000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfOS0xLTEtMS0zOTMzMQ_5c5ddee8-8ee0-48bc-a3de-12e2a3ba1f9d"
      unitRef="usd">426000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfOS0zLTEtMS0zOTMzMQ_b3a53504-6fca-4265-9da7-39ddfdb64fc2"
      unitRef="usd">358000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfMTAtMS0xLTEtMzkzMzE_86acff3e-afd9-4a5e-a8b3-c2934c4b58af"
      unitRef="usd">10857000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="id2ddb987bb1248dfb24dea790e19f923_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOmViZGE2MDNiNzljOTQ4YzA5YjA3NDA1NDY3YzMzZGU1L3RhYmxlcmFuZ2U6ZWJkYTYwM2I3OWM5NDhjMDliMDc0MDU0NjdjMzNkZTVfMTAtMy0xLTEtMzkzMzE_1aebc9c4-558b-4ebd-905a-100f08587600"
      unitRef="usd">3329000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <ccrn:SalesAllowanceBillingRelatedAdjustments
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNTE3Ng_65fd63b9-367f-4332-9a38-89bbe6f21219"
      unitRef="usd">1000000</ccrn:SalesAllowanceBillingRelatedAdjustments>
    <ccrn:SalesAllowanceBillingRelatedAdjustments
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNTE4Mw_e7172148-a9b2-4523-8a93-a710e403d9ff"
      unitRef="usd">800000</ccrn:SalesAllowanceBillingRelatedAdjustments>
    <ccrn:ThresholdPeriodPastDueForPaymentOfServicesProvided
      contextRef="i6b1af1a6ef9b4991a2becb162f578c28_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNTI2NQ_e9e0133c-352d-4c89-a53d-8250a1611275">P30D</ccrn:ThresholdPeriodPastDueForPaymentOfServicesProvided>
    <ccrn:ThresholdPeriodPastDueForPaymentOfServicesProvided
      contextRef="i3442c709c0ae4842936f9b013f384d0b_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNTI3MQ_a2da6dca-18e0-4482-a822-1e615bf09f43">P60D</ccrn:ThresholdPeriodPastDueForPaymentOfServicesProvided>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNjc1NA_69167179-18d9-43bf-b4e7-01606bc34640">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restructuring (Benefits) Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers restructuring activities to be programs whereby it fundamentally changes its operations, such as closing and consolidating facilities, reducing headcount, and realigning operations in response to changing market conditions. As a result, restructuring (benefits) costs on the condensed consolidated statements of operations primarily include employee termination costs and lease-related exit costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNjc0OA_b9aa442d-80de-44cb-b2f6-8c88f17b1b7f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliation of the employee termination costs and lease-related exit costs (benefits) beginning and ending liability balance is presented below:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.593%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Termination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease-Related&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Restructuring (benefits) costs in the condensed consolidated statements of operations for the six months ended June 30, 2022 include a benefit of $1.4&#160;million associated with the early termination of one of the Company's corporate offices which was previously restructured. Other costs were immaterial for the six months ended June 30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i6f2b21ab37dd434787d065fd619cd08e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfMy0xLTEtMS0zOTMzMQ_877fe257-4b4b-4157-abee-9dd038155072"
      unitRef="usd">160000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i56adbc127d1b4228a9fb7d5d917ebda6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfMy0zLTEtMS0zOTMzMQ_23e8b5c3-036a-4fad-9601-3b78e76a1e42"
      unitRef="usd">2423000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="icc7b147a6f3c4703ad97384ca78b4e51_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNC0xLTEtMS0zOTMzMQ_a59c4659-8638-4c29-928c-2f74a3c79aba"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id41486ab11b34eedb4414956313b30ba_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNC0zLTEtMS0zOTMzMQ_42111aec-c04c-428e-b388-d743cf6bad31"
      unitRef="usd">389000</us-gaap:RestructuringCharges>
    <ccrn:PaymentsForRestructuringAndAdjustments
      contextRef="icc7b147a6f3c4703ad97384ca78b4e51_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNS0xLTEtMS0zOTMzMQ_0ec0dc29-81fa-4e1c-b742-9ad89340bce2"
      unitRef="usd">160000</ccrn:PaymentsForRestructuringAndAdjustments>
    <ccrn:PaymentsForRestructuringAndAdjustments
      contextRef="id41486ab11b34eedb4414956313b30ba_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNS0zLTEtMS0zOTMzMQ_9b19c65f-2517-4ceb-9e93-7f0726ca1041"
      unitRef="usd">192000</ccrn:PaymentsForRestructuringAndAdjustments>
    <us-gaap:RestructuringReserve
      contextRef="i24f024b630474e2eba6a4f4bcaa226b9_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNi0xLTEtMS0zOTMzMQ_93fa0e08-1183-4289-bd5c-44b83cf747f2"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i86e3eb14987b43ce8e00a87a48966e2a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNi0zLTEtMS0zOTMzMQ_cd58c2e4-1186-4ac9-bd7d-267ccb98f865"
      unitRef="usd">2620000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i77211dc7914343a3b578681823086312_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNy0xLTEtMS0zOTMzMQ_981d5886-19a5-4e7e-b194-fdf94fdcd722"
      unitRef="usd">200000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic88b4cd36ee341d99b6656eabb36c7e7_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfNy0zLTEtMS0zOTMzMQ_3b47f037-9d9e-4115-b227-2f8fe7b518b4"
      unitRef="usd">-1379000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i77211dc7914343a3b578681823086312_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfOC0xLTEtMS0zOTMzMQ_35f6857b-bf45-4d1d-8f31-2c10d0d14f3c"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ic88b4cd36ee341d99b6656eabb36c7e7_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfOC0zLTEtMS0zOTMzMQ_bdc3fe6e-35c7-4c84-be22-5fa0bbd710a0"
      unitRef="usd">202000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="id2b2bf1c40f44f96806300198d700199_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfOS0xLTEtMS0zOTMzMQ_472fea5a-20a6-48cf-ad46-037ed07d9954"
      unitRef="usd">200000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i37eea076df3941df808a4bb9a9957bf9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RhYmxlOjVkM2JlZDRlMzY4YzRiNjE4Y2UwNzA2NmMzM2QzNTExL3RhYmxlcmFuZ2U6NWQzYmVkNGUzNjhjNGI2MThjZTA3MDY2YzMzZDM1MTFfOS0zLTEtMS0zOTMzMQ_37d43bb2-936a-40fa-bb98-339fa0a69cf8"
      unitRef="usd">1039000</us-gaap:RestructuringReserve>
    <us-gaap:BusinessExitCosts1
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180MC9mcmFnOmRhMTIzYTYwMjQyODQ5N2JhNmNhNjJjMTRlNjlmZTVlL3RleHRyZWdpb246ZGExMjNhNjAyNDI4NDk3YmE2Y2E2MmMxNGU2OWZlNWVfNDM5ODA0NjUyMDMzNA_f1eefc3a-fb84-44c7-b466-9de38da0aeb4"
      unitRef="usd">1400000</us-gaap:BusinessExitCosts1>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RleHRyZWdpb246NGMwYjFhYzg2ZGU0NDY2YTkxZmE2OWYxMTE1NjBjYzlfMzk1_12625a81-5736-4eb6-b9f6-1c4bdb28b7e5">REVENUE RECOGNITION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues from customer contracts are generated from temporary staffing services and other services. Revenue is disaggregated by segment in the following table. Sales and usage-based taxes are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;  Six Months ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,461,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,504,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; Six Months ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     &lt;/span&gt;&lt;/div&gt;See Note 12 - Segment Data.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RleHRyZWdpb246NGMwYjFhYzg2ZGU0NDY2YTkxZmE2OWYxMTE1NjBjYzlfMzkx_93131373-f520-49cf-abad-a555bd282f55">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenues from customer contracts are generated from temporary staffing services and other services. Revenue is disaggregated by segment in the following table. Sales and usage-based taxes are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;  Six Months ended June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,461,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,504,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; Six Months ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Segments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary Staffing Services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec98b500e7134221858e7e81d469419a_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMy0xLTEtMS0zOTMzMQ_ca8f0477-7d7f-4080-b29e-a01427c7e2d1"
      unitRef="usd">712090000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd0f16019530428fa69ea61f71c26e30_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMy0zLTEtMS0zOTMzMQ_492e72aa-5305-4371-82b8-54e7c39c3a86"
      unitRef="usd">21207000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibec9a7eb25a8452ab4f07a8f19d5a7ca_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMy03LTEtMS0zOTMzMQ_d41d04e0-9210-492f-87e3-7d90c514639e"
      unitRef="usd">733297000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie19fee64a40e4a429338db3ef66cb9e8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfNC0xLTEtMS0zOTMzMQ_f80e13b0-e863-4d00-adc6-0a5b98b3a9ae"
      unitRef="usd">19353000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81d0bf790acc4fbf9d552dc8c5ccd7f8_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfNC0zLTEtMS0zOTMzMQ_b01ffaea-7c64-4b47-99f6-7de952bd2cf6"
      unitRef="usd">911000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0637eaa261ae423fbb4cfefcf4952957_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfNC03LTEtMS0zOTMzMQ_f62eff6e-97be-477c-811a-a729ce7c0c07"
      unitRef="usd">20264000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd91226911de469ebcf68a20f0c11784_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfNS0xLTEtMS0zOTMzMQ_7f69567a-ee07-4634-a122-2e826134e6d0"
      unitRef="usd">731443000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48182d1c2a094a3da085fb747d293f3e_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfNS0zLTEtMS0zOTMzMQ_d0494636-7982-407a-80c5-e7d6aeaabfc1"
      unitRef="usd">22118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfNS03LTEtMS0zOTMzMQ_920b3af0-cea7-46bc-9bf3-6655cbbd6f79"
      unitRef="usd">753561000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i796e252f03f54d9bab2ef196b1644ea2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTAtMS0xLTEtMzkzMzE_8a3f0f39-17f6-4c9e-b5a0-2f8c0616eeb3"
      unitRef="usd">308519000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i491217535f4143388e3f0a3eb3413c6e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTAtMy0xLTEtMzkzMzE_3cf56379-1d67-4b3c-a1a1-95ae4b61e92d"
      unitRef="usd">15072000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i551d5f3fb9c24cf798e78e30f611b1d0_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTAtNy0xLTEtMzkzMzE_e128ed26-2c18-4235-8edf-90231b69b331"
      unitRef="usd">323591000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9e70abbbf7c43c7911d3bd4476e4fff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTEtMS0xLTEtMzkzMzE_d0dc8a74-8533-46db-a6e9-2cdc1f8aeac2"
      unitRef="usd">7669000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85c04ae276924053a85cf7f653efd272_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTEtMy0xLTEtMzkzMzE_b9e59e25-4fc1-4ace-9be1-151fffff0a12"
      unitRef="usd">567000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2898ec216b2457c81230fdf865b2026_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTEtNy0xLTEtMzkzMzE_f413a34a-a93d-4839-967f-f00ce5fe5530"
      unitRef="usd">8236000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ccb0817428f4985b0301b681c4ab64a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTItMS0xLTEtMzkzMzE_8203bbf6-4d1f-4ce0-af41-c5f49e1382a1"
      unitRef="usd">316188000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee0a4262a80f406a86e3cfc6a645adae_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTItMy0xLTEtMzkzMzE_229c7c0e-2edb-4141-95b6-ffe3831c98a5"
      unitRef="usd">15639000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTItNy0xLTEtMzkzMzE_b981a28b-3d89-4d4b-baab-35f4ebb25a8e"
      unitRef="usd">331827000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ef77dfdd3394746b59eef004634995d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTctMS0xLTEtMzkzMzE_29ff0131-d623-4e11-bcf6-df0b2e691dde"
      unitRef="usd">1461537000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1db1376854a41a8923d1dd5d7564232_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTctMy0xLTEtMzkzMzE_4f0b3047-05c7-4d0b-b959-65fe30f1ed8e"
      unitRef="usd">43311000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35ea3df9e838469981abd5e5723b5fc5_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTctNy0xLTEtMzkzMzE_ca499ebd-12bb-46f9-be43-d938dd393e83"
      unitRef="usd">1504848000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61ed7a3d39b74440a4a96aaf98594c7c_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTgtMS0xLTEtMzkzMzE_74dd22d3-6f4e-41f6-8e4f-b5445a1fdf58"
      unitRef="usd">35486000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie38297005b1e41d9b478ecea2d5d91e8_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTgtMy0xLTEtMzkzMzE_4c95e1c4-9f9e-4ca7-89b3-6e772424c15b"
      unitRef="usd">1959000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6779ceb8952242a1b84e123a93be0258_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTgtNy0xLTEtMzkzMzE_5ccf6e9d-bfbe-4d22-97b1-6cd6dd956069"
      unitRef="usd">37445000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0d06303bf64411ebac22da90bae8bc6_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTktMS0xLTEtMzkzMzE_4001b803-643c-46d8-bd9e-ac0b58b08155"
      unitRef="usd">1497023000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iababccf169c64eb497cc9f14a300ad39_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTktMy0xLTEtMzkzMzE_673213ce-4798-4017-ab6f-800348541f76"
      unitRef="usd">45270000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMTktNy0xLTEtMzkzMzE_caa78af1-4249-4cc3-a4d4-3ebf3c89c5dc"
      unitRef="usd">1542293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19e1810adf8a4e9c8ff08ecbfcd00221_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjQtMS0xLTEtMzkzMzE_72350e23-442a-4cad-a9a3-a907ef603910"
      unitRef="usd">614494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa24deb39bf0450eba559976b6616ac0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjQtMy0xLTEtMzkzMzE_592b6d93-2250-48c3-aae1-8c0f05680c14"
      unitRef="usd">30478000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d0f582d5c5c480b9e485784c87df1a9_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjQtNy0xLTEtMzkzMzE_6c455729-1228-466a-88eb-106238bb490c"
      unitRef="usd">644972000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4a09364018146ecb6ada9bb466c7e10_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjUtMS0xLTEtMzkzMzE_10dc2fc3-11d3-40a7-9c02-25128c8cc56c"
      unitRef="usd">14702000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idda00ec1c753498c8a69045746a652ca_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjUtMy0xLTEtMzkzMzE_62256862-ebdf-457f-8ed2-8ee1f6fa1e09"
      unitRef="usd">1394000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2eb18fd6b6844a0907cdf3d269c615b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjUtNy0xLTEtMzkzMzE_a09fd552-3db4-46f9-85a5-abc6dc67ed2a"
      unitRef="usd">16096000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d6e818748004cac8bd53aeb8e5fcb4a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjYtMS0xLTEtMzkzMzE_0636f75f-3ac1-4db2-b822-c0afac43ef60"
      unitRef="usd">629196000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6936f0dd73f149a284028ca151da158a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjYtMy0xLTEtMzkzMzE_f915736c-f886-47ef-892e-bad61452726f"
      unitRef="usd">31872000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180My9mcmFnOjRjMGIxYWM4NmRlNDQ2NmE5MWZhNjlmMTExNTYwY2M5L3RhYmxlOjIzMDE2OTFmNTI1ZjQyMjU4NzkzNjMwZTBkMGU2NTA1L3RhYmxlcmFuZ2U6MjMwMTY5MWY1MjVmNDIyNTg3OTM2MzBlMGQwZTY1MDVfMjYtNy0xLTEtMzkzMzE_67a3f408-5ea1-4b5c-83d9-e64ca8f62bfe"
      unitRef="usd">661068000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzU3NQ_ffb0035a-be7d-4043-b518-abb199d82ce2">ACQUISITIONS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Selected&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 16, 2021, the Company purchased and acquired substantially all of the assets and assumed certain liabilities of Selected, Inc. (Selected) for a purchase price of $3.5&#160;million in cash, subject to adjustment, and $1.5&#160;million in shares (or 59,429 shares) of the Company's common stock. The transaction was treated as a purchase of assets for income tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sellers were eligible to receive up to an additional $1.5&#160;million in earnout cash consideration, based on Selected's revenues for each of the twelve-month periods ending on the first and second anniversaries of the first day after the closing date. In the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;second quarter of 2022, the Company determined that the contingent consideration earnout related to the Selected acquisition would not be achieved for 2022 and 2023 and, as a result, the entire liability was reversed. See Note 10 - Fair Value Measurements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assigned the following values to other identifiable intangible assets: (i) an immaterial amount to trade names with a weighted average estimated useful life of 2 years; (ii) $1.7&#160;million to software with a weighted average estimated useful life of 5 years; and (iii) $2.9&#160;million to a database, consisting of education professionals, with a weighted average estimated useful life of 5 years, for a total of $4.6&#160;million in definite life intangible assets with a weighted average estimated useful life of 5 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remaining excess purchase price over the fair value of net assets acquired of $0.4&#160;million was recorded as goodwill on the Company's condensed consolidated balance sheets. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition was not significant and has been accounted for using the acquisition method of accounting. Associated immaterial acquisition-related costs incurred have been included in acquisition and integration-related costs on the Company's condensed consolidated statements of operations for the six months ended June 30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cross Country Workforce Solutions Group (CCWSG)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 8, 2021, the Company purchased and acquired substantially all of the assets and assumed certain liabilities of Workforce Solutions Group, Inc. (WSG) for a purchase price of $25.0&#160;million in cash and $5.0&#160;million in shares (or 307,730 shares) of the Company's common stock. The parties agreed to a final net working capital reduction of $1.1&#160;million which was received in the fourth quarter of 2021. The transaction was treated as a purchase of assets for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sellers are also eligible to receive an earnout based on the business' performance through three years after the acquisition date that could provide up to an additional $15.0&#160;million in cash. The current portion of the liability of $7.5&#160;million is included in current portion of earnout liability and the non-current portion of $7.5&#160;million is included in non-current earnout liability on the condensed consolidated balance sheets. See Note 10 - Fair Value Measurements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of the assets acquired and liabilities assumed on June 8, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnout liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assigned a value to other identifiable intangible assets of $14.2&#160;million in customer relationships with a weighted average estimated useful life of 11.5 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The remaining excess purchase price over the fair value of net assets acquired of $22.1&#160;million was recorded as goodwill on the Company's condensed consolidated balance sheets. See Note 7 - Goodwill, Trade Names, and Other Intangible Assets. &lt;/span&gt;&lt;/div&gt;The acquisition was not significant and has been accounted for using the acquisition method of accounting. The pro-forma impact on the Company's consolidated revenue from services and net income, including the pro forma effect of events that are directly attributable to the acquisition, was not significant.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i81ed68aa78894c6b82beb72c410707bf_D20211216-20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjA2_74bc3605-a069-437a-80c4-92ab51988639"
      unitRef="usd">3500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i81ed68aa78894c6b82beb72c410707bf_D20211216-20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjQ1_36326811-958d-4d7f-b303-b75a077551a4"
      unitRef="usd">1500000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i81ed68aa78894c6b82beb72c410707bf_D20211216-20211216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjYy_87f9d041-fc1a-409e-b5f6-6edaa88022aa"
      unitRef="shares">59429</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id353cd1c4a224e5ca74c740f0046d0e9_I20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfNTEz_7dbd1f0f-53ff-4a89-ab04-14f27b55a9d7"
      unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i60247132b56844b7b090215e36d1bcd5_I20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzg0ODI5MDcwMjE4Mw_ba2e571a-79f3-4808-9a98-7ecb8f84bdf8"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i9c13f3c9c6d5496795d1db28f45e48bf_D20211216-20211216"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfNDM5ODA0NjUxNjcyOQ_d9991f96-c9cd-4ea7-b159-12de6500d929">P2Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib3ea81fad99645bf83db89997adc7652_I20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzg0ODI5MDcwMjA0MA_28012367-933e-4ddc-a378-852d0fcf6bd0"
      unitRef="usd">1700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ibfc8232348364f31b8fab71bfb70b6e5_D20211216-20211216"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfNDM5ODA0NjUxNjczMA_c790f6f5-4ca7-4688-a57a-4c6479c69b51">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic62e27dff65649e6b35f5937f91d27d5_I20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzg0ODI5MDcwMjA1Nw_b60b8874-4ae6-4638-9ba2-40dac30f3244"
      unitRef="usd">2900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if26f3065692a439ea180f58828581dab_D20211216-20211216"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfNDM5ODA0NjUxNjczMQ_753f82e3-5179-4d73-aa62-591bd0eca6c4">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id353cd1c4a224e5ca74c740f0046d0e9_I20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzg0ODI5MDcwMjE5Mg_f4f6e994-1cfe-4a3a-8f17-65cb15caa322"
      unitRef="usd">4600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i81ed68aa78894c6b82beb72c410707bf_D20211216-20211216"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfNDM5ODA0NjUxNjczMg_efaaff99-873d-4e74-9f12-340897aaf10d">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="id353cd1c4a224e5ca74c740f0046d0e9_I20211216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzg0ODI5MDcwMjgxMQ_c006fcd8-4e4c-4778-a86a-2267e17bd887"
      unitRef="usd">400000</us-gaap:Goodwill>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="idff5fc97df814ca3a4732c20943377d7_D20210608-20210608"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMTY0MQ_b6d48a06-c000-41b6-980f-6fd757fd1daf"
      unitRef="usd">25000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="idff5fc97df814ca3a4732c20943377d7_D20210608-20210608"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMTY1Ng_71073730-6fd7-4434-87e7-21bbde2c427a"
      unitRef="usd">5000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="idff5fc97df814ca3a4732c20943377d7_D20210608-20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMTY3Mw_06333609-ed6e-418a-8037-274c356df940"
      unitRef="shares">307730</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <ccrn:BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment
      contextRef="id1d9b43633a64c3b89445a5e452d6ea7_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMTc3OA_c181d15b-576e-4513-b981-e9d5f4aa2d92"
      unitRef="usd">1100000</ccrn:BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment>
    <ccrn:BusinessCombinationContingentConsiderationTerm
      contextRef="idff5fc97df814ca3a4732c20943377d7_D20210608-20210608"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjAwMw_ee91b710-387e-4fe3-aa75-f767a96dae0f">P3Y</ccrn:BusinessCombinationContingentConsiderationTerm>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjA3Mg_b7ef1591-e8cd-467f-8190-e2c75e1c9750"
      unitRef="usd">15000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i2a281909e341489e93181970ce395c4b_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjEyNA_0a9ab7d3-40f5-49f9-a27b-23c1a2c5daab"
      unitRef="usd">7500000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i2a281909e341489e93181970ce395c4b_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjIxMA_c7dd6a19-a489-45d7-aa26-4b55ac9604aa"
      unitRef="usd">7500000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMzU3NA_a1d5c8c5-cb4e-447e-901f-e8bce82fccb1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of the assets acquired and liabilities assumed on June 8, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability - non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnout liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMS0xLTEtMS0zOTMzMQ_43b2dcbc-e4c5-49ef-9522-0055e3f551ca"
      unitRef="usd">957000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMi0xLTEtMS0zOTMzMQ_5daf47a8-a5a5-417c-8d49-c70fe7d97427"
      unitRef="usd">11991000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMy0xLTEtMS0zOTMzMQ_94500847-82ee-497d-bb32-ae5a2caf9d24"
      unitRef="usd">59000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfNC0xLTEtMS0zOTMzMQ_d2bc6959-0383-47ca-862f-f7f17f968671"
      unitRef="usd">10000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfNS0xLTEtMS0zOTMzMQ_11f150e8-184d-4b73-a5dc-f4edd10bf0ea"
      unitRef="usd">1078000</ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets>
    <us-gaap:Goodwill
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfNi0xLTEtMS0zOTMzMQ_27d6d608-d359-461d-b905-2a21b78a43a1"
      unitRef="usd">22066000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfNy0xLTEtMS0zOTMzMQ_143d34f1-f9a8-441b-bd9b-ac91a6ccfbfa"
      unitRef="usd">14200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfOC0xLTEtMS0zOTMzMQ_fd0b068e-e773-4c1b-b3ba-7dae36087e03"
      unitRef="usd">50361000</ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfOS0xLTEtMS0zOTMzMQ_bfed23a5-0b4a-4865-8e38-8a85803451b9"
      unitRef="usd">3562000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMTAtMS0xLTEtMzkzMzE_5594816e-8f2e-41e8-9a07-9cbb3b974f5b"
      unitRef="usd">1387000</ccrn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits>
    <ccrn:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMTEtMS0xLTEtMzkzMzE_b2e58728-29db-4ec1-8614-665d0506a8e0"
      unitRef="usd">316000</ccrn:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent>
    <ccrn:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMTItMS0xLTEtMzkzMzE_75c44932-8b10-4b2c-8329-23b63287f18c"
      unitRef="usd">762000</ccrn:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMTMtMS0xLTEtMzkzMzE_9ec43a55-5d99-4d3b-93ff-47d22022307e"
      unitRef="usd">15000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMTQtMS0xLTEtMzkzMzE_8cee4573-8dfd-4132-a2a6-f5aba413b1db"
      unitRef="usd">21027000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RhYmxlOjBmNDQ5NDQ4YWFkNDQ3YWZiMjlkNDVhOWYyNTNhMTg3L3RhYmxlcmFuZ2U6MGY0NDk0NDhhYWQ0NDdhZmIyOWQ0NWE5ZjI1M2ExODdfMTUtMS0xLTEtMzkzMzE_2d5a0ffd-3748-4eec-9407-63a1e5bb3430"
      unitRef="usd">29334000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ia1c9b2c7cc8a4a979b20f24f8720ad94_I20210608"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjUzMA_60c86c49-a6c4-49dd-8e51-af1f8fc8d6ef"
      unitRef="usd">14200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ib19a69210f684fa48653b01303c034bf_D20210608-20210608"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjYwOA_ee106b58-cdce-43c3-9afb-977d881ab635">P11Y6M</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:Goodwill
      contextRef="i1671691aefa34321882545ccf2019faf_I20210608"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180Ni9mcmFnOjQ4NTJlMjQ0MTA2YjRmOGNiODI0MzFjNjE3OTZlNDExL3RleHRyZWdpb246NDg1MmUyNDQxMDZiNGY4Y2I4MjQzMWM2MTc5NmU0MTFfMjY5NQ_6344d554-7d34-4a29-be3c-7242bf0a3085"
      unitRef="usd">22100000</us-gaap:Goodwill>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180OS9mcmFnOjZkNjYwZTY0OGUxOTRjZjE4OTQxNzc1NjMxODdhYzFhL3RleHRyZWdpb246NmQ2NjBlNjQ4ZTE5NGNmMTg5NDE3NzU2MzE4N2FjMWFfODM3_87563906-04a4-4705-af53-39b09a3a078a">COMPREHENSIVE INCOME&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total comprehensive income includes net income or loss and foreign currency translation adjustments, net of any related deferred taxes, and is included within the accompanying condensed consolidated statements of operations. Certain of the Company&#x2019;s foreign subsidiaries use their respective local currency as their functional currency. Assets and liabilities of these operations are translated at the exchange rates in effect on the balance sheet date. Income statement items are translated at the average exchange rates for the period. The cumulative impact of currency fluctuations related to the balance sheet translation is included in accumulated other comprehensive loss in the accompanying condensed consolidated balance sheets and was an unrealized loss of&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $1.4&#160;million at June 30, 2022 and $1.3 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180OS9mcmFnOjZkNjYwZTY0OGUxOTRjZjE4OTQxNzc1NjMxODdhYzFhL3RleHRyZWdpb246NmQ2NjBlNjQ4ZTE5NGNmMTg5NDE3NzU2MzE4N2FjMWFfNzk3_3de3e541-7558-4454-90e4-e5b772e2837d"
      unitRef="usd">-1400000</ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax>
    <ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM180OS9mcmFnOjZkNjYwZTY0OGUxOTRjZjE4OTQxNzc1NjMxODdhYzFhL3RleHRyZWdpb246NmQ2NjBlNjQ4ZTE5NGNmMTg5NDE3NzU2MzE4N2FjMWFfODIy_a2d9ca17-85b3-4091-b460-5e62431ff1c9"
      unitRef="usd">-1300000</ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RleHRyZWdpb246ZjVkY2VlNDM1NmVlNDBhYThjMWM4NjdmODI2OWQwOGRfNjE2_6d3c9cb5-3496-47f4-9fe2-5cda8399f137">EARNINGS PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(amounts in thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to common stockholders - Basic and Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares - Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of diluted shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to common stockholders - Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to common stockholders - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the share-based awards that could potentially dilute net income per share attributable to common stockholders in the future that were not included in the computation of diluted net income per share attributable to common stockholders because to do so would have been anti-dilutive for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RleHRyZWdpb246ZjVkY2VlNDM1NmVlNDBhYThjMWM4NjdmODI2OWQwOGRfNjE3_f7d992ce-6dbf-417e-ba6c-61dd4e3013ed">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the components of the numerator and denominator for the computation of the basic and diluted earnings per share:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(amounts in thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to common stockholders - Basic and Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares - Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of diluted shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to common stockholders - Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to common stockholders - Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS0xLTEtMS0zOTMzMQ_59c0b380-6f2d-4cdc-bf5c-6e7fced5a390"
      unitRef="usd">52894000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS0xLTEtMS0zOTMzMQ_cd3582dd-adc3-4bf9-8b8d-2568cd690a13"
      unitRef="usd">52894000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS0zLTEtMS0zOTMzMQ_05fe1b13-5ea1-47c1-b2ea-b23489458277"
      unitRef="usd">11548000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS0zLTEtMS0zOTMzMQ_9939e6eb-e91d-452f-a761-55dfd7f7fda3"
      unitRef="usd">11548000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS01LTEtMS0zOTMzMQ_24915f90-af4a-4194-a2f9-aba2b8f5809f"
      unitRef="usd">114877000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS01LTEtMS0zOTMzMQ_4d62d431-33ba-42e8-bb8b-a86151701d08"
      unitRef="usd">114877000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS03LTEtMS0zOTMzMQ_31925176-a353-49f4-81b1-10b30fd03bd3"
      unitRef="usd">30996000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfNS03LTEtMS0zOTMzMQ_547d5f65-1c7f-46a6-8b9e-d22ebacf1cfc"
      unitRef="usd">30996000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfOC0xLTEtMS0zOTMzMQ_d9e811bb-aeaf-4754-b28a-40db03f3285a"
      unitRef="shares">37471000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfOC0zLTEtMS0zOTMzMQ_c35307a8-450d-4362-8a6e-5a5125bc94e0"
      unitRef="shares">36625000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfOC01LTEtMS0zOTMzMQ_083a7aaf-270f-4bb8-a15a-d668abc49f39"
      unitRef="shares">37251000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfOC03LTEtMS0zOTMzMQ_fa5d8ae2-cb25-403b-a656-487c3824a33e"
      unitRef="shares">36404000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTAtMS0xLTEtMzkzMzE_8cf5955a-f632-4508-bcdf-823c6a5a1d2a"
      unitRef="shares">286000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTAtMy0xLTEtMzkzMzE_b7239229-ae10-4965-9da6-ac6c6933529f"
      unitRef="shares">578000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTAtNS0xLTEtMzkzMzE_fca7a5bf-bc17-4304-9774-cc983c4e8f7d"
      unitRef="shares">615000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTAtNy0xLTEtMzkzMzE_6aa34075-9c8a-448b-b0a3-46dea3dc1835"
      unitRef="shares">716000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTEtMS0xLTEtMzkzMzE_da9f25c8-6932-4029-be34-5681bb56090b"
      unitRef="shares">37757000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTEtMy0xLTEtMzkzMzE_051ff3de-88ef-457d-abc8-bb3bdc531fd0"
      unitRef="shares">37203000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTEtNS0xLTEtMzkzMzE_36b0f0fd-c64d-4fff-b958-dd679b37f5fb"
      unitRef="shares">37866000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTEtNy0xLTEtMzkzMzE_bc74d315-b85e-4b77-a303-bf48586b6bc9"
      unitRef="shares">37120000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTMtMS0xLTEtMzkzMzE_cdbc517c-cf90-4d5c-944a-3e95f0b71b59"
      unitRef="usdPerShare">1.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTMtMy0xLTEtMzkzMzE_1eee09c7-d6e7-42c3-8213-1399c30d5a69"
      unitRef="usdPerShare">0.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTMtNS0xLTEtMzkzMzE_7708ab08-4488-47e2-b56a-730ab021b924"
      unitRef="usdPerShare">3.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTMtNy0xLTEtMzkzMzE_ccb4a89b-a91d-45a6-a11c-a09f9323578e"
      unitRef="usdPerShare">0.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTUtMS0xLTEtMzkzMzE_b1d02290-1f71-4a23-b9c2-5dc3b071b7a9"
      unitRef="usdPerShare">1.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTUtMy0xLTEtMzkzMzE_46a59f82-28e9-4767-a0a4-89e27199116e"
      unitRef="usdPerShare">0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTUtNS0xLTEtMzkzMzE_bd2bad28-5bac-419f-9309-9dd07821369f"
      unitRef="usdPerShare">3.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOmMxNzcxZjIwYTYxODQ5YmU5YmNkZDNjZWFkMGE0NzBiL3RhYmxlcmFuZ2U6YzE3NzFmMjBhNjE4NDliZTliY2RkM2NlYWQwYTQ3MGJfMTUtNy0xLTEtMzkzMzE_ccfda9ea-1c22-4ef7-87c0-f3d6e18e3644"
      unitRef="usdPerShare">0.84</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RleHRyZWdpb246ZjVkY2VlNDM1NmVlNDBhYThjMWM4NjdmODI2OWQwOGRfNDM5ODA0NjUxMjExMA_f195302b-e2fa-47a0-a0c9-6bfa8c9b77f4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the share-based awards that could potentially dilute net income per share attributable to common stockholders in the future that were not included in the computation of diluted net income per share attributable to common stockholders because to do so would have been anti-dilutive for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7a171810dfba45719542dcd325b21e11_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOjc4NDM2MjMwYjljYTQ5MGViMDdlZTU1ZTQ3MjI0ODk5L3RhYmxlcmFuZ2U6Nzg0MzYyMzBiOWNhNDkwZWIwN2VlNTVlNDcyMjQ4OTlfNC0xLTEtMS00NDUyMQ_7fa9d64f-3cb5-4a8c-b952-ac34b0abba2d"
      unitRef="shares">220000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i12dc2febc4c84d4288a4906fe94e7c1b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOjc4NDM2MjMwYjljYTQ5MGViMDdlZTU1ZTQ3MjI0ODk5L3RhYmxlcmFuZ2U6Nzg0MzYyMzBiOWNhNDkwZWIwN2VlNTVlNDcyMjQ4OTlfNC0zLTEtMS00NDUyMQ_b24b0542-5485-4c40-8926-38b1505f5400"
      unitRef="shares">21000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i10b1ca7fabaa4095b85f6b18a5b65654_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOjc4NDM2MjMwYjljYTQ5MGViMDdlZTU1ZTQ3MjI0ODk5L3RhYmxlcmFuZ2U6Nzg0MzYyMzBiOWNhNDkwZWIwN2VlNTVlNDcyMjQ4OTlfNC01LTEtMS00NDUyMQ_a2728943-5db4-467b-955a-0923e46ca728"
      unitRef="shares">110000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib72123a2c3914fce9452ab74a8a3a3ba_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181Mi9mcmFnOmY1ZGNlZTQzNTZlZTQwYWE4YzFjODY3ZjgyNjlkMDhkL3RhYmxlOjc4NDM2MjMwYjljYTQ5MGViMDdlZTU1ZTQ3MjI0ODk5L3RhYmxlcmFuZ2U6Nzg0MzYyMzBiOWNhNDkwZWIwN2VlNTVlNDcyMjQ4OTlfNC03LTEtMS00NDUyMQ_2bd75778-d6f3-4bbb-ae35-cbb20a4d4d0f"
      unitRef="shares">13000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RleHRyZWdpb246NmI2ZTY3ZDVhYzYwNDk0Zjg3YTVjNjcwNzY3NDBlNmFfMjk1Ng_139ca939-297e-4125-8945-0b0d106c4553">GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had the following acquired intangible assets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Databases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names, indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, estimated annual amortization expense is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ending December&#160;31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The changes in the carrying amount of goodwill by reportable segment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill, net of impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Changes to aggregate goodwill in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquisition adjustment - Selected &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill, net of impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Represents an adjustment to the fair value of the identifiable net assets acquired, with a corresponding offset to goodwill, made during the measurement period related to the acquisition of Selected. See Note 4 - Acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Goodwill, Trade Names, and Other Intangible Assets Impairment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests reporting units&#x2019; goodwill and intangible assets with indefinite lives for impairment annually during the fourth quarter and more frequently if impairment indicators exist. The Company performs quarterly qualitative assessments of significant events and circumstances such as reporting units&#x2019; historical and current results, assumptions regarding future performance, strategic initiatives and overall economic factors,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; including COVID,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and macro-economic developments, to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of reporting units or intangible assets is less than their carrying value. If indicators of impairments are identified a quantitative impairment test is performed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2022 and 2021, the Company performed a qualitative assessment of each of its reporting units and determined it was not more likely than not that the fair value of its reporting units dropped below their carrying value. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;lthough management believes that the Company's current estimates and assumptions utilized in its qualitative testing are reasonable and supportable, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;including its assumptions on the impact and timing related to COVID,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; there can be no assurance that the estimates and assumptions management used for purposes of its qualitative assessment as of June 30, 2022 will prove to be accurate predictions of future performance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For its long-lived assets and definite-lived intangible assets, the Company reviews for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. As of June 30, 2022, the Company performed a qualitative assessment of its trade names and other intangible assets and determined it was not more likely than not that their carrying value may not be recoverable. During the six months ended June 30, 2021, the Company wrote off a discontinued software development project, resulting in an immaterial impairment charge.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RleHRyZWdpb246NmI2ZTY3ZDVhYzYwNDk0Zjg3YTVjNjcwNzY3NDBlNmFfMjk0NA_21857151-13f1-4f38-8ab4-d4d88c1be473">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had the following acquired intangible assets:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Databases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names, indefinite-lived&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i539c9e6b43fb478fae6799603240e6dc_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNC0xLTEtMS0zOTMzMQ_6e7acab8-a10a-406c-8178-b4fa6c998aab"
      unitRef="usd">33430000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i539c9e6b43fb478fae6799603240e6dc_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNC0zLTEtMS0zOTMzMQ_9d9288a2-4890-4852-b7ee-21824aecf8bc"
      unitRef="usd">20217000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i539c9e6b43fb478fae6799603240e6dc_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNC01LTEtMS0zOTMzMQ_0a566279-8b6b-4f39-8b2e-b36c681fe834"
      unitRef="usd">13213000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i207e780bad744a04ae7391b8036f801f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNC03LTEtMS0zOTMzMQ_9e856a10-9113-4df7-8c5a-38871b2f0f61"
      unitRef="usd">30530000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i207e780bad744a04ae7391b8036f801f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNC05LTEtMS0zOTMzMQ_c9440e45-cbf0-4278-b833-18c5dd2b9cf0"
      unitRef="usd">18375000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i207e780bad744a04ae7391b8036f801f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNC0xMS0xLTEtMzkzMzE_bd56502a-10eb-439d-b3c9-ca8ce9ba05ed"
      unitRef="usd">12155000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6d386cdc5efb4d9582172fa5148def89_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNS0xLTEtMS0zOTMzMQ_f1432fa3-0f3e-47ef-a615-f39c7db6643b"
      unitRef="usd">47738000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6d386cdc5efb4d9582172fa5148def89_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNS0zLTEtMS0zOTMzMQ_9dcbe208-d674-4c14-80c4-28dffcc0eeb2"
      unitRef="usd">19626000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6d386cdc5efb4d9582172fa5148def89_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNS01LTEtMS0zOTMzMQ_d2e95900-e4aa-4d10-9ad1-d7171bab069f"
      unitRef="usd">28112000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i32f84c71196b460ab5a3ae5a4826c77e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNS03LTEtMS0zOTMzMQ_d354048e-364c-466a-9277-37a50cc8eeaf"
      unitRef="usd">47738000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i32f84c71196b460ab5a3ae5a4826c77e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNS05LTEtMS0zOTMzMQ_b9433eb3-519c-44ce-b4f7-f9c2eed3bada"
      unitRef="usd">17581000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i32f84c71196b460ab5a3ae5a4826c77e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNS0xMS0xLTEtMzkzMzE_cc465e27-3ff7-4504-a81b-82e9dfe7dcf0"
      unitRef="usd">30157000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic36e0417ede14c6988b1777707b1f8f9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNi0xLTEtMS0zOTMzMQ_bf8b0ddf-bd62-47d6-82a3-0d4361f546c4"
      unitRef="usd">304000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic36e0417ede14c6988b1777707b1f8f9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNi0zLTEtMS0zOTMzMQ_c4bdc802-cc76-437e-970f-2aa6ddb6c931"
      unitRef="usd">303000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic36e0417ede14c6988b1777707b1f8f9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNi01LTEtMS0zOTMzMQ_b3ae5aa6-9a76-4359-be6b-0676817b4798"
      unitRef="usd">1000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifca6652933cd479d898cbf242f81426d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNi03LTEtMS0zOTMzMQ_9051ce31-f6c8-4e84-8ef9-e887291ffa0c"
      unitRef="usd">304000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifca6652933cd479d898cbf242f81426d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNi05LTEtMS0zOTMzMQ_45c70697-c998-40c3-b271-d2eff31ede0f"
      unitRef="usd">272000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifca6652933cd479d898cbf242f81426d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNi0xMS0xLTEtMzkzMzE_7526591a-bba7-45a1-92a4-3318120eb2a1"
      unitRef="usd">32000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ieabbbda1a0c74a69bcac845525179f61_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy0xLTEtMS00Mjk1Mg_d7abc423-0e4c-400d-ad11-bb22294ddb2d"
      unitRef="usd">30000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ieabbbda1a0c74a69bcac845525179f61_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy0zLTEtMS00Mjk1Mg_c71393ea-9ade-4b9d-93eb-38f71fb7d897"
      unitRef="usd">8000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ieabbbda1a0c74a69bcac845525179f61_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy01LTEtMS00Mjk1Mg_3bd306b7-13af-4b45-bdfd-ca90dd8b2992"
      unitRef="usd">22000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9f1314ae8d2a4bef96916b457d74c9c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy03LTEtMS00Mjk1Mg_b20e54d8-38da-45c5-8429-833179553e7b"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9f1314ae8d2a4bef96916b457d74c9c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy05LTEtMS00Mjk1Mg_654716ce-5f1f-4527-888c-4eef5fe0b13e"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9f1314ae8d2a4bef96916b457d74c9c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy0xMS0xLTEtNDI5NTI_a7eaf6e0-a39e-46a0-a943-3c3ce78eda72"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia8f0cc98b9f24950a7b4b12b08aefbd3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfOC0xLTEtMS00Mjk2Ng_c9053fb0-bafb-4b9e-ac2b-3d9b701e729d"
      unitRef="usd">1700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia8f0cc98b9f24950a7b4b12b08aefbd3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfOC0zLTEtMS00Mjk2Ng_b0b15dec-2974-4cb7-8337-0df3865a57f2"
      unitRef="usd">185000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia8f0cc98b9f24950a7b4b12b08aefbd3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfOC01LTEtMS00Mjk2Ng_ffb2a060-4cb1-4dee-9bab-ce1a6fd818f6"
      unitRef="usd">1515000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibc74fefee46742279f8b45d775c187b8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfOC03LTEtMS00Mjk2Ng_f1a704f3-4c1f-442e-b65d-bbd2640ed1ae"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibc74fefee46742279f8b45d775c187b8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfOC05LTEtMS00Mjk2Ng_b416f5b9-d550-4918-9aa7-a8d7b29e023e"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibc74fefee46742279f8b45d775c187b8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfOC0xMS0xLTEtNDI5NjY_1a078db8-eed7-42b9-b371-da4ee9b27707"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy0xLTEtMS0zOTMzMQ_7bcfbfa1-36f2-492f-b4e6-bb9d7e60104b"
      unitRef="usd">83202000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy0zLTEtMS0zOTMzMQ_9d8aa4ee-8075-416d-b50f-1f6124c79add"
      unitRef="usd">40339000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy01LTEtMS0zOTMzMQ_4b8f63e3-4758-4b67-bdfe-8db3e2bc4e95"
      unitRef="usd">42863000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy03LTEtMS0zOTMzMQ_894e6377-479e-4fa2-9ca1-5d2e01a1e0fd"
      unitRef="usd">78572000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy05LTEtMS0zOTMzMQ_c838b346-1c98-4ec3-8625-e1b127198ad3"
      unitRef="usd">36228000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfNy0xMS0xLTEtMzkzMzE_86f43fd7-4944-4106-9510-8eec96ec7a12"
      unitRef="usd">42344000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfMTAtNS0xLTEtMzkzMzE_263d4385-35ad-4b35-815b-3f874e0ddb97"
      unitRef="usd">5900000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:IndefiniteLivedTradeNames
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjAxN2U0NTAyYjY1MTQ3M2NhYjU4YTY4YTFmOWUzMzU2L3RhYmxlcmFuZ2U6MDE3ZTQ1MDJiNjUxNDczY2FiNThhNjhhMWY5ZTMzNTZfMTAtMTEtMS0xLTM5MzMx_caa79cb7-a8b6-45f3-a544-7b374277ebbd"
      unitRef="usd">5900000</us-gaap:IndefiniteLivedTradeNames>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RleHRyZWdpb246NmI2ZTY3ZDVhYzYwNDk0Zjg3YTVjNjcwNzY3NDBlNmFfMjk0NQ_7561e2d3-3a71-4030-ad4c-6e5f70c92044">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, estimated annual amortization expense is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ending December&#160;31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfMi0xLTEtMS0zOTMzMQ_7d89d1b4-79eb-4b8b-9fa5-b18c11c5b22d"
      unitRef="usd">4040000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfMy0xLTEtMS0zOTMzMQ_e0ad6de5-bd61-4425-95fb-5909a745ae3f"
      unitRef="usd">8051000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfNC0xLTEtMS0zOTMzMQ_3d07b2e7-6b12-4cf9-b83f-49a59c5bb94b"
      unitRef="usd">7399000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfNS0xLTEtMS0zOTMzMQ_7e6d1755-1312-418b-9927-ee0dd402f785"
      unitRef="usd">6840000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfNi0xLTEtMS0zOTMzMQ_30983343-0749-4559-bf8a-aafd0f635a7f"
      unitRef="usd">5632000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <ccrn:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfNy0xLTEtMS0zOTMzMQ_6d94d06d-3e5a-4df8-8159-42b684f80ee4"
      unitRef="usd">10901000</ccrn:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOjk0MjliY2I4NGNjZjQ2MzNiMmNlM2ZhZDBlYjY2NjExL3RhYmxlcmFuZ2U6OTQyOWJjYjg0Y2NmNDYzM2IyY2UzZmFkMGViNjY2MTFfOC0xLTEtMS0zOTMzMQ_4e058302-451b-45f6-a5e9-be1b5de4dab6"
      unitRef="usd">42863000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RleHRyZWdpb246NmI2ZTY3ZDVhYzYwNDk0Zjg3YTVjNjcwNzY3NDBlNmFfNDM5ODA0NjUxNjQ0Ng_2d4edb41-e7ea-4107-9382-098385f741e5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The changes in the carrying amount of goodwill by reportable segment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nurse&lt;br/&gt;And Allied&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Physician&lt;br/&gt;Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill, net of impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Changes to aggregate goodwill in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquisition adjustment - Selected &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances as of June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;433,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(310,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill, net of impairment loss&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Represents an adjustment to the fair value of the identifiable net assets acquired, with a corresponding offset to goodwill, made during the measurement period related to the acquisition of Selected. See Note 4 - Acquisitions.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:GoodwillGross
      contextRef="i50b7d147bfc6416cabda9cebd8aef26b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMy0xLTEtMS00MTk3NA_a805381f-ac99-45c6-a089-e1ae63f21158"
      unitRef="usd">396446000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i04576ab71ad14259b8dde82aaf1a434d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMy0zLTEtMS00MTk3NA_2f962e66-6de9-4044-a67e-ca2a8143644c"
      unitRef="usd">43405000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMy01LTEtMS00MTk3NA_f2a13139-66d4-452c-ae9c-55c82fcd5b6d"
      unitRef="usd">439851000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ic64dfa83d28e423e96e7ed34d4fd500c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNC0xLTEtMS00MTk3NA_472fa93c-8be7-426d-baba-363fed81e047"
      unitRef="usd">9889000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i76c278957a754512b8adac480fa3184b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNC0zLTEtMS00MTk3NA_17fecac1-1b82-4224-8ff5-fa86ae16ae51"
      unitRef="usd">0</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i1105535cc021464682c0f1266a44a41f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNC01LTEtMS00MTk3NA_6bf7d2d9-483c-4575-a47d-13d45789f4e9"
      unitRef="usd">9889000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i50b7d147bfc6416cabda9cebd8aef26b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNS0xLTEtMS00MTk3NA_4b46616d-2423-493d-9dca-3035633562cd"
      unitRef="usd">269874000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i04576ab71ad14259b8dde82aaf1a434d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNS0zLTEtMS00MTk3NA_74ef288b-52e2-4071-b491-b96ea0211e6c"
      unitRef="usd">40598000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNS01LTEtMS00MTk3NA_d5d5964f-15bf-48c3-ab3d-9be3f78204a7"
      unitRef="usd">310472000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i50b7d147bfc6416cabda9cebd8aef26b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNi0xLTEtMS00MTk3NA_765d3746-f999-444b-8993-9cb9fb492e0f"
      unitRef="usd">116683000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i04576ab71ad14259b8dde82aaf1a434d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNi0zLTEtMS00MTk3NA_4a792d37-4c45-4600-8757-18b55309a505"
      unitRef="usd">2807000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfNi01LTEtMS00MTk3NA_d723c0bf-d125-4e3f-8580-9f42edc72240"
      unitRef="usd">119490000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ie0d06303bf64411ebac22da90bae8bc6_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfOS0xLTEtMS00MTk3NA_01c91f0c-cd91-4a21-a178-7096353c88e0"
      unitRef="usd">-6130000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="iababccf169c64eb497cc9f14a300ad39_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfOS0zLTEtMS00MTk3NA_51ec9839-0928-43e2-9f42-23043e9fafd5"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfOS01LTEtMS00MTk3NA_b4a2be9c-7b2d-4e4f-8f76-5bde6cce4ea8"
      unitRef="usd">-6130000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillGross
      contextRef="i8742261c00d64b76a788ed6c05a3ad95_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTItMS0xLTEtNDE5NzQ_7db57869-e21f-4b7b-b828-fbbdf736f8df"
      unitRef="usd">390316000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ic3e8f0444e0d4d5eb1c366333ffac9d3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTItMy0xLTEtNDE5NzQ_98163feb-3960-4893-bea3-19c7e4dc1bc4"
      unitRef="usd">43405000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTItNS0xLTEtNDE5NzQ_5039fbed-240c-4e7c-9783-52299ccad46b"
      unitRef="usd">433721000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ie958469fcde64897ae4e65a0e3c3dca4_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTMtMS0xLTEtNDE5NzQ_8108f028-f65d-47c8-bf99-5148e0ad4c97"
      unitRef="usd">9889000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i4278c04c7f5f4845bcc68a5828e1da06_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTMtMy0xLTEtNDE5NzQ_8f45c6e4-2c1e-4c6c-b69d-23bfbc8531f3"
      unitRef="usd">0</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i09567f48a192498ab1e23194314c8143_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTMtNS0xLTEtNDE5NzQ_893a805a-4dda-472b-bba9-ee66a5d9c42f"
      unitRef="usd">9889000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i8742261c00d64b76a788ed6c05a3ad95_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTQtMS0xLTEtNDE5NzQ_7c356888-9719-43e0-958e-ed49c969904f"
      unitRef="usd">269874000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ic3e8f0444e0d4d5eb1c366333ffac9d3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTQtMy0xLTEtNDE5NzQ_3c78dc17-b36e-4171-ab14-c275520dacf7"
      unitRef="usd">40598000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTQtNS0xLTEtNDE5NzQ_bab08349-3dfc-4807-9e7d-48661d29d03d"
      unitRef="usd">310472000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i8742261c00d64b76a788ed6c05a3ad95_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTUtMS0xLTEtNDE5NzQ_7311a0f7-cf4b-4e51-ba05-e39a82b40699"
      unitRef="usd">110553000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic3e8f0444e0d4d5eb1c366333ffac9d3_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTUtMy0xLTEtNDE5NzQ_968ee99c-da45-42c8-878c-d335e6d84269"
      unitRef="usd">2807000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181NS9mcmFnOjZiNmU2N2Q1YWM2MDQ5NGY4N2E1YzY3MDc2NzQwZTZhL3RhYmxlOmI1MWIxYTgyYjk3MjQ4ODBiZTM3ODY3M2JjYjEwZGEzL3RhYmxlcmFuZ2U6YjUxYjFhODJiOTcyNDg4MGJlMzc4NjczYmNiMTBkYTNfMTUtNS0xLTEtNDE5NzQ_fd11dc8c-6cd1-4255-8dd2-f08c817f4a20"
      unitRef="usd">113360000</us-gaap:Goodwill>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfOTQwMg_455bb6ea-f8dd-45cd-8815-fb0736d59308">DEBT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's long-term debt consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Debt Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Debt Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, interest of 7.39% and 6.50% at June 30, 2022 and December 31, 2021, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Asset-Based Loan, interest of 3.12% and 1.60% at June 30, 2022 and December 31, 2021, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,848)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note Payable, interest of 2.00% per annum at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion - Note Payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion - Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the current portion of the term loan and the note payable are included in current portion of debt on the condensed consolidated balance sheets. The final installment of the note payable, related to contingent consideration assumed as part of a prior period acquisition, was paid in the first quarter of 2022. The Company has elected to present the debt issuance costs associated with its revolving line-of-credit as an asset, which is included in other non-current assets on the condensed consolidated balance sheets. As a result, the long-term debt in the above table will not agree to long-term debt, net of current portion on the condensed consolidated balance sheets herein.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Late in the second quarter of 2022, the Company made an optional prepayment of $50.0&#160;million on its term loan. The Company was entitled to determine the application of the prepayment, which was applied to all future amortization payments, with the balance applied to the remaining balloon payment in 2027. As of June 30, 2022, the aggregate schedule for maturities of debt are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Secured Asset-Based Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Through Years Ending December&#160;31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 Term Loan Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On June 8, 2021, the Company entered into a Term Loan Credit Agreement (Term Loan Agreement) with&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; certain lenders identified therein (collectively, the Lenders) and Wilmington Trust&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, National Association as administrative agent and collateral agent, pursuant to which the Lenders extended to the Company a six-year second lien subordinated term loan in the amount of $100.0&#160;million (term loan). The term loan has an interest rate of one-month London Inter-Bank Offered Rate (LIBOR) plus 5.75% per annum, subject to a 0.75% LIBOR floor. The term loan was used to pay the cash consideration, as well as any costs, fees, and expenses in connection with the WSG acquisition (see Note 4 - Acquisitions), with the remainder used to pay down a  of the asset based credit facility. Fees paid in connection with the Term Loan Agreement have been included as debt issuance costs and as a reduction to the carrying amount of the term loan and are expected to be amortized to interest expense over the term of the Term Loan Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The borrowings under the Term Loan Agreement generally bear interest at a variable rate based on either LIBOR or Base Rate (as defined in the Term Loan Agreement) and are subject to mandatory prepayments of principal payable in quarterly installments, commencing on September 30, 2021, with each installment being in the aggregate principal amount of $0.3 million (subject to adjustment as a result of prepayments) provided that, to the extent not previously paid, the aggregate unpaid principal balance would be due and payable on the maturity date. The Term Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum net leverage ratio. The Company was in compliance with this covenant as of June 30, 2022. Obligations under the Term Loan Agreement are secured by substantially all the assets of the borrowers and guarantors under the Term Loan Agreement, subject to customary exceptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 18, 2021, the Company amended its Term Loan Agreement (Term Loan First Amendment), which provided the Company an incremental term loan in an aggregate amount equal to $75.0&#160;million. Additionally, the Term Loan First Amendment increased the aggregate amount of all increases (as defined in the Term Loan Agreement) to be no greater than $115.0&#160;million. The borrowings will be used primarily to fund organic growth. Commencing on December 31, 2021, installments of the mandatory prepayments will be in the aggregate principal amount of $0.4&#160;million. All other terms, conditions, covenants, and pricing of the Term Loan Agreement remain the same. In conjunction with the Term Loan First Amendment, the Company entered into the Term Loan First Amendment to the Intercreditor Agreement, effective as of November 18, 2021, which sets forth the lien priority, relative rights, and other creditors&#x2019; rights issues in respect of the collateral lenders.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aside from its scheduled payments, on June 23, 2022, the Company made an optional prepayment of $50.0&#160;million to reduce interest costs, and paid a prepayment premium of $0.5&#160;million pursuant to the Term Loan Agreement. As a result of the early prepayment, debt issuance costs of $1.4&#160;million were written off in the three months ended June 30, 2022. The prepayment premium and the write-off of debt issuance costs are included as loss on early extinguishment of debt in the condensed consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The term loan is secured by a second-priority security interest in the collateral as defined in the ABL Credit Agreement (Loan Agreement) (as described below), and Wells Fargo Bank, National Association as agent, as amended by the First Amendment, Second Amendment, Third Amendment, Fourth Amendment, and Fifth Amendment to the Loan Agreement (as described below). The lien priority, relative rights, and other creditors&#x2019; rights issues in respect of the collateral lenders are set forth in the Intercreditor Agreement, by and among Wells Fargo Bank, National Association, as first lien agent, and Wilmington Trust, National Association, as second lien agent, as amended, restated, amended and restated, supplemented or otherwise modified from time to time in accordance with the terms thereof dated June 8, 2021 (Intercreditor Agreement).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2019 Loan Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective October 25, 2019, the Company terminated its commitments under its prior senior credit facility entered into in August 2017 and entered into a Loan Agreement, by and among the Company and certain of its domestic subsidiaries, as borrowers or guarantors, Wells Fargo, PNC Bank N.A., as well as other Lenders (as defined) from time to time parties thereto. The Loan Agreement provides for a five-year revolving senior secured asset-based credit facility (ABL) in the aggregate principal amount of up to $120.0&#160;million (as described below), including a sublimit for swing loans up to $15.0&#160;million and a $35.0&#160;million sublimit for standby letters of credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2020, the Company amended its Loan Agreement (First Amendment), which increased the current aggregate committed size of the ABL from $120.0&#160;million to $130.0&#160;million. All other terms, conditions, covenants, and pricing of the Loan Agreement remained the same. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2021, the Company amended its Loan Agreement (Second Amendment), which increased the current aggregate committed size of the ABL from $130.0&#160;million to $150.0&#160;million, increased certain borrowing base sub-limits, and decreased both the cash dominion event and financial reporting triggers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 8, 2021, the Company amended its Loan Agreement (Third Amendment), which permits the incurrence of indebtedness and grant of security as set forth in the Loan Agreement and in accordance with the Intercreditor Agreement, and provides mechanics relating to a transition away from LIBOR as a benchmark interest rate to a replacement alternative benchmark rate or mechanism for loans made in U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 18, 2021, the Company amended its Loan Agreement (Fourth Amendment), whereby the permitted indebtedness (as defined in the Loan Agreement), was increased to $175.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 21, 2022, the Company amended its Loan Agreement (Fifth Amendment), which increased the current aggregate committed size of the ABL from $150.0 million to $300.0 million, extended the credit facility for an additional five years, and increased certain borrowing base sub-limits. In addition, the agreement provides the option for all or a portion of the borrowings to bear interest at a rate based on the Secured Overnight Financing Rate (SOFR) or Base Rate, at the election of the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;borrowers, plus an applicable margin. The applicable margin will increase 10 basis points due to the credit spread associated with the transition to SOFR.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These amendments were treated as modifications of debt and, as a result, the associated fees and costs were included in debt issuance costs and will be amortized ratably over the remaining term of the Loan Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Availability of the ABL commitments is subject to a borrowing base of up to 85% of secured eligible accounts receivable, subject to adjustment at certain quality levels, minus customary reserves and subject to customary adjustments. Revolving loans and letters of credit issued under the Loan Agreement reduce availability under the ABL on a dollar-for-dollar basis. Availability under the ABL will be used for general corporate purposes. At June 30, 2022, borrowing base availability under the ABL was $300.0&#160;million and the Company had $85.0&#160;million of borrowings drawn, as well as $17.5&#160;million of letters of credit outstanding related to workers' compensation and professional liability policies, leaving $197.5&#160;million of excess availability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2022, the interest rate spreads and fees under the Loan Agreement were based on SOFR plus 1.60% for the revolving portion of the borrowing base. The Base Rate (as defined by the Loan Agreement) margin would have been 0.50%  for the revolving portion&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The SOFR and Base Rate margins are subject to monthly pricing adjustments, pursuant to a pricing matrix based on the Company&#x2019;s excess availability under the revolving credit facility. In addition, the facility is subject to an unused line fee, letter of credit fees, and an administrative fee. The unused line fee is 0.375% of the average daily unused portion of the revolving credit facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Loan Agreement contains various restrictions and covenants applicable to the Company and its subsidiaries, including a covenant to maintain a minimum fixed charge coverage ratio. The Company was in compliance with this covenant as of June 30, 2022. Obligations under the ABL are secured by substantially all the assets of the borrowers and guarantors, subject to customary exceptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfOTQxMg_5bbec4ad-b2db-4b86-ad9e-066d1ffb00bc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's long-term debt consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Debt Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Debt Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, interest of 7.39% and 6.50% at June 30, 2022 and December 31, 2021, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,499)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Asset-Based Loan, interest of 3.12% and 1.60% at June 30, 2022 and December 31, 2021, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,848)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note Payable, interest of 2.00% per annum at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion - Note Payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion - Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfMy0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOjRiNTY5NmRjYjU3NDQ1MWRiY2QxOWE2MjM1ZjM3ZWI3XzI3_f5772e24-1362-475d-9bf5-3561f05ae0fa"
      unitRef="number">0.0739</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i59183c7b0a0d42569a396d37e5f31cf2_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfMy0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOjRiNTY5NmRjYjU3NDQ1MWRiY2QxOWE2MjM1ZjM3ZWI3XzI3NDg3NzkwNjk1OTE_49ee3c8b-45cb-4eae-b03e-e53947ad150b"
      unitRef="number">0.0650</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfMy0xLTEtMS0zOTMzMQ_b071502d-9a82-41b3-be2d-d88a8158796a"
      unitRef="usd">123875000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfMy0zLTEtMS0zOTMzMQ_f0279f85-afae-4a01-9d51-911cfa686dbc"
      unitRef="usd">3499000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i59183c7b0a0d42569a396d37e5f31cf2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfMy01LTEtMS0zOTMzMQ_645e02fe-3ea9-46fc-9dea-ed365185a264"
      unitRef="usd">174312000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i59183c7b0a0d42569a396d37e5f31cf2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfMy03LTEtMS0zOTMzMQ_d551f5e4-c3e2-451b-9a41-37dccf3b391a"
      unitRef="usd">5396000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNC0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOmYxYWMwYmIzZTVlZjQ3MjdhM2I1NjNhMTYxODBhMWVlXzQ5_aa847823-d029-4b4d-83a1-8d5babdaa7f1"
      unitRef="number">0.0312</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i5a27e7c144ff4f158da5313fe7ca7cf6_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNC0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOmYxYWMwYmIzZTVlZjQ3MjdhM2I1NjNhMTYxODBhMWVlXzU2_d244a28e-fe69-48c6-a45a-bb2eae1351e3"
      unitRef="number">0.0160</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNC0xLTEtMS0zOTMzMQ_871a9e6a-3a6f-45fd-a61e-7081f38ebfd9"
      unitRef="usd">85000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNC0zLTEtMS0zOTMzMQ_f7830119-693d-4aca-a06f-4ed1d293f775"
      unitRef="usd">3848000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5a27e7c144ff4f158da5313fe7ca7cf6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNC01LTEtMS0zOTMzMQ_76ac289e-3f76-46cd-ab8b-47e36e04850c"
      unitRef="usd">9200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i5a27e7c144ff4f158da5313fe7ca7cf6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNC03LTEtMS0zOTMzMQ_2e805510-f797-4345-a425-4a6c29fcacd3"
      unitRef="usd">991000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4e98009a6e864c61960639454ed150b9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNS0wLTEtMS0zOTMzMS90ZXh0cmVnaW9uOjkzMjE4M2Q0YzdiYjRkYWE4MWZjZGIwN2IyYjVlNGNkXzMw_58717450-ee71-4498-9b87-10780ef7d0f9"
      unitRef="number">0.0200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifefa74c81dd046a4a182bdbcbbcd35d9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNS0xLTEtMS0zOTMzMQ_cced58e0-50e9-4e0b-9efd-0af413929549"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ifefa74c81dd046a4a182bdbcbbcd35d9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNS0zLTEtMS0zOTMzMQ_821fd933-71ff-4e49-b5a2-cf764dc7764b"
      unitRef="usd">0</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4e98009a6e864c61960639454ed150b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNS01LTEtMS0zOTMzMQ_31824963-2dea-4ef9-a1e2-5a92c7092ccf"
      unitRef="usd">2426000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i4e98009a6e864c61960639454ed150b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNS03LTEtMS0zOTMzMQ_e372788a-7692-438d-9da0-c7b70c03c193"
      unitRef="usd">0</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNi0xLTEtMS0zOTMzMQ_24eb8f13-7612-47cb-8673-b4ed8a269db9"
      unitRef="usd">208875000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNi0zLTEtMS0zOTMzMQ_458b46c0-ad8e-49bd-962b-065ba4deddc8"
      unitRef="usd">7347000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNi01LTEtMS0zOTMzMQ_92782557-5c98-4200-8273-ce37b92de9e8"
      unitRef="usd">185938000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNi03LTEtMS0zOTMzMQ_894f6641-7647-48de-ac41-4468acc40742"
      unitRef="usd">6387000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebtCurrent
      contextRef="ifefa74c81dd046a4a182bdbcbbcd35d9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNy0xLTEtMS0zOTMzMQ_2fc50930-991d-4ad5-8188-48c89c21085e"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i4e98009a6e864c61960639454ed150b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfNy01LTEtMS0zOTMzMQ_5ea64850-77b6-4834-ba96-af2d09261291"
      unitRef="usd">2426000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfOC0xLTEtMS0zOTMzMQ_be70a53c-8ca2-4445-9bba-890cab42c2b4"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i59183c7b0a0d42569a396d37e5f31cf2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfOC01LTEtMS0zOTMzMQ_1966c554-7657-4c14-88b8-dc12678e7bf0"
      unitRef="usd">1750000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfOS0xLTEtMS0zOTMzMQ_44780552-7f61-4b76-ada0-8d44d51f4b2d"
      unitRef="usd">208875000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfOS0zLTEtMS0zOTMzMQ_4764ef23-334d-44e5-82c0-9722e80b6b79"
      unitRef="usd">7347000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfOS01LTEtMS0zOTMzMQ_945cae5a-1dc2-4dcb-aadb-c07b3740185b"
      unitRef="usd">181762000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOmJkNTVmNjE3NGE1MzQzMTk5NTg2ZjBhMjE5MzFmYzdkL3RhYmxlcmFuZ2U6YmQ1NWY2MTc0YTUzNDMxOTk1ODZmMGEyMTkzMWZjN2RfOS03LTEtMS0zOTMzMQ_ebb39c26-7a9a-4832-845a-10c8c80143ce"
      unitRef="usd">6387000</us-gaap:DeferredFinanceCostsNet>
    <ccrn:PaymentForDebtPrepayment
      contextRef="i192f55a490bc4b13a11411bf8375331d_D20220623-20220623"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzg0ODI5MDcwOTI1Ng_b1eca3d1-1d8c-4359-b4b6-77a572dc76cc"
      unitRef="usd">50000000</ccrn:PaymentForDebtPrepayment>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfOTQwNw_4e08b0a9-c971-4ae7-ad90-4246b264e77a">As of June 30, 2022, the aggregate schedule for maturities of debt are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Secured Asset-Based Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Through Years Ending December&#160;31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfMy0xLTEtMS0zOTMzMQ_514580a1-f1b3-4450-801f-963486aec1db"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfMy0zLTEtMS0zOTMzMQ_7c6bb9cd-3623-417f-b340-a5bea48941fa"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNC0xLTEtMS0zOTMzMQ_f4d8b4b8-3566-4776-a77c-652122f16862"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNC0zLTEtMS0zOTMzMQ_3c966f60-8dec-4962-b62e-fd53402945ec"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNS0xLTEtMS0zOTMzMQ_977a36be-d8f1-4d8e-8fc9-744318bd247a"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNS0zLTEtMS0zOTMzMQ_0f6645a2-b8dd-4aff-bac0-9ef6df02bfd5"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNi0xLTEtMS0zOTMzMQ_51a0b6da-c019-4a41-a4e6-658ec2c4817e"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNi0zLTEtMS0zOTMzMQ_bbdab2d1-349d-432b-8cba-aa5eb5ab0b30"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNy0xLTEtMS0zOTMzMQ_681fc178-c5dd-4094-a9fe-8285d7cf72da"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfNy0zLTEtMS0zOTMzMQ_8cc485d7-3bc5-4643-8f88-8a9f174cc0e0"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <ccrn:LongTermDebtMaturityAfterYearFour
      contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfOC0xLTEtMS0zOTMzMQ_41c8d11d-98dc-4367-9c55-0abeaa9729d7"
      unitRef="usd">123875000</ccrn:LongTermDebtMaturityAfterYearFour>
    <ccrn:LongTermDebtMaturityAfterYearFour
      contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfOC0zLTEtMS0zOTMzMQ_29e8f691-2b07-4abc-b3a5-ac2b251fb68a"
      unitRef="usd">85000000</ccrn:LongTermDebtMaturityAfterYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfOS0xLTEtMS0zOTMzMQ_e22631bb-4da0-48dc-8d0b-7cebdc77c567"
      unitRef="usd">123875000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8adc557041bd46c1aad7c9618f831b96_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RhYmxlOjE0NDY0Y2Y3MjdlZjRmMjE4MDJiM2E4MTVjMjk3MGYwL3RhYmxlcmFuZ2U6MTQ0NjRjZjcyN2VmNGYyMTgwMmIzYTgxNWMyOTcwZjBfOS0zLTEtMS0zOTMzMQ_5bd96dda-9f16-4994-9895-5fe762da1003"
      unitRef="usd">85000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentTerm
      contextRef="i50264a0fdd1a433d9a8447d69f0035fd_D20210608-20210608"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfOTQwOQ_1a4f2934-54ba-4b1f-be77-00a734612762">P6Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i68be6e52da804315993d34ceb671e045_I20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMTI1NQ_3c48b456-0c60-4cd0-acdc-5a0b8b315837"
      unitRef="usd">100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i13740719146d46bfa5f350cbdd53411e_D20210608-20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMTM2Mw_d68b00bc-0f03-445e-aa5f-fa48ca583ae5"
      unitRef="number">0.0575</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <ccrn:DebtInstrumentVariableInterestRateFloor
      contextRef="i13740719146d46bfa5f350cbdd53411e_D20210608-20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMTM5MA_ba6ff6ab-e48c-485d-85d8-ae6026920868"
      unitRef="number">0.0075</ccrn:DebtInstrumentVariableInterestRateFloor>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="ided7cff52c6e4850b72dad17899abe6e_D20210930-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMjI1Mw_530e98f5-8190-4e63-9f4a-ede233cd13d0"
      unitRef="usd">300000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iab471474c53b443eb54c1499c93e0f21_I20211118"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzA1NA_b6165a74-1d06-4b85-9b9d-b4cd1f26a012"
      unitRef="usd">75000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i54b8d8616dab4fadae7e75406657ca20_I20211118"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzIxMg_887ba4e6-c693-4c13-83fb-2acf4c32cebb"
      unitRef="usd">115000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i5c3977ce54064bf697411bb87b1c135b_D20211231-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzM5OA_2cd51686-5bf8-4f16-96d7-522f36675162"
      unitRef="usd">400000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <ccrn:PaymentForDebtPrepayment
      contextRef="i192f55a490bc4b13a11411bf8375331d_D20220623-20220623"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzg0ODI5MDcwNzMzOQ_8eb1fb1b-21b5-448e-8c98-7e3cd64b16d2"
      unitRef="usd">50000000</ccrn:PaymentForDebtPrepayment>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i192f55a490bc4b13a11411bf8375331d_D20220623-20220623"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzg0ODI5MDcwNzMyMg_87e0fcff-48c1-4c55-8fc3-8a763ccc10e8"
      unitRef="usd">500000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i292cd5b0d4684b41981daf8445d9f078_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfMzg0ODI5MDcwNzkwNA_38a9e602-154e-45fc-8705-310432bcfcbd"
      unitRef="usd">1400000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="i15fbcb21001e48dbbc8416ff64ed2806_D20191025-20191025"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfOTQxNA_a759d129-d762-4faa-805b-a7c57c806768">P5Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if2408cf0e0744cf0a51dbfcd008b71e2_I20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTE2Ng_857c5aba-9db2-4944-b4f7-947f54ca75f7"
      unitRef="usd">120000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i83732e8193cb492394faa19420b680d4_I20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTIzNA_f6f68f98-191c-428d-95ea-b511e35a443d"
      unitRef="usd">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3c0d2cadfb0a4cfb9357b9111fdacb7a_I20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTI0Mw_d5ee4971-bce1-434b-ad85-bd1b1206a98d"
      unitRef="usd">35000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if2408cf0e0744cf0a51dbfcd008b71e2_I20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTQzMQ_1489aaca-c5b3-43b2-be7a-acf5ccc4cb57"
      unitRef="usd">120000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i82b501029b6b4759a00e12cfe8165a29_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTQzNw_1a3f47d6-21d4-4a51-8427-c86d58583cca"
      unitRef="usd">130000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i82b501029b6b4759a00e12cfe8165a29_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTY4MQ_ecdf2270-86ba-470a-80ac-eba4152f7b24"
      unitRef="usd">130000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if24ce204b488479499da054c091fc827_I20210308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNTY4Nw_e2066efd-f03d-467b-afbf-9bc9a4e6c291"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <ccrn:LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources
      contextRef="i522e12765bc4480e83302783fd04656b_I20211118"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNjM5Mw_d156afc4-89b4-41c4-b734-bf7012a227a0"
      unitRef="usd">175000000</ccrn:LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if24ce204b488479499da054c091fc827_I20210308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNjU0Mw_7f22f4c6-bd43-4ba4-94d5-767401b420b0"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7f0de89c6ea44abd90a514fbdcf1d0c8_I20220321"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNjU0OQ_d306d6d1-c84c-4e53-88ba-6b4aac293b7a"
      unitRef="usd">300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="ia26394bf64ed4410939d860acc9b1d9d_D20220321-20220321"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfOTQwNA_79a44350-4adf-4b86-8b46-86a527e730bb">P5Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <ccrn:LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR
      contextRef="ia26394bf64ed4410939d860acc9b1d9d_D20220321-20220321"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNjkzOA_8e26440a-2bff-4edb-ab5d-c760fa1f7fb9"
      unitRef="number">0.0010</ccrn:LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR>
    <ccrn:LineOfCreditBorrowingBasePercentageOfAssets
      contextRef="if2408cf0e0744cf0a51dbfcd008b71e2_I20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNzMxMg_331e93c0-feda-459f-99fa-5714310adc25"
      unitRef="number">0.85</ccrn:LineOfCreditBorrowingBasePercentageOfAssets>
    <ccrn:LineOfCreditFacilityBorrowingBaseAvailability
      contextRef="i217e4a8af4e34fdba46527b4d110ea93_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNzczOQ_dc330a9e-b78d-489c-bfa8-97ca2e8fc2e5"
      unitRef="usd">300000000</ccrn:LineOfCreditFacilityBorrowingBaseAvailability>
    <us-gaap:LineOfCredit
      contextRef="i217e4a8af4e34fdba46527b4d110ea93_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNzc2Mg_a4e6f0b2-b8b2-4cce-8ded-863aa099b8d1"
      unitRef="usd">85000000</us-gaap:LineOfCredit>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i217e4a8af4e34fdba46527b4d110ea93_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNzc5Nw_27e34538-d19a-4b7c-9ad2-6d14a19228b4"
      unitRef="usd">17500000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i217e4a8af4e34fdba46527b4d110ea93_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfNzkxMQ_9e505152-b056-469e-b283-b838e29db875"
      unitRef="usd">197500000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id1e947347db04c70921aea757a478098_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfODA0NA_045cbd0b-1e23-4345-9a7e-d7fac9e8dfb6"
      unitRef="number">0.0160</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i79663bc76cf8454ea92834abe34d819f_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfODE2OA_f0eb2036-c73e-4a2b-8b5c-eab177e49f4d"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i744622b84e6e4593840fc16870ce088e_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM181OC9mcmFnOjc4ZjFhZWE5NWMxZTQ4YmM5ZjA3OWYyMGFlY2RmMDUyL3RleHRyZWdpb246NzhmMWFlYTk1YzFlNDhiYzlmMDc5ZjIwYWVjZGYwNTJfODUxNg_586e3f68-ef26-4706-964a-0b33e24eeded"
      unitRef="number">0.00375</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfMzMwNg_076e258a-e92b-45b2-90fa-67c574d0bfd7">LEASES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's lease population of its right-of-use asset and lease liabilities is substantially related to the rental of office space. The Company enters into lease agreements as a lessee that may include options to extend or terminate early. Some of these real estate leases require variable payments of property taxes, insurance, and common area maintenance, in addition to base rent. Certain of the leases have provisions for free rent months during the lease term and/or escalating rent payments and, particularly for the Company&#x2019;s longer-term leases for its corporate offices, it has received incentives to enter into the leases, such as receiving up to a specified dollar amount to construct tenant improvements. These leases do not include residual value guarantees, covenants, or other restrictions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in the second quarter of 2020, in connection with the continuing developments from COVID, the Company expedited restructuring plans and either reduced or fully vacated leased office space. The Company is in the process of seeking to sublet some of the space where possible. The Company did not record any lease-related impairment charges for the three months ended June 30, 2022. The decision and change in the use of space resulted in a right-of-use asset impairment charge of $1.5&#160;million for the three months ended March 31, 2022 and $1.7&#160;million for the three months ended June 30, 2021. This loss was determined by comparing the fair value of the impacted right-of-use assets to the carrying value of the assets as of the impairment measurement date. The fair value of the right-of-use assets was based on the estimated sublease income for the space taking into consideration the time period it will take to obtain a subtenant, the applicable discount rate, and the sublease rate. For the three months ended March 31, 2022 and June 30, 2021, the Company wrote off an immaterial amount of leasehold improvements and other property and equipment related to these locations. The measurement of the right-of-use asset impairments, using the assumptions described, is a Level 3 fair value measurement. See Note 10 - Fair Value Measurements for a description of Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the lease-related assets and liabilities included on the condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Classification on Condensed Consolidated Balance Sheets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - non-current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below reconciles the undiscounted cash flows for each of, and total of, the remaining years to the operating lease liabilities (which do not include short-term leases) recorded on the condensed consolidated balance sheets as of June 30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ending December&#160;31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: operating lease liabilities - current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - non-current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides information regarding supplemental cash flows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Cash Flow Information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets acquired under operating lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Included in Condensed Consolidated Statements of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable and other lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Included in Condensed Consolidated Statements of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable and other lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease expense, short-term lease expense, and variable and other lease costs are included in selling, general and administrative expenses, direct operating expenses, and restructuring (benefits) costs in the condensed consolidated statements of operations, depending on the nature of the leased asset. Operating lease expense is reported net of sublease income, which is not material. Variable and other lease costs for the three and six months ended June 30, 2022 include a benefit associated with the early termination of one of the Company's corporate offices which was previously restructured.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2022, the Company does not have any material operating leases which have not yet commenced. The Company has an immaterial&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amount of finance lease contracts related to other equipment rentals which are not included in the above disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfNDM5ODA0NjUxNTA5MQ_1530fd1b-3766-4d3f-a653-793890901975"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfNDM5ODA0NjUxNTA5MQ_77135d52-c685-443f-b198-d02715196cdc"
      unitRef="usd">0</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="i901eb837ca884f56bf62787429027b0d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfMzg0ODI5MDcwMTUzMg_367749dd-d73c-44a1-b4bf-e55ee72ceacc"
      unitRef="usd">1500000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfMzg0ODI5MDcwMDYxOA_971d63be-a997-45bd-8c40-fafb48cde072"
      unitRef="usd">1700000</us-gaap:OperatingLeaseImpairmentLoss>
    <ccrn:AssetsAndLiabilitiesLeasesTableTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfMzMwOQ_641724c0-a7cc-4e80-91b2-ec7b390b169e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the lease-related assets and liabilities included on the condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Classification on Condensed Consolidated Balance Sheets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - non-current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ccrn:AssetsAndLiabilitiesLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmFkYTdjZWJjNTIyMTQ1NDM4Y2JkY2Y5YmM3ODc4MGUyL3RhYmxlcmFuZ2U6YWRhN2NlYmM1MjIxNDU0MzhjYmRjZjliYzc4NzgwZTJfMi0xLTEtMS0zOTMzMQ_1dcd425a-e792-4c5d-a21a-2dd71a73244c"
      unitRef="usd">5058000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmFkYTdjZWJjNTIyMTQ1NDM4Y2JkY2Y5YmM3ODc4MGUyL3RhYmxlcmFuZ2U6YWRhN2NlYmM1MjIxNDU0MzhjYmRjZjliYzc4NzgwZTJfMi0zLTEtMS0zOTMzMQ_2251b7e2-5c36-4861-a8f6-66ad42bd5ac9"
      unitRef="usd">7488000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmFkYTdjZWJjNTIyMTQ1NDM4Y2JkY2Y5YmM3ODc4MGUyL3RhYmxlcmFuZ2U6YWRhN2NlYmM1MjIxNDU0MzhjYmRjZjliYzc4NzgwZTJfMy0xLTEtMS0zOTMzMQ_4bd34f6d-cdd7-4626-bdaf-697cc50621ef"
      unitRef="usd">4145000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmFkYTdjZWJjNTIyMTQ1NDM4Y2JkY2Y5YmM3ODc4MGUyL3RhYmxlcmFuZ2U6YWRhN2NlYmM1MjIxNDU0MzhjYmRjZjliYzc4NzgwZTJfMy0zLTEtMS0zOTMzMQ_57eed3e6-28e0-4cde-badd-a00e3c632c35"
      unitRef="usd">4090000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmFkYTdjZWJjNTIyMTQ1NDM4Y2JkY2Y5YmM3ODc4MGUyL3RhYmxlcmFuZ2U6YWRhN2NlYmM1MjIxNDU0MzhjYmRjZjliYzc4NzgwZTJfNC0xLTEtMS0zOTMzMQ_da456a4c-ccf9-44bc-9eb8-448e5496e19d"
      unitRef="usd">7017000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmFkYTdjZWJjNTIyMTQ1NDM4Y2JkY2Y5YmM3ODc4MGUyL3RhYmxlcmFuZ2U6YWRhN2NlYmM1MjIxNDU0MzhjYmRjZjliYzc4NzgwZTJfNC0zLTEtMS0zOTMzMQ_cd081710-d736-459d-b834-e51e2c7f8bd0"
      unitRef="usd">10853000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjRlZjIyYzJkMzU0MjRjYzk4ODg0NGM2MTI1YTVmMmE3L3RhYmxlcmFuZ2U6NGVmMjJjMmQzNTQyNGNjOTg4ODQ0YzYxMjVhNWYyYTdfMS0xLTEtMS0zOTMzMQ_55219b9d-8cb3-42a2-9a33-a09dbbe256eb">P2Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjRlZjIyYzJkMzU0MjRjYzk4ODg0NGM2MTI1YTVmMmE3L3RhYmxlcmFuZ2U6NGVmMjJjMmQzNTQyNGNjOTg4ODQ0YzYxMjVhNWYyYTdfMS0zLTEtMS0zOTMzMQ_efcbd14f-0caa-483a-94c8-3545e6770899">P3Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjRlZjIyYzJkMzU0MjRjYzk4ODg0NGM2MTI1YTVmMmE3L3RhYmxlcmFuZ2U6NGVmMjJjMmQzNTQyNGNjOTg4ODQ0YzYxMjVhNWYyYTdfMi0xLTEtMS0zOTMzMQ_170eb928-bae9-42fe-9407-86c99018399d"
      unitRef="number">0.0629</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ib1b4fd715e5f4320a19dcfe134293e02_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjRlZjIyYzJkMzU0MjRjYzk4ODg0NGM2MTI1YTVmMmE3L3RhYmxlcmFuZ2U6NGVmMjJjMmQzNTQyNGNjOTg4ODQ0YzYxMjVhNWYyYTdfMi0zLTEtMS0zOTMzMQ_268385d6-4f6a-4320-902a-2b90feda2584"
      unitRef="number">0.0639</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfMzMxMQ_f9c4b61c-5f4c-49f2-bad6-b1661f115498">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below reconciles the undiscounted cash flows for each of, and total of, the remaining years to the operating lease liabilities (which do not include short-term leases) recorded on the condensed consolidated balance sheets as of June 30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ending December&#160;31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: operating lease liabilities - current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - non-current&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfMi0xLTEtMS0zOTMzMQ_6ca37513-a71f-46c3-91b8-9ce5c865ee79"
      unitRef="usd">2174000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfMy0xLTEtMS0zOTMzMQ_bfa13862-5b25-4a08-9dc7-f98f8753d143"
      unitRef="usd">5114000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfNC0xLTEtMS0zOTMzMQ_10b38e5b-8fd7-42a8-bca1-0d90101111f4"
      unitRef="usd">3020000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfNS0xLTEtMS0zOTMzMQ_168b71e3-ee09-45c1-97b6-98fc854d7dd2"
      unitRef="usd">1868000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfNy0xLTEtMS0zOTMzMQ_be48b6ee-7f8e-463e-b674-57c3709d1c1d"
      unitRef="usd">12176000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfOC0xLTEtMS0zOTMzMQ_463ee713-de2a-4be0-8b97-0b79fc44641e"
      unitRef="usd">1014000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfOS0xLTEtMS0zOTMzMQ_49c9c38d-b9ad-4bd9-8745-a43bd83619aa"
      unitRef="usd">11162000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfMTAtMS0xLTEtMzkzMzE_c7f12a93-d41a-4d9f-9362-f083b88de79d"
      unitRef="usd">4145000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOmY2YmQxNDFlM2FmYTRiNjk4M2VhMWFhM2I3MzVhYWQ1L3RhYmxlcmFuZ2U6ZjZiZDE0MWUzYWZhNGI2OTgzZWExYWEzYjczNWFhZDVfMTEtMS0xLTEtMzkzMzE_b7ccf843-6807-402d-88dd-10a3f1db4054"
      unitRef="usd">7017000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RleHRyZWdpb246ZDU5YmQyMTU4ZTU5NDNhZDlmNTdmODUzYWNiZWY3NDhfMzMwNA_84b84236-dc08-4b38-98d8-dcac051cab88">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides information regarding supplemental cash flows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental Cash Flow Information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets acquired under operating lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Included in Condensed Consolidated Statements of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable and other lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Included in Condensed Consolidated Statements of Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable and other lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjJmZDhmYTBlYmQxZDRkNjViNGVkZWE5N2YxN2FjNGE3L3RhYmxlcmFuZ2U6MmZkOGZhMGViZDFkNGQ2NWI0ZWRlYTk3ZjE3YWM0YTdfNS0xLTEtMS0zOTMzMQ_1b42e4d0-ca92-45ea-85bc-4c5dc4f19855"
      unitRef="usd">3135000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjJmZDhmYTBlYmQxZDRkNjViNGVkZWE5N2YxN2FjNGE3L3RhYmxlcmFuZ2U6MmZkOGZhMGViZDFkNGQ2NWI0ZWRlYTk3ZjE3YWM0YTdfNS0zLTEtMS0zOTMzMQ_8dc9bd35-9086-47c8-8e9d-e33052d0fdde"
      unitRef="usd">3189000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjJmZDhmYTBlYmQxZDRkNjViNGVkZWE5N2YxN2FjNGE3L3RhYmxlcmFuZ2U6MmZkOGZhMGViZDFkNGQ2NWI0ZWRlYTk3ZjE3YWM0YTdfNi0xLTEtMS0zOTMzMQ_226a0b59-d6dd-43e5-9f80-18dbd1a768a0"
      unitRef="usd">60000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjJmZDhmYTBlYmQxZDRkNjViNGVkZWE5N2YxN2FjNGE3L3RhYmxlcmFuZ2U6MmZkOGZhMGViZDFkNGQ2NWI0ZWRlYTk3ZjE3YWM0YTdfNi0zLTEtMS0zOTMzMQ_0da02c70-ade8-49d3-b701-7ad46b55d218"
      unitRef="usd">1078000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseCost
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfNS0xLTEtMS0zOTMzMQ_b20f6a59-4cb8-4f95-83e1-eccb0062c678"
      unitRef="usd">645000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfNS0zLTEtMS0zOTMzMQ_93d04f5e-d670-4c3d-bd60-76fb35116831"
      unitRef="usd">938000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfNi0xLTEtMS0zOTMzMQ_0a11bf2c-3c30-4eef-82ed-e8b6ee6fb828"
      unitRef="usd">1241000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfNi0zLTEtMS0zOTMzMQ_820451fd-14cd-4a5b-ac4c-84531e482188"
      unitRef="usd">641000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfNy0xLTEtMS0zOTMzMQ_34231674-6cb4-40e5-bc24-ef303ea4894a"
      unitRef="usd">-1110000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfNy0zLTEtMS0zOTMzMQ_9a8789c4-6ab3-48e2-9f42-79e7f363ac76"
      unitRef="usd">751000</us-gaap:VariableLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfMTQtMS0xLTEtMzkzMzE_050f6852-98cd-487f-a2a1-aee92dd2f9c5"
      unitRef="usd">1447000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfMTQtMy0xLTEtMzkzMzE_6f5807e5-50ec-4892-8dcd-f899699aada1"
      unitRef="usd">1852000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfMTUtMS0xLTEtMzkzMzE_31a729ea-7186-43fc-86bb-a6dd6162d7e3"
      unitRef="usd">2385000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfMTUtMy0xLTEtMzkzMzE_7a0cf056-6f59-4e10-b41b-b3aee51b1529"
      unitRef="usd">1490000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfMTYtMS0xLTEtMzkzMzE_090e097e-4b1f-4b6e-8348-29d65d54050e"
      unitRef="usd">-353000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182MS9mcmFnOmQ1OWJkMjE1OGU1OTQzYWQ5ZjU3Zjg1M2FjYmVmNzQ4L3RhYmxlOjc1YWE5YTliMTE4MTQwZTZhOTc0ZjNkOGMyMDAyYWY2L3RhYmxlcmFuZ2U6NzVhYTlhOWIxMTgxNDBlNmE5NzRmM2Q4YzIwMDJhZjZfMTYtMy0xLTEtMzkzMzE_11e235d7-e8c1-4eb8-8893-d557fe90d32e"
      unitRef="usd">1220000</us-gaap:VariableLeaseCost>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RleHRyZWdpb246Y2E4MWRhM2JlZDJjNGU0M2EzZDRiYTJjN2M3NTFiNTRfNTA0MQ_65c8b806-b37a-4784-8712-32c97aa9de07">FAIR VALUE MEASUREMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy was established which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Items Measured at Fair Value on a Recurring Basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial assets/liabilities required to be measured on a recurring basis were its: (i) deferred compensation asset included in other non-current assets; and (ii) deferred compensation liability included in other long-term liabilities on its condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company utilizes Level 1 inputs to value its deferred compensation assets and liabilities. The Company&#x2019;s deferred compensation assets and liabilities are measured using publicly available indices, as per the plan documents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s financial assets and liabilities measured on a recurring basis is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Items Measured at Fair Value on a Non-Recurring Basis:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's non-financial assets, such as goodwill, trade names, other intangible assets, right-of-use assets, and property and equipment, are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The six months ended June 30, 2022 and 2021 included impairment charges to right-of-use assets along with related property and equipment in connection with leases that were vacated. Accordingly, as of June 30, 2022 and 2021, these assets were recorded at fair value using Level 3 inputs. See Note 9 - Leases for more information about these fair value measurements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Fair Value Disclosures:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Financial instruments not measured or recorded at fair value in the condensed consolidated balance sheets consist of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses. The estimated fair value of accounts receivable and accounts payable and&#160;accrued expenses approximate their carrying amount due to the short-term nature of these instruments. Other financial instruments not measured or recorded at fair value include: (i) note payable, (ii) ABL, (iii) term loan, and (iv) and (v) earnout liabilities, as discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(i) The Company paid the third and final installment on its note payable in the first quarter of 2022. Due to its relatively short-term nature, the carrying value of the note payable approximated its fair value. (ii) The carrying amount of the Company's ABL approximates fair value because the interest rates are variable and reflective of market rates. (iii) The estimated fair value of the Company's term loan was calculated applying an interest rate lattice model using Level 2 inputs from available market information. (iv) Potential earnout payments related to the WSG acquisition are contingent upon meeting certain performance requirements based on 2021 through 2023 performance. The Company performed an analysis using multiple forecasted scenarios to determine the fair value of the earnout liability. The earnout liability's carrying amount approximates fair value and is included in current portion of earnout liability and non-current earnout liability on the condensed consolidated balance sheets. (v) Potential earnout payments related to the Selected acquisition were contingent upon meeting certain performance requirements based on 2022 and 2023 revenues. The earnout liability's carrying amount approximates fair value and was included in current portion of earnout liability and non-current earnout liability on the condensed consolidated balance sheets. In the second quarter of 2022, the Company determined that the contingent consideration earnout related to the Selected acquisition would not be achieved for 2022 and 2023 and, as a result, the entire liability was reversed. See Note 4 - Acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts and estimated fair value of the Company&#x2019;s significant financial instruments that were not measured at fair value are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note Payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Asset-Based Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnout Liability (WSG)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnout Liability (Selected)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See discussion of credit losses and allowance for doubtful accounts in Note 2 - Summary of Significant Accounting Policies. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Overall, based on the large number of customers in differing geographic areas, primarily throughout the United States and its territories, the Company believes the concentration of credit risk is limited.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RleHRyZWdpb246Y2E4MWRhM2JlZDJjNGU0M2EzZDRiYTJjN2M3NTFiNTRfNTA1Mw_97f28c4a-4bc5-4f17-8566-c039269b84d1">The estimated fair value of the Company&#x2019;s financial assets and liabilities measured on a recurring basis is as follows:&#160;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib11f714337624b81b95fbf29632b3e86_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmY3N2JkOWVhNmM4NjQ1NjM4ZGQ4MDY0ODFiYWYyOTVkL3RhYmxlcmFuZ2U6Zjc3YmQ5ZWE2Yzg2NDU2MzhkZDgwNjQ4MWJhZjI5NWRfNC0xLTEtMS0zOTMzMQ_48936987-70c1-42f9-b06c-935c92938bb3"
      unitRef="usd">1181000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iec21b6d449de4e3c8935b693d4938157_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmY3N2JkOWVhNmM4NjQ1NjM4ZGQ4MDY0ODFiYWYyOTVkL3RhYmxlcmFuZ2U6Zjc3YmQ5ZWE2Yzg2NDU2MzhkZDgwNjQ4MWJhZjI5NWRfNC0zLTEtMS0zOTMzMQ_fc38d009-084b-44e0-bcbf-c7f88041491b"
      unitRef="usd">1398000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ife18debf13894b69a0178110599379d5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmY3N2JkOWVhNmM4NjQ1NjM4ZGQ4MDY0ODFiYWYyOTVkL3RhYmxlcmFuZ2U6Zjc3YmQ5ZWE2Yzg2NDU2MzhkZDgwNjQ4MWJhZjI5NWRfNy0xLTEtMS0zOTMzMQ_dd7defd2-018e-48b3-8d92-d6fbacbc891c"
      unitRef="usd">2274000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ib2384a0e875f4fe2ab84ead51c98f914_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmY3N2JkOWVhNmM4NjQ1NjM4ZGQ4MDY0ODFiYWYyOTVkL3RhYmxlcmFuZ2U6Zjc3YmQ5ZWE2Yzg2NDU2MzhkZDgwNjQ4MWJhZjI5NWRfNy0zLTEtMS0zOTMzMQ_f4971b73-6396-4728-b104-33176fa0cb62"
      unitRef="usd">2457000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RleHRyZWdpb246Y2E4MWRhM2JlZDJjNGU0M2EzZDRiYTJjN2M3NTFiNTRfNTAzMw_84797f3a-4d65-4f28-8447-0f8b7ebda503">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts and estimated fair value of the Company&#x2019;s significant financial instruments that were not measured at fair value are as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.108%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note Payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Asset-Based Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnout Liability (WSG)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnout Liability (Selected)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia801d6ec97434f77b5185c504d4dd03d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNS0xLTEtMS0zOTMzMQ_9fec7eb1-28a3-4880-a75c-9860254ecfc3"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i8757da1f937e4835a03d88e39ffd3134_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNS0zLTEtMS0zOTMzMQ_f0e377b4-741c-4a0c-906d-64b53423dea7"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if30c1a9abfaa4b8591cc814cac5da11b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNS01LTEtMS0zOTMzMQ_0647c9d9-b807-472a-be7c-ec39662d5e0d"
      unitRef="usd">2426000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia28c4adf56ef473b81222066e0f6bab4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNS03LTEtMS0zOTMzMQ_c8a699f8-a038-4d0e-906b-1fc1a20f4ba1"
      unitRef="usd">2426000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="if2b289aa8b0f4bb297cf5af62491dd19_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNi0xLTEtMS0zOTMzMQ_8b6e388e-3048-404f-b567-69101e161bee"
      unitRef="usd">85000000</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="ib938672d8ae84dcaaf92e08eb3bd8e91_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNi0zLTEtMS0zOTMzMQ_7e3bdcc3-48c5-4112-8615-4e301cbe7b24"
      unitRef="usd">85000000</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="i34f90c0620cd48ca9ad8a72c38f6bd27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNi01LTEtMS0zOTMzMQ_2aa0c470-9ee0-485a-8ca1-98c2539c7854"
      unitRef="usd">9200000</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:LinesOfCreditFairValueDisclosure
      contextRef="icd2145204d454b038df9969fda6aba63_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNi03LTEtMS0zOTMzMQ_78e597ed-f27c-4c61-b597-bbc49b55191f"
      unitRef="usd">9200000</us-gaap:LinesOfCreditFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="icc259a1981dd4d899a03b46cd1bd6311_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNy0xLTEtMS0zOTMzMQ_b6e396af-dd2b-474a-96ed-c8d7cc9968d9"
      unitRef="usd">123875000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i400cb6bbb3d8415c9ce00409549a9981_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNy0zLTEtMS0zOTMzMQ_7d78a9ec-c105-4061-83b7-ef1180465972"
      unitRef="usd">118386000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i7d0a8e32b5d9415ea6ddc671aea7986c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNy01LTEtMS0zOTMzMQ_47161363-e3f4-462a-9561-5cc8c7551fdd"
      unitRef="usd">174312000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id739059325464c648e732b5b9492ad1b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfNy03LTEtMS0zOTMzMQ_f823c681-2872-440a-bafc-ffc73eb8e781"
      unitRef="usd">174845000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib1337e8b15554efd83e0ffd2872603fa_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOC0xLTEtMS0zOTMzMQ_b41fd570-3076-41fa-8523-cac840198328"
      unitRef="usd">15000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ide48511e0c344631b47d7e4c4b0171bd_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOC0zLTEtMS0zOTMzMQ_afb523fa-1bf3-4a76-b624-9f4c98a3e62d"
      unitRef="usd">15000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i6df7ed8d4d9942dfa095df93b4a7ae83_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOC01LTEtMS0zOTMzMQ_63e24e2c-b043-485f-a969-62095a6a1a26"
      unitRef="usd">15000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie33c5b897ac646ec9c437ba3d4e036bd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOC03LTEtMS0zOTMzMQ_76e549eb-db4b-411c-9cbe-ce3b0dad62f4"
      unitRef="usd">15000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i2fbdf4e4242e42b081d7c65a199e7f48_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOS0xLTEtMS0zOTMzMQ_4a189785-00f6-49b4-a89d-d2a14859779d"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1d26b10494d9470ca481d6bcf4a4096c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOS0zLTEtMS0zOTMzMQ_d8beea54-2ccd-49d4-a75c-894e477a81d7"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4875239875ba43d69f254dacac91eda3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOS01LTEtMS0zOTMzMQ_9d9bbae0-9846-4056-95bd-12e14722e6ab"
      unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ifca25155201b4bddafc6f616f359148c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182NC9mcmFnOmNhODFkYTNiZWQyYzRlNDNhM2Q0YmEyYzdjNzUxYjU0L3RhYmxlOmFhODEyYWNhMjhkZTQ1ZjY5NDJhZGMzY2YyZDEwNmU2L3RhYmxlcmFuZ2U6YWE4MTJhY2EyOGRlNDVmNjk0MmFkYzNjZjJkMTA2ZTZfOS03LTEtMS0zOTMzMQ_f7ba91f3-fb65-44be-90a1-f7ec138587ab"
      unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzIxMg_beed8cbd-627c-4bb0-98b9-bd29e0fa5fe2">STOCKHOLDERS&#x2019; EQUITY&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On February 28, 2008, our Board of Directors authorized our most recent stock repurchase program whereby we may purchase up to 1.5&#160;million of our common shares, subject to the terms of our current credit agreements. The shares may be repurchased from time-to-time in the open market and the repurchase program may be discontinued at any time at our discretion. During the six months ended June 30, 2022 and 2021, the Company did not repurchase any shares of its common stock. As of June&#160;30, 2022, the Company has 510,004 shares of common stock under the current share repurchase program available to repurchase, subject to certain conditions in the Company's Loan Agreement and Term Loan Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share-Based Payments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 19, 2020, the Company's stockholders approved the Cross Country Healthcare, Inc. 2020 Omnibus Incentive Plan (2020 Plan), which replaced the 2017 Omnibus Incentive Plan (2017 Plan), and applies to awards granted after May 19, 2020. The remaining shares available for grant under the 2017 Plan were cancelled and no further awards will be granted under that plan. The 2020 Plan generally mirrors the terms of the 2017 Plan and includes the following provisions: (i) an aggregate share reserve of 3,000,000 shares; (2) annual dollar and share limits of awards granted to employees and consultants, as well as non-employee directors, based on type of award; (3) awards granted generally will be subject to a minimum one-year vesting schedule; and (4) awards may be granted under the 2020 Plan until March 24, 2030.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan and the 2020 Plan (Plans) for the six months ended June&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Performance Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Target &lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock awards, January&#160;1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(575,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock awards, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock awards granted under the Company&#x2019;s Plans entitle the holder to receive, at the end of a vesting period, a specified number of shares of the Company&#x2019;s common stock. Share-based compensation expense is measured by the market value of the Company&#x2019;s stock on the date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards granted to non-employee directors under the 2017 Plan, prior to the adoption of the 2020 Plan, vest in three equal installments on the first, second, and third anniversaries of the grant date, while restricted shares granted under the 2020 Plan on and subsequent to June 2020 will vest on the first anniversary of such grant date, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;or earlier subject to retirement eligibility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In addition, effective in the three months ended June 30, 2020, the Company implemented modified guidelines that provide for accelerated vesting of restricted stock grants on the last date of service when a retirement-eligible director retires.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Plans, the number of target shares that are issued for performance-based stock awards are determined based on the level of attainment of the targets. During the first quarter of 2022, the Company's Compensation Committee of the Board of Directors approved a 120% level of attainment for the 2019 performance-based share awards, resulting in the issuance of 170,278 performance shares that vested on March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the three and six months ended June 30, 2022, $2.1 million and $3.7&#160;million, respectively, was included in selling, general and administrative expenses related to share-based payments, and a net of 80,200 and 499,700 shares, respectively, of common stock were issued upon the vesting of restricted and performance stock.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended June 30, 2021, $2.1 million and $3.5&#160;million, respectively, was included in selling, general and administrative expenses related to share-based payments, and a net of 159,025 and 476,630 shares, respectively, of common stock were issued upon the vesting of restricted stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="iaf0b19c2fa5d44578370990b5584d68a_I20080228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzg0ODI5MDcwMTIzMA_7e93ef3a-5cb1-4ebd-9022-89e6e81dfc73"
      unitRef="shares">1500000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i25f9ce0742594c3b883c445ec9f65431_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMTI5_1b8df652-a6a9-416e-996e-48e2e9bc5c3f"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i8e54d79ab9284085bcf0c45bcd9c139a_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMTI5_8e59cc47-c793-4cd0-9081-ec2817f07942"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
      contextRef="ib8c3eb7e773141eeacba6e9a970bc860_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMjAx_0f5dec32-fbef-49c7-9d4e-b1b5ecbf767c"
      unitRef="shares">510004</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ie26d32fbbb214db89f00ca5ce7718efc_I20200519"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfOTA3_096484a4-a332-492c-b84a-749df20c5647"
      unitRef="shares">3000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if3a6eab5e44b46c9aa104ee3b7965107_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzIyMg_9e5b5dea-fcb8-49a3-869c-2564d4953d64">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzIyNA_cbd3fb70-7777-43a4-98e7-02f643f4d01b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes restricted stock awards and performance stock awards activity issued under the 2017 Plan and the 2020 Plan (Plans) for the six months ended June&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Performance Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Target &lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock awards, January&#160;1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(575,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested restricted stock awards, June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if4eba8a27a3045758fc0c06e41d5704b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMi0xLTEtMS0zOTMzMQ_38bb0c99-8d8d-44be-9833-fd500dba779c"
      unitRef="shares">1039455</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if4eba8a27a3045758fc0c06e41d5704b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMi0zLTEtMS0zOTMzMQ_89a9fe30-593c-4d95-8303-f8ead4fb6574"
      unitRef="usdPerShare">9.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i956eb0b29bb74ffdb6756b06306769ab_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMi01LTEtMS0zOTMzMQ_9dfe94f3-fd5b-420f-b850-1a7bab71e629"
      unitRef="shares">522166</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i956eb0b29bb74ffdb6756b06306769ab_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMi03LTEtMS0zOTMzMQ_6730fd4f-48f7-49bb-a616-8dcbcc5e2ff1"
      unitRef="usdPerShare">8.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMy0xLTEtMS0zOTMzMQ_fadfe065-5621-4a7b-97a9-d7f31d8afcfb"
      unitRef="shares">283625</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMy0zLTEtMS0zOTMzMQ_ff6190fa-b373-47ec-8eea-cc450aff505c"
      unitRef="usdPerShare">20.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMy01LTEtMS0zOTMzMQ_e100d32f-7cd6-487f-8156-451c354c3e5d"
      unitRef="shares">171873</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfMy03LTEtMS0zOTMzMQ_99c525d7-4343-4411-8df0-7cd17d7332c9"
      unitRef="usdPerShare">18.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNC0xLTEtMS0zOTMzMQ_294e2b58-d126-4bb4-918c-01a86e05ea96"
      unitRef="shares">575051</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNC0zLTEtMS0zOTMzMQ_412cea03-887c-4317-916a-98369b06bb35"
      unitRef="usdPerShare">9.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNC01LTEtMS0zOTMzMQ_281cc66d-2934-41a2-8c5a-fc886b921650"
      unitRef="shares">170278</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNC03LTEtMS0zOTMzMQ_0f7844a7-dc47-4532-8aee-cf4ee269d1ba"
      unitRef="usdPerShare">7.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNS0xLTEtMS0zOTMzMQ_5f7f118a-dd2f-43ab-9171-e6e11f8797b5"
      unitRef="shares">35117</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNS0zLTEtMS0zOTMzMQ_05b75417-7be1-47da-b3f0-c39840ac9a55"
      unitRef="usdPerShare">14.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNS01LTEtMS0zOTMzMQ_1f523795-bf25-4ddf-b6c3-ddbfa27f97ca"
      unitRef="shares">13877</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ibe256cd9d0d8428db7c2fed79f760628_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNS03LTEtMS0zOTMzMQ_125297c1-5821-4632-8a1b-f96a7d1dece5"
      unitRef="usdPerShare">12.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ieff115cae5e34e28b5383a9a88245810_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNi0xLTEtMS0zOTMzMQ_02f302a0-f080-4f2d-94d4-99c477df0129"
      unitRef="shares">712912</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ieff115cae5e34e28b5383a9a88245810_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNi0zLTEtMS0zOTMzMQ_ea07ce54-8a67-42a2-b002-9e81778abbd8"
      unitRef="usdPerShare">14.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0ab71c9c84ee4815b1628aa855d13c01_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNi01LTEtMS0zOTMzMQ_c6f3de40-546e-48d6-9fb9-85ff1ab56279"
      unitRef="shares">509884</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0ab71c9c84ee4815b1628aa855d13c01_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RhYmxlOjIwNzI3ZWY0MjE5ZTQ1OTY4YWZkOTJmNDcyNTFkZjhjL3RhYmxlcmFuZ2U6MjA3MjdlZjQyMTllNDU5NjhhZmQ5MmY0NzI1MWRmOGNfNi03LTEtMS0zOTMzMQ_9d140b73-d570-4358-8c9b-003acc8e15e6"
      unitRef="usdPerShare">12.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments
      contextRef="i343cbe120aa04706a172fc551f526ec0_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMTc5Ng_a6a97506-55d4-4555-99cd-f2487c142fd1"
      unitRef="installment">3</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments>
    <ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage
      contextRef="i901eb837ca884f56bf62787429027b0d_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMjU4Ng_87589200-851e-4179-b207-8c926898a07b"
      unitRef="number">1.20</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i488f7313d7ea4152874fdd22f4842f51_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMjY4Mw_faece6cb-8150-437f-adfd-437467d460d6"
      unitRef="shares">170278</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i45d3569daa544f6ba38c9b4d1d64b515_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMjc4MA_651435d0-f02c-4fbc-a41a-94b5b0c50c2e"
      unitRef="usd">2100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie37e701f5bf845919892f1792910aac5_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzg0ODI5MDcwMDUwNQ_c062fe17-d315-4431-8ca8-a75fe569ff3d"
      unitRef="usd">3700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet
      contextRef="id12cc7870c3344898d8faa6c6deb3e69_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMjg5MA_50f4717c-4c5f-4b6d-853f-b134aaa0b116"
      unitRef="shares">80200</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet>
    <ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet
      contextRef="i9a976517796d4a5a90410a85dfa2fcd2_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzg0ODI5MDcwMDUzMQ_51054180-e67b-4a93-9c39-bda9950bca44"
      unitRef="shares">499700</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i272ddda01d4c4d8ab777088cc19278c1_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzAyNg_06eaf671-2371-4286-b882-54e4202a083d"
      unitRef="usd">2100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7aac8a7b75f44c50bf673b0750cb5e38_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzg0ODI5MDcwMDU5OA_ea6b180c-1229-4a83-8ba0-379c8329bb51"
      unitRef="usd">3500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet
      contextRef="i4d1a96b65b9a4f4cb322a36a20b6c8a2_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzEzNg_0b1ef5eb-8348-4262-b10c-73682852f45e"
      unitRef="shares">159025</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet>
    <ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet
      contextRef="i88fe5a3577e44e7f93025fcc20ad13e0_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM182Ny9mcmFnOmNhNjk3ZjhhMzBhODRlZDQ4NDA2Y2MzYmZjZTViYWFmL3RleHRyZWdpb246Y2E2OTdmOGEzMGE4NGVkNDg0MDZjYzNiZmNlNWJhYWZfMzg0ODI5MDcwMDY1MQ_df7f7e15-d23e-46df-8748-13a7b6b1829f"
      unitRef="shares">476630</ccrn:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RleHRyZWdpb246ODc5YmVmOGFkOWFmNDZjMTliMDg0MzBiMWEwMmMxYWVfMjU3MQ_2edc98ec-376f-4bfa-82c5-5a439d42b046">SEGMENT DATA&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s segments offer services to its customers as described below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25cf;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nurse and Allied Staffing &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; Nurse and Allied Staffing provides traditional staffing, recruiting, and value-added total talent solutions including: temporary and permanent placement of travel and local nurse and allied professionals, managed services programs (MSP) services, education healthcare services, in-home care services, and outsourcing services. In addition, Nurse and Allied Staffing provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. Its clients include: public and private acute-care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public schools and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and many other healthcare providers throughout the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25cf;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Physician Staffing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Physician Staffing provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates performance of each segment primarily based on revenue and contribution income. The Company defines contribution income as income (loss) from operations before depreciation and amortization, acquisition and integration-&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;related costs, restructuring (benefits) costs, legal settlement charges, impairment charges, and corporate overhead. The Company does not evaluate, manage, or measure performance of segments using asset information; accordingly, total asset information by segment is not prepared or disclosed. The information in the following table is derived from the segments&#x2019; internal financial information as used for corporate management purposes. Certain corporate expenses are not allocated to and/or among the operating segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information on operating segments and a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reconciliation to income from operations for the periods indicated are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from services:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nurse and Allied Staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Physician Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nurse and Allied Staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Physician Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate overhead &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and integration-related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring (benefits) costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(634)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Corporate overhead includes unallocated executive leadership and other centralized corporate functional support costs such as finance, IT, legal, human resources, and marketing, as well as public company expenses and corporate-wide projects (initiatives).&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RleHRyZWdpb246ODc5YmVmOGFkOWFmNDZjMTliMDg0MzBiMWEwMmMxYWVfMjU1NQ_8c9257da-e65d-459e-9316-e8140d2ea3f2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information on operating segments and a&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reconciliation to income from operations for the periods indicated are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(amounts in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from services:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nurse and Allied Staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;731,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Physician Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution income:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nurse and Allied Staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Physician Staffing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate overhead &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and integration-related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring (benefits) costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(634)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Corporate overhead includes unallocated executive leadership and other centralized corporate functional support costs such as finance, IT, legal, human resources, and marketing, as well as public company expenses and corporate-wide projects (initiatives).&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd91226911de469ebcf68a20f0c11784_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNS0xLTEtMS0zOTMzMQ_fe590dbe-706f-4395-ad41-122b3b264e48"
      unitRef="usd">731443000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ccb0817428f4985b0301b681c4ab64a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNS0zLTEtMS0zOTMzMQ_6858fb90-6f4a-4e36-8fe4-d1f1df93702a"
      unitRef="usd">316188000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0d06303bf64411ebac22da90bae8bc6_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNS01LTEtMS0zOTMzMQ_c5f56d3c-c67d-45a0-911f-5dd1c96005ec"
      unitRef="usd">1497023000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d6e818748004cac8bd53aeb8e5fcb4a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNS03LTEtMS0zOTMzMQ_add32d9a-c0f7-467e-b3de-f488d38d1d96"
      unitRef="usd">629196000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48182d1c2a094a3da085fb747d293f3e_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNi0xLTEtMS0zOTMzMQ_f6d4bc65-0da0-4d12-9745-6694ce103af0"
      unitRef="usd">22118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee0a4262a80f406a86e3cfc6a645adae_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNi0zLTEtMS0zOTMzMQ_c2ab07e5-9d9a-444b-aefa-23ede15d4bd8"
      unitRef="usd">15639000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iababccf169c64eb497cc9f14a300ad39_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNi01LTEtMS0zOTMzMQ_27aa0a1a-9187-4260-9111-5f9b5d67da29"
      unitRef="usd">45270000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6936f0dd73f149a284028ca151da158a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNi03LTEtMS0zOTMzMQ_1bdc2cd4-c4e0-4eaa-b0ae-65d285a0f5bf"
      unitRef="usd">31872000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNy0xLTEtMS0zOTMzMQ_828a551b-c536-46e8-94d1-49f444c6431c"
      unitRef="usd">753561000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNy0zLTEtMS0zOTMzMQ_65666470-b996-425a-a24f-22a61b322b4f"
      unitRef="usd">331827000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNy01LTEtMS0zOTMzMQ_26982b36-524b-4d0a-87b0-c63463c1b694"
      unitRef="usd">1542293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfNy03LTEtMS0zOTMzMQ_c1b9e9cc-a181-40af-8759-96cc60ee81e7"
      unitRef="usd">661068000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="icd91226911de469ebcf68a20f0c11784_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTAtMS0xLTEtMzkzMzE_66bb7622-7eb2-491b-a135-bd4308edcffd"
      unitRef="usd">97567000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="i3ccb0817428f4985b0301b681c4ab64a_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTAtMy0xLTEtMzkzMzE_6dca640e-7159-4d82-8a9f-b093b377d720"
      unitRef="usd">35284000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="ie0d06303bf64411ebac22da90bae8bc6_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTAtNS0xLTEtMzkzMzE_7a6b73ce-d455-432e-a9cd-6d430767574c"
      unitRef="usd">207668000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="i6d6e818748004cac8bd53aeb8e5fcb4a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTAtNy0xLTEtMzkzMzE_56cbd52a-37e7-4017-8ed1-15547b6288e6"
      unitRef="usd">72701000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="i48182d1c2a094a3da085fb747d293f3e_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTEtMS0xLTEtMzkzMzE_888925c5-0e1f-4979-b315-aa0c600b508f"
      unitRef="usd">1220000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="iee0a4262a80f406a86e3cfc6a645adae_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTEtMy0xLTEtMzkzMzE_b04b1ec9-72b9-466d-91b1-ce87c16748f3"
      unitRef="usd">562000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="iababccf169c64eb497cc9f14a300ad39_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTEtNS0xLTEtMzkzMzE_1118d5cf-b007-4617-97cf-13909beef4f5"
      unitRef="usd">2985000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="i6936f0dd73f149a284028ca151da158a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTEtNy0xLTEtMzkzMzE_b3d3201a-b015-4671-b472-f2d4b811d058"
      unitRef="usd">1990000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTItMS0xLTEtMzkzMzE_dbd27b3e-c5ca-412e-91d5-9777098c7c85"
      unitRef="usd">98787000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTItMy0xLTEtMzkzMzE_7eedd93b-be31-4063-8a8d-bdb2b7413ef0"
      unitRef="usd">35846000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTItNS0xLTEtMzkzMzE_f99ba65d-f82f-4b53-90f6-eb99a74397f7"
      unitRef="usd">210653000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTItNy0xLTEtMzkzMzE_ca5f71a0-a504-413b-9ab9-d90f16478a7d"
      unitRef="usd">74691000</ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard>
    <ccrn:SegmentReportingUnallocatedCorporateExpenses
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTQtMS0xLTEtMzkzMzE_b186e9a8-f6bf-4532-8384-040be5f20f89"
      unitRef="usd">17583000</ccrn:SegmentReportingUnallocatedCorporateExpenses>
    <ccrn:SegmentReportingUnallocatedCorporateExpenses
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTQtMy0xLTEtMzkzMzE_26aa3fbe-19b1-4e19-b347-1ceb5e9f7620"
      unitRef="usd">14066000</ccrn:SegmentReportingUnallocatedCorporateExpenses>
    <ccrn:SegmentReportingUnallocatedCorporateExpenses
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTQtNS0xLTEtMzkzMzE_a8e85ef9-c1f8-4f10-aa26-ba8f197cb2e3"
      unitRef="usd">33837000</ccrn:SegmentReportingUnallocatedCorporateExpenses>
    <ccrn:SegmentReportingUnallocatedCorporateExpenses
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTQtNy0xLTEtMzkzMzE_54267610-5018-4724-841d-765080e8e0ed"
      unitRef="usd">28277000</ccrn:SegmentReportingUnallocatedCorporateExpenses>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTUtMS0xLTEtMzkzMzE_45673dbf-d77d-425d-9782-219836608bde"
      unitRef="usd">3481000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTUtMy0xLTEtMzkzMzE_6142724a-b2c4-4856-936a-eff87276adf5"
      unitRef="usd">2199000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTUtNS0xLTEtMzkzMzE_ff00d451-d062-401f-82b7-24b887ccb242"
      unitRef="usd">6200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTUtNy0xLTEtMzkzMzE_cbba06d3-716c-47b9-86d9-799b873455ac"
      unitRef="usd">4452000</us-gaap:DepreciationDepletionAndAmortization>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTYtMS0xLTEtMzkzMzE_295f9c63-6e33-43e7-9b31-f46a1216b00e"
      unitRef="usd">0</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTYtMy0xLTEtMzkzMzE_8c011606-29bb-4c24-a821-6be9e93a6d12"
      unitRef="usd">924000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTYtNS0xLTEtMzkzMzE_07293cdb-2e0f-4595-92a8-6e36632c36cf"
      unitRef="usd">40000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <ccrn:AcquisitionAndIntegrationRelatedCosts
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTYtNy0xLTEtMzkzMzE_a5052f7a-1a8e-410b-a08f-d50554b9d5c8"
      unitRef="usd">924000</ccrn:AcquisitionAndIntegrationRelatedCosts>
    <us-gaap:RestructuringCharges
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTctMS0xLTEtMzkzMzE_20bd9529-dcd6-4aa5-8c78-fe338100b933"
      unitRef="usd">-1114000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTctMy0xLTEtMzkzMzE_b52c9cbe-3158-4e6a-af3d-4b2c67e1a896"
      unitRef="usd">835000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTctNS0xLTEtMzkzMzE_b579e03b-a461-44db-ad91-b5f35acb317d"
      unitRef="usd">-634000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTctNy0xLTEtMzkzMzE_a53099ca-b4c6-480b-be45-2948add94905"
      unitRef="usd">2073000</us-gaap:RestructuringCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTgtMS0xLTEtMzkzMzE_95293a25-a2e5-453c-962e-744e88cc2779"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTgtMy0xLTEtMzkzMzE_4f5fb767-09f8-4509-bae3-13132ca619be"
      unitRef="usd">1921000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTgtNS0xLTEtMzkzMzE_d0d7d022-ff65-4938-b591-669085a1b978"
      unitRef="usd">1741000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTgtNy0xLTEtMzkzMzE_ba1499a1-8610-45a0-bbac-9bdfeca03a02"
      unitRef="usd">2070000</us-gaap:AssetImpairmentCharges>
    <us-gaap:OperatingIncomeLoss
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTktMS0xLTEtMzkzMzE_11202872-ae00-40f9-b57c-dc8a24c28286"
      unitRef="usd">78837000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTktMy0xLTEtMzkzMzE_6acaddb8-f84e-44db-a9b0-e7ccdd616239"
      unitRef="usd">15901000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTktNS0xLTEtMzkzMzE_ae3d9e5e-1b57-4e61-8929-fb6814139dbb"
      unitRef="usd">169469000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183MC9mcmFnOjg3OWJlZjhhZDlhZjQ2YzE5YjA4NDMwYjFhMDJjMWFlL3RhYmxlOjkyZjE5NDQwNzM2ZDQwMzFiOWNjZjI2YTUwZTk0Y2VhL3RhYmxlcmFuZ2U6OTJmMTk0NDA3MzZkNDAzMWI5Y2NmMjZhNTBlOTRjZWFfMTktNy0xLTEtMzkzMzE_cd9f2f4c-4fd3-4277-8724-426d9fff4235"
      unitRef="usd">36895000</us-gaap:OperatingIncomeLoss>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183My9mcmFnOjBhNzVkNjNmYzczYzQ2MzM5MmEzZjE4MDk4MzJlOGVlL3RleHRyZWdpb246MGE3NWQ2M2ZjNzNjNDYzMzkyYTNmMTgwOTgzMmU4ZWVfMjg1Mw_8372adbb-313a-4856-83db-4b0eba0730b7">CONTINGENCIES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company is involved in various litigation, claims, investigations, and other proceedings that arise in the ordinary course of its business. These matters primarily relate to employee-related matters that include individual and collective claims, professional liability, tax, and payroll practices. The Company establishes reserves when available information indicates that a loss is probable and an amount or range of loss can be reasonably estimated. These assessments are performed at least quarterly and are based on the information available to management at the time and involve significant management judgment to determine the probability and estimated amount of potential losses, if any. Based on the available information considered in its reviews, the Company adjusts its loss contingency accruals and its disclosures as may be required. Actual outcomes or losses may differ materially from those estimated by the Company's current assessments, including available insurance recoveries, which would impact the Company's profitability. Adverse developments in existing litigation claims or legal proceedings involving the Company or new claims could require management to establish or increase litigation reserves or enter into unfavorable settlements or satisfy judgments for monetary damages for amounts in excess of current reserves, which could adversely affect the Company's financial results. The Company believes the outcome of any outstanding loss contingencies as of June 30, 2022 will not have a material adverse effect on its business, financial condition, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;Sales and Other State Non-Income Tax Liabilities The Company's sales and other state non-income tax filings are subject to routine audits by authorities in the jurisdictions where it conducts business in the United States which may result in assessments of additional taxes. The Company accrues sales and other non-income tax liabilities based on the Company's best estimate of its probable liability utilizing currently available information and interpretation of relevant tax regulations. Given the nature of the Company's business, significant subjectivity exists as to both whether sales and other state non-income taxes can be assessed on its activity and how the sales tax will ultimately be measured by the relevant jurisdictions. The Company makes a determination for each reporting period whether the estimates for sales and other non-income taxes in certain states should be revised. The expense is included in selling, general and administrative expenses in the Company's condensed consolidated statements of operations and the liability is reflected in sales tax payable within other current liabilities in its condensed consolidated balance sheets.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMTk2Nw_3be8e1e6-a60d-48f5-8d4a-8710697d61a4">INCOME TAXES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and six months ended June 30, 2022, the Company calculated its effective tax rate estimating its annual effective tax rate, as opposed to the three and six months ended June 30, 2021 whereby the Company calculated its effective tax rate based on year-to-date results. The Company&#x2019;s effective tax rate for the three and six months ended June 30, 2022 was 28.7% and 28.8%, respectively, including the impact of discrete items, and 28.9% and 29.5%, respectively, excluding discrete items. The Company's effective tax rate for the three and six months ended June 30, 2021 was 22.5% and 12.1%, respectively, including the impact of discrete items, and 9.5% and 6.6%, respectively, excluding discrete items. The effective tax rate for the three and six months ended June 30, 2022 was primarily impacted by federal and state taxes. As a result of the Company's valuation allowance on substantially all of its domestic deferred tax assets, the effective tax rate for the three and six months ended June 30, 2021 was primarily impacted by international taxes, state taxes, and additional valuation allowance required as a result of the WSG acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2021, the Company concluded that it was more likely than not that a benefit from a substantial portion of its United States federal and state deferred tax assets would be realized and released the majority of its valuation allowance. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2022 and December 31, 2021, the Company had an immaterial amount of valuation allowance on its deferred tax assets related to state net operating losses not expected to be realized before expiration.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax years 2012 through 2021 remain open to examination by certain taxing jurisdictions to which the Company is subject to tax.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMzgx_de986d47-ae5a-4c9b-aed9-c7e8f74e0b91"
      unitRef="number">0.287</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMzg4_a58e7956-ae53-4106-a7ab-1d5d7e63a44c"
      unitRef="number">0.288</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems
      contextRef="iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMzg0ODI5MDY5OTM5Nw_cf0cfe32-842a-4f14-b497-d1268b06dbf3"
      unitRef="number">0.289</ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems>
    <ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMzg0ODI5MDY5OTQwNA_ccd3d24f-fddb-4555-acd1-ed142da7a6c1"
      unitRef="number">0.295</ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfNTYw_2004538a-dee6-4a82-930d-84667672c487"
      unitRef="number">0.225</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfNTY3_6172304f-0a85-471b-9d09-6947ae37dfd6"
      unitRef="number">0.121</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems
      contextRef="i14cec54faf0e41d1ba870b7c21ee6cff_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMzg0ODI5MDY5OTU2Mg_18b04fa0-d451-4f6a-929b-5a8a8d7a88ef"
      unitRef="number">0.095</ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems>
    <ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems
      contextRef="i66e6efc9e8d54194abf5a7d09a45151e_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183Ni9mcmFnOjAzMGE1MjUzNjY3ZjRmNzg5OWJkYWU4MDMyYTM4YjQ0L3RleHRyZWdpb246MDMwYTUyNTM2NjdmNGY3ODk5YmRhZTgwMzJhMzhiNDRfMzg0ODI5MDY5OTU2OA_899c6305-2ba8-4cfd-80d2-9ba442bf6114"
      unitRef="number">0.066</ccrn:EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183OS9mcmFnOjUzMDY1MTIyMzU3YzQ0MjNiNDk2NzQxNTM2MjJkMzkzL3RleHRyZWdpb246NTMwNjUxMjIzNTdjNDQyM2I0OTY3NDE1MzYyMmQzOTNfMjM0NA_07fd9979-c37d-49cc-8cd1-3c989c619d72">RELATED PARTY TRANSACTIONS&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company has entered into an arrangement for digital marketing services provided by a firm that is related to Mr. Clark, the Company's non-executive Chairman of the Board since April 1, 2022, and the Company's Co-Founder &amp;amp; Chief Executive Officer through March 31, 2022. Mr. Clark is a minority shareholder in the firm's parent company and is a member of the parent company's Board of Directors. Management believes the terms of the arrangement are equivalent to those prevailing in an arm's-length transaction and have been approved by the Company through its related party process. The digital marketing firm manages a limited number of digital publishers covering various Company brands for a monthly management fee. During the three and six months ended June 30, 2022 and 2021, the Company incurred an immaterial amount in expenses. The Company had an immaterial payable balance at June 30, 2022 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides services to entities which are affiliated with certain members of the Company&#x2019;s Board of Directors. Management believes the services were conducted on terms equivalent to those prevailing in an arm's-length transaction. Revenue related to these transactions was $0.5&#160;million and $0.9 million, respectively, for the three and six months ended June 30, 2022. Revenue was immaterial for the three and six months ended June 30, 2021. Accounts receivable due from these entities was an immaterial amount at June 30, 2022 and December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the WSG acquisition on June 8, 2021, the Company continues to rent WSG's headquarters. The Chief Executive Officer and Founder of WSG, and currently a business unit president with the Company, is an agent of the lessor. The lease term is from January 1, 2020 through December 31, 2024. The Company paid an immaterial amount in rent expense for these premises for the three and six months ended June 30, 2022 and the month ended June 30, 2021. The Company had an immaterial payable balance at June 30, 2022 and no payable balance at December 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i91fdc80f57044a50afa1d6033fa5183f_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183OS9mcmFnOjUzMDY1MTIyMzU3YzQ0MjNiNDk2NzQxNTM2MjJkMzkzL3RleHRyZWdpb246NTMwNjUxMjIzNTdjNDQyM2I0OTY3NDE1MzYyMmQzOTNfMzg0ODI5MDcwMDQ1NA_11d5fa22-08c8-427e-9f1e-659f1ffca445"
      unitRef="usd">500000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i1e0108cb028149ccb9de91110e533b39_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183OS9mcmFnOjUzMDY1MTIyMzU3YzQ0MjNiNDk2NzQxNTM2MjJkMzkzL3RleHRyZWdpb246NTMwNjUxMjIzNTdjNDQyM2I0OTY3NDE1MzYyMmQzOTNfMzg0ODI5MDcwMDY2Nw_999248de-daaf-491f-894c-9024a44e550e"
      unitRef="usd">900000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i2612021a1b9a4426b3de852fbbf51315_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183OS9mcmFnOjUzMDY1MTIyMzU3YzQ0MjNiNDk2NzQxNTM2MjJkMzkzL3RleHRyZWdpb246NTMwNjUxMjIzNTdjNDQyM2I0OTY3NDE1MzYyMmQzOTNfMzg0ODI5MDcwMDc4Mw_166ac6aa-a390-442b-878d-886670f33946"
      unitRef="usd">0</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i48c021a3ed524ae4a24a7c9d9e8eca04_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM183OS9mcmFnOjUzMDY1MTIyMzU3YzQ0MjNiNDk2NzQxNTM2MjJkMzkzL3RleHRyZWdpb246NTMwNjUxMjIzNTdjNDQyM2I0OTY3NDE1MzYyMmQzOTNfMzg0ODI5MDcwMDc4Mw_2064b892-e776-4ae1-9ba6-9ca8b72c2ac5"
      unitRef="usd">0</us-gaap:RevenueFromRelatedParties>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM184NS9mcmFnOjcxNWUzMTM1MjY1ZjRjYmM4NGQ3ODBiNTlmZjcxMDQ2L3RleHRyZWdpb246NzE1ZTMxMzUyNjVmNGNiYzg0ZDc4MGI1OWZmNzEwNDZfMTE5OQ_f15cd08a-c14f-4b0f-9455-d7d2f8347b43">RECENT ACCOUNTING PRONOUNCEMENTS&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 28, 2021, the FASB issued ASU No. 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires contract assets and contract liabilities such as deferred revenue acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Generally, this amendment will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically such amounts were recognized by the acquirer at fair value in acquisition accounting. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The Company is currently in the process of evaluating this standard and expects to adopt this standard in its first quarter of 2023.&lt;/span&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i847dead6d7ec468e8881bbafff04909d_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiY2MzYjliNGI1ZDRkZmZhYzFjODU2NjljZGZlN2QzL3NlYzpjYmNjM2I5YjRiNWQ0ZGZmYWMxYzg1NjY5Y2RmZTdkM184NS9mcmFnOjcxNWUzMTM1MjY1ZjRjYmM4NGQ3ODBiNTlmZjcxMDQ2L3RleHRyZWdpb246NzE1ZTMxMzUyNjVmNGNiYzg0ZDc4MGI1OWZmNzEwNDZfMTE5Mg_aed9cc70-fdc7-4c22-ac84-59af034bb7fd">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 28, 2021, the FASB issued ASU No. 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires contract assets and contract liabilities such as deferred revenue acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Generally, this amendment will result in the acquirer recognizing contract assets and contract liabilities at the same amounts recorded by the acquiree. Historically such amounts were recognized by the acquirer at fair value in acquisition accounting. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted, including adoption in an interim period. The Company is currently in the process of evaluating this standard and expects to adopt this standard in its first quarter of 2023.&lt;/span&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MEG%^N!0\$,H\ /?G4NKMB?F!<DM[^"]02P,$%     @ *$P$59H_#%@T!P
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M6>+WF//=:P:<!0?J>Z\40'VOT7B?RKOI"F[L4[3I=7?PPV2D&;&*@\2RBL@
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MCKK''E'UN*D-(TO7L7-IL/_=,L<)#<HZX/E"2O-BV"'0S/SX+U!+ P04
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M2?AO"N/49'K[)8J_S.*(P+?9[:>;Z.H>+F;W\/$Y_G(_([>_DMN[^.O5_0T
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M#>#WE81$NK^P#ZC?K4__!U!+ P04    "  H3 15H&K[2:<$  !9"P  &
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M-)BEL0=ZZ+K#Q*I=W^G6RM(SU0^W]*&"VCG0^D8I.T[<!M.GS_)O4$L#!!0
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M'LY&"6S1?._!P*$UB/@0)Y)XIQV))!;'XB>IC/A5%@V)MR1M8XC1V8*@<Q2
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MP\5L($RXRPHO3M?^_FBI';+I'W."\88WX/M*P[OVA0_87BA>_!=02P,$%
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M<X#V]X)RIIL8 _T_U_Q/4$L#!!0    ( "A,!%76 R9[# @  $<4   9
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M\ *\7VA@T$Y8P?;N\.R_4$L#!!0    ( "A,!%5GKHYC?P\  &\O   9
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M<3FN$M*^HPRQJ0*L3VHL9/,;32PFXG8+0U/JR&Z24[MW%.V3\;R-]3CDTI^
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M6Y!/5EM@H*P^LD!<ZN[9D+OBY,"XJLU*Z[=W_1;DC\] 54$I^MM93W&:2B^
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M (FR$%6 Q^\@EU8IE# TD?B'5:B@(%!62.(-2).L3I4P)2GM:#/U6"EH:*R
M,"0\E!!*VFS3%_<F5Z0!]'&D$?11T!@$F0^V53]J;95XD!:F97"(W/C=P55:
M()FM-J*2C\I%V-O55A:)BM@EB<ES0@F(%01FT,)_U%A,4\U>A7X$ >R-OKB#
M.% &E1HE5O)!T68/VK%- $ZQ@!N82>2^:M+:ZF*Y96-C28\!J)5+)(41!,S3
M6H'O$=YLI1/$&3YAX=4V!#__-!O%Y[\@'TRQ5/:4I0:]B)12(C&V-):\YB-)
MKJB@-;DO48#(E,*"_?#H(T)A]5'=FADA79*5:+E(V;HD<HG44(E>: A*308]
MA<Q-#3OP,8%'*ELG>"'_5D+GY"J?(YQ-KG5D:D1AJC9'4($ZK1'S!YG52BQK
MB>A5BE1)((&DX1%&&FAIB;RRFJ$?@F_54A<%*8EXD15.0954_( 4L@XA!.X,
M.=KX4(2>L=;5BLFQAGC4)"!5#VAEI8_(PII<W'WZ]N%MU(T#LKA4R!FX@/6
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M@.\+@X-#>*$-VC\H7/\'4$L#!!0    ( "A,!%6?P)V'^PD  ,4;   9
M>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;,59:V_;.A+]*X1O<6\#.'9L)TV:
M%Y"TZ6X729N-V]X/B_U 2[1-5")5DHKC_OH],Y1D.7$>W;O  D$L6^3,<.;,
MF1GI>&'==S]7*HB[/#/^I#,/H3CL]WTR5[GT/5LH@SM3ZW(9\-7-^KYP2J:\
M*<_ZPYV=-_U<:M,Y/>;?KMWIL2U#IHVZ=L*7>2[=\EQE=G'2&73J'V[T;![H
MA_[I<2%G:JS"U^+:X5N_D9+J7!FOK1%.34\Z9X/#\UU:SPN^:;7PK6M!)YE8
M^YV^?$Q/.CMDD,I4$DB"Q,>M>J>RC 3!C!^5S$ZCDC:VKVOI'_CL.,M$>O7.
M9G_J-,Q/.@<=D:JI++-P8Q=_5]5Y]DA>8C//_\4BKAWM=D12^F#S:C,LR+6)
MG_*N\D-KP\'.(QN&U88AVQT5L97O99"GQ\XNA*/5D$87?%3>#>.TH:",@\-=
MC7WA],/9QQOQ[>SRZX6XNC@;?[VYN+KX]&5\W \03DOZ227H/ H:/B+HC;BR
M)LR]N#"I2M?W]V%48]FPMNQ\^*3 ?Y2F)T8[73'<&0Z?D#=J3CIB>:/'3BJU
M$]]D5BKQ7OLDL[YTRHM_G4U\< #'OS>=.8K<W2R2$N;0%S)1)QUDA%?N5G5.
M?_]M\&;GZ F#=QN#=Y^2_BNA^:\$"?;(+7M$>X(R]J5">A'F2JB[9"[-3(G"
MZ43A)QF08&66BHE"-B8*R90*L(*0R"WOP1^X+J1.1; "'C5^JG!39%I.=*;#
M4KS&2G6G0Q2Y);1A3?AF$EW(C 3DU@<ATUMI CC!EAY@=]\AG#31ZD;52B[D
M0+)UJ7+9,JJ6,><G*BR4,K6,0KJ@294)7MBH/5>2@ ">"2*50?7$F9BN'#/7
MRDF7S)=B <<H'^0DTTBW5"SF.IG#$S]*33BBLYE YN#X2%"=ZY^*-91>"3L5
M=D( P79XVQ1EH"TII?2#E:5YN'8QIV.PK=K,6A;VQ)>Y<O"+(QE.*9&I6Y5Y
M$E3MY=CE<DF1@PH.4'7LEJ!#<4D;Q4#\_MO!<# \^F=I Q9SL#P[F1FT<J;G
MB.B4#IT@=AP7WPZ,5KY7R1S6,C\_.)C%P2FR\%^M/VKLHE# P?#ZCS5#2*V'
MSS+I-BL]NK=!F\9D]@1YRMA0'>>(=D<CVNZB1:TH8$TB"4\BL<[9B762-$R6
M[445RH B&:TL02W FI89X1(!GI99)H)R.46G0?-C7AO57ONZ 1"-E;XL"NLJ
M:R @1'.-K>WA<Q(P"6^K;7IF]!2A ^XI8>=M+#QCWL>@<B^N(H3 &$&TR)5*
MK;A12>D8J>?2:W]((!7O;([46_*A]H\026TD,K\!3[^EI$XL!NND2=,TBG>-
M^ F)%PO* !V@Y[7>(B93CM8F4(C^0<;ZS\0!JLE*%"A"18RZL6:;I!$!1#N.
MV%.O]:.BVM1S7UQFS6R;0]P^#3;!/$A!<32>Y1EO,YU&&,D,CD!,J(S#O^\W
M:JW T/*D* ,4_(3\.G5J<-B:UX-_RAV1@]9BNRE0OR*!P=5$J_04I*($:2;(
M 7DKD;<1Q6E,<N1WH2*U%_""2&U2$AE7IH!Q=<Y.>HC.Y_#TP+2G080_2?22
MH5$%DEJ0OEK5""_0EZBF+T&H$I5/<(#1@'\9H,KEMJ2%7-Y0P6"%WQ(?&N/.
MV#A M0K:UB/QCH!])0;=P<& /T=O#UIR+E<G>U[8"K*OQ+ [W-_ES]V]_1<D
M\R=DR%,)_8?G)+KO_A6!SZQ-%SK+NE2<4["OS"GT->N"(V>:0%'O<]1*;]OI
M-A7$^D<*9N$PC;B*RH@@"HI)=QUS.$$+*UPX Y=(S56:D2<#L3XJ) Z@'1=_
M$DER  MJ)>[+L0;X96$D8[4-79*;L6S:"$[]J=((7:_OT,YP3ZRH)[Z''-+'
M@%EQR'VIG,@;G"$DL0PFA4 -2"9CL=OD&@(AJ,94,Q#OR. H5140)LY;F9 (
M=#X)'1U!SI:<F'#09IN[Y-&5.2SE$;]%!J@+6N2GGABC3_F$(BW>BFW<9(.F
MW/Y1G$P<-CD))I@D*VTMJ:VN#=(^,Y V-_B'K8S1!JU^9!?N %9\X!XSO^I1
M7T3<?$^C?X7?$NGG["Z^H'A 'BF&8^%E)HC811,=1G0W-PJY9)*L?G0E5*D[
M2F;U#"UND/URT4(60-$="Z93:VIZG%M2 ".IB11JJF[!S]%UQ$IG9*!>,M*R
M5VT_U\&9_K4@<(;$ZFX(-M4QNK%*GYU?\A4N8^6UTG2K(GZ[%2_PJ:0SA*96
M26"8IT!+Z2FX$WI(T6,U[3(;IYHY.46[E.71>>)9T-QQIE4EOFU>C9ZI=D#%
MCQ+CAV+:H61"F8_.U!PN9#&Z47#, []V(P+K2*R5P#5MK?"E++4]);"COK0%
M52%=+Z;@<GBS+:HM!@Y*)/$0[0!Q(^]Q,,>K)#.)TPV\G)KRLY=;MK9J1GEM
MKPK6"PL\;&K"RF,8YHVDC+0'0[-X&K-ND,#]0)-K;E-03YN&AG6;-'4V;_4D
ME8DM^NE% %W#R]S&-Q""RR.":_JMDN+/\=^05LAVKR-].>:. .6$D;*P-,4I
M^BX2T+4$0D#;K)"(I.IZHVQZVL2]"I<)#'>VG,WIRZB]I[<.U7B#/$.52F9+
M:FWBZ?,R"[K 0;$"<?1DMT^40= LEYI4D9^U48^, _<3:%F1T?V?__ /4/88
MH @HU'NU^NBZ&:>IAGP(Y0\T\+YVY_YPA?T%YNXQ/[P\S&-^JDA.;L6:J^#_
M)-A-H1UAS:TR94/[?]'3E#S_=U=_C*N]HO7W6;';3OP5(*O!M=)2>YCK;:I<
M;!5JNUX4*WZ21>4'LZ5,YEK53[/6W8\++A$T+7BD3S2/4()8KQQ ?J5(.4]M
M5-/<[**Y.5MIK8)X+V!Q3/F5.:<]NF^NJZO>;JW"KE=5XJ;VP//<8/.NMIL;
MK?5OSPX]FX:5X59TTW55OU[5(^[:%::4X9OF<ZR,1I3&-([@1#Q+;9]S[EQ2
M>7@E#O:Z.SL[[8NWW6'K\PN5DDON$$R<KX:C[L'^'ET-#KJC U(VV-_MC@;#
MZNI@=T]<5.BZ7#W.!-EOT8I:SZ,7&_;6J-QZY-2#[EZ4P)_O+!+(A KH@,4[
M'%X'<:/]]T/&6]7#5+>3>!LM,+=UU.M1D#D-">2I+2=A6F:KOA!QXU@, =EQ
M?$%#@L8MJ)W%M13S:R1WPH\+/@/TDB:[AK\(L1G/1*9D )$]_"(#Z4%Z4CW%
MA$IB9LK.G"SF.B$P2G1CA4,6.,V/R[C<5=V_^&HT)<<XQ%[#Q 8'[. T1CGN
MY-K$@4:.4MK7C+'NO<H]#MZCXI/IG(3W-CVS[[=>K>  ,WZ!1)T^/!'?LC2_
M-N^HSN*KF=7R^(+K"DY!DF+^FF+K3F]_KQ.'N_I+L 6_J)G8 &_QY5QA7G:T
M />G%A&JOI""YLW=Z7\ 4$L#!!0    ( "A,!%62:2O6.P@  ,\4   9
M>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;,U8;7/;N!'^*QA=>K%G:(FDWAW;
M,W:2:W*]:]S8N9M.IQ\@$I)P(0D% *VHO[[/ B!%.;*;Z4QG^D4B@,6^[[-+
M7FR5_FS60ECVM2PJ<]E;6[LY'PQ,MA8E-WVU$15.EDJ7W&*I5P.ST8+G[E)9
M#-(XG@Q*+JO>U87;N]57%ZJVA:S$K6:F+DNN=S>B4-O+7M)K-C[*U=K2QN#J
M8L-7XD[83YM;C=6@Y9++4E1&JHIIL;SL72?G-R.B=P2_2;$UG6=&EBR4^DR+
M]_EE+R:%1"$R2QPX_A[$:U$4Q AJ? D\>ZU(NMA];KC_Y&R'+0MNQ&M5_"YS
MN[[LS7HL%TM>%_:CVKX3P9XQ\<M48=POVWK:%!*SVEA5ALM8E[+R__QK\$/G
MPBQ^XD(:+J1.;R_(:?F&6WYUH=66::(&-WIPIKK;4$Y6%)0[JW$J<<]>W=U_
M>/V7=Q]^>?/VX]U+]O9OG][?__UB8,&9S@=9X'+CN:1/<)FP7U5EUX:]K7*1
M']X?0*-6K;11ZR9]EN'/==5GPSAB:9RFS_ ;MF8.';_A$_S>?JFEW;%_7"^,
MU<B$?QZST;,8'6=!U7%N-CP3ESVDOQ'Z0?2N?OPAF<2OGE%PU"HX>H[[=\?A
M^[G\^,,L3::O B]V9U7VF7T4FUIG:Z0QN]5JI7G)/E3L)['0-4J2I3/R>(Q?
M56MVH[C.F5JR-U*CB)0VC-=VK;3\E\@=1:F,16EFHK+,. %Z+V 3!&S70HO%
MCFT%$G?'VO-ZPZQB27^,O"X**E&((JZ9*DNLS)K#SQ'P8O$'Q!.Q70MFA2Y-
M2UIK3<(S+7)I&5]I(0 9P"EV#UK/PHE=B(YN.5MJ53(+>#FSZHS^F:P<>X([
M7-"? 8B\RMW>$:,"RUR:#)DOJQH\.=W8.:[T3/K1N1:$/WWVIM:R6CF&1GZ%
M[US%"*H8AGP7;;X[N7A((D?\6I4;XIO+G%7*=K6A[6 C'"*M:7U'P>BS:[=_
MP/R0)[BP<1)'<3SJ,.HR8344U.Y2XVQ'>,PI_('+@B\*0;':GQ^$,!/:HE=
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MPE@78PQF>5V(5T[!DU'+.&#2XSAU@X/<E@4R"(7)TA'ET##DT-[QUB6.G]*
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M4<N3@#6,U;"D8^>9M[/8)U$XQ#!\6VM3\ZH=HET!>EOVI6,]_(5 .MVI608
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M' V%"'"^5,HV"Q+0?L.\^C=02P,$%     @ *$P$52$F#G.)!P  CQ$  !D
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M<R]S:&5E=#(Q+GAM;*U7VVX;-Q#]%4(ITA=9-U_B^B) EITV09,8MMN@*/I
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M]1_&)^[)??Q0^"1467<:&MQ2J#=+(@?4^/B.$R-WPX.WD8:NJ6%8T?<**NM
MZULIS7%B-YB^@);_ %!+ P04    "  H3 15>2Z&K4\#   P!P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970R-BYX;6Q]5=N2VC@0_94N;VHKJ6+&-S P :J
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MJ)T#K6^4LH>)2] ]DK.?4$L#!!0    ( "A,!%65H.H8 00  'L*   9
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;+56;6_C-@S^*X0W#%<@C5]B.VF6
M!$A[W>X&7%$TW>[#L ^*S<1";<F3Y*;W[T?)CI/><MGMAGV)18E\R(<B%<YV
M4CWI M' 2U4*/?<*8^JI[^NLP(KIH:Q1T,E&JHH9$M76U[5"ECNCJO2C($C]
MBG'A+69N[UXM9K(Q)1=XKT W5<74IVLLY6[NA=Y^XX%O"V,W_,6L9EM<H?FU
MOE<D^3U*SBL4FDL!"C=S;QE.KQ.K[Q1^X[C31VNP3-92/EGA?3[W AL0EI@9
MB\#H\XPW6)86B,+XL\/T>I?6\'B]1__)<2<N:Z;Q1I8?>6Z*N3?Q(,<-:TKS
M('?OL./C LQDJ=TO[#K=P(.LT496G3%%4''1?ME+EX>O,8@Z@\C%W3IR4;YE
MABUF2NY 66U"LPM'U5E3<%S82UD91:><[,SB=OEP]_[NYQ7<WS[ ZMWRX1;>
M/+)UB?IBYAMR8-7\K .[;L&B+X"E\$$*4VBX%3GFK^U]"JR/+MI'=QV=!?RE
M$4,8!0.(@B@Z@S?JV8X<WNA+;)D27&PUW*."5<$4PN_+M3:*BN./4WQ;N/@T
MG&V8J:Y9AG./.D*C>D9O\<-W81K\>";8N \V/H>^6%$#YDV)(#=P(ZM:"A1&
M6^FNJ5 Q(Q4PD<-;%)(JP\G4I4ZW,<P5/2E?,\VS5I&7C<$<^BS4^RR<HGXV
MN-/4'PND"$IJ=(('8\L(-%+,%)8IP-!Q]HJ(W1&OR.2?D=G;'!&R6^N>5-Z1
MPF-2VI*:PF.A$%_5)*SXR^L-*C%T)=8O;*W9G_!H]895LK%!<T'^9:/)M1X
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ML@ITOI%4,YU@'?3SYN(O4$L#!!0    ( "A,!%5A=F9KF04  'X-   9
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M@0ADHY$^?;P;=.L56\_L"[8#,!)011G^+[6]X11L[=CBUO :PI!$H8="X)'
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MM[EIYOA\ J$GX/B&HZ1V'1V@>Y#-_P502P,$%     @ *$P$5?B1/. #!0
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MP5WU#1Y96EJP+$L"!QZ]TG.\@5]?V9:+'3M/+3G?\O]]5K;08-#08/#=-*C
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MC=/1+C?X'#%I#%"_$D(_;4R X8&;?@-02P,$%     @ *$P$56$K(Z2*!
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M.I.\2=N,U$])R;3X,NU@C+MC]>5<-*F_MJ+570Z-7MFAW1!6WZA$Y=0[Z=K
M*#J5<M<K<M>3YLXFD?^*.(W$X$_2R?@Y&W:;DB=%M7TP(&$6),S.8+VS/..N
MIE7$ /)8$JU?B-:7BQ;L??9**7H\Z=:DEY325B](F 4)LR%A#A"LI.N@T'7P
M72:L :3.D# +$F9#PAP@6$GG8:'S4/K\SHA/PC5%A(O1=NN%82(WVZ ]C3S6
MM J=#6M#4F4\,H>UR4$$6^YC2:-JJT8]I)I#!\AA*<FC(LDCL%7!J'8M>G7
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M=8'Y_4Q*??>F:F#WQ0_C_P!02P,$%     @ *$P$53D]U(BX!   ?1D  !D
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M-= %"-- OU]RKEX*YD*]_L5E\AU02P,$%     @ *$P$5><M/10O @  ^00
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M'"T)M:YI2ZIL ?6Z.$(2UIV!/<>VG88)5]: >[31V?^PKHY3Y'ANWVY@4_*
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M?%3WP*C?,WH./.<3<!W7K9$/F^4C/%-R:.1P7VZK_,4DN,4DN,;/.S0).K$
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M55R9VY6J?S'7'=3[!6/RI:$KK**BCOX"4$L#!!0    ( "A,!%7+#SU"@ ,
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MQK)(W8KE'[R\H&[.FXA(%G_1LFSKM= DDTK$9;#N01PFJT_VK4S$6H#?V1*
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M _BG $$+"(X!_1. L 6$3_70;P']IWH8M  CW6VTF\3%6.)HS-D&<6VMV/3
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M%     @ *$P$59>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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M*7DF] $9K%H\1)0HG+(P85.BUY)H'DQIJC?.Z9R&/B,&I U VD>$_,<V(!T
MTCD*9)+JQ8*%!J0+0+I'A.Q$T@,@O6-".@;D&( <XT)&\8R&P=\T#:*0T+!I
MC4F0D.B"7,4L80;D1P#R(RYD<KU8T/BVH4J"61A<!#X-4T)]/[H.T\" _ 1
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MU1[S6?]+S>P-4$L! A0#%     @ *$P$50=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  H3 15P21T
M->X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    "  H3 15F5R<(Q &  "<)P  $P              @ ', 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( "A,!%6.=(^>Y 4  -X>
M   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    "  H3 15FC\,6#0'  !.'P  &               @($G#@
M>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ *$P$53IV:!"@
M @  _P4  !@              ("!D14  'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;%!+ 0(4 Q0    ( "A,!%6:>H5RP <  ,,D   8              "
M@6<8  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    "  H3 15
MU[^TH'@)   [6   &               @(%=(   >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&UL4$L! A0#%     @ *$P$5>G^3UEA!P  9Q\  !@
M     ("!"RH  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (
M "A,!%6@:OM)IP0  %D+   8              " @:(Q  !X;"]W;W)K<VAE
M971S+W-H965T-RYX;6Q02P$"% ,4    "  H3 15VQ#\M$(-  "@(0  &
M            @(%_-@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#
M%     @ *$P$5?E+T1"R P  !@D  !@              ("!]T,  'AL+W=O
M<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( "A,!%4SX85#A <  %P4
M   9              " @=]'  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL
M4$L! A0#%     @ *$P$51M=DSMR P  Y <  !D              ("!FD\
M 'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    "  H3 15QPN]
MAL4#  !_"0  &0              @(%#4P  >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;%!+ 0(4 Q0    ( "A,!%76 R9[# @  $<4   9
M  " @3]7  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @
M*$P$56>NCF-_#P  ;R\  !D              ("!@E\  'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6Q02P$"% ,4    "  H3 15QV# 738)  !<&   &0
M            @($X;P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4
M Q0    ( "A,!%6?P)V'^PD  ,4;   9              " @:5X  !X;"]W
M;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ *$P$59)I*]8["
MSQ0  !D              ("!UX(  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6Q02P$"% ,4    "  H3 15(28.<XD'  "/$0  &0              @(%)
MBP  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( "A,!%4T
M^.)O]00  !\+   9              " @0F3  !X;"]W;W)K<VAE971S+W-H
M965T,3DN>&UL4$L! A0#%     @ *$P$58=X[==C!   ?PL  !D
M     ("!-9@  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "A,!%7G?EN)R ,   T)   9              "
M@>FV  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ *$P$
M57DNAJU/ P  , <  !D              ("!Z+H  'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6Q02P$"% ,4    "  H3 15E:#J& $$  !["@  &0
M        @(%NO@  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0
M   ( "A,!%5A=F9KF04  'X-   9              " @:;"  !X;"]W;W)K
M<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ *$P$56^+ADS9 P  G D
M !D              ("!=L@  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q0
M2P$"% ,4    "  H3 15^)$\X ,%  #0#0  &0              @(&&S
M>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( "A,!%712%9%
MSP,  *P)   9              " @<#1  !X;"]W;W)K<VAE971S+W-H965T
M,S$N>&UL4$L! A0#%     @ *$P$5;/#4-,Q P  [ 8  !D
M ("!QM4  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    "  H
M3 1582LCI(H$  !<"0  &0              @($NV0  >&PO=V]R:W-H965T
M<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( "A,!%701<\&? ,  *$,   9
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M970S."YX;6Q02P$"% ,4    "  H3 15.3W4B+@$  !]&0  &0
M    @(%%^   >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (
M "A,!%7G+3T4+P(  /D$   9              " @33]  !X;"]W;W)K<VAE
M971S+W-H965T-# N>&UL4$L! A0#%     @ *$P$57HEX;))!   (!(  !D
M             ("!FO\  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"
M% ,4    "  H3 15>+89!?$"  #'"0  &0              @($:! $ >&PO
M=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( "A,!%73B%^HY00
M ,T;   9              " @4(' 0!X;"]W;W)K<VAE971S+W-H965T-#,N
M>&UL4$L! A0#%     @ *$P$527!@,P- P  N@D  !D              ("!
M7@P! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    "  H3 15
M1F*:XP %   R&P  &0              @(&B#P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0U+GAM;%!+ 0(4 Q0    ( "A,!%7-HE#A800  #X4   9
M      " @=D4 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%
M  @ *$P$57V8-8U.!0  V"L  !D              ("!<1D! 'AL+W=O<FMS
M:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    "  H3 157I&@[L #  !/$P
M&0              @('V'@$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+
M 0(4 Q0    ( "A,!%5D86U2K@8  " [   9              " @>TB 0!X
M;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ *$P$5>9LD.^5
M @  J@<  !D              ("!TBD! 'AL+W=O<FMS:&5E=',O<VAE970U
M,"YX;6Q02P$"% ,4    "  H3 15#SP61/$"   P"   &0
M@(&>+ $ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( "A,
M!%7);[=Z,@,  %T+   9              " @<8O 0!X;"]W;W)K<VAE971S
M+W-H965T-3(N>&UL4$L! A0#%     @ *$P$5<L//4*  P  90P  !D
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M=#4W+GAM;%!+ 0(4 Q0    ( "A,!%6W(G&+504  'D9   9
M  " @:=- 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @
M*$P$56EH$"BS @  J@@  !D              ("!,U,! 'AL+W=O<FMS:&5E
M=',O<VAE970U.2YX;6Q02P$"% ,4    "  H3 15)VW8"MP"  !U"0  &0
M            @($=5@$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4
M Q0    ( "A,!%5'M<FN- ,  ,X3   -              "  3!9 0!X;"]S
M='EL97,N>&UL4$L! A0#%     @ *$P$59>*NQS     $P(   L
M     ( !CUP! %]R96QS+RYR96QS4$L! A0#%     @ *$P$5<W[5Q$4!0
M?R<   \              ( !>%T! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( "A,!%68&UJ>^P$  ,LC   :              "  ;EB 0!X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( "A,!%5TTL9BW@$  %HC
M   3              "  >QD 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0  !$ $0 DQ(  /MF 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>216</ContextCount>
  <ElementCount>282</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>49</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION</Role>
      <ShortName>ORGANIZATION AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ACQUISITIONS</Role>
      <ShortName>ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME</Role>
      <ShortName>COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117106 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2121107 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2126108 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2132109 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2138110 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2142111 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2146112 - Disclosure - SEGMENT DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SEGMENTDATA</Role>
      <ShortName>SEGMENT DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2149113 - Disclosure - CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/CONTINGENCIES</Role>
      <ShortName>CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2150114 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2152115 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2154116 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RECENTACCOUNTINGPRONOUNCEMENTS</Role>
      <ShortName>RECENT ACCOUNTING PRONOUNCEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2312303 - Disclosure - ACQUISITIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ACQUISITIONSTables</Role>
      <ShortName>ACQUISITIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/ACQUISITIONS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2318304 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2322305 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2327306 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/DEBT</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2333307 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/LEASES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2339308 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2343309 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2347310 - Disclosure - SEGMENT DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SEGMENTDATATables</Role>
      <ShortName>SEGMENT DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/SEGMENTDATA</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restructuring (Benefits) Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restructuring (Benefits) Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - REVENUE RECOGNITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails</Role>
      <ShortName>REVENUE RECOGNITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - ACQUISITIONS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails</Role>
      <ShortName>ACQUISITIONS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - ACQUISITIONS - Recognized Identified Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>ACQUISITIONS - Recognized Identified Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - COMPREHENSIVE INCOME (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOMEDetails</Role>
      <ShortName>COMPREHENSIVE INCOME (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2419408 - Disclosure - EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails</Role>
      <ShortName>EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2420409 - Disclosure - EARNINGS PER SHARE - Anti-dilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails</Role>
      <ShortName>EARNINGS PER SHARE - Anti-dilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2423410 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2424411 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Estimated Annual Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Estimated Annual Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails</Role>
      <ShortName>GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2428413 - Disclosure - DEBT - Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails</Role>
      <ShortName>DEBT - Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2429414 - Disclosure - DEBT - 2021 Term Loan Credit Agreement Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails</Role>
      <ShortName>DEBT - 2021 Term Loan Credit Agreement Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2430415 - Disclosure - DEBT - Maturities of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails</Role>
      <ShortName>DEBT - Maturities of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2431416 - Disclosure - DEBT - 2019 Loan Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails</Role>
      <ShortName>DEBT - 2019 Loan Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2434417 - Disclosure - LEASES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/LEASESAdditionalInformationDetails</Role>
      <ShortName>LEASES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2435418 - Disclosure - LEASES - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>LEASES - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2436419 - Disclosure - LEASES - Operating Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails</Role>
      <ShortName>LEASES - Operating Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2437420 - Disclosure - LEASES - Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails</Role>
      <ShortName>LEASES - Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2440421 - Disclosure - FAIR VALUE MEASUREMENTS - Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2441422 - Disclosure - FAIR VALUE MEASUREMENTS - Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2444423 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2445424 - Disclosure - STOCKHOLDERS' EQUITY - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2448425 - Disclosure - SEGMENT DATA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails</Role>
      <ShortName>SEGMENT DATA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/SEGMENTDATATables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2451426 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/INCOMETAXES</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="ccrn-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2453427 - Disclosure - RELATED PARTY TRANSACTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS</ParentRole>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="ccrn-20220630.htm">ccrn-20220630.htm</File>
    <File>ccrn-20220630.xsd</File>
    <File>ccrn-20220630_cal.xml</File>
    <File>ccrn-20220630_def.xml</File>
    <File>ccrn-20220630_lab.xml</File>
    <File>ccrn-20220630_pre.xml</File>
    <File>ccrn20220630-10qex31x1.htm</File>
    <File>ccrn20220630-10qex31x2.htm</File>
    <File>ccrn20220630-10qex32x1.htm</File>
    <File>ccrn20220630-10qex32x2.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ccrn-20220630_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="756">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>79
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ccrn-20220630.htm": {
   "axisCustom": 1,
   "axisStandard": 22,
   "contextCount": 216,
   "dts": {
    "calculationLink": {
     "local": [
      "ccrn-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ccrn-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ccrn-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ccrn-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ccrn-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ccrn-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 452,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 4,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 9
   },
   "keyCustom": 30,
   "keyStandard": 252,
   "memberCustom": 19,
   "memberStandard": 28,
   "nsprefix": "ccrn",
   "nsuri": "http://www.crosscountryhealthcare.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.crosscountryhealthcare.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - ACQUISITIONS",
     "role": "http://www.crosscountryhealthcare.com/role/ACQUISITIONS",
     "shortName": "ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - COMPREHENSIVE INCOME",
     "role": "http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME",
     "shortName": "COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117106 - Disclosure - EARNINGS PER SHARE",
     "role": "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121107 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS",
     "role": "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126108 - Disclosure - DEBT",
     "role": "http://www.crosscountryhealthcare.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132109 - Disclosure - LEASES",
     "role": "http://www.crosscountryhealthcare.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138110 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142111 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146112 - Disclosure - SEGMENT DATA",
     "role": "http://www.crosscountryhealthcare.com/role/SEGMENTDATA",
     "shortName": "SEGMENT DATA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149113 - Disclosure - CONTINGENCIES",
     "role": "http://www.crosscountryhealthcare.com/role/CONTINGENCIES",
     "shortName": "CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150114 - Disclosure - INCOME TAXES",
     "role": "http://www.crosscountryhealthcare.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152115 - Disclosure - RELATED PARTY TRANSACTIONS",
     "role": "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2154116 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS",
     "role": "http://www.crosscountryhealthcare.com/role/RECENTACCOUNTINGPRONOUNCEMENTS",
     "shortName": "RECENT ACCOUNTING PRONOUNCEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - REVENUE RECOGNITION (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312303 - Disclosure - ACQUISITIONS (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/ACQUISITIONSTables",
     "shortName": "ACQUISITIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318304 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322305 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327306 - Disclosure - DEBT (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ccrn:AssetsAndLiabilitiesLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333307 - Disclosure - LEASES (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ccrn:AssetsAndLiabilitiesLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2339308 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343309 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2347310 - Disclosure - SEGMENT DATA (Tables)",
     "role": "http://www.crosscountryhealthcare.com/role/SEGMENTDATATables",
     "shortName": "SEGMENT DATA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnbilledContractsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnbilledContractsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "if9d2332650c84b7e8d003bddf5a15b05_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i901eb837ca884f56bf62787429027b0d_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restructuring (Benefits) Costs (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restructuring (Benefits) Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessExitCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - REVENUE RECOGNITION (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails",
     "shortName": "REVENUE RECOGNITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ibec9a7eb25a8452ab4f07a8f19d5a7ca_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib1b4fd715e5f4320a19dcfe134293e02_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - ACQUISITIONS - Additional Information (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
     "shortName": "ACQUISITIONS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i81ed68aa78894c6b82beb72c410707bf_D20211216-20211216",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - ACQUISITIONS - Recognized Identified Assets Acquired and Liabilities Assumed (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "ACQUISITIONS - Recognized Identified Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i1671691aefa34321882545ccf2019faf_I20210608",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DirectOperatingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - COMPREHENSIVE INCOME (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOMEDetails",
     "shortName": "COMPREHENSIVE INCOME (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ccrn:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419408 - Disclosure - EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails",
     "shortName": "EARNINGS PER SHARE - Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i7a171810dfba45719542dcd325b21e11_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420409 - Disclosure - EARNINGS PER SHARE - Anti-dilutive Securities (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails",
     "shortName": "EARNINGS PER SHARE - Anti-dilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i7a171810dfba45719542dcd325b21e11_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423410 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails",
     "shortName": "GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Acquired Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424411 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Estimated Annual Amortization Expense (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails",
     "shortName": "GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Estimated Annual Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib1b4fd715e5f4320a19dcfe134293e02_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
     "shortName": "GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS - Goodwill Rollforward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib1b4fd715e5f4320a19dcfe134293e02_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428413 - Disclosure - DEBT - Long-term Debt (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
     "shortName": "DEBT - Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i192f55a490bc4b13a11411bf8375331d_D20220623-20220623",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ccrn:PaymentForDebtPrepayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429414 - Disclosure - DEBT - 2021 Term Loan Credit Agreement Narrative (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
     "shortName": "DEBT - 2021 Term Loan Credit Agreement Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i192f55a490bc4b13a11411bf8375331d_D20220623-20220623",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "ccrn:PaymentForDebtPrepayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430415 - Disclosure - DEBT - Maturities of Debt (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
     "shortName": "DEBT - Maturities of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i7cd36e49d89f42d8a3c94c429c6d21a1_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i522e12765bc4480e83302783fd04656b_I20211118",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ccrn:LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431416 - Disclosure - DEBT - 2019 Loan Agreement (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
     "shortName": "DEBT - 2019 Loan Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i522e12765bc4480e83302783fd04656b_I20211118",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ccrn:LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i2f3bea820d5244fd87508196dd2090f4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i2f3bea820d5244fd87508196dd2090f4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434417 - Disclosure - LEASES - Additional Information (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/LEASESAdditionalInformationDetails",
     "shortName": "LEASES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435418 - Disclosure - LEASES - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails",
     "shortName": "LEASES - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436419 - Disclosure - LEASES - Operating Lease Maturity (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails",
     "shortName": "LEASES - Operating Lease Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib8c3eb7e773141eeacba6e9a970bc860_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437420 - Disclosure - LEASES - Lease Costs (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails",
     "shortName": "LEASES - Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ife18debf13894b69a0178110599379d5_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440421 - Disclosure - FAIR VALUE MEASUREMENTS - Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ife18debf13894b69a0178110599379d5_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i1671691aefa34321882545ccf2019faf_I20210608",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441422 - Disclosure - FAIR VALUE MEASUREMENTS - Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "ib1337e8b15554efd83e0ffd2872603fa_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iaf0b19c2fa5d44578370990b5584d68a_I20080228",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444423 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iaf0b19c2fa5d44578370990b5584d68a_I20080228",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "if4eba8a27a3045758fc0c06e41d5704b_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445424 - Disclosure - STOCKHOLDERS' EQUITY - Restricted Stock Activity (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i5971e44cedd840cba357c4cbff3aeb0f_D20220101-20220630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448425 - Disclosure - SEGMENT DATA (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails",
     "shortName": "SEGMENT DATA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "ccrn:OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451426 - Disclosure - INCOME TAXES (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "iefea7abb1f1e434dbacf3fcd86a3b3a3_D20220401-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "ccrn:ProvisionForDoubtfulAccountsAndOtherAllowances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i91fdc80f57044a50afa1d6033fa5183f_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453427 - Disclosure - RELATED PARTY TRANSACTIONS (Details)",
     "role": "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails",
     "shortName": "RELATED PARTY TRANSACTIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i91fdc80f57044a50afa1d6033fa5183f_D20220401-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - ORGANIZATION AND BASIS OF PRESENTATION",
     "role": "http://www.crosscountryhealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION",
     "shortName": "ORGANIZATION AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - REVENUE RECOGNITION",
     "role": "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ccrn-20220630.htm",
      "contextRef": "i847dead6d7ec468e8881bbafff04909d_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 49,
   "tag": {
    "ccrn_A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Term Loan Credit Agreement, Aggregate Amount Of All Possible Increases",
        "label": "2021 Term Loan Credit Agreement, Aggregate Amount Of All Possible Increases [Member]",
        "terseLabel": "2021 Term Loan Credit Agreement, Aggregate Amount of All Possible Increases"
       }
      }
     },
     "localname": "A2021TermLoanCreditAgreementAggregateAmountOfAllPossibleIncreasesMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_A2021TermLoanCreditAgreementIncrementalTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Term Loan Credit Agreement, Incremental Term Loan",
        "label": "2021 Term Loan Credit Agreement, Incremental Term Loan [Member]",
        "terseLabel": "2021 Term Loan Credit Agreement, Incremental Term Loan"
       }
      }
     },
     "localname": "A2021TermLoanCreditAgreementIncrementalTermLoanMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_A2021TermLoanCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Term Loan Credit Agreement",
        "label": "2021 Term Loan Credit Agreement [Member]",
        "terseLabel": "2021 Term Loan Credit Agreement"
       }
      }
     },
     "localname": "A2021TermLoanCreditAgreementMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Before Tax",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Before Tax",
        "negatedTerseLabel": "Loss on currency fluctuations"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_AcquisitionAndIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition and integration-related costs include costs for prior acquisitions, costs incurred for potential transactions, and accretion and valuation adjustments on contingent consideration liabilities",
        "label": "Acquisition And Integration-Related Costs",
        "terseLabel": "Acquisition and integration-related costs"
       }
      }
     },
     "localname": "AcquisitionAndIntegrationRelatedCosts",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_AssetsAndLiabilitiesLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Leases [Table Text Block]",
        "label": "Assets And Liabilities, Leases [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Balance Sheet Information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLeasesTableTextBlock",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ccrn_BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Net Working Capital Adjustment",
        "label": "Business Combination, Consideration Transferred, Net Working Capital Adjustment",
        "terseLabel": "Net working capital adjustment"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredNetWorkingCapitalAdjustment",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_BusinessCombinationContingentConsiderationTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Term",
        "label": "Business Combination, Contingent Consideration, Term",
        "terseLabel": "Contingent consideration liability, term"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationTerm",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Current",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Current",
        "terseLabel": "Lease liability - current"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationCurrent",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Noncurrent",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation, Noncurrent",
        "terseLabel": "Lease liability - non-current"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedLeaseObligationNoncurrent",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Compensation And Benefits",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Compensation And Benefits",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedCompensationAndBenefits",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Acquired Including Goodwill",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-Of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-Of-Use Assets",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_DebtInstrumentVariableInterestRateFloor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Variable Interest Rate Floor",
        "label": "Debt Instrument, Variable Interest Rate Floor",
        "terseLabel": "Interest margin floor percentage"
       }
      }
     },
     "localname": "DebtInstrumentVariableInterestRateFloor",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ccrn_DeferredCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation [Member]",
        "label": "Deferred Compensation [Member]",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "DeferredCompensationMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_EarnoutNotesPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnout Notes Payable",
        "label": "Earnout Notes Payable [Member]",
        "terseLabel": "Earnout Notes Payable"
       }
      }
     },
     "localname": "EarnoutNotesPayableMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate, Continuing Operations, Excluding Discrete Items",
        "label": "Effective Income Tax Rate, Continuing Operations, Excluding Discrete Items",
        "terseLabel": "Effective tax rate, excluding discrete items"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsExcludingDiscreteItems",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ccrn_ExitCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exit Costs [Member]",
        "label": "Exit Costs [Member]",
        "terseLabel": "Lease-Related"
       }
      }
     },
     "localname": "ExitCostsMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]",
        "label": "Finite Lived And Indefinite Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ccrn_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite Lived Intangible Asset, Expected Amortization, After Year Four",
        "label": "Finite Lived Intangible Asset, Expected Amortization, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_HealthCareSystemAffiliatedWithABoardMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care System Affiliated With A Board Member",
        "label": "Health Care System Affiliated With A Board Member [Member]",
        "terseLabel": "Health Care System Affiliated with a Board Member"
       }
      }
     },
     "localname": "HealthCareSystemAffiliatedWithABoardMemberMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease Liabilities",
        "label": "Increase (Decrease) In Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit, Amount Of Indebtedness Permitted By Senior Secured Asset Based Loan To Be Borrowed From Other Sources",
        "label": "Line Of Credit, Amount Of Indebtedness Permitted By Senior Secured Asset Based Loan To Be Borrowed From Other Sources",
        "terseLabel": "Amount of indebtedness permitted from other sources"
       }
      }
     },
     "localname": "LineOfCreditAmountOfIndebtednessPermittedBySeniorSecuredAssetBasedLoanToBeBorrowedFromOtherSources",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_LineOfCreditBorrowingBasePercentageOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit, Borrowing Base, Percentage Of Assets",
        "label": "Line Of Credit, Borrowing Base, Percentage Of Assets",
        "terseLabel": "Borrowing base, percentage of assets"
       }
      }
     },
     "localname": "LineOfCreditBorrowingBasePercentageOfAssets",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ccrn_LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Basis Spread On Variable Rate, Additional Credit Spread Associated With SOFR",
        "label": "Line Of Credit Facility, Basis Spread On Variable Rate, Additional Credit Spread Associated With SOFR",
        "terseLabel": "Basis spread on variable rate, additional credit spread associated with SOFR"
       }
      }
     },
     "localname": "LineOfCreditFacilityBasisSpreadOnVariableRateAdditionalCreditSpreadAssociatedWithSOFR",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ccrn_LineOfCreditFacilityBorrowingBaseAvailability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Borrowing Base Availability",
        "label": "Line Of Credit Facility, Borrowing Base Availability",
        "terseLabel": "Borrowing base availability"
       }
      }
     },
     "localname": "LineOfCreditFacilityBorrowingBaseAvailability",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_LineOfCreditSublimitAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Sublimit [Axis]",
        "label": "Line Of Credit Sublimit [Axis]",
        "terseLabel": "Line Of Credit Sublimit [Axis]"
       }
      }
     },
     "localname": "LineOfCreditSublimitAxis",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ccrn_LineOfCreditSublimitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Line Of Credit Sublimit [Axis]",
        "label": "Line Of Credit Sublimit [Domain]",
        "terseLabel": "Line Of Credit Sublimit [Domain]"
       }
      }
     },
     "localname": "LineOfCreditSublimitDomain",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_LongTermDebtMaturityAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, After Year Four",
        "label": "Long-Term Debt, Maturity, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityAfterYearFour",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_NurseAndAlliedStaffingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nurse and allied staffing [Member]",
        "label": "Nurse And Allied Staffing [Member]",
        "terseLabel": "Nurse And Allied Staffing",
        "verboseLabel": "Nurse And Allied Staffing"
       }
      }
     },
     "localname": "NurseAndAlliedStaffingMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_OmnibusPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Omnibus Plan",
        "label": "Omnibus Plan [Member]",
        "terseLabel": "Omnibus Plan"
       }
      }
     },
     "localname": "OmnibusPlanMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income Loss Before D And A Acquisition And Integration Contingent Consideration Restructuring Legal Impairment And Corporate Overheard",
        "label": "Operating Income Loss Before D And A Acquisition And Integration Contingent Consideration Restructuring Legal Impairment And Corporate Overheard",
        "terseLabel": "Contribution income:"
       }
      }
     },
     "localname": "OperatingIncomeLossBeforeDAndAAcquisitionAndIntegrationContingentConsiderationRestructuringLegalImpairmentAndCorporateOverheard",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_OperatingLeaseExpenseNonCash": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Expense, Non-Cash",
        "label": "Operating Lease Expense, Non-Cash",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpenseNonCash",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_OtherServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Services [Member]",
        "label": "Other Services [Member]",
        "terseLabel": "Other Services"
       }
      }
     },
     "localname": "OtherServicesMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_PaymentForDebtPrepayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment For Debt Prepayment",
        "label": "Payment For Debt Prepayment",
        "terseLabel": "Payment for debt prepayment"
       }
      }
     },
     "localname": "PaymentForDebtPrepayment",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_PaymentsForRestructuringAndAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Restructuring And Adjustments",
        "label": "Payments For Restructuring And Adjustments",
        "negatedTerseLabel": "Payments and adjustments"
       }
      }
     },
     "localname": "PaymentsForRestructuringAndAdjustments",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_PhysicianStaffingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physician staffing [Member]",
        "label": "Physician Staffing [Member]",
        "terseLabel": "Physician Staffing"
       }
      }
     },
     "localname": "PhysicianStaffingMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_ProvisionForDoubtfulAccountsAndOtherAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision For Doubtful Accounts And Other Allowances",
        "label": "Provision For Doubtful Accounts And Other Allowances",
        "verboseLabel": "Provision for allowances"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccountsAndOtherAllowances",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_RestrictedStockAndPerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock And Performance Shares",
        "label": "Restricted Stock And Performance Shares [Member]",
        "terseLabel": "Restricted Stock And Performance Shares"
       }
      }
     },
     "localname": "RestrictedStockAndPerformanceSharesMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_SalesAllowanceBillingRelatedAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Allowance, Billing-Related Adjustments",
        "label": "Sales Allowance, Billing-Related Adjustments",
        "terseLabel": "Sales allowance, billing-related adjustments"
       }
      }
     },
     "localname": "SalesAllowanceBillingRelatedAdjustments",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]",
        "label": "Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]",
        "terseLabel": "Schedule Of Indefinite Lived And Finite Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedAndFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ccrn_SegmentReportingUnallocatedCorporateExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Reporting Unallocated Corporate Expenses",
        "label": "Segment Reporting Unallocated Corporate Expenses",
        "terseLabel": "Corporate overhead"
       }
      }
     },
     "localname": "SegmentReportingUnallocatedCorporateExpenses",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ccrn_SelectedIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selected, Inc",
        "label": "Selected, Inc [Member]",
        "terseLabel": "Selected, Inc"
       }
      }
     },
     "localname": "SelectedIncMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_SeniorSecuredAssetBasedLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Asset-Based Loan [Member]",
        "label": "Senior Secured Asset-Based Loan [Member]",
        "terseLabel": "Senior Secured Asset-Based Loan"
       }
      }
     },
     "localname": "SeniorSecuredAssetBasedLoanMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Target Attainment Level, Percentage",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Attainment Percentage",
        "terseLabel": "Performance attainment percentage"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAttainmentPercentage",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other than Options, Vested In Period, Net",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other than Options, Vested In Period, Net",
        "terseLabel": "Vested in period, net (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodNet",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ccrn_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Installments",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number Of Vesting Installments",
        "terseLabel": "Number of vesting installments"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingInstallments",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ccrn_ShareBasedPaymentAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Awards [Member]",
        "label": "Share-Based Payment Awards [Member]",
        "terseLabel": "Share-based Payment Awards"
       }
      }
     },
     "localname": "ShareBasedPaymentAwardsMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_StandbyLettersOfCreditSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Standby Letters Of Credit Sublimit [Member]",
        "label": "Standby Letters Of Credit Sublimit [Member]",
        "terseLabel": "Standby Letters Of Credit Sublimit"
       }
      }
     },
     "localname": "StandbyLettersOfCreditSublimitMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_SwingLoansSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swing Loans Sublimit [Member]",
        "label": "Swing Loans Sublimit [Member]",
        "terseLabel": "Swingline Sublimit"
       }
      }
     },
     "localname": "SwingLoansSublimitMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_TemporaryStaffingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Staffing Services [Member]",
        "label": "Temporary Staffing Services [Member]",
        "terseLabel": "Temporary Staffing Services"
       }
      }
     },
     "localname": "TemporaryStaffingServicesMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ccrn_ThresholdPeriodPastDueForPaymentOfServicesProvided": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold Period, Past Due For Payment Of Services Provided",
        "label": "Threshold Period, Past Due For Payment Of Services Provided",
        "terseLabel": "Threshold period, past due for payment of services provided"
       }
      }
     },
     "localname": "ThresholdPeriodPastDueForPaymentOfServicesProvided",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ccrn_WorkforceSolutionsGroupIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workforce Solutions Group, Inc.",
        "label": "Workforce Solutions Group, Inc. [Member]",
        "terseLabel": "Workforce Solutions Group, Inc."
       }
      }
     },
     "localname": "WorkforceSolutionsGroupIncMember",
     "nsuri": "http://www.crosscountryhealthcare.com/20220630",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Member of the Board of Directors"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r260",
      "r280",
      "r314",
      "r352",
      "r354",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r580",
      "r582",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r257",
      "r258",
      "r259",
      "r260",
      "r280",
      "r314",
      "r352",
      "r354",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r580",
      "r582",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r178",
      "r258",
      "r259",
      "r331",
      "r333",
      "r530",
      "r579",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r178",
      "r258",
      "r259",
      "r331",
      "r333",
      "r530",
      "r579",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r238",
      "r257",
      "r258",
      "r259",
      "r260",
      "r280",
      "r314",
      "r341",
      "r352",
      "r354",
      "r381",
      "r382",
      "r383",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r580",
      "r582",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r238",
      "r257",
      "r258",
      "r259",
      "r260",
      "r280",
      "r314",
      "r341",
      "r352",
      "r354",
      "r381",
      "r382",
      "r383",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r580",
      "r582",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r183",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Schedule of Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r184",
      "r185"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowances of $11,896 in 2022 and $6,881 in 2021"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r12",
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment, accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r25",
      "r48",
      "r49",
      "r50",
      "r566",
      "r587",
      "r590"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r47",
      "r50",
      "r56",
      "r57",
      "r58",
      "r100",
      "r101",
      "r102",
      "r441",
      "r505",
      "r583",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss, net"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r386",
      "r387",
      "r388",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r356",
      "r389",
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r29",
      "r190",
      "r200",
      "r201",
      "r204"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r29",
      "r190",
      "r200"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r203"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write-Offs, net of Recoveries"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Shares excluded from diluted weighted average shares (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r86",
      "r230"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r16",
      "r94",
      "r162",
      "r168",
      "r174",
      "r196",
      "r264",
      "r265",
      "r266",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r438",
      "r442",
      "r464",
      "r516",
      "r518",
      "r550",
      "r565"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r32",
      "r94",
      "r196",
      "r264",
      "r265",
      "r266",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r438",
      "r442",
      "r464",
      "r516",
      "r518"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Deferred compensation asset"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Accounting"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r351",
      "r353",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r351",
      "r353",
      "r416",
      "r417",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Equity consideration for acquisition (shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r428",
      "r429"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Equity consideration for acquisition, value"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r427",
      "r430",
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Earnout liabilities",
        "verboseLabel": "Earnout liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r427",
      "r431"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Current portion of earnout liability",
        "verboseLabel": "Current portion of earnout liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r427",
      "r431"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Non-current earnout liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r422",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability": {
     "auth_ref": [
      "r418",
      "r419"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of liability arising from an inherited contingency (as defined) which has been recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability",
        "terseLabel": "Earnout liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r418",
      "r419"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Other intangible assets",
        "verboseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r418",
      "r419"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Early termination benefit"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Amount"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r11",
      "r88"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r83",
      "r88",
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r83",
      "r473"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r41",
      "r554",
      "r570"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r254",
      "r255",
      "r256",
      "r261",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares reserved for share-based payments (shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r100",
      "r101",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r21",
      "r518"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r52",
      "r54",
      "r55",
      "r63",
      "r558",
      "r573"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r62",
      "r72",
      "r557",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "COMPREHENSIVE INCOME"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/COMPREHENSIVEINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r91",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Nature of Business"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r246",
      "r247",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Restructuring (Benefits) Costs"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DatabasesMember": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal rights granted to the owner or licensee of collections of information stored in electronic form (such as on computer disks or files).",
        "label": "Database Rights [Member]",
        "terseLabel": "Databases"
       }
      }
     },
     "localname": "DatabasesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r92",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r294",
      "r301",
      "r302",
      "r304",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r93",
      "r98",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r284",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r307",
      "r308",
      "r309",
      "r310",
      "r485",
      "r551",
      "r552",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest margin percentage"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r19",
      "r305",
      "r552",
      "r564"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r277",
      "r307",
      "r308",
      "r483",
      "r485",
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r292",
      "r307",
      "r308",
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "verboseLabel": "Note payable, fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r38",
      "r306",
      "r483",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r38",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r39",
      "r93",
      "r98",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r284",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r307",
      "r308",
      "r309",
      "r310",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Quarterly installment amount"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r39",
      "r93",
      "r98",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r284",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r303",
      "r307",
      "r308",
      "r309",
      "r310",
      "r316",
      "r317",
      "r318",
      "r319",
      "r482",
      "r483",
      "r485",
      "r486",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r290",
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedTerseLabel": "Debt Issuance Costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r392",
      "r393"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Non-current deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r86",
      "r95",
      "r399",
      "r407",
      "r408",
      "r409"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax expense"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r392",
      "r393"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Non-current deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r86",
      "r157"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DirectOperatingCosts": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate direct operating costs incurred during the reporting period.",
        "label": "Direct Operating Costs",
        "terseLabel": "Direct operating expenses"
       }
      }
     },
     "localname": "DirectOperatingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r231",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Sale of business"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r64",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r120",
      "r123",
      "r133",
      "r134",
      "r135",
      "r139",
      "r140",
      "r449",
      "r450",
      "r559",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income per share attributable to common stockholders - Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r64",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r123",
      "r133",
      "r134",
      "r135",
      "r139",
      "r140",
      "r449",
      "r450",
      "r559",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income per share attributable to common stockholders - Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r473"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Termination"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r56",
      "r57",
      "r58",
      "r100",
      "r101",
      "r102",
      "r106",
      "r114",
      "r116",
      "r142",
      "r197",
      "r315",
      "r320",
      "r386",
      "r387",
      "r388",
      "r400",
      "r401",
      "r448",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r505",
      "r583",
      "r584",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r292",
      "r307",
      "r308",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r454",
      "r455",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r454",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r454",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Carrying Amounts and Estimated Fair Values of Significant Financial Instrument that were not Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r292",
      "r307",
      "r308",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r455",
      "r519",
      "r520",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r292",
      "r307",
      "r308",
      "r454",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r292",
      "r307",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r292",
      "r342",
      "r343",
      "r348",
      "r350",
      "r455",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r292",
      "r307",
      "r308",
      "r342",
      "r343",
      "r348",
      "r350",
      "r455",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": {
     "auth_ref": [
      "r454",
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations measured on a recurring basis.",
        "label": "Obligations, Fair Value Disclosure",
        "terseLabel": "Deferred compensation liability"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r292",
      "r307",
      "r308",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r519",
      "r520",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSEstimatedFairValuesofFinancialAssetsandLiabilitiesMeasuredonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOptionQuantitativeDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Option, Quantitative Disclosures [Line Items]",
        "terseLabel": "Fair Value, Option, Quantitative Disclosures [Line Items]"
       }
      }
     },
     "localname": "FairValueOptionQuantitativeDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOptionQuantitativeDisclosuresTable": {
     "auth_ref": [
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value under fair value option.",
        "label": "Fair Value Option, Disclosures [Table]",
        "terseLabel": "Fair Value Option, Disclosures [Table]"
       }
      }
     },
     "localname": "FairValueOptionQuantitativeDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r14",
      "r225"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "verboseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r221",
      "r223",
      "r225",
      "r228",
      "r531",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r225",
      "r535"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r221",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r225",
      "r531"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Other intangible assets, net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSEstimatedAnnualAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "terseLabel": "Intangible assets subject to amortization:"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r86",
      "r311",
      "r312"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r13",
      "r208",
      "r209",
      "r216",
      "r220",
      "r518",
      "r549"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "ccrn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAcquiredIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, net of impairment loss, ending balance",
        "periodStartLabel": "Goodwill, net of impairment loss, beginning balance",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL, TRADE NAMES, AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r209",
      "r216",
      "r220"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "periodEndLabel": "Aggregate goodwill acquired, ending balance",
        "periodStartLabel": "Aggregate goodwill acquired, beginning balance"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r209",
      "r216",
      "r220"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedPeriodEndLabel": "Accumulated impairment loss, ending balance",
        "negatedPeriodStartLabel": "Accumulated impairment loss, beginning balance"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r215",
      "r415"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill acquisition adjustment - Selected"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r86",
      "r230",
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Leasehold improvements, impairment loss"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r162",
      "r167",
      "r170",
      "r173",
      "r176",
      "r548",
      "r555",
      "r561",
      "r575"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r235",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r96",
      "r396",
      "r397",
      "r398",
      "r405",
      "r410",
      "r412",
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r115",
      "r116",
      "r160",
      "r394",
      "r406",
      "r411",
      "r576"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r135",
      "r358"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Share-based awards (shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]",
        "terseLabel": "Intangible assets not subject to amortization:"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedTradeNames": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Trade Names",
        "terseLabel": "Trade names, indefinite-lived",
        "verboseLabel": "Trade names, indefinite-lived"
       }
      }
     },
     "localname": "IndefiniteLivedTradeNames",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InsuranceSettlementsReceivableCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Insurance Settlements Receivable, Current",
        "terseLabel": "Insurance recovery receivable"
       }
      }
     },
     "localname": "InsuranceSettlementsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r59",
      "r156",
      "r481",
      "r484",
      "r560"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r501"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r501"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r501"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r501"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r501"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r501"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: amount of lease payments representing interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r35",
      "r94",
      "r169",
      "r196",
      "r264",
      "r265",
      "r266",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r439",
      "r442",
      "r443",
      "r464",
      "r516",
      "r517"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r28",
      "r94",
      "r196",
      "r464",
      "r518",
      "r553",
      "r568"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r10",
      "r37",
      "r94",
      "r196",
      "r264",
      "r265",
      "r266",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r439",
      "r442",
      "r443",
      "r464",
      "r516",
      "r517",
      "r518"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r577",
      "r578"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "terseLabel": "Long-term accrued claims"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r19",
      "r552",
      "r564"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "verboseLabel": "Line of credit, carrying amount"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Line of Credit Facility, Expiration Period",
        "terseLabel": "Line of credit term"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Borrowing availability"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r33",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Quarterly commitment fee on the average daily unused portion percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Senior Secured Asset-Based Loan"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LinesOfCreditFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time.",
        "label": "Lines of Credit, Fair Value Disclosure",
        "terseLabel": "Senior Secured Asset-Based Loan"
       }
      }
     },
     "localname": "LinesOfCreditFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Long-term Debt, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of debt",
        "verboseLabel": "Less current portion"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r98",
      "r262",
      "r296"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r98",
      "r262",
      "r296"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r98",
      "r262",
      "r296"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r98",
      "r262",
      "r296"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r39",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r83",
      "r84",
      "r87"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r51",
      "r53",
      "r58",
      "r61",
      "r87",
      "r94",
      "r105",
      "r109",
      "r110",
      "r111",
      "r112",
      "r115",
      "r116",
      "r131",
      "r162",
      "r167",
      "r170",
      "r173",
      "r176",
      "r196",
      "r264",
      "r265",
      "r266",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r450",
      "r464",
      "r556",
      "r571"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Consolidated net income",
        "totalLabel": "Net income attributable to common stockholders",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r112",
      "r120",
      "r121",
      "r132",
      "r135",
      "r162",
      "r167",
      "r170",
      "r173",
      "r176"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income attributable to common stockholders - Basic and Diluted - Basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r122",
      "r127",
      "r128",
      "r129",
      "r130",
      "r132",
      "r135"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net income attributable to common stockholders - Basic and Diluted - Diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r2",
      "r103",
      "r104",
      "r107",
      "r108",
      "r117",
      "r118",
      "r119",
      "r194",
      "r195",
      "r198",
      "r199",
      "r402",
      "r403",
      "r404",
      "r447",
      "r451",
      "r452",
      "r453",
      "r468",
      "r469",
      "r470",
      "r487",
      "r488",
      "r504",
      "r506",
      "r532",
      "r533",
      "r534",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "RECENT ACCOUNTING PRONOUNCEMENTS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RECENTACCOUNTINGPRONOUNCEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Accounting Pronouncement"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r320",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest in Subsidiary"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expenses (income):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Note Payable"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r162",
      "r167",
      "r170",
      "r173",
      "r176"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Income from operations",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r493",
      "r502"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r489"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Operating Lease, Impairment Loss",
        "terseLabel": "Operating lease, impairment loss"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r491"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Present value of future minimum lease payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r491"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedLabel": "Less: operating lease liabilities - current",
        "terseLabel": "Operating lease liabilities - current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails",
      "http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r491"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities - non-current",
        "verboseLabel": "Operating lease liabilities - non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/LEASESOperatingLeaseMaturityDetails",
      "http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r492",
      "r496"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for amounts included in the measurement of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r490"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r499",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r498",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r6",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "ORGANIZATION AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ORGANIZATIONANDBASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r31",
      "r518"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r46",
      "r48",
      "r471",
      "r472",
      "r474"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Unrealized foreign currency translation loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r36",
      "r518"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebtNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer.",
        "label": "Other Long-Term Debt, Noncurrent",
        "terseLabel": "Long-term debt, less current portion"
       }
      }
     },
     "localname": "OtherLongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash (benefits) costs"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r82",
      "r241"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "verboseLabel": "Prepayment premium paid"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Cash paid for shares withheld for taxes"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r73",
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash consideration, gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Stock Awards"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r8",
      "r30",
      "r206",
      "r207"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Proceeds from term loan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-Term Lines of Credit",
        "verboseLabel": "Borrowings under Senior Secured Asset-Based revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r76",
      "r81"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r233",
      "r518",
      "r562",
      "r569"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net of accumulated depreciation of $19,240 in 2022 and $17,729 in 2021"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r65",
      "r202"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt expense",
        "verboseLabel": "Bad Debt Expense"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAllowanceforDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r167",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r167",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Information on Operating Segments and Reconciliation to Income from Operations"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r349",
      "r509",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r349",
      "r509",
      "r513",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r507",
      "r508",
      "r510",
      "r514",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-Term Lines of Credit",
        "negatedLabel": "Repayments on Senior Secured Asset-Based revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedTerseLabel": "Principal payments on note payable"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedLabel": "Principal payments on term loan"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r86",
      "r239",
      "r246",
      "r250"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring (benefits) costs",
        "verboseLabel": "Charged to restructuring"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails",
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r240",
      "r241",
      "r250",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r241",
      "r248"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r24",
      "r320",
      "r518",
      "r567",
      "r586",
      "r590"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings (accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r100",
      "r101",
      "r102",
      "r106",
      "r114",
      "r116",
      "r197",
      "r386",
      "r387",
      "r388",
      "r400",
      "r401",
      "r448",
      "r583",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r153",
      "r154",
      "r166",
      "r171",
      "r172",
      "r178",
      "r179",
      "r181",
      "r330",
      "r331",
      "r530"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue from services"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.",
        "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
        "terseLabel": "Revenue from Contract with Customer, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r332",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE RECOGNITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r67",
      "r267",
      "r269",
      "r270",
      "r274",
      "r275",
      "r276",
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "terseLabel": "Revenue from related parties"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r497",
      "r502"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets acquired under operating lease"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r416",
      "r417",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r39",
      "r98",
      "r307",
      "r309",
      "r316",
      "r317",
      "r318",
      "r319",
      "r482",
      "r483",
      "r486",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Components of Numerator and Denominator for Computation of Basic and Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Estimated Fair Values of Financial Assets and Liabilities Measured on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill by Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Acquired Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Aggregate Scheduled Maturities of Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Summary of Fair Value of Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r511",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/RELATEDPARTYTRANSACTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r243",
      "r250",
      "r251",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r244",
      "r245",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r355",
      "r357",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Annual Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTLongtermDebtDetails",
      "http://www.crosscountryhealthcare.com/role/DEBTMaturitiesofDebtDetails",
      "http://www.crosscountryhealthcare.com/role/FAIRVALUEMEASUREMENTSCarryingAmountsandEstimatedFairValuesofSignificantFinancialInstrumentthatwerenotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "SOFR"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r150",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r181",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r220",
      "r243",
      "r252",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r162",
      "r165",
      "r170",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r180",
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT DATA"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATA"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]",
        "terseLabel": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r370",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested restricted stock awards, ending balance (shares)",
        "periodStartLabel": "Unvested restricted stock awards, beginning balance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r370",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested restricted stock awards, ending balance (in dollars per share)",
        "periodStartLabel": "Unvested restricted stock awards, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (shares)",
        "terseLabel": "Vested (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r321",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (shares)",
        "periodStartLabel": "Beginning balance (shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r494",
      "r502"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short-term lease expense"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r90",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r150",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r181",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r220",
      "r236",
      "r243",
      "r252",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Business Segments"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSGoodwillRollforwardDetails",
      "http://www.crosscountryhealthcare.com/role/REVENUERECOGNITIONDetails",
      "http://www.crosscountryhealthcare.com/role/SEGMENTDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r43",
      "r56",
      "r57",
      "r58",
      "r100",
      "r101",
      "r102",
      "r106",
      "r114",
      "r116",
      "r142",
      "r197",
      "r315",
      "r320",
      "r386",
      "r387",
      "r388",
      "r400",
      "r401",
      "r448",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r505",
      "r583",
      "r584",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r142",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r20",
      "r21",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Acquisition of WSG (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r20",
      "r21",
      "r315",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Vesting of restricted stock (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r43",
      "r315",
      "r320"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Acquisition of WSG"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r20",
      "r21",
      "r320",
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Vesting of restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased",
        "terseLabel": "Stock repurchase program common stock authorized to be purchased (up to)"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased",
        "terseLabel": "Common shares left remaining to repurchase under the plan (up to) (shares)"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r20",
      "r21",
      "r315",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "terseLabel": "Shares repurchased and retired (shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r21",
      "r26",
      "r27",
      "r94",
      "r192",
      "r196",
      "r464",
      "r518"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r57",
      "r94",
      "r100",
      "r101",
      "r102",
      "r106",
      "r114",
      "r196",
      "r197",
      "r320",
      "r386",
      "r387",
      "r388",
      "r400",
      "r401",
      "r436",
      "r437",
      "r444",
      "r448",
      "r464",
      "r475",
      "r476",
      "r480",
      "r505",
      "r584",
      "r585"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable, net"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/ACQUISITIONSAdditionalInformationDetails",
      "http://www.crosscountryhealthcare.com/role/GOODWILLTRADENAMESANDOTHERINTANGIBLEASSETSAcquiredIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r240",
      "r241",
      "r250",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRestructuringBenefitsCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledContractsReceivable": {
     "auth_ref": [
      "r529"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
        "label": "Unbilled Contracts Receivable",
        "terseLabel": "Unbilled contracts receivable"
       }
      }
     },
     "localname": "UnbilledContractsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r495",
      "r502"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable and other lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/LEASESLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2019LoanAgreementDetails",
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]",
        "terseLabel": "Effect of diluted shares:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r122",
      "r135"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (shares)",
        "totalLabel": "Weighted average common shares - Diluted (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r120",
      "r135"
     ],
     "calculation": {
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (shares)",
        "verboseLabel": "Weighted average common shares - Basic (shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/EARNINGSPERSHAREComponentsofNumeratorandDenominatorforComputationofBasicandDilutedEarningsperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write off of debt issuance costs"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.crosscountryhealthcare.com/role/DEBT2021TermLoanCreditAgreementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14210-108612"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14217-108612"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55302-109406"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r595": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r596": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r597": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r598": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r599": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r600": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>80
<FILENAME>0001628280-22-020893-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-020893-xbrl.zip
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M(CARBH'#K#Q"U'H/[@WF%O')46E:(T"Q=PX4"+:!,Y:FFJRP +_A/ZN"$E.
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MJK OF5$F[70U3YE$B\H74\E&XC1M5B\LHS&M3(XF"*FU0)0P%(1WL^^<OFC
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M4'(@]080;_YP&P-3EE?)8PYGG;('R+C*=;NY/17H*#KI_I?-QOS!=7VSHNM
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MZ_)VS[2/\K0#UF >H\I*J\,0+XPHWMPJHJT;"@RR:>MIUK%JI ^/8(5P)IH
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M-.E]R[VQ_SO;4CO#,',>SW;5E0.XEGYMVQ!XMUA^ Q.WW!L)C%H-B%J#,T:
M3$XE$JG05I0"7R8; EVZCGX@]T7%JNY,[1';?U>L>A2LFG-:4"<E6F2ECY8
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M=XWW[CD_NDPE9C74VJ(2BP4OOJQ <J=Z1&L-4FT%?%9\6B$^O;F&8D1+G0B
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MZ@"#B> TIT"U=BE8QHUS6]NRS\B][8NJV-U5[/:S":IB/ZQBS[L-I&?,64-
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M'3#C=.#&$LGHUC9YQMMJ\%4AJ$+00T'0/9W*%8)6 D'S!11<S =%(*Y4OB:
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M,;KM*H3WUK;- )B-P)B'\@E5C'D0C)GC,9G$*,UU AI+96?E9$:;Q,%%081
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M]6L9;<- O?.>.^/0B8 A)>NIUT)*XT.**O#?F=ZZ^-#;\<4,WMLW$=PXVC_
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M^?:*!\2Q%YAML>I3]MK\Q8,^C#]4^C.*@Y-&MV]_K+?CZOJ1GM5%7*W [[
MN\/A&  L[J7]Z,>#&.K>LPNC4[-GJ35CFCD2D6*$(LZ)0XX*C&!1F:*848O%
M,O:>K7W#RU[S94Z=KNVD!RKV]+DF$9S*^;T&>XFX$1$Y(@TB-E(G8Q0TF7P0
M #=!!)=(L5]9#MU?@PZ0]5/;S77IBE!* _3T81SD=638+)R$O(N3):AAZI%@
M:O8<M</$TY \(B[FKK21H%R8"E$7HS$8>TN!?PA\:\FY^B#UTFKR<S*/>RER
M;4/\N Y/GRPBCB?C#8)5S#VXHD%::H$\@'("&T)I)I<QZ_65N3FR#C0Z%1.O
MVTD_5QK<7LH+,;&(MO(RU!1C8?!T,7LD.L;(H@@"89L(@NU%(A<3 )7@EMF0
MK @TAY*)F"W.7>>]O0AE?K2\MUJ9'UN9IQ/=L$Y:NX28XZ#"SN6^@)ZC)!)3
MP1GL:%C;X$W^$@O#K0#)^*T_&/3/8.!#T,<0!XW]V.OT\S\%#V\4+:W0;S9G
MQ WBEW[W2XY4>GBK,VHDZW-9H_-7YO58ELC+G_W>X4$<G/R9SQ7MI:UB46HX
M6QR<[<R&7Q(&H.$<,8T=XKD<MR9>(6RP%YP[>)>L;1B,FX3,IK/4!P9?C&(_
M:OBE5NS'5^SIGH-&6".M0$'CS%. HEBC'&+$.,:"$,KBG*;&FD;/-O2J?2)/
MI*%7KL(<=GDRKO(ZK*Y'C=#4F/;(F+8[>X"0VJBPYH@$XA&G/B*3C$(L@!T&
MOPA%U-J&IKS);B$KM2OE12CUHT9K:J5^?*6>(BH R"IXC5%2,B)NDD"&.XJ8
M(5[[2$R@0%08(4U^2YY([5)Y?.TL$KQ/;2=D/6@,C^P KGW6&1T=Q6[YMQ]O
MG[RZMM52Q'+>Q:X=Q7#0/[!?/^05Z7?S//[>'^SG92JHXU;_)#>7M'F0-90M
M#LIFJR\EX7%,T2##G$+< IXY1RUB4EDEDV$8Z[4-T:3R(:5O:R_*$FOZHP5Z
M:DU_5DV?/@2H#4V6:22Q]=F[PI#UCB&E >$UYT%AGSN 45978%J>K-9>?Q0G
M[9=KM\GSN$W:L 973=]KC%H41MU2;LDZRB.7B*H4$(\V(:N905Q0Q4RP,:F0
M,8I3N1QF5>TK67HV4FORDVCR=#-")[GUV" A/4<<E!IISS H-J/1,6&CP4NE
MR=]A&Z$S/.W:\SS.^&WE?ZI/OC*/3MT_\;G*.UV/BD],.[#AB@7Y?5(XX7HI
MEQHZYX#.CS,DR*LH&9<&*9;#X 8[I F1R)'@E3'$.D_7-@1ERV&FU0Z9):1
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M_5SS<F2_Q(:+L3>9H;#>V(0Q%)>\/I!\J<XP7P=NF$?9R[Z!;F.0.P<,\G+
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MPQ(UXM?3Z(N%S)7#X4/GT0YR+#1??ALN=^+BH'QX1IJ-K/BS!N%R[H@P4U?
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M9.7 X(RC4;?"B<)=4,KTM2^#4(\!$& L5^M=>+O*C\ EQ\433%9Y@E@P)K@
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MU>,JJQO3G<<MNW V4;ME'Q&/9G,SA!<AQ*B1SB@$> 2V#@L1$1HIK* ER03
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M>+>SM?='>_=@=Z\]BVNW\I@["KC.-EOX_I"F'B'!/J*MUHPQ'ABS+@85?+"
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M#D\RRQ6CGF+#&5,JJ*H:@L0:37ZI\R$?83L[^(AA"W,R<&VQ1+"78<2)D\B
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MU Z_$6:\-<P@:E1$G% !NCD7"#L<0)QX+@0;R"3 D!BV<@9$+2F35@B!L]I
MJ:.".NR\DYYB1>1X9,R'O;WMK[M__;5>J7_:VMZIU+:J.Y_7*UNU[<I>_3\[
MGRJ[M?H6S.G;OW8J6Y\_[]0_3P+9S/$88X@W6-1?]_CF")-1WNC B19 AS%J
MZPWHOS1J+HQ2E]$^3Q79-4Z^0-$CXJX712Q>+Q'CVM8W"NNDB""(L$003TPC
M;4'%!1C6VA,7N6(3X5K/%:F5]2O;.J\<V3"(E+J,W++^O_U&IPB/&BUWQ1;K
M?5D8=&4"C:C<H&RV<)#Y@DPTOU_0R]UOY%@OO*^$;#!ZOUBKI^_L*DWL*O5U
MY8A@MKXN-EG $E35O=7#0<2*A]%49MR@_Z6?9F5G8COZF--[5Q@I9N->N^LO
M@)1G",98YDB Z8O[H=/N=@L[X)WM=,ZAX\4/ T?5HJ;B@:$I=T:GK-Z4;WG?
M/^DW;<Z3,IQKZ-Q%86^5,_X8,UZ+O0>0>#FG)7 LQ927P+&LP/'@\.H5URT6
M'&4H%QYF"-/Y3).P.^Z,JG3[[CCZ7CYF9Z]Q\)N'A5^FXL_4L[PK4%QUV_9L
MCL.<","<9[PKGJ5@IB&NZ.Y\OQO&MN8%,]Y$Z3A+CBN=;)3*&(D9Y3C*X+_M
MSA8:\[X![XA_-7[$B5VJ0D59C=)3]_3\#W?BMW[6Z#^X5M\ZWS_>)]6\\TYK
M1_O'__#]^C[\?7^R]_6?B^K%/W1\)[ZZO<,.ZA])=?O/1C[ 7=OV%_OT?:-6
M/SJJ'1\=5;_NBX-Z-4<%7(\1O=B#WU4_?I-166^=1I9@BSB6'FFB-'(\6>F-
MT=;F6G)LG;-Y$\C- W"/57Q^[)6W95(IL:G$IGFQZ9HN?UV-+]%J@6AU,896
M)I@<$DT1U[F@CA84.14CHD13;J-/VOE\?FB=DGFK4Y=H5:+5"T8KL(-+9%H@
M,I$Q9,)62$F50=I)ER,P\C<:D6/22TU2U(SGB$9 IGD3T)7(5"+3<R$3Q2HJ
MC9T-BG.+0<8J9HC3F,FD,4D%,A%"&2EMO*7!)C:N-44M)-AWR!#"$ \Y+9T7
M%C&M%7$TX20)V'AX790V7HE-)3:5-MY3HI480RMO.&B]/!\&26#CT>R,THPA
M I@5 G7&)PR:E%YG:L[*1B5:E6CUDM&JM/$6["N?J+42A!286D1P!"./F0#V
MG3?(6^VC<1:+& ":Z#H1RP1-"TH$LRH[D>_Z77AY[%0&Y_C:K>Y1X_3VO#!T
MOHF8"KHKC4PR,"U]\"(FQX,1FA)%DQ6$ZQ"3-N4^WM)AT^>)?;Q$.(-%8P@G
M%G.QV(2L) (E9KP*3DK.W-HF5^N*S5DN=BYX>"RM:=:C]"4S/SXSET;1X[/W
MY,:7=Y'B?&!><<0]X4ACSQ'5(27O<8R.@N9AUB65)7N7[%WN%"T-*X_O% 4:
MC3 8H\BM13QDOZP-! 5%%''6X:)0$=7K8 R6K/QR61G4-<V](L1(QR6V3EAF
MH[!<4^F5BN76RA(R\_C62F""8ZXC8I)[Q*6TR%"E$%-68.]UC#:5:G?)S.5>
MQ$JP]_A>A#.<L>@8$L0 >W,?<V"L0LEX&F-@S@8+:K=:%WK>TJ8E>Y?L7:K=
MC^@@&W?>>\^EB!1D<P(.Y@)S9#5Q2(,^7N0G*_85&5XGXL&QHPODY5=VC*C6
M;J%<%2WV8L4>=F(\R27<[N6\GW7'=*61R3,9,2<JADBXET9K1Q3\P<J1I-,"
MG?<E_,P./XT)_[Q+VN$0$G)!4L15D  \V5T?.),D"2X]S^@S;V70%0AI*)GU
M"9GU5BNA9-]YV'?<_^ZY"UYCBKQ7$G&F(C(*)T2ME2$XZ0TK0BA?8&QWR;Y/
MR+Z%%5"RZCRL.NY?=X5E9B4RMF!589"+TB$LE=1$.:Y,3O)>,NK+9=3DK92"
M&L9\@.4.VFCO$N5@Q1-.95B<:[UDU7E8=>)@ A;$1T90DEXC'C5'.B:#HM:*
M&I*2Q;Y4BDMF?337><F^\[#ON'><"Z^P- KE/!&(8\^0HXJ@0&-*C(":E*LX
M4/7@;>R2?5\U^Y9*\?SNIW'OMQ)4"D,L<LYF[[<ER%#+$6,P*(JCHS8;L,O$
MJJ\L;+W>L2$63%'&JM^*-M$ZYX(EH!@J;J5QWGK-A:""*),D*=W=SX$WYU>E
M1W-5E>KAMZ"L\YPRA&..B\$X(!L( ?2AE!H>@LNE1Q]^W+C<-'_5O%HJ]@OA
MWHLQ[O6*,,.BS8&I$7%G H(?'6(Z*9*< B5/K6V6 6TE\Y:^[B=E5#+&J,P%
MAJ53B#";@%&Y0"XDH%1K< C:46-HKO!=<NK+Y523""/<1AW GG,Q&6F(!$I0
M07%OO'Z<./+4^!D#NHB==LG#\_$P&^-A!]:WX$&#= T6+',OD.;4( VFN3)"
ML*A<KFRB*:%_E(Q<,O)CQY"7K'U?UA9CK"T%5T3ZB$0B()X%54AK#?8P4+-(
M$3O"8LG:)6LO@K4GXL=+-KZW,VOD/*]M[XI:??>;5=$F&3&RS( ]+"U\,YPA
MYIF/2L=@%5U&/GYEL>.?VZEW9CNQC!:_#8>L3MA[HYU)E!N!K7+<$>JPMC&!
M+5FF>EDV.-I[=\.W3FN'W[S!@B6'D;/)9>]<1-93AU@P3F$2%34Y"]6ZPB\P
MFV?)RT_(RZ5[?2$,?#'&P X4?P%+@J@IDKDXE8U]A7!(3$MAA4HYF8M>IAQR
M)?NN'ON61TH7R\=DC(]3<M1BB3,+$\1#C,@XZY"/Q,H4--%)9D$L2,G)+YB3
MG5<\Q10CEXI3JDS28-H'I80G6KG2 ;]D;,S&V9A8A7EB.:U:0ISGJAU2!.1<
MH)+C&(A=G)>N9.17S<BE _Y165N,:]J<R"2<04$($-.&:&2L5<CJH!PU$=,%
M.N!+UG[5K%TZX!?G\;KA@#_>_T8L5CHXC6(,"G$*'.U8/FEB>8S&T7P&=QGY
M>$$A[$OM==_K'<5.I3%>)'N]THJ]>3<];BV=_J+K7LPW^)>#R=JSZ%14BA%.
M8K3>61F--0H[KR4N-R.6#9JO!?J/S@ JYY-+EB F$P4-BR;D>)1@/)F@HL0$
M<[>VJ=DZK.6"=D9GXY-GCGTHD:Y$NJ=$NC([Z-,=D[A*RJ]M5D"1QDH@,#4#
M<@(G1)(DE'ME@)C7-CE>9\R4V%=B7XE]CX-]Y3[7XYPRN<SSX'22+#+$E="(
M.ZGR*1. O>!8I,[S: 3@'%W7\L'YSTJ<*W%N>48]#\X1QU-01$21.*/8$A-\
MBH1Q:EC$M"SGL(1(-YZ02ANP79E2@'0YT#=9BHP'XU8$&C&Q).($&IW2Z^+A
M26U*I"N1;GE&O5Q(5UJS3W=8Z3+%K6;:,2X1\3F;5_0,:4D%BL01JHC1-K"U
M32;7*5W4R?\2^TKL6X)1+Q?VE=;L(YWF&J5"TQ*6+N5]9,,YX@1+9 3!2,?H
MC8Q>64(+<Y;Q!R<>?1*@^\4N<VAT3YOV/ \CWHV-Y9VK>>=T I!S'_1;:MFT
M.QYA4&FU@97Z[CCZ7J77KMAKFN*;&QSZ>C,)KE<:K1!3(6U0,XN;6P]'/BPL
M9?FD^G2D7NBY]G+*%JQ$#T;_A@&OA78_L_IHT*]'EYYQ#I:;DIYA@VCW$N@*
MM;H P5K&P%*;7I0V7:UO]6ICVC25+'"F!6+"!L0=$T@3X1!+6O&(0W Y5Z!8
M-P\_C7P?/EF6%"BEJ"BGK)2NI71=58=5*5V?1+I6!SYYD+!54;VH_OSFK54F
M9PBPVDG$16+("LZ1<DQQJE1T+JR@>"TL\M][%MK='/6[UC\!=O#P<VC\V/PW
M?(SZ>JUM'X&X.T.^V_RWZ_R^>3G XK$;;=WD!<U5B#;(H*+G4D>M-7'.II0P
M-]B$;]N%IDDP05<JYTTV^.R/8N@W8SO=X<%]W^_U._'ZQM7.S]/8ZL9Z'F\=
M^O.VV?;?5Y,EFO$_G\X/OH931[FLG>S2@_H^.]C^ OW:/ZMM?\<'QX=LO_[E
MN';LSVKP?&W[;;-V\CY5C[_CVL=O2D@2:6"(6440QPPC&[A'$@!*86\HYGRM
M$@$W3O/*=_K9RS6=%H[[W5XCG3\]"-,,PEO=2CM5_NRWXH#/&%ZO9+)9A\[W
M /QZ,51LJ]6WS1N>J4H<T$*ET:W8+H!GL]D^Z[ZY2<3%QVT47GP4K'/)RP.6
MA9$W[6DWOAE]^6/D+&RTBOX7#_UQ8CN'C=:(P;,S:XQ5BRD>7/[CK!%Z1V^,
MV>!$9,DS]*(-7SRX2C8*H30&,(-K&F]H0FZ]C#=NOW97LT1N&&UF:O:A2=#N
MI9_^VK\Z +*G42O,3%K%OX!,^ZU>M])H57I'[3XT%;J_/88C=4DT2S5U&O:C
M[70K.ZW<X<IV]/'$Q<Z0Q<F;A:OO"\K1MR13.IVR,BP^Y/CE2S-)I@WQY5@<
M3W#895*U^A1/;-[JZ.R!9I:-CLS&K\$V^8ZKT*]]NLMK'VK'!\<?H:>U1O6D
MUJS2@Z,#4+[ 9H$^[OP<MTWVZA_/][[^>;Q_?(CACI/:]OX%]/E\G_YS<7#R
M_GOUPQ>P66#D=5#>)BO:YRH@ :Q+I$S,:0BU0R99@1S1GA O',TE?O@ZYLN4
MAO!E2;!;X9:5)<26"Y]J\/[Z66S^B%7HS-&K<)L\$31-'DJ..%OY,1=#D21G
M=!+(B.20 "O?*BYL9&EM4Z]C\> RX,N7K7G9H8F7Z9F7"YJRIE0_:Y>(M"A$
MJKV;0"06L'(T*B0=H8C[9)#3+"%NK#"@*SF3TR2H=68>?%*X5);F1211*DM+
MB$A'G1A+3%H8)GV>-."B#$0)@0C+F$2R 6>H0C%';7!,D])B;5.NZX<;<*66
M-"\FR5)+6CY,>M_NESZEQ4'2I$^)8:,9XPQAQ0WB0H":E+1%UJ: DV3"JI1W
MN^5++%2_U)!4/XJ=:%,O=DIEZ;& R?M.ZPY4RD#DQT[$;N45*:%IX= TZ5.2
MP?" 94 L"HMX2#K'N9J<C%1JGC2.D:]M$KQN<.E46H; RE^-\)=Q3K<>VGOI
M$9.+GZ 2XLOSO\\"Y'N3KC@>L= ,@\4KB,L1E1)9$4'1C,2)$'FP3BXJF]7"
M.6DQ\99%!-E$U"7\G&F]T>H7JL6OH]!&XQXR$Z>#HY&G[6ZC.(/9B4UHZ4<<
M!I$-F>W:@\,)P5>/6 =C[_=N?V2>4- 9'GOJH$%";W;Q^N=19]2;4WL8D0-]
M^SLJ5.XWMGEFS[MKO]\8TTFCA<:F?GS6;I^;RV#9ZTL^P)-DE#<Z<**%YBI&
M;;W);NNHN3!*Q;6G"K+=2Q_:[7#6:#9?:\QL;;LJ]K:W<!$Z?OP1UPZ_T<!C
M<)R@J*+-V0L4,DQ3E"UG+9("J22FQ<\^.;T3.C ;*_X(Y%L<AA7"C[;3.<^Q
M=8-PPQQ$>SA<YHH[KW3B*9@W@^C6>'@"S%JQG?B+4-FGC88%_MK  QZ;-QP6
M&)5+]1CAL)RS>S5[]RL5OOVEKZ>SLRW8+TRM.>*)ER1L>,: V5J_TXV%B-EJ
MA<I6L]F(H?CQ<P]@'\8Q0\SL/,'6-Y2IN].I+/G,_7UTWFWXAFV5TS7+=-7;
M/=N<)QY]]9T8EX,B8GQ%?YU,:&F6LSQO< =5O[5-V_*Q. T$NM#HQ$&%D>(\
M$7FDA"VKQ@#/?Z*\G+&%G6J9FEAIR6=[Z_"P$P]M+UZ9*];_M]_H3.94FC+*
MU?81OTQGKL!.!<*52UYR(KUUP1H?7<@EN*ETLYZ-'WDI7DM^[I-=4OVZ^W._
M?GB^?_R=58\_\KWMMXV#>I7M;<,S-/MF=\X./NQ<C/MN]X__^;E__/YH;_O/
MQE[=G]>V#WGUPY_-ZH7GM6-_ 6-H5.MOO^_7:]<#NW&U_IW5MKY9C073)"'K
M38X/\!)9K V*Q$;)$BR6T&N;S,AUSN5\SMO'2QKSBZP=)4HL-TI@+I2T3A$+
M6$&%<3J$J*FUB5C.>"A1XKE1XF(,)6@RDD8ID0P14 )SCJQ4$7E+K2:<2<[]
MVB9GZQR+$B1*D%BB-#LE2#P62) QD$C4$D:805(&#JH$]<A&XY$07M/D@W R
M'U]E9EW/>TILB6(*5\*R^@QTG%T?KM^%:]WN*XLP_-<<. .&2DA6LT!UY)1%
M(Z.* ;000!^!L2]QYEEQYMK)KQ'.<$63-<PC[6(N79Z+1%IG$0-[)09-(N9J
M;1-01D^>_/KM.2(&%^U">IE,.P?/*NFITD8HJP07A#IM@_5<XV09T7P1;H;4
M^!D#NHB==LFN\['KN.U 5(K>>H*(TQ38E7*D4Q) 1%K:2."O(-GSJBFA?RQ1
MG&_)M8L6M81@(9CP'IB32RXU]3@1*J7EW'*22E'[W+P[KM)+EU2@ 4Q^#?*6
M"R60Y2H@P@+\H$WBT2R5J'V)NR17E=LJC9-3V^@4(5S-]DQJ_0N'E$5O..P6
M$QS#M4G?O9SSOTJX623<?)[4[!V7,A=]IV")(6Y80"9XT.PQ$Y+!7^K#VB:5
M #AJLI#4;8#S]"[&U\>'BW;IEWSXE'PXKK(K#N"IM4."1E#9L2+(<0,?1D:;
MUS'*[.['Z\),%JXLV?#YV'#13O.2#9^2#<>U[R"",)(G1(1+H()[AJS+,M%%
MEI2FF%NUMLD(7N=3BF<_)A^^)E_ZB!?6*ZU8G*V87PE_C$JWRP=4SZBVES"T
M,!AJ3&CE2HK %)<HF1PBQ+E#VAB&C'<F@5Y (TYKFX3(=:D??+YSE>I8EYS^
M](9!R>D+Y/1QO1_T"4.!UQ'W7" N,49:"86(=D(P;*S  NSO=8U5R><EGS^F
MY5'R^0+Y?,*P4)1Y##9%(!3X'*P)I(7&R"1.8_"*4HZS1#?KW"RX"-;C%FP?
MRY] 1,''"SL]NK*WOH937^^&A^)SW?+)@R6-5F5:S92E.-KSDMIXI/.CSY%N
MX8;U/SB9-,BI4K$A%THK/ "H\CDVBR1RE1%M+;2;<D/,T,\I&6(RT"*V,27]
M@K/=F!O(YT5_&\MA\FH]IQ&'G#B%N20Y)R0"U5,:K,'.1NV\G)IDY:8BTX4!
MP[?;-)J_^QU_!%._Y7T^I MSN75)1J4?=6'JSM[DMB(FWI"$/?+!$,0M)<@2
MI9'"1C+!O-81Y[3,A$TJ.^5NQK.9%-99YWTBTGC)H^-&>6\2X99A; ,S,[#D
M@SFQ# .\+Q..^Q8$B=YH9A V5"/.(BW,#409AA],LBF(>X8!EKSX^/+Q7DG(
M2OFXE*PY[@YP(!)=/JFC' V(1YZ03DHBX4*4H.SS:/5SR,=[&/6K:32]I#96
M,H'03'ED<F'JRJ@F]6)32BWGK2_+:_3@'"0O/))_'F5 <4HE\1@'R9V25H$)
M%:3'PC(;C)@U9W,9R/\X9W/KNUF\%V9P;7M'0#^^J>"$TM*@2$E"L&@..0V*
M>'(N),5DTB'E/!]XG9$Y\WR4IW!6B7<]BQIT=LXC#CR(Z(AG4C+&4K+>!%;R
M[O/S[OE-WC6:Y*.M#C$C,>+:,.2B98@8KR(/GCC/[Y=]HV3=56+=195**%GW
MT5BW-B9V!68FN9A/M& /IK7RR"C-D*#4&.]MX-)EUF7KBJY0D9M5TO#OD0MC
M!6%DKKTN(S27)OD0)4@392./4E@<F6?!6U[BR#/C2'5"?=<$@]:6]74I N+*
M:^22,4@0KG-M=N[-W#DO2K?YHTML3I7VF'N51.*:"^>]U%: X15)L%@N@-/*
M':K[,]F8GJU3SG\9.:*>1,2]],A) [*;N00*EF DL7*+:FG%&C9"*F S2PSE
M1EM'(F7$<%"6?4Y26(JU9^>X<?483-F<@#97?PSPH:A#SEF#8I32BF \I^DY
MQ-JK\'P_**_$2S+!Y]H'7[#KNSQA^X0 ]''2+>Z9D%IKL,J)R5$I&(%Q%%$,
MW'@CC<$\S9]QHG2KK11/+]HE7O+TT_+TF!K/O-+!$X4<DZ#&$T40Z((<>:J$
MH#A8G]3<V2M*EEXIEEZTJ[QDZ2=EZ7$[P5F'->,&L9 \XCJ7Z(PJP#<I2: F
M8!;FSX11>M ?)P/&:'KOJM'\D(.R2S=!MQ:"7\0,+#<H/Z/I5$+NXB#WGTG+
MB!%B<5+()^X0CX(@9[% D1FKJ>,8C*-\1AC4*#%OUH\%L,63U@HID:Q$LL<T
M&$LD6RB2C8=/21VC,1X%F[.:4*^15AI^9$Q$&32GTMPOJTF)8R6.K3*.+=I*
M+G%LD3@V;@2G0$CP %S2!P(X)@32(5"4L/::J,0M+;*VL'4FY\W:\HQ(5AC*
MO_<LO&Z4AN QLST4+;YI]* K_NXS0(0"-WT;^W,S7\)SI*6@@TK?OU4^Q=-.
M[.;3D15[(R=%KUWI'<5* AN]\L,V^T7X6_Y-(\#E1FKDN2YL>=OMQOSX\,3+
M>N6LT3NJ6$")#C1]VF[EU86G$]R6FSV\] 2<V! KH=_)UW/3)]%V^YU8O/\4
MQM0.E2(510RC[EQ/H ']&:7-V(!OL5)K]V*%5U!EZ^JN[L98<HH!1=?Z)]"^
MOS;YF_]VG=\WGVYEYB2A*_=)O9-GK0;8V5V'-0N5/9B83F6WU;.MPT9>E*W!
M@ESY%BNW#.NIQWPG-=9A>=^UH<^M\THO=F$ G7C:[N0SO(7XZ18Q,^J/:V>L
M8/"-JV$/Z;"@OD8KQ-2 IV*EV?@!G029<MWC9%NMOFTVSZ]37VKW._#H?_NV
MTX,)S:V?M#OP^T[\;Q\>@KL;-]Q6\!( I%Z[TZW$GXUN;Z-R?0Q P%F0=4<-
MPN/PK0DKGE.K%+WM=HMSR9F2\[EF8"IOH=WX8\B/H)XU.KY_TNT-CA!V^_XH
MGR.\96*.H _M3L;(P;-]X#]H#IBPW^QE8NEV^R>G!5=4\GFU3L&8J=\#GAMU
M-[]H'9:^ UQWV/"5/(>-HL>##K4!AF'B*A%T@/8)W #&2IZ!]6F):R9]HZGX
M\\=3T11TWS?[Q3#?[7W9W9[:RR?K3$%1UG?:Z'+V JQULWU:D,%Z!KD0@51.
MX-F") NRBK DF41. =X >6WS.N'==*3F-PP(JR!5(-'N@(:;C>\1"+!W!,-N
MM7OY2V\*OH\15B4SS02#09O-_(:B,6@#&O"VTSG/CQ4M;51VTZU]!#+J7 D1
M0':;V0)^&/+%M=%D%,AO&Y(FP/PJX-C6Y#G?8EURZL+U8L['$&(T!U.@(;<$
M"O51,863B%BT>TDQ(2_X&<!#7N!Y5GU:RZ'3/CV%)AV0Y]DMJ[R4++_UG"S>
M[!VU^X='P.4M>SC08V "&S&CY^7D#Y?__W4O$1KH'(R;WA!BK\-TO]=HPONS
MG"N6Z3J99/;(JY'YJ0.:4[M5J&2YB6[_-"]G_GE].9?I"I@+.KXVY'9KH&;"
M)/D!HL'DY!NOJ8)+ .99Z8K $BU886"N8@B=+#VO%OKV9;U&'_TN#"EK)Z?]
MSFD;&'_$D;<@PI0T I5"&SKMM#-1M'-_K ?2RN?10;D'&!Y.;)HBZQ\$J<].
M1>^S@(*Y:K9;AR@K>N'2&BF0<: "#J],2+*;:-R)/QKQ;$)3/#N*+>#?SD@K
M@ZM^F"02>/*F?C:4>0/9?8F6]B2GHH$U/R] V&5N]84>!5W9J$R1%_<1$WD:
M>H5ID-TJ0V6ML PF)?@]Q<:$"+AU3-M76G6W\1-:;?6.0$D&I3S<&.F80#SK
M9 L.+$48:6ATLYNIT>K#,]UVZIUEG+NF+V6"/P;K;WVHX!98TLI6;.,D<UVG
MT)2N%A)6K7,X3N_9'!R^QA8>CE]RP,#MY)WWS!G'G0@\9(\]\5I(:7Q(407V
M3>BU^7CJY5\<2\'#Z8;*B24GLTZ>-4+O:.2(O/;@T+.$KQZQKMMN]GNW/W+-
MB^2!"&)G;:8NWO;84TL9PL;(]=KG4>?*87\8D0,5X#NR"3K[QC;/['EW[?<;
M8P)>1V-3/SYKM\_-D^G4$]Z/8A[TQL#S./GY[QO^G 6D&[OIE-Z.KK<-2-1L
M9\=4'9I^VVS[[\_L?-Y[-W(^>WYP_/[HX.N.J,&]!_6/?/^D*@Z.M]C>U_WS
MZH?WS?Q<=?N?\[_8IV;\SZ?S@Z_AU%$N:Q=')]6O<+W^G4"_FK7MH\;^11/N
M]?#\[MG^UR_0Q_VS6OW/M%?_>%8]_,:%<$Y&BY(. 7'A X(9%2@YK)@,PC"L
M!YL#!6IO91<^H\0SQ4GRU/-D-?S'+><RZ20Y]7(-M"1O3S//=?IQ;7-[YVU]
MPDDW.\R,P?E@F7[=AYM]ED29I(!28B#<F*@)\5Y2+4A05@MVN3WR6%3WV1_%
MT&_&O93I;[?5A;DI;.=73( _@0"!_&!.;4".!H>XTQ+98"+"4@:2@ RQ\^,$
MM10.S?\W5%&SR@4ZC.MEDNDVN@/?W\#YV 1#.V^#3*'VPI ;VV:!433M:3>^
M&7WY S2FTZ8]?]-H%7TI'OKC!)0> /ZAZ)R2R+D0=8/+5_)@ P]DPC#T</CF
MX>6-XM+8YL_@FA ;7.E;+^,-<NNUNYK5&]*(>[5Z]S4CS8KTE6PH?/L[EZNO
MCS>OL[4Z8]#LK8'O9I;XVH%:N%29!A>>6G!5)V([^GCBP/)E9&!EWIB,AY+'
MM;,5LVYI+_E\_0W&NF^<VN8LA2U^.>;9)VXHE,;:>2FSFE6WRFZWVR^<@N_:
M(.P7F^_S5<QB29O/09MS'UT?^GU_?:B,_+J1U9OD6XZ:#1R_A9\X[PM!6Z'[
MV\/F^8$I IZM DX]&SY_M6UK/;NC8R?O[(+E<VN88:N?!?A8I*'R@<G(3= Y
MZ7_0EGG#/:?&RT"))=,C#?DTG\Z53;T[[,XGVXL[*46?79!_QTXF*'L8+P,.
M$5U-FWL8<?CG]UK]"[QMA]4^[)#JQ<>+:OV[J-4/Z<'QVZ/J\8ZH7KP_V;\(
MWR<B#D\^DMI7&%G=X_WZ/Q>U[>K//;#9][8/3JH?=LZAG8OJUX/C&OV4JN?X
M;)@7_F*O7KVH?C;XX'^/L#_YTK)?37\OC[.^+VHGGX[WC_]AM>V/I/KU$\S;
MQY][7W=H];A*#HZK[.#K+OO?BUWV+0FE:*0<$28IXDKDPM5)("8D25C8B)-=
MVU0;;#*UQ_\4VQSS49@P1#.O'+8X<"JDL<S(P%04B1&?;BE 6%+8ZE)8;?N0
MU2Z^G]6.X7WUG6_<Q,B\=MF]F4\LV8@<9A%%P0Q7-A"!W=JFW!"3P;% <+TI
M<1\3UDBQ874Z((/F^?3:60\^>;TZP?0S#?'%1,O?3X9-1LO?A)AWPVW9K4+C
M6(T(^A5!FY\WT.;C-X<58  %.60U2"3B<AYE^#%H;3416AD)$@E$Q+I6+S"1
M<@E,JP1,\V2[6!PRI=CIQ/"^T<K696%<UF()2HL$I8LQ4$J8*I.T0#:!PL(M
M)L@$ 1\$M%8KM0S.KVVR=6YF3X%7HE&)1L^F)MW/$"O5I&=#)#*&2)*+B&F*
MB$5K$)?) R)%BR((&4&TL%1R4),47V=D,ME.J2:5P+2D:M+BD*E4DQX;E-@8
M* 4A2!*1(Y\KQW)!'%AQG""F@O>).68(V&YB'59T.=2DA^[#K,S^P.?8:K0[
ME<_1]X$G!B=8T5N;ST8\=-= V^"%4!A,]<"E)]8&Y8TD.FE&G+DE?7[ITWTZ
M3JV]^X5/]V3_)XSO;/]D]^*@_J5Y</R158_#$<P!C+=V5*WO_]S;AOY\_=+\
MWXN/XINUFBM-&0J8@O+A>$":68)T$,ZZ8*U*!,RAC2F:Q[UV#2Q547G">4H\
M$:&#%8RP!+^SRB=9[AJ\+ K[AWX+E'-+=40I2J P[26R7%CD'(TV$B9(9*#>
M;DS)H;'(;8*9DK5.D0DKDJQUGKR ]T+YTF!\-GX<]ZMK1:R)TB)F90+=+ 5D
M)8E(84T2T]&E8-8VM5@'DGNHO3A=2WI4>W'F )D7R<AS%4=8&">7!M9C,_&$
M'UIIA@DQ2!H6$+?>(HLS.\>0,RRSI)3(?FC-'Y(TO63?Y97#]].%2SG\;"P\
M[KA5TGJJ343 K!(! (,<=CD>1D4F(^9:8)^K*=%2#*\<'\_EYUP8(]\BADLV
MG8=-QUV9-&HL!,$H*:,09UR  4H%R%SIJ4G>^@ &J#&3]8"?1<Z^FD#G(@?A
MW_9\D'KG_EY+'HW&V%@9M>1>$B-!XS5<9$U*8&>FL]]N[?WL7J7/O9Q.IW0I
MW9,G/_\J$!7N/=[A5?H1P[L:,.[O^U_A9WC^X,/N68WNGN\??VG6/M2^_^]%
M]>R;  M8<8%1C(H@SHU&QFF%"%8:QZ0"3CG#],84N?L_.4=,D=/P)#N7;C__
M-K_S:'4K_<PAZU),5N7ZGB%@+BVW1%,7G'<.4%0$LWCGT1(6W%T1IAOW&P&!
M!J$C1@)' X8F=LC$%!"VB1-FJ!'<W+/>[BH$&I1,O'@FGL%O5/+O??EWW&4$
M?)F"80PIDK*CB!ODP/9 'LQ/'KR"3U?R[RO@W_MIO*7GZ-DX>=QSQ !PN9$,
MT1SHQV,RR))(D;"&>H7AP^<RN.N<3D;7E'Q<\G$IAY^2>\<=2I$IJK2V2$E#
M$6<Z(!,L1EXYA3UFGABVC'+XJ4/DGN7T?+MGFT7>L%NS8,S@L'Y :::5!J1%
M%2@J%8LG@:;&A(E/>70Z$3 1),E) +Q#6BJ&'(@4;:DTP67/&-:+.'(Y;Q*2
M5=FN>E'<_QQ5O,MXDL?G_''G !?:<>DQLD%'Q(T#I412A[ 4SO(00_!Z;5.M
M,SY9=7'N?:Z2Y9>9Y>?A>.)X"HJ(*!)G%%MB@D^1,$X-B[@\/+AL;#_N23!@
MB5 A%!+>:,0IQDA3$/@>C!1G:(@F ML3+=8-FPPD*P7^R^/^N03^PMB_%/B/
MS?GC7@AM>)*2$U#UN4)<AXBLYWD[7&KK/<>*T[5-N<[TT@O\IPYY>0ZV_"O7
M@1M5L2H*B %KHLKU()A[>2Q>A:-T41N6?[5;ASF_8E97W@W6HG22+@*>)I,_
MT>0%-@PC8TB.;P\"::)U/@"FC:<$:Q&7T4E:;G+,PKO#=2N7:;F7Z1GVHGX)
ML:4:^""<'3< 1;0RGS1 2CD)Z,HX<M9(9!,-V%!)J"'E5O)JLN^SH^QKV#&\
M13&_3,/]D'W$%:2Y9TB#6&KECR,M]B:/CKNHL!7,(^TM19QS@8QS%FF#O76<
M>NKXPK3R\M#:2LB+<IF6%V(7E4*MU,H?%V?'M7(PGZ07@B,EA4+<$XZT=AH%
M3ZA4.BJ7\-HF65=3DN.7[+O<[/OL*/LJW.4W:H#.:_O<K$S%8)Y#NY\+@XZ7
MIJ(W-C-FVO%;NJF:.]WHHF9GN=GT&>*>KDO96KOE2T&[8$$[>::1<Y5/]U.D
MDB2(.Y7K'%N,=. \")*XHV%A 8^+Y9\ES[M<8FB)H67PZ,M$T8G@425Y3)0A
MQGA G$>!-/48&45S]A0GG3(/#QXMX;.$SU<%G\\0B5>JH(\.GA,AN%QX&X5%
M)'B*>/ .61L<\E@YIC@F6K@<@DO6E5Q4_8X20TL,?1T86H8SOTP4G3A4[1PS
MGDJDK+$YCH4BG=/$$^RUUYAPYN/#PYF7 SX+!^[OO1SS>YEI;#"D6O\$V,07
M6?E&H[C6]G&_VVND\R$K;O[;=7[?O)FQ[-IS)[9SV&B-!BD+Y'UB#J:9@[>Z
M.:??E*3]O:,X$7@!=^9?%Y[?9ALZFQ/^Y]^T<J#TZ2!0NF([L=)H^68_Q)!K
MQD]I);N-*^W6X"7M5HBM7"$%OA7+F=/Y59QM9O:N=(]B['4W*G6X-0'+-Z')
M;L\VF_DLTZA'U]^?ZPTTBR9Z[0*!@"#RK;GU!I".+3IANUU8S0#_PG.=HB%;
M.>WDXBVG,)-MN.+_VV]T&_GN]<I9<5^C&$^OZ$FGVZO\MP^/PJS!P]E\'G3R
M7?L$UO&\<@2/Q&;TPYZ<=F(W=R,_70R_ 3TH1N@S@N4.M7VCZ/=9HW=4:<#O
M.O%'N_D#^E\I%JZ=D ?@:_1RKVTQAMB#OATU/-S?O3'I;7A/!^:EA4;37]S=
MG7/6@3QLKM_0;_8&)-&\X?H?38=U[1] %\7RGS6:S;P@%7O8B3$/_>8SZY56
M+.9[@B[FZ%D%1A<;K8VEYZ^_H/.C6>K&/+9QJAG,ZXAJ3FR(>6W;IWE.@-J!
M;H"P1\3^_\TA<(FA20C+#7:>.\(L(9P0ES13@C$2OFT/?#Z4H=&7&Y)7C"2O
M]YW6F[\'G7C?[F3KY>_+7LTF=^5JRMUF_,^G\X.OX=11+FL71R?5KW =Y";T
MJUG;/FKL7S3A7@_/[Y[M?_T"?=P_J]7_3-6+0[RWO2O@VME>?9?4#K\Y$KUE
M@8 EHCWB3!CDN .1JJQ0-'@EO5_;%'CCMDUGH,[FD$\R.%RB\$W8R4@%R]+H
M-0>X$V*^$>ARP*BGITV0?-?1_(K 1E"2FRAN'+0 6%M)_5X?8-V>9%Z]&#P_
M?*J[/@"LW-:(2:\]G7_=B2>VT<HX!C<TVU?/9LX VE,;HZRR0Q$[5DF!JQ!M
MD$%%SZ6.6FOBG$TI82!N,R)D@@FZ\F+>5!H_^Z,8^LVXEZH61@*H'KM[Z;H]
M7L_@58=WOFVV_?=71JY[]8]GM;-O/&+ML#7(FYRZU4:%;# 8<6C.4<DCT.K:
M4*;V8]C*3)_S4[I !-PMN7%:)RZ%X9$0Z[V4;JT2 0-.LZK4Z<>1PG&C;M
M >TAR(O##)?=X6)E9 % '*W7I>*0%0P@T=0&6CKKOIE0SV:6"7],U=Z@M>$0
M!W1>4,(OAPFJ;2'^1MKM0$T%,=.TI]WX9O3EC]#HGC;M^9M&JQ 6Q4-_W.R9
M.)U048N.#B[_<=8(O:-L@&W@@2-K&&TP?//P\D9Q:4SG'ER3<D-K>NMEO$%N
MO797LX1O",[NU>S=UP2[_:4/ZJR8M=DI_I31.@+AQ>6X\Q>1)[\,")J\=8IG
M)N?8CIUG<D*HZ5FE?AD,?J])N&F&WGVP=LEGZ!=5*6>8MY6C]OO'Q9E%I218
M)KJXQ7UGBQP@W8&!TNY#6Z%[TU_SLL+9;@&0(QC!X5%E/]I.M[+3RAV_=(D,
M=&]&WLS )?<_(K5\;;P\CK_N%%1+0Y+3.3.KQ0^)7GUINRK3AKC<6R//?%3K
MRLS]-#+OP>#]N]-H^<:I;7XJ+'(08GOI?2/[:#+VO>QS7<<[N+:]C_?I?BZ)
MVSPXANNYKLGVGXTJA7_K7XZKQ]]9%4SB\=V3:OTCKAU_.CXX]N<U^N6D]@'>
M43\\JY[L7NS7#W]"'\[WZO[LX/AM+M<^'@8I"!<:6X(2<0SQ7!M%8Y*0D8QK
M::,G87&IX9?OQ$&)6R\4MQ95X;3$K>7 K?' 0^6E<\8'Q/(> 2<J(<<X1E:X
M:+DVG"2[.KCU A3:.Y('K(!"R\H46DND >ZV:O#Z^EEL_HA5Z,M1MX31!<#H
ME(KPB0?MN-.("2D15_D4C%(>20&X21.16M(RV=8KX/)GT)=*+G\L+A]7E@"Q
MI4PR'VZ+'G$C*7*21I2" )V)&BZB7QTN?P'*TFI[_WB9V6BIE*5L9];/VB5Z
M+@(])T\*&Z4LDRZBH!-!/%=)T,D;I#AG1+M N5HA4[-,RK%:.E+)W ME[G'5
M".=4Z+D6JM,A9QM."0%UXUS?6(:$J0,=:768^P6H1JOM1Q*E'VGY5*.C3HPE
M?BX"/R?KQ@EBL9/!(H^) ?SD!%D>)9)"1T\]UT25V=I? WL_GW)4LO?BV'M<
M/7(N6$<#00R &W%&'=+>662MB$Y8AQVLY\JP]PM0CU;;<R1+S]'2J4?OV_TR
M2F$A\#D9724U29XHC;S(UB4V'%F3(M)4"Q"/2=%0NHY> W<_FW94<O?BN'M<
M.=(>[!O@8\2<%XA+SA"LIT8:>)PH[CV.BU..2M_1B_8=U7/2 )MZL5-ZD!Y+
M12IR!4Q!T/.M/._3T?)%)NMY(LB<4D:$$Z\#(0$9'7*B :F0 <&(L'716J.H
M"6IMDU"VP*R[I;MH"7GYH0I1R<M/SLOCZ@\U42=I"*(.*\2M\\@Q*Y#UU%%!
MDI,:C!LMUH'HEIZ57X#V<X>&2-BRJS_MGFW>L[;T]&1L<^5C>Z%'>Q8X02]&
M\"S*SY9ESFZKV^OTL^']SG8ZYS!96\6A]5+L+$SL3(9C14HEJ @.\5RN@6<]
M4@?LD/+1!:^4%W)Q*N3"&6G)SSN6D%I"ZK,Y-TM(?2)('=?DA0M&AF"1240B
M;@P'^]P()%)4D@8+%,$6I<DO.:(NJ1UPF?-W+ '<_3/)/1*F%"V^:8 VW_!W
MI[>APSUA<E4QN?)ND$)V*V=GS1@PD2[OR;&0Y%QT>ZU!4D!]/0'Q**EED3JI
M2&R;\U'>,9C*OZZN7?[RMR)!Y6B<UP=W*^L\U:@K'MC'-EJ59LRGVKL K3EY
M9RJ29PYRW%;^!9W)>80;/V+S?# O?PWN_JU(P/RUT3P!1NV! *EW@/:F#?2I
MQK->J=EAXMJM84+C0;;EB@W0R08('IL'4K%%3N;<_3PZ"\L+CQ2_7*^<]CLY
M-7(OIP\=9"2]-N8*,%K^=IE<=$0C]LX<H@)3R2U.(1#+&0O&:LY5D"8![HHT
MR"%*L,0:C;[<+3HSG=T0F#!E_DWH=\X 5+NQM9I2\D$91/<^?H/)3=0PC@1W
M%G%'$G)1*82Q58Q+0E4^Z]IM_$3GT7;&,W>.,B0W&Q$HMY_%4Z,U2.5]F7)\
ME'&ZT%CF38DLM8LR"A"W&G-&A#$L, Y&C50D8BX&-0@&BW^E1>W6WM]-"^^M
MC_.H4*\N&W+.@)R/2'+MN) (>PE6I0\860^FI;#8:0?+H5FV*O&O4R#_ZY(>
M?AMD/[ZBCZ-!;O1&(3&ZO4HG9Y0%,@%ICT[R"5@0#JT ;>SF.]!;V_I>V4NI
M$"^?\KW_^FOW[=ZGWRJGS7ZW<BMMP=*ZV!G/N)TKRBAB")>@I+MD16(">Q?R
M&5!"XE20F8/.WMINH_OYM!-MV&M]L9U&5EARI\DE:2'ZZFBK2JMGWP*P-L;.
M(YQPD6,IYOC)!%*.:V^!LFP4:YMB8XJ[XG]RQG^@&5C2]8PZQR!KB[S7S[;Z
MQ<;+S:4?K?;ND*[SJK]OMMN=5[WRHKKUS5F9DK0.19[SJFL1$/S5R$8),M]0
MK*5>V\335[[@]4K*$SD.)#D+>K\[+-Y@SP>U"6SWZ&8AB?6LVYS%9G-0D^%\
M4,UAO9)BA,^LW\2?I[F<09%D$QYMQ0$M7>9,__KYP_5:$Y5_=6.LU')!"UY!
ME:VK*]W?KF5:[XP2(=WH8VB?@;)5&:5V+TH^5%R1Z'58.2)9WV@V>N<;E??0
MP\N:%M,Z-D63!G0%W<W%V+HJ-@'CGEK/HE5<RM4C0G_0\E!A\T.GPS49/EE5
M).?XSC,W*I_A+I//#WZ^Q/?A]%;:8(A>M3-L<\H0QDI&3!I[EQ;0+RJX#/5>
M3H&R0#<^;0]6Z4U1?014W*L\W=G3<^W!H=6(KQZQ#DSO?N_V1R;2R*[-U,7;
M'GM"JZ"P0 D?F_1KGT>=J]S,AQ$Y$&[?41&D\\8VS^QY=^WWFZ8WV-UC4S\^
M:[?/S>!S:H)W291)RCD; ^'&1$V(]Y)J08*R6K#QO/>@-C+BM<AF!8@;Z2B-
MEDJK" DL<;RV;.5("OLL0QRHU9WV&3 @X%N!(+<Q.UACV2QKG@/WV<X5RUGX
MO_)C*) &"M8 8V N8Z,H/#/ U7:GDK-,#_6J B@2=.FRBLY46WW$_=<D,0P[
MV%Z[<WZM6$51#N!T%(AY67P(6A[65X%N7ZL4!&#LVR?PS6?D@8Y^CJ>]8<TC
M/'(Y%- 7;:ZF<ZW&D(OYD9'=<5FEX.K=][-% #N53TE0+T%R">QRH'(@2AMC
MLY4R5!<,PVCT97IYENFZXM]%%:.&']9MN0Q9+2V4J;K$\2X!+5(P'(U. FF2
MRUY$R9!)W*(8(F7,!\("SKH$FU E*I>FR74-,F1?X,F@^M)E(:4!X5[2,5@:
MG?:/1N'1.+*YS-) 3!9^CEY120GN_M%H][M TEE@C]?+Z+<*,7Y%D*,R+&?M
M?C-DT1GZL>"K$9<,2RT-:VN W@#-#/2?:3B0R1:4C6[!\]"-/(X>V.N%4C+T
MX?R(+9N9<EA@)K]DW#\#]^6Z-3 _H#XUH*FL(0W4B$(;N&QEP/*-XJ7PZ^PW
M.NF?%&6CFA'$/,B)2J%]35:^*529$^C"8/P#5:;1O6K:3I8?V:CL.9"1=C"<
MNR&Q *9A&GUW7HRE!\TV"I3,A7(NU:[N2 <9P&WV7.49. 1P@@?:G5^\Z88E
MXH&* /L!_^)/'XO*4-W)TE?/(]OW6J"L_A@@*9GJO 60*OQU>?&GS>DUE^W[
MHJS:5GZ@$ :CBD37..0Z067JZ12- -'?<!%E+?*2/X;X'$$P-/-TSH/2UG%%
MN.)>,,<YBTYPG_4#GVM6)DJ&52L)*3U&BZV?M45J8-M)(H55')& )>)."V2<
M"<AQP.($VA8F=&U3B5\YC#8J6R$T!H[ID0_]5JH;4%6AT-S$V2LYGSE]=%=W
M9LUF8,:TVA7X5?9X9[QOS46- J8@:)B4 '29;+!1124XEE(H;RDNJ?&1J''W
M9_7PF];*%0?OO30, 0XPI%ERB%J?P!J@/KI<2YK,0(YC>GA1,Q%HH[#E08X#
MU@-29X))("5 CS[\_]G[TJ8X<B[=OU+AN3/3'8%XM:8D]UQ'T,;VN&\#;1O;
M 5\<6J%P+;RU&.-??X^4646M4-@L!>3$.S2FLC*5TM%SGG-T%M-I.I";[MG@
M>#,AX 237="\<Y+XCO308A(]>O*-TUOAF);2A22=W,9"R]1\T,(4$I@X84MZ
MF]K]HH5]?VMZ>Z,"O"/VMKY0YT4J-XJ$C0KQ%(B@"R^1H#2RHI#P(4WTEE^)
MIB T98?1I'6S;=4I\37_7I'!TO\%@E1*ZE*73.7,*GMDPIIO-MYFC]3)L+/4
M)36#V9<<%U^.]=4%V:U:NLC :)U@82'&\NBU8HX+N$Y)43+E ]FK1IJ/L'(_
M6>#754O:=)<<-%'-3#F#HZ?V<Q*;_*.Z)/O32J\AT.WD"!O-X,2!:75JO(P+
M+G$/W5>G86!PC=CKMDLSH&KRYR?Z2':K& #*-NK6J(\7BRY:H^[^V/FQ]^Z+
M"I9$2T"3$BL0YZGZG],*R0 V-V@/X#MTI=:HL)NSNSE<.*LJ?WQI_8*5;";%
M!GYM-X?M>Q.?D6[[9YQ:G"3HU??4LWK8[!_G&+WT K4HK2!*YXFC23#+7(R(
M*T> HPF1"DD"43.R8,XY@D,^#5H6M3R2I,D8E&4G"9/=L4?@'$QR/$[VU%UT
M.')->:,Z:6Z+/2\4MYQH1;R)BG/A=<125?+&IQK@7B9OGT$KA;T8D[S%T(,]
MD]E5-<@D<;7 72UP7\_ 1&7*Z'32B(C@ 7$1'5(2"\0(3J5\7'36@U%P%:=J
MG %<-<Y@708AM6:.(T8^2*67&CER(35V3DZ0&>_5_E03YS&F)<1+-TCW3+WC
MX[A_[NQ)72],G>:UNOW<)KX4Y3 %1A?WN+19.U@?@S"V/KJGU6%I?[-Q/::R
M1L<GM,H@G_0S]2=]@::*7D(CUE=^F'X9*Z/QK%V$O,VY#K;^_'M!6..L+Z'T
M.?1=KVG3XT.K>_9[J>4^AU:KWW@-,]9MI.B62T+RRG"[]%OEHK/E,?<<N?Y0
MQF5-_&7_N-F;^D-*!07N._&7-)C7S3CYQQ&:SGH %[Q,*==W2J,K[^Z@HO'5
M>BPU#6SITP;S&*R;U68]3W;,LYO?;+0""Z(X+[G!9)3<W!IN9.]\VH4;XV5-
M][_X:W]X>MK*[Y".['KE_)TU^PEE?!EZFEGZ '9.7K#TW^13=:[;\Y..]7(S
M],M(U80,>?-/AO$V?ELR?;_/VRP/-+B:Z!EQ7A-[Z]78<MUS@VXR6:E(BT+T
MM%F5EK"*LDQV63HE;0Y*["Y/*-)?\Q8$P<M]A&="2:;-;1"4K>$1K%)ZE"PC
M8*:CMV</.J;VT>R)T2@^&J0KC<-W888&33=SB@3B?W', B.\.&79F-R9&XU_
M=E_F[=G8W=S:G(K=*5%D%&0\X=+]?<%N.#6]W)$^"_Z@.H>: ;7JS"([!:X(
M3B8B6F<IP9@$KKRU3G&2HIIX\%3A(O$[H@FF HU^F2M:!$/=BZ7>>%TMS*OO
MI\U2\9;>LCI<>3)<^3N0-R.%]H1JY&5!$8_&((6%148Z(1W,O$RQ8Q$VT>)X
MY5[XUFU]2]ZM:FN,^$ ^ D0+(Z\:OX&&_WTUA^OP]+KG59%RK%S$ 4O.X;]&
M$&^C\Q@K*TF@Z81@)$&7GA L$J@=\SV=Q/XY<ER_-*?PR>"\-A86R=CN_BNZ
M"Q8I2)(PUB#M+<B8YAQ9'B727$;!'8A@S+FT*T0]+^1\DR?H@(JM9KN9&4RC
MGY8H,]7^3PB28I+1H(AFSG)-F4Z[@VA.L2T46**U(-VA(+W] 6 5BUBHJ!6"
M:7>(4^61%L$@*P@)3!C.6;(TKSQ]*K7MM82!.>RI,SY:; !5K&9"6DT(B=XX
M*TTM#'<I##C%NXL0N)8$61<(XHR#TO)*(.N)!2PIC%8@#.QJ89B&C '(!O"Q
M5A@,,I6*E?:ZDJVG'-+[L\M'R8.54P0O#T"9M3R719Q,QP" 4N_E\)^QMBYI
M<O9UP#A'-F6RW3-;K%7V ]U<[U*N-N%*&^,,<B(U[&:@MVV0!AD7A7...RM6
M5-G75;K4"@PKK6UA.7!3@W$@U$70PX4P5.?X#CSKWZU%X99$8??L"S$LICQ1
M1(GGB,/>1(I3B9PJO%!",><,B *[4A1^Z=!\X7EYA4WEB?G:X_..Z0&L7AD@
M.(O/LY['^P#H>E>NT:X\X*D^D?.14HF1*E*:L<3);C<.!6LX$31*N.]*N_(G
MS&L7*.:6*\6EYEI[@\&*PYI$IZBL$HC9E8F=M2C<A"@ 0,-J%$6('D7,/.*%
M!"(<;43:.IV"]1S5)%E%5XK"Q@2DC+R.XQ"]G."2N#+*9+E":5B"Z@NV6SG$
M<X:@[Z:8]72$]FU4Y2 V =U=T[0 O$]3'EOR=?::1T<+PW?6#;R75^:X#+MG
MSH@NHKF3QWF0O:=ISC-TNPS1*:/1 F9W0K\*ET]NW/3)^"PMGW_,'-',!NEW
M_++SBJ6'.:72K3RV[>".4\!EOSIP2FN5/-<#&$V5I6G.S'FI2<I4IYS?8>$]
MCF'-OLZDG^<OP[JWC*M&V(*/.^51UL67RE3UWNCQ_7:VR4H'3@Y^@I?ZN/EA
M$^2KU3(/06ZND1DP9YC-G"=FZ8$YK8XH2QG*AQ:3,K,@%'OFY'2CRA,9LX?K
M*0!!:4A5+(1UG"L<%&.82L6BQ[P0A;TR KLLJCN!_F7@]5Y\._$>_XS>[L_S
M#]FQ_*'T*V\EMW)*J?/IK?:[?X92603_&D1Q+Y'+#S!O+M0!0XMUQLF.2,X3
M(@H3'4=*6R#U!'ZSDL&/*#&A!IB%P: S%N85C!*]UG_SE8R;DD6QE)>[1.+<
MQKM[ETA-L]9ERWQ,_D8)?#MR5R#K.4,<>#;2W LD"\DQL>E8 "^C68V?)-LR
M8A^4=D4PG!OK=7*-\6B]B\1CIZJ:AXR26@KN0 KVWGWQ#!>^\ 0YQ1WB03"D
M%%A@8!<; TR;V=2FFRVLX-,8\^R+"EX)1V9.1_-I.?"K<;[6I2?GAA9,I_02
M'CSG*4E:>U6 *>BT)5Z/(G%!1-"%K-0GY[]8Z&MWZXO4Z;Q)8,2-CRDSKT#*
M<OA1&$%ED RG7*AT<MY()^?]V:/SC8JEKVQQY:20D52,,J#G8BW2G\O\@%*0
MDLLM15]DDZO;F<[)S:E7.2EOKKK!=%&#])6*@37VO@%S3XJV\;HTZ6"H97V#
M#WNOW_\^5?-@(]TL1P6WJN(JU?-7J$%2EQFY?ID1L?YE1GZJ;,C]4LEQ9-5&
M61,MH?-%EG\YQ#(":N[/97KA:)=?LY[63V'[:C;7".>7%E2[2!<NOU!>,PK$
M#/YS<W"<]OM%]2W^Q/3 [LG7'WM;7U0 2>;8(&I3TD7P%ADK/'*RP-&0**/5
MJ:;?/!VP:>X!F)LITC 5J!B5ARH)03_/> JDJJ9\(NCTP@T#WTG+L.;&&.R-
M?BAMKBKK-@7[#W(6> ZY+P-O756"8A1C#QIR8[)PR,:HNL1H1E*1L:K^1G]T
MUW$D/^R^976Y1DF_%Q6U0-^!Z)]?5-$JCYBRYVNBGM:EI;36;=:WOIEFR]B2
M5DY8HY,1KLW^=,6_&?HQ#L&['G+]\HG^'&"-S93$+8"3)CT+>FPO9H]0_^D6
M =S]L9-2\QDC03.'40S>("YT1%I'@X0DG!%LO(.Y?J$6E0 <.9=A%P3@,,VD
MO9+K>)CDHQ=<:'Y+6F&Z-.1$89_!F+NF^B))UE*1FA9H2^ 0H"XOBK? +@Z]
M;]6675C>Y>*^P'??CX-+2Q=P^M9<8$Z9W^ GBLG,G17G?$@SN1DN+D[[(7FS
M*Y<R M*,RE]+?-YL;"W_XE35@D2WJX)AL!EZ0+AS4.L0?NN'=)_!=-[2QNQ>
MNV2$R6-[K7PY(@,WRD0>&(_>&EZ 46*Y)P0'H]GB9@DK$8;)?3@Y-;7;8/'N
M="F_USO&L-% NZ7RB"OMD(U&(9V*E@05'4W%61>[#>9#%R?]F,= $6Y?,N83
M*"=EHU[Z)4M/ 9C3$6S$*8!*I>AGYP)2P$Z0*I@Q6&NK/$G ?.7* ^)-6.V^
M9\ZF:Z_>BQ24:#P2A+WA( =07K.ARA.4#+%[]H5*F'S!%/)$IU+QTB%M/$6%
M)]P03:FR*89#7IFJ#9(QKQ:[%VM1'N*61WUGW=Y7N/"_<Y6XT.E7N9#EX6\,
M_7[I<FPU1XKHM L6;<XQ:@63E?%]P\U(%;T?,?3:A;VBV'W]OO/NBPX""R(
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M]E7O4N5GA"GHL'^0T>0-O"VFD?2A>?M%%,&2LT;JGI$,1&:E[_1!NTA</)%
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MTLGG./\J_<RQ<?**/]_"N3- I0Z!H<9CL,7WC=."AQZ7/38U[1D?[WZ/Z76
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MC? >=F]"^8'?N'^.Q,X&9&QD9I+KA>;-O* ZP[>[@[W@K =$TS4[39$'7O"
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MY$Z#:A?PJ8(**XN)AV*9VN:9A2K04&46R0W-T/'VTRQ+;T'B<)U'ZNLTBFC
MPG)QC6)4<#R2L>0B6K0H3SKOQ/W;&-3%EYN875C?7:^E9C[A'TWN'B>%=D>/
M:\T][+%R7&4?*ZLFIG1B-*[@28*VXX3<L3?!KZ.X''%3"=YTF\4%5<!R;+X1
MYWG)LH$+K;-T4D73.N^L2!0M/BE) 70CC')5*:^<HBJ4_EN"F<KS]5QW+E#
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M,U'HK4$?^R?UF%-P[[&.<Z55?5;KJVR$HVP=LK@%NGAA@[ZO1<:L/#'!S-]
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M4B.G0!TD94A9 &4T@N>SF O^DD\+86:4/!5"D2N;Z";.T^R.V6/-UQ8)?KA
M"BE(4I38N,3:C8M2#%A(_RW!EN.1&JZFMKQ)K=ED^Q"W#I?O@RFR)5N _V2O
M=Y]=:N^> 5<\2ZG'1AO80!G7Z2R8T=E-M1FDPQ?JP-[4]\M3M"C@\FT,Q(T/
M\DD\0.(@IUM;:LS=#[C^#HV[\=T_T<S+)BF&'M&K87'>VV$<#-ERP52YB=,R
MAU>UZZ;A8E<H'5^GN*>$F7J<[I':Z6B2I'=@AG57PRX/I&G<KL5@MPC3UII$
M:S6+&:]$]WR2K6C12FLFKRS2%C[,!:/7<0"WA+#4"I8Q>P;=/6;YP:K3 A8
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M*2T)[ 7V;TCNI#T^&F\UT.SER3TKZII-)R#WJ.1;T-O^T)MIB<D0_3:2-#$
MM><8,M3!ND/9MH.BOMBW3Q1I%K>*J.]LU'?^I#T1[CW:=QQ.N/<]N<NE*$X2
M\.\.,^RKRZ8(HCT%9#W9<>ZOL1: W0BPNFP_T'\M +L98)W!_2W3!V(6'X:%
MMFQ 6QM[Q)CC$MTE0D'[$PK29&?MLQ3Z%VH0%+=/%&>O?>9 _RCNL(-;V@'(
MA /'D#;8S7%S?;&S1/BQ1^''0VWSNHR_B28OT:<DFKQ$DY=H\A)-7L^^?='D
M)0 @FKR.\),'%4Q^PB8OZ269&_#?BRRU>(?(_!]IHY<C&KV>I-%+]40IQ1,
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M-L5W!6==42&UQ11=.5L3^V*977]Y56EJ=J -3_(@ 2*,R?,QAS_[O1([W.R
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MW6'Q\R!ZG#^8]' .2,!>+#4,,1Z&C^1DA(E64 ,E(M6#2V8ZWSN?HHHH4D,
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M-NZ$G%B FC^BP+&U>(SV"T;SH+M4?[:7X=A"R6;%ZWF!TX %<.XO2#=!:$W
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MRDPHU4@/I4IWSF3)_S?U9]9/_P=02P,$%     @ *$P$571%\ENC$0  X:\
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MOV?WCULS.&)U_5C*GCN26L)<N^Q)BBD^%$/Q%J!G3LD,?_[IOU!+ P04
M"  H3 15Y3R^?%<@   $1P$ %0   &-C<FXM,C R,C V,S!?8V%L+GAM;.5]
M67-;1[+F>_\*C>9UTJI]<;3[!B51;D;0HD>DQW>>$%D;A6D0T 5 +??73Q9
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M$%RT4K0FT8.H^A2RM^9-6Y&TH\ILEN>S033*E"PR6)OIV9Z38UGH"QDY7:)
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M+(\LW_[+*9F-Y=*)EED%DE>5'[=<.JT-5)[6&B:"Q1(-W41>R,MGK(.N7P^
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MW6_>X,.9C$8Z32;2<7*\7 ;DMH!AVIL2F':I]<646UR=]!=+1S>023-^/-S
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M3HA@UFOOUC'0/B34^[@.>D>2I[8CJ\31K;/]/L\'J9CL$Q/@(I.@A)4UH>2
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M%U= 9$[168_HK>$@LC5@54)G)@8C4TEUH6MMZBLT=^>EW9F!.XE]5$-F%1W
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MUSF-VV>B 6),)F=B<^:UD]6W@-G]2E65/P_=E;:*:G"3N$0><]>-N$@<*_7
M7(E%(;Z<<EH%WJ(DHI(L5[]J?@I/5P<I33E23>"'<FIR71=D<89X-G_NO"Y(
M8,;;Q#5H35!4N71,(R2!<LI'D7RRZT4Y;W(T]Q2@?9V8U%/[LLI*.XN_Q2'N
M',N5+;@.F$:'(G> [+F2TNZ*ND^!G:7<7/4QHKU(K :;$8HP,8-W2H*/,G%/
MC-:Q>JG6]BI?MV)28XUO(MS:J7D?+L>35"['!X-^BCCBC*+]M @A]D&A=R:!
MZV+;1$?!9"& YN %FCM11[+*%5KYECUTR]I>^J,6HJM]3O'Q\[=)/_3=\!ZF
M*)D+42=@CE(0C&9 ]]Z#067Y0$)RVJ^ESB4O>+::K"&PROD/'\>C>!FF)^.K
MO,RK,U4A/246,B<:!X@FJRNEXA-E7&=!25ZO.=6*2/K'WOUB[*XJPJT8%G8+
M3TFG6Z3A7M^#K 95,?=L*9#N,]%VU]%#A5<2<)NI_@@XSYUT1.>2<RUP_6&X
M]%CC2TL]K3QA1*_7W_.PM/Y$^EI'2M]$KM5K(:2++Z.Q&W];[#4+; O#(7IK
MJ,+MQNA0S$K$QAD%RQ+3)FOCZ'JAGRM>U&V&5"5=C!H)LK8%-JMV=P]/)DID
M-!H0C\?-RA<[I=13R%IDI6WFE,JU%/O(PY^],G<5V#YNC(Y>_\?O[\YF=R/5
M:WZM_>SJ]TG;C>K>]1+W.D2&)G<02L0HG%2S@B'4!/1[;.ZM_98Z$:BWFIK<
MG +COF)H( )TXO8J0%+AYB)E<,89:DFL?<7R%)Y:,>7GH]G3QVGQLC3YM>B\
MERP7AO, G)B,DU-&](QL*"6>M<J>1!IJ=QA;A:E[C[$:(Y8%F%<1?X.+H@6<
MUZ,+WQ_.YMCK$5ID^/39#[/^9#F-QRDN.GS,:S-.YHV"<+$OW\S\+A%MUCY0
MT%&4.R^JB@>&8A,D!QFIC;'VO5)%^"^(=/M2:H/SYD=D]"CDD_$"\8?+(O63
M/._3,_]KKYRT69'0^,@L@4B&@E<F@7:!!T^4\??/N%HLZEL@?X&L[%"5#0J0
M/3ZWINAHX#)_9Y:][SO?'^#X>@Q]T6PB@^B)!"$$NAO24B RIA)M(W/UED1;
MP'R!5&NEI :Y?X] OFIQ^S\IOHN(NY_[95*4*)/IY,J:*$OU8@C]-,&_75[@
MQX=3-_S4QP]/>M$C<J,$T,1(\9DX^)0,1$&"<D[J4+V]1:.AO&Q^=J[L%EV_
MKW"^+9I)[_M?;Z.;#^4?J?_I<ZE!6N)W/Z7?)RE?#M[W<T+L(F@9.01M;8F^
M,6!,B0PO-09-5,Y7K_NQ"]X7Q,;.U-:@[?:OHU'\HS\8])AFI5NR!D,8^E'4
M,3!"*["!1,ZTI2K6CDA:O/L%46$K<5;L/#T[]=O ??F0IO\8C?]9<DWFO69N
MLOE[63)T67+&Q="59'X3P"J/[G661 2G/$_W"HPM.5FM@^<%L&1?VJG8C?J)
M(3QF'IZG\44OR$"Y4 G0#4:/0QA54J8IL*0"TY2I$-<K.KW9>U\V8:I(NT%S
MZ2U<A]>72':D-!$VI\0B2)<\"%YJ_'GC0):X'J=9TJ1V--SV:%\ NSI668.&
MUEL@+YURKL!SY:4RBH"D0H/(U(&U3$&6&8?$M;>T=E68G0!_WY3;4G&/G*GN
M?.A_D^?_B( FK[[=^FD>4642DTZG ,I3!"Q"0D/0:,B>!9:(]F*]"+.M*G&L
MA[&K+))FE&JJE$/)*GED:+-@'G0J<E::0=;%W8C*@W4Y@68N1>IL4*EV#8XE
M4/9?>Z.%^E<?Q6^LAFXN>Z[.)M)5),DZ !OEFJP$MY_\DRJJ7(,>N^MA+X1A
M/"K!):[(MH0,,17!TB"!&)VI*(4=>2L;J6.BK,A:V0]/-A%_[9#*LS1(85K.
M,L-5Z)B505":!) H'5K[P:&3*23B\LGA6DJY61F"]?BC#\*TW47VHVJ"JQTT
M64Z0\F@<TMEH<#G;#'\=CRZ_W("3I>*4H 9X*H5;0SE\3H1!D(0PCVZ<\VXM
MK:YZTXM2<E6Q-EC:G[B,>/7M-_=?H_'K@9O,<^Z8<(QZET#.8GJ=GL50H5'$
M"2,>Q</\6JTD-ECD-X#W75B4K=35((+C":@W0#^XB^LIM@;<1C;GAE#W8X$V
M4_WZ%*NFMVX7LD=A>RT=";BBD^ ,SD*F 9=V I$2QU2I2FQJ5[HY")JML%\/
ME66;J*M%*<*QBZG 6:1'**+1=(\)J HEUX*CJ2:T@-)83R<9DDFUBT3?Q]"]
MG=14:?>K$.XB\081W&>C//W#C=.;]#4-1E_**=UUSRF%1IPGH+0NB<^2XBB]
M )^-Y=:@\6Y-[5/;96!>-B?JZ*#!\O#&3=%,GUQSU5@ADR<<F"U<E<*!(XD"
MX2:HF*D+ZS5=VX 2]R"\;"+L(N\&INZB1-FL?'.Q^C_WORR@Z>QXS$E#]"GC
MUNAPV5(A@J8EDBMYRZIW1'X"SLNF12T]+(T[[BB?\6&0:HIW0U3=8R&JE3(>
M=WQ[TYS(FI*YW]Q/H]W*2RBE8R));W500MEH!6>6\=BKB*-A7F62*9-H#"0C
MT"B/DH'G1H/+1"MI%,NV=A^SEGF5-4.X7[O)9_Q#R8;YZ@:S3D0N91F30L<E
M2 N"!@6>,%XZ$07J(^XDOK;MUG9$!W%XNAT;6T;O[ZCZ;C)"MQ_=/.!E_LF;
M3O"3GBJ)"D$HP+$P$&I6 7Z66LAIY,'32#K(B*H^KA\D;T>#AM?'U<<XJUO1
M(SQ2(YF%(-%81$= @_'90^12<L,()40]%Y+/1O2#WBU4WTV2ZM:C^S@>?4GC
MZ;>/ S><7FU5LQ..7J(<I<\3&)=BJ=UOP$I)P?D0HN666G_(J85+!_:#Y@V)
M4#%U=EEVP=8C/"U);B?Y]\G5AWO",RVLGC7+2R <.OY.X1 333X)KYBWZQ5G
M:HGR!=#UL#39(#/V.J^.)H8; (G 4D(</A4S7Q'<(@S)T5#-56V;X$#3%'=9
MUK829X/LTU9YW")S%[D.D+FFR%;) <=#T0]42ECF.9.MSDI>=M+^H>REVRJ[
M@U3;K<=T]R/OAE==4:[GJF8L"OQ?,%8+$,)G%#L.EM!,.4YD9^Z3NH/-= 7H
M%T#?@]9SQ<S>AI[=[3^$V87 Y*/[=E5KVJF,\Q2<PQ$+S3QXQR5HJACS/FL7
M.\C!:S? %S !#I\8%=.8Z\]V?.)EZ?Q[\24-)[-GX>=>I2%2H=C5-"M+HP7<
MN]  DU*#M5J!H<9(G9U,:0^+^I.87P"E#UG+%=.DMQCF(Z/\=C7&]\E-THD?
M].=- Q8IX#$JXV) >RN8TO4+E6 8^A&1*<>TUC:Q]9)"&@/]/FG;5I\UDZN;
M#NY6\KB1G+(0.$C)T%V0-(*-'+<80D(RA#A_/Q>[8[X>;,+_P5%V2ZT^PMK#
MN@J[KH1P4UW1$=P^HI; HRGFT.S\+0B(2>48$B>F>BQJXR&] '(?HO(?(?=!
M78?=^DW/4A\]BKK8^!E$)@),$A2RD8X%1TBL7A:CT5!^D+FJLA\A\;X*Q"Z.
M91X=WX<T[;%H"1&$ 0F9@^!6@-><@9*\%$%BGNO:"2.-AO*#Q%65_0B)=[X'
MVS@GE5@I<-YIP W$@F"1@>4L0.1<)"U-TJ1VC,&SK#RT"]F:*N70*P_I8%G6
MG,PR<D!0F<%:._,9%9HKFH;8RC!]KI6'-E+_FI6'-E'#7@K)K /P1^6AC56Y
M<469;?2P%\((HR*3:"]:ZW!%EHC1\9()IC6.(%/*[Y<E>:Y$V;+R4%N>;"+^
MVI6'5M96$5%EKR4NSZ7 BN!2E5%KT,D9R4.,.JT75_8<2]9LI)F-2M9L(M:E
MF1,-4^F.CTX_O/OPZ]G'X].SOQV='A^A&1_[92Q?TUD*E^.9N;Y#MMQF+ZB>
M$+?#^.[EO(6@#2>9>^VR"*A-EB(QAA(=(@TT]C9[U8YM+1Y]]O&?)? AQ;<X
M!<J]V>7TJA?UL1L/^\-/DX]I/&M<=&.D:R>R%[CB*5M6/",DF,@T,(&LCSX&
MQ6N?%]7"OG-KD-UP'%T4UO6L"$GG)$'ZS'""BP0XLQ.DTOY7X$0(KG;Z>A7@
MW2_#>^'L@\8BG2N]17V-:_=HQ^',G2?OLA+9,&"RI'MG;L"G4B=8)DM42,3+
MVI5NZXZ@J^..@V#P'I5_* <G.P[\U;?''S#OX<XH-R%F- !IZ3)C#!BN!; H
M>':.E=H*A[6>/S6<_1_@=$_2NBM^-;(T\/@?1W:K0,@Z^!J=$*W"MI\#HH,A
MPUHDW5&3^V"<\L$:30PHE07N;"3@SA83.KU$QDR#Y*P;<WC/M0&?+=$V46#U
M\MBSH3NT(ZYZE!_]X<9Q496("*,C3Q3PBP,1,P=/:8(<G)*$2$Z36'4:L?HU
MA^(7;:N241-Y[N-HZM>3DS?_>/?^_?GIT9OC#T>_'9\=?7AS<OZWX]-W'\Z/
M/OSZ[M7[XZ.SL^/SLYO$C[M%LW8XMJKW\NI'6HWD<N^X"Q<8EIWDNA2$4X1[
M2Y4G2B:O'<]:]NK!V&'%N%4QK72('UY)^/$::C?^EXDZ46T\J!C*.;]&>S(J
M#3JF@$NIE^1^9\XE2\EV[V]8O_=#FA[YR73LPK1GF?-&E:X_S)6*#T[,V]8I
M1XD5.8>4;>6]>#UDW:VQ79%D@Y*]VVJHP3G2$RA_+8M0CZ$E80TG8)13(!)^
MYY0B$!SG"5>%+'SMFDBK,!U45<:M=;D^73971+<%PX]"N+RX'+C2B?EB-)[V
M_V=FTO:2]50HGH"C@X[6A5'@$F4@G&>.&,M3JATEM3G*[XU,-935;?N#$B%H
MJ)&)6P-)*E-BM15X'PA^IX)5RA"::A_)/8WH>Z/-IDJH6%!G@6[%KCUWK&^E
M?%^+Q.E@20X"?1N"A+99@]/H.U.M2]U]ZD2N'4N\+=:7;Q9UHL4&^]\]W#?U
M]GO99^(-YV!P[" X.N@NI @J\<AI5%GJVK&:2\%TORQUH\^G2;2E,JJ?75W?
M>-S#AW/KB:5U?K^1N O.R@0ZAU"Z[Z;2V,H!SB;G.='>D?6"KW9!T?H6M>M%
MIUNU',K=Z"9-:0@A/N&^#D[,YHMQ8&B4X#5)FA N**V]>!UPD[*.^;)#M[)-
M]'8 [:/6@?NC6UD#U>_81VH;O1T W8),.62K<*\H=15MCN 8S>"58#QY'62L
M7<_P(&A6L5M9ERS;1%T=M"-BS--R[0'<X<HM2@M3D[@"F:.0WFGMJ^>>/KMV
M1!NI;$4[HDWDW> (_*DV.#9QP[B($-&Z!.%+ 0SN% 02C:)$":]KQT4^ZW9$
MN]"BEAX:K!"E)$HI0C5-1Y_&:6:M+Y!QJ25';Q62M1(-OE"*4!&##HHP,MJ4
MO:I]/[(<S<LF2"4M-#B]?MA]42IFC+'@"44\/I2\HB0ABQ@\(SQH6IL5SZ_?
MY2Y<V$GB#0ZGE_=:I)9:K3-!.*7I D&/T,C2R3HB8:TVW+H?_2ZK<**.#I;6
M63^(.*?%,>KI:##(HW$)YNHDQ.F)]^XQNFE=:=P+;.("]P.N.%66BA"YCSPC
MN92)-. ?Z :!34\@J%.;_^8 U#)3F@)PB-)1$*S80(8;_!*X=]*DP%H5Z7]?
M*VSIMKC>SL75(S9941)BD9<6IR3#(6D:@%)'T/;/DO':,4J/P.A^:=Q-P\N:
M#VPKV0:.U0+2/'[%^9R4-P$TU02$41D,QQ%JSJ(-)BKM:G>0OP-@?PK>6B5+
M5+RY/!NX1 LP[RZ^N%FELINXDOFORO;[O@ 5QGOG? "60RE]2A580FR)74XQ
MIQ2YJ7V<LC:XET.*NGIHX"-=5^(W(=I,308M/%KJ*40P*F3(VD0;60CQ?FGC
M9]QLII6Z-Y)B W]G@>/CY3A\=I-T56B^/_QT%/_K<C*=.><]%8VE3I8F(FC(
MBVPH6"?H+(11Q,RR\;7[$*P%[.7PH)[\&_:7NMJP7"C))@)T" Y$D!H,KCD0
MC>?.6IG0#^O. &BYXZ6HK%8<)V-4OI1-+C7IK83(-#52EC@Z<1@[W@[+>'8.
MV:,]Y%E"+C&H3I4-<!>-S,QE*D,GR_@6AS77-_R+)\XO[UEF0I3;^LPYZDV4
MV,E<*E+JXAU2RX)H5P7A#I2NRAG4]4%JR/50@FC.ICAWRH,6I:/.YL^=WX[B
MJIJLM&A&Q>A*)U4&'O==4$HXJD)I/)EK,^4I0/M/\M]!X_=95$WR#=R>*RQ7
MIY7K@&D4UG('R'Z"5BHJZCX%=I9R<]7[%"C3V:*_C>06+&=PU'*0QG).$S6\
M>NN #E2^(H"D*XUO(MS:4;P?+L=H3@_CT6#03Q%'G%&TGZXN$F0(6AC$Q+7#
M(6H=P5NC0&NGDU$I"W8O#V5)E.Y3;^G>.]E!^J,6HJMX&#D#]O'SMTD_]-WP
M'B9F [$D* A1JE+$*X CP0+3N(%Y(Y229"UU+GG!L]5D#8&UB-3J3[Z,)FXP
MJ[ YNSKLYWYPU\5;4PFQ#>B))(9.+QH@HA1OQ9$G&Z(-.3A9^[QA!:279)C5
ME'Z# \8GX%U-AW4 -C+75H+;CPE75:7KTV4'?72[JEQ;H-)$CUZP%N7HG,4$
M%IUAX &W 1J4%*+V%>6>"+/" -PO7S910VN>S'](\22_^G;F!NG#:(J_"K,^
M4Y?X:URKYU&,5SMG#E%$QS@8I34NMX2 DVC^!$.$LSKF%)I2:$.\W5LNE=7_
M%+E:ZFX?99+>'+\Z?S\:?IJF\<6;Y*<[1 0M>U3U()^U,-^+VR$\I^22TU(E
MD91SR //)5&&2T>EZ"U[Z([S'I_T;CB9CB]GA^BWNMM$'@.5:/U259Q>M*ZU
M*:0D3#%M/<^U"V<O@;+SRG;GL>^&*+\TF9ZBLW^<D=RE+-E'M#WQ;^Y3ZG$O
M:.)605)&EEZ0&6RR&50)Q9;*H1<0FXY[!< ]K%T5&/)@Q6JFDP:A/LO!SHZ,
MXBVDB7ET04D$Y9E%PT R1)H#4*52YD(;[:MOA&NC>^G4V4D;+4RJ.TA?N_'X
M6[G"GI=8=X0X94OV&9&R]/<.X'SPX&-P1.C(I:A]P_@4GI?(C1TDWL*#3SF-
MQZED6;MA2*]'DZO",T)3P;2$$$KS85<0"9] !I,)KGK,U;>='X?R4CBPNYP;
MQ!05R^W\RG);]$UW:/%3M.X@4H:0J+* AC@'@AN>5M+JH&O;&H_ >!EJWU6^
M#2*$;D.ZW7=<2,YL])"RPL4H)PV&H5W#9@M44-2XVBO_XTA>GN*WE/)#W<NZ
M>__\>%HGDT2F#K(, NE8JOQ+32$QEZ-21$=6_0#_(8RNHF_:[^^;2_50XF]N
MN_'G^&_FS?F(<)0P 9:A.(0@)9Y1,_"9LD"5\3;4OG1_#,>^+G5VUNTCZ\).
M,F[@$=S'M&BPN0:J1E<WCR/:SWW-[AI;08$=Q-T=&:30)').("G%02B&3JO)
M HAGD@5)C:CN&'9)@A5W,%UQ8!,I-PFW0CLEQ0)JT4@S>>J8]$"9PJ7.*1R>
M1T>%6B*L,Z6T5FU?X &([@W"&MIY$&RUBV@;'!\6T^<DOT9,_6M$PNN060)4
M23F/L&@#><$@$NV$2\R@PU)[CC] \2*TO:-PFY13F:;)1_>M&# GT\]I?/7]
M=5L2JBWCQ()R.B ;T?XUF5.0C#I<U#@+N79T]0I(+X((-<7>Y/3OMG4[V]5R
M\)RER,'/FC*7@VE?LDVX=]YHKY-M[ Z^)&M_1_DVU_BM*B#KX&H5J+4$TY[B
MLW;4V9,4V%'@S:^#;O>_0ON#N>B!&(_XB"H585( Z4PB@JK$4MLKYSU7;NR*
M!YO(N7;@_1&J@)9CRO<C-YR;*]=UOA9U?$)BV7D'L\1#$80 XPW!'2J'&)S@
M4MV["%H2K[WZ7?L^^=U6*:-V$JT=E5\Z'HXNI[?-DD68N<*7<Z^ IFQ!9+1$
M/,D)<@EE\$G31-;3\])7O 3UUI%?@V5\3K6W+O0'_>FWJ]6*HG:09UD7NS7@
M0N48FC Q4^D5CI&*VL6+'J)X*9;<CO)M<'5[%]&U4;$:4R,K[C$\^['@=M75
MDZK?0=#-I_T"6^8FE1:C2@D&0JK2FB/A?N.TDSR$[&GMZC_=*7^%U=:)[C>0
M;_6&)VG8'XVO3A-G11UGG6:+M7&U$1GE>&0V0XH25SD5&:YRS@#51E'/<\B$
MKK61KWQ5]QOZ[NH8-9/EOJ+0GS X/[AQB:K_FG:,3M_D%4VBUK<>X[UH=MSD
M@W?1"$>,",HX);RS0A#MJ9".]39]69LH]U)'3LO,@;" *Q;7":SD&=<NM$L=
M$8[QME&8[W>-<I]GM,[;7[\=C<O3/X[3E_DO>C0)Z27ZT3'-RQ*5"%BF<%G6
MA&I'N11ZK25JV1OV[6ILI\J[Z< UA-<\[+S,DYX*(=I(.%!:'%HQ+T+ T*O-
MECN7B=%MDS(*BN>M\DK2;7X^B%MON@I<-D2S*&4")5TN&5H!+$$KBQG)@B6<
MT]#V?/ &RTO4_9:2;GYE@"92?W+V99Q</!G^W8W[Q;4N>0ZTISF1,1$+(>/R
M)*2D8"TB#@QW8$XUB:XM(Y9C>XD,J:2)BD<3LXWK+L@%KML9,6\'H]&X)X)+
M-"@',28+PH1B6TO<UK1#NE/&-5UIG&[RPN=-@6:B;1!A?A?FQS3NCV(_7!DT
M'\?]8>A_<8->]"QR&R48*TMW28J&C+<&G$DV2R)XMK7/)]=#]KR9TE +#2+2
MK_!,3G+!>_QG*:=ZV9]\GF5*E229'N?9EXQ*2*:TV.:>@U=.0T@DX\Z8N?2U
M(U-6@GH9#*DK^X?D4+N2XQ_C_C2=Y%P SM.G9F*83"X7.50])[PE#G$)2V2)
MHD,BZQ1!>..9,HG06+O$_6I4+X,>E:7_D!^Z13H+[FXF.\?!QI1 1-S[;& "
M@I$DQNPMSVV-T(-(9ZGH@VXLU8-.9Z$Q,EN*<3GE<2 ^:K I*0@RF*2LBH34
MKH1_Z.DL&^EVG726363<70;#.JB^UW26C32V7BK#-N+NC@Q*,^^DLL %*R6W
MT55V.KG2>9=*C<LC?GW&)-@FG:4!!S:1<B?I+,1D4YQ?X!&-6A&C ,,) 64-
M24;E$$+U&N('F\ZRD796IK-L(MKFUQ(S0H?(C+14@"R7_X(%6DJ(,313I156
M.V1[[=8"AQW)OLM&OZ-\NXQD7P?7]QK)OI'.UHU@WD;@74:R.Q&=<MKBII9+
M!64KP7KA06F>":?HL=X_:7YF1-@\DKT)#S:1\QXBV8VR6I/L -? $J%K$OAL
M</OC6@JB.5?FWGGS2XADWT@I&T:R;R+1VI'L3\%[-PSCV3=NL/C$%>+H4LKE
M I4FG7$+5!'-'9P&)$D7O=7&RO4NG;9Z?7>T:*+!==E11_Q=KA!'G_"[3VYZ
M=>-^DH\&@X^CR:0_NU[#T;C)=<JFSBI[*A7PG$E) E+@N&7 8I(T6N'5?;-R
M"PIM .@[(54K%36P3&_?Q<]W6Q.2\TQ"LMF#L"S/VX!Z&2P/21M:O?[F?0PO
MQ0_92;8-LC!NXUF8PVL@:N1_/$2S'\]C-RT]H?(=1-S XW@$F:;9"EXBM!1N
M;L)8@]RF!GC*D009I)"U8R&[4OH*+Z.USC>1;)N#Y#@:SF)MO!O^\R3GA!M4
MP??^W:N3TZN=!VUL'!Z/@!M/*>?I2JT(R<!E85*2G/I(*ZM_+6#=.R2[:O#A
M"7-E\>\K7^,W-[T<XW/39#2+N]@Q-V/9XYKD8:R%_5[.A994$18I-RD(E:+A
M6BC'=.(V$V]5[ZD'M\FOX"KGX'("Q$21)EZ 48:"8I83%7GBJ7;02.7\BMM'
M^XLRHZ^^74GQVY''%[DP[1E<>9U2#AS#:2>"4CCW& =&@_+1B<B%J[\</8%H
MWP<CVW'@J>*N.TJ]166O6^ANYM7I(H%D<I*OH_].4Y$AOO8DO^U/@AO\9W+C
M'J7!T!PM.$H,"&'8O$FZL(HKHG#SMBU+ 6^#>3^7:K4X\ 2]FBNPT9W[FOC?
M#3_@=G'^1QI\3;^-AM//DYYV(0>;*1 C)%H)R8-+7H*SG 41F+.NQ=7\UH"_
M5^KMJ+H&YRX;@2\3Y?R/44]$4CIS*B"DG!4%;L%2F]''M58;+PC5M6^)M\'Y
M_;)L&T4U[I2P'F9D2^J9G- 7R0JHBZ7LHT]@3"S]U$S6TMAD4^U:#-LA_<X)
MMK&R&G=F6 OUV]'EN)=P5W?!E3JRI81D<!(,CPIBSC@]6(@X-_;-L +T^R;8
MQJJJF&LSNUMY!/&WHSQ-XVMT,DHI0K*E%8T'H0(!EQGNWH2@TTZSMW:]1NLK
M7_4BJ-! J@U2:.ZZO_=Z3Q'*,I>.0U"E)C&C%)RB"8A41ABE> RU3>VG\+P(
M6E07?$=Y,XXZEJ+*0#0M58Y#!!-X*J62<,6B+G!2VU YP+R974Z%=I7J0>?-
M:)9P_8H2/)I!I<LT T_02$+[*'H:J<FRQ4GB(>?-;*3;M=K ;"#C#MO K('J
M>\V;V4AC:[:!V4+<W9%!B$R8RP("\26 *Q&P!GUR9WD4S#IE5>V<_4//FVG
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M6D>)3XQVBI&(5M7,E[N33!?+BF-O^WNA#L9SZ#(<?H%#^>P-"(DPF9N_6KH
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M1*Y(@*$.L16$'=8#L_@L\0>U4COSOZU5\MLZ);^I4?(/Z]/?HVNDI[M/4(]
M&:^"DE((06/!/ZZ21 T<$9)0;$>%WY'V^_V!D%3X1CJ9/^Z.9?$0<@I(08U_
M4C"$S+>"R7S;:S*R?THN*3D9^7^TPV1EOQ5+_ENQ$#)_3IU2TG*R_ZA<"O*_
MUJ/\MX))(;_GZ+XU.HE?6?0RZO?<QJ]<Q.\5-]BK22VTO(^C(O@#?L /^ $_
MX ?\@/_WX.M)$ 8'!2]>0JHJ"Y^8CVAK:%A#(9"F]J%]U,,KYOV'G'%XFG4
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MV MJX%W=;'$^ "RVF0KK?[/ONZJC_C#S3P)%MXNIL<-4G<$VE'S%?8\.?P<
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MB,RK<S'V8U2*P/WDZZ=Z35Y!7H"E>$RY8TSYXH=G@.U]-+]/]+O.G+:F5!M
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M@;-1D7]=29Z]&E34G76XMA_[<Y>[[SXS@HF,]*#,0I8(YVCC2) M;VGWU=\
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M3?B_AK,2*U]EG50L]9)YXM(>M:?J7"3WF;:;D3P&G/VBZL9QWQHZ= X83SE
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M(UX='7)GH\J]IQ_L*/TX K*MZV$C>QD@(?1V+E/9VZZ5\;)H(7TKT[-#J?<
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MA72;B 5PU3'SM5W:C#E+^MI138>>?9!V@ L%-L3LAZ3JE_;@[3%3>6%47F[
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M[N[CI''1U"#VQ[+SU0Z^[9HO) 96O9TP/?64U[TB%VB^+FUPBIJ93@4?-VS
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M,,!086,\S-(MVU7\H"ZZ8.:+!$,7H2OJ0R%T0*!4;E]T*U103/S^Z+B4S!.
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M4OS,SN8?A)%GS>"QDKM-J-. ->S<T"#NJ2G].<21"I'9I*;Y0 GO->X&B_Y
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M751#9:\7.U_JS/P+(+"I<^.<P/_;GR;X7KZQTQ.@]"^):@]HSE#5O8S2.91
MB&"FM3?C-+J>_%O!W!%E<'3WS &#2<#A[N=#P]7K+3-# %_$F5[; R83IP%L
M@("D4V7! 0#Z+VHTL(73P/9?16)']C,/*YGTS._\TM%_GS=,R)H73)>"[&BD
M<DMA<=M&Z@EHM%@'0-\M6./3$UI^CFZD=Q6][XV]#N#(\>(7C5%M+A& 0.3F
M7&3S87/ GKXIQ!OZQ>V(_^ 5WSSOV=:*^O_QQOW?E/_Z9,0NHZ-K'KY#BL*
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MSGPR),H-&>M%T5N*LFOPP!=4CC")2!0!$P#>)0HF1S58WZ;#6"13464I>HL
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MTD4-6+;><R>>/5NM*'T,";EV8"N[V F)CM#C*+)S,T2Y<G8ZZ(W(WP, ]DH
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MFV1[HHSU.1'+XQYIW7/9/JY3FQR(Q *!@&T_'/9*J?LSH(&]G-/]2#:WZM?
MC%\AS=OU.+S2)NFH11%1XL")'_1/0\^!R^IPWP[;D%_!X%K5!CVOP+,3[?D.
M&IEC"@%MR3=#1!%@&V4;T>3BY&+.IX.+?)SN- "3BZ:M;\F?AF7G'&FKXSNL
M,4S)_,+2<KJ* C!RGUHG,WIL8RIJ.W/T1FEM!'E%A$!4YXLJ9+77+G_Q?WA[
M"ZBH]BYL?*2D)09$2KJ[4XFAAJ$FZ"X)!:0D1*4;Z0:I&9@AI%,409#T(J&
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M4!YO$<!GZX= N7UJ;;<&RBVK:@K^$J("8;E[-T8%H@20TE6->$('XR#ZCE.
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M.^B+/D5G#K;$MJ9R)>5 N._&QC_H!T (%)_?48<$HA% F&/4>:C%N*>.Q 5
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M1_Q8<FXF72G/Y7LE/MW\>@=3]84FT[X6(X@'JJIUO#LND?J$=0\4S:=?HI6
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M;=;W_,2_FE\"\&[?PS.I^/1 1-,=HGK93DZ,4_T)^R?"U@5<HC4ICHET;TR
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MIN%7XD8 KF;<E^??LG:WTX;$:+@MG$.OR,SRO5*7O?+V(>6I2AUN*NJBT#7
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M;<Y\G)B*^,DDS>9QXMCEUWZ-:G42SHU[)ZOJ-_>BFY]3]W;V$Q&OLU3P,AJ
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M.D?>7.[OX<_)<.)BO7DD9BWP08'A2]]&WFMHY8G>N1T4>O<[9<:=*+BI;MZ
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M>A2.3^V9-J6N'-.7)&\T8G2E02W]-)S80<FJ%+=W#\:2<P$A:B2&2HQ0E:_
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M2Y4Y',$B!<X<-8.+NF<:<QV="& J8(=XNFPQ3@NG6<(/9O^((DHE'1)'QJ7
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MU9BJ\.FE,)-GH%/U?F_^ T;)-=6TP-F6Q+%^9:+A#?1RQL]UYOKJ\PGHFZ_
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M^$K.J15T%[2F_5RXUHU=YM<]PP.-"@/>I*<K\GQ/U\7F_X90;TD6C8^^2TZ
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MZ6%_/\O%?#.3*@=3#M?WN)ZY+',?I"F%48-+WC*&=S#!-]/"'C2K5QREP6-
MB#/?WIFU/!AT:4_N%DI?4RC7;'UQ:4KONN-O$A6FW6$:9MPL)Z7&S98^B:.[
MX#QJ-PX.[UY+B1H+L3@IKKOM!)@X0O>X=WD'[/:;,!7?,&'1 JZ$K!R!WJE
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M"5+QIQ]AJ5-.WK<ZM5$YD(1T6_X,UMM:G[A\DKNEKFYG:&@JR^#F7:_I$-X
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ME>NSK &#Y]@H>1S(*,/")!C-%V80],]7<B@D1G4=(0L3W0P")E)PN9.ENH:
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M-41<I69G!'74?Q01\#3);_8>=VXCUG#!S-K+R':]Y;3EQSG\'+<(=,@FYN6
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M\9/QC)#AB)23B>=;!2MCV^'J7O=25=:BF6A=C_&8(*9@C,&U6Y5,Z%W)!2>
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M2>0U88="K9+B04:+ER#M!S"EG*%-]0"L6@)W&\>"I3#2&5TER%W!%4Q^+7$
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M;Q;7T.>#RJ>#^U@MGX@_3H7^DR7QR7+Z).T5%UD> 7DMCX!MU1^RCX"]RD?
MC5JD=/OK ;.AV*UQXWZ%PM-+ND? >S CBQ1[&@/&(*@_(L[Z(M%UP--B;Y^4
MUF$"XXH$VHDS<F#][:1RCV+^W!2L]X;*V%+5^A<IO:OD.4>3[W1-+[=S7,D"
MC?$".\[OIW:Z<4@^+*:Y[KB&\9<AR@VQ3J]')@)W_2X&OC"_A;USQS)V>"*&
M5S88P5R)VSSN-!\+^H,3OZ>.$E#;S2&7D4N3 > *$I6(BZ(I-"3N>=4G6)/0
MC[H1'7M1T945#K5&4,A(J)(9K7*X.M.UP^#G3%&%C6W^6,>I*>?RXF(?!B&8
MU=:L36GM$'AH?P[>0B=4Q=A9E\[8P&$Q&[,;56L[AM,8Q.<S>=?>[V9EX%B3
M4MU@WK/_TJ$SB+@":W;)V2USL-YBP&C(2=V*3SU(%-4H7IIH:7\FRS]W)YU0
MX:":WD."9-Y !D]1E.[6^5#%0UL'QHFUP?FEJFL;G.7=ZOOJ(:98096,"8MM
M98>9U/(&NQYFNSI,"8&R[NX"-6!)!,I,&.7-.YQ"B7HK';8DFTM=WK=D5@X>
M6HH=K'L%[]DW3>6#TT341B_4]I6O0FI %F,@DQ$O !Z $1D 4 ,0XU<F(F*Y
M)\BGI-GH#%70G*T++$B*X712B)R8:"4HJ-@OA9_MM'N.0V-;I%M /1!G7_NY
M:5U]D2S6_50SE\B)J0:HR*PA9^86 &CTTE):C[^=7<28'$3(Z^ KGW9F,J$O
MIP6 '@%F.[>5EN5!7X@68\2 ^"Z?<SHUC,BMYGU#*"-;/\=1CT#M8"516:6E
MMZ[69EO--8:GA@X=Z1!'H,GP &!<>EC6[WTY]I[J .B*#<D%Z9R-@;0P-!<Z
M'?81$/) &4>S4ASQ)2KJ31U50RD;FDV/*Z9:;7;U6K[@ID!-\VI ET7)N2ZV
M@K $6'*742FP#BW*[KT'W33E)S5WT>X"I8_9.@I&;/+&O+YC&#_91/S=,E?%
M]YWBB%0SKQBSS_=P=*4SG4VM0S\R^K"+&-_C<5Z]/5'?*(F+04&?<IO_[G=C
MLPO1$R<U8A8T<5UV+(O/6!]I-U"(:I(9ZR<O850XPVVUM>W7^9 2W,Q@4K*L
M#B7Q;2G<LZ5&4H10BP"SLQ?3"=,6-[F<'B<UET^"+@)6BB YB,09!@5XQG5P
MRT4YK*N]0!^U%4<[[QNZ3;S<A;7*J:+$)URZQB-,+$HDJ;-*F(C;L#=,2!:0
M)YDQ:;\2^,>*<.1(J\3!KK=\ @)=3\O#-<L5QYG9,N75;K.LWDF7)&%!2X$_
M;%)9!#N]'^ ;@4?XP&0BV37[N=4P)3Y)\921,R:;O>QX3^+2>%$RR38H_YP
MZF),C[\'ZD4+7D9'F-':^>)9)9&[A%O3A_#JS2">=[LC,B.AJ>S$_O48 &<7
M-,B/8U7.(9!Z4CPTHC$B'AL\?E@@/&")=OH457\Y8:0WQ>1YW8]/H=_I?E7Q
M8!XQ'S& S(5(\;-\:8&<E^4;-M7!!IA<LD!,<3$L8P0L7-F^QJSI-%SZ/@
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M"1H1_/YQ>)Z0Q6TF4"H*JI*\$\IP;ORY.D.V9"2MYMT4_8O4.]*6?OC,Y1.
M+7VKZE.PZV97L/J:#:W'+3K6>9RW&HW9KD:]L;3^:21Q.%RT-"S@V#X>T"-Q
MPN=%:I69'TCJSIX]%_ UY!(RP3>@H;&%XKJ%(/QZ>C0T0K= 90 6F2-3V72P
M))1=XT[',,UP7O@#6.IL[*%AR#EE=MUKYCS^GXX&R4@[:3U%1@X?3!51<P9
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M@A*M6*/9>@U8E8.4-<X8JD!C265@_\\PQTYH#Y:1%HOU15CSSC@-D-9*[08
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M>YY#$.EK7!/_.[@^Q3JY_THYQ+0MF-XCCT;RCH(UK6!T/7BJ1:/5*(2*VX%
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MP*F3B+YEPXZ6,O6FK?AL<K]B:H(GN/@Q!K.<'\)I@$[@&%E0Y+?8XA6G)<5
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MQLP7)(-*H^_M9W(T6N6??-K&,)[^:]/P",?(4IDX<)'^LV_8[J\'_;I3\E<
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MHCOM'$ID8\R0F,>N,<6'DBM?*=I;0@7;?P+()-_]_WIOOJG.FE&H!DXFA\G
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MAI38\J:=6M.I?$;<\::F?2G_H+;!7#STZ0W+.[P>"8Q^*@3,;XTL7D(R)#G
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MI:!5W"L,<*^]Q@!&V=ZDE 40;1=5I.:>G8.Y \62QI/7 E_QPTQ^8\#"?\(
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M/_G\THW EXOD*6S=T[Y#S%#>.X;S.?:"ANWIS/$\W5\X+[^#-\E8=E_J%+D
MHJ4<2I2&3WU>/,EAMT320KJP9I#<H_8(_@W>]Z:SK'F@22V^\\4'YJZAOTA?
ME-EJ6IP/./1''PPO3@\R@]&EPV6P$"95J(T:."WK6MD2L;S9ULGU8F@^9%A>
M"0R&*-[I3G$%;"5^ZX(A1*@26W+\SF1V?(S9J9K\&C;?!C1^5RXT:._]F\+"
MZV_">^7=(1H=!Z>/9]T>_*US'V_/GF&2\>+(:WO10/ZF9@GA/]D:P4C\)I>6
MA%*2I].>$-R R&'NJ8%F+T!@?;\7UIQH>G?(=3N5TJQOTO+FO9N4UMY-[R93
M5UCVVJ'"CKTIR.&XC.N$CK.?6ZH5[+&R2$E)4*0VI(#R#2&#O;^5?,QZ286(
M')]P*-9J[JIO9?^6?48)O<J@U9<)HWI_-770)BEY^=EU2BOX>Y[W[-K=LK=_
M[WS5-<@Y.*.NA?V]5WK>?R1USCC75/<'0/&SRK4@[L,T^C.,<H64Q,^M2:C:
MN NUT/22]0!XR\Y:^9' 0\'_/S;%*SP/GMN,Z*$8&MK<^)E*4E7&C!QYT3AM
M8\1V)K4E'Q44^-ID$>/CMD_*$^:;0STO,%PBLP7I:+P=[RXTC7*Q;CU-*F$U
MW&]TZP/I<_8]@MI*11%^SGAGLQZ<:?VT*QQ')&;L!%&$LEW>_8A8*_@K<^'U
M)PW)R[/<H+T-P:LIA./IX\@97?7<?F)CQHT_W,TUT.M<D86WY@*J[I$ L&07
MYC+S2!!+Z'&<<T/3+/:@%&S317O&ZTJ:R+K!>&X-<Z];9X@@^'6 !*%ZFWK^
M>3:DX;%_7TSJ?%D#1CKEI$Z4>'T@KYZX5SZ2NK_CGLT)D%*>IIBPAWFN=\W7
M5*4*()Z)R2/G]:4*G:UXBUF@N"YX4H:*PT<*TW?>8<&QR9?.MA-*9(BY<41$
MKG[/_NRSM\P%?AN"AVW8Y>;M&@S<SOB?$M% ,OXO .2+"(07"'9./<X<>L"B
M[&XJTN^_$?63@[K;?PG]MWS,PG;]FI9UK>9,VN,8=7/)1OA##&PHZ!_N]J]U
MH=\W45]F#;V8X4?3 H5UDG<\@'*=  RQ^!ZV.0L4E:HB5(9DZ+\XFG"X!58F
MK7=23T#]]K\XD0Y)EF@M/1:DX@P!X14,M' &]4 C_GFQY@S. XG?\J5=,=,7
M>&E/83JE+57*H@/&NK\,N+QYHCM]/W?IC?KU;;C&[M 0YS_5(J+A%+V?\$Z8
MY.U6LF5-:0L,S$QR:V$ @(>H?3+.)4O5'P#W_V.%-C9>D/1/9^4H>VT4?^2,
M/??_GHG5-&8NT'ID:],O M!XESD5$M'P/R,SA/]D87:JEZ82#&=@-O\4*"4+
MI,:C_PQZ<!VGA6\AP58_*HH)]+:IOW=3J#DNFED>1 ?WRR9PU>K*K/(B?M(:
MC:.-ERZ?JZ/$6P,]_JBY>-S^^VF/,W;TB&7!%RQ._]94"ZQ42^\[",C9?U+!
MR%$:L^"[S^B1*V= 12#+*?$EG=\.QO_F:GLDTEZ=R#%9--VDSQV39"D<,8$W
M71V/L9=GUF-W Y$S=F00_$T)*_%/O^?>(L>/#3S*_::X\7X>(KUX?(+Z+6VD
M7O48^B<D*"U_;OJKQC_5-DI,6MX.HB&QO(LD(;<\[+3(*GBG++>B) _6D>2X
M/-1;;[4094+K00"6T!]=.N('D67)L-!&H4U$#@L%*1*@^:(X1+<ABOH;)>5D
M3O^O&<K?NOSI?(SDR=U>9T$E(T9Y2_V2F(=NU(O=5&@F^K,^<\-1[4NK9+Y2
M?=2Q8X*&,O A#MZ;&2.FV[T2)H':!=1"HRWGIA"Z3N4[F/!T3G_TD"49L2^H
M"K$.7ZVAX^RCGE#UQ[L1>!\)(%"UM 3]F[QO"(-,SJ&)RA_P;&6&[50+L%O^
M0@(MM_#]&8%3T&R/:.4?70G,%Y]UC&&(5_Z8FNJ,A1(1:#DO@6#(K_7/P&T9
MEZ<@.3.[PO6KABD6AXQVD&KM3=/?*]O-6"Y>8#8OB5<,A;-#8))DB2;JG:^,
M+K?VK-D9\O4#>A$YC,;X)@G6L/51)(^?I@X;]2/^9_=/F(36.ILM#IYOBN=A
MS;"ZK-.8RJO=E_?61:T1ZGAZ/;%)(X5'\7N\]K<:L<2_--E!"R(PF[6$@@>+
M^SW*5)HS>"<YP)90E>/R&MZRCQYKK0\-$ 5W(.M_''-]7WG\]QW[1-PZ>7TL
MTP6N";T/IHM:B6<*%9FPSZ1Z@S8L_#3Q\A&11^J9Q%.T_$=H Q%(?Q&7]\-B
M6]3Z<S[RUR,EDQDXA;K2VIB,*+LP*'E[5U386\J. U,/]O!3=;%FMM6XE8>=
M!0$MB?M"(!8!MEV]D5)^<)$6]B+3Y*"^$J3B/"**WR"<CR+!.@OS][R?WT(1
M*U)N(/(^<6BP4JKXIYMZBC"\9F+T;IO]KTYS(0(\6$0X(H<2$3'H3?H8=DFB
MM5;(&<2;;'H4/]5X@5Y&]IM&BF HP?(I3*;HEAGJ1341_QS?R?.X&^!6#*?U
MFT_R&/?(>X<???ZH)^89GM2-QE:64XFE;P/>NX-Y2_%U//472&AOMD+M--7'
M<R6DF#F'4Y$-+!SS]4 Y^3W21(:!B)_(E;?4QY\[$DZUV3  9AT#^=2XP:U#
MR/9)PGING*'9ULY-YUOGOQ5@;PZE>I67OS&\M"?A-8N_5R1RO)F(2(M)E5D7
MQ&N)"/\9$P>K!,N0J5Y 'RH2N/Q@1P1Z]85_9GU_/;G&;J223Y1$\,6A=\G>
M^ZXR[FDGP6+-02URJ03?W'E;'@B9A^%B0K>:-SA_ P=@*P P?E-A.*21V5H,
M^B]U;ILF0U^X@R#\_]I@?'QX%.HR*R3$9&74T.1+&RG(!D0'V'.:S!!V$T\=
M1L??%G_Q?,>"%J3_JX;5@%:&3/CNX"+9 ^D,/E#3@&:1ATC+KQK%SG%]G%=P
ME 1YL(N7#<+$J1(#8+P8*?'.ESCL1=7_3>,O8" -$T*C;&KHQ:GD1GVJ]^M%
MFWB'AY9)$KDVMJ<U<);JTTD#DJ=#J[J3RW4@5,N_:HJU/%"<ALD\T\9"FW9"
M59>H.*-9]2KR\8__+YON7  O:@6B9OM(\OT3[##20=)=^@+Y=7>G7S5Q:<A;
M8)"_0R%..6:@S(HZV$^W]X^BM1N&HIO(YFG/R&?_Z1*=DN=/\("\^)0_ %16
MD>5QUV4-GT1@)3RL^CNF0RAA8)]]#?/+XC$<!671+C[!SRI5(O38ZZ0SMTC&
MI6!;=7&Y=)TMPRT>>8&8NSU-KU -AP?)Y$#@YG]T&X'='F(4%%N3D9U%0R_3
M$M"+?W0;67@L*E!(*.:\WM!K.1)$18_G_,]F4O:5)I?N$7QH78^=:ER-9Y6<
M&_>E)6(++%NX_T I]V]-])F1(F\57[T<BAU7E<PZWS^*_5\V1<WKQ8J\TU@T
M7B%=8)DH,0'R1WQ[)7B#[Y,DQ6SR=^_^ #CS_%@& %'04#'O GX ODBMID2)
M]44GHWM\&^A)Z=.LWRB7']HVSO6-P4=VI]RA7X8X+H %][-_ +S)-7(9DGV2
M '"1#67S';(5J]NI4NP/:>+L0!(VB>P^Y;SC/@^-]<J.O!ND) @B0-DIFI%[
M:XP7@P7\=?ER\U%T@>E&OLH2BC1BLNJ]X.CB'BCU:3L^"RT*?(X-7U(@!3W@
MG868["G'PR287&;!;>PEG:W8K7)-[\_RGFB:><3Y:6$D?A2Q)/N3KI>EAXJ/
M58JN^PFW^U*3NU0YGI?0,!#H*:LBU_=>"R72O[AU0\PA4<9D'13]C<X_<RH_
MZDY^(!LV5"\@;1 ZH)F^2_&DNX+DLPI\:?$Q-7TP'ZG>_N[S72L)G_U)%@FJ
M=$I9IVIX/U(DNVQPJ_HKZ*:$8G*:D HD02FTY[ABRE=]FP#%<;6$"3/;'QT+
MNR[NL0R7D2AGB'#AE;P; +)!(^:S)_K5>DJY@44*76?1CE&O6/1J1**A7+UZ
M3^?ZN6#4IN'GQZ"]$O$)M)1(R.<NGQE9(&3 ^DNZ?]HB_0XS"9N7AL">D%R
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M96LM-B57J$M9>;EUG^A;\_QTWM/SL.R'97'LB-9E+'[7Z3-YY( 6*K?]+S*
M5VW34-S-(6&3<"3(7'1N_=)^.RP\@K'A4!CLU100$^_,8"MS*$Q!0=U!LL'T
M :. ;&*[D#SAO &#I4L]X3Y*LV?"*$9V4-GUP@-##T18<C_8JJ%U5?I0EF.9
M-)%*Y "M?O!D&\]J7G0@[^/)*ZX//H3Y+8FXBN\=R_T]MCR0U *I:KM&1K;
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M?P]A"O\*87X_0]C*\DT($T.&L-74L44DE4+&L !^'ET\"G7URIE82B^6$J5
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M\JNQ,<*U >,EM\=,JN4.C93OMTN6?C/,Y(URS7T%N535P3FW=UVEM)^3LPQ
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M]8]YV-NB0")("[39F4,@PE^ E/3\L(</7'I8F2'-$N^/]9E,E9-[7D3S[T^
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M;#+H7G\;GRWNN%'8+340]W3WU2=1;<WRIZ+AK%UC;#AE>.=P1%5AM3*=+ (
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ME/082F&4) @4Z3MB3 3+FX,Z^J6^'(X1"<5-=\)R&.>78Z;P@EBF,0N#CI\
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MVC6U3B+[-W'H67!_P(ST=YA!D*@,L[W"=TIZ-26;_?P'U/\6EE8(5/U!SIC
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MA%W,IMSI*K*](*%H?1I[X?D/+ O\F*T=]+;&;KDQ!L1)&-2&#UJIKJ_;0.-
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M%HR!*OX%?'<R5&PEO[Z<;AJ7&'QJ[1HEAFG$SMR[OV*T=;+,W>P+UC5F-,C
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MU/L"["QG>S/I0?@)?>$&S:F3!YY&;T,(YMY)\M&T8A8+@9__%$FVWLT?JGI
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M4HOAC@*21<1U,# IF2T\#5Z?\_Z2LTB/'7CW?$TKKD<>QQ7I%G,4TI*5^8<
MFW+/,XRZ/KJ?<8LP5J*-^C(F<4N E$DZ6@:T7+RSMWFG5'\=_6=4:BA;/ Y/
MB/U9A4-1^<W][_NB?7Z%FD@.3J!),#DSF +:BP6JQ'!:U'ATJG21$$Z[.K(Q
M)E_[G;^>,E5>@'W3OI8(!!CQV1I#IU1RX)8B^WUD&FFFEI1BMS=G>:'RN',,
M*:2.TII\E(7JD;?D4M,?P:02%H6*Z,C(J &%[M4G=9?V)_1/CNK_8I&1QS!4
MME/#?0-*IRL3MV,$9);Y_6/H/2@4/[<C&?Z).]7&4*@,=7BA1KA &KLZ2E T
M<BRBOJ@S"-&Z&!D86,B#!H& 9=HL8W5\/JT/>JB5V:WTE2.'49:!S,M$%R/8
MDD+ B_0#LF9,55JM8C9B[E+)$%GOX_*-8;F=)Y: 2[9U89]8(Y;5_<7A8DJ%
MOLO+)AB*-]9Z9V>ZK#Z7BH<_V1(<_?#K6$Z92=!@6TV:KGMY?EABD@*0VK-O
M7#<697;)CF8?6:15IUVZK^D_$I6[$&VTR6,>M%M4L=%*W^?-R,B,<JP=M7 >
M2;X)YA?!NQ@@>90)<\)S9BAR_:,Q\5$08RMBZ3/+M28M <(]]'(L'*4^!I/'
MA!^;.-I  6*L$K$; ]J:+7UN&JYQ@OW.ZVWF/C%63:^<>9R>RI17*S5^:D#,
ML=K!*6#,CDDPR#1,2]!+]LM66%W'KXLL1N;@801<N".<*..*$9-=/]L/FA_J
M.H WQU$KZG[G[+&K>U=]JMG7[WR:_8TQ_950771NM;7X"JR.&LF89B[UZ*L2
M-BWC<VD-? WJCZ$&);$(^6\;-(O=7LFCJK/N3?P7/&+RMZ8YV2W41N&$//:_
MVNI-\(P0U,O"U/.H^<O+]2SOH&^\[/K'+):$X.\#]@ZZZI[JH>OBYX]3#(F'
M[%J8\P1"DGB_J%!;-@W35Z=>'$,T$_5WYJF+6AB=?M+R?QV_F 5)Z8NWHX&?
M#<A+EX,HT7;$350/;]W/M*D>A'B7^0DG(ZXPEO6NWS<[,KYX8$.TWK:J$88!
MA @K:M%4R=MQ[%.J%B!AT&-Q 7="7]]R9 5ZWWY]L*:JJB9L1 6%ATL71"(R
MJAD1C)# !_+\<P29OAX#UE"SN:&3[-KWJD[* "-ZD*LQD-7;&!76K#%8OV/J
MLS,H-9T"@VVU8T6C+617PJ4)F[]>]5(M$P+?SSM?O#LL$Y:-LV+&V*WAW^WF
MJR,R$, "J2^!CVA5P1!5U"LP!*"*,@!3@,_1=P0#@(VR_GYX[G,:-$+9O+&#
M_T8-W9UA^?@2<7:XAF1Z.[ 6TBN(]8(TYI69]W<M9_>A2J,7US3C5^IR]83^
MDLY(O\[/G'4<E%*_J<5W+8791=2>'^P(5" 7 #L>4WA?J5$47I+O1;U,KRU=
M7.V:$_BTH".6C(.O.<*C-N*9W;2O?4<N-WOLW"$<SME-(IQFJ:+U6>JZ#4['
MV1>8C@QL*#1T VDE,;MJF3 , 3MQ"+L_WQ?ROBB>L<%=\\D'K50NH?O>.Y3W
M_3F0KXMA$JGJ&4Y(=H+,+H>U=30K53Z=;[8?T^_ZX2:EU7E2-CI:-X ^-:=L
M75%H"C_&%MWYO6@I_(B4B[EUDQI_JT>,99_C%U4"5E1.HT?L)=^B\OQQF)!=
MF&VZ==',#8VLRXBX"/%  C$Q,7663_@_A/*7$B_^/PB=+VG..OG87;5E[)$(
M:5&UWVABN<SX ?J31I?[+N03PU3;WBL.GK)GP>B7Y18<Z2Q'/_0)[,*=!/DT
MTRRG[C=DFN9?!5DB2\4(36=2J5$H#="%V"FC=0%AF?K_M ;,7%PY.]D9DU'*
M*BD(>LIO2:1P'&O1OA9<?(V8^>%\7UFLZ*G)& )2XLZ4*%QND!A2A:G"P2$)
MKT(2W'4XS(%E]3FRX]V9^]0QV:O\S4%U(6*<SO2C!>!O;.U*VP!9Z2N"TLQW
M,H5H=/XOU^P3P7J++$#/&::R@J,E$9UPP(.\W16H*NLJ,^?3$%M'<[_>FYT?
M.'1>54ZT[,C;UN.:@HWXL,IYD0<%&X1MJEJ@"6OYZ**8>YP5D%\EQ2#B>^MW
MTHW7%S<27EE+CZW%W6SX!^W(:< 'ZM!JOZ'O!;6DT S.;[[3+\'M>X5A0E$A
M_GGN(MZGQ<>E^] 0_M?6^M%D4O#9P LFD*&R\K.G!#4I9CXF\>N9M^]U-FIZ
MG60H))MSV5MD,UIFZC+MY4_@_=32-YQR+[<IAME%0BZ^$%1EO2D,TOLN]S,D
M%/Q?+X /I8500LY!?KS3.;72D*SH-V8<;^MT8&3=['@5GL*7.1D1ZI,K/C03
MTAIE.G;DN?&'U.(Z=M*^[SF\GG(FCX1+LLR3]>>H2&^F<K:\I*.1!-*1!BU
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M1]=A^WN@.L3HK8>;@T $P$/\6?'"XJ)6XH8X S4^>=^*SSS!*X7FKZHI.A0
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M1O4YY;5A!0AQ.P*$?2MK7NK4M<?.;;D1H1];O30\8\<4H[I6D:5<C?0/@1:
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MREC'6$M+5O'7\B>#\:TO/&(XAPO@/;,$I^#-&M9\T)J2]@.9\O1^W$M$K[F
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M:52_)MI]66"$A+,E^<->6EJ^%77K^3*KD2Y72O LBA@I7OJ,#L'%%^8?RHW
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M+[4H326\KX3CO.(2N5VS%FHRR"E-/M:+2&6)RR;^QHN0G:I69*U5:O*H8OS
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M=$HL,FOE(E+OT"IF=5T?'R"7#4[2F1]?ZF(_O8<9>KGH7V],#7JLH1X7M_D
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M>Q([U]!=Z=[O<5BNQ6)K$88QY,+VK_'P[BKNCZ;?$MRHP=\?C1<9IP\'5FQ
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M]+[)#C&?2)*4BSE@LX,)0(F,T_R#N@ M\#-$_ATZ9X+>)<=XG$NM^JO'@C,
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M ;^)CB1"<W/S%[?9]4JO172?@W#294,N)><=[OQL43"X@QI*F)AR<!M;'))
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ME#P*!)]X5_:*;,([2T,@P4=/?7O-K9UDJ.&2)V_X)'V/S8SJC*[.?J6Z+P/
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M_N7_O"[FEWEBD+[<[M6L\<KK,KH.0*0>NC+R))(.5G)7S8<7IR]Z7/D;;4"
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M*)X$\6(.#I?$ENCW*E*3L^ZI3_9B']NL4KMKPL8RR.@"./'8HS[MXP. L8[
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MIC"(7;O<H%UY^$1*E7&T:VH<QSA4;>M88U4I#85<<+7<'$_2MMI8SU2V '4
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MTQOV?]CM?0#=7KHQC=R]V8V0C'WY,MJ#!P:K=;9^K$+1V@# Z[P^E[1$:8*
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M/"CSC32:3^J8D7%D9/84*!LRZE 5W_G/1^A9C\$XJM),!'B87[%@;[.D#HS
M?C'> "JW"(>X<*59>,<[/R25L']D+C#=<284!&!@07]4+H P(.<W)I^)BIZ)
MRE._YE_+E%7-[QT1CDEO<X-NNV*>#'+NO2_. KG&:88BSMCW*II!+*W_M,1)
MKZW](MO.P4Z8R\/*REUW1T]O0<W_E4SP;3)S5CJ?'=R_*-[@;XH')8T))#*A
MMULS^!Y2%\9?[6CPLEK\HW79#A_BO$3 R5)=V)[D_6UD#Y#M9%#1Q&>\B3S[
M5=-LP%>;INV-3!IZ2U<: 09R:&/FO>?_4G64R640\/ZOJB-/+%R2[H? \O6^
M!%](=W>BS>-CB>5ZIY=[6;]W)DHUS+*BS\-'.0.OQ.B_:!]V(O.Q\ND?%OF8
M3=<9(FO_:!YF\MRJ["Q(^6WD6ID.=)8$*&-!)I+-K9MN>LV_?[@+2:B@ V89
MK0O#Z^X6+WNZ:),3OTLNG%T68<FA(N%A:(]Z-V[L_<]9LPO^;TL>_FW)U67_
MI25K?0\^N:../]U#6,27&FOQER4+F?ZV9(B:]<I GN-;9B4<C2AVC8WDY-:S
M=Z[EPMUNNU>?Q]U&^_E%7PQLBEK+<)8YGQ*\?A7U^_"W5O(;U%TIJ8HSW2WM
M^=F C7KVU:;E<@%NA1,923?&M^;78K]2,"^TZ2Q$E(T[:!RW>YK.2ZK6^)\E
M[M(C8#AF8]&Q%X/)<$]%PGIHG_ I0M;!3_0)/2]<)55X;^^J4T-?DW);#2RD
M$OBPEQVA8?']/;.)6,*4+KI<&EE8% :LAU9AH%"Y!?,J1V*H+E@5JGL#(, T
MH0GD*'5%](J:OI?9WU8+-.*;IHDDAY500)S:LX$9AX\KVC 1623L,=EPO#M!
MX'OWV%GN<0S)R!C;(MN48KO^B30KD;V]V4A=?5TF>7--33/'F2.G(TLK7X%T
M*#YO2J+D61A7W;1%D242%(.*[I6/>D0$)#J0?&$@JZB'YF+3RS:M]3C+G-0
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M)2*;4#<=^B4&-DMB<65J:,'KNKPUS#@4'SY%:ILP4EGR NRY/D&MK5$17,E
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M[DVDNE:1%W@G%I? 3=&T==0.PA2_,9ET6L;J"B9W)JKX/56\92Q%ESE+(0F
M3*JY)PTTBVS9=:P\,MT&7%;M^<B>DO'SH(1,NT-G@EK#\0MZC)4+)*K[?D[<
M2VNY#4,7!U7]VTO%-API'QP^VV/WO^/KG':.N8(S=XQ+@A=H .7>\V3EP[5#
M=M';KY,7D#CY%"[N,_AWU&WNJ9SD]!S"4=?$JVJNVJUY*TA6J_WZ%>&O.Z,[
MG7PBMK'JH#& ZOBPGIZG:6F2# W+N=$.P7\S=L[HCUQ7-ON+%O_K5. OU\^8
MLNH11U*)R^,W1Z9Q _\9X9<,B?,#30,\&4H&KL]0';H$AP/'=6%=>V.&QF<W
M)ZZCF R?MXI9CG,3>D);5[ VERMEE'L5< 3@&6K!PZQ7(_WJ<P$U*4F77)ET
M@D:91LF&U6#;F+DY:8I8]A& SZ Y97]U,S"O#AHI(J4B!=RE^1&!FZPF(KG)
M"CI HAP^6^E-/:&9K\&:-VEKOU+165,7Z+$M4./(!!V!T:(@(DD+"+8IKZ4.
M0'-/ZX[-GCK :4?]J?LNN= 4,[?IT;HLQ3$U-&#Z><Q<R""ZKE=K_!)=!>Q#
MX!GQLKZ@1\@IHZ!ATM95H R%?/W2[#[!(A'0RD N83#)_,U5/4W3&[X/2-+7
M63VN5R.?KH4<T6/U=W39VR%XCD0R;'39W%WXFGLNTH2D-GY7L6\#:!-H.;:<
M^H%[W&^&*HDIJ>+D?8VPWB&6 L/!F\?E>H)CE"SH(R[Y>)_U$^E9W-H5.W!M
M\P0IG/M@< ?-99<>HX\(B+- H+:T].4%3@]?*5K;5?L8<)<,XDHJ7=.W46CI
M1@0'\@/DUE.,7(:Z,X[$[^7#M@ U9<\O*0G:[K+L]QUN3Z<,9>F#DS:GU^S;
M6-GL+FJUZ5IF,$!0LE>NX,Z1O*QV74M]+V+'GR<:]-<AL/ZC+#?^ 1K(5=Z.
M4+21E\'+@<P</U>Q832"N&AI-1Q"!4)YX,?0?Q3\:VH:6\?^6]G4./5$CXL7
M-Z#1XR<IO#I=+EDWX@7;N^61-\AJ9R?;2/E!O A8*%W;?KL$:]0*O?9*7,OW
M"<02DFW"8CH[":,DP0I<W'<FQ6/22$!-^4F@ ?<.*0]]*3K3'2AA5YAM%WHQ
MJA*VQO"MSN^C3E41I-IU:LZMM_.]95B6<^J2BJ#QYTL>/_8F4?$A-Q)SB8=!
MEL%48D=Y:('E[&^$(RY:5MR"2 ], $*).I.RUQY+Y:F78&_YQSI&L5,F#T&J
MI8S;;.4WE4ENZ6KL'V/OIQU"#*VDJ;GWHJ,.E3">OG1B^AS!V'5V1(4]S]PH
M#NJ3 T4[OF7RK^":KO*-@%X)@_FYF^/2Z4!"3 )UXX2M1RP'KO\0_:Z%?S!]
M\#8?"16@#R%YXU&"'-@_^C$DX0]5)!+'PR.B99#$(P32,ACBRA ,EQ\S$2UB
MP]C(,&&\DA$*F:>C"K.>*<Z4/Q*.M1$<U.?,DNPXZH[SPK%_&$J956L3I1-U
MLNW^<G1'?9TBW'DL$VH-U!=/./0B@=\DV$'0<EDKA+E;ZI;XI!SU;, !T^^Q
M&Q8P0;"%/ &XR5\7U/W!\XS@B.U]QY3S;;1P .SU2_WL"5/5^&+>J,EOCLG'
M4#OH<:*-CHT:D?RH#!Y036CPBCS%[4]FU/5S2EQ;[(2J+JP8+0C;V@MO&C.W
M/U8)*9U4JQ2XU(E\CVLUHD>J=SE;]8M5F-5A[F. BYDJ)Z C4K?OM.5)A7!.
MN!3,DJ*HJEG!@<W\@)4-G\"8I<T6!OLLB.J<?M_;:G)K!<Q6OR+ZS[R;66,B
MU.LV4E']APZR)ASLJXL[-SJ_$7*$!C(9QB0*1-\,O8X;-8A>TNK [PM4!\JN
M87]^\,X961S7%7A$;*Y[4Q%;#NW^WB1$.6SS/N+SK.)&=!S@<SRNC%@&TX>_
M)8R+/B0U"XR7A ,VZ@.-L_GNDQ)J#-+B3=1/+1AG_0M>RJ7P#Z,^ZGP6@FPE
MT$7*I>-\P-\8,2WCMI3U:-I2B'ZT.<*GZYPJ37L-Q7T-A?QY#@XZ_\TJ] 6R
M:EP$ZKE?X?V7N[*T7>/9SLQ?USU;-&[ET47"=>L9<L%)+,HXH^0C_FV8+AT#
M2=Z-<2F#-5,P4QHX*_9S41)ZKPG\[,,V/2%TY%P'6(W!Q?H:)N:ZHN0=,O+V
MVQB1Q[R!INHU.'6X0[QK(7L@9G7+>X>NYF57L?[G+\)>Y%-6XE]GZ*#@Q*-B
M@5&8&A!YAJA^MI[;L&OAUU#@KK#GZC9^F34NC7=VA3@^4."#IN6<\W%^<^]^
M2"M^P[X;=2Y7B>)$E]'6\ENSM@0)1T!=/9.88A_C>C30G[8'<2\JN9BC@'?O
M(UP&5V&T&8'Q5WB1VAT%?"1 FPHC>N]+H61"6<,\E^ZZJ ^SOE&1.%E'UF1L
M^[>7\2DA^]<K%\+-UYUN#:+H7KBUG^JWKKZ/><6D2 U#WD:4L"9<[(Z+-Q3.
MOMLTJ,8FMRE$^XT0>'7*LTS!+7;H6A[KR+@J3$4ZM"UO"#1NMM'S1$E(A-*T
MF:+OM:@A4R!O:OY*&JNE6"ZF=(M3<UX_>;:>$SL9>.F0]:7HA.2C=NS4.Y[+
M5/>WBH'T38(6MTQXH81?*=IR(Y?>12=@T&;(#I?#/S>>&FIDMGS5L\NXU_B7
M[;W9Q[RQ+;#YE8C=DK\F-^;1C;Z:A!R.-'2.W#8/Y=DG-@U\KZ F%"7HW$.P
M<.PW:SM@.'R2-GB92ML&*:_A=E 80ES%^$,'T<_'Q*(@%QBWG"6IWX0+'>4D
M")=+?^3T0@;Q=FC+X0N#'PE)I.G)/N28&)JL_Z25"\<1_4NK*ZVEE;%MOH#T
MQR[Q]7XZY@-3([P-0G@+_DNH\ \G:U\65L*_]=I1<T@FS2^EZ\F4V*Z ,5.7
M)M U;V/F[<A<0IEI@_ YE2P]*1+\6.NCAZEWU,W+HFJX[!C)!Z_2QT18Q*J:
M-/#U:J ?RE<6:"&)+H9*JAC\EC+2:!X>'C7I:.='1^5;T?)<$*XEZF  'Q+<
MA!F"0<ND_CFEI$\643-!X-;?P:)['/+!E"PTSHE>ITC$8F*_5_H%71@\!8GR
M+M+"!U4^@<)!'84!!9B\,UN8DJ^EJ2F99&EKSGVY;46/<2?EV'Y0_1&VP,SR
MD]9%-_',)T&,[^0I.(9F<%%:-<Q+??Q%0!S+^^^0UH7YC-\(=>_"=OK\$HW\
M^;Q1).T=!8Y 2\->Q-\>WJ]DC[[U]OP\DSRMRW=);IK&SPC. FN>FV4$E:93
M<;-<UQD8D?=$6'?H!P:?%(AWO1UBZ6=HRS7:AY263B>48= =S45RWMH_3XKX
MD-96U3TVM*0XH8SVF2<T' D1"XVDR[IOJ2.2M'K8F8Z\Q/[<M@D2@X)K3=Y'
M41*^5EN,P"&7U8_!IY<?*^#>[(L=1OL3FM\B(("#_IJEG,)%?Z*O'Q]+[RM(
MR=XUX\#6Z%@3MBI$X]=3.#)HKP;3#6 N!NKTD]!=7#6_RQ+%*X<B)=DCKR8[
M'KM/\> 9L3W6KBPG$6C\BVT>JSKV)=>#;><HX\^E'=CEOXZX_*%L>_^,<D:%
M"[FK*-7EF9W_A*+N7IG[!2X2-LK7=Y3H@AFWN5R]]I1N)I>83(UN=#WEKW4)
M/)>44[4UTE5^9/[4@][&(V^5T$K94EY/$/Y&R/Z4.UO$I&35F0R[VG-_I^;$
M.07;>#I-_P^$:?0G]/%SOZMH5<D>./W5G"OL\AM!S?$WPF[QY"\]+?>;X*MJ
M+XFZXU\TU82/MDIKI_W]Z@K*F^3$'JGIQ]OJKOU#4Z!:=4\CD0U1DP&=(^RA
M;L6-$!.59$:UF,71HL':ML_P![*,O4C^4,"LV/?:\OI@:O$K)ZY'4.MDB4X\
MI"0I6M1#=%_M%B?K!?8J!EH'_-V+4VP^K6>\3$I<EO*/E7J,E=2,A4'3*]WI
M(CVEV>*#:Q5=;U+F:%0 6^ZH-'3?4JWFHG9?I["_GM90%4T#%8;KO]"BP[S4
M)"3EX!6?6F9-)WT)RK7P;%$!.#&X,WLVX0\;Q.Y\O:VH6>/AIQ2UB:G[$0P
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MM8'TB!T$XO H8P;E]'^ 4U=_)MYK3_Z="Z#^ T9*^JJ<R.#*+@)V._T?YC6
M!*V!L,<2/@R'P?T>HY\9\%/MW>YM:5 Z':-$C$ MP@/HSG+E<<?:[-;UHOJP
MLJ^B%N-7Y7++@VP<6ZZ?VNNR=GH[MFO@Z4)BPLYO!.E%@,N$XK^9IG\27_YB
M=:0:/\AFSWC0@D]D__@E\\\R^(/E+V?PB*M4JI\DX([Y0&J&&:NVGNPE\RDR
M#F<O8L=?^T)E-%#&;P]N:AJ&!,8<$=L'O,2L'$-)#',+<11A8WMK?ENRBY8I
M^C*T//\0BH"&!-4QZ4N!MC#_@^)9T TRJ,%FGZXYE@D_=%,N/BI;?H%6FS!"
M :B@ /0P5HC92K4_^'IBJU/>W_Y>Z[WI@%%-H8->6<\M@YXMR9HV1%##YG-5
M[3!!5MZR+0Z)DF/3EM,JL*W+B32=IW!;E!)'+5:1*#1QTQ,Z!ZVM,!6Z-F<G
MTE<G"98C0U)&];Y9FMAP8')Q&11F("QXC\[6R$S4DIRBC(C/ST,8\)EP3CA9
MSZ^$##BCG<_1WV]@0W1.]T[ ][ZZD9C\K8N>]HY2*O-/7%#Q=_EEYR%D&2*@
M&D%T@6!9.HUGZLNK:$RK<N5"V) 9D1O PC+N@]^+ME0?IIRN5:O 'Z9F?2ZJ
M8]*I!;$;.GYBR^&L(XZ'%Z..D8U5#W\6]LR/ZO+*L+G2R*T)(>Q8: 3T)Y2Q
MO)^FP5F=\'C)&4>W35CL_2P/H*<)/*7_U1LYR!H#X85'XZ"4R(") 36)H8?V
MD^V9HWQLS8,%65N+(/C:E";Z4M]*P_JVMC<9B- V)DD$=)\N(L824)%NJ2.-
M( J[UJ9*HNFU#),D6:35)+S]5%$<$A9_:+^A)2U'".R-0N+J,\661"'R1N37
M)%2U)3A%C6KA46MPJ;P<.PIO)<*[^AS%4 :&1I:?)1<C CR.V(%X>.XJJ2$9
M7LN@^4-?'@=V^_'ZL16A8XIR:.16C!N$DZ64);8TJB19'+"97E+0\GJ"J:>P
MP+%!.8%?T+ZTF)L&89)(9MW9\,6T%+Z4C*:F46Z(+:#!(4J?+ESK[9M\EA8E
M;-ML#T*_8$;"/O$039FC?=!_+8/E9SG,[6N@G&(W\_&4.ID<8@_9-C5X4A09
M)!&<,G;'8RL',Z HI"Z!N@ R0J,W@N(.VY5\(?4]=<XF"]5CYTJ"T;7M51V8
M:BKW-8R6=?0*E/KJ=,P)/(4=7.>+;;<C=%\$PF)R#T]F&_)%L:?A\BP)9CI)
MI]6B-S.0R@]UN[,#6Q7>D:HB]8!O"O_%_8ASN*/F($7IDSLGO^17:T+Q/F-7
M-U/R,U:430Y0IJQ28:[4+JO] @[ZO$SQV8CRO,G4>U<\;M=%4)!'#C6#VNS1
M^C?"3DCI]*3(8]DE;7_Y;8?O92B_-)#^NOQ8CKDLU"]ZA_!&Y_F#@L7@4%53
M47.8QTUR4D&N6L,C!YDCQKT,4&A8H.-[IJ#CF<_H-QL>6^JC8*_ Q1'N""3-
M;D*"&JBS2FL7@8R&@X4KICKI[H'.'==R9J$USO(1,^G+T;&<0SH^GQ2'2 /3
M[X\C!0Y& [:4X-529O$<V>\Y-0S['\X; PS90.-K2_,3_)]?;"\OFUOI^^8O
M\5T@00*W71&':U1]0['+\?B(&",^:[2[.5J*$+(,G%R(!U1G=;]6K$=V+>!;
M#OL^K:+3VJ&DY^<_S7:E1F :3O)$I-LDX/&3Z\=D8ZJU !]:Z69D!M*WMP'\
MFOB: %]P^;'SD,'9Z;!F="BW2<6M!DH 9Y)-Y'I=74DX3VP9%*?5+N/^4Z3.
M\_4)__XXKR/&]*D E542N<-0"1)+=YK?9@0Z1IX]!%*23!)F*>-=QEW8 +_8
MYEH7ZSD60]OBY+FR@[R7*I62@D9&03W\P]-S]XQD[@U/4TCOYV.?M:U/7T7]
M1EA%=9-P_39]/O'XS6%^=LRIK!WP&V'1_WFO7;5D@W>_&'5'P?#OZ!__6B_7
M1DE@[7XG_YOT*+$HNPHUNIH;^:':U=63[)"F0<37,.+,M[$B9FP 4+#&2Q5%
M89'B):SA-KV61/N*(S;S=QC=K=T$.V\L2']L@YM'1IOIX95"?UT:)1\9F2W&
MZ@7KOWAR$_W.26>\!1LM$6ID#F',C> .U22!#)NL1/$(/PZDN?3'$&)K1.M_
MYIHU@RW.Z+'W=C_M6XQW\2[=O*^RL4CTV3+Y 4\WI XEVH_CV4 3JN);*_PO
M&A>"SCA&J@XO*HS?E&=ZQ5N0N)G/S6AH:@TP:QQ7E S3_,$E#O*CHPEX!'&A
M+G6Y+\P]^]K(K6V8K:+!4TR]7Q\M_7/U);TU6C/=M[ 2^?+H1V7-N-;+QUJM
MIR;:]7>21RC//LW4B#>>P5U:L$ P;M":!6S,KC1RMF/&,T.29O9E!3G*MD_U
MU*E+QB?G'F_8 =.N#Z?KPPM'?QVR:%:7,/FOBN0)G%MUN,M[?* 6.GP-L (1
MB@/SR?I(!:PLDP,V#O/U,E.IK@FZE\E\Z:#] ]"DYXS>1,8GA2\C(ZUYH+G-
M1ZQA6VWCL&ZH;J"EX$F1#.PPR,O6MS3F#B6PO:%TH+#]3D]#(R4CH\(-&/ZB
MS-@D2'YZ7KF='[/"Y=&RHOE1N^IUT-(K+XR-(,=Q*NI;T]460N6LR,-7I+OG
MI^QY&AOZ'M&+.Z3(L]),*0QN&%O.>370R.L6E5L7TP&J+U>G C]H$R <VT[C
M[ANA, _?Z]:'D/AC<%H_+Y8Z#G?D7%+Y3"\:H)X"'4^TA^!34G8/<'_]D2Z6
M+8UOFLH@V,7UTPEF3SAHC"_L6T5J+P<+1GOIT<<\F%)!XK:<P]?WX' \N"].
MAH!XF,G"B0IKM/H'J5-66V8:9(R[04>6S)"8(-;89FE'_(1TO$3H;X0@#7LO
M58^CXRNP[WJ;:=/W.?MF"6?RI;Z:LBIG\[DWE_CH!B-A&!WRGZ&T(^7GB[7-
M.:AZ\EM8.SYEIH*"0X9(\XGN8IZAPX=WG*\Z)EOPV?0/@8;>"2B_$8[B(@VG
M(W#D/G%HKGNQ@SR$!YP;K[2//!>AQ;D@@M4#:@.@].VPTGS7DH67YSU*)ABR
M$[/R=43W%*-9]6W6T.Y69-:N)23U:[(OM#,N%_3LEV%2[]/K,\%U7'SU.GDU
MCI.UTT7^$74TJR#?OEK=1Z'7RN0NI'/Y39AH@V>FU]&1(+U5@7P0,Q/MH)YH
MPZ&J;\42K*BJ$-K*(EER :BY? N^1S+RJ--"M=7C2"LMCSTY-:>VJ/E.'&(U
M^U0B#/36I27\(!9L<NM$N/RR@&]Z[FM-48MAJAIF=PC5JXTF&LHI?!8H6)B6
M&F9!'Y-^67WGEO[LL6V<O'I@FIO]Z6S'\\OZW;=?ZUZ\>ZR_WF']1FB[&?,S
MF'O([%W[E?J'D?KT/GPAD(@T^:*9_.._@G&?0ZMC 8EYOQ&.[3>92,IB_@2]
M@? VY\V:W%]')$]EOQ$62O#]KZH>I,FKE.J//9W$])[L/[L(@57)C_U*8NQ=
MH:704E9K^:-QA:C9\HJLM*SOB<#O>:,N9!E/4<3#MD=U6)X/Q4INK!RVH$WD
MAQ$A_ P@R1OO)%2$I.'(G(3_FN!R<&;5=M&B*63 'WO5,*,BD73%5GG3<2C9
M>_'6X*I$2!:"#.)=KJ\6"]>U1>_R=SR_T](';K1BW5C*=(E=A+LJGUJ@MBT]
MC@W5!4$7"ZS 3W8VXX3RIZZ9X=PWNO$4;-8V%Y.INA'2 G7L,V/ZI@8Q828?
M+3!T1TC0Y#%\^S2#@>0)/D,<B%2LV)U'GV!K)M<U%Z.B&'G0?NY(EO./X4 Y
M)336HWR>$*ABP \,YG1F_$-I145H9]I\#'9-X>DY: )F5?Z9]<B<RB7&T2!_
MZAN?-\R#N,""EF6Y21/YY:#P,N_G7H(2@'VB3NO<L&-NVCJ\"RO+PTQK_AVS
M?_G].<]JV=JDHHNQ<T(];<CQG"3N*C[Q_V^"<U%8#W8"M91=:-NYQ5PG8W>_
MST[Z1L'&%8V^AZB&WHR7C1DQ!GU-<-9U1)+?S#R)AZ?^CR:RZK3 260U,6AG
MMPOEHV"I?.951S30,C,V44\Z-U(#-M0&/ID0Y*9.]N%LH>U"0=&R/Q-07)<S
M27K"<WNWYG!(S(]WGOCZE)\@<81_C*G?*0MZ06X)D2L2A@8T7[C*FF=A*!T+
MM#\9F+:)L_3T%(\K[H&3%XKJ(UJ\Q2AAHY?1-_@\UU9K5'OS,U[8>7A<C],O
MULI:#S)CFRVV8H44'84VJKG3T^V@T'(H]-Z/L9JCF\?^Z1U+02*OK:NRT6IW
MV$.Q#F,P8^M297^NQ2211GH3GCM0E?9"H^F+P!'%>&VBT \SIR],VL0"MK)3
M&3R<5G?9YB#9IM@%*$'B4::9"1B/@/B5,%3M5&!NEX]T]U6B[%6K0>:;&K/A
M*GLSN^DQNM&JRO81,$ ^=C^JXD\6SGM)S_Q,9N6?[4VRX]6J8[UG)'IOF-LL
MP?D;X1/%Z/WP;P35GG>GO^J-M?D[BR\$?R-8_D9XS+F0R V9@*11)3.X"_P-
M$\^_S#/YYDIN2!25XKWHR9ZSGG\&Q-A2WY0<HA(H0A_"N&*Y&PWWJ"?")U+3
MU 2NGYVWWB?ZBCA6?GW$;H 97<J;>;9ZG\ 6EX<9:$GR:9,:8\5:AT+ I2KB
ME,9,*JB!OW8[=OI<[=$Y/_D-LN7L6%,,.U"Z^E4MCGP]O(Q6L@;O:-J/# EE
M1T=NCIGH'OP]@_BQE[X?#^G='!&=33VY0OF;XR]']/':*;=  A-9O4-B8S_D
M3/!#>21Y 806RE+\K?*I^D:NQ9_8Y6'MST!:^*1>6%/]=_WF?)MF*5J4= N
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M7]E=LV0?,^>Z96C\E\+R+"J/X&=>\?,A+>:RSM:J(I@M!K19>CSK(ZAV9T0
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M+)')PY+EVQB#7225]F60]?E*5#22:0DM._;CX "(P01:6CK1A\X>-LV;9D[
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MET65LK=><PL;L-&DH5>5!I\$ -7S9+&DMY:28GM]R(W?.W%303J2,U*'7A9
M'E5>_MPLQ!F:&OOY+9F+O77I[=LG+#WO#,7N$\BZJUV-(^VT[*@8^A+7^.@>
MO>FH%5B/B<LF<L+(3"RO8.E@@/QL5.WQY)NZRQO-P%+TP3KQ9NAEP=5.1BNT
MB^N!W@S(&)8,IY"ZX&]&?[\RE8 YL%,LVB5[];*ZMS'GQ%$XC5=Z?Q1C+3Q_
MG]BI3MDVIZ&'Z<$IBOW?$#8VD(E!?/<II.4%[4+UB%*,-.'IO'Q.E.DP@<X-
MT[H1&L->G<MI X=\?WSU^Z3UA5*J",$,"Q)/[UWUA"6>ANK*.M:=7&RQA6J2
M"V/K=5I.@$X5"*Q.\OGJ[RU<^K\-VMK=5=YX_X"77Z+]ZS#1"\P"E<NU%,:W
MP5T,V3Y?J9R(*/C):<E8<;R_UF=V]%BGFNU&MQ_4LC'_D%/=,6MM_3]%*8>\
MX>6JQ,JB2KQC<=QS24B XS<"Z<+"(#EVH%4X0&%)7II !OH9DK[L0C72F*%1
M18(0Y75Q).=(\7QX])@&:X.(DZ1D,(@72C TDC%@R%Z(P%I=58*9&757K5A'
M0608R'250"+?1.HW"I7#]B\NP:N?\030@VL1N<LZ:K._BF^8<S.'W,V#[P]=
M_MFJ?/!Q Y77_\C!_WSZR]%=2W*CC8-W[%&ATP3. N ="=\YP]$N<\VO+(K0
M06F2G[R <SCW8QDE&:6PAU#+P)9=A%6>1C)OUDJ&1I<*[NL8<$.H&CL#2_/7
M_-!6H\^?I*5?NAO*:]B4*$('<JE\^])$EH^BVYP<FD$DZ'9!J^IV\FYQK1U\
M>9%F3WI8EN*)K96FT_*DVV*'+4UMHHA*&!C@?YV6#V.(0> C? "2X5MDIU-;
MXJSVJ+D*\*FCKH=_1N>6;DF @;>J(6#N7=J)?O*3D67'\&N"EG!\1PQJ0 8M
MU9N/ [F/7%LH&!Z2[70F#@Y47EY^!B#159!TXWM:X&>0ZFP4+)8@M'R#QVL;
M=T01S?[<!/+DXT1_A,+GRJC+5-]K=,6D/: CO[FKJ[G0XNJBXWMQ(R-1YT^-
M[QKS;U7RS,W%M"CJI"[*-,0.PDJL$'((1-6T5Q_2%;258[*Q.D(Y!F'DK>8H
M]J&T8]QJ,&1&E\5Z#G-B8"$D<M-M V"VX(KIB4S(FA!NA@(K&^ =%?F3W6BS
M^:MD<PMSZJ_;X\KG719=2"KE'M[<2D+^ET'>'^_ENY=BHD)4#/ 6M[DHEU7&
M:1CDH+/9N\$"O:LE0Y^E7V1-_XT[RK>H3L\VA3:[*<X(#-!P%3@S]%4L  JW
M3ST_\\LMD M]<<S20I^@!9YK,.H5P0DH=0/$G+:<.GN=E]4LK/S1G:JL>;(\
M-\WJ%UG G_NEK.WYK2#5=\RRK=$+="3B9:-<RTY7)\9>YVLGM!:9)>@T.&:/
M^C^>>^+QQDI[9"05SN5=?]*S:B^YZ-,@1'@$EP4M0WN?+T$:=%P'<7U>HJ"#
MP6 3 J+1 8IH*[#=$T]A7%FW%O=.1P4/CO0?]'9&44J,7\)9V0<$T,EEF>Z_
M68NMZ1S4J0J\+ZY5;AOHT;3U<3W>B_=)9OD&%\=V02QY/\U5B$Z[U<6:!%[7
MR<2SE\%DI^,VNM_6X4A(6,].B$=;NT?-1=KR+1E@:(JSCH-EJ1H\4K]&8Y4H
MHWX-'5H8TXZ1>EIQ\7H\?JS5'2BQG)F\J0RA3F#CB  %#RP_EGV""F( @<#R
MWV_]S)%"]=7^&L>2#!$-%6-MY*^/3%\(Z+*_CTKL YL:L+&M3_9Y$YLFLM--
MN4EXD0>:Q,6V\1\R#P<ZWEZ8>8*&WS&*U8UD<.GL*VS5DA&T;B0G$3Y8TCI-
M%PF5;7QPSLK54,Y@_59 'J6MD]"YZJE)'J"7@$>5HL4V]$-V5!A&+?#R6]Z_
MUMK_^\Y.:<LM66L6\?'^CWM37KV457%5M[68ZH!'L>?\.$SEUK*4HK8(>-7E
MA_ Q=A3IWR@J?Z\/;,II&#OJ*&3T'LH07/22,(F/G8BQHZ)@3V0O)Z)KF!!Q
M6:?Y\3#*)EYL+9*S..@I+6T4>156I &&J#2!X',#1[ _HA*QCZCZKZU?]U'T
ML*2.<B<DX@>PBNTSL?=-E?='_%9$Y[Y7<VVYF!T<'OF#O&[9V-;'TX$I*=8F
MLR_.R%6TH.I]E7_DAH0#8_4N?HZ) "I%"EF_N@<)!=,JI 6%+]9X:XNB*%8Q
MG (J5*LV%3@-:/+W>?RY^E/J[N=Q7KY@"6F)Z-&AY8@QHF/&B9UCDR'0)"@2
M2BWNGV!D9B2Q0(SSEN8?""=46)*1)I"%3O\3X>4:Y<__0OASC@SJRGY[$X$9
MI2;B%"D5#.*]/@P-0HR@/PA?C?D5*!E@#/2=BR.Y7WZPEF*_4<8'-Z]NY.4?
MT*WY\>C66Z.KSCR@]A\X_\5%% ?X4\ET&.@>?+"BVZ M^2O) J^;/X[SWR,I
MH(?OMK^/MW8&[ 3V<%)X'U5FL4KIDO:6RAV<8X*APOU!R55U9MXQ,[51URC"
MO<Z5Z4[?O?UJ&UN4)BTI9GW*9FK?G8^9(S,UO+;GDCD[W[Q1/6'B&6)_1_39
M3J@7JM^T^AOE63T!C(?%>EY ]'AE#JOX32:UM"5""=;KZP5*QROQD'Z^V?T4
M-)3".V\R5#JZ&-_GQ=T =V7G]Y??PRHD<.M0L(^=MR_C$IK>7AP,>!G-_TDH
M]V#/O87&7_@9Y5*US#,>QO##9C)=MS[QONK!/3CV.\<R_'UIO*=>^0SR#'@@
ML.I1\6G[S.Z$X_9VFIY/]A"TU:^R%1J/K%:*YN[A)\>:FP+CPIPI!X,)J)*G
M-20)?+V?#T'"S0UVR7YN 7A2^S_Q5H8 &VL;Q2,-97379WLAM].4TN#GV5Q:
M]#N I9^12Q$DZSC 0LN1EH"(S'<CC:P1[_@DD ?M8/DT<XZ51(LP^&0%SVQL
MTWR"DE>H\[[$M<^]E'1S5^1SRL#S0;XE/?1/_#C@(CO1U20"BAO=YFY_A/I0
M_"1[BN#WB +S.=* R$>[IE;#+0;01EG(;"ZJ/"% 3HO!1,MW.EHR_PQY.>L
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MOSC? [VZ,W8XNJ/T@1Z>0\_*:[SEYUH6M\Y<8NHP\C6Y"M[&-Y^_):&)6=H
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MHVVV33$I/'=(%MG37WXDU*X4>S#^T66*4NEEA417DMT6C2OKA!3D_:7&)$1
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M'GBX/4D%V/&21W?]-L&&__9B%\/4QG+O;[WR&5O<;H>X>8:8SH9EM$V?3MV
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M6I.+EF9=TT F08T_H2IO@?5I7-*;$W ?<Q28T0 -DL!/9LY"RXWN.@)):#4
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M6;IL85U"@%.R_?U:@J5KN$=!9J2S1-!0$W]"3",UV3,!K:\-4_G PSB5J(%
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M%,<MF4+N <MWP9-P0F5EE#=G?J,;0<JI5$XIB/F!F:W]1415WRL>*. ^@S^
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M]YC*7/I*6\'AM=Q-66_YQXVO_8=Z9]^61Q=*]/FV45,TAEY$2T. G5B:(SA
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MX!06K' (P=W=$MS=]9&<G;W/O7O?(_>=]_<^X&.V^;':6G..T7L??8RRUD6
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MGR'P=OJF(4<P\WH$!<\W6\L;"[^WIFW;75I4,(KG;'M:98*.5'5"#Z1NC>U
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MLRWHJL[%J[.MIGAQL7OT!U7PZJIS491=V/J."]XZ.-F'N;UP^UO3T-]ZT'[
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M2@ZA/<=+<*3/K@E:N>VORPIZN(C(KW^O=%0;8'(XH6L_5=81M'QB8%V!YYM
M4TGG!T^"&T-GT+]D5;2VBISS,+PJ;_,W9WC2R'#IX)1X5:?'A$'>5 Y8X46
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M3Q"DO1.\QK_,S?UD2M3/9V2)ZEXSC[BKX4E H>*/'>\ #H<XH5%GT.) [CW
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MO^?S^8RKA%*:::[G+(289'K1+YF C.NMO\1FX:]L#J+&5GQJ9UQ?C Q V_1
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M1LJ49E*"U28EF-":.B9&.PRFW6[P<H"&W@:NDZ49%:\Z)P;#R:MKI%]HW5U
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MQTK +*)F'16P@.$88V9U@NLD=6JDLEV_ZG[Y]#1OEL=T#MY0_1R7>B,GI3E
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MH;7MG_I@A66D[4@013 (5&B..P.8,2Y@0).4,2Y%K+%T*D-S(9KC%)\Q&9P
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MC+' 'IAA5F: QHXKL+*DP?X9&&.,]V%;K&AES[:[HG]G;A_(^JIN=(DJX]9
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MJX"+[)%]!WK LN],T*>1G@DH.P?#=M<FFRQWGV0]$R(F+ @)5"C-3!)9!+.
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M<8/25;2G"E%?$GVI#X IK)IM='\3E-'UOZ>)T'C\&G3"-1ZWCTSLQF>@8YC
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M0);H]/,'5B<R<G9?I,CLMH^?DWR>S_1:FUY?:__V/H$I*3G/$U!BF*BY">*
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M\UPVV19ULL6NROS7UY56F.\)<MS\]2)F2[&3"1M+EB0H+8$L"06P3$J 6"J
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M)Y?B@S0\W,)]2-RVEOF#-N0V^=G:;OBL&O\AU*!-2\E0AD$94PI@R@C &>&
M)#')F,B2/+5*"C[4R-C&W>W=KU^HF E9K9;_<!&Z. AJ662%X%D"DK*4"E1]
MTI<E:NI8\A2G5&1%7$Y4F$?G0\':;RP<L(UA/%K-&]VDSF /D)I-]RZ%*7!
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MEH<YD(RI"2#AD HKI87])L8VMZN3I'2*V4699!H[,TZX#)' ++"3,:;BG5/
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MC"/6;JTX'+OFLG-U3_.V_&<G""Z6=V)U+_7!L*XPZ"0K1)'"- 48ECF F#%
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M=47@^*,O-+=-^QO/(OI^6)!.>W;5_$_4=>?#Z>ZTG@Z&P-W3'-*K:8-./$.
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M'7N-"_;(5*:-;V[D=>:;J-4/QH.H7+V)=DX<JO".06[^((;2\' W8%IM#V^
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M_K<P.<<1>E^8+!%B*!D4=Q$\'2 HZ+B,PK/G<_FVP<Y:A T!2SL!8-:U- 8
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M]A7GRQ\?)X'8,<W5^/]:]2-9:Z-(Q-:D&[#1*U">;/Y@8X:(.C/G%<_QN49
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M!@#%+?S@6[J=<6(JRP4,FAJQ21Z<]P%60S(9>A-M:V6X$\&#"65T!];]"70
MZ+WO9-_:24EDQ#+'(<F0Z2(PF3QN*4 S%;*),2&VCMT^3<U@(AQ=.QL[BV(
MH+JUB1%7F0M%ZCN5.IV/W"*(09%R%RJ1IL\Z-"^:N;7\8((<>TG5V8C9 XAU
MU*;)X]7=O[('KI1LJEM)+ IG:J^\3$!7RA;P*1@H4HA28HGRV?$66[76>9J<
M?I-2]X*C5L(8@/YYAD/.1(U1,/"![$H5LP$ON(3 T5J#-CMLG6.S8YYJ^Y'.
M>X55(UD, %6W6KQ?])N2-D2II(*DG8?Z* $1R6\Q/#/M,+L06F/I/@U]]QML
M(]M'--'6C!X 4 YR7B5[A\G',,[OIV_"US%=F;>V-?*H<ZK)BBQJ.E'!D8-0
M<\"ES[6N &-H'I)XF:J^T^8[ 5-C80P!7BF=GYVO,A=7+D,=33+'+TB.Z3>\
MB.]]F"UJ5.^XG(;O(YV84O6X1&X=*!0.8O'51O0^\12X4:U##!N2V&^4ORO@
M=2BF :#P$R[#>(KY,,RG9"@N;FWW+99Q&B]''%-VBHP%@R*2-R+);&#DET@7
MLRU&<]&\L/EEJOJ-]7>$M<;"& "\'C)JI+AF63E=(VN)/)&2P6NNR!.I5=L,
MN6K>T? A%?T&ZSN"SX[,'D DX2579F0$%BV,@X">3$C!"MWQPD(0):> ,FC9
MNJW82S2M9[O_:>K(=I=+,YSU/-'@XTH^7W Y3F%R=W.MQAO<7:*760?/['*?
M@P^"%2(5C&!<;7OG66T/;6OO*>$MDSD1Q)K?&GL8?#"9S/ZH/4/?S>9O9^=Q
M6<XG#YL:7^7 11<-(V\9G,^%'.A 'H[,$7P,S@M!9@%OWDUZ$P+[#F,TQM$#
M5Z S80W 4KMC:Q(1Q+W*./IZ@BL.3O/!69W-_M^KGS_977 DR )EW$E@098:
M:0X0')DQY XIJ2W:I%L7K+6BO>_(2=?X[4/$KWA^T<DI_?G;X='IR?&[XX^'
MGPY.W]/?-KOIG_CX?=WRZ^RNT0U_$2:YQO<UF)FQW&<=@'M%$/;5F;5HP"+/
MP87DN6GM"CY!RNYAE&\X/<=W=*CKDUO]R+^/EU_>G"^6M-R<CE(^3_40G>#\
MVSCA867LHO8Q^S!>T(%BJJ AKR]S*VLMA"9&> TB,<4\II)4ZS*HW2CN]Z9O
M@:>'L9>]27  M_T+NSW\GB;G=>9Q;7Y$_\LULNE**0XU@E<J@6+9@4>O@'Z<
M=-+%AN9U4EN0V>\=W@,R=Y;5 .!XG3Q_F3QZT[G+V2@X<E/[==6\A60@B!R
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MZT;&6N=#EE!"8K6-E >/O$ .1),0&45I#;/G*>HW/MTMQAK*8E> -;KRKJS
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MG2V=SC;E9G1.L: ,:%%?N4SMM*^*A%AGQB"=5BE;%R=UL8^>>]GO%\6] V$
MAV&M08X&2R@J%Y#&^GH/10C)(:24./)<F..M8X3-!FMVIG+[1\\V,SDW$67?
M,SF?&V!+^UJ].!U,R&(*TX2+D47N@^*,SGX=%)!1$]N*@!*EDJ+V+70O>C-;
MK-NORAP,"KN6V" "DV\O%WZJSWHBRUQ4=MG@B7'6&@A6!(B!&\=8[:K:>CS#
M"R3UFS\W&'1V(<"^U>,UCS[4\-KE1HYFT\K/4<C:19T2B%"?*W5.M1C20R$
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M]@;)-D(;!"#79^6(#'&9$A>$&QM !4X6<J%OF5)11^<RLZTK8=:G;I!V9%>
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MH,)!14N7&L$1LA<Z6:^LQ]9USWO28V_'B_#Y\[Q:\ZNA8)?+WFN16%1 QI*
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MUP+#$POTG+C6!@<MF-=S8\B/\UD^3\OC^647G<M$<J4C9QZ*)$]/N:(A1&,
MN9"V*,Z*6LNJ?:$_Y&-K]XN+YE9&$Q8/ R*UO=-5JZ7+@Q-ET('94CLKD2$O
M1*RCVR/DHJR)3##+UGH^70\G#PGHKYGL[C)]") =&=RW;7&*9U]G\S#_<:4,
MK_9R=2_FZ!TWI ^=3=7BHKU(P<$+%-85ZP)?+^'GA85Z!\6N<IQUQ-2^ ;(:
MQGB/_E)G?=*-2/1'TJFQ7L*U55NQJACKB^1<KP6*1SZ\OX[#'0!A5^8-P#E]
MXG+]<)TIX*Q3)L<(FAORR7RJ(2%2HCR%2%>L-BA:9Y>^1%._:8.=!3V:BF(
MT'HA\GCX/4W.<TV+7"R0_I=/P_<1:J%%[5F!JOIIG/2G1YX@9W2E,%^*;-V
M;PLR!QEUVQ(GFSV>[RRTU_$0=?#F7W]_?[)ZQSG9YNWISK_OX+GI:?H:O3!=
MA>?>S,[B>'H![6FN0E\>I/\Z'R]6(ZMNVC1HJWWP$B379/9HC^!#<E K%[D3
M+.K.TN[6H[!5JN&MU>@8ILEL<3Z_,U70:E<+-6-B$516HB91*LAHK6<Q%,%:
MJZ_U*.M78W6(IJ>2$QL*ZO6IK.V3?A[YE([55X>)/AO"3KJ27)T\7TK-V+"*
M5<N=0PIH,AENGH?6U<3[56*W*X/3[/-T_-^8WV<2Z+B,\6+5Q6I9 GAM&SX.
M<3Q933>GOSL_JY?]G024&!+Y.KH0KZJQ*WT IU0&'K7BFHZ1$EWV-&JPA5>E
M%C?!YW.]D/8M^M>G/UN/)UW[LSO6M7L?-;HIPIG,N*J#<_56EMR"M_25]RPX
MBT((U_IMO"\-?+7NK446O_RX]=U%/,&1JQ8LV2EF-4A3)3*%DK-0HD@"F8UJ
MO4>?K53L>C2^+AVZ <*>UJ$="&\ \9I'=K5Z06%9EE+;>Q<K2.'7'J8^% 0K
M F8>?#+8^II_@I2A-)'K0OY/^#&["&.@F+HP,_ R^"YD-DJ2ZV5K2V\E3":K
M)FE@SA:N:BF];%TV_")1PU!I.XE^#3AM+X>^'ZU.<()I21;L-%V^NGB=%.>H
M@.5:RB-3(,]>:=I'Q$!GD$OWHI7V^$</#PL[R&W6C(E]0^#OL_E_D@F;\&0V
M.5\IX%_GL_.O-YO1M865X@XDUOX<J;9<1"8@:<9$S#:$&-9"Q$LK]9L<TR%
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M+#+!+1I%L"AU-K>AM3%'?Y5%)HR<.]':T=J&OOY.GX?#71,9C7WP='MA5Q,
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M=C#&[$M\Q][&-GA[TJH?5+A]>1JKI;\^#XO%:MB\M,%:IBA618Q04\(@9A3
M0ST+QZ3D_9ZE+5V+N\1T@KK#@N-IQV,/2?4$N4MV/N7!_SZ=Q07._ZB,>S?]
M<;&DKV?3VF=^)?C;7%C/%1<I<[32@%")/"XD!R\:94%Z3%9$*[D>V*XV6TLG
M@-\/:L_;V''D/O8,N]_6[WP]^_X#IXO5DM:S[#$:'R1/8*,WH#+6FR9!JY+&
M<1:SR3&\Y >_\(Y.8#4J &;MI=&347WU\R83]UIM*;!%+J6CQ5Q.W*" UY@
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MM-G6_?ZZ;D9KFZ6-%#=SLQHBH"!JB6 P",^ES.VO<+8D<=S)VP<_=!U ;AW
MLEZ<WY2A7"_VS'*6T-H()=?;D!JKN*ARS615$;F0K'GWVB=(Z>3(:PCQS]K+
MHN%$W#T2Z.HN<%JNKMD>5IP6KH(/2I-"KMKYI +!1@>9:VY02XVZ=>G[2S0=
M0WIF&Y@UE4X')NS*ZW@]^QXGTY7(7L^F=? ?,9X^+29Y-0BPUOY=S8JL%4G9
MD4J95"RHVO8IU RD&))(3J!+JG69S0YD'D,.3AM,#BW#8QD4_OG+Z>O_^]?3
M][^]^?3YS7_\_N[+?]Y=P6:EMX\\98!JV)=H;52@^H8"B.7/Z_+"$C-+VG P
M/G,R3G4$5@Z$LJ*4$24)VBQ;GT'?H6#_H9[$Q6^S<P+T8OWD:5[]XRIMY&K8
M\LV($2VT=HGTRGM/*[84]09G:PV&QAS(!U"I]8JWI7%<'VT/A#P<"#J@<(ZC
MU<!#M=Y]'-N3SSJ(.1IP$-L]R%$8*3 K"5;4P]'("0"YCAI*->M82#2E^<58
M6Z-T/8=K!?98P7Z[9>8GI/=,Z@',YR7!GI3BWK_\/ITL%R>)G .BZMY8+F32
M6RXU<*Q9EZF.[/"1 ?..%>](&KFUMS_D>KHR=ML@[^GA:R,+_5@-XTG.JT/.
MVLFCS.;?5R_<HV7*EF\XB!'=?(W#F%;MC6*9<Z@#_$ )X<&I6,M^* I%-%%G
M?4RF]=5]+3N9SP.%.2N_XM7/![[&R3_#/%\>8R+]+Y9<JV,R,<#9 CXD#IE4
MC0>*>I09;H;EGL1W932WP=0+1O- XNS@F.4SB6NUK$MFUC7/IG65J^MA(R5J
M:SUYV;5#J!$!?/8:K.5."H.EI-9ID\\2-"[>1@+)?:@VDU@'\+NWAJNBC2Q<
M<B:NFK:3_HIZE<@M2.Z3RZ&P4EK7]C]*R,AP:R?H^\EF>W.] ^@0^=]GTY7'
MNKX[EHR9G+0#G@R25K%2Q_X4,*Q$BUJ*S)K7Q]TGHH<=<2_!WD^4W8O+'<#D
MXWF8?@C?+QL:,*Z,4\5#T,& *N0=.(I:P 2KLQ<Z<-NZ6/OV^\>]C>IC^]I9
M'AUAZ2KMA=L2:__T%)P"9:VE=10'+&6CR>5T6?.!T-3#_K2[))^ Q YL'3L+
M[/3[=!(O%G4%UPTM@HS,%T#&*0JIAR->(H-D"]E&HQ6[OPD]D07VX-%]2'L7
M(<V:<6Q$>2_FR[-/U4"N\!Y,=(:I!#&%3'NJ3K0+TOJ3Y5ZQ9*6P&^D^/?66
MWM/?;G3^S@O'O30>=^O8G?,]P.4JL9'G;(U,H 33A'*NP#EAP6GGI2>6N,V<
MTTT ,Z:]V$-8]\6] ^=&%OC?)M/)]XOO5PT",#!II*[^L:ME.K+V'O! _Q=>
MD*/LS49E""^(_,Y+1Q;Z+B*;M>#?R(+_,EE6Z_ANFB=_3/)%N&P76I1*S/$,
M6$0]D8QD[(QSM #Z A4O(K70^4=?/F[SA/$WC/TETAND_C%9?ON$YY?3$+Y-
M?GR9O:FI6U>=3IQ GC $T,R1!Y[JK)N<8_VK9<(4]'&C^]AMP?8\6>/9HP8
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M:(==APD4?IPI5EBQ,8+D-27-& XQ& \FT\[J$HM<M+8]FU/7KR7:!B_W+=%
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MES9+TWKV30NZQ[69A\;L?;-Z<,D/;X'77]0_:N_P__.__C]02P,$%     @
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M,"YH=&U02P$"% ,4    "  H3 15=$7R6Z,1  #AKP  $0
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M>#(N:'1M4$L! A0#%     @ *$P$5016_;]U!0  5Q,  !H
M ( !8RD) &-C<FXR,#(R,#8S,"TQ,'%E>#,R>#$N:'1M4$L! A0#%     @
M*$P$57TG]KV+!0  UA,  !H              ( !$"\) &-C<FXR,#(R,#8S
E,"TQ,'%E>#,R>#(N:'1M4$L%!@     +  L [ (  -,T"0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
